sample_id,temperature,variation_id,label,source_text,variation_text,delta_score_2gram,delta_entropy_2gram,delta_variance_2gram,delta_score_3gram,delta_entropy_3gram,delta_variance_3gram,delta_score_4gram,delta_entropy_4gram,delta_variance_4gram,delta_score_5gram,delta_entropy_5gram,delta_variance_5gram
0,1.1,1,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Does losing consciousness indicate neuropsychological impairments after a concussion? There's evidence suggesting that loss of consciousness could predict neuropsychological deficits post-concussion, but more studies are necessary to clarify this relationship.",3.079176455639091e-07,0.30435977110071066,0.047500000000000014,0.023574544042164393,0.34755549894081383,0.024375,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
0,1.1,2,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Is loss of consciousness a predictor of neuropsychological decline following a concussion? Some evidence supports that it may indicate neuropsychological deficits after concussion, though additional research is required to understand this link fully.",2.3685972735685321e-07,0.20591969828745738,0.047500000000000014,0.018134264647818754,0.24577280463087137,0.024375,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
0,1.1,3,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Can loss of consciousness forecast neuropsychological problems after a concussion? Evidence suggests it might be a predictor of such deficits, but further investigation is needed to confirm the connection.",3.316036182995944e-07,0.33945109091197967,0.047500000000000014,0.025387970506946272,0.3839231431116885,0.024375,0.025351221573340195,0.43078291609245367,0.0,3.316036182995957e-07,0.4446858212614444,0.0
0,1.1,4,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Does experiencing loss of consciousness signal neuropsychological deficits after a concussion? Current evidence points to it possibly predicting these deficits, with more research needed to establish the relationship.",3.552895910352797e-07,0.37581873508285435,0.047500000000000014,0.027201396971728152,0.4216634710945355,0.024375,0.02716202311429307,0.47000362924573613,0.0,3.552895910352811e-07,0.4855078157816992,0.0
0,1.1,5,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Is there a correlation between loss of consciousness and neuropsychological declines after concussion? Some data indicate loss of consciousness may predict such declines, but more research is required to comprehend the association.",2.605457000925385e-07,0.3271067424807397,0.016709274673008298,0.019947691112600634,0.3247724394911926,0.008918697978596915,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
0,1.1,6,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Does loss of consciousness serve as an indicator of neuropsychological issues following a concussion? Evidence indicates it might, however, further study is necessary to fully understand this.",3.78975563770965e-07,0.41355906306570134,0.047500000000000014,0.02901482343651003,0.46088418424781796,0.024375,0.028972824655245942,0.5108256237659909,0.0,3.789755637709665e-07,0.5280674302004948,0.0
0,1.1,7,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Can loss of consciousness be used to predict neuropsychological decrement after concussion? Available evidence supports this idea, yet more research is essential for a complete understanding.",4.026615365066503e-07,0.4527797762189838,0.047500000000000014,0.03082824990129191,0.5017061787680728,0.024375,0.030783626196198816,0.5533852381847866,0.0,4.026615365066519e-07,0.5725191927713289,0.0
0,1.1,8,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Does loss of consciousness predict neuropsychological impairments post-concussion? There is some evidence suggesting this, but further research is needed to delineate their relationship.",4.737194547137062e-07,0.5806131477288683,0.047500000000000014,0.03626852929563755,0.6352375713925964,0.024375,0.036216030819057436,0.6931471805599458,0.0,4.73719454713708e-07,0.7191226669632043,0.0
0,1.1,9,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Is loss of consciousness a reliable predictor of neuropsychological deficits after concussion? Evidence hints at this possibility, though more comprehensive research is needed.",4.737194547137062e-07,0.5806131477288683,0.047500000000000014,0.03626852929563755,0.6352375713925964,0.024375,0.036216030819057436,0.6931471805599458,0.0,4.73719454713708e-07,0.7191226669632043,0.0
0,1.1,10,ai,"Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: There is evidence to suggest that loss of consciousness may be a predictor of neuropsychological deficits following a concussion, however, further research is needed to fully understand the relationship between these factors.","Does loss of consciousness indicate neuropsychological deficits following concussion? There is supporting evidence for this, but additional research is necessary to clearly understand how they are related.",3.78975563770965e-07,0.41355906306570134,0.047500000000000014,0.02901482343651003,0.46088418424781796,0.024375,0.028972824655245942,0.5108256237659909,0.0,3.789755637709665e-07,0.5280674302004948,0.0
1,1.1,1,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy feasible? Answer: This technique is a minimally invasive surgery that extracts the spleen via the stomach.,7.105791820705595e-08,0.0794882745003811,0.04338842975206613,0.005440279394345639,0.14660347419187536,0.0,0.005432404622858621,0.15415067982725672,0.0,7.105791820705606e-08,0.16251892949777424,0.0
1,1.1,2,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,"Question: Can transgastric endoscopic splenectomy be performed? Answer: Yes, it is a minimally invasive operation removing the spleen through the gastric route.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
1,1.1,3,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is it possible to perform a transgastric endoscopic splenectomy? Answer: The procedure is minimally invasive and entails spleen removal through the stomach.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,1.1,4,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Does transgastric endoscopic splenectomy work? Answer: It is a minimally intrusive method to remove the spleen by accessing it through the stomach.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,1.1,5,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Can the spleen be removed endoscopically through the stomach? Answer: Transgastric endoscopic splenectomy is a minimally invasive surgery for spleen removal via the stomach.,2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
1,1.1,6,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is transgastric endoscopic splenectomy achievable? Answer: This minimally invasive procedure removes the spleen through a stomach approach.,1.42115836414112e-07,0.24200720399815534,0.04338842975206613,0.01088055878869127,0.3184537311185345,0.0,0.010864809245717238,0.3364722366212112,0.0,1.4211583641411212e-07,0.356674943938732,0.0
1,1.1,7,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Can transgastric endoscopic splenectomy be done? Answer: It is a minimally invasive technique that accesses and removes the spleen through the stomach.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
1,1.1,8,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,"Question: Is transgastric endoscopic splenectomy a viable procedure? Answer: Yes, it involves extracting the spleen through the stomach with minimal invasiveness.",7.105791820705595e-08,0.0794882745003811,0.04338842975206613,0.005440279394345639,0.14660347419187536,0.0,0.005432404622858621,0.15415067982725672,0.0,7.105791820705606e-08,0.16251892949777424,0.0
1,1.1,9,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Is it possible to perform spleen removal using transgastric endoscopy? Answer: Transgastric endoscopic splenectomy is done minimally invasively by removing the spleen via the stomach.,4.73719454713706e-08,0.14365527681382861,0.04338842975206613,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
1,1.1,10,ai,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy is a minimally invasive procedure that involves removing the spleen through the stomach,Question: Does transgastric endoscopic splenectomy exist as a technique? Answer: It is a minimally invasive procedure for spleen removal performed through the stomach.,2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
2,1.1,1,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Do blood pressure readings in treated hypertensive patients vary based on whether the measurement is taken by a physician or a nurse? Answer: Blood pressure measurements in hypertensive patients may show minor differences depending on if a physician or nurse takes them, but these variations are usually minimal and not clinically important. Standardized procedures and precise techniques by both professionals ensure dependable results.",2.3685972735685406e-07,0.15938206949588452,0.008589853847582964,0.018134264647818782,0.15263723209175506,0.002238563958288614,0.01810801540952868,0.15180601286800588,0.0,2.3685972735685406e-07,0.15415067982725894,0.0
2,1.1,2,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Can the role of the measurer—physician versus nurse—influence blood pressure readings in patients undergoing hypertension treatment? Answer: While there might be slight discrepancies in blood pressure readings between physicians and nurses in treating hypertensive patients, these differences are typically insignificant clinically. Consistent use of standardized protocols and accurate methods by both professionals is crucial for reliable measurements.",3.789755637709665e-07,0.22008874586567106,0.019569053657384976,0.029014823436510018,0.2568155963805907,0.003965105965791263,0.02897282465524588,0.25534669180884517,0.0,3.789755637709665e-07,0.25951119548508306,0.0
2,1.1,3,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Does blood pressure measurement in hypertensive patients under treatment differ when taken by a doctor rather than a nurse? Answer: There can be modest differences in blood pressure readings taken by doctors versus nurses in treated hypertensive patients, but these are usually negligible in clinical terms. Ensuring both follow strict measurement standards and accurate techniques helps achieve reliable values.",3.316036182995957e-07,0.18395369157729125,0.020753804718741456,0.025387970506946272,0.19696902012075146,0.013886133703630229,0.025351221573340146,0.21962860920676608,0.0,3.316036182995957e-07,0.22314355131420882,0.0
2,1.1,4,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Question: Are blood pressure values affected by whether a physician or a nurse performs the measurement in hypertensive patients receiving treatment? Answer: Small variations in blood pressure readings between physicians and nurses may occur in treated hypertensive patients, but these are generally minimal and not of clinical significance. It's vital that both apply standardized protocols and precise measurement practices for trustworthy results.",2.6054570009253947e-07,0.10972330771708982,0.038485678309515735,0.019947691112600655,0.1465381664938601,0.013886133703630229,0.019918816950481547,0.16833531481921682,0.0,2.6054570009253947e-07,0.17095779814363965,0.0
2,1.1,5,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Does the healthcare professional type impact blood pressure measurements in patients with treated hypertension? Answer: Blood pressure measurements might differ slightly when taken by a physician versus a nurse in patients with treated hypertension, yet these differences usually hold no significant clinical weight. Adherence to standardized measurement protocols and accuracy by both practitioners is essential for consistent results.",3.552895910352811e-07,0.27356323032538743,0.030829282269932458,0.027201396971728145,0.28732362394419386,0.03858300209883889,0.027162023114293013,0.2620834427547365,0.017851239669421492,3.552895910352811e-07,0.2411620568168873,0.0
2,1.1,6,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Question: Is there a notable difference in blood pressure readings in treated hypertensive patients when measured by a physician compared to a nurse? Answer: Minor variations may exist between physician and nurse blood pressure readings in hypertensive patients under treatment, but these rarely amount to clinical importance. Both must follow reliable measurement protocols and techniques to ensure valid readings.",3.316036182995957e-07,0.23094672076779466,0.012827640557491048,0.025387970506946272,0.2447722739524716,0.020552641806573863,0.025351221573340146,0.24394956291062364,0.017538265306122455,3.316036182995957e-07,0.22314355131420882,0.0
2,1.1,7,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Are treated hypertensive patients’ blood pressure readings influenced by whether a doctor or nurse measures it? Answer: Although slight discrepancies can occur between blood pressure measurements taken by doctors or nurses in treated hypertensive patients, these differences are usually minimal and clinically insignificant. Standardized measurement guidelines and accurate methods performed by both professionals are key for reliability.",3.789755637709665e-07,0.22008874586567106,0.019569053657384976,0.029014823436510018,0.2320603399320209,0.013886133703630229,0.02897282465524588,0.25534669180884517,0.0,3.789755637709665e-07,0.25951119548508306,0.0
2,1.1,8,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Question: Does the professional conducting blood pressure measurement affect readings in treated hypertensive individuals? Answer: Blood pressure readings in treated hypertensive patients may show small differences depending on whether a nurse or physician measures them, but such differences generally lack significant clinical impact. Ensuring both medical staff follow standardized protocols and use correct measurement techniques is important for dependable results.",3.079176455639103e-07,0.212573168145064,0.011716154640810293,0.0235745440421644,0.22686761595195648,0.019970437549062896,0.02354042003238728,0.2261384934107573,0.017236072637734686,3.079176455639103e-07,0.2054439742148082,0.0
2,1.1,9,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Are there differences in blood pressure measurements in treated hypertensive patients depending on if a nurse or a physician takes the reading? Answer: There can be slight, generally non-clinically significant variations in blood pressure measurements taken by nurses versus physicians in treated hypertensive patients. It is crucial for both to utilize standardized protocols and accurate measurement procedures to guarantee reliable outcomes.",2.8423167282822487e-07,0.21725492745689046,0.026703399538769483,0.021761117577382527,0.23238218650106468,0.03597536214124511,0.021729618491434413,0.2086389477308499,0.01694411414982164,2.8423167282822487e-07,0.18805223150293937,0.0
2,1.1,10,ai,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: There may be slight variations in blood pressure measurements between physicians and nurses when treating hypertensive patients, but these differences are generally considered to be minimal and not clinically significant. It is important to ensure that both physicians and nurses follow standardized protocols and use accurate measurement techniques to obtain reliable readings.","Question: Does the individual performing blood pressure measurements influence the readings in treated hypertensive patients? Answer: Minor deviations in blood pressure results between physicians and nurses may occur in patients treated for hypertension, though these are normally clinically insignificant. Following uniform protocols and accurate measurement techniques by both ensures consistent and trustworthy readings.",4.974054274493935e-07,0.28991389465569073,0.03538700034667487,0.03808195576041938,0.3255863979428453,0.013886133703630229,0.03802683236001021,0.35065687161317083,0.0,4.974054274493935e-07,0.35667494393873156,0.0
3,1.1,1,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are we overlooking any prognostic indicators? Answer: We present for the first time the etiology of ESLD as a prognostic factor for survival. Renal function (measured by serum creatinine) and urinary Na (<5 mEq/l) at diagnosis were linked with outcomes.,9.474389094274162e-08,0.09097177820572666,0.0,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
3,1.1,2,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: might we be missing certain prognostic factors? Answer: This study reports for the first time that ESLD etiology serves as a prognostic factor for survival. Renal function, represented by serum creatinine, and urinary sodium below 5 mEq/l at diagnosis were associated with survival.",2.3685972735685406e-08,0.021978906718775004,0.0,0.0018134264647818726,0.022472855852057716,0.0,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
3,1.1,3,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: are there unrecognized prognostic factors? Answer: We identify ESLD etiology as a prognostic survivability factor for the first time. Renal function indicated by serum creatinine levels and urinary Na under 5 mEq/l at diagnosis correlated with prognosis.,1.6580180914979774e-07,0.1650797503594501,0.0,0.012693985253473108,0.16907633004393308,0.0,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
3,1.1,4,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: could we be neglecting some prognostic factors? Answer: For the first time, we report ESLD etiology as a survival prognostic factor. Serum creatinine levels and urinary sodium (<5 mEq/l) at diagnosis were found to be associated with renal function and survival.",7.105791820705622e-08,0.06744128079553224,0.0,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
3,1.1,5,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are prognostic factors missing? Answer: We newly identify ESLD etiology as a key prognostic factor for survival. Renal function, expressed by serum creatinine, alongside urinary Na less than 5 mEq/l at diagnosis, was linked to outcomes.",1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
3,1.1,6,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: might certain prognostic factors be overlooked? Answer: This report highlights ESLD etiology for the first time as a prognostic factor of survival. Renal function, based on serum creatinine, and urinary sodium concentration below 5 mEq/l at diagnosis showed associations with prognosis.",7.105791820705622e-08,0.06744128079553224,0.0,0.005440279394345618,0.06899287148695166,0.0,0.0054324046228586,0.07061756721395396,0.0,7.105791820705622e-08,0.07232066157962613,0.0
3,1.1,7,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: are some prognostic factors being missed? Answer: We document for the first time that ESLD etiology influences survival as a prognostic factor. Renal function, monitored by serum creatinine, and urinary Na under 5 mEq/l at diagnosis were connected to outcomes.",9.474389094274162e-08,0.09097177820572666,0.0,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
3,1.1,8,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: could prognostic factors be unrecognized? Answer: We report ESLD etiology as a novel prognostic indicator for survival. Renal function, represented by serum creatinine levels and urinary Na below 5 mEq/l at diagnosis, correlated with prognostic outcomes.",1.8948778188548304e-07,0.19105523676270808,0.0,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
3,1.1,9,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,Question: Hepatorenal syndrome: is there a chance prognostic factors have been missed? Answer: We reveal for the first time the role of ESLD etiology as a survival prognostic factor. Kidney function (serum creatinine) and urinary sodium levels less than 5 mEq/l at diagnosis related to disease prognosis.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
3,1.1,10,human,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: We report for the first time ESLD etiology as a prognostic factor for survival. The renal function (expressed as serum creatinine) and urinary Na (<5 mEq/l) at the time of diagnosis were found to be associated with,"Question: Hepatorenal syndrome: have we neglected some prognostic factors? Answer: For the first time, we show that ESLD etiology acts as a prognostic factor in survival. Renal function assessed by serum creatinine and urinary Na below 5 mEq/l at diagnosis was associated with survival outcomes.",4.737194547137081e-08,0.04445176257083272,0.0,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
4,1.1,1,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Evidence indicates that aripiprazole, a drug prescribed for schizophrenia and bipolar disorder, might contribute to pathological gambling. Further",1.421158364141118e-07,0.07464393536034253,0.09000000000000004,0.010880558788691277,0.12099596720824968,0.06222222222222223,0.010864809245717241,0.17039220667759558,0.0322222222222222,1.4211583641411244e-07,0.2231435513142097,0.0
4,1.1,2,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Could aripiprazole be a new risk factor for pathological gambling? Answer: Research suggests that aripiprazole, used in treating schizophrenia and bipolar disorder, may increase the risk of pathological gambling. Further",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
4,1.1,3,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Is aripiprazole a novel risk factor for pathological gambling? Answer: There is data implying that aripiprazole, employed to manage schizophrenia and bipolar disorder, could be linked to pathological gambling. Further",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
4,1.1,4,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Does aripiprazole represent a new risk factor for pathological gambling? Answer: Studies show that aripiprazole, which treats schizophrenia and bipolar disorder, might be associated with pathological gambling. Further",1.184298636784265e-07,0.03827629118946785,0.09000000000000004,0.009067132323909398,0.08325563922540269,0.06222222222222223,0.009054007704764368,0.13117149352431312,0.0322222222222222,1.1842986367842703e-07,0.1823215567939549,0.0
4,1.1,5,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Aripiprazole as a new risk factor for pathological gambling? Answer: Evidence points to aripiprazole, a medication for schizophrenia and bipolar disorder, as a potential contributor to pathological gambling. Further",9.47438909427412e-08,0.05098822520991897,0.055561224489795946,0.007253705859127518,0.04688799505452801,0.06222222222222223,0.007243206163811494,0.09343116554146613,0.0322222222222222,9.474389094274162e-08,0.14310084364067244,0.0
4,1.1,6,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Can aripiprazole be considered a new risk factor for pathological gambling? Answer: There is information indicating that aripiprazole, prescribed for schizophrenia and bipolar disorder, may increase pathological gambling risk. Further",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
4,1.1,7,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Investigating aripiprazole as a new risk factor for pathological gambling? Answer: Findings suggest aripiprazole, used in schizophrenia and bipolar disorder treatment, could be implicated in pathological gambling. Further",1.184298636784265e-07,0.03827629118946785,0.09000000000000004,0.009067132323909398,0.08325563922540269,0.06222222222222223,0.009054007704764368,0.13117149352431312,0.0322222222222222,1.1842986367842703e-07,0.1823215567939549,0.0
4,1.1,8,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Is there a link between aripiprazole and pathological gambling as a new risk factor? Answer: Evidence suggests aripiprazole, a drug for schizophrenia and bipolar disorder, might elevate the risk of pathological gambling. Further",0.0,0.12602676010180813,0.09000000000000004,0.0,0.08664339756999428,0.06222222222222223,0.0,0.044719172939351015,0.0322222222222222,0.0,0.0,0.0
4,1.1,9,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Aripiprazole and pathological gambling: a new risk factor? Answer: Research data implies that aripiprazole, employed in treating schizophrenia and bipolar disorder, may contribute to the onset of pathological gambling. Further",7.10579182070559e-08,0.03071658029748292,0.09000000000000004,0.005440279394345639,0.011796675243259003,0.06222222222222223,0.005432404622858621,0.05706352137059145,0.0322222222222222,7.105791820705622e-08,0.10536051565782545,0.0
4,1.1,10,ai,"Question: Aripiprazole: a new risk factor for pathological gambling? Answer: There is evidence suggesting that aripiprazole, a medication used to treat schizophrenia and bipolar disorder, may be a risk factor for pathological gambling. Further","Question: Might aripiprazole be a new risk factor for pathological gambling? Answer: There is suggestive evidence that aripiprazole, used to treat schizophrenia and bipolar disorder, could be involved in pathological gambling. Further",4.73719454713706e-08,0.06350640312047462,0.09000000000000004,0.003626852929563759,0.02210487643242276,0.06222222222222223,0.003621603081905747,0.021972201559322446,0.0322222222222222,4.737194547137081e-08,0.06899287148695077,0.0
5,1.1,1,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are there different risk levels for transitioning to psychosis within the Ultra High Risk (UHR) criteria? Yes, the UHR criteria identify different risk tiers, including basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher tiers indicating a greater risk of transition to psychosis.",4.263475092423373e-07,0.16573110857405204,0.14454023965808482,0.03264167636607371,0.18243952983011358,0.109375,0.0325944277371516,0.23114681877845067,0.08002462296091106,4.263475092423373e-07,0.2814953372771307,0.049048751486325794
5,1.1,2,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Does the Ultra High Risk (UHR) criteria include various levels of risk for psychosis transition? Yes, there are distinct risk levels such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, where higher levels correspond to a higher chance of developing psychosis.",4.737194547137081e-07,0.18141589329555963,0.16521368833930183,0.03626852929563745,0.22790190390687082,0.109375,0.03621603081905733,0.2776668344133446,0.08002462296091106,4.737194547137081e-07,0.32912338626638515,0.049048751486325794
5,1.1,3,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Within the Ultra High Risk (UHR) for psychosis framework, are there varying degrees of risk for transition? Yes, the UHR criteria categorize risk into levels like basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with increased risk levels indicating a greater probability of psychosis transition.",4.026615365066519e-07,0.11344686018298944,0.16666212876742884,0.030828249901291835,0.16046062311133857,0.109375,0.030783626196198732,0.20867396292639295,0.08002462296091106,4.026615365066519e-07,0.2585058190524312,0.049048751486325794
5,1.1,4,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Is there a range of risk levels under the Ultra High Risk (UHR) criteria for psychosis transition? Indeed, the UHR criteria define multiple risk levels including basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, where higher levels denote increased transition risk.",4.974054274493935e-07,0.23737752898875497,0.14152771759575472,0.038081955760419325,0.25143240131706523,0.109375,0.0380268323600102,0.3017643859924046,0.08002462296091106,4.974054274493935e-07,0.35381599885675685,0.049048751486325794
5,1.1,5,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are distinct risk categories acknowledged in the Ultra High Risk (UHR) criteria for psychosis development? Yes, these include stages such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with risk escalating across these categories.",6.395212638635056e-07,0.3606483397095457,0.16092249657064478,0.04896251454911056,0.40558308114432284,0.109375,0.0488916416057274,0.45998839120729906,0.08002462296091106,6.39521263863506e-07,0.5163349283545311,0.049048751486325794
5,1.1,6,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Do different risk stages exist within the Ultra High Risk (UHR) criteria for psychosis transition? Yes, the UHR framework identifies basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms as risk levels, with greater risk indicating a higher chance of conversion.",5.210914001850789e-07,0.19642921890500098,0.18792866941015093,0.0398953822252012,0.27552995289612525,0.109375,0.039837633900963065,0.3264569985827763,0.08002462296091106,5.210914001850789e-07,0.3791338068410486,0.049048751486325794
5,1.1,7,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Is risk of psychosis transition stratified within the Ultra High Risk (UHR) criteria? Yes, UHR criteria specify varying risk levels such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms; higher levels mean a larger likelihood of psychosis onset.",5.447773729207643e-07,0.25433882807235086,0.16355366941015093,0.04170880868998307,0.30022256548649695,0.109375,0.04164843544191593,0.35177480656706805,0.08002462296091106,5.447773729207643e-07,0.40510929324430656,0.049048751486325794
5,1.1,8,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Within the scope of Ultra High Risk (UHR) criteria, is there variability in risk levels for psychosis transition? Yes, different tiers like basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms exist, each associated with increasing probability of psychosis.",5.684633456564497e-07,0.2452193830744327,0.18792866941015093,0.04352223515476494,0.3255403734707887,0.109375,0.0434592369828688,0.37775029297032603,0.08002462296091106,5.684633456564497e-07,0.4317775403264674,0.049048751486325794
5,1.1,9,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Are there multiple layers of risk identified in the Ultra High Risk (UHR) for psychosis criteria? Yes, the criteria encompass basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, with higher layers indicating a higher likelihood of progressing to psychosis.",5.447773729207643e-07,0.25433882807235086,0.16355366941015093,0.04170880868998307,0.30022256548649695,0.109375,0.04164843544191593,0.35177480656706805,0.08002462296091106,5.447773729207643e-07,0.40510929324430656,0.049048751486325794
5,1.1,10,ai,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Yes, there are different levels of risk for transition to psychosis within the Ultra High Risk (UHR) criteria. These levels include basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms. The higher the level of risk, the greater the likelihood of transition to psychosis.","Does the Ultra High Risk (UHR) criteria differentiate between various levels of transition risk to psychosis? Yes, it includes levels such as basic symptoms, brief limited intermittent psychotic symptoms, and attenuated psychotic symptoms, where elevated levels correlate with increased transition risk.",5.684633456564497e-07,0.2798767421024291,0.16294510596504902,0.04352223515476494,0.3255403734707887,0.109375,0.0434592369828688,0.37775029297032603,0.08002462296091106,5.684633456564497e-07,0.4317775403264674,0.049048751486325794
6,1.1,1,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,Question: What is the most effective duration of acid suppression for the healing of Los Angeles grades C and D reflux oesophagitis? Answer: No clear consensus exists regarding the ideal length of acid suppression therapy to achieve maximal healing in Los Angeles grades C and D reflux oesophagitis; further studies are necessary.,2.6054570009253947e-07,0.03813433542565159,0.16236641478917227,0.0199476911126006,0.06118856177917298,0.12138071051423328,0.019918816950481533,0.08464209054685723,0.07901234567901237,2.6054570009253947e-07,0.10500771380580165,0.07003460207612461
6,1.1,2,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: Is there an optimum time period for acid suppression to maximize healing in Los Angeles grades C and D reflux oesophagitis? Answer: Currently, there is no agreement on the best duration of acid suppression for optimal healing of Los Angeles grades C and D reflux oesophagitis, and additional research is required.",2.6054570009253947e-07,0.010952093050752065,0.1800186301926291,0.0199476911126006,0.033462674556774985,0.14038387345679013,0.019918816950481533,0.08464209054685723,0.07901234567901237,2.6054570009253947e-07,0.10500771380580165,0.07003460207612461
6,1.1,3,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: For Los Angeles grades C and D reflux oesophagitis, what is the recommended acid suppression duration to achieve maximum healing? Answer: At present, no consensus has been reached on the optimal acid suppression timeframe for maximal healing of Los Angeles grades C and D reflux oesophagitis, and further investigation is needed.",2.6054570009253947e-07,0.03813433542565159,0.16236641478917227,0.0199476911126006,0.061188561779172534,0.12138071051423331,0.019918816950481533,0.11293381220236531,0.05927685950413231,2.6054570009253947e-07,0.13388884632913278,0.049612196199173245
6,1.1,4,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,Question: Can the healing of Los Angeles grades C and D reflux oesophagitis be optimized by a specific duration of acid suppression? Answer: There is no established consensus to date on the ideal acid suppression duration for maximal healing of Los Angeles grades C and D reflux oesophagitis; more research is warranted.,2.6054570009253947e-07,0.03813433542565159,0.16236641478917227,0.0199476911126006,0.08891444900157008,0.1028594191304609,0.019918816950481533,0.1412255338578734,0.039935100054083336,2.6054570009253947e-07,0.16276997885246391,0.029498576596886594
6,1.1,5,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,Question: What is the optimal acid suppression time to maximize healing in Los Angeles grades C and D reflux oesophagitis? Answer: The current medical consensus has not defined the optimal time for acid suppression to achieve maximal healing in Los Angeles grades C and D reflux oesophagitis and further studies are necessary.,2.6054570009253947e-07,0.09249882017545064,0.12938558266582245,0.0199476911126006,0.08891444900157008,0.1028594191304609,0.019918816950481533,0.1412255338578734,0.039935100054083336,2.6054570009253947e-07,0.16276997885246391,0.029498576596886594
6,1.1,6,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: Does an optimal time exist for acid suppression to treat Los Angeles grades C and D reflux oesophagitis most effectively? Answer: Presently, there is no consensus on the best duration of acid suppression to maximize healing for Los Angeles grades C and D reflux oesophagitis, warranting additional research.",3.316036182995957e-07,0.11235007842953593,0.15379962192816624,0.025387970506946217,0.13368239039094432,0.11422366605525812,0.025351221573340132,0.15520144129591307,0.07383219954648527,3.316036182995957e-07,0.1753224614480393,0.06593029368610193
6,1.1,7,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: What duration of acid suppression best promotes healing in Los Angeles grades C and D reflux oesophagitis? Answer: There is no universally agreed upon optimal acid suppression duration for maximal healing of Los Angeles grades C and D reflux oesophagitis, highlighting the need for further study.",3.789755637709665e-07,0.13481847022340698,0.1665280900412498,0.029014823436509962,0.15422646089371028,0.12977430555555558,0.028972824655245866,0.20513262821899936,0.07000000000000003,3.789755637709665e-07,0.22508342269106052,0.06288182429834682
6,1.1,8,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,Question: Is there a recommended acid suppression timeframe that achieves maximal healing for Los Angeles grades C and D reflux oesophagitis? Answer: No consensus currently exists regarding the optimal acid suppression duration required for the maximal healing of Los Angeles grades C and D reflux oesophagitis; more research is needed.,3.079176455639103e-07,0.08701550428421578,0.15675024655636383,0.023574544042164344,0.08006089558169549,0.13639105785409536,0.023540420032387266,0.13113039914410818,0.07563007030827477,3.079176455639103e-07,0.15133443246677158,0.06735687838163507
6,1.1,9,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: How long should acid suppression be applied for effective healing of Los Angeles grades C and D reflux oesophagitis? Answer: The optimal duration of acid suppression for maximal healing in Los Angeles grades C and D reflux oesophagitis is not yet agreed upon, thus further investigation is necessary.",3.316036182995957e-07,0.0834689459062048,0.17221723049449583,0.025387970506946217,0.10418676568626584,0.13427402210884354,0.025351221573340132,0.15520144129591307,0.07383219954648527,3.316036182995957e-07,0.1753224614480393,0.06593029368610193
6,1.1,10,ai,Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: There is currently no consensus on the optimal time of acid suppression for maximal healing of Los Angeles grades C and D reflux oesophagitis. Further research is needed to determine the most effective duration of acid suppression,"Question: For maximizing healing in Los Angeles grades C and D reflux oesophagitis, is there an ideal period for acid suppression? Answer: Currently, no consensus has been achieved on the optimal time frame for acid suppression to maximize healing in Los Angeles grades C and D reflux oesophagitis, and additional research is needed.",2.3685972735685406e-07,0.06785338001548347,0.13239372623655632,0.018134264647818726,0.09248855014780455,0.08771609841656156,0.018108015409528666,0.1453537071640909,0.02371011357490535,2.3685972735685406e-07,0.167495358966121,0.01219192435243012
7,1.1,1,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to predict discordance between TEOAE and AABR results in newborns? With current screening methods, some healthy newborns whose mothers had prenatal care may inevitably have differing TEOAE and AABR outcomes due to specific types of hearing loss. This suggests that the limitations of using perinatal morbidity to guide targeted screening in these cases should be further investigated.",9.474389094274162e-08,0.07362193352346624,0.002455283499887863,0.0072537058591274906,0.07322945486480048,0.0012758533145614953,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
7,1.1,2,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can we foresee discordant TEOAE and AABR results in newborn hearing tests? Given the screening tools available, discordance between TEOAE and AABR may be unavoidable for certain hearing loss types in apparently healthy newborns whose mothers underwent prenatal care, indicating a need to explore the constraints of perinatal morbidity–based targeted screening.",1.1842986367842703e-07,0.10035125020839786,0.003618700802974578,0.009067132323909363,0.09978335231063973,0.0018873796032593745,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
7,1.1,3,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is the discordance between TEOAE and AABR outcomes in newborns predictable? Current screening technologies imply that for some types of hearing loss, discordance may be inevitable in newborns who seem healthy and had mothers with prenatal care, highlighting the need to further study the limitations of perinatal morbidity as a basis for targeted screening.",4.737194547137081e-08,0.012787065019247645,0.017450908007018855,0.0036268529295637453,0.012068210184330574,0.01851192595229618,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
7,1.1,4,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can one predict discordance in TEOAE and AABR tests in newborns? Based on existing screening technologies, discordance is sometimes unavoidable in cases of hearing loss among healthy newborns with mothers who received prenatal care, suggesting that the role of perinatal morbidity in targeted screening requires further examination.",2.1317375462116866e-07,0.1282810847026532,0.03631185475258099,0.016320838183036854,0.15664943899543893,0.01851192595229618,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
7,1.1,5,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it predictable when TEOAE and AABR outcomes will differ in newborns? With the current screening methods, discrepancies between these tests may be inevitable for certain hearing loss categories in apparently healthy newborns from pregnancies with prenatal care, warranting additional research on the limitations of perinatal morbidity for targeted screening.",1.4211583641411244e-07,0.06510218308112092,0.03631185475258099,0.010880558788691236,0.0921109178578674,0.01851192595229618,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
7,1.1,6,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Are discordant TEOAE and AABR results foreseeable in newborn hearing screenings? Considering screening technologies available, some discordance may be unavoidable in healthy newborns with mothers who obtained prenatal care for specific hearing loss types, suggesting a need to reassess perinatal morbidity as the foundation for targeted screening.",2.1317375462116866e-07,0.1282810847026532,0.03631185475258099,0.016320838183036854,0.15664943899543893,0.01851192595229618,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
7,1.1,7,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discordance in TEOAE and AABR outcomes be anticipated in newborns? The existing screening technology indicates that for certain kinds of hearing loss, discordant results might be inevitable in apparently healthy newborns whose mothers had prenatal care, emphasizing the importance of further study on perinatal morbidity's role in targeted screening.",1.4211583641411244e-07,0.06510218308112092,0.03631185475258099,0.010880558788691236,0.0921109178578674,0.01851192595229618,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
7,1.1,8,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is it possible to anticipate differences between TEOAE and AABR outcomes in newborn hearing assessments? Given the current screening methods, some discordance might be inevitable in newborns considered healthy and whose mothers received prenatal care, especially regarding some hearing loss types, pointing to the need for further investigation into perinatal morbidity as a basis for targeted screening.",2.3685972735685406e-08,0.06842920954340181,0.03631185475258099,0.0018134264647818726,0.04402125646671262,0.01851192595229618,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
7,1.1,9,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Can discrepancies in TEOAE and AABR results be predicted for newborns? The available screening technologies suggest that discordance may inevitably occur in some categories of hearing loss in apparently healthy newborns whose mothers underwent prenatal care, indicating further research is needed into the limitations of perinatal morbidity-driven targeted screening.",1.6580180914979784e-07,0.08572147028385668,0.03631185475258099,0.012693985253473108,0.11316432705570056,0.01851192595229618,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
7,1.1,10,human,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Given the available screening technologies, discordant TEOAE and AABR may be inevitable for some categories of hearing loss among apparently healthy newborns whose mothers received prenatal care. The potential limitations of perinatal morbidities as basis of targeted screening for such cases therefore merit further","Is predicting discordance between TEOAE and AABR in newborns possible? Current screening technologies imply such discordance could be inevitable for certain hearing loss categories among apparently healthy newborns with prenatal care histories, thus warranting more study about the constraints of perinatal morbidity as a targeted screening criterion.",2.1317375462116866e-07,0.1282810847026532,0.03631185475258099,0.016320838183036854,0.15664943899543893,0.01851192595229618,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
8,1.1,1,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This article examines the cultural suitability of the RAQ within Australian contexts and highlights the necessity for creating robust, inclusive recovery outcome measures.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,1.1,2,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.",The paper explores whether the RAQ is culturally appropriate in Australia and emphasizes developing comprehensive and inclusive recovery outcome metrics.,4.026615365066502e-07,0.6005717825918953,0.02775510204081633,0.030828249901291953,0.6649763035932486,0.0,0.030783626196198847,0.6931471805599458,0.0,4.0266153650665164e-07,0.7239188392266991,0.0
8,1.1,3,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Focusing on AU settings, this work critiques the RAQ’s cultural relevance and calls for development of rigorous, inclusive measures for recovery outcomes.",3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
8,1.1,4,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This study analyzes the cultural fit of the RAQ in Australian environments and stresses the importance of formulating strong, inclusive recovery outcome tools.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,1.1,5,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","An exploration of the RAQ’s cultural applicability in Australia, this paper underscores the need for rigorous and inclusive recovery assessment methods.",3.7897556377096486e-07,0.5492784882043451,0.02775510204081633,0.029014823436510073,0.6109090823229733,0.0,0.028972824655245977,0.635988766719997,0.0,3.789755637709663e-07,0.6632942174102641,0.0
8,1.1,6,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The discussion centers on the RAQ’s appropriateness across Australian cultures and advocates crafting robust, inclusive measures for recovery results.",4.2634750924233556e-07,0.6546390038621706,0.02775510204081633,0.03264167636607383,0.7221347174331973,0.0,0.032594427737151724,0.7537718023763809,0.0,4.26347509242337e-07,0.7884573603642697,0.0
8,1.1,7,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Examining the RAQ through the lens of Australian cultural contexts, the article points out the demand for inclusive, scientifically sound recovery outcome measures.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,1.1,8,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","This publication addresses whether the RAQ is culturally appropriate in Australia and suggests the creation of precise, inclusive metrics to gauge recovery outcomes.",3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
8,1.1,9,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","Cultural relevance of the RAQ in Australian settings is reviewed here, alongside the emphasis on developing rigorous and inclusive recovery outcome indicators.",3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
8,1.1,10,human,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: This paper discusses the cultural appropriateness of the RAQ in Australian settings, and identifies the need to develop rigorous, inclusive recovery outcome measures.","The research discusses the RAQ’s cultural suitability in Australian settings and highlights the urgent need to build inclusive, well-validated recovery outcome metrics.",3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
9,1.1,1,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Diffusion-weighted echo-planar MR imaging has the potential to forecast various histologic types of primary parotid gland tumors, although more research is necessary to confirm its clinical accuracy and dependability.",4.974054274493923e-07,0.3332820146913589,0.15704937537180247,0.03808195576041938,0.43095848228690636,0.10275824770146022,0.03802683236001026,0.5330598142792184,0.04246913580246913,4.974054274493935e-07,0.6097655716208945,0.0
9,1.1,2,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.",The use of diffusion-weighted echo-planar MR imaging might enable prediction of distinct histologic subtypes of primary parotid gland tumors but requires additional validation through further studies.,5.684633456564482e-07,0.446610699998363,0.15704937537180247,0.04352223515476502,0.5487415179432906,0.10275824770146022,0.04345923698286888,0.6556621363715514,0.04246913580246913,5.684633456564497e-07,0.737598943130779,0.0
9,1.1,3,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Primary parotid gland tumor subtypes may be predicted using diffusion-weighted echo-planar MR imaging; yet, further investigation is needed to establish its clinical reliability and validity.",5.921493183921335e-07,0.4874326945186178,0.15704937537180247,0.0453356616195469,0.5913011323620863,0.10275824770146022,0.045270038523821755,0.7001138989423854,0.04246913580246913,5.921493183921352e-07,0.784118958765673,0.0
9,1.1,4,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Diffusion-weighted echo-planar MR imaging shows promise in predicting different histologic subtypes of primary parotid gland tumors, but more clinical studies are essential for confirmation.",6.158352911278188e-07,0.5299923089374134,0.15704937537180247,0.04714908808432878,0.6357528949329203,0.10275824770146022,0.04708084006477463,0.7466339145772793,0.04246913580246913,6.158352911278206e-07,0.8329091229351042,0.0
9,1.1,5,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","Predicting histologic subtypes of primary parotid gland tumors via diffusion-weighted echo-planar MR imaging is possible, pending further research to verify its efficacy.",6.632072365991894e-07,0.6209640871431414,0.15704937537180247,0.05077594101389254,0.7310630747372455,0.10275824770146022,0.050702443146680376,0.8467173731342608,0.04246913580246913,6.632072365991912e-07,0.9382696385929297,0.0
9,1.1,6,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","There is potential for diffusion-weighted echo-planar MR imaging to distinguish histologic subtypes of primary parotid gland tumors, though comprehensive studies are required to confirm this applicability.",5.684633456564482e-07,0.446610699998363,0.15704937537180247,0.04352223515476502,0.5487415179432906,0.10275824770146022,0.04345923698286888,0.6556621363715514,0.04246913580246913,5.684633456564497e-07,0.737598943130779,0.0
9,1.1,7,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.",Diffusion-weighted echo-planar MR imaging could serve to predict various histologic types of primary parotid gland tumors if further clinical validation is conducted.,6.632072365991894e-07,0.6209640871431414,0.15704937537180247,0.05077594101389254,0.7310630747372455,0.10275824770146022,0.050702443146680376,0.8467173731342608,0.04246913580246913,6.632072365991912e-07,0.9382696385929297,0.0
9,1.1,8,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.",The prediction of different histologic subtypes in primary parotid gland tumors by diffusion-weighted echo-planar MR imaging is conceivable but still needs extensive research for clinical confirmation.,5.684633456564482e-07,0.446610699998363,0.15704937537180247,0.04352223515476502,0.5487415179432906,0.10275824770146022,0.04345923698286888,0.6556621363715514,0.04246913580246913,5.684633456564497e-07,0.737598943130779,0.0
9,1.1,9,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.",Using diffusion-weighted echo-planar MR imaging to anticipate different histologic subtypes of primary parotid gland tumors is promising; additional research is necessary to authenticate its clinical utility.,5.684633456564482e-07,0.446610699998363,0.15704937537180247,0.04352223515476502,0.5487415179432906,0.10275824770146022,0.04345923698286888,0.6556621363715514,0.04246913580246913,5.684633456564497e-07,0.737598943130779,0.0
9,1.1,10,ai,"Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: Diffusion-weighted echo-planar MR imaging can potentially predict different histologic subtypes of primary parotid gland tumors. However, further research and studies are needed to validate its accuracy and reliability in clinical practice.","While diffusion-weighted echo-planar MR imaging may predict distinct histologic subtypes of primary parotid gland tumors, further studies are required to validate its accuracy and reliability in practice.",5.447773729207629e-07,0.40738998684508054,0.15704937537180247,0.04170880868998314,0.5079195234230358,0.10275824770146022,0.04164843544191601,0.6131025219527557,0.04246913580246913,5.447773729207643e-07,0.693147180559945,0.0
10,1.1,1,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Does the measurement of end-tidal carbon dioxide correlate with arterial carbon dioxide levels in extremely low birth weight infants during their first week?,7.105791820705603e-07,0.4966625341602042,0.35786255091274405,0.054402793943456276,0.5882985288770062,0.199375,0.0543240462285861,0.6944836340949729,0.15419501133786845,7.105791820705621e-07,0.7776309890111386,0.1200648999459167
10,1.1,2,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Is there a correlation between end-tidal carbon dioxide and arterial carbon dioxide measurements in extremely low birth weight infants in the first week of life?,6.632072365991897e-07,0.40440004216633074,0.3616261231343233,0.05077594101389252,0.4973267506712782,0.199375,0.050702443146680355,0.5991734542906477,0.15419501133786845,6.632072365991914e-07,0.6775475304541572,0.1200648999459167
10,1.1,3,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,"In extremely low birth weight infants within the first week, does end-tidal carbon dioxide measurement align with arterial carbon dioxide levels?",7.579511275419309e-07,0.5982740519696197,0.35335252899077124,0.058029646873020035,0.6883819874339876,0.199375,0.05794564931049185,0.7998441497527984,0.15419501133786845,7.579511275419328e-07,0.8888566241213627,0.1200648999459167
10,1.1,4,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Do end-tidal carbon dioxide readings correspond to arterial carbon dioxide measurements in extremely low birth weight infants during their first week?,7.579511275419309e-07,0.5982740519696197,0.35335252899077124,0.058029646873020035,0.6883819874339876,0.199375,0.05794564931049185,0.7998441497527984,0.15419501133786845,7.579511275419328e-07,0.8888566241213627,0.1200648999459167
10,1.1,5,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Are end-tidal carbon dioxide values correlated with arterial carbon dioxide in extremely low birth weight newborns within one week of birth?,7.579511275419309e-07,0.5982740519696197,0.35335252899077124,0.058029646873020035,0.6883819874339876,0.199375,0.05794564931049185,0.7998441497527984,0.15419501133786845,7.579511275419328e-07,0.8888566241213627,0.1200648999459167
10,1.1,6,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,"Within the first week of life, does end-tidal carbon dioxide monitoring correlate with arterial carbon dioxide levels in extremely low birth weight infants?",7.105791820705603e-07,0.4966625341602042,0.35786255091274405,0.054402793943456276,0.5882985288770062,0.199375,0.0543240462285861,0.6944836340949729,0.15419501133786845,7.105791820705621e-07,0.7776309890111386,0.1200648999459167
10,1.1,7,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Is there a relationship between end-tidal and arterial carbon dioxide measurements in extremely low birth weight infants during their initial week?,7.579511275419309e-07,0.5289593339136252,0.40321402483564656,0.058029646873020035,0.6883819874339876,0.199375,0.05794564931049185,0.7998441497527984,0.15419501133786845,7.579511275419328e-07,0.8888566241213627,0.1200648999459167
10,1.1,8,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,"For extremely low birth weight infants in the first week, do end-tidal carbon dioxide values match arterial carbon dioxide measurements?",7.816371002776163e-07,0.6532154894127484,0.3507448890331774,0.059843073337801915,0.7424492087042629,0.199375,0.05975645085144472,0.8570025635927472,0.15419501133786845,7.816371002776182e-07,0.9494812459377977,0.1200648999459167
10,1.1,9,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,"In the initial week of life, is there a correlation between end-tidal and arterial carbon dioxide in extremely low birth weight infants?",7.342651548062456e-07,0.4801691697441939,0.40321402483564656,0.056216220408238156,0.6370886930464374,0.199375,0.056134847769538976,0.7457769284825231,0.15419501133786845,7.342651548062474e-07,0.8316982102814139,0.1200648999459167
10,1.1,10,ai,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: Studies have shown that there is a correlation between end-tidal carbon dioxide measurement and arterial carbon dioxide in extremely low birth weight infants in their first week of life.,Do studies confirm a correlation between end-tidal and arterial carbon dioxide levels in extremely low birth weight infants during their first week?,7.342651548062456e-07,0.4801691697441939,0.40321402483564656,0.056216220408238156,0.6370886930464374,0.199375,0.056134847769538976,0.7457769284825231,0.15419501133786845,7.342651548062474e-07,0.8316982102814139,0.1200648999459167
11,1.1,1,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does comorbidity between major depression and alcohol use disorder in adolescence result in worse depression outcomes? Answer: The analyses indicate that slightly elevated depression rates up to age 35 in the comorbid MD/AUD group are attributed to greater exposure to adverse childhood conditions within this group. Adolescent comorbidity of MD/AUD is likely to be,1.1842986367842703e-07,0.06505688274619104,0.01694411414982164,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
11,1.1,2,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,"Question: In adolescence, does having both major depression and alcohol use disorder lead to poor depression outcomes? Answer: Findings suggest the marginal increase in depression rates through age 35 among the comorbid MD/AUD individuals is explained by their higher exposure to adverse childhood experiences. The coexistence of MD and AUD in adolescence is likely to be",9.474389094274162e-08,0.04670774407799527,0.01694411414982164,0.0072537058591274906,0.07145896398214369,0.0,0.007243206163811466,0.07275935428242919,0.0,9.474389094274162e-08,0.07410797215372167,0.0
11,1.1,3,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: How does the coexistence of major depression and alcohol use disorder in adolescence affect depression outcomes? Answer: Results reveal that the slightly higher depression rates by age 35 in the comorbid MD/AUD group stem from increased adverse childhood experiences in this group. Adolescent MD/AUD comorbidity is likely to be,2.3685972735685406e-07,0.16222063119983954,0.01694411414982164,0.018134264647818726,0.18924199963852795,0.0,0.018108015409528666,0.19290366612449228,0.0,2.3685972735685406e-07,0.19671029424605502,0.0
11,1.1,4,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does comorbid major depression and alcohol use disorder during adolescence predict poorer depression outcomes? Answer: The analysis suggests marginally higher depression rates through age 35 among those with comorbid MD/AUD due to greater exposure to adverse childhood environments. Adolescent MD/AUD comorbidity is likely to be,3.316036182995957e-07,0.24737843954014682,0.01694411414982164,0.025387970506946217,0.2762533766281572,0.0,0.025351221573340132,0.2818511521409879,0.0,3.316036182995957e-07,0.2876820724517817,0.0
11,1.1,5,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,"Question: In adolescents, is having both major depression and alcohol use disorder related to worse outcomes of depression? Answer: The findings indicate barely higher rates of depression by age 35 in the comorbid MD/AUD group, which can be attributed to more frequent adverse childhood events among these individuals. Adolescent MD/AUD comorbidity is likely to be",1.1842986367842703e-07,0.06505688274619104,0.01694411414982164,0.009067132323909363,0.09015109699429802,0.0,0.009054007704764333,0.09180754925312229,0.0,1.1842986367842703e-07,0.09352605801082436,0.0
11,1.1,6,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,"Question: Among adolescents, does major depression combined with alcohol use disorder result in poorer depression prognosis? Answer: Data suggest that the modest increase in depression up to age 35 in comorbid MD/AUD patients is due to heightened exposure to adverse childhood situations within this group. Adolescent MD/AUD comorbidity is likely to be",1.8948778188548325e-07,0.12221529658614116,0.01694411414982164,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
11,1.1,7,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does having major depression and alcohol use disorder during adolescence lead to inferior depression outcomes? Answer: Analyses show that the marginally higher depression rates at age 35 in the comorbid MD/AUD group can be explained by a greater incidence of adverse childhood conditions in these individuals. Adolescent MD/AUD comorbidity is likely to be,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
11,1.1,8,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: What effect does adolescent comorbidity of major depression and alcohol use disorder have on depression outcomes? Answer: The study results suggest that the slight elevation of depression rates by age 35 among comorbid MD/AUD subjects is accounted for by their increased exposure to adverse childhood experiences. Adolescent MD/AUD comorbidity is likely to be,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
11,1.1,9,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Does adolescent comorbidity of major depression and alcohol use disorder lead to worse depression outcomes? Answer: Findings imply that marginally increased rates of depression to age 35 in the comorbid MD/AUD group are due to greater exposure to adverse childhood experiences in this group. Adolescent MD/AUD comorbidity is likely to be,1.8948778188548325e-07,0.12221529658614116,0.01694411414982164,0.014507411718254981,0.14842000511827358,0.0,0.014486412327622933,0.15123096972392336,0.0,1.8948778188548325e-07,0.1541506798272585,0.0
11,1.1,10,human,Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: The results of these analyses suggest that marginally higher rates of depression to age 35 amongst the comorbid MD/AUD group were explained by increased exposure to adverse childhood circumstances amongst members of the comorbid group. Adolescent MD/AUD comorbidity is likely to be,Question: Is the presence of both major depression and alcohol use disorder in adolescence linked to poorer depression outcomes? Answer: The evidence shows that slightly elevated depression rates through age 35 among those with comorbid MD/AUD can be explained by their increased experience of adverse childhood circumstances. Adolescent MD/AUD comorbidity is likely to be,1.4211583641411244e-07,0.08374901575834537,0.01694411414982164,0.010880558788691236,0.10919929196499112,0.0,0.0108648092457172,0.11122563511022499,0.0,1.4211583641411244e-07,0.11332868530700413,0.0
12,1.1,1,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Does having an optimistic perspective improve the chances of survival in older age? Answer: Studies indicate that optimism positively affects health and increases survival rates in later life. People with an optimistic mindset often use more effective coping methods, maintain healthier habits, and possess stronger immune systems.",7.105791820705622e-08,0.06796903311257019,0.0014484404281270083,0.005440279394345618,0.06744128079553224,0.0,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
12,1.1,2,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Can an optimistic attitude predict increased longevity in elderly populations? Answer: Research demonstrates that optimism enhances health outcomes and is linked to better survival among the elderly. Those who are optimistic usually adopt healthier lifestyles, deploy better coping mechanisms, and exhibit more robust immune responses.",2.3685972735685406e-08,0.053979545877510304,0.02271498107084911,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
12,1.1,3,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Is there a correlation between optimism and improved survival rates in advanced age? Answer: Scientific findings show that optimism benefits overall health and supports greater survival at older ages. Individuals who remain optimistic are more likely to engage in healthy behaviors, handle stress well, and have stronger immunity.",9.474389094274162e-08,0.11851806701508183,0.02271498107084911,0.0072537058591274906,0.0889474860164956,0.0,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
12,1.1,4,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: How does optimism influence survival chances among the elderly? Answer: Studies have found that optimistic individuals tend to live longer, as optimism improves health and well-being. Such individuals often develop superior coping strategies, maintain a healthier lifestyle, and enjoy enhanced immune function.",4.737194547137081e-08,0.015013325609441353,0.02271498107084911,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
12,1.1,5,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Does maintaining an optimistic outlook enhance survival in later life? Answer: Evidence suggests that optimism contributes positively to health, thereby boosting survival rates in advanced ages. Optimists typically adopt effective coping skills, healthier habits, and have a stronger immune system.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
12,1.1,6,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Can an optimistic outlook serve as a predictor for longevity in old age? Answer: Research supports that optimism is linked with better health and improved survival chances among the aged. Optimistic persons usually employ healthier lifestyles, are better at coping with stress, and have a robust immune response.",9.474389094274162e-08,0.11851806701508183,0.02271498107084911,0.0072537058591274906,0.0889474860164956,0.0,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
12,1.1,7,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: What role does optimism play in survival at older ages? Answer: Findings confirm that optimism exerts a positive influence on health and survival in the elderly. People with an optimistic viewpoint commonly utilize healthier behaviors, effective coping mechanisms, and exhibit a stronger immune system.",0.0,0.03150669002545259,0.02271498107084911,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
12,1.1,8,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Is an optimistic disposition associated with better survival outcomes in advanced years? Answer: Scientific evidence indicates that optimism promotes health and can lead to increased survival rates at older ages. Optimistic individuals are more apt to maintain healthier lifestyles, have good coping strategies, and robust immunity.",4.737194547137081e-08,0.07595845259628531,0.02271498107084911,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
12,1.1,9,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: How does an optimistic mindset impact longevity in senior years? Answer: Research shows optimism benefits health and enhances survival chances in the elderly. Those who possess optimism tend to manage stress well, live healthier lives, and have stronger immune functions.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
12,1.1,10,ai,"Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: Research has shown that optimism can positively impact health and well-being, including survival rates at advanced ages. Optimistic individuals tend to have better coping strategies, healthier lifestyles, stronger immune function,","Question: Does optimism influence survival and health among elderly people? Answer: Studies reveal that optimism positively affects well-being and survival rates in older adults. Optimistic individuals often have better coping techniques, healthier lifestyles, and increased immune strength.",1.8948778188548283e-07,0.16916400543669896,0.02271498107084911,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
13,1.1,1,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia a predictor of adverse outcomes for both mother and newborn?,5.447773729207623e-07,0.5506270560421282,0.13296398891966765,0.041708808689983175,0.6042708234047014,0.11426592797783926,0.04164843544191604,0.6612026047245565,0.09418282548476452,5.447773729207641e-07,0.7217641360432729,0.07271468144044323
13,1.1,2,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the first measurement of urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia serve as a prognostic indicator for negative maternal and neonatal outcomes?,4.7371945471370643e-07,0.4170956634176046,0.13296398891966765,0.036268529295637536,0.46450888102954213,0.11426592797783926,0.03621603081905742,0.5145991305326811,0.09418282548476452,4.737194547137081e-07,0.5676134562160162,0.07271468144044323
13,1.1,3,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the primary urinary albumin/creatinine ratio (ACR) in pregnant women suspected of preeclampsia forecast maternal and neonatal complications?,6.395212638635037e-07,0.7619361497093338,0.13296398891966765,0.048962514549110686,0.8274143747189107,0.11426592797783926,0.04889164160572754,0.8975913827887863,0.09418282548476452,6.395212638635055e-07,0.9730785643241795,0.07271468144044323
13,1.1,4,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio (ACR) a reliable predictor of adverse maternal and neonatal outcomes in cases of suspected preeclampsia?,5.684633456564476e-07,0.5994172202115595,0.13296398891966765,0.043522235154765054,0.6555641177922515,0.11426592797783926,0.043459236982868917,0.7152698259948318,0.09418282548476452,5.684633456564495e-07,0.7789225498832217,0.07271468144044323
13,1.1,5,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the initial urinary albumin/creatinine ratio (ACR) in women with probable preeclampsia predict the risk of maternal and neonatal adverse events?,5.684633456564476e-07,0.5994172202115595,0.13296398891966765,0.043522235154765054,0.6555641177922515,0.11426592797783926,0.043459236982868917,0.7152698259948318,0.09418282548476452,5.684633456564495e-07,0.7789225498832217,0.07271468144044323
13,1.1,6,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first ACR test in women with suspected preeclampsia a prognostic factor for negative outcomes in mothers and their newborns?,5.684633456564476e-07,0.5994172202115595,0.13296398891966765,0.043522235154765054,0.6555641177922515,0.11426592797783926,0.043459236982868917,0.7152698259948318,0.09418282548476452,5.684633456564495e-07,0.7789225498832217,0.07271468144044323
13,1.1,7,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Can the initial urinary albumin/creatinine ratio (ACR) in suspected preeclampsia cases be an independent predictor for adverse outcomes in both mother and infant?,5.21091400185077e-07,0.5041070404072343,0.13296398891966765,0.039895382225201295,0.5554806592352701,0.11426592797783926,0.03983763390096317,0.6099093103370063,0.09418282548476452,5.210914001850788e-07,0.6676969147729976,0.07271468144044323
13,1.1,8,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the first urinary albumin/creatinine ratio measurement in women suspected of preeclampsia an independent prognostic marker for maternal and neonatal adverse outcomes?,5.447773729207623e-07,0.5506270560421282,0.13296398891966765,0.041708808689983175,0.6042708234047014,0.11426592797783926,0.04164843544191604,0.6612026047245565,0.09418282548476452,5.447773729207641e-07,0.7217641360432729,0.07271468144044323
13,1.1,9,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Does the first urinary albumin/creatinine ratio (ACR) act as an independent risk factor for adverse maternal and neonatal outcomes in women with suspected preeclampsia?,4.974054274493917e-07,0.45965527783640026,0.13296398891966765,0.038081955760419416,0.5089606436003762,0.11426592797783926,0.038026832360010296,0.5611191461675751,0.09418282548476452,4.974054274493935e-07,0.6164036203854475,0.07271468144044323
13,1.1,10,human,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: ACR is an independent prognostic factor for maternal and neonatal adverse outcomes in suspected preeclampsia. ACR may be useful to inform risk,Is the initial ACR level in pregnant women with suspected preeclampsia effective in predicting adverse outcomes for both the mother and neonate?,5.447773729207623e-07,0.5506270560421282,0.13296398891966765,0.041708808689983175,0.6042708234047014,0.11426592797783926,0.04164843544191604,0.6612026047245565,0.09418282548476452,5.447773729207641e-07,0.7217641360432729,0.07271468144044323
14,1.1,1,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular cell abnormalities in Pap smears detected by rapid prescreening? Rapid prescreening techniques like liquid-based cytology can identify glandular cell abnormalities in Pap smears, but specialized tests such as colposcopy and biopsy are usually needed for confirmation and precise diagnosis.",2.6054570009253947e-07,0.32721112997257773,0.059615078079606774,0.0199476911126006,0.3550993870769532,0.0763888888888889,0.019918816950481533,0.3271969994958135,0.05246913580246914,2.6054570009253947e-07,0.2977505134290679,0.027006172839506164
14,1.1,2,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Do rapid prescreening methods detect glandular cell abnormalities in Pap smears? Yes, rapid prescreening approaches including liquid-based cytology can spot glandular cell abnormalities, however, additional specialized assessments like colposcopy and biopsy are often necessary for definitive diagnosis.",3.5528959103528067e-07,0.3709585629139651,0.01621296778014928,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
14,1.1,3,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Can rapid prescreening find glandular cell abnormalities in Pap smears? Rapid prescreening methods such as liquid-based cytology are effective at detecting glandular cell abnormalities, though further testing like colposcopy and biopsy is commonly required for accurate diagnosis.",3.5528959103528067e-07,0.3709585629139651,0.01621296778014928,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
14,1.1,4,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular abnormalities in Pap smears identified through rapid prescreening? Rapid prescreening methods, particularly liquid-based cytology, can detect glandular cell abnormalities, but confirmation via specialized tests like colposcopy and biopsy is often essential.",4.5003348197802187e-07,0.41172524517479925,0.039150354019158694,0.03445510283085561,0.4780358009429988,0.0,0.0344052292781045,0.4906229164484719,0.0,4.500334819780227e-07,0.5039051809214179,0.0
14,1.1,5,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Is rapid prescreening capable of detecting glandular abnormalities in Pap smears? Rapid screening methods like liquid-based cytology can detect such abnormalities, but further confirmation through colposcopy and biopsy is typically necessary.",4.974054274493925e-07,0.4762637663123708,0.039150354019158694,0.03808195576041937,0.5447271754416723,0.0,0.03802683236001025,0.5596157879354227,0.0,4.974054274493935e-07,0.5753641449035616,0.0
14,1.1,6,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Do Pap smears with glandular cell abnormalities get detected by rapid prescreening? Yes, methods such as liquid-based cytology can effectively identify these abnormalities, though additional specialized evaluations like colposcopy and biopsy are usually required.",4.2634750924233657e-07,0.38095358650804556,0.039150354019158694,0.03264167636607373,0.446287102628419,0.0,0.03259442773715163,0.4578330936254802,0.0,4.263475092423373e-07,0.47000362924573613,0.0
14,1.1,7,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular cell abnormalities in Pap smears found using rapid prescreening methods? Rapid prescreening—especially using liquid-based cytology—can detect these abnormalities, but further diagnostic steps like colposcopy and biopsy are often needed for confirmation.",4.5003348197802187e-07,0.41172524517479925,0.039150354019158694,0.03445510283085561,0.4780358009429988,0.0,0.0344052292781045,0.4906229164484719,0.0,4.500334819780227e-07,0.5039051809214179,0.0
14,1.1,8,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Can rapid prescreening procedures detect glandular cell abnormalities in Pap smear tests? Yes, liquid-based cytology and similar rapid methods can detect them, yet specialized testing such as colposcopy and biopsy remains important for accurate diagnosis.",4.0266153650665127e-07,0.3511006233583638,0.039150354019158694,0.03082824990129185,0.4155154439616653,0.0,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
14,1.1,9,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Are glandular abnormalities detected by rapid prescreening in Pap smear tests? Rapid screening techniques, including liquid-based cytology, are effective at detection, but confirmation via colposcopy and biopsy is usually necessary for proper diagnosis.",4.5003348197802187e-07,0.41172524517479925,0.039150354019158694,0.03445510283085561,0.4780358009429988,0.0,0.0344052292781045,0.4906229164484719,0.0,4.500334819780227e-07,0.5039051809214179,0.0
14,1.1,10,ai,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Rapid prescreening methods, such as liquid-based cytology, can effectively detect glandular cell abnormalities in Pap smears. However, further evaluation and confirmation through specialized testing, such as colposcopy and biopsy, are often required for accurate diagnosis and appropriate management.","Is it possible to detect glandular cell abnormalities in Pap smears with rapid prescreening? Rapid prescreening methods like liquid-based cytology can detect these abnormalities, although further specialized diagnostic procedures like colposcopy and biopsy are typically required for accurate diagnosis.",3.0791764556391007e-07,0.23987498824813924,0.039150354019158694,0.023574544042164344,0.30110509278391984,0.0,0.023540420032387266,0.30830135965451655,0.0,3.079176455639103e-07,0.31585294941847764,0.0
15,1.1,1,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Do provider service networks lead to reduced costs compared to HMOs or primary care case management in the Florida Medicaid system?,9.000669639560433e-07,0.7539895870862456,0.2054320987654321,0.06891020566171127,0.855402751629533,0.16749660479855144,0.06881045855620904,0.9616931376989979,0.12244897959183676,9.000669639560452e-07,1.0480930810744464,0.08999999999999998
15,1.1,2,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Are expenditures lower with provider service networks than with HMOs or primary care case management under Florida’s Medicaid?,9.711248821630993e-07,0.9165085165840199,0.2054320987654321,0.0743504850560569,1.0272530085561922,0.16749660479855144,0.07424286317906767,1.1440146944929523,0.12244897959183676,9.711248821631012e-07,1.2422490955154042,0.08999999999999998
15,1.1,3,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"In Florida’s Medicaid program, do provider service networks result in decreased expenses relative to HMOs or primary care case management?",9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,1.1,4,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Do provider service networks achieve cost savings when compared to Health Maintenance Organizations or primary care case management within Florida Medicaid?,9.000669639560433e-07,0.7539895870862456,0.2054320987654321,0.06891020566171127,0.855402751629533,0.16749660479855144,0.06881045855620904,0.9616931376989979,0.12244897959183676,9.000669639560452e-07,1.0480930810744464,0.08999999999999998
15,1.1,5,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Does Florida’s Medicaid program see lower spending with provider service networks versus HMOs or primary care case management?,9.711248821630993e-07,0.9165085165840199,0.2054320987654321,0.0743504850560569,1.0272530085561922,0.16749660479855144,0.07424286317906767,1.1440146944929523,0.12244897959183676,9.711248821631012e-07,1.2422490955154042,0.08999999999999998
15,1.1,6,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Are provider service networks associated with reduced expenditures in Florida Medicaid as opposed to HMOs or primary care case management?,9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,1.1,7,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"Compared to HMOs or primary care case management, do provider service networks incur less expense in Florida’s Medicaid program?",9.474389094274141e-07,0.8593501027440711,0.2054320987654321,0.07253705859127503,0.9666283867397572,0.16749660479855144,0.07243206163811479,1.0794761733553817,0.12244897959183676,9.474389094274159e-07,1.173256224028452,0.08999999999999998
15,1.1,8,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Do provider service networks cause a reduction in spending compared to HMOs and primary care case management in Florida Medicaid?,9.237529366917287e-07,0.8052828814737958,0.2054320987654321,0.07072363212649316,0.9094699728998084,0.16749660479855144,0.07062126009716192,1.0188515515389467,0.12244897959183676,9.237529366917306e-07,1.1087177028908815,0.08999999999999998
15,1.1,9,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,Is there a decrease in expenditures using provider service networks over HMOs or primary care case management within Florida’s Medicaid program?,9.000669639560433e-07,0.7539895870862456,0.2054320987654321,0.06891020566171127,0.855402751629533,0.16749660479855144,0.06881045855620904,0.9616931376989979,0.12244897959183676,9.000669639560452e-07,1.0480930810744464,0.08999999999999998
15,1.1,10,ai,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: Provider service networks (PSNs) have been found to result in lower expenditures compared to Health Maintenance Organizations (HMOs) or primary care case management in Florida's Medicaid program. This is due to the increased flexibility and efficiency offered,"Within Florida’s Medicaid program, do provider service networks offer lower expenditure levels compared to traditional HMOs or primary care case management?",9.000669639560433e-07,0.7539895870862456,0.2054320987654321,0.06891020566171127,0.855402751629533,0.16749660479855144,0.06881045855620904,0.9616931376989979,0.12244897959183676,9.000669639560452e-07,1.0480930810744464,0.08999999999999998
16,1.1,1,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the",Is lumbar drainage effective for treating postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage may effectively relieve pressure and aid healing in some cases after spine surgery cerebrospinal fluid fistula.,2.36859727356853e-07,0.06818546527446578,0.13970884920045024,0.018134264647818768,0.011897742067296768,0.1914672216441208,0.018108015409528715,0.050011635660676124,0.17481789802289285,2.3685972735685406e-07,0.0902765556474816,0.1560874089490115
16,1.1,2,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Can lumbar drainage treat cerebrospinal fluid fistulas post spine surgery effectively? Yes, lumbar drainage can alleviate pressure and support recovery in specific postoperative cerebrospinal fluid fistula cases after spine surgery.",2.605457000925383e-07,0.10527390053892871,0.13744827418855246,0.019947691112600648,0.046989061878565774,0.1914672216441208,0.019918816950481588,0.0863792798315508,0.17481789802289285,2.6054570009253947e-07,0.1280168836303286,0.1560874089490115
16,1.1,3,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the",Does lumbar drainage help with postoperative cerebrospinal fluid fistulas after spine surgery? It can be an effective method to reduce pressure and encourage healing in select postoperative cerebrospinal fluid fistula cases after spine surgery.,1.658018091497971e-07,0.006482421497289614,0.11603537981269509,0.01269398525347313,0.04322063196095893,0.1602497398543185,0.012675610786670094,0.051771058649266344,0.17481789802289285,1.6580180914979784e-07,0.015083960010343844,0.1560874089490115
16,1.1,4,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the",Is lumbar drainage a successful treatment for cerebrospinal fluid fistula after spine surgery? Lumbar drainage has proven beneficial by relieving pressure and fostering injury repair in targeted postoperative cerebrospinal fluid fistula instances.,2.131737546211677e-07,0.07713353719486893,0.11037211450657265,0.01632083818303689,0.02420600242894455,0.1581735236655239,0.01629721386857584,0.014920315849407118,0.17481789802289285,2.1317375462116866e-07,0.053908911476606924,0.1560874089490115
16,1.1,5,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","How effective is lumbar drainage for postoperative cerebrospinal fluid fistulas following spine surgery? In some situations, lumbar drainage is useful for pressure management and promoting tissue healing after spine surgery.",2.605457000925383e-07,0.057470646707208584,0.17159660430249102,0.019947691112600648,0.046989061878565774,0.1914672216441208,0.019918816950481588,0.0863792798315508,0.17481789802289285,2.6054570009253947e-07,0.1280168836303286,0.1560874089490115
16,1.1,6,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the",Is lumbar drainage an efficacious approach for cerebrospinal fluid fistulas after spinal procedures? Lumbar drainage can assist in pressure relief and tissue recovery for some postoperative cerebrospinal fluid fistula patients.,2.605457000925383e-07,0.10527390053892871,0.13744827418855246,0.019947691112600648,0.046989061878565774,0.1914672216441208,0.019918816950481588,0.0863792798315508,0.17481789802289285,2.6054570009253947e-07,0.1280168836303286,0.1560874089490115
16,1.1,7,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the",Can lumbar drainage effectively manage postoperative cerebrospinal fluid fistula after spine surgery? This method might help by reducing pressure and aiding healing in appropriate cases.,3.789755637709648e-07,0.1989093925140164,0.20603537981269512,0.029014823436510045,0.24369935612462035,0.1914672216441208,0.028972824655245956,0.29117369247756475,0.17481789802289285,3.789755637709665e-07,0.3415909839283895,0.1560874089490115
16,1.1,8,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the",Is lumbar drainage beneficial for postoperative cerebrospinal fluid fistula treatment post spine surgery? It may work well by alleviating pressure and assisting healing after surgery in certain circumstances.,3.079176455639089e-07,0.08112635685763214,0.20603537981269512,0.023574544042164407,0.12109703403228744,0.1914672216441208,0.023540420032387335,0.16334032096768025,0.17481789802289285,3.079176455639103e-07,0.20805959130386587,0.1560874089490115
16,1.1,9,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the",Does lumbar drainage serve as an effective solution for cerebrospinal fluid fistulas following spine surgery? It can facilitate pressure reduction and healing in specific postoperative cases.,3.552895910352795e-07,0.1580873979937616,0.20603537981269512,0.027201396971728166,0.20113974170582472,0.1914672216441208,0.027162023114293082,0.2467219299067307,0.17481789802289285,3.552895910352811e-07,0.29507096829349555,0.1560874089490115
16,1.1,10,ai,"Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery can be effective in certain cases, as it helps to relieve pressure and promote healing. However, the","Is the use of lumbar drainage effective for postoperative cerebrospinal fluid fistulas after spine surgery? In particular cases, lumbar drainage helps by lowering pressure and supporting recovery.",3.316036182995942e-07,0.1721856987297059,0.1676353798126951,0.025387970506946286,0.1603177471855699,0.1914672216441208,0.02535122157334021,0.20416231548793506,0.17481789802289285,3.316036182995957e-07,0.2506192057226615,0.1560874089490115
17,1.1,1,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Are increased depression rates among women explained by differences in symptom reporting? There is evidence suggesting that the higher incidence of depression in women might be partly due to how they report symptoms. Women often report more symptoms.,7.10579182070559e-08,0.16463997172627032,0.16712580348943987,0.005440279394345618,0.09768733862388634,0.12543252595155707,0.0054324046228586,0.027206193430387327,0.0783673469387755,7.105791820705622e-08,0.00962255769725795,0.05387755102040818
17,1.1,2,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Do differential symptom reports account for the higher rates of depression seen in women? Some evidence indicates that the elevated depression rates in women could be partially attributed to varying symptom reporting habits. Women are more likely to report a greater number of symptoms.,7.105791820705622e-08,0.314922174775607,0.16712580348943987,0.005440279394345618,0.25183801845114395,0.12543252595155707,0.0054324046228586,0.18543019864528176,0.0783673469387755,7.105791820705622e-08,0.1528963718005163,0.05387755102040818
17,1.1,3,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Is the greater frequency of depression in women a result of differences in symptom reporting? Research shows that women's higher depression rates may be partly because of how they report symptoms, with women tending to disclose more symptoms.",7.10579182070559e-08,0.16463997172627032,0.16712580348943987,0.005440279394345618,0.09768733862388634,0.12543252595155707,0.0054324046228586,0.027206193430387327,0.0783673469387755,7.105791820705622e-08,0.00962255769725795,0.05387755102040818
17,1.1,4,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Can elevated depression rates in women be explained by how symptoms are reported differently? Evidence suggests that women’s higher depression prevalence might partly stem from their tendency to report symptoms more frequently.,2.131737546211677e-07,0.012290736432808647,0.16712580348943987,0.01632083818303689,0.084634218170069,0.12543252595155707,0.01629721386857584,0.16084603807255293,0.0783673469387755,2.1317375462116866e-07,0.2037785721382157,0.05387755102040818
17,1.1,5,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Are women's higher depression rates due in part to varying approaches to symptom reporting? There is supporting evidence that differences in how symptoms are reported may partially explain why depression is more commonly reported among women, who tend to share more symptoms.",2.3685972735685406e-08,0.2672941257863526,0.16712580348943987,0.0018134264647818726,0.20304785428171224,0.12543252595155707,0.0018108015409528666,0.13541977807061834,0.0783673469387755,2.3685972735685406e-08,0.10160307741296659,0.05387755102040818
17,1.1,6,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Is the observed increase in depression among women related to variations in symptom reporting? Studies indicate that differential symptom reporting might partially account for women's higher depression rates, as women generally report more symptoms.",1.658018091497971e-07,0.05022962054852487,0.16712580348943987,0.01269398525347313,0.020095697032497473,0.12543252595155707,0.012675610786670094,0.09415466357387947,0.0783673469387755,1.6580180914979784e-07,0.13478570065126494,0.05387755102040818
17,1.1,7,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Do higher depression rates in women reflect differences in symptom reporting? It appears that the greater depression prevalence in women is partially explained by the way symptoms are reported, with women more likely to report numerous symptoms.",9.47438909427412e-08,0.09873282084038015,0.13937070144862354,0.0072537058591274906,0.0695164616571895,0.12543252595155707,0.007243206163811473,0.0017813434428641806,0.0783673469387755,9.474389094274162e-08,0.03947552084693973,0.05387755102040818
17,1.1,8,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Is the disparity in depression rates between genders a matter of differential symptom reporting? Evidence supports that women's higher rates of depression may be partly explained by their tendency to report symptoms in greater detail or frequency.,9.47438909427412e-08,0.137240997538155,0.16712580348943987,0.0072537058591274906,0.0695164616571895,0.12543252595155707,0.007243206163811473,0.0017813434428641806,0.0783673469387755,9.474389094274162e-08,0.03947552084693973,0.05387755102040818
17,1.1,9,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,"Are increased depression rates in females attributable to differences in their symptom reporting? Research provides some evidence that the disproportionate depression burden on women may be linked to how symptoms are reported differently, with women reporting more symptoms.",7.10579182070559e-08,0.16463997172627032,0.16712580348943987,0.005440279394345618,0.09768733862388634,0.12543252595155707,0.0054324046228586,0.027206193430387327,0.0783673469387755,7.105791820705622e-08,0.00962255769725795,0.05387755102040818
17,1.1,10,ai,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: There is evidence to suggest that higher rates of depression in women may be partially explained by differential symptom reporting. Women tend to report more symptoms,Could the elevated depression rates in women be due to differential symptom reporting? Findings suggest that the higher prevalence among women may be partially driven by their inclination to report a wider array of symptoms.,1.421158364141118e-07,0.08008258369820664,0.16712580348943987,0.01088055878869125,0.010675961634256215,0.12543252595155707,0.01086480924571722,0.062405965259299645,0.0783673469387755,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
18,1.1,1,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime linked to over-the-counter pharmacy syringe sales? Our research indicates that OTC pharmacy syringe sales did not correlate with a rise in reported crime within Los Angeles communities from 2006 to 2008.,2.36859727356853e-08,0.00992448261612111,0.029136316337148777,0.0018134264647818796,0.031748698314579826,0.0,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
18,1.1,2,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does crime relate to over-the-counter pharmacy syringe sales? Findings show that OTC pharmacy syringe sales were not connected to increases in reported crime in local Los Angeles areas during 2006-2008.,9.47438909427412e-08,0.09299714524385472,0.02591502261674699,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,1.1,3,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there an association between crime and over-the-counter pharmacy syringe sales? Data reveals no increase in local reported crime in Los Angeles communities tied to OTC syringe sales during 2006-2008.,9.47438909427412e-08,0.04519389141213459,0.06035379812695108,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,1.1,4,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales related to crime rates? Evidence from 2006 to 2008 in Los Angeles indicates no link between OTC syringe sales and increases in local reported crime.,9.47438909427412e-08,0.09299714524385472,0.02591502261674699,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,1.1,5,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does selling syringes over the counter at pharmacies associate with crime? Our study shows that OTC pharmacy syringe sales were not connected to a rise in reported crime in Los Angeles neighborhoods from 2006 through 2008.,4.73719454713706e-08,0.14285834009080567,0.06035379812695108,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
18,1.1,6,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there a connection between crime and OTC pharmacy syringe sales? Our results demonstrate no association between OTC syringe sales and an increase in local crime reports in Los Angeles from 2006 to 2008.,0.0,0.08401784006787238,0.06035379812695108,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
18,1.1,7,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Are over-the-counter pharmacy syringe sales correlated with crime? Findings from 2006 to 2008 in Los Angeles communities show no increase in reported crime related to OTC syringe sales.,1.421158364141118e-07,0.11665285539427828,0.06035379812695108,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
18,1.1,8,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is crime incidence linked to OTC pharmacy syringe sales? Research findings reveal that OTC syringe sales in pharmacies did not raise reported crime levels in Los Angeles neighborhoods during 2006-2008.,9.47438909427412e-08,0.04519389141213459,0.06035379812695108,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
18,1.1,9,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Does the sale of syringes at pharmacies over-the-counter have any link to crime? Our findings indicate no association between OTC syringe sales and increased crime reports in Los Angeles communities between 2006 and 2008.,0.0,0.08401784006787238,0.06035379812695108,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
18,1.1,10,human,Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: Our findings demonstrate that OTC pharmacy syringe sales were not associated with increases in reported crime in local communities in Los Angeles during 2006-2008.,Is there any relationship between crime and the sale of syringes over the counter in pharmacies? Data confirms no rise in reported crime in local Los Angeles communities corresponding with OTC pharmacy syringe sales during 2006-2008.,4.73719454713706e-08,0.14285834009080567,0.06035379812695108,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
19,1.1,1,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is expert breast pathology evaluation essential for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology evaluation is crucial for managing ductal carcinoma in situ.",2.36859727356853e-08,0.1953886540202392,0.07917515408259973,0.0018134264647818796,0.2056837522151369,0.13062500000000005,0.0018108015409528735,0.2170060717101241,0.16568163265306124,2.3685972735685406e-08,0.17405534240362286,0.14876033057851235
19,1.1,2,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Does managing ductal carcinoma in situ require expert breast pathology assessment? Answer: Yes, management of ductal carcinoma in situ necessitates expert breast pathology assessment.",1.184298636784265e-07,2.0786554634444343e-05,0.05540166204986144,0.009067132323909398,0.018552805306723208,0.11250000000000004,0.009054007704764368,0.04025762088527962,0.15873015873015875,1.1842986367842703e-07,0.00029804474115557866,0.14876033057851235
19,1.1,3,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is specialized breast pathology analysis important for handling ductal carcinoma in situ? Answer: Yes, specialized breast pathology analysis is important in the management of ductal carcinoma in situ.",2.36859727356853e-08,0.1953886540202392,0.07917515408259973,0.0018134264647818796,0.2056837522151369,0.13062500000000005,0.0018108015409528735,0.2170060717101241,0.16568163265306124,2.3685972735685406e-08,0.17405534240362286,0.14876033057851235
19,1.1,4,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: For ductal carcinoma in situ, is an expert breast pathology review required? Answer: Yes, expert breast pathology review is required for proper management of ductal carcinoma in situ.",2.36859727356853e-08,0.1953886540202392,0.07917515408259973,0.0018134264647818796,0.2056837522151369,0.13062500000000005,0.0018108015409528735,0.2170060717101241,0.16568163265306124,2.3685972735685406e-08,0.17405534240362286,0.14876033057851235
19,1.1,5,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Should ductal carcinoma in situ management involve expert breast pathology input? Answer: Yes, expert breast pathology input is involved and necessary in the management of ductal carcinoma in situ.",0.0,0.28681952299032254,0.11490747922437675,0.0,0.29706307738283266,0.1689940828402367,0.0,0.30806541358219786,0.20408163265306126,0.0,0.21327605555690532,0.14876033057851235
19,1.1,6,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is expert pathological examination of the breast needed to manage ductal carcinoma in situ? Answer: Yes, managing ductal carcinoma in situ requires expert pathological examination of the breast.",2.36859727356853e-08,0.1458781411231005,0.05096037178636012,0.0018134264647818796,0.15433951661810497,0.09633270321361068,0.0018108015409528735,0.16368705782089732,0.1276927437641724,2.3685972735685406e-08,0.11860356795882776,0.10882977502295679
19,1.1,7,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: In the treatment of ductal carcinoma in situ, is expert breast pathology assessment needed? Answer: Yes, expert breast pathology assessment is needed for treatment of ductal carcinoma in situ.",0.0,0.14340976149516038,0.032365330464046105,0.0,0.14853153869141655,0.06986767485822307,0.0,0.15403270679109804,0.09470663265306126,0.0,0.15995704166767855,0.11036033057851233
19,1.1,8,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Does ductal carcinoma in situ management demand expert breast pathology expertise? Answer: Yes, managing ductal carcinoma in situ demands expertise in breast pathology.",1.421158364141118e-07,0.06540992063554585,0.12180747922437671,0.010880558788691277,0.028895286258414643,0.15000000000000005,0.010864809245717241,0.009263031894894969,0.15658163265306124,1.4211583641411238e-07,0.04908820891058685,0.14876033057851235
19,1.1,9,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: Is an expert breast pathology assessment mandatory for ductal carcinoma in situ management? Answer: Yes, it is mandatory to have expert breast pathology assessment for managing ductal carcinoma in situ.",2.36859727356853e-08,0.2808850298062362,0.0893074792243767,0.0018134264647818796,0.28776566149322,0.13792899408284026,0.0018108015409528735,0.2949225448559334,0.1684163377285071,2.3685972735685406e-08,0.2510163835397523,0.14876033057851235
19,1.1,10,ai,"Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ? Answer: Yes, expert breast pathology assessment is necessary for the management of ductal carcinoma in","Question: For effective management of ductal carcinoma in situ, is expert breast pathology assessment necessary? Answer: Yes, effective management of ductal carcinoma in situ requires expert breast pathology assessment.",2.36859727356853e-08,0.09636762822596179,0.02708525700215461,0.0018134264647818796,0.10299528102107214,0.06438016528925619,0.0018108015409528735,0.11036804393167232,0.09066008255854331,2.3685972735685406e-08,0.06315179351403089,0.06936524551234975
20,1.1,1,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Does the first night affect sleep bruxism? Answer: Findings indicated no general first night impact on the severity of RMMA frequency in young, healthy patients with sleep bruxism. Clinically, a single-night sleep recording might be adequate for patients with moderate to high SB frequency. Yet, a low RMMA frequency on the first night should ideally be verified by a second night.",2.3685972735685406e-08,0.018944879631669576,0.0022487501275380295,0.0018134264647818726,0.06419175608347238,0.034039651841776646,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
20,1.1,2,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Is there an initial night effect on sleep bruxism? Answer: The study showed no overall effect of the first night on RMMA frequency severity in young healthy individuals with SB. In practice, one-night recording could suffice for moderate to high frequency SB patients, but low RMMA frequency initially may require confirmation with a second night.",1.1842986367842703e-07,0.03513350949807359,0.11762688614540469,0.009067132323909363,0.01806385355568718,0.0507015306122449,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
20,1.1,3,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Does the first night influence sleep bruxism? Answer: Results revealed no overall first night effect on RMMA frequency severity in young healthy SB patients. Clinically, a single night of recording may be enough for patients exhibiting moderate to high SB frequency. Nonetheless, low RMMA levels on that first night might need validation through a follow-up night.",9.474389094274162e-08,0.019503137271035698,0.06310013717421127,0.0072537058591274906,0.000285285112508582,0.0507015306122449,0.007243206163811466,0.04755733706628362,0.017236072637734686,9.474389094274162e-08,0.07275935428242919,0.0
20,1.1,4,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Is there any first night impact on sleep bruxism? Answer: The data found no general first night effect on the severity of RMMA frequency in young, healthy SB patients. For clinical use, recording one night’s sleep might be sufficient for those with moderate to high SB frequency, though a second night may be needed to confirm low RMMA frequency initially observed.",2.3685972735685406e-08,0.11842726632419653,0.10305325913867522,0.0018134264647818726,0.08729666210213693,0.0507015306122449,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
20,1.1,5,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Is the first night biased in sleep bruxism assessment? Answer: No overall first night effect on RMMA frequency severity was found among young and healthy patients with SB. In clinical settings, one night of sleep monitoring may suffice for moderate-high frequency SB patients; however, if RMMA frequency is low the first night, a second night’s recording might be recommended.",2.3685972735685406e-08,0.06005357640592601,0.08510093852355759,0.0018134264647818726,0.053395110426456505,0.0507015306122449,0.0018108015409528666,0.006509884203991234,0.017236072637734686,2.3685972735685406e-08,0.01769957709940062,0.0
20,1.1,6,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Is there a first night phenomenon in sleep bruxism? Answer: The findings did not show an overall first night effect on the severity of RMMA frequency in young healthy SB patients. One-night sleep assessment may be adequate for patients with moderate to high frequency SB, but lower RMMA frequencies seen on the first night should be reevaluated by a second night.",2.3685972735685406e-08,0.08712329083428783,0.05227095902878698,0.0018134264647818726,0.08729666210213693,0.0507015306122449,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
20,1.1,7,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Does the first night alter sleep bruxism severity? Answer: Results demonstrated no significant first night effect on RMMA frequency severity in young patients with SB. Clinically, one night of sleep recording is likely sufficient for those with moderate to high frequency SB, but low RMMA values seen on the initial night may require a second night for confirmation.",4.737194547137081e-08,0.08954705991652334,0.1185663964980678,0.0036268529295637453,0.036003367714587675,0.0507015306122449,0.003621603081905733,0.011189692895409387,0.017236072637734686,4.737194547137081e-08,0.03571808260207909,0.0
20,1.1,8,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Is sleep bruxism affected by the first night effect? Answer: The study showed no comprehensive first night influence on RMMA frequency severity among young, healthy patients with SB. A single night recording may suffice in clinical practice for patients with moderate-high SB frequency, yet low RMMA frequency initially observed could necessitate a second night to confirm.",9.474389094274162e-08,0.004091597675405012,0.08240268273494808,0.0072537058591274906,0.000285285112508582,0.0507015306122449,0.007243206163811466,0.04755733706628362,0.017236072637734686,9.474389094274162e-08,0.07275935428242919,0.0
20,1.1,9,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Does the first night cause changes in sleep bruxism? Answer: No overall first night effect on the severity of RMMA frequency was observed in young and healthy patients with SB. For clinical purposes, one-night sleep recordings might suffice for those with moderate to high SB frequency, but a second night may be advisable if the first night shows low RMMA frequency.",2.3685972735685406e-08,0.08712329083428783,0.052270959028787034,0.0018134264647818726,0.06419175608347238,0.034039651841776646,0.0018108015409528666,0.040996060275159785,0.017236072637734686,2.3685972735685406e-08,0.01739174271186883,0.0
20,1.1,10,human,"Question: Is there a first night effect on sleep bruxism? Answer: The results showed no overall first night effect on severity of RMMA frequency in young and healthy patients with SB. In clinical practice, one-night sleep recording may be sufficient for moderate-high frequency SB patients. However, low RMMA frequency in the first night could be confirmed by a second night based","Question: Is there a first night effect on sleep bruxism symptoms? Answer: There was no overall first night effect found on RMMA frequency severity in young, healthy SB patients. Clinically, one night’s recording is often sufficient for moderate to high frequency SB cases; however, cases with low initial RMMA frequency could benefit from a second night’s assessment.",9.474389094274162e-08,0.004091597675405012,0.08240268273494808,0.0072537058591274906,0.02492006690785331,0.0325259476218471,0.007243206163811466,0.04755733706628362,0.017236072637734686,9.474389094274162e-08,0.07275935428242919,0.0
21,1.1,1,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,"Does minimal access major surgery cause less pain in newborns? Evidence shows that for esophageal atresia or congenital diaphragmatic hernia repair, it doesn't reduce total opioid use.",1.421158364141118e-07,0.16431766599324638,0.031217481789802305,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,1.1,2,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is the pain experience less with minimal access surgery in newborn major operations? Minimal access repair of esophageal atresia and congenital diaphragmatic hernia does not correlate with decreased opioid consumption.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
21,1.1,3,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does newborn surgery using minimal access techniques result in less pain? Opioid doses for esophageal atresia or congenital diaphragmatic hernia repairs remain unchanged with minimal access surgery.,1.421158364141118e-07,0.21763667988247315,0.007182518210197705,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,1.1,4,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is pain decreased in newborns undergoing minimal access major surgery? Repair of esophageal atresia or diaphragmatic hernia via minimal access does not lead to lower opioid usage.,1.421158364141118e-07,0.21763667988247315,0.007182518210197705,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,1.1,5,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Are newborns subjected to minimal access surgery less likely to need opioids? The cumulative opioid dose is not reduced when minimal access methods are used for esophageal atresia or congenital diaphragmatic hernia.,2.36859727356853e-08,0.033146172468933255,0.0010047404324198955,0.0018134264647818796,0.0327898228229917,0.0,0.0018108015409528735,0.03390155167568176,0.0,2.3685972735685406e-08,0.035091319811269006,0.0
21,1.1,6,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Does minor access surgery for major newborn conditions mean less pain? Repairs via minimal access in esophageal atresia or congenital diaphragmatic hernia do not result in smaller opioid doses.,9.47438909427412e-08,0.09020969383952471,0.031217481789802305,0.007253705859127518,0.13815033848081715,0.0,0.007243206163811494,0.14310084364067244,0.0,9.474389094274162e-08,0.14842000511827314,0.0
21,1.1,7,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Is less pain associated with minimal access surgery during newborn major operations? Opioid dosage remains consistent for minimal access repairs of esophageal atresia and congenital diaphragmatic hernia.,1.421158364141118e-07,0.21763667988247315,0.007182518210197705,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
21,1.1,8,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,"Does minimal access surgery lessen pain in newborns requiring major surgery? For esophageal atresia or congenital diaphragmatic hernia repairs, minimal access is not linked to reduced opioid requirements.",1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,1.1,9,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,"Is the opioid use diminished in newborns having minimal access major surgery? For esophageal atresia or congenital diaphragmatic hernia repair, minimal access techniques don't reduce cumulative opioid doses.",1.184298636784265e-07,0.17792157360743266,0.005764766730907742,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
21,1.1,10,human,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access surgery for the repair of esophageal atresia or congenital diaphragmatic hernia is not associated with less cumulative opioid doses.,Are pain levels lower with minimal access surgeries in newborn major operations? Opioid consumption during repairs of esophageal atresia or congenital diaphragmatic hernia via minimal access surgery is not lessened.,7.10579182070559e-08,0.10292162785997583,0.003221293720401787,0.005440279394345639,0.10178269430994247,0.0,0.005432404622858621,0.10536051565782545,0.0,7.105791820705622e-08,0.10919929196499067,0.0
22,1.1,1,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites mirror community practice? Family practice at residency teaching sites aims to closely reflect community practice, but some differences may exist due to the emphasis on teaching and learning. Residency programs strive",7.10579182070559e-08,0.05735446312874082,0.013492782223183425,0.005440279394345618,0.0918913774266974,0.008150510204081599,0.0054324046228586,0.09161903752274636,0.006593590561224494,7.105791820705622e-08,0.09116928482195785,0.004716198979591822
22,1.1,2,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Is family practice at residency teaching sites representative of community practice? Family practice at residency teaching sites is designed to reflect community practice closely, though differences can arise because of the focus on education. Residency programs aim to",7.10579182070559e-08,0.05735446312874082,0.013492782223183425,0.005440279394345618,0.0918913774266974,0.008150510204081599,0.0054324046228586,0.09161903752274636,0.006593590561224494,7.105791820705622e-08,0.09116928482195785,0.004716198979591822
22,1.1,3,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites align with community practice? Family practice at residency teaching sites seeks to mirror community practice as much as possible; however, certain differences happen due to the teaching and learning focus. Residency programs strive",2.36859727356853e-08,0.004896299886270938,0.01989619377162638,0.0018134264647818726,0.029717171588468982,0.002581738577784015,0.0018108015409528666,0.029626200911009093,0.0020824800508438407,2.3685972735685406e-08,0.029480497252859283,0.0014857707788997962
22,1.1,4,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Is the family practice conducted at residency teaching sites similar to community practice? Family practice at residency teaching sites attempts to replicate community practice closely, notwithstanding some differences resulting from the emphasis on teaching. Residency programs work to",7.10579182070559e-08,0.0198870479633384,0.03880897683980419,0.005440279394345618,0.01487502403114771,0.04586116799661043,0.0054324046228586,0.012402216887323902,0.04982063413600735,7.105791820705622e-08,0.00962255769725795,0.05387755102040818
22,1.1,5,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","How closely does family practice at residency teaching sites resemble community practice? Family practice at residency teaching sites endeavors to align well with community practice, although differences might occur because of the instructional focus. Residency programs strive",9.47438909427412e-08,0.08995724497871604,0.010052965300706873,0.0072537058591274906,0.12446318887313934,0.011158444647369814,0.007243206163811473,0.12410143412991248,0.009041602072670907,9.474389094274162e-08,0.12349336091481211,0.006476247106542904
22,1.1,6,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","To what extent does family practice at residency teaching sites reflect community practice? Family practice at residency teaching sites aims to emulate community practice closely, though variations may exist due to emphasis on teaching. Residency programs strive",9.47438909427412e-08,0.08995724497871604,0.010052965300706873,0.0072537058591274906,0.12446318887313934,0.011158444647369814,0.007243206163811473,0.12410143412991248,0.009041602072670907,9.474389094274162e-08,0.12349336091481211,0.006476247106542904
22,1.1,7,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice experience at residency teaching sites correspond to community practice? Family practice at residency teaching sites intends to reflect community practice, yet some differences may arise from the teaching emphasis. Residency programs strive",1.421158364141118e-07,0.11766822957918954,0.029773164167627833,0.01088055878869125,0.10888788769310054,0.04087069166896732,0.01086480924571722,0.10572766404429723,0.0471498651489732,1.4211583641411244e-07,0.10199587782827324,0.05387755102040818
22,1.1,8,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Is family practice at residency teaching sites indicative of community practice? Family practice at residency teaching sites strives to represent community practice closely; however, disparities can appear because of the focus on education and learning. Residency programs aim to",4.73719454713706e-08,0.02575629299850002,0.016770409346691245,0.0036268529295637453,0.060329357109093706,0.00529525308746083,0.003621603081905733,0.06014745969624036,0.004277281160398036,4.737194547137081e-08,0.059851841459428456,0.003055415003466927
22,1.1,9,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive","Does family practice at residency teaching sites parallel community practice? Family practice at residency teaching sites is designed to parallel community practice as closely as possible, with some variations owing to a teaching-centered approach. Residency programs strive",9.47438909427412e-08,0.1284654216764909,0.014671280276816606,0.0072537058591274906,0.12446318887313934,0.011158444647369814,0.007243206163811473,0.12410143412991248,0.009041602072670907,9.474389094274162e-08,0.12349336091481211,0.006476247106542904
22,1.1,10,ai,"Question: Does family practice at residency teaching sites reflect community practice? Answer: Family practice at residency teaching sites aims to closely reflect community practice. However, there may be some differences due to the emphasis on teaching and learning. Residency programs strive",Is family practice at residency teaching sites consistent with community practice? Family practice at residency teaching sites attempts to stay consistent with community practice despite some differences due to teaching priorities. Residency programs strive,1.658018091497971e-07,0.27849017871702575,0.05141684240699407,0.01269398525347313,0.27225020021696533,0.0496671425771955,0.012675610786670094,0.2283121823919334,0.017295918367346966,1.6580180914979784e-07,0.22720532472592403,0.012448979591836697
23,1.1,1,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the length of psychological treatment for depression connected to the chance of resuming therapy? The length of psychological treatment for depression does not directly influence the probability of returning to treatment. Instead, elements like how effective the treatment is, the person's individual situation and support network, and their readiness to keep undergoing treatment are more crucial in deciding whether future treatment is necessary.",4.737194547137081e-08,0.035314944562331974,0.002829766019093724,0.0036268529295637453,0.05690323309296641,0.017802400738688842,0.003621603081905733,0.05715139329219543,0.017750846414281277,4.737194547137081e-08,0.05738536793963256,0.017639273622653134
23,1.1,2,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does the duration of psychological treatment for depression affect the likelihood of returning to therapy? The duration of depression treatment psychologically is not directly linked to returning for treatment. Other factors such as treatment success, personal circumstances, support availability, and patient willingness to continue therapy have a greater impact on the need for further treatment.",2.6054570009253947e-07,0.10878182559425209,0.05437081094496074,0.0199476911126006,0.1281042696171788,0.04336127547666009,0.019918816950481533,0.12587699061392144,0.047500000000000014,2.6054570009253947e-07,0.15058957938141493,0.0322222222222222
23,1.1,3,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is there a relationship between how long psychological treatment for depression lasts and returning to therapy? The time spent in psychological treatment for depression does not have a direct connection with returning to treatment. Factors including treatment effectiveness, the individual's life situation and social support, as well as motivation to continue treatment, are more decisive in the requirement for future interventions.",1.1842986367842703e-07,0.04449669841405246,0.02502652885342592,0.009067132323909363,0.04169527107446491,0.028365650969529095,0.009054007704764333,0.04057932556479038,0.03026392736226533,1.1842986367842703e-07,0.03936394427118994,0.0322222222222222
23,1.1,4,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does how long psychological treatment for depression lasts influence whether a patient returns for treatment? The period of psychological treatment does not correlate directly with the tendency to return for treatment. More relevant are the quality of the treatment, the patient's private circumstances, their support network, and their willingness to continue therapy.",3.316036182995957e-07,0.14177824621206803,0.0717530594656708,0.025387970506946217,0.16021668036153347,0.06222222222222222,0.025351221573340132,0.1853004110847225,0.047500000000000014,3.316036182995957e-07,0.21121420119784906,0.0322222222222222
23,1.1,5,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the length of psychological therapy for depression tied to the chance of returning for care? The length of psychological treatment for depression doesn’t directly affect the likelihood of returning to treatment. Instead, factors such as treatment effectiveness, personal aspects, social support, and willingness to continue therapy hold greater importance.",3.789755637709665e-07,0.29605994672840685,0.00937008103019693,0.029014823436509962,0.25880093992844966,0.02063432052089896,0.028972824655245866,0.2564687321899699,0.026233459357277913,3.789755637709665e-07,0.2537738156166456,0.0322222222222222
23,1.1,6,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the duration of a psychological depression treatment related to treatment re-entry? The duration itself is not directly related to whether individuals return for treatment. More influential are the treatment's efficacy, individual circumstances, support systems, and the patient's willingness to continue treatment.",5.684633456564497e-07,0.40047368503376557,0.04270085696731445,0.04352223515476494,0.38336023167574274,0.06222222222222222,0.0434592369828688,0.4135590630657049,0.047500000000000014,5.684633456564497e-07,0.44482905237935366,0.0322222222222222
23,1.1,7,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the amount of time spent in psychological treatment for depression associated with returning to therapy? No, the duration of psychological therapy for depression is not directly linked to the chances of returning for treatment. Instead, the effectiveness of the treatment, individual situations, support networks, and the desire to continue treatment have a stronger influence.",2.6054570009253947e-07,0.08310970779573523,0.07284113351337461,0.0199476911126006,0.10194777223755791,0.06222222222222222,0.019918816950481533,0.12587699061392144,0.047500000000000014,2.6054570009253947e-07,0.15058957938141493,0.0322222222222222
23,1.1,8,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Does the length of psychological treatment for depression impact the risk of returning to treatment? No, the duration alone does not determine if someone will return to treatment. More crucial factors include how effective the therapy is, the individual's personal situation and their support network, and whether they are eager to keep undergoing treatment.",2.8423167282822487e-07,0.07612972300937271,0.0913530594656708,0.02176111757738247,0.12099596720825101,0.06222222222222222,0.0217296184914344,0.14529507647102413,0.047500000000000014,2.8423167282822487e-07,0.1703922066775947,0.0322222222222222
23,1.1,9,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is time spent in psychological treatment for depression linked to future treatment return? The duration of treatment does not directly influence the likelihood of re-entering therapy. Other factors such as treatment success, personal circumstances, availability of support, and patient willingness play a more important role.",4.974054274493935e-07,0.2622320026432319,0.0913530594656708,0.038081955760419325,0.3110395700961166,0.06222222222222222,0.0380268323600102,0.33945109091198145,0.047500000000000014,4.974054274493935e-07,0.36884314540143226,0.0322222222222222
23,1.1,10,ai,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The duration of psychological treatment for depression is not directly related to the likelihood of returning to treatment. Factors such as the effectiveness of the treatment, the individual's personal circumstances and support system, and their willingness to continue receiving treatment play a more significant role in determining the need for future treatment.","Is the length of psychological depression treatment correlated with return to therapy? Duration itself isn't directly related to returning to treatment. Instead, factors like treatment efficacy, individual personal conditions, support systems, and willingness to maintain treatment impact the necessity of further care.",5.684633456564497e-07,0.33284956985718583,0.0913530594656708,0.04352223515476494,0.38336023167574274,0.06222222222222222,0.0434592369828688,0.4135590630657049,0.047500000000000014,5.684633456564497e-07,0.44482905237935366,0.0322222222222222
24,1.1,1,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can a new surgical method for the temporomandibular joint enhance access while minimizing complications? The VMPA offers direct access and excellent visibility to the TMJ area, ensuring favorable aesthetic and functional outcomes. It may be regarded as the preferred approach for standard TMJ surgeries.",1.1842986367842703e-07,0.0055236348789953205,0.08264462809917356,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
24,1.1,2,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is it possible for an innovative surgical technique to improve access to the temporomandibular joint and lower complication risks? Utilizing the VMPA grants direct entry and optimal visibility of the TMJ region, yielding satisfying cosmetic and functional results, and is considered the recommended approach for typical TMJ operations.",2.3685972735685406e-08,0.09447112089549092,0.08264462809917356,0.0018134264647818726,0.007989419483715121,0.021266540642722105,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
24,1.1,3,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Could a novel surgical approach to the temporomandibular joint provide better access and reduce complications? The VMPA allows for direct access with good visibility to the TMJ, achieving positive aesthetic and functional results, thus serving as the ideal method for routine TMJ procedures.",1.4211583641411244e-07,0.05101387112929068,0.058849268194355,0.010880558788691236,0.10707991030107156,0.021266540642722105,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
24,1.1,4,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Does a new surgical technique for the temporomandibular joint enhance accessibility and reduce complications? The VMPA provides direct and clear visualization of the TMJ, producing good aesthetic and functional outcomes. It is often chosen as the primary approach in common TMJ surgeries.",1.6580180914979784e-07,0.042104414110259114,0.08264462809917356,0.012693985253473108,0.13177252289144326,0.021266540642722105,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
24,1.1,5,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Can an innovative surgical strategy for the temporomandibular joint improve access and decrease complications? The VMPA offers direct access and favorable visualization of the TMJ zone, resulting in excellent aesthetic and functional performance and is preferred for usual TMJ surgeries.",2.1317375462116855e-07,0.12766084394440647,0.0570213594011126,0.016320838183036854,0.18306581727899296,0.021266540642722105,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
24,1.1,6,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is a new surgical approach to the temporomandibular joint effective in improving access and limiting complications? By using the VMPA, surgeons can achieve direct access, enhanced visibility of the TMJ, and good esthetic and functional results, making it the favored option for typical TMJ interventions.",9.474389094274162e-08,0.028513153103694844,0.08264462809917356,0.0072537058591274906,0.05945186131181712,0.021266540642722105,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
24,1.1,7,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Could a newly developed surgical method improve temporomandibular joint access and reduce complications? The VMPA provides direct and clear access to the TMJ, with excellent esthetic and functional outcomes, establishing it as the approach of choice in common TMJ surgeries.",2.1317375462116855e-07,0.09211483468492254,0.08264462809917356,0.016320838183036854,0.18306581727899296,0.021266540642722105,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
24,1.1,8,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Might a novel surgical approach to the temporomandibular joint enhance access and minimize complications? The VMPA facilitates direct access and optimal visibility to the TMJ, resulting in strong aesthetic and functional results and is considered the best approach for standard TMJ surgeries.",1.6580180914979784e-07,0.10972852928683885,0.033992425600817215,0.012693985253473108,0.13177252289144326,0.021266540642722105,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
24,1.1,9,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Does an innovative technique for the temporomandibular joint allow improved access and fewer complications? The VMPA delivers direct access and excellent visualization of the TMJ, yielding good functional and aesthetic results, and is preferred for routine TMJ surgery cases.",2.3685972735685385e-07,0.15457175164396686,0.05634806126206618,0.018134264647818726,0.20973406436115383,0.021266540642722105,0.018108015409528666,0.24512245803298427,0.0,2.3685972735685406e-07,0.2513144282809061,0.0
24,1.1,10,human,Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: The VMPA can provide direct access and favorable visibility to the TMJ region and yield good esthetic and functional results. The VMPA can be considered the approach of choice for common TMJ surgeries.,"Is it feasible that a new surgical method to the temporomandibular joint can enhance access and reduce complications? The VMPA provides direct and favorable visibility to the TMJ area, with strong functional and esthetic outcomes, making it the preferred approach in common TMJ surgeries.",1.1842986367842703e-07,0.026715768867978884,0.05940199771368603,0.009067132323909363,0.08298235872201154,0.021266540642722105,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
25,1.1,1,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Question: Do French lay individuals and healthcare providers consider it acceptable to violate confidentiality to safeguard a patient's wife from a sexually transmitted infection? Answer: In France, people's decisions about whether a doctor should breach confidentiality to protect a patient's spouse from an STD are heavily influenced by situational circumstances.",4.737194547137081e-08,0.015042050800014639,0.017851332616568565,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,1.1,2,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Question: Is breaching confidentiality to protect a patient's wife from a sexually transmitted disease deemed acceptable by French laypeople and medical professionals? Answer: For most in France, whether a physician breaches confidentiality to protect a patient's spouse infected with an STD depends largely on the situation at hand.",9.474389094274162e-08,0.11811380270828176,0.025776179691725257,0.0072537058591274906,0.11834033630642216,0.024969390361156182,0.007243206163811466,0.1184791694012386,0.023948990820864127,9.474389094274162e-08,0.11851806701508183,0.02271498107084911
25,1.1,3,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Question: Do members of the French public and healthcare professionals agree on breaching confidentiality to defend a patient's wife against a sexually transmitted disease? Answer: Opinions in France vary depending on circumstances when deciding if a doctor should disclose confidential information to protect a patient's spouse infected with an STD.,4.737194547137081e-08,0.013249670855493001,0.03819444444444445,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.013380974745060836,0.020399305555555556,4.737194547137081e-08,0.04255961441879652,0.0
25,1.1,4,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Question: Is it acceptable in France for health professionals and laypeople to breach confidentiality to protect a patient's wife from an STD? Answer: In France, situational factors greatly influence people's views on whether a physician should reveal confidential information to safeguard a spouse from a sexually transmitted disease.",9.474389094274162e-08,0.00013130388956783534,0.05859375,0.0072537058591274906,0.027929834494255346,0.039930555555555566,0.007243206163811466,0.0568660866847992,0.020399305555555556,9.474389094274162e-08,0.08701137698962924,0.0
25,1.1,5,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Question: Are French health workers and laypeople willing to breach confidentiality to prevent a patient's wife from contracting an STD? Answer: Most French individuals base their judgment on the specific context when deciding if a doctor should breach patient confidentiality to protect an infected patient's wife.,1.4211583641411244e-07,0.0744229571875259,0.03638300619834711,0.010880558788691236,0.07238159706508807,0.039930555555555566,0.0108648092457172,0.10232846076155644,0.020399305555555556,1.4211583641411244e-07,0.13353139262452318,0.0
25,1.1,6,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,"Question: Do French citizens and healthcare providers find it justifiable to break confidentiality to protect a patient's wife from an STD? Answer: In France, situational elements play a key role in shaping opinions about doctors breaching confidentiality to protect a patient's spouse from a sexually transmitted disease.",1.1842986367842703e-07,0.14218484486008665,0.027574050453514756,0.009067132323909363,0.14232836528768944,0.026395975056689322,0.009054007704764333,0.14235232258776165,0.024952168367346938,1.1842986367842703e-07,0.14224029896130297,0.023242630385487524
25,1.1,7,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Question: Do laypeople and health professionals in France accept breaching confidentiality to protect a patient's wife from a sexually transmitted infection? Answer: Most people in France decide on breaching confidentiality to protect a patient's spouse from an STD based on the situation involved.,2.1317375462116866e-07,0.310651338904814,0.08029513888888887,0.016320838183036854,0.2782473946322015,0.05649018951383818,0.0162972138685758,0.2786211994251735,0.05410763381624868,2.1317375462116866e-07,0.2787313832972149,0.05113221329437545
25,1.1,8,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Question: Is breaching patient confidentiality to shield a patient's wife from a sexually transmitted disease accepted by French laypeople and healthcare professionals? Answer: French people's acceptance of confidentiality breaches by doctors to safeguard a patient's wife with an STD largely depends on the circumstances.,1.8948778188548325e-07,0.15355759740001185,0.012192798185603794,0.014507411718254981,0.1519086212980736,0.01613519565073701,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
25,1.1,9,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Question: Do French healthcare professionals and laypeople consider it acceptable to violate confidentiality to protect a patient's wife from an STD? Answer: The majority in France take situational factors into account when concluding if physicians should breach confidentiality to protect a patient's spouse infected with a sexually transmitted disease.,7.105791820705622e-08,0.09460242478505876,0.02405087809917357,0.005440279394345618,0.09491050338732743,0.023602502295684086,0.0054324046228586,0.09516084784080192,0.022989124196510568,7.105791820705622e-08,0.09534506249579122,0.02221074380165289
25,1.1,10,human,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: Most people in France are influenced by situational factors when deciding if a physician should breach confidentiality to protect the spouse of a patient infected with STD.,Question: Are breaches of confidentiality acceptable to French health workers and laypeople to protect a patient's wife from STDs? Answer: Most French individuals' views on whether doctors should breach confidentiality to defend a patient’s wife from a sexually transmitted infection are influenced by context.,1.8948778188548325e-07,0.12131819365303764,0.035351119614512476,0.014507411718254981,0.118901612699982,0.039930555555555566,0.014486412327622933,0.14995650975081087,0.020399305555555556,1.8948778188548325e-07,0.1823215567939549,0.0
26,1.1,1,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? The ACE gene I/D polymorphism may be a candidate gene for insulin resistance because it influences the renin-angiotensin-aldosterone system, which affects glucose metabolism, but more studies are required.",1.6580180914979784e-07,0.2423827963759897,0.058557935570922634,0.012693985253473108,0.2390258447937832,0.05790123456790121,0.012675610786670066,0.23511490951008085,0.05483284336807048,1.6580180914979784e-07,0.23058286565211583,0.049861495844875335
26,1.1,2,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Due to its effect on the renin-angiotensin-aldosterone system involved in glucose metabolism, the ACE gene I/D polymorphism is considered a potential candidate gene, though further investigation is necessary.",1.8948778188548325e-07,0.14002609820276168,0.023585769556557765,0.014507411718254981,0.16651751754915667,0.008272972880544432,0.014486412327622933,0.19387400980328717,0.008273594143552075,1.8948778188548325e-07,0.2221319648398974,0.025623268698060954
26,1.1,3,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The insertion allele of the ACE gene I/D polymorphism as a candidate gene for insulin resistance? Its role in the renin-angiotensin-aldosterone system that modulates glucose metabolism makes it a potential candidate, but additional research is essential.",3.5528959103528056e-07,0.19031962060434493,0.11776859504132227,0.027201396971728097,0.252292886872433,0.08098765432098766,0.027162023114293013,0.3169311843947491,0.04158790170132326,3.552895910352811e-07,0.38441169891033145,0.0
26,1.1,4,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Is the ACE gene I/D polymorphism's insertion allele a possible candidate gene associated with insulin resistance? Given its participation in the renin-angiotensin-aldosterone system impacting glucose metabolism, it is regarded as a candidate, but more research is needed.",3.3160361829959526e-07,0.16214874363764809,0.11776859504132227,0.025387970506946217,0.2233053499991815,0.08098765432098766,0.02535122157334014,0.2870782212450673,0.04158790170132326,3.316036182995957e-07,0.35364004024357776,0.0
26,1.1,5,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Questioning whether the insertion allele of the ACE gene I/D polymorphism is a candidate gene for insulin resistance: It is a likely candidate since it is involved in the renin-angiotensin-aldosterone system, which influences glucose metabolism; however, further studies are warranted.",2.6054570009253936e-07,0.1531980544830822,0.06663638174694682,0.0199476911126006,0.14106725176220847,0.08098765432098766,0.019918816950481533,0.20252083321700365,0.04158790170132326,2.6054570009253947e-07,0.26662866325394763,0.0
26,1.1,6,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Is the ACE gene I/D polymorphism insertion allele linked to insulin resistance? It is potentially a candidate due to its role in the renin-angiotensin-aldosterone system important for glucose metabolism, though further research remains necessary.",4.0266153650665116e-07,0.24916012062727821,0.11776859504132227,0.030828249901291856,0.3129175086888685,0.08098765432098766,0.03078362619619876,0.3794515413760826,0.04158790170132326,4.026615365066519e-07,0.44895022004790297,0.0
26,1.1,7,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The ACE gene I/D polymorphism insertion allele's candidacy for insulin resistance: it may be involved because it acts through the renin-angiotensin-aldosterone system affecting glucose metabolism, but more evidence is needed.",4.974054274493924e-07,0.3783718521072852,0.11776859504132227,0.038081955760419374,0.44644890131339077,0.08098765432098766,0.038026832360010254,0.5176018798568998,0.04158790170132326,4.974054274493935e-07,0.5920510636885754,0.0
26,1.1,8,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Could the insertion allele in the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? As it is part of the renin-angiotensin-aldosterone system regulating glucose metabolism, it is a potential candidate though it requires more research.",2.8423167282822466e-07,0.14456295292315824,0.09147202820421489,0.02176111757738247,0.16773549884436934,0.08098765432098766,0.0217296184914344,0.22991980740511897,0.04158790170132326,2.8423167282822487e-07,0.2947995402206445,0.0
26,1.1,9,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","Is the insertion allele of the ACE gene I/D polymorphism considered a candidate gene for insulin resistance? Its role in the renin-angiotensin-aldosterone system related to glucose metabolism makes it a potential candidate, pending further scientific validation.",3.5528959103528056e-07,0.19031962060434493,0.11776859504132227,0.027201396971728097,0.252292886872433,0.08098765432098766,0.027162023114293013,0.3169311843947491,0.04158790170132326,3.552895910352811e-07,0.38441169891033145,0.0
26,1.1,10,ai,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: The ACE gene I/D polymorphism is a potential candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system, which plays a role in glucose metabolism. However, further research is needed to","The ACE gene I/D polymorphism insertion allele might be a candidate gene for insulin resistance due to its involvement in the renin-angiotensin-aldosterone system which plays a crucial role in glucose metabolism, however, additional research is needed.",3.5528959103528056e-07,0.19031962060434493,0.11776859504132227,0.027201396971728097,0.252292886872433,0.08098765432098766,0.027162023114293013,0.3169311843947491,0.04158790170132326,3.552895910352811e-07,0.38441169891033145,0.0
27,1.1,1,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there a link between androgens and sexual desire in females? Evidence suggests that androgens like testosterone may influence sexual desire in women. Nonetheless, this relationship is intricate and affected by hormone levels, personal differences, and psychological aspects. Further research is necessary.",3.552895910352811e-07,0.18742951036155775,0.15542943015470487,0.02720139697172809,0.21757072743082162,0.10501643655489809,0.027162023114293,0.24840604703908076,0.05536332179930796,3.552895910352811e-07,0.2803927590664932,0.037677816224529016
27,1.1,2,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Do androgens correlate with sexual desire in females? Research indicates that androgens such as testosterone could impact sexual desire in women, but the connection is complicated and shaped by hormone levels, individual variability, and psychological factors. More studies are needed.",4.026615365066518e-07,0.24090783427860973,0.15294941935868575,0.030828249901291835,0.2706880933461613,0.10370343316289263,0.030783626196198732,0.3010497805244996,0.05536332179930796,4.026615365066519e-07,0.3344599803367694,0.037677816224529016
27,1.1,3,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there an association between androgens and sexual desire among women? Some evidence points to androgens, including testosterone, having a role in female sexual desire. However, this correlation is complex, influenced by hormone concentrations, individual traits, and mental health factors. Additional investigation is required.",3.079176455639103e-07,0.07217734619572358,0.2040816326530612,0.023574544042164344,0.13412320423339352,0.13,0.023540420032387266,0.19839562646441733,0.05536332179930796,3.079176455639103e-07,0.2290994646789435,0.037677816224529016
27,1.1,4,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Can androgens affect sexual desire in women? Evidence shows that hormones like testosterone may contribute to women's sexual desire. The relationship is complex and modulated by hormone levels, individual differences, and psychological influences. Further exploration is needed.",4.737194547137077e-07,0.2498585234331756,0.2040816326530612,0.03626852929563745,0.316444761027348,0.13,0.03621603081905734,0.3856071685525633,0.05536332179930796,4.737194547137081e-07,0.4214713573263995,0.037677816224529016
27,1.1,5,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Does sexual desire in women correlate with androgen levels? Available evidence implies that androgens such as testosterone might influence female sexual desire. Yet, the relationship is multifaceted, influenced by hormone levels, personal differences, and psychological factors. More research should be done.",3.789755637709665e-07,0.1444980077753497,0.2040816326530612,0.029014823436509962,0.20823117638711697,0.13,0.028972824655245866,0.27438153344233873,0.05536332179930796,3.789755637709665e-07,0.30706100614865406,0.037677816224529016
27,1.1,6,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Are androgens linked to sexual desire in women? Studies suggest androgens like testosterone may help regulate sexual desire in females. However, this link is complicated, impacted by hormone variations, individual differences, and psychological factors. Further examination is warranted.",4.500334819780224e-07,0.297394379575866,0.15020408163265303,0.03445510283085558,0.326782060758426,0.10224489795918368,0.034405229278104466,0.35661963167931177,0.05536332179930796,4.500334819780227e-07,0.39161839417671773,0.037677816224529016
27,1.1,7,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there a connection between androgen hormones and sexual desire in women? Data suggests that testosterone and other androgens can affect sexual desire, but their relationship is complex, depending on factors such as hormone levels, individual variations, and psychological aspects. Additional research is necessary.",3.079176455639103e-07,0.07217734619572358,0.2040816326530612,0.023574544042164344,0.13412320423339352,0.13,0.023540420032387266,0.19839562646441733,0.05536332179930796,3.079176455639103e-07,0.2290994646789435,0.037677816224529016
27,1.1,8,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Do androgens have a role in female sexual desire? Evidence supports that testosterone and similar androgens might play a role in women's sexual desire, though the relationship is intricate, influenced by hormone levels, individual differences, and psychological factors. More studies are needed.",3.552895910352811e-07,0.18742951036155775,0.15542943015470487,0.02720139697172809,0.21757072743082162,0.10501643655489809,0.027162023114293,0.24840604703908076,0.05536332179930796,3.552895910352811e-07,0.2803927590664932,0.037677816224529016
27,1.1,9,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is sexual desire in women related to androgen levels? There is some evidence indicating that hormones like testosterone may influence sexual desire in women, but this association is complex and subject to various factors including hormone levels, individual variability, and psychological dimensions. Further study is required.",2.6054570009253947e-07,0.08832805483540573,0.15973333627664152,0.0199476911126006,0.11910987862395217,0.10728501892915089,0.019918816950481533,0.1507675774751629,0.05536332179930796,2.6054570009253947e-07,0.18030930050951177,0.037677816224529016
27,1.1,10,ai,"Question: Is there a correlation between androgens and sexual desire in women? Answer: There is evidence suggesting that androgens, such as testosterone, may play a role in sexual desire in women. However, the relationship between androgens and sexual desire in women is complex and influenced by various factors including hormone levels, individual differences, and psychological factors. Further","Is there a correlation between androgens and women's sexual desire? Research indicates that androgens such as testosterone may impact sexual desire in women; however, this relationship is complex and affected by diverse factors like hormone levels, individual differences, and psychological elements. Additional research is warranted.",2.8423167282822487e-07,0.049187827971024056,0.2040816326530612,0.02176111757738247,0.1105927068231991,0.13,0.0217296184914344,0.1742980748853573,0.05536332179930796,2.8423167282822487e-07,0.2044068520885718,0.037677816224529016
28,1.1,1,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals pertinent and useful for practitioners and athletes? Indeed, these journals offer current research, data, and recommendations on diverse elements of sports medicine, such as injury prevention, diagnosis, and treatment.",2.84231672828224e-07,0.0979069009403708,0.15339663988312632,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,1.1,2,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Do sports medicine journals hold relevance and practical value for practitioners and athletes? Yes, they deliver the latest studies, insights, and guidelines regarding multiple aspects of sports medicine including injury prevention, diagnosis, and therapeutic approaches.",2.3685972735685343e-07,0.07805564268628506,0.12401188322564238,0.01813426464781874,0.10349553549221158,0.11426592797783926,0.018108015409528687,0.1729126896893627,0.0710059171597633,2.3685972735685406e-07,0.2119607470425815,0.04865220249835634
28,1.1,3,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals applicable and meaningful to practitioners and athletes? Absolutely, they provide updated research, knowledge, and direction on various sports medicine topics like injury prevention, diagnosis, and care.",3.5528959103527993e-07,0.24415022758534421,0.11895786437292223,0.027201396971728138,0.26779858678348756,0.11426592797783926,0.027162023114293055,0.34281172648475966,0.0710059171597633,3.552895910352811e-07,0.38785141350624563,0.04865220249835634
28,1.1,4,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Is the content in sports medicine journals beneficial and applicable to practitioners and athletes? Indeed, these publications supply timely research, information, and protocols concerning injury prevention, diagnosis, treatment, and other sports medicine areas.",2.84231672828224e-07,0.1412285997253684,0.12217915809332403,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,1.1,5,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Do sports medicine journals serve as relevant and practical sources for practitioners and athletes? Yes, they contain current research, informative content, and guidelines focusing on injury prevention, diagnosis, and treatment in sports medicine.",2.84231672828224e-07,0.0979069009403708,0.15339663988312632,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,1.1,6,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals important and applicable to both practitioners and athletes? Certainly, as they furnish the latest research, data, and advice on injury prevention, diagnosis, treatment, and additional aspects of sports medicine.",2.84231672828224e-07,0.0979069009403708,0.15339663988312632,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,1.1,7,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals significant and usable for practitioners and athletes? Yes, they offer updated research findings, information, and recommended practices on areas including injury prevention, diagnosis, and sports injury management.",3.3160361829959463e-07,0.16244542207794233,0.15339663988312632,0.02538797050694626,0.23270726697221855,0.11426592797783926,0.02535122157334018,0.306444082313885,0.0710059171597633,3.316036182995957e-07,0.35011108552339865,0.04865220249835634
28,1.1,8,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Can practitioners and athletes rely on sports medicine journals for relevant and applicable information? Yes, these journals provide contemporary studies, knowledge, and recommendations on different facets of sports medicine such as injury prevention, diagnosis, and treatment.",2.1317375462116813e-07,0.04790315256839506,0.12484992708035816,0.01632083818303686,0.0736425723425298,0.11426592797783926,0.016297213868575813,0.142141031022609,0.0710059171597633,2.1317375462116866e-07,0.18021204872800167,0.04865220249835634
28,1.1,9,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Do sports medicine journals have relevance and applicability for practitioners and athletes? Absolutely, they present current scientific research, valuable information, and guidelines on many sports medicine subjects including injury prevention, diagnosis, and treatment.",2.84231672828224e-07,0.1412285997253684,0.12217915809332403,0.0217611175773825,0.1660158924735451,0.11426592797783926,0.021729618491434434,0.2374512108269342,0.0710059171597633,2.8423167282822487e-07,0.27865212154125496,0.04865220249835634
28,1.1,10,ai,"Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: Yes, sports medicine journals are relevant and applicable to practitioners and athletes as they provide up-to-date research, information, and guidelines on various aspects of sports medicine, including injury prevention, diagnosis, treatment, and","Are sports medicine journals useful and relevant for practitioners and athletes? Yes, as these journals provide the most recent research, details, and recommendations relating to injury prevention, diagnosis, and treatment in the field of sports medicine.",2.1317375462116813e-07,0.008294742250683829,0.15339663988312632,0.01632083818303686,0.0736425723425298,0.11426592797783926,0.016297213868575813,0.142141031022609,0.0710059171597633,2.1317375462116866e-07,0.18021204872800167,0.04865220249835634
29,1.1,1,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does the quantity of needles influence acupuncture treatment for neck pain? Answer: The amount of needles applied in acupuncture for neck pain can differ based on the patient's condition and how the practitioner chooses to proceed. Although studies focusing on the exact effects of needle count are scarce, the",7.105791820705622e-08,0.12898790634195256,0.04611503639588015,0.005440279394345618,0.12615160385401092,0.04434829637641968,0.0054324046228586,0.09746465781724867,0.02271498107084911,7.105791820705622e-08,0.06744128079553224,0.0
29,1.1,2,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Is the number of needles significant in acupuncture therapy for neck pain? Answer: The number of needles selected in acupuncture sessions for neck pain often depends on the patient's specific condition and the method adopted by the practitioner. Research specifically examining needle quantity's role remains limited, but the",4.737194547137081e-08,0.048838121489085395,0.004320871870223314,0.0036268529295637453,0.046106945246820796,0.0018791605739505515,0.003621603081905733,0.04582161865889667,0.0009865860091207122,4.737194547137081e-08,0.04546237407675724,0.0
29,1.1,3,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: For neck pain acupuncture treatment, does how many needles are used matter? Answer: The needle count in acupuncture aimed at relieving neck pain varies according to individual health status and the practitioner's technique. Despite limited scientific data regarding the influence of needle numbers, the",4.737194547137081e-08,0.07472571709065878,0.08436413850083442,0.0036268529295637453,0.016150708639682154,0.04434829637641968,0.003621603081905733,0.015013325609441353,0.02271498107084911,4.737194547137081e-08,0.047628048989254435,0.0
29,1.1,4,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does acupuncture needle quantity affect neck pain treatment outcomes? Answer: The use of a particular number of needles in treating neck pain through acupuncture is influenced by the patient's condition and the practitioner’s preferred method. There is limited research directly exploring the effect of needle numbers, however, the",4.737194547137081e-08,0.16436265158240992,0.08625521735348525,0.0036268529295637453,0.10509819465617776,0.04434829637641968,0.003621603081905733,0.07595845259628531,0.02271498107084911,4.737194547137081e-08,0.04546237407675724,0.0
29,1.1,5,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: When treating neck pain with acupuncture, is the needle count important? Answer: The number of needles utilized during acupuncture for neck pain treatment depends on individual patient circumstances and practitioner approach. Although definitive research on how needle quantity impacts success is limited, the",7.105791820705622e-08,0.051003485144437644,0.08383648918619602,0.005440279394345618,0.007379788770512263,0.04434829637641968,0.0054324046228586,0.03911087718850137,0.02271498107084911,7.105791820705622e-08,0.07232066157962613,0.0
29,1.1,6,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Neck pain acupuncture: does the quantity of needles matter? Answer: Needle numbers in acupuncture treatment for neck pain are variable and hinge on the patient's specific issues and the technique employed by the practitioner. Existing studies on the direct effects of needle quantity remain limited, yet the",2.3685972735685406e-08,0.11319912549855049,0.0646099837692144,0.0018134264647818726,0.0835919894352144,0.04434829637641968,0.0018108015409528666,0.053979545877510304,0.02271498107084911,2.3685972735685406e-08,0.022989518224699523,0.0
29,1.1,7,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: How does the number of needles impact acupuncture treatment for neck pain? Answer: The quantity of needles used in acupuncture for neck pain differs based on the patient’s condition and practitioner's strategy. While empirical evidence regarding needle count effects is limited, the",9.474389094274162e-08,0.006301625714966619,0.05957911957168352,0.0072537058591274906,0.03147734034957228,0.04434829637641968,0.007243206163811466,0.06380348977887307,0.02271498107084911,9.474389094274162e-08,0.09763846956391786,0.0
29,1.1,8,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Is the count of acupuncture needles relevant in neck pain therapy? Answer: Needle counts in acupuncture treatment for neck discomfort often depend on individual health factors and practitioner approaches. Research specifically addressing the significance of needle quantity is minimal, but the",1.1842986367842703e-07,0.035614839902157414,0.10707911957168353,0.009067132323909363,0.05616995293994398,0.04434829637641968,0.009054007704764333,0.0891212977631648,0.02271498107084911,1.1842986367842703e-07,0.12361395596717584,0.0
29,1.1,9,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does increasing the number of acupuncture needles improve neck pain treatment? Answer: The number of needles chosen for acupuncture in neck pain cases varies depending on the individual’s clinical condition and the practitioner’s approach. While direct studies concerning needle quantity effects are sparse, the",4.737194547137081e-08,0.011712337039754495,0.0392623438429506,0.0036268529295637453,0.01608869510729205,0.02110566599093216,0.003621603081905733,0.015013325609441353,0.02271498107084911,4.737194547137081e-08,0.047628048989254435,0.0
29,1.1,10,ai,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: The number of needles used in acupuncture treatment for neck pain may vary depending on the individual's condition and the practitioner's approach. While research on the specific impact of needle quantity is limited, the","Question: Does the number of needles used during acupuncture influence neck pain treatment? Answer: The use of varying numbers of needles in acupuncture therapy for neck pain is tailored according to patient condition and the practitioner's methodology. Although scientific data on the impact of needle number is limited, the",4.737194547137081e-08,0.1354815190590788,0.06549121787036027,0.0036268529295637453,0.10509819465617776,0.04434829637641968,0.003621603081905733,0.07595845259628531,0.02271498107084911,4.737194547137081e-08,0.04546237407675724,0.0
30,1.1,1,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Preparing patients prone to falls for discharge post-rehabilitation: Are we adhering to guidelines? Answer: There was scarce evidence showing that those at high fall risk underwent systematic falls risk assessments throughout rehabilitation. When a risk was detected, strategies were typically applied. Nevertheless, failure to",1.1842986367842703e-07,0.005536222429666893,0.08098765432098766,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
30,1.1,2,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are protocols followed when preparing high fall-risk patients for discharge after rehabilitation? Answer: Evidence indicates minimal systematic falls risk assessments for high-risk individuals during rehabilitation. When risks were found, appropriate strategies were usually implemented. Yet, failure to",2.8423167282822456e-07,0.16773549884436934,0.08098765432098766,0.02176111757738247,0.20103867488178784,0.06222222222222222,0.0217296184914344,0.2358082908112875,0.04246913580246913,2.8423167282822487e-07,0.272144037935544,0.021728395061728398
30,1.1,3,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we follow guidelines in preparing high fall-risk patients for discharge after rehab? Answer: Little evidence supports systematic falls risk evaluations for patients at high fall risk during rehab. When risks were identified, relevant strategies were mostly enacted. However, failure to",1.8948778188548325e-07,0.06508134478428707,0.08098765432098766,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
30,1.1,4,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Preparing high fall-risk patients for discharge after rehabilitation: Are guidelines met? Answer: Few data suggest that a systematic falls risk assessment occurs during rehabilitation for those at high risk. When risks are detected, a strategic intervention usually follows. Nonetheless, failure to",1.8948778188548325e-07,0.06508134478428707,0.08098765432098766,0.014507411718254981,0.09567815922396194,0.06222222222222222,0.014486412327622933,0.1275947061710565,0.04246913580246913,1.8948778188548325e-07,0.16091840282531944,0.021728395061728398
30,1.1,5,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Is discharge preparation for patients at elevated fall risk after rehab guideline-compliant? Answer: Documentation shows limited systematic risk assessment for falls among high-risk patients during rehab. When a risk was identified, an intervention was commonly applied. However, failure to",2.3685972735685396e-07,0.11509176535895049,0.08098765432098766,0.018134264647818726,0.14697145361151165,0.06222222222222222,0.018108015409528666,0.18023843965647535,0.04246913580246913,2.3685972735685406e-07,0.21498562409559563,0.021728395061728398
30,1.1,6,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we meet discharge guidelines for patients with high fall risk post-rehabilitation? Answer: There is little proof that systematic falls risk assessments are conducted for high-risk individuals during rehabilitation. If a risk is identified, typically a strategy is put in place. Still, failure to",1.1842986367842703e-07,0.005536222429666893,0.08098765432098766,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
30,1.1,7,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Assessing readiness for discharge in high fall-risk patients post-rehabilitation: Guideline adherence? Answer: Evidence of systematic assessment for fall risk in high-risk rehab patients is scarce. Most identified risks lead to intervention strategy implementation. However, failure to",3.0791764556390986e-07,0.19513447303248466,0.08098765432098766,0.023574544042164344,0.22920955184848468,0.06222222222222222,0.023540420032387273,0.264795827684539,0.04246913580246913,3.079176455639103e-07,0.30199700108522576,0.021728395061728398
30,1.1,8,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Are rehabilitation discharge procedures for high fall-risk patients guideline compliant? Answer: There is limited evidence to confirm systematic fall risk assessment during rehab for patients at high risk. Once identified, strategies tend to be implemented. However, failure to",2.6054570009253926e-07,0.14106725176220847,0.08098765432098766,0.0199476911126006,0.17363970069367252,0.06222222222222222,0.019918816950481533,0.20763741384459067,0.04246913580246913,2.6054570009253947e-07,0.24315650106229247,0.021728395061728398
30,1.1,9,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Do we comply with guidelines when preparing high fall-risk patients for discharge after rehabilitation? Answer: Systematic falls risk assessments during rehab for those with high fall risk are hardly evidenced. Nonetheless, if a risk is found, a strategy is generally applied. Still, failure to",1.1842986367842703e-07,0.005536222429666893,0.08098765432098766,0.009067132323909363,0.023357497644335812,0.06222222222222222,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.08493249584739804,0.021728395061728398
30,1.1,10,human,"Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: There was little evidence that people at high risk of falls received systematic falls risk assessment during rehabilitation. When a risk was identified, generally a strategy was implemented. However, failure to","Question: Preparing high fall risk patients for discharge after rehabilitation: Compliance with guidelines? Answer: Sparse evidence exists that high risk patients are assessed systematically for falls during rehab. When a risk was found, an intervention strategy was mostly enacted. Even so, failure to",1.6580180914979784e-07,0.07399080180331863,0.057192294416169104,0.012693985253473108,0.07098554663359025,0.06222222222222222,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.13494291642206147,0.021728395061728398
31,1.1,1,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Do symptoms play a role when selecting patients for phase I clinical trials? Yes, symptoms are important in considering patients for phase I clinical trials.",4.73719454713706e-08,0.06214132936440109,0.07268698060941828,0.003626852929563759,0.06850803410538919,0.0885664819944598,0.003621603081905747,0.07577318814187173,0.10390581717451527,4.737194547137081e-08,0.08410887609719842,0.1187049861495845
31,1.1,2,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Are symptoms important in the evaluation of patients for phase I clinical trials? Yes, symptoms are indeed significant when selecting patients for phase I clinical trials.",2.36859727356853e-08,0.11220528629212012,0.0784919692715498,0.0018134264647818796,0.11860185700853343,0.09361750240262309,0.0018108015409528735,0.12570437506495802,0.10773801672100054,2.3685972735685406e-08,0.133629528877373,0.120853512226682
31,1.1,3,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","When choosing patients for phase I clinical trials, do symptoms have importance? Yes, symptoms are relevant when evaluating patients for phase I clinical trials.",7.10579182070559e-08,0.00953610363314139,0.0664819944598338,0.005440279394345639,0.015837135006176783,0.08310249307479223,0.005432404622858621,0.023251898216416045,0.09972299168975071,7.105791820705617e-08,0.03201801106795754,0.11634349030470917
31,1.1,4,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Should symptoms be taken into account when considering patients for phase I clinical trials? Yes, symptoms matter in the selection process for phase I clinical trials.",2.36859727356853e-08,0.16765706073691522,0.11491838556809604,0.0018134264647818796,0.1763641220551957,0.13342185389528627,0.0018108015409528735,0.18597804293973574,0.15051738742244913,2.3685972735685406e-08,0.1966429089282773,0.1662049861495845
31,1.1,5,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Is the presence of symptoms a factor in deciding patient eligibility for phase I clinical trials? Yes, symptoms are a key consideration in phase I clinical trial selection.",2.36859727356853e-08,0.3082849540133661,0.15908698060941834,0.0018134264647818796,0.31861234593282894,0.17766648199445978,0.0018108015409528735,0.32963331975356436,0.19390581717451527,2.3685972735685406e-08,0.283654285917907,0.1662049861495845
31,1.1,6,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Do symptoms influence the decision-making process for enrolling patients in phase I clinical trials? Yes, symptoms do influence patient selection for phase I clinical trials.",4.73719454713706e-08,0.17766585945772562,0.15004235251024478,0.003626852929563759,0.18905536985494464,0.17267805224239366,0.003621603081905747,0.20179994824367986,0.19390581717451527,4.737194547137081e-08,0.15012289329338335,0.1662049861495845
31,1.1,7,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","When assessing patients for phase I clinical trials, are symptoms considered? Yes, symptoms are an important factor in patient assessment for phase I trials.",7.10579182070559e-08,0.13008343938269684,0.1465191801559036,0.005440279394345639,0.14186389510798447,0.1707150080715573,0.005432404622858621,0.15527993260878592,0.19390581717451527,7.105791820705617e-08,0.10133272912395208,0.1662049861495845
31,1.1,8,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Does symptomatology affect patient selection for phase I clinical trials? Yes, symptoms are taken into account for phase I clinical trial considerations.",1.184298636784265e-07,0.03838305466203007,0.09379809172052944,0.009067132323909398,0.029062340757424643,0.11730104989569436,0.009054007704764368,0.01776638705976863,0.14143668137204612,1.1842986367842687e-07,0.004027786533873368,0.1662049861495845
31,1.1,9,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Are patient symptoms relevant when evaluating candidates for phase I clinical trials? Yes, symptoms are a relevant factor for phase I clinical trial eligibility.",7.10579182070559e-08,0.06980977150791912,0.1051869806094183,0.005440279394345639,0.07885051505708063,0.1260664819944598,0.005432404622858621,0.08926591541260098,0.14640581717451526,7.105791820705617e-08,0.10133272912395208,0.1662049861495845
31,1.1,10,ai,"Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Yes, symptoms do matter when considering patients for phase I clinical trials. This is","Is symptom status significant when considering patients for phase I clinical trials? Yes, symptoms are significant when considering candidates for phase I clinical trials.",7.10579182070559e-08,0.050737564241636335,0.03206969665880105,0.005440279394345639,0.015837135006176783,0.08310249307479223,0.005432404622858621,0.08926591541260098,0.14640581717451526,7.105791820705617e-08,0.10133272912395208,0.1662049861495845
32,1.1,1,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Surgical intervention might improve blood lipid profiles in OSA patients, particularly those with preoperative dyslipidemia, possibly offering significant metabolic and cardiovascular benefits. Further prospective studies are recommended.",1.1842986367842692e-07,0.005398772313191635,0.09,0.009067132323909363,0.05913514847322743,0.046400951814396206,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
32,1.1,2,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can airway surgery decrease serum lipid levels in obstructive sleep apnea patients? Surgery appears to have the potential to enhance blood lipid levels in those with OSA, especially in cases with preexisting dyslipidemia, which could lead to notable metabolic and cardiovascular improvements. Prospective research is needed to confirm this.",9.474389094274162e-08,0.15527587204477644,0.04841209829867674,0.0072537058591274906,0.12393066880576553,0.025134411171674104,0.007243206163811466,0.09097177820572666,0.0,9.474389094274162e-08,0.09309042306601167,0.0
32,1.1,3,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is airway surgery effective in lowering serum lipid levels for obstructive sleep apnea patients? Surgical treatment may help improve blood lipid concentrations in individuals with OSA, mainly if they have preoperative dyslipidemia, potentially providing significant benefits in metabolism and cardiovascular outcomes. Further prospective studies should be conducted.",4.737194547137081e-08,0.17047852267264174,0.09,0.0036268529295637453,0.10994118157070565,0.046400951814396206,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
32,1.1,4,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does undergoing airway surgery help reduce serum lipid levels in patients suffering from obstructive sleep apnea? Surgery may have a positive impact on blood lipid levels in OSA patients, particularly those with dyslipidemia prior to surgery, possibly resulting in major metabolic and cardiovascular advantages. Prospective studies should investigate this further.",1.1842986367842703e-07,0.1770739809831583,0.04925758261656856,0.009067132323909363,0.14559857018494649,0.025577049596197922,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
32,1.1,5,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Can surgery aimed at the airway lower serum lipid levels in obstructive sleep apnea sufferers? Surgical intervention might improve lipid levels in the blood for OSA patients, especially those diagnosed with dyslipidemia before surgery, potentially offering substantial metabolic and cardiovascular benefits. Additional prospective research is advised.",2.3685972735685406e-08,0.08688653323742734,0.045651703623580314,0.0018134264647818726,0.055961635693195344,0.023685970743547096,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
32,1.1,6,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is serum lipid level reduction achievable through airway surgery in obstructive sleep apnea patients? Airway surgery could lead to improved blood lipid profiles in OSA patients, notably in those with preoperative dyslipidemia, which may translate into meaningful metabolic and cardiovascular benefits. This warrants additional prospective studies.",2.3685972735685406e-08,0.11769307459564704,0.06778925619834711,0.0018134264647818726,0.08746832571864793,0.046400951814396206,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
32,1.1,7,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery contribute to lowering serum lipid levels among patients with obstructive sleep apnea? The procedure may enhance blood lipid levels in individuals with OSA, particularly those exhibiting preoperative dyslipidemia, potentially providing major metabolic and cardiovascular advantages. Prospective investigations should be pursued.",4.737194547137081e-08,0.0464997358688235,0.06620464009518144,0.0036268529295637453,0.016850758504693975,0.046400951814396206,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
32,1.1,8,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Will serum lipid levels decrease in obstructive sleep apnea patients following airway surgery? Surgical treatment might improve lipid profiles in patients with OSA, especially in those with existing dyslipidemia before surgery, possibly producing significant metabolic and cardiovascular benefits. Future prospective studies should explore this.",2.3685972735685406e-08,0.1030372418771095,0.09,0.0018134264647818726,0.04094831008375399,0.046400951814396206,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
32,1.1,9,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Is it possible for airway surgery to decrease serum lipid levels in obstructive sleep apnea patients? Surgery may positively affect blood lipid levels in OSA, especially when dyslipidemia is present preoperatively, potentially resulting in substantial metabolic and cardiovascular benefits. Prospective studies are recommended to assess this.",2.3685972735685406e-08,0.08688653323742734,0.045651703623580314,0.0018134264647818726,0.055961635693195344,0.023685970743547096,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
32,1.1,10,human,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: Surgery may improve blood lipid levels in patients with OSA, especially in patients with preoperative dyslipidemia, potentially yielding a major benefit in metabolism and cardiovascular sequelae. Prospective studies should examine this","Does airway surgery have a role in reducing serum lipid levels in obstructive sleep apnea patients? Surgery could improve blood lipid parameters in OSA patients, particularly in those with preoperative dyslipidemia, potentially leading to important metabolic and cardiovascular benefits. This requires evaluation through prospective studies.",0.0,0.12602676010180902,0.09,0.0,0.06447880749394841,0.046400951814396206,0.0,0.0,0.0,0.0,0.0,0.0
33,1.1,1,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Is it possible for computerized tomography to replace bone scintigraphy in identifying bone metastases from breast cancer? Our results indicate that routine bone scintigraphy is unnecessary for patients with metastatic breast cancer if CT scans of the thorax, abdomen, and pelvis are conducted.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
33,1.1,2,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Can CT scans substitute bone scintigraphy for detecting bone metastases in breast cancer cases? The evidence suggests that routine bone scintigraphy isn't needed for metastatic breast cancer patients when thorax, abdomen, and pelvis CT imaging is done.",2.36859727356853e-08,0.04884547642885284,0.055363321799307974,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
33,1.1,3,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Does computerized tomography have the potential to replace bone scintigraphy in the detection of bone metastases from breast cancer? According to our data, routine bone scintigraphy isn't required if a CT scan covering the thorax, abdomen, and pelvis is performed.",9.47438909427412e-08,0.07266757538074708,0.025623268698060954,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
33,1.1,4,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Can computerized tomography supplant bone scintigraphy for the purpose of detecting bone metastases from breast cancer? Our findings show that routine bone scintigraphy can be omitted for patients presenting with metastatic breast cancer if CT imaging of the thorax, abdomen, and pelvis has been carried out.",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
33,1.1,5,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Can bone scintigraphy be replaced by computerized tomography in diagnosing bone metastases resulting from breast cancer? The results indicate that if CT scans of the thorax, abdomen, and pelvis are performed, routine bone scintigraphy is not necessary in metastatic breast cancer patients.",1.421158364141119e-07,0.12441194762660457,0.024375,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,1.1,6,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Is routine bone scintigraphy necessary for detecting bone metastases from breast cancer when computerized tomography is performed? Our study suggests that CT scans of the thorax, abdomen, and pelvis may eliminate the need for routine bone scintigraphy in metastatic breast cancer cases.",1.421158364141119e-07,0.05678783245002483,0.07271468144044323,0.010880558788691243,0.12786157046977786,0.02498356344510192,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
33,1.1,7,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Can computerized tomography replace the need for bone scintigraphy in identifying bone metastases in breast cancer patients? Our findings imply that routine bone scintigraphy is avoidable if CT scans of the thorax, abdomen, and pelvis are conducted.",2.36859727356853e-08,0.010337299731077998,0.02775510204081633,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
33,1.1,8,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Can CT imaging of the thorax, abdomen, and pelvis stand in place of bone scintigraphy for detecting bone metastases from breast cancer? Evidence from our research suggests that routine bone scintigraphy may not be necessary for patients with metastatic breast cancer when CT is performed.",2.1317375462116813e-07,0.1973348824033958,0.02271498107084911,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
33,1.1,9,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Does conducting computerized tomography scans of the thorax, abdomen, and pelvis negate the routine use of bone scintigraphy for detecting bone metastases in breast cancer patients? Our results suggest it can.",1.184298636784265e-07,0.1541506798272585,0.0,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
33,1.1,10,human,"Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Our findings suggest routine BS of patients presenting with MBC is not required if CT (thorax, abdomen, and pelvis) is performed.","Is computerized tomography an effective alternative to bone scintigraphy for the detection of bone metastases originating from breast cancer? Our findings recommend that routine bone scintigraphy is unnecessary if CT imaging of the thorax, abdomen, and pelvis is conducted.",7.10579182070559e-08,0.04575666768118669,0.026296566837107373,0.005440279394345625,0.08455738802806367,0.0,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
34,1.1,1,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: Is pain a significant issue in general adult psychiatry? Answer: Yes, pain is an important clinical concern in general adult psychiatry because it frequently coexists with mental health disorders like depression, anxiety, and PTSD. Addressing pain in conjunction with psychiatric symptoms is essential for thorough patient treatment and better outcomes.",4.737194547137081e-08,0.06528455406960143,0.07349099453896243,0.0036268529295637453,0.06761415560529294,0.07648160181684521,0.003621603081905733,0.07008155436933672,0.07939508506616257,4.737194547137081e-08,0.04320246856595489,0.060964083175803374
34,1.1,2,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: Does pain pose a clinically relevant problem in adult psychiatry? Answer: Indeed, pain is a clinically relevant challenge in general adult psychiatry since it is commonly linked with mental health issues such as depression, anxiety, and post-traumatic stress disorder. Managing pain alongside psychiatric symptoms is vital for effective patient care and recovery.",0.0,0.10663802777845266,0.075021550094518,0.0,0.10872896949959987,0.07728090737240077,0.0,0.11090354888959109,0.07939508506616257,0.0,0.08487516496652381,0.060964083175803374
34,1.1,3,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: Is pain an important clinical problem in general adult psychiatry? Answer: Yes, pain is a critical clinical issue in general adult psychiatry as it often accompanies mental illnesses like depression, anxiety, and PTSD. Treating pain along with psychiatric symptoms is necessary for comprehensive care and improved patient health.",9.474389094274162e-08,0.022152068947480785,0.07183364839319474,0.0072537058591274906,0.02473755615555362,0.07561436672967867,0.007243206163811466,0.027521939950540197,0.07939508506616257,9.474389094274162e-08,0.0002826433737834755,0.060964083175803374
34,1.1,4,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: Does pain constitute a clinically relevant concern in general adult psychiatry? Answer: Pain is certainly a relevant clinical concern in general adult psychiatry due to its frequent association with psychiatric conditions such as depression, anxiety, and PTSD. Effectively addressing pain alongside mental health symptoms is key to holistic patient management.",4.737194547137081e-08,0.03755866684720388,0.05366600459881857,0.0036268529295637453,0.039322433949785296,0.05613848998896933,0.003621603081905733,0.04120042184600603,0.05857118284796428,4.737194547137081e-08,0.04320246856595489,0.060964083175803374
34,1.1,5,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: Is pain a problem of clinical significance in adult psychiatry? Answer: Yes, pain has clinical significance in adult psychiatry because it is often related to mental health conditions including depression, anxiety, and post-traumatic stress disorder. Proper treatment of pain combined with psychiatric symptoms is crucial for complete patient care.",7.105791820705622e-08,0.015658456230354556,0.052457466918714626,0.005440279394345618,0.01752432501140344,0.055293005671077505,0.0054324046228586,0.019532520466825076,0.05812854442344047,7.105791820705622e-08,0.02169626334499153,0.060964083175803374
34,1.1,6,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: In general adult psychiatry, is pain considered a clinically relevant issue? Answer: Pain is considered clinically relevant in general adult psychiatry as it commonly occurs with mental health disorders such as depression, anxiety, and PTSD. Integrating pain management with psychiatric care is essential for optimal patient treatment.",1.1842986367842703e-07,0.029625949317725997,0.04988849224327835,0.009067132323909363,0.0025901417018801,0.07515251231067237,0.009054007704764333,0.005543033231765193,0.07939508506616257,1.1842986367842703e-07,0.02275549922584119,0.060964083175803374
34,1.1,7,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: Is pain a noteworthy clinical problem in the context of adult psychiatry? Answer: Yes, pain is acknowledged as a noteworthy clinical problem in adult psychiatry given its frequent links to conditions like depression, anxiety, and PTSD. Addressing pain together with psychiatric symptoms improves patient care quality.",1.4211583641411244e-07,0.08319261617420937,0.027253749641003244,0.010880558788691236,0.08167155515416535,0.030554376760155877,0.0108648092457172,0.07994320267119726,0.03404361114326007,1.4211583641411244e-07,0.07798442119751492,0.03772145279031585
34,1.1,8,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: Is pain regarded as a clinically important problem in general adult psychiatry? Answer: Pain is recognized as clinically important in general adult psychiatry because it typically co-occurs with mental health disorders such as depression, anxiety, and post-traumatic stress disorder. Managing pain alongside psychiatric symptoms is critical for holistic patient treatment.",4.737194547137081e-08,0.03755866684720388,0.05366600459881857,0.0036268529295637453,0.06761415560529294,0.07648160181684521,0.003621603081905733,0.07008155436933672,0.07939508506616257,4.737194547137081e-08,0.04320246856595489,0.060964083175803374
34,1.1,9,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: In adult psychiatry, does pain represent a clinically relevant issue? Answer: Absolutely, pain represents a clinically relevant issue in adult psychiatry since it is often associated with psychiatric disorders including depression, anxiety, and PTSD. Treating pain together with mental health symptoms is fundamental for comprehensive care.",1.4211583641411244e-07,0.053055782236820725,0.04852160417780625,0.010880558788691236,0.02005847243772596,0.07467016357074788,0.0108648092457172,0.016929822620292523,0.07939508506616257,1.4211583641411244e-07,0.045745017450540715,0.060964083175803374
34,1.1,10,ai,"Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: Yes, pain is a clinically relevant problem in general adult psychiatry as it is often associated with mental health conditions such as depression, anxiety, and post-traumatic stress disorder. Treating pain alongside psychiatric symptoms is crucial for comprehensive patient care and improving","Question: Is pain considered a clinically significant problem in general adult psychiatry? Answer: Yes, pain is clinically significant in general adult psychiatry as it is commonly linked with mental health conditions like depression, anxiety, and post-traumatic stress disorder. Comprehensive patient care involves addressing both pain and psychiatric symptoms.",1.1842986367842703e-07,0.029625949317725997,0.04988849224327835,0.009067132323909363,0.0025901417018801,0.07515251231067237,0.009054007704764333,0.005543033231765193,0.07939508506616257,1.1842986367842703e-07,0.02275549922584119,0.060964083175803374
35,1.1,1,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do preoperative statins decrease the incidence of atrial fibrillation following coronary artery bypass grafting? Answer: Our research suggests that statin therapy before surgery appears to lower the risk of AF after CABG.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
35,1.1,2,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,"Question: Can preoperative statins prevent atrial fibrillation after coronary artery bypass graft surgery? Answer: According to our study, taking statins before the operation seems to reduce the chance of developing AF post-CABG.",1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
35,1.1,3,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is the use of preoperative statins effective in reducing atrial fibrillation after coronary artery bypass surgery? Answer: Our investigation revealed that preoperative statin treatment may lessen AF occurrence after CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,1.1,4,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do statins administered preoperatively help mitigate atrial fibrillation post-coronary artery bypass grafting? Answer: The findings from our study indicate that pre-surgical statin use appears to diminish AF development post-CABG.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
35,1.1,5,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does preoperative statin therapy lower the risk of atrial fibrillation following CABG surgery? Answer: Our results suggest that preoperative use of statins seems to decrease the onset of AF after CABG.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
35,1.1,6,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Can administering statins before CABG reduce the incidence of atrial fibrillation? Answer: Our study's data implies that statin therapy prior to CABG appears to reduce AF occurrence.,2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
35,1.1,7,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Are preoperative statins linked to a reduction in atrial fibrillation after coronary artery bypass grafting? Answer: Findings from our study suggest preoperative statin therapy seems to prevent AF development post-CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,1.1,8,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Do patients given statins before coronary artery bypass surgery experience less atrial fibrillation? Answer: Our research indicates that preoperative statin use seems to reduce the development of AF following CABG.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
35,1.1,9,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Does the use of statins before CABG surgery reduce the incidence of atrial fibrillation? Answer: Our study suggests that patients treated with statins preoperatively appear to have a lower chance of AF after CABG.,1.894877818854824e-07,0.2682639865946794,0.0,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
35,1.1,10,human,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: Our study indicated that preoperative statin therapy seems to reduce AF development after CABG.,Question: Is preoperative statin treatment associated with decreased atrial fibrillation after coronary artery bypass grafting? Answer: The study results indicate that preoperative statin therapy seems to reduce the development of AF after CABG.,1.421158364141118e-07,0.16431766599324638,0.031217481789802305,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
36,1.1,1,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals useful and applicable to practitioners and athletes? There's a lack of studies focusing on diagnostic and treatment interventions in sports medicine literature. The evidence base in this field needs to grow both in quantity and quality.,1.1842986367842692e-07,0.08126861372982042,0.06734725284388915,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,1.1,2,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do sports medicine journals hold relevance and applicability for practitioners and athletes? The sports medicine literature shows a shortage of research on diagnostic and treatment interventions. It is essential to expand the evidence base in sports medicine both in volume and quality.,7.105791820705622e-08,0.0760984489201686,0.006963732238457573,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
36,1.1,3,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals pertinent and practical for use by practitioners and athletes? There is a scarcity of studies concerning diagnostic and therapeutic interventions within sports medicine literature. Increasing the amount and quality of evidence in sports medicine remains necessary.,1.1842986367842692e-07,0.13023124206019032,0.012215745806479397,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,1.1,4,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Is the content of sports medicine journals relevant and applicable to athletes and practitioners? Few studies exist on diagnostic and treatment interventions in the body of sports medicine research. Continued growth in both the quantity and quality of evidence is required.,9.474389094274162e-08,0.08971951454203886,0.04310902569707476,0.0072537058591274906,0.1331844788234018,0.025623268698060954,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,1.1,5,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Do practitioners and athletes find sports medicine journals relevant and applicable? The sports medicine field lacks sufficient studies on diagnostic and treatment methods. It's important to develop a larger and higher-quality evidence base for sports medicine.,2.1317375462116813e-07,0.19354459942827873,0.06442380873918194,0.01632083818303686,0.23483959107740038,0.0,0.016297213868575813,0.24116205681688774,0.0,2.1317375462116866e-07,0.2478361639045814,0.0
36,1.1,6,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are sports medicine journals applicable and relevant to practitioners and athletes? The literature reveals a deficiency of research addressing diagnosis and treatment interventions. There is a need to enhance both the volume and the quality of evidence supporting sports medicine.,1.1842986367842692e-07,0.04572260447033649,0.0929705215419501,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
36,1.1,7,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Is the relevance of sports medicine journals clear to practitioners and athletes? There are limited studies on diagnostic and treatment strategies within the sports medicine literature. Efforts must persist to augment the quantity and quality of the evidence base.,1.4211583641411222e-07,0.10817952142938081,0.06667395470484272,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
36,1.1,8,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are journals covering sports medicine relevant and useful to athletes and practitioners? A gap remains where few studies focus on diagnostic or treatment interventions in this area. The evidence supporting sports medicine should continue to grow in both scope and standard.,9.474389094274162e-08,0.055062155514041144,0.06798695809684818,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,1.1,9,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Are publications in sports medicine journals meaningful and applicable to practitioners and athletes? Research on diagnostic and treatment interventions is sparse in current sports medicine literature. The field requires a continuous increase in the volume and quality of its evidence base.,9.474389094274162e-08,0.055062155514041144,0.06798695809684818,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
36,1.1,10,human,Question: Are sports medicine journals relevant and applicable to practitioners and athletes? Answer: There is a dearth of studies addressing diagnostic and treatment interventions in the sports medicine literature. The evidence base for sports medicine must continue to increase in terms of volume and quality.,Does the sports medicine literature serve as a relevant and applicable resource for athletes and practitioners? There is a notable scarcity of studies on diagnosis and treatment within this field. The expansion of the evidence base in sports medicine in both degree and caliber is crucial.,2.3685972735685406e-08,0.06657169781211891,0.07075977774029721,0.0018134264647818726,0.022989518224699523,0.0,0.0018108015409528666,0.023530497410194418,0.0,2.3685972735685406e-08,0.024097551579060017,0.0
37,1.1,1,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? This research indicated for the first time that RALP causes less tissue damage than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,1.1,2,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy result in less invasiveness than retropubic radical prostatectomy? The study demonstrated initially that RALP leads to reduced tissue trauma relative to RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,1.1,3,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is RALP considered a less invasive procedure than retropubic radical prostatectomy? This investigation revealed for the first time that robotically assisted laparoscopic radical prostatectomy results in lower tissue injury than RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,1.1,4,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy (RALP) less invasive than retropubic radical prostatectomy (RRP)? The study showed for the first time that RALP produces less tissue trauma than RRP.,0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,1.1,5,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Does robotically assisted laparoscopic radical prostatectomy cause less invasiveness than retropubic radical prostatectomy? This study was the first to show that RALP induces less tissue trauma than RRP.,2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,1.1,6,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? This study provided initial evidence that RALP results in less tissue trauma compared to RRP.,4.73719454713706e-08,0.06899287148695077,0.0,0.003626852929563759,0.07145896398214369,0.0,0.003621603081905747,0.07410797215372167,0.0,4.737194547137081e-08,0.07696104113612945,0.0
37,1.1,7,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotic-assisted laparoscopic radical prostatectomy a less invasive technique than retropubic radical prostatectomy? The study showed for the first time that RALP causes significantly less tissue trauma than RRP.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
37,1.1,8,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,"Compared to retropubic radical prostatectomy, is robotically assisted laparoscopic radical prostatectomy less invasive? This study revealed for the first time that RALP induces less tissue trauma than RRP.",2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
37,1.1,9,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotic-assisted laparoscopic radical prostatectomy associated with reduced invasiveness relative to retropubic radical prostatectomy? This research demonstrated for the first time that RALP produces a lower degree of tissue trauma than RRP.,7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
37,1.1,10,human,Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: This study showed for the first time that RALP induces lower tissue trauma than RRP.,Is robotically assisted laparoscopic radical prostatectomy less invasive when compared to retropubic radical prostatectomy? The study evidenced for the first time that RALP leads to less tissue trauma than RRP.,2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
38,1.1,1,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there an optimal duration of acid suppression for maximum healing in Los Angeles grades C and D reflux oesophagitis? Answer: After 4 weeks of acid-suppressive treatment for LA grade C or D oesophagitis, healing reaches a plateau beyond which further improvements are unlikely despite prolonged intragastric pH>4 periods.",3.079176455639103e-07,0.23531408693446476,0.0,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,1.1,2,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the ideal acid suppression time for optimal healing of Los Angeles grades C and D reflux oesophagitis? Answer: Healing following 4 weeks of acid-suppressive therapy in LA grade C or D oesophagitis plateaus, with minimal additional benefits even if the duration of intragastric pH>4 is extended.",3.316036182995957e-07,0.2559333741372005,0.0,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
38,1.1,3,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: For Los Angeles grades C and D reflux oesophagitis, is there a best timing of acid suppression to maximize healing? Answer: After 4 weeks of therapy reducing acid in LA grade C or D oesophagitis, successful healing reaches a maximum threshold; extending the time with intragastric pH>4 does not substantially enhance recovery.",2.3685972735685406e-07,0.1758906664636637,0.0,0.018134264647818726,0.17904823144898518,0.0,0.018108015409528666,0.182321556793954,0.0,2.3685972735685406e-07,0.1857171457950919,0.0
38,1.1,4,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Does an optimal duration of acid suppression exist for maximal healing in Los Angeles grades C and D reflux oesophagitis? Answer: In LA grade C or D oesophagitis, after 4 weeks of acid-suppressing treatment, healing levels off and increasing hours with intragastric pH above 4 yields minimal further improvement.",3.079176455639103e-07,0.23531408693446476,0.0,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,1.1,5,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is four weeks the optimal time for acid suppression in healing Los Angeles grades C and D reflux oesophagitis? Answer: Successful healing of LA grade C or D oesophagitis generally plateaus after 4 weeks of acid suppression, with little likelihood of additional gains by further increasing intragastric pH>4 duration.",3.079176455639103e-07,0.23531408693446476,0.0,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,1.1,6,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the healing model regarding acid suppression duration in Los Angeles grades C and D reflux oesophagitis? Answer: Healing in LA grade C or D oesophagitis reaches a threshold after 4 weeks of acid suppression, and additional increments in intragastric pH>4 time typically do not improve outcomes.",3.316036182995957e-07,0.2559333741372005,0.0,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
38,1.1,7,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: Is there an optimal acid suppression period for maximal healing of grades C and D reflux oesophagitis according to the LA classification? Answer: After 4 weeks of acid-suppressive therapy in LA grade C or D oesophagitis, healing plateaus and further increased intragastric pH>4 exposure rarely leads to more improvement.",3.079176455639103e-07,0.23531408693446476,0.0,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
38,1.1,8,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: How long should acid suppression be applied to maximize healing in Los Angeles grades C and D reflux oesophagitis? Answer: Following 4 weeks of acid suppression therapy, healing for LA grade C or D oesophagitis reaches a plateau where longer periods of intragastric pH>4 provide minimal benefit.",3.552895910352811e-07,0.30648240803971216,0.0212665406427221,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,1.1,9,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.",Question: A model investigating acid suppression duration for healing Los Angeles grades C and D reflux oesophagitis: what is the optimal time? Answer: Healing improvements after 4 weeks of acid-suppressive therapy in LA grade C or D oesophagitis do not substantially increase despite longer durations of intragastric pH>4.,3.552895910352811e-07,0.2769867833350337,0.0,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
38,1.1,10,human,"Question: A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? Answer: After 4 weeks' acid-suppressive therapy for LA grade C or D oesophagitis, successful healing appears to reach a threshold above which improvements are unlikely to be achieved despite an increase in number of hours with intragastric pH>4.","Question: What is the effective duration of acid suppression treatment required for Los Angeles grades C and D reflux oesophagitis to heal maximally? Answer: Treatment of LA grade C or D oesophagitis with acid suppression beyond 4 weeks rarely results in further healing benefits, despite increased hours of intragastric pH>4.",3.079176455639103e-07,0.26360580858997285,0.020399305555555556,0.023574544042164344,0.23967285326541932,0.0,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
39,1.1,1,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Does viral infection contribute to benign paroxysmal positional vertigo? BPPV is linked to positive viral serology, especially in spring and autumn. Viral infections may trigger BPPV attacks by causing vestibulopathy or lead to secondary BPPV through viral neurolabyrinthitis.",3.3160361829959537e-07,0.3209077200800996,0.0,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
39,1.1,2,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is there a connection between viral infections and benign paroxysmal positional vertigo? BPPV correlates with viral serology positivity, mainly seen in spring and autumn months. Viral infections could incite BPPV due to vestibulopathy development or cause secondary BPPV by viral neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,1.1,3,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",Are viral infections involved in benign paroxysmal positional vertigo? BPPV shows association with positive viral serology particularly during spring and fall seasons. Viral infections might provoke BPPV via vestibulopathy or induce secondary BPPV caused by viral-induced neurolabyrinthitis.,3.5528959103528067e-07,0.38681487096598977,0.02775510204081633,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,1.1,4,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections play a role in benign paroxysmal positional vertigo? There is an association between BPPV and positive viral serology, especially in the spring and autumn months. Viral infections might trigger BPPV attacks due to vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",1.8948778188548325e-07,0.2028649207777371,0.023242630385487524,0.014507411718254981,0.17435338714477755,0.0,0.014486412327622933,0.17824823140631896,0.0,1.8948778188548325e-07,0.1823215567939549,0.0
39,1.1,5,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Can viral infections influence benign paroxysmal positional vertigo? BPPV is connected to positive viral serology, notably in certain months like spring and autumn. Viral infections may lead to BPPV attacks via the emergence of vestibulopathy or cause secondary BPPV through viral neurolabyrinthitis.",2.3685972735685406e-07,0.2520656236083072,0.024375,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
39,1.1,6,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Is benign paroxysmal positional vertigo related to viral infections? BPPV is associated with positive viral serology, especially during spring and autumn. Viral infections could induce BPPV attacks by developing vestibulopathy or cause secondary BPPV through virus-related neurolabyrinthitis.",3.5528959103528067e-07,0.3483066942682149,0.0,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,1.1,7,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Does benign paroxysmal positional vertigo have a viral infection component? There is a link between BPPV and positive viral serology, particularly in spring and autumn. Viral infections might cause BPPV attacks by leading to vestibulopathy or induce secondary BPPV through viral neurolabyrinthitis.",2.3685972735685406e-07,0.21825356602001733,0.0,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
39,1.1,8,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.",Are viral infections a factor in benign paroxysmal positional vertigo? BPPV shows a correlation with positive viral serology mainly observed in the spring and autumn months. Viral infections may promote BPPV by developing vestibulopathy or trigger secondary BPPV via viral neurolabyrinthitis.,2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
39,1.1,9,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Could viral infections contribute to benign paroxysmal positional vertigo? BPPV is connected to positive viral serology, predominantly during spring and autumn. Viral infections might cause BPPV through vestibulopathy or secondary BPPV as a result of viral neurolabyrinthitis.",3.5528959103528067e-07,0.38681487096598977,0.02775510204081633,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
39,1.1,10,human,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: BPPV is associated with positive viral serology, particularly during certain months of the year, mainly in spring and autumn. Viral infection might promote BPPV attacks due to the development of vestibulopathy or induce secondary BPPV via viral infection-related neurolabyrinthitis.","Do viral infections have any role in benign paroxysmal positional vertigo? BPPV is linked with positive viral serology, mainly in the months of spring and autumn. Viral infections may facilitate BPPV attacks via vestibulopathy or initiate secondary BPPV via virus-associated neurolabyrinthitis.",2.6054570009253947e-07,0.2776035376383854,0.02498356344510192,0.0199476911126006,0.248461359298501,0.0,0.019918816950481533,0.25423413838424036,0.0,2.6054570009253947e-07,0.26028309826366547,0.0
40,1.1,1,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in healthy adults at risk for Type 2 diabetes? In those with skin microvascular dysfunction, maximal oxygen uptake was not lower compared to healthy controls. Yet, within this 'at-risk' group, higher aerobic fitness correlated with improved microvascular and endothelial function.",2.3685972735685406e-07,0.1810665327796479,0.014101110950928097,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
40,1.1,2,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is microvascular function influenced by aerobic fitness in healthy adults at risk for Type 2 diabetes? Among individuals with skin microvascular impairment, maximal oxygen uptake did not differ from healthy controls. Nevertheless, greater aerobic fitness in the 'at-risk' individuals was linked to enhanced microvascular and endothelial response.",2.1317375462116866e-07,0.18855475257743093,0.007076574999485136,0.016320838183036854,0.21312809815217548,0.02221074380165289,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,1.1,3,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness impact microvascular function in healthy adults predisposed to Type 2 diabetes? The 'at-risk' adults with skin microvascular dysfunction showed no reduction in maximal oxygen uptake compared to healthy controls. However, higher aerobic fitness within this group was associated with better microvascular and endothelial function.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
40,1.1,4,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","In healthy adults at risk of Type 2 diabetes, does aerobic fitness alter microvascular function? Those with skin microvascular dysfunction in this 'at-risk' population had comparable maximal oxygen uptake to controls. Still, those with greater aerobic fitness exhibited superior microvascular and endothelial responsiveness.",3.079176455639103e-07,0.2852668801045639,0.011188145247419026,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
40,1.1,5,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","How does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Maximal oxygen uptake was not diminished in the 'at-risk' group with skin microvascular dysfunction relative to healthy controls. Yet, higher aerobic fitness was linked to improved microvascular and endothelial function within this group.",1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
40,1.1,6,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness play a role in microvascular function among healthy adults at risk of Type 2 diabetes? In this group with skin microvascular issues, maximal oxygen uptake was not decreased versus healthy controls. Still, individuals with higher aerobic fitness among the 'at-risk' had enhanced microvascular and endothelial responsiveness.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,1.1,7,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Is there an effect of aerobic fitness on microvascular function in healthy adults at risk for Type 2 diabetes? Maximal oxygen uptake was similar between 'at-risk' individuals with skin microvascular dysfunction and healthy controls. However, within the 'at-risk' group, those fitter aerobically had better microvascular and endothelial responses.",1.8948778188548325e-07,0.10677487948168984,0.03631185475258099,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
40,1.1,8,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Can aerobic fitness influence microvascular function in healthy adults susceptible to Type 2 diabetes? Among 'at-risk' adults with skin microvascular dysfunction, maximal oxygen uptake levels matched those of healthy controls. However, higher aerobic fitness correlated with improved microvascular and endothelial functionality in this group.",2.8423167282822487e-07,0.22796176924515965,0.013069224367093464,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
40,1.1,9,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","Does aerobic fitness affect microvascular function in individuals at risk for Type 2 diabetes but otherwise healthy? The 'at-risk' group with skin microvascular dysfunction did not show reduced maximal oxygen uptake compared to controls. However, greater aerobic fitness within this group was associated with better microvascular and endothelial responses.",1.6580180914979784e-07,0.11460260280718737,0.015487952534382704,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
40,1.1,10,human,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: In this 'at-risk' group with skin microvascular dysfunction maximal oxygen uptake was not reduced compared with healthy controls. However, in the 'at-risk' group alone, individuals with higher levels of aerobic fitness also had better microvascular and endothelial responsiveness.","In healthy adults at risk for Type 2 diabetes, does aerobic fitness impact microvascular function? Maximal oxygen uptake was not reduced in individuals with skin microvascular dysfunction compared to healthy controls. Yet higher aerobic fitness was linked to improved microvascular and endothelial responsiveness in the 'at-risk' group.",2.1317375462116866e-07,0.15841791864004184,0.01458345969085259,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
41,1.1,1,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) criteria for psychosis: do varying degrees of risk exist for progressing to psychosis? Answer: Our findings indicate that UHR intake criteria forecast transition within 6 months ranked as Trait only < APS < BLIPS. The observation that BLIPS patients have the greatest short-term transition risk aligns with the 'early' versus 'late' prodrome concept, suggesting...",1.4211583641411244e-07,0.07677922342075583,0.015621063240110858,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
41,1.1,2,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Regarding ultra high risk (UHR) criteria for psychosis, are there distinct risk levels for conversion to psychosis? Answer: Our evidence shows UHR intake criteria predict six-month transition risk in this sequence: Trait alone less than APS, which is less than BLIPS. The highest short-term risk seen in BLIPS patients supports the 'early' versus 'late' prodrome model and further implies...",1.1842986367842703e-07,0.08318130465670848,0.0013230509097107834,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
41,1.1,3,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: For ultra high risk (UHR) psychosis criteria, is there a variation in the risk levels for transitioning to psychosis? Answer: Data reveal UHR criteria predict psychosis onset over six months following a hierarchy: Trait alone < APS < BLIPS. The elevated immediate risk in BLIPS aligns with distinctions between 'early' and 'late' prodrome, indicating that...",2.1317375462116866e-07,0.12988904873470375,0.015621063240110858,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
41,1.1,4,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Does the ultra high risk (UHR) classification for psychosis encompass differing degrees of transition risk? Answer: Our data estimate the likelihood of transition within six months according to UHR criteria, ordered as Trait alone < APS < BLIPS. Notably, BLIPS participants show the highest short-term transition probability, which is consistent with the theory contrasting 'early' versus 'late' prodromal phases, implying...",9.474389094274162e-08,0.06598257776373995,0.0010408155303573991,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
41,1.1,5,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates",Question: Are there multiple risk strata within ultra high risk (UHR) criteria for psychosis conversion? Answer: Findings suggest six-month transition risk predicted by UHR intake falls in the order Trait only < APS < BLIPS. The maximum risk seen among BLIPS patients supports the 'early' vs. 'late' prodromal model and suggests...,3.316036182995957e-07,0.2251992285390294,0.015621063240110858,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
41,1.1,6,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) psychosis criteria: is there a gradient in risk levels leading to psychosis? Answer: Our results indicate that the risk of transition over six months ranks from lowest to highest as Trait alone, then APS, then BLIPS. The fact that BLIPS individuals face the highest short-term risk accords with the 'early' and 'late' prodrome framework, revealing that...",9.474389094274162e-08,0.042877671745075396,0.015621063240110858,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
41,1.1,7,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: In ultra high risk (UHR) for psychosis criteria, are different risks for psychosis transition recognized? Answer: According to our analysis, UHR criteria predict six-month transition risks in the ascending order Trait alone < APS < BLIPS. The greater susceptibility to rapid transition observed in BLIPS cases aligns well with the 'early' versus 'late' prodrome hypothesis, indicating that...",1.6580180914979784e-07,0.11849191983648222,0.001917202066011597,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
41,1.1,8,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates",Question: Are distinct progression risks identified within ultra high risk (UHR) criteria for psychosis? Answer: Data demonstrates the risk of transitioning to psychosis within six months follows this pattern: Trait alone < APS < BLIPS. The highest risk present in BLIPS patients conforms to the 'early' versus 'late' prodrome distinction. This suggests that...,2.8423167282822487e-07,0.18597851538574695,0.015621063240110858,0.02176111757738247,0.21130909366720996,0.0,0.0217296184914344,0.21511137961694615,0.0,2.8423167282822487e-07,0.21905356606268356,0.0
41,1.1,9,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Ultra high risk (UHR) criteria for psychosis: do varying transition risks exist across categories? Answer: Our data support that transition to psychosis in six months is most likely in BLIPS, less in APS, and least in Trait only categories. This aligns with the concept of an 'early' versus 'late' prodromal phase, demonstrating that...",2.6054570009253947e-07,0.16693032041505385,0.015621063240110858,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
41,1.1,10,human,"Question: Ultra high risk (UHR) for psychosis criteria: are there different levels of risk for transition to psychosis? Answer: Our data suggest that UHR intake criteria predict transition over 6 months in the order of Trait alone<APS<BLIPS. The fact that BLIPS patients are at the highest risk of transition over the short term is consistent with the ""early"" versus ""late"" prodrome model. It also indicates","Question: Are there progressive levels of psychosis risk in the ultra high risk (UHR) criteria? Answer: Evidence from our study shows six-month psychosis transition risk is stratified as Trait alone < APS < BLIPS. The elevated short-term transition rate found in BLIPS individuals is consistent with the delineation between 'early' and 'late' prodrome stages, signifying that...",2.1317375462116866e-07,0.12988904873470375,0.015621063240110858,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
42,1.1,1,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: Is the preoperative platelet count a prognostic indicator in esophageal squamous cell carcinoma? Answer: The preoperative platelet count in esophageal squamous cell carcinoma might serve as a prognostic marker, potentially reflecting the risk of disease progression and overall survival, though additional studies are necessary to clarify this association.",4.737194547137081e-08,0.010717861529098371,0.06023166752324571,0.0036268529295637453,0.018196586941742865,0.016353210804142468,0.003621603081905733,0.012691247799749839,0.03925619834710743,4.737194547137081e-08,0.04500176217429708,0.06353305785123965
42,1.1,2,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: Can preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? Answer: It is possible that the preoperative platelet count acts as a prognostic factor in esophageal squamous cell carcinoma, suggesting the likelihood of disease progression and survival rates. However, more research is required to fully elucidate this link.",2.3685972735685406e-08,0.07061074505941489,0.10109091846104842,0.0018134264647818726,0.034195923504811265,0.038500918273645504,0.0018108015409528666,0.06497549619081244,0.06137808745645146,2.3685972735685406e-08,0.06698066889307208,0.06353305785123965
42,1.1,3,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: Does preoperative platelet count influence prognosis in esophageal squamous cell carcinoma? Answer: The platelet count measured before surgery in esophageal squamous cell carcinoma could be indicative of the patient’s prognosis, including chances of disease progression and survival, but further investigation is needed to confirm this relationship.",9.474389094274162e-08,0.02834311596586714,0.11564625850340139,0.0072537058591274906,0.005312282779206701,0.05637484411944804,0.007243206163811466,0.0029935369217577446,0.05992964702832444,9.474389094274162e-08,0.0004606119024601618,0.06353305785123965
42,1.1,4,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: Is preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? Answer: Preoperative platelet count may be a useful prognostic factor in esophageal squamous cell carcinoma, indicating the potential for disease progression and overall survival. Additional research is necessary to understand this fully.",1.4211583641411244e-07,0.11610814103357425,0.048417419073789825,0.010880558788691236,0.15035859287439512,0.013542787481971533,0.0108648092457172,0.11702788832547784,0.011638710939410254,1.4211583641411244e-07,0.11571277606829433,0.014880855352883311
42,1.1,5,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: Could the preoperative platelet count predict prognosis in esophageal squamous cell carcinoma? Answer: Preoperative platelet count might be a marker for prognostic evaluation in esophageal squamous cell carcinoma, reflecting the risk of disease progression and patient survival, though more studies are needed to comprehend this link.",9.474389094274162e-08,0.0017937179715215024,0.09473493938523261,0.0072537058591274906,0.0361188241374264,0.034396609883622836,0.007243206163811466,0.0029935369217577446,0.05992964702832444,9.474389094274162e-08,0.0004606119024601618,0.06353305785123965
42,1.1,6,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: What is the prognostic value of preoperative platelet count in esophageal squamous cell carcinoma? Answer: The preoperative platelet count might have prognostic value in esophageal squamous cell carcinoma by indicating the likelihood of disease progression and overall survival, but further research is essential to validate this.",9.474389094274162e-08,0.03193055190891059,0.07431405895691615,0.0072537058591274906,0.0361188241374264,0.034396609883622836,0.007243206163811466,0.0029935369217577446,0.05992964702832444,9.474389094274162e-08,0.0004606119024601618,0.06353305785123965
42,1.1,7,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: Is the preoperative platelet count linked to prognosis in esophageal squamous cell carcinoma? Answer: Preoperative platelet count may relate to prognosis in esophageal squamous cell carcinoma, suggesting risks related to disease progression and survival; however, more research is crucial to fully understand this.",1.6580180914979784e-07,0.14422665530892864,0.04517825648778037,0.012693985253473108,0.17772711454018264,0.016150489891276154,0.012675610786670066,0.14354058687512916,0.00992994665873033,1.6580180914979784e-07,0.1420959915380804,0.013671562006364317
42,1.1,8,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: How does preoperative platelet count affect prognosis in esophageal squamous cell carcinoma? Answer: It is possible that preoperative platelet count impacts prognosis in esophageal squamous cell carcinoma by reflecting the chance of disease progression and overall survival, requiring further study for evidence.",1.8948778188548325e-07,0.14012337807886022,0.06292517006802728,0.014507411718254981,0.17203785348193845,0.004302395426473982,0.014486412327622933,0.1361117447566249,0.03278313225429822,1.8948778188548325e-07,0.13364509072586195,0.0379097891531787
42,1.1,9,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: Does preoperative platelet count serve as a prognostic factor in esophageal squamous cell carcinoma? Answer: The preoperative platelet count could potentially serve as a prognostic indicator in esophageal squamous cell carcinoma for disease progression and survival, but more data is needed to confirm this.",1.4211583641411244e-07,0.14761483105902684,0.02897455278407665,0.010880558788691236,0.15035859287439512,0.013542787481971533,0.0108648092457172,0.08402087972738315,0.03514462809917354,1.4211583641411244e-07,0.048088660891714596,0.06353305785123965
42,1.1,10,ai,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: The preoperative platelet count in esophageal squamous cell carcinoma may be a prognostic factor, indicating the likelihood of disease progression and overall survival. However, further research is needed to fully understand the relationship between platelet count","Question: Is the preoperative platelet count an indicator of prognosis in esophageal squamous cell carcinoma? Answer: The preoperative platelet count might indicate prognosis in esophageal squamous cell carcinoma by highlighting the potential for disease progression and survival, though further research is warranted.",2.1317375462116866e-07,0.20286328118739405,0.038319249268334826,0.016320838183036854,0.23476903085913614,0.021725839095969007,0.0162972138685758,0.19875286246337476,0.006255739210284661,2.1317375462116866e-07,0.16055599842542234,0.037236491014132275
43,1.1,1,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do leadership abilities of residents correlate with their technical skill ratings? Research on general surgery residents indicated a strong link between intraoperative leadership and perceptions of skill loss and task difficulty during bowel repair. Assessing residents' directional commands might offer another personalized surgical assessment measure. Additional research is needed.,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,1.1,2,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Is there a connection between residents' leadership qualities and technical skill ratings? Studies in general surgery research residents revealed significant associations between their leadership during surgery and perceived skill degradation and task complexity in bowel repair. Analyzing their guidance instructions could serve as a personalized performance metric. Further study is warranted.,4.737194547137081e-08,0.06970312704358506,0.020823902218198284,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
43,1.1,3,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are residents' leadership skills related to their technical skill ratings? Research involving general surgery residents demonstrated significant correlations between intraoperative leadership ability and perceived skill decay and difficulty of bowel repair tasks. Evaluating directional instructions may offer an individualized intraoperative assessment method. More evaluation is required.,7.105791820705622e-08,0.03565738861424084,0.020823902218198284,0.005440279394345618,0.06595796779179608,0.0,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
43,1.1,4,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Does the leadership capability of residents impact ratings of their technical skills? Intraoperative leadership among general surgery research residents correlated significantly with their perceptions of skill decline and task challenge during bowel repair. Assessing residents' directional commands could be a useful individualized evaluation metric. Further analysis is advised.,2.3685972735685406e-08,0.007827723325497526,0.020823902218198284,0.0018134264647818726,0.02150620522096336,0.0,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
43,1.1,5,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,To what extent do resident leadership skills influence technical skill ratings? Studies have shown general surgery residents' intraoperative leadership is significantly connected to their views on skill decay and task difficulty in bowel repair. Examining their directional instructions might provide an additional personalized assessment tool. Further evaluation is necessary.,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,1.1,6,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Are intraoperative leadership skills of residents associated with technical skill ratings? Data from general surgery research residents showed significant correlations between leadership during bowel repair and perceived skill loss and task difficulty. Establishing assessments based on residents' directional instructions might provide individualized metrics. More research is needed.,4.737194547137081e-08,0.013678481895465833,0.020823902218198284,0.0036268529295637453,0.04348511193973836,0.0,0.003621603081905733,0.04445176257083272,0.0,4.737194547137081e-08,0.04546237407675724,0.0
43,1.1,7,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Do leadership skills among residents relate to how their technical skills are rated? Research on general surgery residents identified significant links between intraoperative leadership and perceptions of skill decay and task difficulty during bowel repair procedures. Reviewing directional instruction could offer an enhanced intraoperative assessment measure. Further study is important.,2.3685972735685406e-08,0.04950041972606645,0.020823902218198284,0.0018134264647818726,0.02105340919783316,0.0,0.0018108015409528666,0.02150620522096336,0.0,2.3685972735685406e-08,0.021978906718775004,0.0
43,1.1,8,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Is there a relationship between a resident's leadership skills and their technical skill evaluations? Findings from general surgery research residents found significant associations between leadership abilities and perceptions of skill deterioration and task difficulty in bowel repair. Considering residents' directional instructions may augment individualized assessment. Further investigation is recommended.,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,1.1,9,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,How do resident leadership skills associate with technical skill ratings? General surgery research resident data indicated significant correlations between their intraoperative leadership capabilities and views of skill decline and task challenge during bowel repair. Assessments based on their directional instructions could add personalized intraoperative metrics. Additional evaluation is encouraged.,0.0,0.028881132523330688,0.020823902218198284,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
43,1.1,10,human,Question: Do resident's leadership skills relate to ratings of technical skill? Answer: General surgery research residents' intraoperative leadership skills showed significant correlations to their perceptions of skill decay and task difficulty during a bowel repair. Evaluating resident's directional instructions may provide an additional individualized intraoperative assessment metric. Further evaluation,Does the degree of leadership skill in residents connect with ratings of their technical abilities? Studies in general surgery research residents showed that intraoperative leadership skills significantly relate to perceptions of skill decay and difficulty in bowel repair tasks. Evaluating their directional instructions may provide further individualized assessment tools. Continued evaluation is warranted.,9.474389094274162e-08,0.10892384019686752,0.020823902218198284,0.0072537058591274906,0.0816780310142673,0.0,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
44,1.1,1,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is there a link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphism and chronic kidney disease in patients with hypertension? Answer: The ACE-DD genotype is identified as a potential risk factor for the onset and progression of chronic kidney failure in hypertensive patients.,7.1057918207056e-08,0.11513671050120466,0.02809413580246914,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
44,1.1,2,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the polymorphism of the ACE-1 gene contribute to chronic kidney disease among hypertensive individuals? Answer: It has been concluded that the ACE-DD genotype may increase the risk of chronic kidney failure in patients with hypertension.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,1.1,3,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Can angiotensin-converting enzyme-1 (ACE-1) gene polymorphism cause chronic kidney disease in those with high blood pressure? Answer: The presence of the ACE-DD genotype is associated with an elevated risk of developing chronic kidney failure in hypertensive patients.,2.36859727356853e-08,0.008827198864009844,0.025462962962962975,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,1.1,4,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is ACE-1 gene polymorphism a factor in chronic kidney disease for hypertensive patients? Answer: Findings suggest that the ACE-DD genotype could be a risk factor for the development of chronic kidney failure among patients suffering from hypertension.,2.36859727356853e-08,0.008827198864009844,0.025462962962962975,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
44,1.1,5,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does ACE-1 gene polymorphism influence the development of chronic kidney disease in hypertensive patients? Answer: Research conclusions indicate the ACE-DD genotype may contribute to the likelihood of chronic kidney failure in these patients.,1.184298636784265e-07,0.15213357721620557,0.007884662324481942,0.009067132323909384,0.18850370862949672,0.031217481789802305,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
44,1.1,6,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is chronic kidney disease among hypertensive patients linked to ACE-1 gene polymorphism? Answer: The ACE-DD genotype is considered a risk factor in the causation and progression of chronic kidney failure in individuals with hypertension.,9.47438909427412e-08,0.07903613756100114,0.023084379144985203,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
44,1.1,7,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the ACE-1 gene polymorphism play a role in chronic kidney disease in patients with hypertension? Answer: It is concluded that having the ACE-DD genotype may heighten the risk of chronic kidney failure among hypertensive patients.,4.73719454713706e-08,0.019612536856477902,0.02471403376165281,0.0036268529295637453,0.055569851154812167,0.0,0.00362160308190574,0.05715841383994835,0.0,4.737194547137081e-08,0.058840500022933284,0.0
44,1.1,8,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Is the chronic kidney disease in hypertensive patients associated with polymorphism of the ACE-1 gene? Answer: The ACE-DD genotype may serve as a risk factor for developing chronic kidney failure in hypertensive individuals.,1.184298636784265e-07,0.15213357721620557,0.007884662324481942,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
44,1.1,9,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does the polymorphism of angiotensin-converting enzyme-1 gene cause chronic kidney disease in hypertensive patients? Answer: It is concluded that the ACE-DD genotype potentially raises the risk of chronic renal failure among those with hypertension.,9.47438909427412e-08,0.03826277399865141,0.05246913580246914,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
44,1.1,10,human,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: It is concluded that ACE-DD genotype may be a risk factor for the causation and development of chronic kidney failure among hypertensive patients.,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism contribute to chronic kidney disease development in hypertensive patients? Answer: The data conclude that the ACE-DD genotype might pose a risk factor for causing and advancing chronic kidney failure in patients with hypertension.,2.36859727356853e-08,0.06339233825534718,0.026845867104408186,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
45,1.1,1,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness","Are labs accurately reporting serum quantitative hCG results? Several factors lead to incorrect hCG reporting, such as (a) the complex nature of the hCG molecule and ambiguous nomenclature of its variants; (b) laboratory staff's insufficient knowledge.",1.6580180914979731e-07,0.14931454819586287,0.023795359904818555,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
45,1.1,2,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Do laboratories report serum quantitative hCG results correctly? Inaccurate reporting can stem from (a) the complicated structure of hCG and unclear naming of its different forms; (b) unawareness among lab workers.,2.842316728282238e-07,0.30346522802312137,0.023795359904818555,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
45,1.1,3,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Are serum quantitative hCG results being reported properly by laboratories? Errors arise due to (a) the intricate hCG molecule and confusing nomenclature across hCG variants; (b) lack of awareness among lab personnel.,2.605457000925385e-07,0.27067540520012967,0.023795359904818555,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
45,1.1,4,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Is the reporting of serum quantitative hCG results by laboratories accurate? Incorrect results often come from (a) the complex hCG molecule and confusing terminology for its variants; (b) insufficient knowledge by laboratory staff.,2.3685972735685321e-07,0.23892670688554984,0.023795359904818555,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
45,1.1,5,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Do laboratories provide correct serum quantitative hCG reporting? Mistakes occur owing to (a) the complexity of the hCG molecule and confusing naming conventions of its types; (b) lack of awareness in lab personnel.,2.3685972735685321e-07,0.23892670688554984,0.023795359904818555,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
45,1.1,6,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Are serum quantitative hCG test results reported correctly by labs? Many errors are due to (a) the complexity of hCG molecule and confusing names for its forms; (b) laboratory personnel not being sufficiently informed.,2.1317375462116791e-07,0.20815504821879616,0.023795359904818555,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
45,1.1,7,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Is the serum quantitative hCG reporting by laboratories accurate? Several causes for errors include (a) the complex hCG molecule and ambiguous naming of its various forms; (b) the lack of awareness among lab workers.,2.1317375462116791e-07,0.20815504821879616,0.023795359904818555,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
45,1.1,8,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Do labs correctly report serum quantitative hCG results? Mistaken results may result from (a) complex hCG molecular structure and confusing nomenclature of its variants; (b) laboratory staff's limited awareness.,3.316036182995944e-07,0.37245809951007214,0.023795359904818555,0.025387970506946272,0.4177352006999784,0.0,0.025351221573340195,0.43078291609245367,0.0,3.316036182995957e-07,0.4446858212614444,0.0
45,1.1,9,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Are serum quantitative hCG test reports from laboratories reliable? Faulty reporting can be attributed to (a) the intricate nature of the hCG molecule with confusing variant names; (b) lab personnel’s inadequate awareness.,2.605457000925385e-07,0.27067540520012967,0.023795359904818555,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
45,1.1,10,human,"Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: Many factors contribute to the erroneous reporting of hCG results, including (a) the complexity of hCG molecule and confusion of nomenclature on the various forms of hCG; (b) laboratory personnel's lack of awareness",Are serum quantitative hCG outcomes being accurately reported by labs? The errors often come from (a) the complex hCG molecule and confusing nomenclature for its types; (b) unawareness among lab professionals.,2.842316728282238e-07,0.30346522802312137,0.023795359904818555,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
46,1.1,1,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex found in cervical disk disease? Yes, it is a crucial part of the extracellular matrix in intervertebral discs and plays a role in their degeneration and structural breakdown.",3.3160361829959473e-07,0.15702949577763414,0.1502770083102493,0.02538797050694625,0.28847218217975,0.06781677572873293,0.025351221573340174,0.3616648819601149,0.023242630385487524,3.316036182995957e-07,0.4054651081081637,0.0
46,1.1,2,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Does the fibronectin-aggrecan complex exist in cervical disk disease? Indeed, it is present and serves as a vital element of the extracellular matrix within intervertebral discs, contributing to disc degeneration and damage.",3.3160361829959473e-07,0.15702949577763414,0.1502770083102493,0.02538797050694625,0.28847218217975,0.06781677572873293,0.025351221573340174,0.3616648819601149,0.023242630385487524,3.316036182995957e-07,0.4054651081081637,0.0
46,1.1,3,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex detected in cervical disk disease? Yes, it is an important extracellular matrix component in intervertebral discs and is associated with the disc's degeneration and breakdown.",4.0266153650665063e-07,0.2588121900875766,0.1502770083102493,0.03082824990129189,0.39383269783757546,0.06781677572873293,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
46,1.1,4,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Can the fibronectin-aggrecan complex be found in cervical disk disease? Yes, this complex is part of the extracellular matrix in intervertebral discs and participates in the degeneration and structural deterioration of the disc.",3.0791764556390943e-07,0.1686024962480519,0.11905952652044699,0.023574544042164372,0.2556823593567583,0.06781677572873293,0.0235404200323873,0.32776333028443316,0.023242630385487524,3.079176455639103e-07,0.3703737882968947,0.0
46,1.1,5,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex involved in cervical disk disease? Yes, it is a key extracellular matrix element in intervertebral discs, implicated in the breakdown and degeneration of the disc.",4.0266153650665063e-07,0.2588121900875766,0.1502770083102493,0.03082824990129189,0.39383269783757546,0.06781677572873293,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
46,1.1,6,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex present within cervical disk disease? Yes, it plays a significant role as part of the extracellular matrix in intervertebral discs and is involved in the structural degradation and degeneration of the disc.",2.3685972735685353e-07,0.07527704909107857,0.12173029550748113,0.018134264647818733,0.16330903922574302,0.06781677572873293,0.01810801540952868,0.23245315048010795,0.023242630385487524,2.3685972735685406e-07,0.2719337154836414,0.0
46,1.1,7,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Does cervical disk disease feature the fibronectin-aggrecan complex? Yes, it is a fundamental component of the extracellular matrix in intervertebral discs, involved in disc degeneration and degradation.",4.5003348197802123e-07,0.3329201622412983,0.1502770083102493,0.03445510283085565,0.4707937389737049,0.06781677572873293,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
46,1.1,8,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex part of cervical disk disease pathology? Yes, it is a crucial component of the extracellular matrix in intervertebral discs contributing to the degeneration and breakdown of the discs.",3.3160361829959473e-07,0.20174866871698516,0.11805478608802708,0.02538797050694625,0.28847218217975,0.06781677572873293,0.025351221573340174,0.3616648819601149,0.023242630385487524,3.316036182995957e-07,0.4054651081081637,0.0
46,1.1,9,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex identified in cervical disk disease? Yes, it constitutes a key part of the extracellular matrix in intervertebral discs and plays a role in disc degeneration and structural breakdown.",3.3160361829959473e-07,0.15702949577763414,0.1502770083102493,0.02538797050694625,0.28847218217975,0.06781677572873293,0.025351221573340174,0.3616648819601149,0.023242630385487524,3.316036182995957e-07,0.4054651081081637,0.0
46,1.1,10,ai,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Yes, the fibronectin-aggrecan complex is present in cervical disk disease. It is a key component of the extracellular matrix in the intervertebral discs and is involved in the degeneration and breakdown of the disc structure.","Is the fibronectin-aggrecan complex associated with cervical disk disease? Yes, this complex is a vital constituent of the extracellular matrix in intervertebral discs involved in the breakdown and degeneration of the disc.",3.3160361829959473e-07,0.20174866871698516,0.11805478608802708,0.02538797050694625,0.28847218217975,0.06781677572873293,0.025351221573340174,0.3616648819601149,0.023242630385487524,3.316036182995957e-07,0.4054651081081637,0.0
47,1.1,1,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Does the selection criteria for residency predict how well someone will perform in an orthopaedic surgery residency? The criteria might suggest some degree of a candidate’s future performance, but they are not a certain predictor. Other aspects like work ethic, dedication, and clinical abilities honed during residency play a crucial role as well.",7.105791820705622e-08,0.04473194143040393,0.07227989234909649,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
47,1.1,2,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Do residency selection criteria forecast performance in an orthopaedic surgery residency? While these criteria can offer some insight into potential performance, they do not guarantee it. Additional elements such as commitment, perseverance, and clinical skill development during the residency are significant factors too.",3.079176455639103e-07,0.16884215886765608,0.07227989234909649,0.023574544042164344,0.2497398620614506,0.01851192595229618,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
47,1.1,3,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Can residency selection standards predict success in an orthopaedic surgery residency? Selection criteria may give an indication of a candidate’s probable performance, but they are not conclusive. Other important factors include the resident’s work ethic, dedication, and clinical skills acquired throughout residency.",3.316036182995957e-07,0.1929397104467161,0.07227989234909649,0.025387970506946217,0.2744324746518223,0.01851192595229618,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
47,1.1,4,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Is performance in an orthopaedic surgery residency foreseeable through residency selection criteria? These criteria may provide some clues about candidate performance, though they are not definitive. Factors like dedication, work ethic, and clinical proficiency developed during training also significantly influence outcomes.",3.552895910352811e-07,0.2176323230370878,0.07227989234909649,0.02720139697172809,0.29975028263611403,0.01851192595229618,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
47,1.1,5,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Do the criteria used for selecting residents predict how well they perform in orthopaedic surgery residency? The selection standards might hint at potential performance, but cannot definitively forecast it. Work ethic, devotion, and clinical skill enhancement during residency are additional, crucial elements.",3.316036182995957e-07,0.1929397104467161,0.07227989234909649,0.025387970506946217,0.2744324746518223,0.01851192595229618,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
47,1.1,6,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Are residency selection criteria reliable predictors of performance in orthopaedic surgery residency? They may partially indicate a candidate’s suitability but are not definite predictors. Performance is also shaped by factors such as clinical skill growth, dedication, and personal work ethic during residency.",3.316036182995957e-07,0.1929397104467161,0.07227989234909649,0.025387970506946217,0.2744324746518223,0.01851192595229618,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
47,1.1,7,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Can we anticipate orthopaedic surgery residency performance based on selection criteria? Selection criteria might indicate some potential but are not conclusive. Critical influences also include the resident’s dedication, commitment, and clinical competencies developed during the residency.",4.737194547137076e-07,0.35116371566161053,0.07227989234909649,0.03626852929563746,0.43695140414959655,0.01851192595229618,0.036216030819057346,0.47378435208564085,0.0,4.737194547137081e-07,0.48550781578170144,0.0
47,1.1,8,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Does the residency application criteria serve as a reliable predictor of performance in orthopaedic surgery training? These criteria could suggest some level of expected performance but don’t fully determine it. Other factors, including hard work, devotion, and clinical skills gained during residency, equally affect performance.",2.6054570009253947e-07,0.12232214323276214,0.07227989234909649,0.0199476911126006,0.20211181307219617,0.01851192595229618,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
47,1.1,9,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Will residency selection guidelines predict how well a candidate performs in an orthopaedic surgery residency? They might provide an initial impression of performance potential but won’t be a definitive forecast. Additional considerations like work ethic, dedication to training, and clinical proficiency developed during residency play pivotal roles.",2.1317375462116866e-07,0.07787038066192942,0.07227989234909649,0.016320838183036854,0.15664943899543893,0.01851192595229618,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
47,1.1,10,ai,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: The residency selection criteria may provide some indication of a candidate's potential performance in an orthopaedic surgery residency, but it may not be a definitive predictor. Other factors such as work ethic, dedication, and clinical skills developed during residency can also greatly impact performance.","Are the criteria used for selecting orthopaedic surgery residents accurate predictors of their residency performance? The selection benchmarks may offer some indication but aren’t absolute predictors. Performance also depends heavily on work ethic, perseverance, and practical skillsets acquired during the residency.",3.552895910352811e-07,0.2176323230370878,0.07227989234909649,0.02720139697172809,0.29975028263611403,0.01851192595229618,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
48,1.1,1,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Older individuals with a history of amblyopia who later experience vision loss in their previously unaffected eye may gradually regain visual function in the amblyopic eye over time. This improvement in vision happens,2.605457000925386e-07,0.19874600165291278,0.06937499999999999,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
48,1.1,2,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"In seniors who have amblyopia, if they lose sight in the eye that was once normal, they can sometimes recover vision in the amblyopic eye as time passes. Such visual function recovery occurs",2.605457000925386e-07,0.24206770043791037,0.03815751821019769,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
48,1.1,3,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Visual loss in the previously unaffected eye of older patients with amblyopia may lead to a recovery of vision in the amblyopic eye over time. This restoration in visual capability takes place,2.842316728282239e-07,0.2752138729068436,0.03715277777777779,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
48,1.1,4,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"Among older patients with amblyopia, experiencing vision loss in the formerly normal eye can result in gradual recovery of vision in the amblyopic eye over a certain duration. This enhancement of function occurs",2.605457000925386e-07,0.24206770043791037,0.03815751821019769,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
48,1.1,5,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"When older persons with amblyopia suffer vision loss in their previously good eye, the amblyopic eye often recovers visual function gradually over time. The recovery of sight happens",3.789755637709651e-07,0.36864503844830976,0.06937499999999999,0.029014823436510025,0.4795730802618854,0.0,0.028972824655245935,0.49469624183610783,0.0,3.789755637709665e-07,0.5108256237659909,0.0
48,1.1,6,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"In elderly individuals with amblyopia history, losing vision in the previously normal eye can lead to gradual restoration of vision in the amblyopic eye over a period. This recovery occurs",3.316036182995945e-07,0.3927925821296063,0.0007878943758573287,0.025387970506946266,0.45497562100530287,0.035665294924554176,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
48,1.1,7,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"For older adults with amblyopia, developing visual loss in the eye that used to be normal may result in a slow recovery of visual ability in the amblyopic eye through time. Visual function improvement happens",2.1317375462116802e-07,0.17889474339882705,0.03999024334251605,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
48,1.1,8,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Elderly patients having amblyopia who develop visual loss in their previously unaffected eye may see a gradual recovery of vision in the amblyopic eye across some time. This recovery in visual function takes place,2.3685972735685332e-07,0.1679743429861591,0.06937499999999999,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
48,1.1,9,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,"In aged persons with a history of amblyopia, if visual loss occurs in the previously normal eye, rejuvenation of vision function can arise in the amblyopic eye over time. Visual recovery occurs",2.842316728282239e-07,0.2752138729068436,0.03715277777777779,0.021761117577382506,0.33647223662121295,0.0,0.02172961849143444,0.3462762367178347,0.0,2.8423167282822487e-07,0.356674943938732,0.0
48,1.1,10,human,Question: Amblyopia: is visual loss permanent? Answer: Older people with a history of amblyopia who develop visual loss in the previously normal eye can experience recovery of visual function in the amblyopic eye over a period of time. This recovery in visual function occurs,Older people who have amblyopia and then lose sight in their previously normal eye can experience improvement in function of the amblyopic eye over time. This recuperation in vision occurs,3.316036182995945e-07,0.2971860744661661,0.06937499999999999,0.025387970506946266,0.4054651081081637,0.0,0.025351221573340188,0.4177352006999784,0.0,3.316036182995957e-07,0.43078291609245367,0.0
49,1.1,1,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae louder than bubble CPAP for preterm babies? Studies indicate that high flow nasal cannulae (HFNC) tend to be quieter than bubble continuous positive airway pressure.,4.73719454713706e-08,0.08562289104339493,0.009267296786389406,0.003626852929563759,0.08172497413789648,0.005382971729125552,0.003621603081905747,0.08106857998389128,0.0029483070348455126,4.737194547137081e-08,0.08004270767353727,0.0
49,1.1,2,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? Research shows that high flow nasal cannulae (HFNC) are usually less noisy than bubble continuous positive airway pressure systems.,1.184298636784265e-07,0.2019891840435415,0.02121831719455264,0.009067132323909398,0.1930903483634152,0.012179614215880569,0.009054007704764368,0.19156351920142045,0.0066368575769586435,1.1842986367842703e-07,0.18924199963852795,0.0
49,1.1,3,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Is the noise level of high flow nasal cannulae higher compared to bubble CPAP in preterm infants? Evidence suggests that high flow nasal cannulae (HFNC) are generally quieter than bubble CPAP.,7.10579182070559e-08,0.17210802193396812,0.044901864687623916,0.005440279394345639,0.12023081208000397,0.007801783264746218,0.005432404622858621,0.11926994685466008,0.004265260631001383,7.105791820705622e-08,0.11778303565638426,0.0
49,1.1,4,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae noisier for preterm infants than bubble CPAP? Studies have found that high flow nasal cannulae (HFNC) typically generate less noise than bubble continuous positive airway pressure.,7.10579182070559e-08,0.12589820989663858,0.013489781993489935,0.005440279394345639,0.12023081208000397,0.007801783264746218,0.005432404622858621,0.11926994685466008,0.004265260631001383,7.105791820705622e-08,0.11778303565638426,0.0
49,1.1,5,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Do preterm infants experience more noise from high flow nasal cannulae or bubble CPAP? Studies indicate that the HFNC is commonly quieter than bubble continuous positive airway pressure.,0.0,0.20537694238813176,0.14366729678638937,0.0,0.10663802777845355,0.07638888888888888,0.0,0.0554517744447951,0.03993055555555556,0.0,0.0,0.0
49,1.1,6,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Is the sound output of high flow nasal cannulae greater than bubble CPAP for preterm infants? Research suggests high flow nasal cannulae (HFNC) are usually less noisy than bubble CPAP.,4.73719454713706e-08,0.08562289104339493,0.009267296786389406,0.003626852929563759,0.08172497413789648,0.005382971729125552,0.003621603081905747,0.08106857998389128,0.0029483070348455126,4.737194547137081e-08,0.08004270767353727,0.0
49,1.1,7,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are high flow nasal cannulae noisier than bubble CPAP in preterm babies? The data imply that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous positive airway pressure.,4.73719454713706e-08,0.08562289104339493,0.009267296786389406,0.003626852929563759,0.08172497413789648,0.005382971729125552,0.003621603081905747,0.08106857998389128,0.0029483070348455126,4.737194547137081e-08,0.08004270767353727,0.0
49,1.1,8,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,"Comparing noise levels in preterm infants, are high flow nasal cannulae louder than bubble CPAP? Studies suggest HFNC are typically quieter than bubble continuous positive airway pressure.",2.36859727356853e-08,0.114317600516058,0.10526729678638935,0.0018134264647818796,0.06741731462517109,0.07638888888888888,0.0018108015409528735,0.014629779924540287,0.03993055555555556,2.3685972735685406e-08,0.04255961441879563,0.0
49,1.1,9,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Are flow rates of nasal cannulae noisier than bubble CPAP in preterm infants? Studies show high flow nasal cannulae (HFNC) tend to be quieter than bubble continuous positive airway pressure.,4.73719454713706e-08,0.1812293987068352,0.0750801911622467,0.003626852929563759,0.18074599993217522,0.07638888888888888,0.003621603081905747,0.13241281558092455,0.03993055555555556,4.737194547137081e-08,0.08004270767353727,0.0
49,1.1,10,ai,Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: Studies suggest that high flow nasal cannulae (HFNC) are generally quieter than bubble continuous,Is noise from high flow nasal cannulae higher than bubble CPAP in preterm infants? Evidence indicates that high flow nasal cannulae (HFNC) are generally less noisy than bubble continuous positive airway pressure.,9.47438909427412e-08,0.1646505891115435,0.017467022437966856,0.007253705859127518,0.1573192473444669,0.010062358276644007,0.007243206163811494,0.1560685257313481,0.005491780045351467,9.474389094274162e-08,0.15415067982725894,0.0
50,1.1,1,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is emergency double-balloon enteroscopy with real-time capsule endoscopy visualization a practical combined method in acute overt-obscure gastrointestinal bleeding? Answer: Yes, this combined approach is feasible in such cases.",3.07917645563909e-07,0.1258133072952461,0.24408284023668642,0.0235745440421644,0.05750307925435694,0.2496570644718793,0.02354042003238733,0.014459006253835227,0.23852040816326525,3.079176455639103e-07,0.09037745985610668,0.21403091557669443
50,1.1,2,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Can emergency double-balloon enteroscopy paired with real-time capsule endoscopy viewing be effectively used for acute overt-obscure GI bleeding? Answer: Yes, it is a viable combined technique.",3.552895910352796e-07,0.05170533514152442,0.24408284023668642,0.02720139697172816,0.019457961881772512,0.2496570644718793,0.027162023114293075,0.0945017139273725,0.23852040816326525,3.552895910352811e-07,0.17375906879515712,0.21403091557669443
50,1.1,3,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is it practical to use emergency double-balloon enteroscopy together with real-time capsule endoscopy in acute overt-obscure gastrointestinal hemorrhage? Answer: Yes, this combined method is feasible.",3.789755637709649e-07,0.012484621988241962,0.24408284023668642,0.02901482343651004,0.060279956402027324,0.2496570644718793,0.02897282465524595,0.13706132834616813,0.23852040816326525,3.789755637709665e-07,0.21821083136599118,0.21403091557669443
50,1.1,4,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Does combining emergency double-balloon enteroscopy with real-time capsule endoscopy provide a feasible approach for acute overt-obscure GI bleeding? Answer: Yes, it does.",4.500334819780208e-07,0.11534874952164254,0.24408284023668642,0.03445510283085568,0.19381134902655095,0.2496570644718793,0.03440522927810457,0.2768232707213274,0.23852040816326525,4.500334819780226e-07,0.36481430555786654,0.21403091557669443
50,1.1,5,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is the combined use of emergency double-balloon enteroscopy and real-time capsule endoscopy a workable solution in acute overt-obscure gastrointestinal bleeding? Answer: Yes, this approach is feasible.",3.552895910352796e-07,0.05170533514152442,0.24408284023668642,0.02720139697172816,0.019457961881772512,0.2496570644718793,0.027162023114293075,0.0945017139273725,0.23852040816326525,3.552895910352811e-07,0.17375906879515712,0.21403091557669443
50,1.1,6,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Can emergency double-balloon enteroscopy combined with real-time capsule endoscopy be feasibly applied to acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is feasible.",4.500334819780208e-07,0.11534874952164254,0.24408284023668642,0.03445510283085568,0.19381134902655095,0.2496570644718793,0.03440522927810457,0.2768232707213274,0.23852040816326525,4.500334819780226e-07,0.36481430555786654,0.21403091557669443
50,1.1,7,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is emergency double-balloon enteroscopy along with real-time capsule endoscopy viewing a viable combined intervention for acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is feasible.",4.026615365066502e-07,0.02833737253201285,0.24408284023668642,0.030828249901291918,0.10283957082082296,0.2496570644718793,0.030783626196198823,0.18151309091700218,0.23852040816326525,4.026615365066519e-07,0.2647308470008851,0.21403091557669443
50,1.1,8,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Can the combination of emergency double-balloon enteroscopy with real-time capsule endoscopy viewing be used effectively in acute overt-obscure gastrointestinal bleeding? Answer: Yes, it is a feasible combined technique.",3.07917645563909e-07,0.1258133072952461,0.24408284023668642,0.0235745440421644,0.05750307925435694,0.2496570644718793,0.02354042003238733,0.014459006253835227,0.23852040816326525,3.079176455639103e-07,0.09037745985610668,0.21403091557669443
50,1.1,9,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Is emergency double-balloon enteroscopy combined with simultaneous capsule endoscopy viewing a feasible approach for managing acute overt-obscure GI bleeding? Answer: Yes, it is.",4.263475092423355e-07,0.07089698695080848,0.24408284023668642,0.0326416763660738,0.147291333391657,0.2496570644718793,0.032594427737151696,0.22803310655189613,0.23852040816326525,4.2634750924233726e-07,0.3135210111703164,0.21403091557669443
50,1.1,10,ai,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Yes, emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy is a feasible combined approach in acute overt-obscure gastrointestinal bleeding.","Question: Does the combination of emergency double-balloon enteroscopy and real-time capsule endoscopy represent a feasible approach to acute overt-obscure gastrointestinal bleeding? Answer: Yes, it does.",4.026615365066502e-07,0.02833737253201285,0.24408284023668642,0.030828249901291918,0.10283957082082296,0.2496570644718793,0.030783626196198823,0.18151309091700218,0.23852040816326525,4.026615365066519e-07,0.2647308470008851,0.21403091557669443
51,1.1,1,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does misclassifying gestational age account for the difference in birthweights between Australian Aborigines and whites? It is improbable that gestational age misclassification explains the observed discrepancy in average birthweights between Aborigines and whites. These findings could assist in interpreting other population comparisons.,7.105791820705622e-08,0.07753366990246713,0.004897905711710296,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,1.1,2,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is gestational age misclassification a reason for the differing birthweights of Australian Aborigines compared to whites? Gestational age misclassification likely does not explain the reported birthweight differences between Aborigines and whites. The results may aid in understanding other between-population differences.,1.1842986367842692e-07,0.0971999362312288,0.01668456243435748,0.009067132323909363,0.12785598277598798,0.0030539364516198493,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
51,1.1,3,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Can the difference in birthweights between Australian Aborigines and whites be attributed to gestational age misclassification? It is unlikely that mistakes in gestational age classification account for the birthweight gap seen between Aborigines and whites. These findings might support interpretations of other population comparisons.,2.3685972735685406e-08,0.0070517443577089445,0.021415823914336725,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
51,1.1,4,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is the difference in birthweights for Australian Aborigines and whites caused by gestational age misclassification? Gestational age misclassification is an improbable reason for the reported divergence in birthweights between Aborigines and whites. The results might help explain other differences between populations.,9.474389094274162e-08,0.1047621868119597,0.0066901636430713035,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
51,1.1,5,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does inaccurately classifying gestational age explain birthweight differences between Australian Aborigines and whites? The disparity in average birthweights between Aborigines and whites is unlikely due to gestational age misclassification. Such results could be useful for interpreting other population comparisons.,1.4211583641411222e-07,0.1250462652270916,0.015347639926263791,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
51,1.1,6,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Could errors in gestational age classification clarify birthweight variances for Australian Aborigines and whites? It is doubtful that gestational age misclassification is responsible for the birthweight differences reported between Aborigines and whites. These results may assist in interpreting findings in different populations.,7.105791820705622e-08,0.043721612314176816,0.019164573230376597,0.005440279394345618,0.04008125783265193,0.023242630385487524,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
51,1.1,7,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is gestational age misclassification behind the birthweight difference between Australian Aborigines and whites? Misclassification of gestational age likely does not explain the observed difference in average birthweights between Aborigines and whites. This might help interpret other between-population comparisons.,1.6580180914979753e-07,0.15368648152848507,0.013939224708324753,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
51,1.1,8,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Does misjudging gestational age explain why Australian Aborigines and whites have different birthweights? It seems unlikely that gestational age misclassification accounts for the average birthweight differences reported between Aborigines and whites. The findings could help interpret other population differences.,1.4211583641411222e-07,0.1250462652270916,0.015347639926263791,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
51,1.1,9,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is the birthweight disparity between Australian Aborigines and whites explained by gestational age misclassification? Gestational age misclassification probably does not explain the reported birthweight discrepancy between Aborigines and whites. This data could help with the analysis of other population comparisons.,1.1842986367842692e-07,0.0971999362312288,0.01668456243435748,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
51,1.1,10,human,Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification is an unlikely explanation for the reported divergence in average birth-weights for Aborigines and whites. The results might help with the interpretation of other between-population comparisons.,Is the difference in birthweights for Australian Aborigines and whites a result of gestational age misclassification? It is unlikely that mistakes in gestational age explain the reported divergence in average birthweights for Aborigines and whites. Such results might aid in interpreting other between-population variances.,2.3685972735685406e-08,0.025187659389265704,0.0015582242712670613,0.0018134264647818726,0.008708906336779787,0.023242630385487524,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
52,1.1,1,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Can a zero central line-associated bloodstream infection rate be maintained sustainably? Answer: Reaching zero central line-associated bloodstream infections is tough yet achievable. It demands a thorough strategy involving good hygiene, staff training, strict adherence to protocols, and ongoing monitoring and enhancements. Although maintaining zero infections is challenging, applying effective measures makes it possible.",2.3685972735685406e-08,0.047719740175276915,0.02009687754592976,0.0018134264647818726,0.07482804146747579,0.039463286555002274,0.0018108015409528666,0.07579804658847333,0.04015554549569944,2.3685972735685406e-08,0.07678615062853433,0.040742417383431435
52,1.1,2,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Is it feasible to maintain a zero rate of central line-associated bloodstream infections? Answer: Achieving a zero central line-associated bloodstream infection rate is difficult but attainable. This goal requires comprehensive efforts such as proper hygiene, educating staff, following correct protocols, and continuous assessment and improvement. Despite its difficulty, sustaining zero infections can be accomplished with proper implementation.",1.1842986367842703e-07,0.15214222286461476,0.04259650475887088,0.009067132323909363,0.17749977106185444,0.06001204688558079,0.009054007704764333,0.17848784147151875,0.05975554549569943,1.1842986367842703e-07,0.15374719176466423,0.040742417383431435
52,1.1,3,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Can zero central line-associated bloodstream infections be sustained? Answer: Maintaining a zero infection rate for central line-associated bloodstream infections presents challenges but is achievable with a robust approach. This includes strict hygiene, ongoing staff education, the use of appropriate guidelines, and continuous quality improvements. Even though it’s hard to sustain, effective practices make it possible.",7.105791820705622e-08,0.11377094531302401,0.04070173523589619,0.005440279394345618,0.11454314774251628,0.04088103803429223,0.0054324046228586,0.11529007241154776,0.040894598750137304,7.105791820705622e-08,0.1160068637818168,0.040742417383431435
52,1.1,4,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Is sustaining a zero rate of central line-associated bloodstream infections achievable? Answer: Completely preventing central line-associated bloodstream infections is challenging but not out of reach. Success relies on a multifaceted strategy incorporating hygiene protocols, training healthcare workers, utilizing established guidelines, and consistently monitoring outcomes for improvements. While sustaining zero infections is demanding, it is possible through dedicated efforts.",1.4211583641411244e-07,0.14689031902461602,0.026478534937197346,0.010880558788691236,0.17131269720210884,0.04282196424095268,0.0108648092457172,0.17175109052562743,0.04190430582627794,1.4211583641411244e-07,0.17209633043286,0.040742417383431435
52,1.1,5,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Can zero incidence of central line-associated bloodstream infections be consistently upheld? Answer: Achieving and maintaining zero infections related to central line-associated bloodstream infections is challenging but feasible. It necessitates comprehensive hygiene measures, staff education, adherence to protocols, and continuous evaluation and refinement. Though difficult, proper execution of these steps allows sustainability.",2.3685972735685406e-08,0.03233272174126389,0.036471890561339995,0.0018134264647818726,0.03347456775862456,0.03793273099944672,0.0018108015409528666,0.0346832326941664,0.03935623994014388,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
52,1.1,6,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Is it possible to consistently achieve zero central line-associated bloodstream infection rates? Answer: Attaining zero central line-associated bloodstream infections is arduous but doable. It requires an integrated approach involving stringent hygiene, staff training, protocol compliance, and ongoing monitoring and enhancements. Despite the challenges, sustaining zero infections is attainable with effective methods.",2.3685972735685406e-08,0.005150479366363481,0.01720235400633771,0.0018134264647818726,0.03347456775862456,0.03793273099944672,0.0018108015409528666,0.0346832326941664,0.03935623994014388,2.3685972735685406e-08,0.035964156108279965,0.040742417383431435
52,1.1,7,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Does zero central line-associated bloodstream infection rate sustainability exist? Answer: Achieving zero infections related to central line-associated bloodstream infections is difficult but possible with a comprehensive plan. This plan must include hygiene best practices, continuous staff education, proper protocol adherence, and ongoing outcome monitoring and improvements. Maintaining zero rates is challenging but achievable.",2.3685972735685406e-08,0.10003273493451781,0.05738782433681098,0.0018134264647818726,0.10148754841208918,0.058639910930242574,0.0018108015409528666,0.10298028896337286,0.05975554549569943,2.3685972735685406e-08,0.07678615062853433,0.040742417383431435
52,1.1,8,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Is it realistic to sustain a central line-associated bloodstream infection rate of zero? Answer: Reducing central line-associated bloodstream infections to zero is challenging but can be realized. It depends on comprehensive hygiene standards, education of healthcare teams, strict protocol use, and continual review and advancement. While sustaining zero infections is difficult, it remains within reach with effective action.",1.4211583641411244e-07,0.19469357285633704,0.0606268650511359,0.010880558788691236,0.1956336509059673,0.060325021248879826,0.0108648092457172,0.19650634697419722,0.05975554549569943,1.4211583641411244e-07,0.17209633043286,0.040742417383431435
52,1.1,9,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Can healthcare facilities maintain a zero rate of central line-associated bloodstream infections over time? Answer: Achieving zero central line-associated bloodstream infections is demanding but achievable by implementing thorough hygiene routines, educating staff, utilizing proper protocols, and performing continuous monitoring and improvement. Despite the difficulties, sustaining zero infection rates is possible through persistent efforts.",2.3685972735685406e-08,0.07387623755489736,0.03866564056133997,0.0018134264647818726,0.07482804146747579,0.039463286555002274,0.0018108015409528666,0.07579804658847333,0.04015554549569944,2.3685972735685406e-08,0.07678615062853433,0.040742417383431435
52,1.1,10,ai,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: Achieving a zero central line-associated bloodstream infection rate is challenging but not impossible. It requires a comprehensive approach that includes proper hygiene practices, staff education, use of appropriate protocols, and continuous monitoring and improvement. While sustaining zero infections may be difficult, implementing effective","Question: Is a zero central line-associated bloodstream infection rate maintainable in the long term? Answer: Maintaining zero infections related to central line-associated bloodstream infections is complex but achievable. It requires a full-fledged approach that includes hygiene control, continuous staff education, adherence to established protocols, and perpetual evaluation and enhancement. Though challenging, it can be sustained with effective strategies.",1.1842986367842703e-07,0.17646317656847232,0.06002431824729039,0.009067132323909363,0.17749977106185444,0.06001204688558079,0.009054007704764333,0.17848784147151875,0.05975554549569943,1.1842986367842703e-07,0.15374719176466423,0.040742417383431435
53,1.1,1,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"What is the characterization of gender dimorphism following injury and hemorrhagic shock, and are hormonal differences the cause? The protective effect associated with female gender against multiple organ failure and nosocomial infections remains significant in both premenopausal and postmenopausal women compared with age-matched men. This finding contradicts previous experimental studies and existing knowledge.",4.737194547137081e-08,0.03774032798284743,0.0,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
53,1.1,2,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"How is gender dimorphism depicted after injury and hemorrhagic shock, and do hormones play a role? Female gender independently confers protection against multiple organ failure and hospital-acquired infections in premenopausal and postmenopausal women compared to men of the same age group. This outcome contrasts earlier experimental results and established understanding.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
53,1.1,3,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"In the context of injury and hemorrhagic shock, how is gender dimorphism characterized, and are hormonal differences responsible? Females exhibit a significant independent protective effect against multiple organ failure and nosocomial infections in both premenopausal and postmenopausal stages relative to similarly aged males, which opposes prior experimental observations and known data.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
53,1.1,4,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"What is the explanation for gender dimorphism following injury and hemorrhagic shock, and to what extent do hormonal differences contribute? The female gender shows a consistent protective effect on multiple organ failure and rates of nosocomial infection across both premenopausal and postmenopausal women compared to men of similar age, defying earlier experimental findings and prevailing knowledge.",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
53,1.1,5,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"Can gender dimorphism after injury and hemorrhagic shock be characterized, and are hormones the underlying factors? Female gender independently protects against multiple organ failure and hospital-acquired infections in pre- and postmenopausal women versus age-matched men, a result that runs counter to past experimental studies and current understanding.",1.8948778188548325e-07,0.16034265007518078,0.0,0.014507411718254981,0.16362942378180145,0.0,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
53,1.1,6,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"How is gender dimorphism characterized after injury and hemorrhagic shock, and does hormone variation account for it? Female patients demonstrate a significant protective effect against multi-organ failure and nosocomial infection both before and after menopause when compared to men of the same age, opposing prior experimental findings and known theories.",1.1842986367842703e-07,0.0971637484536485,0.0,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
53,1.1,7,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"What defines the gender dimorphism observed after injury and hemorrhagic shock, and are hormonal variations causing it? There is a notable independent protective influence of being female on organ failure and nosocomial infection rates in both premenopausal and postmenopausal women compared to men with similar ages, contrasting earlier experimental data and accepted knowledge.",4.737194547137081e-08,0.03774032798284743,0.0,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
53,1.1,8,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"How does gender dimorphism manifest after injury and hemorrhagic shock, and are hormonal differences the cause of this? The independent protective effects found in females against multiple organ failure and nosocomial infection hold true for both premenopausal and postmenopausal women compared to men of similar age, contradicting prior experimental research and established knowledge.",4.737194547137081e-08,0.03774032798284743,0.0,0.0036268529295637453,0.038466280827795796,0.0,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
53,1.1,9,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"What does the gender dimorphism after injury and hemorrhagic shock look like, and do hormones explain it? Females retain a significant protective effect against multiple organ failure and hospital-acquired infections for both premenopausal and postmenopausal groups compared with similarly aged males, which is inconsistent with earlier experimental findings and known concepts.",9.474389094274162e-08,0.07696104113612989,0.0,0.0072537058591274906,0.07847161544149417,0.0,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
53,1.1,10,human,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The independent protective effect of female gender on multiple organ failure and nosocomial infection rates remains significant in both premenopausal and postmenopausal women when compared with similarly aged men. This is contrary to previous experimental studies and the known,"How is gender dimorphism characterized post-injury and hemorrhagic shock, and are hormonal differences behind it? Female gender consistently lowers the risk of multiple organ failure and nosocomial infections in both premenopausal and postmenopausal women compared with men of similar age, contrary to former experimental studies and prevailing knowledge.",1.6580180914979784e-07,0.13883644485421742,0.0,0.012693985253473108,0.14165051706302645,0.0,0.012675610786670066,0.14458122881110835,0.0,1.6580180914979784e-07,0.14763599880606337,0.0
54,1.1,1,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women need fewer calories to maintain their weight? Answer: There isn't a clear answer since caloric requirements depend on factors like age, height, weight, activity level, and metabolism. Still, studies...",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,1.1,2,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Is caloric intake lower to maintain weight for African American women? Answer: A definitive conclusion cannot be made because calorie needs vary according to age, height, weight, physical activity, and metabolism. Research does suggest...",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,1.1,3,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women require fewer calories for weight maintenance? Answer: The answer isn't definitive as calorie needs differ based on age, height, weight, activity level, and metabolism. Research indicates...",1.184298636784265e-07,0.1541506798272585,0.0,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
54,1.1,4,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Is it true African American women need fewer calories to stay at the same weight? Answer: No conclusive answer exists since calorie needs change with age, height, weight, activity levels, and metabolism. However, studies show...",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
54,1.1,5,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women have a lower calorie requirement for weight maintenance? Answer: There is no exact answer because caloric needs vary depending on age, height, weight, activity level, and metabolism. Still, research suggests...",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
54,1.1,6,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Are fewer calories necessary for African American women to maintain weight? Answer: It's unclear because calorie needs depend on individual factors like age, height, weight, exercise habits, and metabolism. Though research points to...",4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
54,1.1,7,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women require less caloric intake to maintain weight? Answer: No definitive conclusion as caloric needs vary with age, height, weight, activity level, and metabolism. Research, however, shows...",1.184298636784265e-07,0.1541506798272585,0.0,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
54,1.1,8,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Is the calorie requirement lower for weight maintenance in African American women? Answer: There's no definitive answer since calorie needs are influenced by age, height, weight, activity, and metabolism. Nonetheless, studies imply...",7.10579182070559e-08,0.08961215868968697,0.0,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
54,1.1,9,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women need to consume fewer calories to keep weight stable? Answer: We can't say definitively because calorie needs differ based on factors such as age, height, weight, activity, and metabolism. Research has found...",2.36859727356853e-08,0.028170876966696845,0.0,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
54,1.1,10,ai,"Question: Do African American women require fewer calories to maintain weight? Answer: There is no definitive answer as caloric needs vary based on factors such as age, height, weight, activity level, and overall metabolism. However, research","Question: Do African American women require fewer calories to sustain weight? Answer: It's not definitive due to calorie needs varying with age, height, weight, activity level, and metabolism. Research does indicate...",1.184298636784265e-07,0.1541506798272585,0.0,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
55,1.1,1,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Could heightened neutrophil migration following major trauma play a role in causing acute respiratory distress syndrome? Answer: Evidence indicates that increased neutrophil migration after significant trauma may be involved in the onset of acute respiratory distress syndrome (ARDS).,9.474389094274141e-08,0.0545283185603993,0.1015634489089754,0.0072537058591274906,0.06275077630425496,0.11503464348702448,0.007243206163811466,0.0332689204541623,0.09876543209876547,9.474389094274162e-08,0.03712156612126272,0.05113221329437545
55,1.1,2,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Is enhanced neutrophil migratory activity post-major trauma a contributing factor to acute respiratory distress syndrome? Answer: Studies suggest that elevated neutrophil movement after severe trauma might contribute to the development of ARDS.,2.3685972735685321e-07,0.007877646698900342,0.1799307958477509,0.018134264647818754,0.07671251668942158,0.14204081632653065,0.0181080154095287,0.14905263633979304,0.09876543209876547,2.3685972735685406e-07,0.22517379762420298,0.05113221329437545
55,1.1,3,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Does the rise in neutrophil migration after major trauma influence the etiology of acute respiratory distress syndrome? Answer: There is support for the idea that increased neutrophil migratory activity following major trauma could lead to acute respiratory distress syndrome (ARDS).,4.737194547137081e-08,0.11129382753131845,0.10542385647594667,0.0036268529295637453,0.1173159156955923,0.1164175476284697,0.003621603081905733,0.08733614172443849,0.09876543209876547,4.737194547137081e-08,0.01844828503354945,0.05113221329437545
55,1.1,4,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Can increased neutrophil migratory activity after traumatic injury be a factor in acute respiratory distress syndrome? Answer: Research shows that enhanced neutrophil migration post-major trauma could play a role in causing ARDS.,2.3685972735685321e-07,0.007877646698900342,0.1799307958477509,0.018134264647818754,0.07671251668942158,0.14204081632653065,0.0181080154095287,0.14905263633979304,0.09876543209876547,2.3685972735685406e-07,0.22517379762420298,0.05113221329437545
55,1.1,5,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Is the increased migration of neutrophils after severe trauma linked to the development of acute respiratory distress syndrome? Answer: Evidence suggests that neutrophils’ increased migratory behavior following serious injury might contribute to ARDS.,2.1317375462116791e-07,0.022894011967853345,0.1799307958477509,0.016320838183036875,0.04496381837484176,0.14204081632653065,0.016297213868575827,0.11626281351680134,0.09876543209876547,2.1317375462116866e-07,0.1912722459485212,0.05113221329437545
55,1.1,6,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,"Question: Does major trauma-induced neutrophil migration contribute to the pathogenesis of acute respiratory distress syndrome? Answer: There are indications that after major trauma, heightened neutrophil migratory activity may be a factor in ARDS pathogenesis.",2.1317375462116791e-07,0.022894011967853345,0.1799307958477509,0.016320838183036875,0.04496381837484176,0.14204081632653065,0.016297213868575827,0.11626281351680134,0.09876543209876547,2.1317375462116866e-07,0.1912722459485212,0.05113221329437545
55,1.1,7,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Could the increase in neutrophil migratory activity following major trauma be involved in acute respiratory distress syndrome? Answer: Available evidence points to a potential role of increased neutrophil movement in the development of ARDS after trauma.,1.42115836414112e-07,0.10990538895748347,0.1799307958477509,0.010880558788691236,0.044648340314845214,0.14204081632653065,0.010864809245717207,0.023889493385786054,0.09876543209876547,1.4211583641411244e-07,0.095962066144196,0.05113221329437545
55,1.1,8,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Is there a connection between neutrophil migration elevation post-major trauma and the development of acute respiratory distress syndrome? Answer: The data supports that increased neutrophil migration after trauma can contribute to ARDS etiology.,2.1317375462116791e-07,0.019114908066082403,0.1496573583477509,0.016320838183036875,0.04496381837484176,0.14204081632653065,0.016297213868575827,0.11626281351680134,0.09876543209876547,2.1317375462116866e-07,0.1912722459485212,0.05113221329437545
55,1.1,9,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Might the elevated neutrophil migratory activity following major trauma have a role in the etiology of acute respiratory distress syndrome? Answer: Findings indicate that post-trauma neutrophil activity rise could influence ARDS occurrence.,2.3685972735685321e-07,0.007877646698900342,0.1799307958477509,0.018134264647818754,0.07671251668942158,0.14204081632653065,0.0181080154095287,0.14905263633979304,0.09876543209876547,2.3685972735685406e-07,0.22517379762420298,0.05113221329437545
55,1.1,10,ai,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: There is evidence to suggest that increased neutrophil migratory activity after major trauma could contribute to the development of acute respiratory distress syndrome (ARDS).,Question: Does heightened neutrophil motility after significant trauma factor into acute respiratory distress syndrome onset? Answer: Evidence suggests that increased neutrophil migration post-trauma is associated with the development of ARDS.,3.079176455639091e-07,0.10631771951215363,0.1799307958477509,0.023574544042164393,0.17849521099936405,0.14204081632653065,0.02354042003238732,0.2544131519976185,0.09876543209876547,3.079176455639103e-07,0.33437308958919365,0.05113221329437545
56,1.1,1,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective in treating spinal cord sarcoidosis with compressive cervical myelopathy? The impact of decompression on spinal cord sarcoidosis complicated by compressive myelopathy appears unclear. Early diagnosis of sarcoidosis in other organs and corticosteroid treatment are necessary.,7.1057918207056e-08,0.013700537736335061,0.0439516092669246,0.005440279394345618,0.046114238579118894,0.02285532300536917,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
56,1.1,2,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does decompressive surgery provide benefits for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The benefits of decompression in cases with spinal cord sarcoidosis and compressive myelopathy are not apparent. Timely detection of sarcoidosis in other organs along with steroid therapy is essential.,2.3685972735685406e-08,0.09333176473603544,0.04892074506939373,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
56,1.1,3,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery successful for spinal cord sarcoidosis with compressive cervical myelopathy? Decompression's effectiveness in spinal cord sarcoidosis with compressive myelopathy remains uncertain. Early diagnosis from other organ involvement and steroid treatment are required.,1.894877818854825e-07,0.24985195502041257,0.022485319139880958,0.014507411718255002,0.28379392961320615,0.04288523423835892,0.01448641232762296,0.28346677826371636,0.03858600597494736,1.8948778188548325e-07,0.2825985901015611,0.033293697978596916
56,1.1,4,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery effectively treat spinal cord sarcoidosis when compressive cervical myelopathy is present? The effect of decompressive surgery on spinal cord sarcoidosis accompanied by compressive myelopathy is not clear. Prompt diagnosis of sarcoidosis in other organs and steroid therapy is necessary.,0.0,0.0,0.0,0.0,0.034657359027997714,0.024877932399773414,0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0
56,1.1,5,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompression surgery beneficial for spinal cord sarcoidosis with compressive cervical myelopathy? The results of decompression in spinal cord sarcoidosis with compressive myelopathy are inconclusive. Early diagnosis of sarcoidosis involving other organs and steroid treatment should be prioritized.,9.474389094274131e-08,0.1172755843685338,0.010098997813985489,0.0072537058591274906,0.15157032769515633,0.03278313225429821,0.007243206163811466,0.1518843960161691,0.03130969732581415,9.474389094274162e-08,0.15199899867257427,0.029384756657483937
56,1.1,6,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Does surgery to decompress help in spinal cord sarcoidosis with compressive cervical myelopathy? There is no clear evidence that decompression benefits spinal cord sarcoidosis with compressive myelopathy. Early diagnosis of sarcoidosis from other organs and treatment with steroids is important.,4.7371945471370706e-08,0.056946227259440096,0.0048037447265246586,0.0036268529295637453,0.09142286799891597,0.02850585109390017,0.003621603081905733,0.09203255455674064,0.028254282322347224,4.737194547137081e-08,0.09257539796805103,0.02775510204081633
56,1.1,7,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompression an effective treatment for spinal cord sarcoidosis complicated by compressive cervical myelopathy? Decompression effectiveness in such cases is not evident. Early diagnosis of sarcoidosis in different organs and steroid therapy is necessary.,1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
56,1.1,8,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is decompressive surgery effective for spinal cord sarcoidosis associated with compressive cervical myelopathy? The effect of decompression remains uncertain in spinal cord sarcoidosis with compressive myelopathy. Early identification of sarcoidosis from other organs and steroid therapy is essential.,9.474389094274131e-08,0.07980816920313138,0.015970918079774396,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
56,1.1,9,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Can decompressive surgery improve outcomes in spinal cord sarcoidosis with compressive cervical myelopathy? The role of decompression is not clearly established. Early detection of sarcoidosis from other organ sites and steroid treatment is required.,1.894877818854825e-07,0.08181627488466825,0.09642074506939374,0.014507411718255002,0.1538288332582156,0.049861495844875335,0.01448641232762296,0.19402843238501388,0.025623268698060954,1.8948778188548325e-07,0.23638877806423153,0.0
56,1.1,10,human,Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: The effect of decompression for spinal cord sarcoidosis with compressive myelopathy was not evident. Early diagnosis for sarcoidosis from other organ and steroid therapy should be needed.,Is surgery to relieve compression effective for treating spinal cord sarcoidosis with compressive cervical myelopathy? Decompression does not show a definite effect in such cases. Early diagnosis of sarcoidosis beyond the spinal cord and steroid therapy are necessary.,9.474389094274131e-08,0.004873338872325217,0.06941457222988758,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
57,1.1,1,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a contraindication for GERD laparoscopic surgery? Laparoscopic antireflux surgery remains safe and effective for GERD in elderly patients, showing low morbidity and mortality with symptom improvements similar to younger individuals.",2.3685972735685321e-07,0.315255414268639,0.031217481789802305,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
57,1.1,2,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Does advanced age contraindicate GERD laparoscopic surgery? Even in older patients, laparoscopic antireflux surgery is safe, effective, and provides significant symptom relief with low complication rates, comparable to younger patients.",3.079176455639091e-07,0.3703737882968947,0.0,0.023574544042164393,0.3813675565291037,0.0,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
57,1.1,3,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is being elderly a contraindication for GERD laparoscopic surgery? Laparoscopic antireflux procedures are safe and effective for GERD in elderly individuals, with low morbidity and mortality and symptom improvements comparable to those in younger patients.",1.8948778188548261e-07,0.2520824572295557,0.029384756657483937,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
57,1.1,4,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced age a factor against undergoing GERD laparoscopic surgery? Laparoscopic antireflux surgery is a safe and effective option for elderly GERD patients, boasting low risks and symptom improvements on par with younger patients.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,1.1,5,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Does advanced age disqualify patients from laparoscopic GERD surgery? Laparoscopic antireflux surgery is safe and effective for elderly GERD sufferers, delivering low morbidity, mortality, and symptom relief similar to younger populations.",2.842316728282238e-07,0.33647223662121295,0.0,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
57,1.1,6,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is elderly age a contraindication for laparoscopic surgery treating GERD? GERD patients of advanced age can safely and effectively undergo laparoscopic antireflux surgery, with low rates of complications and symptom relief comparable to younger patients.",1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
57,1.1,7,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is it contraindicated to perform laparoscopic surgery for GERD in elderly patients? Laparoscopic antireflux surgery proves safe, effective, and yields significant symptom improvement with minimal morbidity and mortality, even in advanced age.",2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
57,1.1,8,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Does GERD laparoscopic surgery carry risks that contraindicate it in elderly patients? The procedure is safe, effective, and offers symptom improvements akin to younger patients, with low morbidity and mortality rates among the elderly.",2.1317375462116791e-07,0.24116205681688774,0.0,0.016320838183036875,0.2478361639045814,0.0,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
57,1.1,9,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Is advanced patient age a contraindication to laparoscopic antireflux surgery for GERD? The surgery is safe and effective in elderly individuals, ensuring low risk and significant symptom improvement comparable to younger patients.",2.605457000925385e-07,0.30368241379822125,0.0,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
57,1.1,10,human,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Laparoscopic antireflux surgery is a safe and effective treatment for GERD even in elderly patients, warranting low morbidity and mortality rates and a significant improvement of symptoms comparable to younger patients.","Can elderly age be considered a barrier to GERD laparoscopic surgery? Laparoscopic antireflux surgery safely treats GERD in elderly patients, showing low morbidity, mortality, and symptom relief similar to that in younger patients.",2.3685972735685321e-07,0.2719337154836414,0.0,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
58,1.1,1,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Do French laypersons and medical professionals consider it permissible to violate confidentiality in order to protect a patient's wife from a sexually transmitted infection?,6.632072365991896e-07,0.44296226592147736,0.22506925207756232,0.050775941013892524,0.5159957926234537,0.20249835634451027,0.05070244314668036,0.5926723654876334,0.174375,6.632072365991914e-07,0.6733008096905833,0.14158239143367046
58,1.1,2,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Is it acceptable for French health workers and non-professionals to break confidentiality to safeguard a patient's wife from an STD?,7.579511275419309e-07,0.6340175026841868,0.22506925207756232,0.05802964687302004,0.7166664880856044,0.20249835634451027,0.057945649310491856,0.8039814591548389,0.174375,7.579511275419328e-07,0.8964443610047925,0.14158239143367046
58,1.1,3,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,"Among French laypeople and healthcare providers, how acceptable is it to disclose confidential information to protect a patient's spouse from a sexually transmitted disease?",6.632072365991896e-07,0.44296226592147736,0.22506925207756232,0.050775941013892524,0.5159957926234537,0.20249835634451027,0.05070244314668036,0.5926723654876334,0.174375,6.632072365991914e-07,0.6733008096905833,0.14158239143367046
58,1.1,4,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Do French medical practitioners and the general public find it justifiable to breach patient confidentiality to shield the wife from an STI?,7.105791820705602e-07,0.5339340441272054,0.22506925207756232,0.05440279394345628,0.611305972427779,0.20249835634451027,0.05432404622858611,0.6927558240446148,0.174375,7.10579182070562e-07,0.7786613253484087,0.14158239143367046
58,1.1,5,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,What is the stance of French laypersons and healthcare professionals on breaking confidentiality to protect a patient's wife from a sexually transmitted infection?,6.868932093348749e-07,0.4874140284923114,0.22506925207756232,0.052589367478674404,0.5625158082583477,0.20249835634451027,0.052513244687633236,0.6414625296570646,0.174375,6.868932093348767e-07,0.7245941040781334,0.14158239143367046
58,1.1,6,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Is it considered acceptable by French health professionals and lay individuals to compromise confidentiality for the sake of a patient's wife's protection against STD?,6.632072365991896e-07,0.44296226592147736,0.22506925207756232,0.050775941013892524,0.5159957926234537,0.20249835634451027,0.05070244314668036,0.5926723654876334,0.174375,6.632072365991914e-07,0.6733008096905833,0.14158239143367046
58,1.1,7,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,How do French health professionals and laypeople view the acceptability of breaching confidentiality to prevent a sexually transmitted disease in a patient's wife?,6.868932093348749e-07,0.4874140284923114,0.22506925207756232,0.052589367478674404,0.5625158082583477,0.20249835634451027,0.052513244687633236,0.6414625296570646,0.174375,6.868932093348767e-07,0.7245941040781334,0.14158239143367046
58,1.1,8,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Is breaching confidentiality to protect a patient's wife from an STI deemed acceptable by French health workers and laypersons?,7.816371002776163e-07,0.6880847239544621,0.22506925207756232,0.05984307333780192,0.7738249019255532,0.20249835634451027,0.05975645085144472,0.8646060809712739,0.174375,7.816371002776181e-07,0.9609828821423632,0.14158239143367046
58,1.1,9,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,Do health professionals and lay members of the public in France accept breaching confidentiality in order to protect a patient's wife from a sexually transmitted disease?,6.15835291127819e-07,0.3595806569824269,0.22506925207756232,0.047149088084328765,0.42898441563382406,0.20249835634451027,0.047080840064774615,0.5017005872819054,0.174375,6.158352911278206e-07,0.577990629886258,0.14158239143367046
58,1.1,10,ai,Question: Do French lay people and health professionals find it acceptable to breach confidentiality to protect a patient's wife from a sexually transmitted disease? Answer: The acceptability of breaching confidentiality to protect a patient's wife from a sexually transmitted disease may vary among French lay people and health professionals. It is important,What do French lay people and health professionals think about the acceptability of violating confidentiality to protect a patient's wife from an STD?,6.868932093348749e-07,0.4874140284923114,0.22506925207756232,0.052589367478674404,0.5625158082583477,0.20249835634451027,0.052513244687633236,0.6414625296570646,0.174375,6.868932093348767e-07,0.7245941040781334,0.14158239143367046
59,1.1,1,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,Does diffusion-weighted echo-planar MR imaging allow prediction of different histologic subtypes in primary parotid gland tumors? epiDWI can distinguish pleomorphic adenoma and myoepithelial adenomas from other types but overlap exists between benign and malignant groups.,3.5528959103528046e-07,0.3654597734944649,0.0,0.027201396971728103,0.3746934494414109,0.0,0.02716202311429302,0.38441169891033145,0.0,3.552895910352811e-07,0.3946541920039479,0.0
59,1.1,2,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Can diffusion-weighted echo-planar MRI predict histologic subtypes of primary parotid tumors? epiDWI effectively differentiates pleomorphic and myoepithelial adenomas from other lesions, although overlaps occur among benign and malignant cases.",4.974054274493923e-07,0.5596157879354227,0.0,0.03808195576041938,0.5753641449035616,0.0,0.03802683236001026,0.5920510636885754,0.0,4.974054274493935e-07,0.6097655716208945,0.0
59,1.1,3,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Is it possible to predict histologic subtypes of parotid gland tumors using diffusion-weighted echo-planar MR imaging? epiDWI helps separate pleomorphic and myoepithelial adenomas from others, but some benign and malignant lesions overlap.",4.2634750924233636e-07,0.4578330936254802,0.0,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
59,1.1,4,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,Can primary parotid gland tumor subtypes be predicted with diffusion-weighted echo-planar MR? epiDWI differentiates pleomorphic adenoma and myoepithelial adenomas from other types despite some overlap between benign and malignant lesions.,4.7371945471370696e-07,0.5245244681241537,0.0,0.0362685292956375,0.5389965007326869,0.0,0.03621603081905739,0.5543107357057284,0.0,4.737194547137081e-07,0.570544858467612,0.0
59,1.1,5,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Does epiDWI in diffusion-weighted echo-planar MRI differentiate histologic subtypes in parotid tumors? It can separate pleomorphic and myoepithelial adenomas from other entities; however, overlaps happen in benign versus malignant groups.",4.7371945471370696e-07,0.5245244681241537,0.0,0.0362685292956375,0.5389965007326869,0.0,0.03621603081905739,0.5543107357057284,0.0,4.737194547137081e-07,0.570544858467612,0.0
59,1.1,6,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,Is histologic subtype prediction in primary parotid tumors feasible with diffusion-weighted echo-planar MRI? epiDWI shows potential for distinguishing pleomorphic adenoma and myoepithelial adenomas but some lesions overlap in benign and malignant categories.,4.2634750924233636e-07,0.4578330936254802,0.0,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
59,1.1,7,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,"Diffusion-weighted echo-planar MRI of primary parotid tumors: Can it predict histologic subtypes? epiDWI can discriminate pleomorphic and myoepithelial adenomas from other lesions, yet overlaps occur within benign and malignant groups.",4.7371945471370696e-07,0.5245244681241537,0.0,0.0362685292956375,0.5389965007326869,0.0,0.03621603081905739,0.5543107357057284,0.0,4.737194547137081e-07,0.570544858467612,0.0
59,1.1,8,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,Can diffusion-weighted echo-planar MR imaging distinguish histologic subtypes of parotid gland tumors? epiDWI is capable of separating pleomorphic and myoepithelial adenomas from other examined entities but overlapping occurs in benign and malignant lesions.,4.0266153650665106e-07,0.42608439531090037,0.0,0.030828249901291863,0.43721380642274443,0.0,0.030783626196198767,0.44895022004790297,0.0,4.026615365066519e-07,0.4613455665026214,0.0
59,1.1,9,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,Is prediction of different histologic subtypes in primary parotid tumors possible using diffusion-weighted echo-planar MR imaging? epiDWI differentiates pleomorphic and myoepithelial adenomas from other types but overlaps exist between benign and malignant lesions.,4.0266153650665106e-07,0.42608439531090037,0.0,0.030828249901291863,0.43721380642274443,0.0,0.030783626196198767,0.44895022004790297,0.0,4.026615365066519e-07,0.4613455665026214,0.0
59,1.1,10,human,Question: Diffusion-weighted echo-planar MR imaging of primary parotid gland tumors: is a prediction of different histologic subtypes possible? Answer: epiDWI has the potential to differentiate pleomorphic adenoma and myoepithelial adenomas from all other examined entities. Due to an overlap not only within the group of benign and malignant lesions but,Does diffusion-weighted echo-planar MR imaging differentiate subtypes of primary parotid gland tumors? epiDWI helps identify pleomorphic adenoma and myoepithelial adenomas distinctly from other entities despite some overlap within benign and malignant groups.,4.2634750924233636e-07,0.4578330936254802,0.0,0.03264167636607374,0.47000362924573613,0.0,0.03259442773715164,0.48285177172358473,0.0,4.263475092423373e-07,0.4964368863138904,0.0
60,1.1,1,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Is it possible to obtain correlated results from in-house assays for BCRABL transcript detection via quantitative real-time PCR?,1.1132407185772118e-06,1.1523829441634694,0.12244897959183677,0.08523104384474814,1.260522642158111,0.07877526753864449,0.08510767242478487,1.3296458380641774,0.06420927467300831,1.1132407185772137e-06,1.4036381233554347,0.049048751486325794
60,1.1,2,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Can homebrew assays yield correlated results in the quantitative real-time PCR detection of BCRABL transcripts?,1.184298636784268e-06,1.3465389586044272,0.12244897959183677,0.09067132323909377,1.468162006936355,0.07877526753864449,0.09054007704764348,1.552789389378387,0.06420927467300831,1.1842986367842699e-06,1.6448001801723224,0.049048751486325794
60,1.1,3,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Are correlated outcomes achievable with homebrew assays detecting BCRABL transcripts through quantitative real-time PCR?,1.2079846095199534e-06,1.4206469307581484,0.12244897959183677,0.09248474970387564,1.5482047146098914,0.07877526753864449,0.09235087858859636,1.6398007663680172,0.06420927467300831,1.207984609519955e-06,1.7401103599766476,0.049048751486325794
60,1.1,4,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Do homebrew assays provide correlated results for BCRABL transcript detection using quantitative real-time PCR?,1.2079846095199534e-06,1.4206469307581484,0.12244897959183677,0.09248474970387564,1.5482047146098914,0.07877526753864449,0.09235087858859636,1.6398007663680172,0.06420927467300831,1.207984609519955e-06,1.7401103599766476,0.049048751486325794
60,1.1,5,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Is BCRABL transcript detection via quantitative real-time PCR reliable with homebrew assays producing correlated results?,1.184298636784268e-06,1.3465389586044272,0.12244897959183677,0.09067132323909377,1.468162006936355,0.07877526753864449,0.09054007704764348,1.552789389378387,0.06420927467300831,1.1842986367842699e-06,1.6448001801723224,0.049048751486325794
60,1.1,6,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Can quantitative real-time PCR homebrew assays consistently detect BCRABL transcripts with correlated results?,1.2316705822556386e-06,1.5006896384316848,0.12244897959183677,0.09429817616865752,1.6352160915995215,0.07877526753864449,0.09416168012954923,1.7351109461723424,0.06420927467300831,1.2316705822556405e-06,1.8454708756344735,0.049048751486325794
60,1.1,7,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Are results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR correlated?,1.2079846095199534e-06,1.4206469307581484,0.12244897959183677,0.09248474970387564,1.5482047146098914,0.07877526753864449,0.09235087858859636,1.6398007663680172,0.06420927467300831,1.207984609519955e-06,1.7401103599766476,0.049048751486325794
60,1.1,8,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Is the correlation of results feasible with homebrew assays for BCRABL transcript detection by quantitative real-time PCR?,1.1369266913128972e-06,1.2130075659799044,0.12244897959183677,0.08704447030953001,1.3250611632956817,0.07877526753864449,0.08691847396573774,1.3986387095511295,0.06420927467300831,1.136926691312899e-06,1.477746095509156,0.049048751486325794
60,1.1,9,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Do quantitative real-time PCR homebrew assays generate correlated results when detecting BCRABL transcripts?,1.2316705822556386e-06,1.5006896384316848,0.12244897959183677,0.09429817616865752,1.6352160915995215,0.07877526753864449,0.09416168012954923,1.7351109461723424,0.06420927467300831,1.2316705822556405e-06,1.8454708756344735,0.049048751486325794
60,1.1,10,ai,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: Correlated results from homebrew assays for BCRABL transcript detection by quantitative real-time PCR are possible if the assay is properly designed, validated, and executed following established protocols and guidelines. However, it is recommended to use commercially available kits that have undergone rigorous testing for accurate and reliable results.",Is it feasible to get correlated results from homebrew assays in quantitative real-time PCR detection of BCRABL transcripts?,1.1132407185772118e-06,1.1523829441634694,0.12244897959183677,0.08523104384474814,1.260522642158111,0.07877526753864449,0.08510767242478487,1.3296458380641774,0.06420927467300831,1.1132407185772137e-06,1.4036381233554347,0.049048751486325794
61,1.1,1,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Clinical evaluation is crucial for diagnosing appendicitis in children. Still, for girls above 10 years, targeted imaging is recommended to prevent unwarranted appendectomies. Imaging is preferred in uncertain situations.",3.7897556377096523e-07,0.4384822565892921,0.009686178998348317,0.029014823436510018,0.4653632496892328,0.0,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
61,1.1,2,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Diagnosing appendicitis in children primarily relies on clinical assessment. However, in girls over 10, selective imaging should be considered to avoid unnecessary surgeries. Imaging is advised for unclear cases.",3.7897556377096523e-07,0.3889717436921529,0.045351473922902494,0.029014823436510018,0.4653632496892328,0.0,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
61,1.1,3,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Appendicitis diagnosis in children hinges on clinical judgment. Yet, in girls older than 10, using imaging selectively can help reduce unnecessary appendectomies. Imaging is the preferred method when cases are ambiguous.",3.3160361829959463e-07,0.31997887220520216,0.045351473922902494,0.02538797050694626,0.39390428570708913,0.0,0.02535122157334018,0.4054651081081637,0.0,3.316036182995957e-07,0.4177352006999784,0.0
61,1.1,4,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","The main method for diagnosing appendicitis in children is clinical assessment. In girls older than 10 years, targeted imaging should be used to prevent needless appendectomies. Imaging is best reserved for doubtful cases.",2.84231672828224e-07,0.25544035106763063,0.045351473922902494,0.0217611175773825,0.32721291120841567,0.0,0.021729618491434434,0.33647223662121295,0.0,2.8423167282822487e-07,0.3462762367178347,0.0
61,1.1,5,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","For diagnosing appendicitis in children, clinical evaluation is essential. However, girls over 10 years might need selective imaging to avoid unnecessary surgeries. Imaging is the choice in ambiguous cases.",3.7897556377096523e-07,0.3889717436921529,0.045351473922902494,0.029014823436510018,0.4653632496892328,0.0,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
61,1.1,6,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Clinical assessment remains the cornerstone in diagnosing appendicitis in children. Nonetheless, selective imaging is beneficial in girls above 10 to prevent needless operations. Imaging is indicated in equivocal instances.",3.7897556377096523e-07,0.4384822565892921,0.009686178998348317,0.029014823436510018,0.4653632496892328,0.0,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
61,1.1,7,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Diagnosis of appendicitis in children depends on clinical assessment. Still, for girls older than 10 years, imaging should be selectively applied to avert unnecessary appendectomy. Imaging should be used in unclear cases.",3.0791764556390933e-07,0.37662739526091293,0.01885780075010582,0.02357454404216438,0.4062125460687369,0.033293697978596916,0.023540420032387308,0.3703737882968947,0.0,3.079176455639103e-07,0.3813675565291037,0.0
61,1.1,8,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","To diagnose appendicitis in children, clinical assessment is key. Nevertheless, in girls older than 10, imaging should be selectively utilized to avoid extra appendectomies. Imaging is preferred when the diagnosis is uncertain.",3.0791764556390933e-07,0.28718904938221046,0.045351473922902494,0.02357454404216438,0.36000273403140737,0.0,0.023540420032387308,0.3703737882968947,0.0,3.079176455639103e-07,0.3813675565291037,0.0
61,1.1,9,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","The cornerstone for diagnosing appendicitis in children is clinical evaluation. For girls older than 10, selective imaging is advised to avoid unnecessary surgeries. Imaging is recommended in inconclusive cases.",3.7897556377096523e-07,0.4384822565892921,0.009686178998348317,0.029014823436510018,0.4653632496892328,0.0,0.028972824655245928,0.4795730802618854,0.0,3.789755637709665e-07,0.49469624183610783,0.0
61,1.1,10,human,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Clinical assessment is the key to diagnose appendicitis. Nevertheless, in girls older than 10 years, selected use of imaging should be implemented to avoid unnecessary appendectomies. Imaging of choice in equivocal cases should be","Clinical assessment is fundamental in diagnosing pediatric appendicitis. Yet, in girls older than 10 years, selective use of imaging is important to prevent unnecessary operations. Imaging should be employed in equivocal scenarios.",3.0791764556390933e-07,0.28718904938221046,0.045351473922902494,0.02357454404216438,0.36000273403140737,0.0,0.023540420032387308,0.3703737882968947,0.0,3.079176455639103e-07,0.3813675565291037,0.0
62,1.1,1,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Monitoring motor evoked potentials (MEP) and somatosensory evoked potentials (SSEP) shows that losing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe, yielding low immediate and delayed paraplegia rates. This evidence suggests routine surgical reattachment of segmental arteries is unnecessary.",7.105791820705622e-08,0.02770471655935225,0.016388888888888894,0.005440279394345618,0.05129329438754926,0.0,0.0054324046228586,0.05218575317056917,0.0,7.105791820705622e-08,0.05310982531394792,0.0
62,1.1,2,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: In thoracic and thoracoabdominal aneurysm repair, is reimplanting spinal cord arteries futile? Answer: Through MEP and SSEP monitoring, the sacrifice of up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is deemed safe, producing acceptable low rates of immediate and delayed paraplegia. This observation indicates that standard surgical reimplantation of segmental vessels may be unwarranted.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
62,1.1,3,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Regarding thoracic and thoracoabdominal aneurysm repair, is reimplanting spinal arteries a needless effort? Answer: Utilizing MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair proves to be safe, with acceptably low immediate and delayed paraplegia incidence. This data implies that routine surgical reimplantation of segmental arteries might not be necessary.",2.3685972735685406e-08,0.01709443335929972,0.0,0.0018134264647818726,0.01739174271186883,0.0,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
62,1.1,4,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: For thoracic and thoracoabdominal aneurysm repairs, is reimplanting spinal arteries a waste of resources? Answer: With the help of MEP and SSEP monitoring, the sacrifice of up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is considered safe, leading to low rates of immediate and delayed paraplegia. These results suggest that routine surgical reimplantation of segmental vessels could be avoided.",1.1842986367842703e-07,0.08269171584511614,0.0,0.009067132323909363,0.0840831172105414,0.0,0.009054007704764333,0.08552217343816082,0.0,1.1842986367842703e-07,0.08701137698962835,0.0
62,1.1,5,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Is reimplantation of spinal cord arteries pointless in thoracic and thoracoabdominal aneurysm surgery? Answer: Monitoring MEP and SSEP demonstrates that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation in TAA/A repair is safe, causing low immediate and delayed paraplegia risk. This experience suggests that routinely implanting segmental vessels surgically may be unnecessary.",7.105791820705622e-08,0.05310982531394792,0.0,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
62,1.1,6,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: When repairing thoracic and thoracoabdominal aneurysms, is reimplantation of spinal cord arteries ineffective? Answer: With MEP and SSEP monitoring, sacrificing up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is a safe practice with a low occurrence of immediate and delayed paraplegia. This indicates that routine surgical reimplantation of segmental vessels might not be essential.",0.0,0.023901626915860064,0.017236072637734686,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
62,1.1,7,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: In repairing thoracic and thoracoabdominal aneurysms, is spinal artery reimplantation a waste? Answer: The use of MEP and SSEP monitoring confirms that sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and associated with low rates of immediate and delayed paraplegia. This suggests that routine surgical reimplantation of segmental arteries is likely unnecessary.",4.737194547137081e-08,0.03390155167568043,0.0,0.0036268529295637453,0.03448617607116855,0.0,0.003621603081905733,0.03509131981126945,0.0,4.737194547137081e-08,0.03571808260207909,0.0
62,1.1,8,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Is the reimplantation of spinal arteries during thoracic and thoracoabdominal aneurysm repair unnecessary? Answer: MEP and SSEP monitoring allow the safe sacrifice of up to 15 intercostal and lumbar arteries without reimplantation during TAA/A repair, resulting in acceptably low immediate and delayed paraplegia rates. This implies that routine surgical reimplantation of segmental vessels might be redundant.",4.737194547137081e-08,0.059846576259839246,0.017851239669421492,0.0036268529295637453,0.03571808260207909,0.0,0.003621603081905733,0.036367644170874236,0.0,4.737194547137081e-08,0.037041271680350096,0.0
62,1.1,9,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal arteries futile? Answer: Under MEP and SSEP monitoring, sacrificing as many as 15 intercostal and lumbar arteries without reimplantation during TAA/A repair is safe and yields low immediate and delayed paraplegia incidence. This experience points to the conclusion that routine surgical implantation of segmental vessels is not necessary.",2.3685972735685406e-08,0.01739174271186883,0.0,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
62,1.1,10,human,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: With monitoring of MEP and SSEP, sacrifice--without reimplantation--of as many as 15 intercostal and lumbar arteries during TAA/A repair is safe, resulting in acceptably low rates of immediate and delayed paraplegia. This experience suggests that routine surgical implantation of segmental vessels is","Question: In thoracic and thoracoabdominal aneurysm repair, does reimplanting spinal cord arteries serve no purpose? Answer: Monitoring with MEP and SSEP indicates that sacrificing up to 15 intercostal and lumbar arteries without reimplantation in TAA/A repair is safe, leading to acceptably low rates of immediate and delayed paraplegia. This shows that routine surgical reimplantation of segmental vessels may be avoidable.",2.3685972735685406e-08,0.01709443335929972,0.0,0.0018134264647818726,0.01739174271186883,0.0,0.0018108015409528666,0.01769957709940062,0.0,2.3685972735685406e-08,0.018018505502678472,0.0
63,1.1,1,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there a connection between cervical cord plaques and discopathy in individuals with multiple sclerosis? There is no direct connection between cervical cord plaques and discopathy in these patients.,4.73719454713706e-08,0.00032184656904465925,0.022675736961451393,0.003626852929563759,0.0029016530894212522,0.03174603174603169,0.003621603081905747,0.0058705486801184925,0.04081632653061215,4.737194547137081e-08,0.009297274666885347,0.04988662131519275
63,1.1,2,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Does a relationship exist between cervical cord plaques and discopathy among patients diagnosed with multiple sclerosis? No direct relationship exists between cervical cord plaques and discopathy in such patients.,4.73719454713706e-08,0.09934287236332207,0.07476563404189651,0.003626852929563759,0.10559012428348735,0.09216036761270358,0.003621603081905747,0.1125085764585716,0.10880067212770415,4.737194547137081e-08,0.12020082355647643,0.12468654758689866
63,1.1,3,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Are cervical cord plaques associated with discopathy in multiple sclerosis patients? There is no direct association between cervical cord plaques and discopathy in these cases.,1.421158364141118e-07,0.019457961881772956,0.12244897959183679,0.010880558788691277,0.09035074872166104,0.1924392346470268,0.010864809245717241,0.10541153346308363,0.2222222222222221,1.4211583641411244e-07,0.05675098530128997,0.20408163265306126
63,1.1,4,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there an association between cervical cord plaques and discopathy in patients suffering from multiple sclerosis? No direct linkage is observed between cervical cord plaques and discopathy in these patients.,2.36859727356853e-08,0.09516723366996382,0.052081324022993064,0.0018134264647818796,0.09978214635679894,0.06569533925731597,0.0018108015409528735,0.10482900372096582,0.07855492543583273,2.3685972735685406e-08,0.11036804393167188,0.09066008255854331
63,1.1,5,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Do cervical cord plaques correlate with discopathy in individuals with multiple sclerosis? There is no direct correlation between cervical cord plaques and discopathy in patients with multiple sclerosis.,7.10579182070559e-08,0.10515085029001048,0.10123066239728412,0.005440279394345639,0.21990772479954535,0.19742766439909293,0.005432404622858621,0.23324490497296813,0.2222222222222221,7.105791820705622e-08,0.1902823779258136,0.20408163265306126
63,1.1,6,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is any relationship found between cervical cord plaques and discopathy in multiple sclerosis patients? No direct relationship can be established between cervical cord plaques and discopathy in these patients.,4.73719454713706e-08,0.04983235946618336,0.0465508517456569,0.003626852929563759,0.054245888686454524,0.06020782968834909,0.003621603081905747,0.059189562569345266,0.07346189164370975,4.737194547137081e-08,0.06474904911168045,0.08631303761173899
63,1.1,7,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Are cervical cord plaques related to discopathy in patients with multiple sclerosis? There is no direct relation between cervical cord plaques and discopathy in such patients.,1.184298636784265e-07,0.06721142820762482,0.1271293641423512,0.009067132323909398,0.13542176596857436,0.19423976269776969,0.009054007704764368,0.14986329603391768,0.2222222222222221,1.1842986367842703e-07,0.10327100093618391,0.20408163265306126
63,1.1,8,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Can a link be found between cervical cord plaques and discopathy in multiple sclerosis patients? There is no direct link between cervical cord plaques and discopathy in these patients.,4.73719454713706e-08,0.04983235946618336,0.0465508517456569,0.003626852929563759,0.054245888686454524,0.06020782968834909,0.003621603081905747,0.059189562569345266,0.07346189164370975,4.737194547137081e-08,0.06474904911168045,0.08631303761173899
63,1.1,9,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is there any connection between cervical cord plaques and discopathy among those with multiple sclerosis? No direct connection between cervical cord plaques and discopathy is present in patients.,7.10579182070559e-08,0.002462379095944378,0.040816326530612235,0.005440279394345639,0.006631669242640026,0.054421768707483,0.005432404622858621,0.011437807193785066,0.0680272108843536,7.105791820705622e-08,0.016995582785828578,0.08163265306122455
63,1.1,10,ai,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: There is no direct relation between cervical cord plaques and discopathy in patients with,Is an association present between cervical cord plaques and discopathy in multiple sclerosis patients? There is no direct association between cervical cord plaques and discopathy in these individuals.,7.10579182070559e-08,0.002462379095944378,0.040816326530612235,0.005440279394345639,0.006631669242640026,0.054421768707483,0.005432404622858621,0.011437807193785066,0.0680272108843536,7.105791820705622e-08,0.016995582785828578,0.08163265306122455
64,1.1,1,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the 30-day and 1-year mortality rates following emergency general surgery laparotomies concerning and in need of enhancement? Answer: Yes, the mortality rates at 30 days and 1 year post-emergency general surgery laparotomies raise concerns and highlight the necessity for improvements in the area.",0.0,0.15753345012725983,0.10502273044410657,0.0,0.09671821124092217,0.06880207704383531,0.0,0.06601401719618405,0.047500000000000014,0.0,0.0,0.0
64,1.1,2,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Is there a concern and need for improvement regarding 30-day and 1-year mortality in emergency general surgery laparotomies? Answer: Yes, the observed mortality rates at both 30 days and 1 year after emergency general surgery laparotomies are worrisome and suggest a need for advancement.",0.0,0.15753345012725983,0.10502273044410658,0.0,0.09671821124092217,0.06880207704383531,0.0,0.06601401719618405,0.047500000000000014,0.0,0.0,0.0
64,1.1,3,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the 30-day and 1-year death rates in emergency general surgery laparotomies problematic and require betterment? Answer: Indeed, the mortality percentages at these intervals reveal issues and underscore the requirement for improvements.",2.84231672828224e-07,0.06640021091491866,0.1728395061728395,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.3462762367178347,0.0
64,1.1,4,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Does the mortality within 30 days and 1 year after emergency general surgery laparotomies present an area needing improvement? Answer: Yes, these mortality rates are concerning and clearly point to the necessity of improving outcomes.",2.1317375462116813e-07,0.023211947774768316,0.1728395061728395,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.2478361639045814,0.0
64,1.1,5,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are 30-day and 1-year mortality statistics in emergency laparotomies a source of concern requiring action? Answer: Yes, these mortality figures reflect an area of concern and call for enhancement efforts.",3.3160361829959463e-07,0.17714854408981973,0.1395458081942426,0.02538797050694626,0.26494667071919276,0.09204470742932283,0.02535122157334018,0.33945109091197967,0.047500000000000014,3.316036182995957e-07,0.4177352006999784,0.0
64,1.1,6,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Is the mortality observed at 30 days and 1 year in emergency general surgery laparotomies an important concern that could be improved? Answer: Yes, the data signals worry and a pressing need for progress in surgical care.",1.6580180914979753e-07,0.07878179892958048,0.1728395061728395,0.012693985253473108,0.04872356224955565,0.09204470742932283,0.012675610786670066,0.1163075395977704,0.047500000000000014,1.6580180914979784e-07,0.18721154208814594,0.0
64,1.1,7,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are emergency general surgery laparotomies associated with concerning 30-day and 1-year mortality rates that warrant improvement? Answer: Yes, the mortality rates at these time points indicate a significant concern and the urgent necessity of improvements.",2.1317375462116813e-07,0.016396462542942913,0.14429279337007134,0.01632083818303686,0.105881976089504,0.09204470742932283,0.016297213868575813,0.1751480396207037,0.047500000000000014,2.1317375462116866e-07,0.2478361639045814,0.0
64,1.1,8,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Do the 30-day and 1-year mortality rates following emergency general surgery laparotomies demand attention and improvement? Answer: Certainly, these rates are cause for concern and emphasize the need for better practices.",3.0791764556390933e-07,0.09814890922949848,0.1728395061728395,0.02357454404216438,0.231045119043511,0.09204470742932283,0.023540420032387308,0.30435977110071066,0.047500000000000014,3.079176455639103e-07,0.3813675565291037,0.0
64,1.1,9,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Are the short-term and long-term mortality outcomes in emergency general surgery laparotomies problematic and in need of advances? Answer: Yes, mortality at 30 days and 1 year presents clear challenges requiring improvement.",2.84231672828224e-07,0.06640021091491866,0.1728395061728395,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.2704582194250289,0.047500000000000014,2.8423167282822487e-07,0.3462762367178347,0.0
64,1.1,10,ai,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Yes, the 30-day and 1-year mortality rates in emergency general surgery laparotomies are a cause for concern and indicate the need for improvement in the field.","Question: Does the evidence of 30-day and 1-year mortality in emergency general surgery laparotomies suggest it is an area needing improvement? Answer: Yes, the mortality rates are alarming and demonstrate the need for further enhancements.",2.3685972735685343e-07,0.0057755890984831915,0.1728395061728395,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.20591969828745738,0.047500000000000014,2.3685972735685406e-07,0.27958486221916123,0.0
65,1.1,1,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Emergency double-balloon enteroscopy (DBE) combined with real-time capsule endoscopy viewing is a practical method for acute overt-obscure gastrointestinal bleeding (OGIB).,5.210914001850768e-07,0.7353210299495778,0.024375,0.039895382225201316,0.7985076962177713,0.0,0.03983763390096319,0.8303483020734284,0.0,5.210914001850787e-07,0.8649974374866054,0.0
65,1.1,2,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Performing emergency DBE along with real-time capsule endoscopy is a viable approach for managing acute OGIB.,6.158352911278182e-07,0.9717098080138076,0.024375,0.04714908808432882,1.0498221244986778,0.0,0.047080840064774684,1.0986122886681073,0.0,6.158352911278201e-07,1.1526795099383857,0.0
65,1.1,3,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Combining emergency double-balloon enteroscopy and real-time capsule endoscopy viewing is an effective strategy in cases of acute overt-obscure gastrointestinal bleeding.,5.210914001850768e-07,0.7353210299495778,0.024375,0.039895382225201316,0.7985076962177713,0.0,0.03983763390096319,0.8303483020734284,0.0,5.210914001850787e-07,0.8649974374866054,0.0
65,1.1,4,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Emergency DBE, when used with real-time capsule endoscopy, is safe, feasible, and effective for acute OGIB.",6.158352911278182e-07,0.9717098080138076,0.024375,0.04714908808432882,1.0498221244986778,0.0,0.047080840064774684,1.0986122886681073,0.0,6.158352911278201e-07,1.1526795099383857,0.0
65,1.1,5,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","For acute overt-obscure gastrointestinal bleeding, emergency DBE combined with capsule endoscopy provides a feasible diagnostic and therapeutic option.",5.684633456564475e-07,0.8465466650598019,0.024375,0.04352223515476507,0.9162907318741551,0.0,0.04345923698286894,0.955511445027434,0.0,5.684633456564493e-07,0.9985288301111281,0.0
65,1.1,6,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Using emergency double-balloon enteroscopy together with real-time capsule endoscopy is an effective and safe approach to treat acute OGIB.,5.447773729207622e-07,0.7893882512198531,0.024375,0.041708808689983196,0.8556661100577201,0.0,0.04164843544191606,0.8909729238898634,0.0,5.44777372920764e-07,0.929535958624176,0.0
65,1.1,7,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Emergency DBE with real-time capsule endoscopy viewing can successfully diagnose and treat most patients with acute overt-obscure gastrointestinal bleeding, potentially avoiding major surgery.",4.500334819780208e-07,0.5887175557577025,0.024375,0.03445510283085568,0.6443570163905146,0.0,0.03440522927810457,0.6678293725756541,0.0,4.500334819780226e-07,0.6931471805599463,0.0
65,1.1,8,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",The combined use of emergency double-balloon enteroscopy and real-time capsule endoscopy is practical and efficient in managing acute OGIB cases.,5.210914001850768e-07,0.7353210299495778,0.024375,0.039895382225201316,0.7985076962177713,0.0,0.03983763390096319,0.8303483020734284,0.0,5.210914001850787e-07,0.8649974374866054,0.0
65,1.1,9,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.",Acute overt-obscure GI bleeding can be effectively addressed by emergency DBE combined with real-time visualization from capsule endoscopy.,5.684633456564475e-07,0.8465466650598019,0.024375,0.04352223515476507,0.9162907318741551,0.0,0.04345923698286894,0.955511445027434,0.0,5.684633456564493e-07,0.9985288301111281,0.0
65,1.1,10,human,"Question: Emergency double-balloon enteroscopy combined with real-time viewing of capsule endoscopy: a feasible combined approach in acute overt-obscure gastrointestinal bleeding? Answer: Emergency DBE is feasible, safe and effective in acute OGIB and may avoid major surgery, diagnosing and successfully treating most patients.","Emergency double-balloon enteroscopy paired with real-time capsule endoscopy is a feasible, safe, and successful treatment for patients with acute OGIB, reducing the need for major surgery.",3.789755637709649e-07,0.46088418424781796,0.024375,0.02901482343651004,0.5108256237659909,0.0,0.02897282465524595,0.5280674302004948,0.0,3.789755637709665e-07,0.5465437063680709,0.0
66,1.1,1,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does sex affect the response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register indicate that intravenous thrombolysis might alter the survival and recovery benefits typically seen in men during the natural progression of ischemic stroke.,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
66,1.1,2,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the response to intravenous thrombolysis in ischemic stroke influenced by sex? Evidence from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggests that intravenous thrombolysis can change the expected survival and recovery advantage Männer typically have during ischemic stroke.,1.1842986367842703e-07,0.1187445534356879,0.002646604938271603,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
66,1.1,3,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,","Does sex impact how patients respond to intravenous thrombolysis in ischemic stroke? According to data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, intravenous thrombolysis may modify the survival and recovery benefits men usually experience in the natural course of ischemic stroke.",4.737194547137081e-08,0.04582161865889667,0.0009865860091207122,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
66,1.1,4,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is intravenous thrombolysis response in ischemic stroke affected by patient sex? Findings from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest intravenous thrombolysis could influence the survival and recovery advantage generally observed in men during ischemic stroke progression.,1.4211583641411244e-07,0.17893982649376383,0.028133100783146937,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
66,1.1,5,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does gender influence outcomes after intravenous thrombolysis for ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register propose that intravenous thrombolysis may alter the male-associated survival and recovery benefits expected in ischemic stroke.,2.1317375462116834e-07,0.22505406507288273,0.005277777777777767,0.016320838183036854,0.22314355131420927,0.0,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
66,1.1,6,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is the efficacy of intravenous thrombolysis in ischemic stroke dependent on sex? Analysis from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register evidence that intravenous thrombolysis might change the survival and recovery benefits commonly seen in men during ischemic stroke.,1.1842986367842703e-07,0.1187445534356879,0.002646604938271603,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
66,1.1,7,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does men and women’s sex affect how they respond to intravenous thrombolysis treatment in ischemic stroke? Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data indicates that intravenous thrombolysis could alter the survival and recovery advantage typically found in men.,1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
66,1.1,8,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,","Does the biological sex influence intravenous thrombolysis treatment effects in ischemic stroke? According to the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register, this treatment might modify the survival and recovery benefits that are usually more favorable in men during ischemic stroke.",9.474389094274162e-08,0.06083494426833802,0.021728395061728398,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
66,1.1,9,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Is sex a factor that influences response to intravenous thrombolysis in ischemic stroke? Data from the Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest intravenous thrombolysis may adjust the survival and recovery advantages traditionally attributed to men in the natural ischemic stroke course.,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
66,1.1,10,human,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Data from Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register suggest that intravenous thrombolysis may modify the observed survival and recovery advantage for men expected in the natural course of an ischemic stroke,",Does intravenous thrombolysis affect men and women differently in ischemic stroke recovery? The Safe Implementation of Treatments in Stroke-International Stroke Thrombolysis Register data suggests that intravenous thrombolysis may modify the survival and recovery benefit generally expected in men during ischemic stroke.,1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
67,1.1,1,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers secrete GABA? No, mossy fibers do not secrete gamma-aminobutyric acid (GABA). Instead, these nerve fibers in the cerebellum release the neurotransmitter glutamate. GABA is mainly released by inhibitory neurons in the brain.",1.8948778188548261e-07,0.181376505860376,0.06369421844181462,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
67,1.1,2,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Are mossy fibers responsible for releasing GABA? No, they are not. Mossy fibers, found in the cerebellum, release glutamate and not gamma-aminobutyric acid (GABA). GABA is predominantly secreted by inhibitory neurons.",2.842316728282238e-07,0.2249929216896831,0.12228796844181462,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
67,1.1,3,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Is GABA released by mossy fibers? No, mossy fibers do not release gamma-aminobutyric acid (GABA). These fibers in the cerebellum release glutamate, while GABA is primarily released by inhibitory neurons.",3.079176455639091e-07,0.306697727197085,0.08784919293161053,0.023574544042164393,0.3813675565291037,0.0,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
67,1.1,4,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers emit GABA? No, mossy fibers do not emit gamma-aminobutyric acid (GABA). Instead, they release glutamate in the cerebellum. The neurotransmitter GABA is mostly released by inhibitory neurons.",3.079176455639091e-07,0.306697727197085,0.08784919293161053,0.023574544042164393,0.3813675565291037,0.0,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
67,1.1,5,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers produce GABA? No, mossy fibers do not produce gamma-aminobutyric acid (GABA). These cerebellar nerve fibers release the neurotransmitter glutamate, as GABA release is mainly associated with inhibitory neurons.",2.842316728282238e-07,0.27120273372701265,0.0889942704632177,0.021761117577382513,0.3462762367178347,0.0,0.021729618491434448,0.356674943938732,0.0,2.8423167282822487e-07,0.36772478012531495,0.0
67,1.1,6,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Are GABA molecules released by mossy fibers? No, mossy fibers do not release GABA. They are cerebellar fibers that release glutamate, while GABA is released primarily by inhibitory neurons.",3.316036182995944e-07,0.29398579317663387,0.12228796844181462,0.025387970506946272,0.4177352006999784,0.0,0.025351221573340195,0.43078291609245367,0.0,3.316036182995957e-07,0.4446858212614444,0.0
67,1.1,7,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Is gamma-aminobutyric acid released by mossy fibers? No, mossy fibers release glutamate, not gamma-aminobutyric acid (GABA). GABA is largely released by inhibitory neurons in the brain.",4.026615365066503e-07,0.51821802737323,0.04289288337565203,0.03082824990129191,0.5355182363563626,0.0,0.030783626196198816,0.5533852381847866,0.0,4.026615365066519e-07,0.5725191927713289,0.0
67,1.1,8,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Do mossy fibers discharge GABA? No, discharge of gamma-aminobutyric acid (GABA) is not characteristic of mossy fibers. They are cerebellar nerve fibers that release glutamate, with GABA being released by inhibitory neurons.",2.605457000925385e-07,0.1922030988666914,0.12228796844181462,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
67,1.1,9,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Is GABA released from mossy fibers? No, mossy fibers do not release GABA. These fibers in the cerebellum secrete glutamate, whereas inhibitory neurons primarily release GABA.",4.026615365066503e-07,0.4627662529284331,0.08235741288625906,0.03082824990129191,0.5355182363563626,0.0,0.030783626196198816,0.5533852381847866,0.0,4.026615365066519e-07,0.5725191927713289,0.0
67,1.1,10,ai,"Question: Do mossy fibers release GABA? Answer: No, mossy fibers do not release gamma-aminobutyric acid (GABA). Mossy fibers are a type of nerve fiber found in the cerebellum that release the neurotransmitter glutamate. GABA is primarily released by inhibitory neurons in the brain.","Are mossy fibers a source of GABA release? No, mossy fibers are not a source of gamma-aminobutyric acid (GABA) release. They release glutamate in the cerebellum, while inhibitory neurons predominantly release GABA.",2.605457000925385e-07,0.32636061768474534,0.02662470313569215,0.019947691112600634,0.3585844970794825,0.033293697978596916,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
68,1.1,1,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Marital status, living arrangements, and mortality: Is the relationship influenced by gender? Understanding living arrangements is essential for revealing and explaining how marital status impacts mortality risks differently for men and women. The effects of living alone versus living with a partner appear to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,1.1,2,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Does the link between marital status, living arrangements, and mortality differ by gender? Assessing living arrangements is key to identifying and interpreting gender disparities in mortality risks related to marital status. The consequences of living solo and cohabiting with a partner seem to",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
68,1.1,3,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","How does gender affect the association between marital status, living arrangement, and mortality? Analyzing living arrangements is fundamental to understanding and explaining the gender-based differences in mortality risk associated with marital status. Living alone and living with a partner seem to have",4.737194547137081e-08,0.01538864524228023,0.023242630385487524,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
68,1.1,4,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to",Is there a gender difference in how marital status and living arrangements relate to mortality? Evaluating living arrangements is vital for detecting and clarifying the gender-specific mortality risk variations tied to marital status. The influence of residing alone or with a partner appears to,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,1.1,5,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Marital status, living arrangements, and mortality: Do these associations vary based on gender? Careful examination of living arrangements helps identify and explain gender differences in mortality risks linked to marital status. The effect of living alone or living with a partner seems to",2.3685972735685406e-08,0.024298102261311794,0.0005527295193310314,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
68,1.1,6,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Does the connection between marital status, living arrangement, and mortality vary according to gender? Investigating living arrangements is crucial for understanding gender distinctions in mortality risk by marital status. Living by oneself compared to living with a partner appears to",9.474389094274152e-08,0.06539906581694366,0.023242630385487524,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
68,1.1,7,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","How does the association between marital status, living arrangement, and mortality differ between genders? Evaluating living arrangements is important to uncovering gender-related variances in mortality risks concerning marital status. The impact of living alone versus cohabiting with a partner seems to",7.105791820705622e-08,0.04008125783265193,0.023242630385487524,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
68,1.1,8,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Is gender a factor in the relationship between marital status, living arrangements, and mortality? Examining living arrangements is essential for explaining and detecting gender differences in mortality risk related to marital status. The role of living alone and living with a partner seems to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
68,1.1,9,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Does the relationship between marital status, living arrangements, and mortality show gender differences? Understanding living arrangements is key to explaining how mortality risks differ by gender when considering marital status. The influence of living independently or with a partner appears to",7.105791820705622e-08,0.04008125783265193,0.023242630385487524,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
68,1.1,10,human,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: Evaluation of living arrangements is crucial for identifying and explaining gender differences in mortality risks by marital status. The impact of living alone and living with a partner seems to","Can gender modify the association between marital status, living arrangements, and mortality? Analyzing living arrangements is important for identifying and explaining gender disparities in mortality risks that stem from marital status. The effects of living alone compared to living with a partner seem to",0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
69,1.1,1,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is preventing osteoporosis the key to eliminating musculoskeletal symptoms related to aromatase inhibitors? Not necessarily; while bone health maintenance is crucial, managing other aspects like inflammation, hormonal changes, and individual factors is also important.",5.68463345656449e-07,0.44925989155263846,0.06977572089711641,0.043522235154764964,0.5348605314868533,0.017851239669421492,0.043459236982868826,0.5733459807473245,0.0,5.684633456564497e-07,0.5877866649021204,0.0
69,1.1,2,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Eliminating aromatase inhibitor-associated musculoskeletal symptoms may not depend solely on osteoporosis prevention. Ensuring bone health is vital, but addressing inflammation, hormonal imbalances, and personal patient factors is equally essential.",6.868932093348755e-07,0.6135629428439144,0.06977572089711641,0.05258936747867436,0.7047595682822503,0.017851239669421492,0.052513244687633194,0.7492366472109886,0.0,6.868932093348768e-07,0.7701082216960753,0.0
69,1.1,3,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Does preventing osteoporosis fully resolve aromatase inhibitor-induced musculoskeletal symptoms? Likely not, since besides bone care, tackling inflammation, hormonal fluctuations, and patient-specific characteristics is also needed.",7.816371002776167e-07,0.7677136226711734,0.06977572089711641,0.05984307333780188,0.8651022183574302,0.017851239669421492,0.05975645085144469,0.9162907318741556,0.0,7.816371002776184e-07,0.9444616088408537,0.0
69,1.1,4,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Preventing osteoporosis might not be the only way to get rid of musculoskeletal symptoms linked to aromatase inhibitors. Bone health matters, but factors like inflammation, hormonal shifts, and individualized patient aspects also influence symptom management.",5.447773729207637e-07,0.4194069284029567,0.06977572089711641,0.041708808689983085,0.5040888728200996,0.017851239669421492,0.04164843544191595,0.5415972824327446,0.0,5.447773729207643e-07,0.5549968420791287,0.0
69,1.1,5,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is osteoporosis prevention the definitive solution to aromatase inhibitor-related musculoskeletal issues? Probably not; maintaining bones is important, yet managing inflammation, hormonal imbalances, and patient-specific traits also plays a critical role.",6.632072365991902e-07,0.5784716230326454,0.06977572089711641,0.05077594101389248,0.6683919241113756,0.017851239669421492,0.05070244314668032,0.7114963192281416,0.0,6.632072365991914e-07,0.7308875085427928,0.0
69,1.1,6,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Stopping osteoporosis alone may not eliminate musculoskeletal symptoms caused by aromatase inhibitors. Apart from bone integrity, controlling inflammation and hormonal imbalances, as well as considering patient individuality, is necessary.",6.868932093348755e-07,0.6135629428439144,0.06977572089711641,0.05258936747867436,0.7047595682822503,0.017851239669421492,0.052513244687633194,0.7492366472109886,0.0,6.868932093348768e-07,0.7701082216960753,0.0
69,1.1,7,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Osteoporosis prevention may not fully address musculoskeletal symptoms from aromatase inhibitors. While keeping bones healthy matters, dealing with inflammation, hormone levels, and personalized patient factors is also crucial.",7.105791820705608e-07,0.6499305870147891,0.06977572089711641,0.05440279394345624,0.7424998962650973,0.017851239669421492,0.05432404622858607,0.788457360364271,0.0,7.105791820705622e-07,0.8109302162163301,0.0
69,1.1,8,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Preventing osteoporosis might not suffice to remove musculoskeletal symptoms associated with aromatase inhibitors. Bone health is essential, but inflammation, hormonal issues, and individual patient features also contribute to effective symptom control.",6.395212638635049e-07,0.5445700713569637,0.06977572089711641,0.0489625145491106,0.6333006043001066,0.017851239669421492,0.04889164160572745,0.6751286750572669,0.0,6.39521263863506e-07,0.6931471805599458,0.0
69,1.1,9,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Is the key to resolving musculoskeletal symptoms from aromatase inhibitors purely osteoporosis prevention? This seems unlikely as managing bone health alongside inflammation, hormonal imbalances, and patient-specific conditions is important.",6.868932093348755e-07,0.6135629428439144,0.06977572089711641,0.05258936747867436,0.7047595682822503,0.017851239669421492,0.052513244687633194,0.7492366472109886,0.0,6.868932093348768e-07,0.7701082216960753,0.0
69,1.1,10,ai,"Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Preventing osteoporosis may not be the sole solution to eliminating aromatase inhibitor-related musculoskeletal symptoms. While maintaining bone health is important, addressing other factors such as inflammation, hormonal imbalances, and individual patient characteristics may also play a significant role in managing these symptoms effectively.","Preventing osteoporosis does not solely guarantee the disappearance of aromatase inhibitor-related musculoskeletal symptoms. Though bone health is vital, other factors like inflammation, hormonal imbalances, and personalized characteristics must also be addressed.",6.395212638635049e-07,0.5445700713569637,0.06977572089711641,0.0489625145491106,0.6333006043001066,0.017851239669421492,0.04889164160572745,0.6751286750572669,0.0,6.39521263863506e-07,0.6931471805599458,0.0
70,1.1,1,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young individuals considered a distinct clinical entity? Answer: Colorectal cancer in younger patients might represent a separate clinical entity. Additional research is required to confirm these observations and determine the best treatment strategy for this group.,2.36859727356853e-08,0.0626411177067503,0.02652739304401356,0.0018134264647818726,0.026910907699560394,0.0006732981390464195,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,1.1,2,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young patients represent a unique clinical entity? Answer: Colorectal cancer occurring in young patients could be a distinct clinical entity. More studies are needed to validate our results and establish the ideal management in this population.,2.36859727356853e-08,0.027983758678753468,0.0018819495170846606,0.0018134264647818726,0.026910907699560394,0.0006732981390464195,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
70,1.1,3,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young people a separate clinical entity? Answer: Colorectal cancer in younger individuals may be classified as a distinct clinical entity. Further investigation is necessary to confirm these insights and to develop an optimal treatment approach.,0.0,0.03554600925948437,0.025256675594513445,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
70,1.1,4,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Colorectal cancer in young patients: could it be a distinct clinical entity? Answer: It is possible that colorectal cancer in young patients forms a unique clinical entity. Further research should be undertaken to verify these findings and identify the best clinical approach.,7.105791820705611e-08,0.08172497413789737,0.0053829717291255935,0.005440279394345618,0.04484322235712801,0.022355635661248967,0.0054324046228586,0.04330418244171419,0.02498356344510192,7.105791820705622e-08,0.08004270767353416,0.0
70,1.1,5,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer among young patients a distinct clinical entity? Answer: Colorectal cancer diagnosed in young patients might constitute a distinct clinical entity. Additional research is essential to confirm this and to define optimal care strategies.,7.10579182070559e-08,0.12743738668618088,0.032986111111111105,0.005440279394345618,0.08536507799889792,0.002250145965660786,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
70,1.1,6,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Does colorectal cancer in young adults constitute a distinct clinical entity? Answer: Colorectal cancer in young adults may be considered a distinct clinical entity. More studies are needed to substantiate our conclusions and provide guidance on the best treatment options.,2.36859727356853e-08,0.07598831840523879,0.06893983083429453,0.0018134264647818726,0.07972712007889182,0.07492792295881102,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
70,1.1,7,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in the young a unique clinical entity? Answer: It is conceivable that colorectal cancer in young patients represents a distinct clinical entity. This warrants further investigation to verify the findings and optimize clinical management.,4.73719454713706e-08,0.020940536037771906,0.022511337868480717,0.0036268529295637453,0.05609396741226469,0.0014585352037089563,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
70,1.1,8,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Could colorectal cancer in youth be a distinct clinical entity? Answer: Colorectal cancer occurring in young patients may represent a unique clinical entity. Further research is needed to solidify our findings and to guide appropriate therapeutic approaches.,4.73719454713706e-08,0.0165268791276314,0.04938271604938273,0.0036268529295637453,0.017585790714489846,0.026296566837107373,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
70,1.1,9,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Is colorectal cancer in young patients a unique clinical entity? Answer: There is a possibility that colorectal cancer in young patients constitutes a distinct clinical entity. More extensive research is necessary to validate this and define the best treatment protocols.,2.36859727356853e-08,0.006673600349243802,0.02237654320987656,0.0018134264647818726,0.0441811108194079,0.05009232205178152,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
70,1.1,10,human,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: Colorectal cancer among young patients may constitute a distinct clinical entity. Further research is needed to validate our findings and define the optimal approach in this population.,Question: Colorectal cancer in younger patients: is it a unique clinical entity? Answer: Colorectal cancer among younger patients might be a unique clinical entity. Further studies are required to confirm these observations and determine the optimal management approach.,4.73719454713706e-08,0.05840795120317477,0.0040609381007304796,0.0036268529295637453,0.05609396741226469,0.0014585352037089563,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
71,1.1,1,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? The current study indicates that septoplasty does not affect compensatory hypertrophy of the middle turbinate even after one year.,9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.003184971378198842,0.09000000000000004,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,1.1,2,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Is the dimension of compensatory hypertrophy in the middle turbinate changed by septoplasty? Findings from this study suggest septoplasty does not impact compensatory hypertrophy of the middle turbinate one year post-operation.,9.47438909427412e-08,0.10069912481659715,0.016790123456790138,0.007253705859127518,0.05098822520991897,0.055561224489795946,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,1.1,3,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Does septoplasty affect the degree of compensatory hypertrophy of the middle turbinate? According to this study, compensatory hypertrophy in the middle turbinate remains unchanged after septoplasty, even after one year.",1.184298636784265e-07,0.09157774804373053,0.04696844993141293,0.009067132323909398,0.03827629118946785,0.09000000000000004,0.009054007704764368,0.08325563922540269,0.06222222222222223,1.1842986367842703e-07,0.13117149352431312,0.0322222222222222
71,1.1,4,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Does septoplasty modify the compensatory hypertrophy size of the middle turbinate? The study results show that septoplasty does not change middle turbinate compensatory hypertrophy even after a year.,1.658018091497971e-07,0.11877443995946724,0.07857330703484555,0.012693985253473157,0.11238426334318952,0.09000000000000004,0.012675610786670115,0.16021668036153214,0.06222222222222223,1.6580180914979784e-07,0.2112142011978504,0.0322222222222222
71,1.1,5,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Can septoplasty change the dimensions of the compensatory hypertrophy in the middle turbinate? This study's findings reveal no changes in compensatory hypertrophy of the middle turbinate one year following septoplasty.,1.184298636784265e-07,0.13938100187545066,0.01348454963839582,0.009067132323909398,0.03827629118946785,0.09000000000000004,0.009054007704764368,0.08325563922540269,0.06222222222222223,1.1842986367842703e-07,0.13117149352431312,0.0322222222222222
71,1.1,6,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Is there any change in the compensatory hypertrophy of the middle turbinate after septoplasty? The evidence from the present study suggests that septoplasty does not alter compensatory hypertrophy of the middle turbinate after one year.,0.0,0.08154672712469946,0.052811791383219994,0.0,0.08401784006787238,0.05668367346938767,0.0,0.08664339756999295,0.060226757369614504,0.0,0.08943834587870292,0.06344104308390028
71,1.1,7,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Does the size of compensatory hypertrophy in the middle turbinate vary following septoplasty? The study results imply that septoplasty has no effect on middle turbinate compensatory hypertrophy even at the one-year mark.,7.10579182070559e-08,0.018718211760319292,0.05134628088254728,0.005440279394345639,0.03071658029748292,0.09000000000000004,0.005432404622858621,0.011796675243259003,0.06222222222222223,7.105791820705622e-08,0.05706352137059145,0.0322222222222222
71,1.1,8,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Are the dimensions of compensatory hypertrophy in the middle turbinate impacted by septoplasty? Findings indicate that septoplasty does not influence middle turbinate hypertrophy after one year.,2.131737546211677e-07,0.1998430199433585,0.07562500000000003,0.016320838183036916,0.1924269710167268,0.09000000000000004,0.016297213868575862,0.24359828930058258,0.06222222222222223,2.1317375462116866e-07,0.2982255781874801,0.0322222222222222
71,1.1,9,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.","Does septoplasty influence the extent of compensatory hypertrophy of the middle turbinate? Current study data show that compensatory hypertrophy in the middle turbinate remains unaffected by septoplasty, even after twelve months.",9.47438909427412e-08,0.05448931277926761,0.04922902494331072,0.007253705859127518,0.003184971378198842,0.09000000000000004,0.007243206163811494,0.04688799505452801,0.06222222222222223,9.474389094274162e-08,0.09343116554146613,0.0322222222222222
71,1.1,10,human,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: The present study findings suggest that compensatory hypertrophy of the middle turbinate is not affected by septoplasty, even after one year.",Does septoplasty result in changes to the compensatory hypertrophy dimensions of the middle turbinate? The study concludes that septoplasty does not affect the size of compensatory hypertrophy in the middle turbinate even a year after surgery.,2.36859727356853e-08,0.11286417048722797,0.05862258953168049,0.0018134264647818796,0.1558797232514899,0.09000000000000004,0.0018108015409528735,0.11741505623674797,0.06222222222222223,2.3685972735685406e-08,0.07646787125393084,0.0322222222222222
72,1.1,1,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Do the attributes of general practice affect how primary care adopts IT innovations? Yes, factors like practice size, existing IT resources, and healthcare professional attitudes can influence technology adoption in primary care.",7.342651548062466e-07,0.5589896617418901,0.09566326530612247,0.056216220408238086,0.6414980713085381,0.049048751486325794,0.056134847769538906,0.7270487322356263,0.0,7.342651548062476e-07,0.7453329337305146,0.0
72,1.1,2,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Can general practice features determine the acceptance of IT innovation in primary care? Yes, elements such as the practice's scale, IT infrastructure availability, and healthcare provider beliefs impact adoption.",8.053230730133025e-07,0.6607723560518326,0.09566326530612247,0.061656499802583725,0.7468585869663635,0.049048751486325794,0.06156725239239753,0.836248024200617,0.0,8.053230730133038e-07,0.8586616190375187,0.0
72,1.1,3,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Are uptake rates of IT innovations in primary care affected by general practice characteristics? Yes, variables such as practice size, IT setup, and staff attitudes play a role in IT adoption.",7.579511275419319e-07,0.5917794845648818,0.09566326530612247,0.058029646873019966,0.6753996229842198,0.049048751486325794,0.05794564931049178,0.7621400520468953,0.0,7.57951127541933e-07,0.7817005779013892,0.0
72,1.1,4,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Does general practice setting influence the integration of IT innovation in primary care? Yes, practice dimensions, IT infrastructure, and healthcare professionals' mindsets can affect technology uptake.",8.763809912203584e-07,0.7741010413588367,0.09566326530612247,0.06709677919692936,0.8646416226227478,0.049048751486325794,0.06699965701525615,0.9588503462929499,0.0,8.7638099122036e-07,0.9864949905474032,0.0
72,1.1,5,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Do characteristics of a general practice influence the implementation of IT innovations in primary care? Yes, factors including the size of the practice, existing IT facilities, and staff attitudes influence adoption.",7.579511275419319e-07,0.5917794845648818,0.09566326530612247,0.058029646873019966,0.6753996229842198,0.049048751486325794,0.05794564931049178,0.7621400520468953,0.0,7.57951127541933e-07,0.7817005779013892,0.0
72,1.1,6,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Is the adoption of IT innovations in primary care impacted by general practice traits? Yes, aspects such as practice size, IT resources, and healthcare professionals' beliefs matter for technology uptake.",7.816371002776172e-07,0.6256810362405636,0.09566326530612247,0.059843073337801846,0.7104909427954889,0.049048751486325794,0.059756450851444654,0.79850769621777,0.0,7.816371002776184e-07,0.8194409058842362,0.0
72,1.1,7,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Can characteristics of general practices shape the adoption of IT innovation in primary care? Yes, size, IT infrastructure availability, and professional attitudes all affect implementation.",9.000669639560437e-07,0.8149230358790915,0.09566326530612247,0.06891020566171124,0.9072012370415434,0.049048751486325794,0.06881045855620901,1.003302108863784,0.0,9.000669639560454e-07,1.0330150061822971,0.0
72,1.1,8,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Does uptake of IT innovations vary according to general practice characteristics in primary care? Yes, factors like practice size, IT infrastructure, and healthcare staff beliefs influence adoption.",8.526950184846731e-07,0.7348803282055543,0.09566326530612247,0.06528335273214748,0.823819628102493,0.049048751486325794,0.06518885547430328,0.9162907318741542,0.0,8.526950184846746e-07,0.9420432279765691,0.0
72,1.1,9,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Are IT innovation adoption rates in primary care influenced by the nature of general practices? Yes, practice size, IT capability, and professional attitudes contribute to uptake.",8.763809912203584e-07,0.7741010413588367,0.09566326530612247,0.06709677919692936,0.8646416226227478,0.049048751486325794,0.06699965701525615,0.9588503462929499,0.0,8.7638099122036e-07,0.9864949905474032,0.0
72,1.1,10,ai,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: Yes, general practice characteristics can influence the uptake of an IT innovation in primary care. Factors such as the size of the practice, the presence of IT infrastructure, and the attitudes and beliefs of healthcare professionals can all impact the adoption and implementation of new technology.","Is the uptake of IT technology in primary care determined by general practice traits? Yes, the size of the practice, the presence of IT infrastructure, and the attitudes of healthcare professionals influence adoption.",7.105791820705613e-07,0.5705626622123079,0.06444578351632016,0.05440279394345621,0.6087082484855464,0.049048751486325794,0.05432404622858603,0.6931471805599445,0.0,7.105791820705622e-07,0.7102416139192456,0.0
73,1.1,1,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","The fragility of the esophageal mucosa could be an important endoscopic indicator of primary eosinophilic esophagitis, reflecting possible esophageal damage and inflammation. Nonetheless, additional diagnostic assessments are needed to establish the diagnosis.",4.5003348197802176e-07,0.2839545903862142,0.13628988642509465,0.034455102830855615,0.3491643081709319,0.10072314049586774,0.03440522927810451,0.41726178335142494,0.06222222222222221,4.500334819780227e-07,0.48844746683017526,0.0212665406427221
73,1.1,2,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","The delicate nature of the esophageal mucosa may serve as a key endoscopic sign of primary eosinophilic esophagitis, suggesting underlying inflammation and damage in the esophagus. Further tests are essential to confirm this diagnosis.",4.0266153650665116e-07,0.22143423340488066,0.13628988642509465,0.030828249901291856,0.2846257870333604,0.10072314049586774,0.03078362619619876,0.3505704088527515,0.06222222222222221,4.026615365066519e-07,0.4194545953432245,0.0212665406427221
73,1.1,3,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Fragility of the esophageal mucosa might be a defining endoscopic feature of primary eosinophilic esophagitis, pointing to esophageal injury and inflammation, although confirmatory diagnostic procedures are required.",5.684633456564483e-07,0.4598452568498783,0.13628988642509465,0.04352223515476501,0.5314858649648868,0.10072314049586774,0.043459236982868875,0.6065037829899529,0.06222222222222221,5.684633456564497e-07,0.6851577610762298,0.0212665406427221
73,1.1,4,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","The esophageal mucosa's fragility potentially represents a hallmark endoscopic sign of primary eosinophilic esophagitis, indicative of damage and inflammation, but diagnosis confirmation requires additional evaluation.",6.158352911278189e-07,0.5398879645234156,0.13628988642509465,0.04714908808432877,0.6148674739039373,0.10072314049586774,0.04708084006477462,0.6935151599795826,0.06222222222222221,6.158352911278206e-07,0.7761295392819578,0.0212665406427221
73,1.1,5,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Fragile esophageal mucosa could indicate primary eosinophilic esophagitis during endoscopy, signaling mucosal damage and inflammation; however, diagnosis must be verified through further assessments.",6.632072365991895e-07,0.6268993415130453,0.13628988642509465,0.05077594101389253,0.7058392521096652,0.10072314049586774,0.05070244314668037,0.7888253397839078,0.06222222222222221,6.632072365991913e-07,0.8762129978389392,0.0212665406427221
73,1.1,6,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","The fragile condition of the esophageal mucosa may function as a significant endoscopic sign for primary eosinophilic esophagitis, showing potential damage and inflammation, though further diagnostic testing is necessary for confirmation.",4.7371945471370706e-07,0.3167444132092059,0.13628988642509465,0.036268529295637494,0.3830658598466137,0.10072314049586774,0.03621603081905738,0.45235310316269395,0.06222222222222221,4.737194547137081e-07,0.5248151110010499,0.0212665406427221
73,1.1,7,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Observing fragility in the esophageal mucosa may represent an important endoscopic sign of primary eosinophilic esophagitis, hinting at esophageal damage and inflammation, but additional diagnostic verification is needed.",5.44777372920763e-07,0.4221049288670313,0.13628988642509465,0.04170880868998313,0.49226515181160435,0.10072314049586774,0.041648435441916,0.5656817884696981,0.06222222222222221,5.447773729207643e-07,0.6425981466574342,0.0212665406427221
73,1.1,8,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Fragility in the esophageal mucosa might be a telltale endoscopic sign of primary eosinophilic esophagitis, indicative of esophageal inflammation and damage, yet diagnosis requires further testing.",5.921493183921336e-07,0.4990659700031608,0.13628988642509465,0.04533566161954689,0.5723078594851416,0.10072314049586774,0.04527003852382175,0.6490633974087485,0.06222222222222221,5.921493183921352e-07,0.7296095236470639,0.0212665406427221
73,1.1,9,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","The fragility found in the esophageal mucosa on endoscopy can be a significant sign suggestive of primary eosinophilic esophagitis, reflecting mucosal injury and inflammation; however, additional diagnostic confirmation is essential.",4.974054274493924e-07,0.35064596488488764,0.13628988642509465,0.038081955760419374,0.4181571796578827,0.10072314049586774,0.038026832360010254,0.48872074733356863,0.06222222222222221,4.974054274493935e-07,0.5625554389838969,0.0212665406427221
73,1.1,10,ai,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: The fragility of the esophageal mucosa may be a significant endoscopic sign of primary eosinophilic esophagitis, indicating potential damage and inflammation in the esophagus. However, further diagnostic tests and evaluations are necessary to confirm the diagnosis.","Fragile esophageal mucosa observed during endoscopy may serve as a pathognomonic sign of primary eosinophilic esophagitis, indicating inflammation and damage, though further diagnostic procedures are required to confirm the condition.",4.974054274493924e-07,0.35064596488488764,0.13628988642509465,0.038081955760419374,0.4181571796578827,0.10072314049586774,0.038026832360010254,0.48872074733356863,0.06222222222222221,4.974054274493935e-07,0.5625554389838969,0.0212665406427221
74,1.1,1,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.",Is it necessary to perform untethering before scoliosis correction surgery in a patient with myelomeningocele? The study indicates that spinal cord untethering might not be required for patients with MM undergoing scoliosis surgery if they do not display clinical signs of tethered cord despite radiographic evidence.,1.1842986367842703e-07,0.10536051565782589,0.0,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
74,1.1,2,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For a myelomeningocele patient, does scoliosis correction require prior untethering? According to the study findings, untethering may be unnecessary in MM patients having scoliosis surgery without clinical symptoms of tethered cord even if imaging shows tethering.",3.5528959103528056e-07,0.356674943938732,0.0,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
74,1.1,3,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.",Should untethering be done before scoliosis correction in myelomeningocele cases? The data suggests that spinal cord untethering is likely unnecessary in patients with MM undergoing scoliosis correction surgery if no clinical tethered cord symptoms are present despite radiographic tethering.,2.8423167282822466e-07,0.3109182762575453,0.026296566837107373,0.02176111757738247,0.2809023854664012,0.0,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
74,1.1,4,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In patients with myelomeningocele, is spinal cord untethering needed before scoliosis correction? Study results imply untethering might not be needed when there are no clinical signs of tethered cord, even if imaging indicates cord tethering.",3.7897556377096586e-07,0.3856624808119835,0.0,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
74,1.1,5,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Does scoliosis correction in a patient with myelomeningocele require prior untethering? The research suggests that untethering may be not necessary for MM patients lacking clinical symptoms of tethered cord, despite radiographic tethering evidence.",4.2634750924233646e-07,0.446287102628419,0.0,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
74,1.1,6,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","For patients with myelomeningocele, is untethering essential prior to correcting scoliosis? Findings indicate that spinal cord untethering may be unnecessary if no clinical symptoms of tethered cord appear, even when radiographs demonstrate tethering.",4.2634750924233646e-07,0.446287102628419,0.0,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
74,1.1,7,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is spinal cord untethering mandatory before scoliosis surgery in myelomeningocele patients? According to the study, if patients do not show clinical tethered cord symptoms, untethering could be unnecessary regardless of radiographic tethering.",4.5003348197802176e-07,0.4780358009429988,0.0,0.034455102830855615,0.4906229164484719,0.0,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
74,1.1,8,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","In the context of myelomeningocele, should untethering be done before scoliosis corrective surgery? The study suggests untethering might not be essential if clinical signs of tethered cord are absent despite imaging showing tethering.",4.2634750924233646e-07,0.446287102628419,0.0,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
74,1.1,9,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","When correcting scoliosis in myelomeningocele patients, is untethering required first? Evidence shows untethering may be unwarranted if clinical symptoms of tethered cord are lacking, even with radiographic tethering present.",5.210914001850777e-07,0.5798184952529413,0.0,0.039895382225201254,0.5959834321062973,0.0,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
74,1.1,10,human,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The study results suggested that spinal cord untethering may be unnecessary in patients with MM who are undergoing scoliosis corrective surgery and do not present with clinical symptoms of a tethered cord, even though tethering is radiographically demonstrated.","Is untethering necessary before scoliosis correction in myelomeningocele patients? According to study findings, spinal cord untethering may be unnecessary when no clinical tethered cord symptoms exist despite tethering seen on imaging.",4.7371945471370706e-07,0.5108256237659905,0.0,0.036268529295637494,0.5245244681241537,0.0,0.03621603081905738,0.5389965007326869,0.0,4.737194547137081e-07,0.5543107357057284,0.0
75,1.1,1,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","The clinical importance of bile duct sludge: does it differ from bile duct stones? Bile duct sludge consists of thickened bile, cholesterol crystals, and other materials that accumulate in the bile ducts, resembling bile duct stones in some respects.",1.1842986367842682e-07,0.19289230921347755,0.1546144787480729,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
75,1.1,2,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Is the clinical relevance of bile duct sludge distinct from bile duct stones? Bile duct sludge is a combination of thickened bile, cholesterol crystals, and other substances that gather in the bile ducts, showing similarities to bile duct stones.",1.1842986367842682e-07,0.22937373976926434,0.18509537698972228,0.009067132323909363,0.1642191208045447,0.027006172839506164,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
75,1.1,3,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","How does the clinical significance of bile duct sludge compare to that of bile duct stones? Bile duct sludge is made up of thickened bile, cholesterol crystals, and various other components that build up in the bile ducts, bearing some resemblance to bile duct stones.",2.3685972735685406e-08,0.08940325295116658,0.17043328753391424,0.0018134264647818726,0.04094831008375399,0.046400951814396206,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
75,1.1,4,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","What is the clinical implication of bile duct sludge, and how is it different from bile duct stones? Bile duct sludge is an accumulation of thickened bile, cholesterol crystals, and other materials within the bile ducts, somewhat similar to bile duct stones.",4.737194547137081e-08,0.10622891036556936,0.1354279786632744,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
75,1.1,5,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","In terms of clinical significance, how does bile duct sludge differ from bile duct stones? Bile duct sludge comprises thickened bile, cholesterol crystals, and additional substances that cluster in the bile ducts, resembling bile duct stones.",1.8948778188548272e-07,0.3272467368158596,0.21074988192078853,0.014507411718254988,0.2520824572295557,0.029384756657483937,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
75,1.1,6,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Does bile duct sludge have a different clinical significance compared to bile duct stones? Bile duct sludge is a mix of thickened bile, cholesterol crystals, and other components that collect in the bile ducts, akin to bile duct stones.",1.1842986367842682e-07,0.2658551703250511,0.21519505257539995,0.009067132323909363,0.201686535969948,0.05387755102040818,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
75,1.1,7,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","How significant is bile duct sludge clinically, and is it different from bile duct stones? Bile duct sludge contains thickened bile, cholesterol crystals, and miscellaneous substances accumulating in the bile ducts, showing some likeness to bile duct stones.",1.4211583641411212e-07,0.26097190989950514,0.19315648508228694,0.010880558788691236,0.19265885652503245,0.02775510204081633,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
75,1.1,8,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","What distinguishes the clinical significance of bile duct sludge from bile duct stones? Bile duct sludge consists of a thickened bile mixture, cholesterol crystals, and other material found in the bile ducts, similar to bile duct stones.",1.6580180914979742e-07,0.2935746917494808,0.20169356038072578,0.012693985253473108,0.22192996711166568,0.02854671280276816,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
75,1.1,9,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Can the clinical importance of bile duct sludge be distinguished from that of bile duct stones? Bile duct sludge is a blend of thickened bile, cholesterol crystals, and other substances that accumulate in bile ducts, sharing similarities with bile duct stones.",7.105791820705622e-08,0.20361744677076432,0.19869611140113408,0.005440279394345618,0.14519999067269174,0.05113221329437545,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
75,1.1,10,ai,"Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: Bile duct sludge refers to a mixture of thickened bile, cholesterol crystals, and other substances that can accumulate in the bile ducts. While it shares similarities with bile","Are bile duct sludge and bile duct stones clinically different in significance? Bile duct sludge refers to a mix of thickened bile, cholesterol crystals, and other substances accumulating in the bile ducts, much like bile duct stones.",1.6580180914979742e-07,0.2935746917494808,0.20169356038072578,0.012693985253473108,0.22192996711166568,0.02854671280276816,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
76,1.1,1,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Question: Is it possible to obtain correlated results from homemade assays for BCRABL transcript detection using quantitative real-time PCR? Answer: The findings indicate that quantitative real-time PCR assays for detecting BCRABL can yield comparable results between different labs despite methodological differences, provided the same positive control cell line and quality control gene are utilized. Establishing a standardization protocol across laboratories is essential.",7.105791820705622e-08,0.05013979453644435,0.0015317282073249762,0.005440279394345618,0.026785491770707992,0.01586888657648284,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
76,1.1,2,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Question: Can homemade assays for BCRABL transcript detection by quantitative real-time PCR produce correlated results? Answer: It appears that quantitative real-time PCR assays for BCRABL detection can be consistent across labs with significant methodological variations, as long as the same control cell line and quality control gene are applied. Standardization among labs is crucial.",2.6054570009253947e-07,0.24989546054103773,0.04375128122560794,0.0199476911126006,0.22320534930060631,0.02253111342351717,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
76,1.1,3,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Question: Are consistent results achievable from self-developed assays in BCRABL transcript detection through quantitative real-time PCR? Answer: Data suggest that quantitative real-time PCR assays for BCRABL detection are comparable across laboratories despite different methods if the same positive control cell line and quality control gene are used. Some degree of assay standardization between labs is necessary.,2.1317375462116866e-07,0.1334335513625673,0.013041898799404494,0.016320838183036854,0.1321460074285321,0.01586888657648284,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
76,1.1,4,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Question: Is it feasible to get correlated BCRABL transcript detection outcomes using homebrew quantitative real-time PCR assays? Answer: The evidence suggests that despite methodological differences, quantitative real-time PCR assays for BCRABL detection can be comparable across labs when using the same positive control cell line and quality control gene. Adoption of some assay standardization between labs is critical.",1.6580180914979784e-07,0.12115202414784232,0.0038238405242473107,0.012693985253473108,0.12053361970622767,0.0019823530929386525,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
76,1.1,5,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Question: Can homemade quantitative real-time PCR assays yield correlated results for BCRABL transcript detection? Answer: Results suggest that quantitative real-time PCR assays to detect BCRABL across different labs can agree despite diverse techniques if the same positive control cell line and quality control gene are employed. Assay standardization among laboratories is vital.,3.079176455639103e-07,0.2652824789750503,0.027376268210197705,0.023574544042164344,0.26455882300945754,0.024061668979072727,0.023540420032387266,0.26360580858997285,0.020399305555555556,3.079176455639103e-07,0.23967285326541932,0.0
76,1.1,6,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Question: Question: Do homebrew assays allow for correlated quantitative real-time PCR results in BCRABL transcript detection? Answer: Findings indicate that despite significant methodological variations, quantitative real-time PCR assays for BCRABL detection can be consistent between labs by using the same positive control cell line and quality control gene. It is important to implement assay standardization between labs.",1.8948778188548325e-07,0.13972020673666652,0.004447813134751875,0.014507411718254981,0.13900222078069824,0.0023066964139149618,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
76,1.1,7,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Question: Is the correlation of results possible from in-house assays detecting BCRABL transcripts by quantitative real-time PCR? Answer: These findings imply that quantitative real-time PCR assays for BCRABL detection are comparable across different laboratories regardless of methodological differences if the same positive control cell line and quality control gene are applied. Some level of assay standardization is necessary.,1.6580180914979784e-07,0.09683107044398387,0.01367921648367984,0.012693985253473108,0.09577836325765787,0.01586888657648284,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
76,1.1,8,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not",Question: Are comparable results achievable using homemade methods for BCRABL transcript quantitative real-time PCR detection? Answer: The outcomes suggest that quantitative real-time PCR assays for BCRABL detection may be similar between labs even with varied methodologies when the same positive control cell line and quality control gene are utilized. Standardizing assays between laboratories is essential.,2.3685972735685406e-07,0.20359369140595174,0.024145840009505665,0.018134264647818726,0.17699463782030733,0.0029920601690792935,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
76,1.1,9,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Question: Can homebrew quantitative real-time PCR assays produce correlated results for BCRABL transcript detection? Answer: According to the results, despite methodological differences, quantitative real-time PCR assays for BCRABL detection can produce comparable outcomes across labs if the same positive control cell line and quality control gene are used. It is necessary to adopt a form of assay standardization between labs.",1.1842986367842703e-07,0.1320099990499659,0.03622053473912333,0.009067132323909363,0.10849029727810855,0.018569888933721253,0.009054007704764333,0.10840407091439896,0.017538265306122455,1.1842986367842703e-07,0.08552217343816082,0.0
76,1.1,10,human,"Question: BCRABL transcript detection by quantitative real-time PCR : are correlated results possible from homebrew assays? Answer: These results suggest that quantitative real-time PCR assays for BCRABL detection can be comparable between laboratories despite significant differences in methodologies if the same positive control cell line and quality control gene are used. It is imperative that some level of assay standardization be adopted between laboratories, not","Question: Can quantitative real-time PCR methods using homebrew assays detect BCRABL transcripts with correlated results? Answer: The studies indicate that despite discrepancies in technique, quantitative real-time PCR assays for BCRABL detection may remain comparable from lab to lab when using the same positive control cell line and quality control gene. Adoption of some assay standardization is critical.",1.8948778188548325e-07,0.13972020673666652,0.004447813134751875,0.014507411718254981,0.13900222078069824,0.0023066964139149618,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
77,1.1,1,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex found in cases of cervical disk disease? Biochemical studies of damaged cervical intervertebral disks show inflammatory markers like MCP, fragments of matrix proteins such as FAC, and a link to pH levels. Additional analysis of FAC indicates",1.1842986367842703e-07,0.08697649429816368,0.02221074380165289,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
77,1.1,2,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does the fibronectin-aggrecan complex appear in cervical disk disease? Analysis of injured cervical disks identifies inflammatory markers including MCP, fragments from structural matrix proteins like FAC, and associations with pH. Further investigation into the FAC reveals",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
77,1.1,3,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex detectable in cervical disk disease? Injured cervical intervertebral disks display inflammatory markers, for example MCP, fragments of matrix proteins such as FAC, and are correlated with pH changes. More detailed assessment of FAC suggests",1.8948778188548293e-07,0.16493803576787425,0.02221074380165289,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
77,1.1,4,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the fibronectin-aggrecan complex present in cervical intervertebral disk disease? Biochemical evaluation of damaged cervical disks uncovers inflammatory markers including MCP and matrix protein fragments such as FAC, alongside a pH correlation. Further study of FAC shows",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
77,1.1,5,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Can the fibronectin-aggrecan complex be found in cervical disk disease? Biochemical tests on injured cervical intervertebral disks reveal inflammatory markers such as MCP, fragments of structural matrix proteins like FAC, and link to pH. Further examination of the FAC indicates",1.4211583641411233e-07,0.1122943022824554,0.02221074380165289,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
77,1.1,6,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is the presence of the fibronectin-aggrecan complex observed in cervical disk disease? Injured cervical disks exhibit inflammatory markers including MCP, fragments of matrix proteins such as FAC, correlated with pH. Further evaluation of FAC points to",2.3685972735685353e-07,0.2205078869226864,0.02221074380165289,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
77,1.1,7,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Does cervical disk disease involve the fibronectin-aggrecan complex? Biochemical analyses indicate that injured cervical disks contain inflammatory markers like MCP and fragments from matrix proteins such as FAC, with pH being a related factor. Further analysis on FAC shows",1.6580180914979763e-07,0.13826978868571338,0.02221074380165289,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
77,1.1,8,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is fibronectin-aggrecan complex detected in cervical disk disease? Studies of injured cervical intervertebral disks reveal inflammatory markers such as MCP, fragments from structural matrix proteins like FAC, and a pH correlation. Further FAC evaluation reveals",2.6054570009253883e-07,0.24949542379593792,0.02221074380165289,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
77,1.1,9,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","Is fibronectin-aggrecan complex associated with cervical disk disease? Biochemical assessment of injured cervical disks reveals inflammatory markers including MCP, fragments of matrix proteins like FAC, and a correlation with pH levels. Additional analysis of FAC",2.6054570009253883e-07,0.24949542379593792,0.02221074380165289,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
77,1.1,10,human,"Question: Is the fibronectin-aggrecan complex present in cervical disk disease? Answer: Biochemical analysis of injured cervical intervertebral disks reveals the presence of inflammatory markers such as MCP, fragments of structural matrix proteins such as FAC, and a correlation with pH. Further evaluation of the FAC as","In cases of cervical disk disease, is the fibronectin-aggrecan complex present? Injured cervical disks demonstrate inflammatory markers such as MCP and fragments from structural matrix proteins like FAC, linked with pH changes. Further study of FAC suggests",2.1317375462116823e-07,0.19233700995598957,0.02221074380165289,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
78,1.1,1,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Is alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis an early indicator of bronchiectasis? A diminished alveolar macrophage response to apoptotic cells or NTHi might lead to neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis. However, it is still unclear if this process contributes to PBB progressing into bronchiectasis.",9.474389094274162e-08,0.052279090842322073,0.016711854752580996,0.0072537058591274906,0.051288923337613035,0.01851192595229618,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
78,1.1,2,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Could alveolar macrophage phagocytic dysfunction in children suffering from protracted bacterial bronchitis be a precursor to bronchiectasis? A weakened phagocytic response by alveolar macrophages to apoptotic cells or NTHi may cause neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. The role of this mechanism in the advancement of PBB to bronchiectasis is still unknown.,0.0,0.05041070404072334,0.03631185475258099,0.0,0.025672117798516858,0.01851192595229618,0.0,0.0,0.0,0.0,0.0,0.0
78,1.1,3,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Does impaired alveolar macrophage phagocytosis in children with protracted bacterial bronchitis signal the onset of bronchiectasis? A reduced host response by alveolar macrophages to apoptotic cells or NTHi could promote neutrophilic inflammation and NTHi colonization seen in PBB and bronchiectasis. Whether this also leads to PBB developing into bronchiectasis is not yet determined.,7.105791820705622e-08,0.005678762610319854,0.03631185475258099,0.005440279394345618,0.03148629604143327,0.01851192595229618,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
78,1.1,4,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is phagocytic dysfunction of alveolar macrophages in children with protracted bacterial bronchitis a potential early marker for bronchiectasis? A deficient alveolar macrophage reaction to apoptotic cells or NTHi may underlie neutrophilic inflammation and NTHi colonization in both diseases. The link between this mechanism and the progression from PBB to bronchiectasis remains undetermined.,9.474389094274162e-08,0.02509684846742255,0.03631185475258099,0.0072537058591274906,0.051288923337613035,0.01851192595229618,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
78,1.1,5,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Might alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis predict bronchiectasis? A lowered phagocytic activity toward apoptotic cells or NTHi by alveolar macrophages may contribute to neutrophil-driven inflammation and NTHi colonization in PBB and bronchiectasis. It remains unknown whether this contributes to PBB progressing into bronchiectasis.,1.8948778188548325e-07,0.10677487948168984,0.03631185475258099,0.014507411718254981,0.13467053227666392,0.01851192595229618,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
78,1.1,6,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is alveolar macrophage phagocytic impairment in children with protracted bacterial bronchitis an early event leading to bronchiectasis? A reduced alveolar macrophage response to apoptotic cells or NTHi might promote neutrophilic inflammation and colonization by NTHi in PBB and bronchiectasis alike. Whether this dysfunction drives PBB toward bronchiectasis remains to be established.,1.1842986367842703e-07,0.07262536298600031,0.016320184615138254,0.009067132323909363,0.07149163065513164,0.01851192595229618,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
78,1.1,7,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Can alveolar macrophage phagocytic dysfunction in pediatric protracted bacterial bronchitis be an initial step in the development of bronchiectasis? Reduced clearance of apoptotic cells or NTHi by alveolar macrophages may foster neutrophilic inflammation and NTHi colonization in PBB and bronchiectasis, but its role in disease progression is still unknown.",1.6580180914979784e-07,0.08572147028385668,0.03631185475258099,0.012693985253473108,0.11316432705570056,0.01851192595229618,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
78,1.1,8,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,Is the phagocytic dysfunction of alveolar macrophages in children with protracted bacterial bronchitis a forerunner of bronchiectasis? A compromised response to apoptotic cells or NTHi by alveolar macrophages could cause neutrophilic inflammation and bacterial colonization in both conditions. The contribution of this impairment to PBB progressing into bronchiectasis remains uncertain.,1.4211583641411244e-07,0.09339390473662901,0.015912549197025432,0.010880558788691236,0.0921109178578674,0.01851192595229618,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
78,1.1,9,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Does alveolar macrophage phagocytic dysfunction in children with protracted bacterial bronchitis precede bronchiectasis? A weakened host defense by alveolar macrophages against apoptotic cells or NTHi may contribute to neutrophilic inflammation and colonization in PBB and bronchiectasis, yet its involvement in the transition from PBB to bronchiectasis is unknown.",1.8948778188548325e-07,0.10677487948168984,0.03631185475258099,0.014507411718254981,0.13467053227666392,0.01851192595229618,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
78,1.1,10,human,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: A reduced alveolar macrophage phagocytic host response to apoptotic cells or NTHi may contribute to neutrophilic inflammation and NTHi colonization in both PBB and bronchiectasis. Whether this mechanism also contributes to the progression of PBB to bronchiectasis remains unknown.,"Is the impaired phagocytic function of alveolar macrophages in children with protracted bacterial bronchitis an early sign of bronchiectasis progression? A diminished ability of alveolar macrophages to clear apoptotic cells or NTHi might result in neutrophilic inflammation and bacterial colonization seen in both conditions, but whether this leads to bronchiectasis developing from PBB is uncertain.",2.3685972735685406e-08,0.019282670224506138,0.0006703937681290656,0.0018134264647818726,0.019176512593258366,0.0003490207932659514,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
79,1.1,1,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Do biochemical markers of bone turnover accurately reflect bone histomorphometry in 370 postmenopausal women? Answer: Yes, the study demonstrates that biochemical markers of bone turnover correspond well with bone histomorphometry in these women.",1.184298636784265e-07,0.04464504820591664,0.2908093278463649,0.009067132323909384,0.018729483661266588,0.07731320827974472,0.00905400770476436,0.007921019663017947,0.09579072532699172,1.1842986367842703e-07,0.04192685059374357,0.07908923646469129
79,1.1,2,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Are biochemical markers of bone turnover indicative of bone histomorphometry in 370 postmenopausal women? Answer: Yes, findings show that biochemical markers reliably represent bone histomorphometry in 370 postmenopausal women.",2.131737546211677e-07,0.11933268606079572,0.27083219885852394,0.016320838183036902,0.1275056198372182,0.09416218787158141,0.016297213868575855,0.15932148345919916,0.08640000000000005,2.1317375462116866e-07,0.19213689608631324,0.07398293444328821
79,1.1,3,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Can biochemical markers of bone turnover serve as representatives of bone histomorphometry in 370 postmenopausal women? Answer: Yes, the study supports that biochemical markers of bone turnover reflect bone histomorphometry in this group.",1.184298636784265e-07,0.013219876184520807,0.18998019496594992,0.009067132323909384,0.018729483661266588,0.07731320827974474,0.00905400770476436,0.007921019663017947,0.09579072532699172,1.1842986367842703e-07,0.04192685059374357,0.07908923646469129
79,1.1,4,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Are biochemical indicators of bone turnover reflective of bone histomorphometry in 370 postmenopausal women? Answer: Yes, results confirm that biochemical markers represent bone histomorphometry accurately in these women.",2.36859727356853e-07,0.03337449132397863,0.392642916859441,0.018134264647818782,0.015341725316676325,0.19976218787158145,0.01810801540952873,0.09437334024797961,0.16000000000000003,2.3685972735685406e-07,0.17803859535036892,0.11238293444328822
79,1.1,5,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Do biochemical markers of bone turnover correlate with bone histomorphometry in 370 postmenopausal women? Answer: Yes, evidence from the study indicates that biochemical markers are representative of bone histomorphometry in 370 postmenopausal women.",1.184298636784265e-07,0.04464504820591664,0.2908093278463649,0.009067132323909384,0.02459221512373011,0.1070154577883472,0.00905400770476436,0.007921019663017947,0.09579072532699172,1.1842986367842703e-07,0.04192685059374357,0.07908923646469129
79,1.1,6,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Are biochemical bone turnover markers valid proxies for bone histomorphometry in 370 postmenopausal women? Answer: Yes, the study results affirm that bone turnover markers reliably represent bone histomorphometry in this population.",1.658018091497971e-07,0.05530151967079444,0.3374485596707819,0.012693985253473143,0.002400833733509966,0.1334356572593366,0.012675610786670108,0.014825951717011066,0.16000000000000003,1.6580180914979784e-07,0.0647099100433648,0.11238293444328822
79,1.1,7,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Is bone histomorphometry in 370 postmenopausal women effectively represented by biochemical markers of bone turnover? Answer: Yes, findings reveal that biochemical markers are representative of bone histomorphometry in these women.",1.894877818854824e-07,0.016549140455889955,0.3334713192263049,0.014507411718255023,0.008313984833747234,0.16532341236137738,0.014486412327622981,0.02026536809425794,0.16000000000000003,1.8948778188548325e-07,0.10107755421423947,0.11238293444328822
79,1.1,8,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Do biochemical markers serve as accurate reflections of bone histomorphometry in 370 postmenopausal women? Answer: Yes, according to the study, biochemical markers of bone turnover reflect bone histomorphometry well.",2.131737546211677e-07,0.02407707543436599,0.3615778281020446,0.016320838183036902,0.021025918854198355,0.19976218787158145,0.016297213868575855,0.05663301226513262,0.16000000000000003,2.1317375462116866e-07,0.13881788219708646,0.11238293444328822
79,1.1,9,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Are biochemical markers indicative of bone histomorphometry among 370 postmenopausal women? Answer: Yes, the study confirms that biochemical markers of bone turnover represent bone histomorphometry in these patients.",2.36859727356853e-07,0.016136021573160075,0.35804883401920434,0.018134264647818782,0.015341725316676325,0.19976218787158145,0.01810801540952873,0.09437334024797961,0.16000000000000003,2.3685972735685406e-07,0.17803859535036892,0.11238293444328822
79,1.1,10,ai,"Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Yes, biochemical markers of bone turnover are representative of bone histomorphometry in 370 postmenopausal women, as indicated by the results of the study.","Question: Can bone histomorphometry be reliably inferred from biochemical markers of bone turnover in 370 postmenopausal women? Answer: Yes, the research supports that biochemical markers represent bone histomorphometry accurately in this cohort.",1.658018091497971e-07,0.14473986554949736,0.39943955934619607,0.012693985253473143,0.09001879034114912,0.19976218787158145,0.012675610786670108,0.014825951717011066,0.16000000000000003,1.6580180914979784e-07,0.0647099100433648,0.11238293444328822
80,1.1,1,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) recorded in the medical record? Yes, these should be noted as they play a crucial role in a patient's medical history and ongoing treatment planning.",2.605457000925386e-07,0.005309579171068002,0.19463667820069205,0.019947691112600627,0.07263335361157264,0.16000000000000003,0.019918816950481567,0.1433143971007036,0.11959876543209881,2.6054570009253947e-07,0.21761154704347208,0.07450693937180423
80,1.1,2,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Yes, documenting these is essential because they are significant components of a patient's medical history and treatment plan.",3.079176455639092e-07,0.06984810030863953,0.19463667820069205,0.023574544042164386,0.1393247281102461,0.16000000000000003,0.023540420032387314,0.21230726858765436,0.11959876543209881,3.079176455639103e-07,0.28907051102561576,0.07450693937180423
80,1.1,3,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) included in the medical record? Yes, it is important to document them since they are key aspects of a patient's medical history and ongoing care.",2.605457000925386e-07,0.005309579171068002,0.19463667820069205,0.019947691112600627,0.07263335361157264,0.16000000000000003,0.019918816950481567,0.1433143971007036,0.11959876543209881,2.6054570009253947e-07,0.21761154704347208,0.07450693937180423
80,1.1,4,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is there a record of opioid dependence and methadone maintenance treatment (MMT) in the medical notes? Yes, they must be documented as important elements of a patient's medical background and treatment strategy.",2.842316728282239e-07,0.03705827748564783,0.19463667820069205,0.021761117577382506,0.10542317643456434,0.16000000000000003,0.02172961849143444,0.17721594877638536,0.11959876543209881,2.8423167282822487e-07,0.2527028668547411,0.07450693937180423
80,1.1,5,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? Yes, these conditions should be included because they are vital parts of the patient's medical history and treatment protocol.",2.842316728282239e-07,0.03705827748564783,0.19463667820069205,0.021761117577382506,0.10542317643456434,0.16000000000000003,0.02172961849143444,0.17721594877638536,0.11959876543209881,2.8423167282822487e-07,0.2527028668547411,0.07450693937180423
80,1.1,6,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is opioid dependence and methadone maintenance treatment (MMT) reflected in the medical record? Yes, documenting them is necessary as they constitute important factors in the patient's history and treatment planning.",3.316036182995945e-07,0.15155290581604142,0.16019790269048795,0.025387970506946266,0.1744160479215151,0.16000000000000003,0.025351221573340188,0.24867491275852904,0.11959876543209881,3.316036182995957e-07,0.32681083900846275,0.07450693937180423
80,1.1,7,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) documented within the medical record? Yes, they are crucial to record since they significantly influence the patient's medical history and ongoing treatment.",3.316036182995945e-07,0.10374965198432129,0.19463667820069205,0.025387970506946266,0.1744160479215151,0.16000000000000003,0.025351221573340188,0.24867491275852904,0.11959876543209881,3.316036182995957e-07,0.32681083900846275,0.07450693937180423
80,1.1,8,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Do medical records document opioid dependence and methadone maintenance treatment (MMT)? Yes, their documentation is important as they represent critical aspects of the patient’s past medical history and current treatment plan.",3.079176455639092e-07,0.06984810030863953,0.19463667820069205,0.023574544042164386,0.1393247281102461,0.16000000000000003,0.023540420032387314,0.21230726858765436,0.11959876543209881,3.079176455639103e-07,0.28907051102561576,0.07450693937180423
80,1.1,9,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Is opioid dependence along with methadone maintenance treatment (MMT) entered into the medical record? Yes, it should be recorded because it is essential to a patient’s medical history and treatment planning.",3.079176455639092e-07,0.06984810030863953,0.19463667820069205,0.023574544042164386,0.1393247281102461,0.16000000000000003,0.023540420032387314,0.21230726858765436,0.11959876543209881,3.079176455639103e-07,0.28907051102561576,0.07450693937180423
80,1.1,10,ai,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Yes, opioid dependence and methadone maintenance treatment (MMT) should be documented in the medical record as they are important factors in a patient's medical history and ongoing treatment plan.","Are opioid dependence and methadone maintenance treatment (MMT) routinely documented in the medical record? Yes, proper documentation is important as these elements are key to the patient’s health history and ongoing treatment management.",2.605457000925386e-07,0.005309579171068002,0.19463667820069205,0.019947691112600627,0.07263335361157264,0.16000000000000003,0.019918816950481567,0.1433143971007036,0.11959876543209881,2.6054570009253947e-07,0.21761154704347208,0.07450693937180423
81,1.1,1,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: It is necessary to conduct additional research to confirm the relevance of existing prediction equations for estimating basal metabolic rate in Chinese populations.,7.10579182070559e-08,0.13855454517820087,0.03616753416775034,0.005440279394345632,0.13602178369588858,0.034636678200692064,0.005432404622858621,0.09332544715697333,0.002670768987034146,7.105791820705622e-08,0.09237332013101529,0.0
81,1.1,2,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Basal metabolic rate estimation in Chinese: do existing equations apply? Answer: Further studies are required to validate the accuracy of current prediction formulas for estimating basal metabolic rate in Chinese individuals.,7.10579182070559e-08,0.022055151802030437,0.07847800237812126,0.005440279394345639,0.015493231739846625,0.05670630202140312,0.005432404622858621,0.0551183740282557,0.031217481789802305,7.105791820705622e-08,0.10178269430994247,0.0
81,1.1,3,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Can current basal metabolic rate prediction equations be used for Chinese people? Answer: More investigation is needed to ascertain the suitability of existing equations for estimating basal metabolic rate in Chinese subjects.,4.73719454713706e-08,0.05659879842531845,0.08046505482890734,0.003626852929563759,0.018787230181123604,0.05777777777777784,0.003621603081905747,0.02121682235257394,0.031217481789802305,4.737194547137081e-08,0.06669137449867346,0.0
81,1.1,4,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimating basal metabolic rate in Chinese: Are present prediction equations valid? Answer: Additional research must be done to verify if current equations reliably estimate basal metabolic rate in Chinese populations.,9.47438909427412e-08,0.05992576125424742,0.04392184495236412,0.007253705859127518,0.0987914790416391,0.021412894375857375,0.007243206163811494,0.13972020673666385,0.004447813134751871,9.474389094274162e-08,0.13815033848081715,0.0
81,1.1,5,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Is the estimation of basal metabolic rate in Chinese accurate using current equations? Answer: The adequacy of existing prediction equations for Chinese basal metabolic rate estimation calls for further examination.,9.47438909427412e-08,0.013715949216917878,0.0763607464388847,0.007253705859127518,0.05098822520991897,0.055561224489795946,0.007243206163811494,0.09020969383952471,0.031217481789802305,9.474389094274162e-08,0.13815033848081715,0.0
81,1.1,6,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Question: Can current basal metabolic rate prediction equations be applied to Chinese individuals? Answer: There is a necessity to further assess the applicability of these equations to ensure precise basal metabolic rate estimation in Chinese people.,4.73719454713706e-08,0.18400887825614687,0.0873239552518216,0.003626852929563759,0.1452588498070302,0.06145328719723188,0.003621603081905747,0.10394632060143305,0.031217481789802305,4.737194547137081e-08,0.06252035698133351,0.0
81,1.1,7,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Estimation of basal metabolic rate in the Chinese population: Are current equations appropriate? Answer: Existing prediction equations require further validation to confirm their accuracy when used with Chinese individuals.,1.184298636784265e-07,0.04480212318205945,0.14268727705112957,0.009067132323909398,0.03827629118946785,0.09000000000000004,0.009054007704764368,0.1265773380103994,0.031217481789802305,1.1842986367842703e-07,0.17589066646366414,0.0
81,1.1,8,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Are the current basal metabolic rate prediction equations suitable for Chinese individuals? Answer: More detailed investigation is essential to ensure these equations accurately estimate basal metabolic rate in the Chinese population.,7.10579182070559e-08,0.022055151802030437,0.07847800237812126,0.005440279394345639,0.015493231739846625,0.05670630202140312,0.005432404622858621,0.0551183740282557,0.031217481789802305,7.105791820705622e-08,0.10178269430994247,0.0
81,1.1,9,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Question: Do present basal metabolic rate prediction models fit Chinese individuals? Answer: Additional studies are needed to determine the applicability of current models to the Chinese population for precise basal metabolic rate estimation.,2.36859727356853e-08,0.08999601459419404,0.0823334789241785,0.0018134264647818796,0.05193340265005686,0.05878251821019773,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
81,1.1,10,ai,Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: The applicability of current prediction equations for estimating basal metabolic rate in Chinese individuals needs further investigation to ensure accuracy.,Question: Is it valid to use existing basal metabolic rate equations for Chinese people? Answer: The current prediction equations need more research to establish their accuracy for estimating basal metabolic rate among Chinese individuals.,2.36859727356853e-08,0.08999601459419404,0.0823334789241785,0.0018134264647818796,0.05193340265005686,0.05878251821019773,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
82,1.1,1,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate inhibit colon cancer in coronary artery disease patients? Our findings from patients with coronary artery disease support the hypothesis that bezafibrate may help prevent colon cancer.,2.3685972735685332e-07,0.2519921830540315,0.00902120187304891,0.018134264647818747,0.24924139707245496,0.01628251821019771,0.018108015409528694,0.24577280463087137,0.024375,2.3685972735685406e-07,0.28768207245178123,0.0
82,1.1,2,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can the lipid-lowering agent bezafibrate, a peroxisome proliferator-activated receptor ligand, prevent colon cancer in patients suffering from coronary artery disease? Data from these patients suggest a potential preventive role of bezafibrate in colon cancer development.",2.1317375462116802e-07,0.17889474339882705,0.03999024334251605,0.016320838183036868,0.1751480396207037,0.047500000000000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
82,1.1,3,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Is bezafibrate, a lipid-lowering peroxisome proliferator-activated receptor ligand, effective in reducing colon cancer risk in coronary artery disease patients? Our patient data support the idea that bezafibrate might prevent colon cancer.",3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
82,1.1,4,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does the peroxisome proliferator-activated receptor ligand bezafibrate, which lowers lipids, prevent colon cancer in patients with coronary artery disease? Our analysis from CAD patients supports a possible protective effect against colon cancer.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,1.1,5,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Can bezafibrate, a lipid-lowering ligand of peroxisome proliferator-activated receptors, prevent the onset of colon cancer in coronary artery disease patients? Our data derived from such patients supports its potential preventive effect.",3.079176455639092e-07,0.2632845227904843,0.06937499999999999,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
82,1.1,6,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Is there evidence that the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate can prevent colon cancer in coronary artery disease patients? Our findings from these patients back the preventive hypothesis.,3.552895910352798e-07,0.3322773942774351,0.06937499999999999,0.027201396971728145,0.37581873508285435,0.047500000000000014,0.02716202311429306,0.4216634710945355,0.024375,3.552895910352811e-07,0.47000362924573613,0.0
82,1.1,7,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.","Does bezafibrate, known for lowering lipids as a peroxisome proliferator-activated receptor ligand, have a preventive effect on colon cancer in coronary artery disease patients? Our coronary disease patient data affirm this possibility.",2.842316728282239e-07,0.2304946999674926,0.06937499999999999,0.021761117577382506,0.2704582194250289,0.047500000000000014,0.02172961849143444,0.31246417912954483,0.024375,2.8423167282822487e-07,0.356674943938732,0.0
82,1.1,8,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Might the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Data we gathered from these patients uphold this potential effect.,4.026615365066504e-07,0.40638536643115675,0.06937499999999999,0.030828249901291904,0.4527797762189838,0.047500000000000014,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
82,1.1,9,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Is the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate effective in colon cancer prevention among coronary artery disease patients? Our data derived from these patients lend support to that hypothesis.,3.552895910352798e-07,0.3322773942774351,0.06937499999999999,0.027201396971728145,0.37581873508285435,0.047500000000000014,0.02716202311429306,0.4216634710945355,0.024375,3.552895910352811e-07,0.47000362924573613,0.0
82,1.1,10,human,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: Our data, derived from patients with coronary artery disease, support the hypothesis regarding a possible preventive effect of bezafibrate on the development of colon cancer.",Does treatment with the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate prevent colon cancer development in patients with coronary artery disease? Data from these patients support the preventive hypothesis.,3.789755637709651e-07,0.36864503844830976,0.06937499999999999,0.029014823436510025,0.41355906306570134,0.047500000000000014,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
83,1.1,1,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","The survey reveals notable unhappiness among consultant radiologists in the UK regarding the training and support provided for suspected child abuse cases, highlighting a shortage of paediatric radiologists in this field, and indicating the possibility of a 27% rise in child abuse radiology specialists with enhanced training.",2.3685972735685406e-07,0.23222870567226295,0.025537190082644625,0.018134264647818726,0.20067069546215155,0.0,0.018108015409528666,0.2047944126460135,0.0,2.3685972735685406e-07,0.2090917978585587,0.0
83,1.1,2,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","UK consultant radiologists express considerable dissatisfaction with the existing training and support for suspected child abuse, with few paediatric radiologists involved, but improved training could boost the number of experts in this area by 27%.",5.210914001850783e-07,0.47423590967041784,0.017851239669421492,0.03989538222520121,0.5108256237659909,0.0,0.039837633900963086,0.5232481437645489,0.0,5.210914001850789e-07,0.5363047090669744,0.0
83,1.1,3,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","According to the survey, many consultant radiologists in the UK are dissatisfied with the current support and training for dealing with suspected child abuse, there are few paediatric radiologists engaged, and better training might increase specialists by 27%.",4.500334819780224e-07,0.38967852164235417,0.017851239669421492,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
83,1.1,4,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","There is significant dissatisfaction among UK consultant radiologists towards their current training and support in suspected child abuse cases; few paediatric radiologists undertake this role, but improved training could raise the number of specialists by 27%.",4.97405427449393e-07,0.44524837279716634,0.017851239669421492,0.03808195576041933,0.48097266061630917,0.0,0.03802683236001021,0.4924764850977952,0.0,4.974054274493935e-07,0.5045560107523945,0.0
83,1.1,5,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Consultant radiologists in the UK report discontent with the services currently provided for suspected child abuse, a shortage of paediatric radiologists handling these cases, and the potential to enhance expert numbers by 27% through better training.",4.97405427449393e-07,0.44524837279716634,0.017851239669421492,0.03808195576041933,0.48097266061630917,0.0,0.03802683236001021,0.4924764850977952,0.0,4.974054274493935e-07,0.5045560107523945,0.0
83,1.1,6,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","The findings show that UK consultant radiologists are largely dissatisfied with their training and support regarding suspected child abuse, with a small count of paediatric radiologists involved, and a 27% potential increase in child abuse specialists if training is improved.",4.026615365066518e-07,0.3370347881569353,0.017851239669421492,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
83,1.1,7,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","UK consultant radiologists are notably unhappy with the current training and support in suspected child abuse cases, few paediatric radiologists are taking such cases, and a 27% increase in experts is possible with enhanced training programs.",4.97405427449393e-07,0.48485678311487757,0.010695473133346668,0.03808195576041933,0.48097266061630917,0.0,0.03802683236001021,0.4924764850977952,0.0,4.974054274493935e-07,0.5045560107523945,0.0
83,1.1,8,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Survey results indicate a high level of dissatisfaction among UK consultant radiologists about the training and support in suspected child abuse, alongside a limited number of paediatric radiologists; better training could increase specialists by 27%.",5.210914001850783e-07,0.47423590967041784,0.017851239669421492,0.03989538222520121,0.5108256237659909,0.0,0.039837633900963086,0.5232481437645489,0.0,5.210914001850789e-07,0.5363047090669744,0.0
83,1.1,9,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","The survey points to marked dissatisfaction among consultant radiologists in the UK concerning training and support for suspected child abuse, a low involvement of paediatric radiologists, and the chance to grow the number of experts by 27% through improved training.",4.026615365066518e-07,0.3370347881569353,0.017851239669421492,0.030828249901291835,0.3697470255060846,0.0,0.030783626196198732,0.37806613392004973,0.0,4.026615365066519e-07,0.3867729750960107,0.0
83,1.1,10,human,"Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: The survey shows significant dissatisfaction amongst consultant radiologists with the current service, confirms a low number of paediatric radiologists taking on this work, and suggests the potential to increase numbers of radiology child abuse experts by 27% if given improved training","Consultant radiologists in the UK demonstrate significant dissatisfaction with existing training and support for suspected child abuse, with few paediatric radiologists practising in this field, and an opportunity to expand the expert workforce by 27% with better training.",4.500334819780224e-07,0.38967852164235417,0.017851239669421492,0.03445510283085558,0.4238142467763608,0.0,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
84,1.1,1,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Can Residency Selection Criteria Forecast Success in Orthopaedic Surgery Residency? Answer: Our study revealed that USMLE Step 2 scores, the count of honors during medical school clerkships, and AOA membership showed the strongest associations with resident performance. We aimed to equip residency programs broadly with insights on which criteria might be considered ""high"".",4.737194547137081e-08,0.037041271680350096,0.0,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
84,1.1,2,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Are Residency Selection Standards Predictive of Performance in Orthopaedic Surgery Residency? Answer: We discovered the most significant correlations with resident performance were USMLE Step 2 results, number of honors received in medical school clerkships, and AOA membership. Our objective was to offer residency programs general guidance on which criteria may be classified as ""high"".",2.3685972735685406e-08,0.018349138668195764,0.0,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
84,1.1,3,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Does the Selection Criteria for Residency Indicate Performance in Orthopaedic Surgery Residency? Answer: The findings highlighted that USMLE Step 2 scores, honors in medical school clerkships, and AOA membership had the strongest correlation with resident outcomes. Our purpose in analyzing this data was to inform residency programs overall about which criteria could be labeled as ""high"".",2.3685972735685406e-08,0.018018505502678472,0.0,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
84,1.1,4,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Can Residency Selection Metrics Predict Orthopaedic Surgery Residency Performance? Answer: We found strong links between resident performance and USMLE Step 2, the number of honors earned during clerkships in medical school, along with AOA membership. Our goal was to provide residency programs nationwide an understanding of potentially ""high"" criteria.",1.4211583641411244e-07,0.11551288712184427,0.0,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
84,1.1,5,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Do Residency Selection Factors Forecast Residency Performance in Orthopaedic Surgery? Answer: Our study identified that USMLE Step 2 scores, clerkship honors in medical school, and AOA membership most strongly correlated with resident performance. We aimed to help residency programs at large recognize which criteria might be deemed ""high"".",1.6580180914979784e-07,0.13613217432458002,0.0,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
84,1.1,6,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Is Resident Performance in Orthopaedic Surgery Predictable by Residency Selection Criteria? Answer: Results indicated that USMLE Step 2, number of medical school clerkship honors, and AOA membership correlated best with resident success. We sought to assist residency programs broadly in understanding which criteria may be viewed as ""high"".",1.6580180914979784e-07,0.13613217432458002,0.0,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
84,1.1,7,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Does Selection Criteria for Residency Influence Performance in Orthopaedic Surgery? Answer: Our data showed that USMLE Step 2 performance, honors in medical school clerkships, and AOA membership held the strongest associations with resident performance. The intention was to guide residency programs in identifying ""high"" criteria.",2.3685972735685406e-07,0.20067069546215155,0.0,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
84,1.1,8,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Are Criteria Used for Residency Selection Indicative of Performance in Orthopaedic Surgery Residency? Answer: Evidence showed USMLE Step 2 scores, the number of honors during clerkships, and AOA membership had the top correlations with performance. We aimed to provide broader residency programs insight on potentially ""high"" criteria.",1.8948778188548325e-07,0.15718558352241319,0.0,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
84,1.1,9,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Can Criteria for Selecting Residents Predict Their Performance in Orthopaedic Surgery Residency? Answer: Findings demonstrated USMLE Step 2, honors in medical school clerkships, and AOA membership as having the most significant links with resident performance. Our analysis intended to offer residency programs insights on which criteria may be deemed ""high"".",1.1842986367842703e-07,0.09531017980432566,0.0,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
84,1.1,10,human,"Question: Does Residency Selection Criteria Predict Performance in Orthopaedic Surgery Residency? Answer: We found that USMLE Step 2, number of honors in medical school clerkships, and AOA membership demonstrated the strongest correlations with resident performance. Our goal in analyzing these data was to provide residency programs at large a sense of which criteria may be ""high","Question: Are Selection Criteria Effective Predictors of Orthopaedic Surgery Residency Performance? Answer: We observed that USMLE Step 2 scores, the count of honors in medical school clerkships, and AOA membership hold the strongest correlations with resident outcomes. Our aim was to help residency programs broadly gauge which criteria might be considered ""high"".",9.474389094274162e-08,0.07550755250814589,0.0,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
85,1.1,1,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy an effective treatment for gallbladder carcinoma? It appears that external radiotherapy is a safe and effective approach for palliatively managing gallbladder carcinoma. Nonetheless, additional research is needed to clarify the role of radiotherapy in palliative or adjuvant treatment for this cancer.",0.0,0.031506690025452144,0.022636492852053384,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0,0.0,0.0,0.0
85,1.1,2,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external palliative radiotherapy work well for gallbladder carcinoma? External radiotherapy seems to be both a safe and effective palliative treatment option for gallbladder carcinoma, though further studies are required to fully understand its role in palliative or adjuvant care.",1.1842986367842692e-07,0.09316061699719658,0.01972820522484154,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
85,1.1,3,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy effective as a palliative therapy for gallbladder carcinoma? External radiotherapy appears to be a safe and effective way to manage gallbladder carcinoma palliation. However, more research is needed to define its role in either palliative or adjuvant treatment.",9.474389094274162e-08,0.0669541587814173,0.020367910477800573,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
85,1.1,4,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How effective is external palliative radiotherapy in treating gallbladder carcinoma? External radiotherapy is considered a safe and efficient palliative treatment method for gallbladder carcinoma, but further investigation is necessary to establish its place in palliative or adjuvant therapy.",1.6580180914979753e-07,0.1102583412231315,0.045351473922902494,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,1.1,5,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Can external palliative radiotherapy effectively manage gallbladder carcinoma? It seems that external radiotherapy provides a safe and effective palliative treatment for gallbladder carcinoma, although additional studies are needed to determine its role in palliative or adjuvant treatment.",1.8948778188548283e-07,0.13765731541124682,0.045351473922902494,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,1.1,6,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external radiotherapy a safe and effective palliative treatment for gallbladder carcinoma? External radiotherapy appears to safely and effectively manage gallbladder carcinoma palliation; however, further studies are essential to ascertain its role in palliative or adjuvant therapy.",1.8948778188548283e-07,0.17616549210902166,0.017596371882086164,0.014507411718254981,0.17361265045717467,0.023242630385487524,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
85,1.1,7,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","What is the effectiveness of external palliative radiotherapy in gallbladder carcinoma? External radiotherapy seems to be a secure and effective palliative management option for gallbladder carcinoma, but more research is necessary to determine its role in palliative or adjuvant care.",1.1842986367842692e-07,0.05761460773771265,0.045351473922902494,0.009067132323909363,0.09137455222020163,0.023242630385487524,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
85,1.1,8,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Does external radiotherapy offer effective palliative treatment for gallbladder carcinoma? External radiotherapy is likely a safe and effective way of palliative management for gallbladder carcinoma; nevertheless, further studies are required to define its role in palliative or adjuvant treatment.",1.4211583641411222e-07,0.15655295525254376,0.007117661879566646,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
85,1.1,9,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","How reliable is external palliative radiotherapy for gallbladder carcinoma? External radiotherapy appears to be a safe and effective palliative approach for gallbladder carcinoma; however, additional research is needed to clarify its role in either palliative or adjuvant therapy.",1.6580180914979753e-07,0.1477257563885339,0.01834530108339633,0.012693985253473108,0.14544177349047782,0.023242630385487524,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
85,1.1,10,human,"Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: External radiotherapy seems to be a safe and effective method of palliative management of gallbladder carcinoma. However, further studies are necessary to determine the role of radiotherapy in palliative or adjuvant treatment of gallbladder carcinoma.","Is external palliative radiotherapy beneficial for gallbladder carcinoma patients? External radiotherapy seems to be a safe and effective method for palliative treatment of gallbladder carcinoma, though more studies are necessary to confirm its role in palliative or adjuvant treatment.",1.4211583641411222e-07,0.08359009414097063,0.045351473922902494,0.010880558788691236,0.1180427993023625,0.023242630385487524,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
86,1.1,1,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure an indicator of fluid responsiveness? Answer: Evidence does not support the routine use of central venous pressure for guiding fluid therapy. This method of fluid resuscitation should be discontinued.,4.73719454713706e-08,0.1056504394893194,0.033067033976124934,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,1.1,2,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Can central venous pressure predict fluid responsiveness? Answer: There is no data backing the use of central venous pressure to direct fluid therapy, and this practice should be stopped.",1.421158364141118e-07,0.2044419185309585,0.011654139600267559,0.010880558788691277,0.20289316377574718,0.00628053826707024,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
86,1.1,3,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Does measuring central venous pressure help predict fluid responsiveness? Answer: Current evidence shows no basis for using central venous pressure to guide fluid therapy; thus, this strategy should be abandoned.",1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,1.1,4,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Is central venous pressure a reliable predictor of fluid responsiveness? Answer: There is no supporting data for the common practice of utilizing central venous pressure to manage fluid therapy; this should be discontinued.,4.73719454713706e-08,0.06364151945538365,0.003420832103075977,0.003626852929563759,0.06317295703908332,0.0018327251323183684,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
86,1.1,5,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Does central venous pressure assessment predict fluid responsiveness? Answer: No data support using central venous pressure to guide fluid therapy widely, so this approach should be abandoned.",1.894877818854824e-07,0.2829828460437285,0.01666703397612488,0.014507411718255037,0.28080963692155647,0.009015243342516074,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
86,1.1,6,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,Question: Can central venous pressure measurements inform about fluid responsiveness? Answer: Data do not support the frequent use of central venous pressure for guiding fluid therapy; this practice should be stopped.,1.184298636784265e-07,0.16735348326649557,0.00939356458836977,0.009067132323909398,0.16609458489905915,0.005054018852720155,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
86,1.1,7,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Is the central venous pressure a predictor for fluid responsiveness? Answer: There is a lack of data endorsing the use of central venous pressure in fluid therapy decisions, and this practice should be halted.",2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,1.1,8,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Does central venous pressure serve as a predictor of fluid responsiveness? Answer: The evidence does not support using central venous pressure to guide fluid resuscitation, and this approach should be ceased.",9.47438909427412e-08,0.13158238224754726,0.007276308649133208,0.007253705859127518,0.1305995914289868,0.003908941321112979,0.007243206163811494,0.12921173148000697,0.0,9.474389094274162e-08,0.1335313926245223,0.0
86,1.1,9,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Is it valid to use central venous pressure to predict fluid responsiveness? Answer: There is no evidence supporting the common use of central venous pressure for fluid management, so this method should be abandoned.",2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
86,1.1,10,human,Question: Does the central venous pressure predict fluid responsiveness? Answer: There are no data to support the widespread practice of using central venous pressure to guide fluid therapy. This approach to fluid resuscitation should be abandoned.,"Question: Does central venous pressure reliably predict fluid responsiveness? Answer: No data justify using central venous pressure to guide fluid therapy; therefore, this practice should be stopped.",2.131737546211677e-07,0.32467273061096247,0.019455922865013776,0.016320838183036916,0.32216311063040726,0.010545798898071623,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
87,1.1,1,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Does (18)F-FDG serve as an effective surrogate tracer for assessing tumor hypoxia? This study demonstrated that FDG does not effectively act as a surrogate tracer for tumor hypoxia, whether under normal oxygen levels or hypoxic conditions, and only specific hypoxia...",1.421158364141118e-07,0.13797098617813175,0.02085877579437545,0.010880558788691257,0.13536882637087366,0.026296566837107373,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
87,1.1,2,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG an appropriate surrogate tracer for detecting tumor hypoxia? The research indicated that FDG is not a reliable surrogate tracer for tumor hypoxia in either ambient or low oxygen environments; it is only specific to certain types of hypoxia...,1.421158364141118e-07,0.13797098617813175,0.02085877579437545,0.010880558788691257,0.13536882637087366,0.026296566837107373,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
87,1.1,3,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Can (18)F-FDG be used as a surrogate tracer to measure tumor hypoxia? According to this study, FDG is ineffective as a surrogate tracer for tumor hypoxia in both normoxic and hypoxic conditions, showing specificity only to particular hypoxia...",9.47438909427412e-08,0.04401702571547261,0.05017638948961935,0.007253705859127511,0.04076668226083413,0.055363321799307974,0.007243206163811494,0.08175244668655557,0.02854671280276816,9.474389094274162e-08,0.125163142954007,0.0
87,1.1,4,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Is (18)F-FDG suitable as a surrogate marker for tumor hypoxia measurement? The findings of this study revealed that FDG is a poor surrogate tracer for tumor hypoxia regardless of ambient or hypoxic states, being sensitive only to certain hypoxia...",1.184298636784265e-07,0.11012465718226894,0.02219569830246914,0.009067132323909384,0.10771459467909672,0.027006172839506164,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
87,1.1,5,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Does (18)F-FDG function well as a surrogate tracer of tumor hypoxia? This study found that FDG does not serve as an adequate surrogate tracer for tumor hypoxia under either normal or hypoxic oxygen levels but only corresponds to specific hypoxia...,1.421158364141118e-07,0.17351699543761612,0.004650168801939046,0.010880558788691257,0.17185025692666,0.0,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
87,1.1,6,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG effective as a surrogate tracer for tumor hypoxia? Findings from the study suggest that FDG is not an effective surrogate tracer for tumor hypoxia under both ambient and hypoxic conditions; it is limited to identifying specific hypoxia...,1.184298636784265e-07,0.0736432266264817,0.048093909438775506,0.009067132323909384,0.07024717951369341,0.05387755102040818,0.00905400770476436,0.1110235572731888,0.02775510204081633,1.1842986367842703e-07,0.1541506798272585,0.0
87,1.1,7,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Can tumor hypoxia be measured using (18)F-FDG as a surrogate tracer? The current study showed FDG is not suitable as a surrogate tracer for tumor hypoxia in ambient or hypoxic settings, responding only to distinct types of hypoxia...",9.47438909427412e-08,0.04401702571547261,0.05017638948961935,0.007253705859127511,0.07927485895860897,0.02775510204081633,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
87,1.1,8,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG a valid surrogate imaging tracer to detect tumor hypoxia? Research revealed that FDG is not a reliable surrogate tracer to measure tumor hypoxia under normal or low oxygen conditions but is sensitive only to certain hypoxia...,9.47438909427412e-08,0.11895185604627878,0.0032672646604938356,0.007253705859127511,0.11778303565638382,0.0,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
87,1.1,9,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,"Can (18)F-FDG act as a surrogate tracer for evaluating tumor hypoxia? The study demonstrated that FDG fails to be an effective surrogate tracer for tumor hypoxia whether in ambient or hypoxic environments, being selective for only specific hypoxia...",9.47438909427412e-08,0.08148444088087547,0.023604113520408178,0.007253705859127511,0.07927485895860897,0.02775510204081633,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
87,1.1,10,human,Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: This study showed that FDG is not a good surrogate tracer for tumor hypoxia under either ambient or hypoxic conditions. Only specific hypoxia,Is (18)F-FDG a surrogate tracer for assessing tumor hypoxia? The study concluded that FDG is not a proper surrogate tracer for tumor hypoxia in either ambient or hypoxic conditions except for certain specific hypoxia...,0.0,0.042008920033936636,0.030080360626951082,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0,0.0,0.0,0.0
88,1.1,1,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is an expert breast pathology evaluation essential for managing ductal carcinoma in situ? Expert breast pathology evaluations remain crucial for DCIS management.,1.894877818854824e-07,0.26358841132854094,0.040217174515235404,0.014507411718255037,0.30676592888292964,0.021144421314887994,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
88,1.1,2,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Does ductal carcinoma in situ management require expert breast pathology assessment? Expert pathology review is still important for DCIS treatment.,2.368597273568531e-07,0.23164383549315248,0.13439999999999996,0.018134264647818796,0.34281172648476055,0.07100591715976333,0.018108015409528732,0.4626235219481134,0.0,2.368597273568538e-07,0.48550781578170144,0.0
88,1.1,3,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is specialized breast pathology review needed for the treatment of ductal carcinoma in situ? Expert assessments are still required for DCIS management.,1.894877818854824e-07,0.13156037693617106,0.13439999999999996,0.014507411718255037,0.2374512108269351,0.07100591715976333,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
88,1.1,4,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Must expert breast pathology assessment be part of managing ductal carcinoma in situ? Such expertise remains vital for DCIS care.,2.368597273568531e-07,0.23164383549315248,0.13439999999999996,0.018134264647818796,0.34281172648476055,0.07100591715976333,0.018108015409528732,0.4626235219481134,0.0,2.368597273568538e-07,0.48550781578170144,0.0
88,1.1,5,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology evaluation necessary in the care of ductal carcinoma in situ? The expert review continues to be necessary for managing DCIS.,1.421158364141118e-07,0.04058859873044307,0.13439999999999996,0.010880558788691277,0.1421410310226099,0.07100591715976333,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
88,1.1,6,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is a specialist breast pathology assessment important for managing ductal carcinoma in situ? Expert pathology input remains essential for DCIS management.,2.1317375462116776e-07,0.18035054110560234,0.13439999999999996,0.016320838183036916,0.28874450521448525,0.07100591715976333,0.016297213868575862,0.4054651081081646,0.0,2.1317375462116844e-07,0.4248831939652664,0.0
88,1.1,7,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert assessment by breast pathologists required to manage ductal carcinoma in situ? The role of expert breast pathology persists in DCIS treatment.,1.658018091497971e-07,0.08504036130127712,0.13439999999999996,0.012693985253473157,0.18866104665750383,0.07100591715976333,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
88,1.1,8,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert breast pathology crucial for the management of ductal carcinoma in situ? Managing DCIS still depends on expert pathology evaluation.,2.1317375462116776e-07,0.18035054110560234,0.13439999999999996,0.016320838183036916,0.28874450521448525,0.07100591715976333,0.016297213868575862,0.4054651081081646,0.0,2.1317375462116844e-07,0.4248831939652664,0.0
88,1.1,9,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Is expert pathology assessment indispensable in handling ductal carcinoma in situ? Expert breast pathology remains necessary for DCIS care.,2.6054570009253846e-07,0.2857110567634278,0.13439999999999996,0.019947691112600672,0.39997014032470934,0.07100591715976333,0.019918816950481606,0.5232481437645484,0.0,2.6054570009253915e-07,0.5500463369192721,0.0
88,1.1,10,human,Question: Is expert breast pathology assessment necessary for the management of ductal carcinoma in situ ? Answer: Expert breast pathology assessments continue to be necessary in the management of DCIS.,Does managing ductal carcinoma in situ necessitate expert breast pathology evaluation? Such expert assessments continue to be essential for DCIS.,2.368597273568531e-07,0.23164383549315248,0.13439999999999996,0.018134264647818796,0.34281172648476055,0.07100591715976333,0.018108015409528732,0.4626235219481134,0.0,2.368597273568538e-07,0.48550781578170144,0.0
89,1.1,1,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy harm the kidneys in women with higher parity? Our research indicates that pregnancy-induced glomerular hyperfiltration does not negatively impact the kidneys of women with more parities. Pregnancy might provide protective effects against the harmful consequences of glomerular hyperfiltration on the kidneys.,1.4211583641411244e-07,0.09692359066558609,0.021267763897151196,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,1.1,2,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is kidney damage seen in women with multiple pregnancies due to glomerular hyperfiltration? We suggest from our study that the kidney is not adversely affected by pregnancy-related glomerular hyperfiltration in women with higher parity. Pregnancy could offer protective mechanisms against glomerular hyperfiltration's damaging effects on the kidneys.,1.1842986367842703e-07,0.0003644498606090174,0.07216712580348944,0.009067132323909363,0.0529893953488525,0.037544801694046545,0.009054007704764333,0.051047220881349276,0.040742417383431435,1.1842986367842703e-07,0.08111976269099808,0.020823902218198284
89,1.1,3,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does the increased glomerular filtration in pregnancy cause kidney damage in women with numerous births? Our findings suggest that glomerular hyperfiltration during pregnancy does not harm the kidneys in women with many parities. Pregnancy may have protective functions that shield the kidneys from the adverse impacts of this hyperfiltration.,7.105791820705622e-08,0.015825434862972276,0.05333333333333336,0.005440279394345618,0.008193366755572917,0.038489004852977335,0.0054324046228586,0.006595458310516555,0.040742417383431435,7.105791820705622e-08,0.03565738861424084,0.020823902218198284
89,1.1,4,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Can glomerular hyperfiltration in pregnancy lead to kidney damage in women with several childbirths? Our study indicates that pregnancy-induced glomerular hyperfiltration does not have detrimental effects on the kidneys in women with more parities. Pregnancy may exert protective mechanisms to prevent damage from glomerular hyperfiltration.,1.6580180914979784e-07,0.07906261463302089,0.04773877982682265,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,1.1,5,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Is there kidney injury in women with multiple pregnancies due to pregnancy-associated glomerular hyperfiltration? According to our study, glomerular hyperfiltration caused by pregnancy does not harm the kidneys in women with greater parity. Pregnancy might protect the kidneys from the negative consequences of glomerular hyperfiltration.",1.6580180914979784e-07,0.07906261463302089,0.04773877982682265,0.012693985253473108,0.09988463181436424,0.03651291511021191,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
89,1.1,6,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does pregnancy-related glomerular hyperfiltration result in kidney damage in women with increased parity? Our research suggests that the kidneys in women with more parities are not adversely affected by glomerular hyperfiltration during pregnancy. Pregnancy could have mechanisms that protect the kidney from the harmful effects of this condition.,9.474389094274162e-08,0.007071450878903374,0.05202249770431591,0.0072537058591274906,0.030340781209246437,0.038027150433971035,0.007243206163811466,0.02857436502929156,0.040742417383431435,9.474389094274162e-08,0.05813024446629855,0.020823902218198284
89,1.1,7,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration during pregnancy damage kidneys in women who have had multiple children? Our study proposes that pregnancy-induced glomerular hyperfiltration does not adversely affect renal function in women with higher parity. Pregnancy may offer protective pathways against the damaging effects of glomerular hyperfiltration on kidneys.,1.4211583641411244e-07,0.0661170493073664,0.0016099773242630455,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,1.1,8,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Is there harm to the kidneys from glomerular hyperfiltration in pregnancies with higher parity? Our findings indicate that glomerular hyperfiltration associated with pregnancy does not damage kidneys in women with more parities. Pregnancy might have protective effects that guard the kidneys against hyperfiltration-related damage.,1.8948778188548325e-07,0.07201087027531194,0.06915460374115937,0.014507411718254981,0.09117572547758446,0.05975554549569943,0.014486412327622933,0.12166478809530323,0.040742417383431435,1.8948778188548325e-07,0.1534404242706242,0.020823902218198284
89,1.1,9,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.",Does glomerular hyperfiltration caused by pregnancy damage the kidneys of women with more live births? The study suggests no adverse kidney effects from pregnancy-related glomerular hyperfiltration in women with higher parity. Pregnancy may confer protective mechanisms for the kidneys against the harmful impacts of such hyperfiltration.,1.4211583641411244e-07,0.054489312779265386,0.049229024943310676,0.010880558788691236,0.044655709842690516,0.05975554549569943,0.0108648092457172,0.0740367391060488,0.040742417383431435,1.4211583641411244e-07,0.1046502601011925,0.020823902218198284
89,1.1,10,human,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: In our study, we suggest that glomerular hyperfiltration due to pregnancy does not have adverse effects on kidney in women with more parities. Pregnancy may have possible protective mechanisms for kidney against adverse effects of glomerular hyperfiltration.","Does kidney damage occur in women with multiple pregnancies due to glomerular hyperfiltration? According to our study, glomerular hyperfiltration resulting from pregnancy does not negatively affect the kidneys of women with greater parity. Pregnancy might have protective features that prevent kidney damage from glomerular hyperfiltration.",1.6580180914979784e-07,0.047555924607568745,0.07020408163265307,0.012693985253473108,0.06764522806739004,0.05975554549569943,0.012675610786670066,0.09756723651624322,0.040742417383431435,1.6580180914979784e-07,0.1287478116802525,0.020823902218198284
90,1.1,1,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.",How trustworthy are stroke patients' self-reported home blood pressure readings? The dependability of these readings can differ among patients. Healthcare providers should verify the accuracy and consistency by cross-checking with clinic measurements or employing automated blood pressure monitors at home.,4.263475092423372e-07,0.17778746363793152,0.2100538146352724,0.03264167636607371,0.20513501901583808,0.16326530612244897,0.0325944277371516,0.2703885124864369,0.08999999999999998,4.263475092423373e-07,0.30277663691409806,0.07359999999999998
90,1.1,2,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Are home blood pressure readings reported by stroke patients reliable? These reports can vary in trustworthiness, so medical professionals need to validate them by comparing with clinical measurements or using automated monitoring devices.",5.921493183921343e-07,0.3400671977083656,0.23567708333333334,0.045335661619546844,0.4087339742570779,0.16326530612244897,0.0452700385238217,0.4801090434685076,0.08999999999999998,5.921493183921352e-07,0.5189997453837352,0.07359999999999998
90,1.1,3,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Can stroke patients' reports of home blood pressure measurements be considered reliable? The reliability varies; thus, healthcare workers must assess their accuracy by validating against in-office readings or automated home devices.",6.395212638635049e-07,0.4046057188459371,0.23567708333333334,0.0489625145491106,0.4754253487557514,0.16326530612244897,0.04889164160572745,0.5491019149554583,0.08999999999999998,6.39521263863506e-07,0.5904587093658789,0.07359999999999998
90,1.1,4,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Do stroke patients provide dependable home blood pressure reading reports? The reliability may differ, making it essential for healthcare personnel to confirm accuracy via methods such as comparison to clinic measurements or use of automated devices.",5.210914001850784e-07,0.2504550390186786,0.23567708333333334,0.039895382225201205,0.3163606541260626,0.16326530612244897,0.03983763390096308,0.38479886366418237,0.08999999999999998,5.210914001850789e-07,0.4205596725704819,0.07359999999999998
90,1.1,5,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Are reports of home blood pressure measurements by stroke patients dependable? Their reliability is not always consistent, so healthcare providers should evaluate this by validating against clinical data or automated monitors.",6.395212638635049e-07,0.4046057188459371,0.23567708333333334,0.0489625145491106,0.4754253487557514,0.16326530612244897,0.04889164160572745,0.5491019149554583,0.08999999999999998,6.39521263863506e-07,0.5904587093658789,0.07359999999999998
90,1.1,6,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Is the information given by stroke patients on home blood pressure readings accurate? Reliability can vary, necessitating assessment by healthcare practitioners through validation against in-clinic readings or automated home monitors.",6.632072365991902e-07,0.43850727052161886,0.23567708333333334,0.05077594101389248,0.5105166685670204,0.16326530612244897,0.05070244314668032,0.585469559126333,0.08999999999999998,6.632072365991914e-07,0.6281990373487258,0.07359999999999998
90,1.1,7,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","How accurate are stroke patients' home blood pressure measurement reports? Such reports might vary in reliability, requiring healthcare professionals to perform validity checks using clinic-based comparisons or automated devices.",6.868932093348755e-07,0.47359859033288787,0.23567708333333334,0.05258936747867436,0.5468843127378951,0.16326530612244897,0.052513244687633194,0.62320988710918,0.08999999999999998,6.868932093348768e-07,0.6674197505020083,0.07359999999999998
90,1.1,8,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Do home blood pressure readings reported by stroke patients maintain reliability? This can fluctuate, thus healthcare professionals must verify accuracy using validation techniques like in-clinic comparatives or automated monitoring.",6.868932093348755e-07,0.47359859033288787,0.23567708333333334,0.05258936747867436,0.5468843127378951,0.16326530612244897,0.052513244687633194,0.62320988710918,0.08999999999999998,6.868932093348768e-07,0.6674197505020083,0.07359999999999998
90,1.1,9,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","Are the home blood pressure readings reported by stroke patients consistent and reliable? Their trustworthiness varies, making validation against clinic measurements or automated devices crucial for healthcare professionals.",7.105791820705608e-07,0.5099662345037625,0.23567708333333334,0.05440279394345624,0.584624640720742,0.16326530612244897,0.05432404622858607,0.6624306002624625,0.08999999999999998,7.105791820705622e-07,0.7082417450222631,0.07359999999999998
90,1.1,10,ai,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: The reliability of stroke patients' reports of home blood pressure readings may vary. It is important for healthcare professionals to assess the accuracy and consistency of these readings through validation methods, such as comparing them to in-clinic measurements or using automated home blood pressure monitoring devices.","How consistent and trustworthy are home blood pressure reports from stroke patients? Reliability may vary, so medical experts must assess these by comparing with in-clinic readings or employing automated home blood pressure monitors.",5.921493183921343e-07,0.42671059527835986,0.1734548611111111,0.045335661619546844,0.45345314719642893,0.13104308390022676,0.0452700385238217,0.4801090434685076,0.08999999999999998,5.921493183921352e-07,0.5189997453837352,0.07359999999999998
91,1.1,1,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do heightened carotid artery pulsatility and resistance indices signal early vascular irregularities among young obese men? Our findings indicate that reduced vessel compliance alongside elevated vascular resistance characterize young, obese, normotensive individuals beyond mere cardiovascular risk considerations. Alterations in arterial wall traits might...",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
91,1.1,2,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is an increase in carotid artery pulsatility and resistance an early indicator of vascular anomalies in young obese males? The data show that young, obese subjects with normal blood pressure demonstrate decreased vessel flexibility and heightened vascular resistance independently of cardiovascular risks. This points to possible arterial wall property changes...",7.105791820705622e-08,0.05942342047080107,0.0,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
91,1.1,3,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are elevated carotid artery pulsatility and resistance indexes indicative of initial vascular dysfunction in young obese males? Our research reveals that young obese normotensive people exhibit diminished vascular compliance and increased resistance, irrespective of other cardiovascular risk factors, implying potential early modifications in arterial walls...",1.8948778188548325e-07,0.19856077468861866,0.02271498107084911,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
91,1.1,4,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Can increased carotid artery pulsatility and resistance metrics be considered early markers of vascular abnormalities in young obese males? Results suggest impaired vessel compliance and heightened vascular resistance exist in young obese, normotensive subjects independent from cardiovascular risk, possibly due to changes in arterial wall characteristics...",1.6580180914979784e-07,0.17538777016932805,0.02221074380165289,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,1.1,5,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Do higher carotid artery pulsatility and resistance values reflect early vascular abnormalities in young obese men? Findings demonstrate that young obese individuals with normal blood pressure possess reduced vessel elasticity and increased vascular resistance separately from classic cardiovascular risk factors, hinting at arterial wall property modifications...",1.6580180914979784e-07,0.17538777016932805,0.02221074380165289,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,1.1,6,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are rising carotid artery pulsatility and resistance levels early signs of vascular issues among young obese men? Our outcomes propose that decreased vessel compliance and increased vascular resistance are typical in young obese normotensive subjects beyond established cardiovascular risks, possibly related to arterial wall property changes...",1.6580180914979784e-07,0.17538777016932805,0.02221074380165289,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
91,1.1,7,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Is an elevation in carotid artery pulsatility and resistance indicators an early manifestation of vascular abnormalities for young obese males? Study results affirm depressed vessel compliance and increased resistance in young obese normotensive subjects, regardless of cardiovascular risks, signifying changes in arterial wall structures...",2.1317375462116866e-07,0.2222830066348398,0.023242630385487524,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,1.1,8,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are increased carotid artery pulsatility and resistance indexes early predictors of vascular dysfunction in young obese males? The study findings imply that reduced vessel compliance combined with elevated vascular resistance are traits of young obese normotensive subjects independently of cardiovascular risk factors, associated with arterial wall alterations...",1.4211583641411244e-07,0.152739156029722,0.021728395061728398,0.010880558788691236,0.12516314295400566,0.0,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
91,1.1,9,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","May increased carotid artery pulsatility and resistance indices signal early vascular abnormalities in young obese men? Evidence suggests diminished vessel flexibility and greater vascular resistance occur in young obese normotensive individuals independently and additionally to cardiovascular risk factors, likely reflecting arterial wall property changes...",2.1317375462116866e-07,0.254522410381814,0.046400951814396206,0.016320838183036854,0.2271630230390489,0.023795359904818555,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
91,1.1,10,human,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Our results suggest that depressed vessel compliance and increased vascular resistance are features of young, obese, normotensive subjects independently of and in addition to cardiovascular risk factors. As changes in arterial wall properties may","Are enhanced carotid artery pulsatility and resistance metrics early indicators of vascular anomalies in young obese males? Data indicate that young obese normotensive subjects experience lowered vessel compliance alongside increased vascular resistance beyond cardiovascular risks, pointing toward modifications in arterial wall characteristics...",2.6054570009253947e-07,0.2714837094654099,0.024375,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
92,1.1,1,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can having an optimistic perspective forecast improved longevity in very old ages? Answer: Optimism seems to be a key factor in predicting survival for the oldest-old women and might also be important for men, although the male sample size is limited.",7.105791820705622e-08,0.08691588291330543,0.11176857330703485,0.005440279394345618,0.024397549661296924,0.06937499999999999,0.0054324046228586,0.041100963555631864,0.023795359904818555,7.105791820705622e-08,0.0759859069779214,0.0
92,1.1,2,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is an optimistic mindset linked to greater survival rates in the elderly? Answer: An optimistic outlook is a strong predictor of survival among the oldest-old women and possibly for men as well, but the male sample size is small.",1.1842986367842692e-07,0.0013594530791580794,0.0861453046089739,0.009067132323909363,0.02689574472625278,0.06937499999999999,0.009054007704764333,0.0937446970410507,0.023795359904818555,1.1842986367842703e-07,0.1300531282481976,0.0
92,1.1,3,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does optimism contribute to better survival chances at advanced ages? Answer: Optimistic outlooks notably predict survival among the oldest-old women and might also do so for men, albeit with a small male sample.",2.605457000925387e-07,0.1301486223245223,0.11176857330703485,0.01994769111260062,0.19874600165291278,0.06937499999999999,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
92,1.1,4,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Can optimism serve as a reliable indicator of longevity in advanced age groups? Answer: Yes, optimism is a significant predictor for survival among the oldest-old women and potentially for men, though the male group studied is small.",1.6580180914979753e-07,0.01573827114677684,0.11176857330703485,0.012693985253473108,0.08096296599652897,0.06937499999999999,0.012675610786670066,0.14931454819586287,0.023795359904818555,1.6580180914979784e-07,0.18721154208814594,0.0
92,1.1,5,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,Question: Does having an optimistic view associate with improved survival in the oldest adults? Answer: An optimistic attitude is a significant survival predictor for the oldest-old women and may also be significant for men given the small sample size.,1.4211583641411222e-07,0.025551454620402314,0.08547200646992748,0.010880558788691236,0.05356399180841365,0.06937499999999999,0.0108648092457172,0.12114367122916603,0.023795359904818555,1.4211583641411244e-07,0.15822400521489444,0.0
92,1.1,6,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is there a link between optimism and survival rates in the elderly population? Answer: An optimistic outlook appears to significantly predict survival among the oldest-old women and might be predictive for men, despite their small sample group.",1.6580180914979753e-07,0.01573827114677684,0.11176857330703485,0.012693985253473108,0.08096296599652897,0.06937499999999999,0.012675610786670066,0.14931454819586287,0.023795359904818555,1.6580180914979784e-07,0.18721154208814594,0.0
92,1.1,7,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does possessing optimism correlate with better survival at very old ages? Answer: Optimism is a meaningful predictor of survival in the oldest-old women and potentially men, although men's sample size is limited.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,1.1,8,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Does maintaining an optimistic attitude indicate survivorship potential in advanced old age? Answer: Optimism significantly predicts survival among the oldest-old women and might also for men, with the male sample being small.",2.84231672828224e-07,0.16092028099127598,0.11176857330703485,0.0217611175773825,0.2304946999674926,0.06937499999999999,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
92,1.1,9,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Is an optimistic outlook related to higher survival chances at advanced ages? Answer: An optimistic perspective is an important survival predictor for the oldest-old women and possibly for men, though the male count is low.",2.1317375462116813e-07,0.15052494293701102,0.05483560728315975,0.01632083818303686,0.13812137983647732,0.06937499999999999,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
92,1.1,10,human,Question: Optimism and survival: does an optimistic outlook predict better survival at advanced ages? Answer: An optimistic outlook appears to be a significant predictor of survival among the oldest-old women. It may also be a significant predictor for men but the sample size is small.,"Question: Could optimism predict longevity in the very elderly? Answer: It appears that an optimistic outlook significantly predicts survival for oldest-old women and may do so for men, despite the small sample size for men.",2.3685972735685343e-07,0.10029565917484051,0.11176857330703485,0.01813426464781874,0.1679743429861591,0.06937499999999999,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
93,1.1,1,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: Is there a correlation between the radiographic transition zone and the extent of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone usually aligns with the level of aganglionosis found on the specimen in Hirschsprung's disease.",7.10579182070559e-08,0.13790940573435506,0.030612244897959134,0.005440279394345618,0.09485354486498698,0.00984322847091948,0.0054324046228586,0.09161903752274592,0.006593590561224494,7.105791820705622e-08,0.08786333642501098,0.0023785838179777724
93,1.1,2,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: Does the position of the radiographic transition zone correspond to the area of aganglionosis in Hirschsprung's disease specimens? Answer: Yes, typically, the radiographic transition zone matches the extent of aganglionosis seen in the specimen.",7.10579182070559e-08,0.08955589421116006,0.10255668934240356,0.005440279394345632,0.021511666431370813,0.07492195629552548,0.005432404622858621,0.014108626521551315,0.053743455710197695,7.105791820705622e-08,0.05159995656866556,0.029384756657483937
93,1.1,3,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: For Hirschsprung's disease, is the transition zone visible on radiographs consistent with the aganglionic segment on pathology? Answer: Yes, the radiographic transition zone generally reflects the aganglionosis level present in the specimen.",1.184298636784265e-07,0.14870302785912548,0.18689476310815684,0.009067132323909391,0.043009149517909684,0.13527575442247655,0.009054007704764368,0.035325448874125254,0.0849609375,1.1842986367842703e-07,0.11829133106733902,0.029384756657483937
93,1.1,4,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: In Hirschsprung's disease, does the radiographic transition zone indicate the precise level of aganglionosis on the tissue specimen? Answer: Yes, the radiographic transition zone commonly corresponds with the level of aganglionosis identified in the specimen.",4.73719454713706e-08,0.08359483374525478,0.07922335600907027,0.003626852929563752,0.013062378961876675,0.04786680541103014,0.003621603081905747,0.01797581089626421,0.0546875,4.737194547137081e-08,0.019851258254085735,0.029384756657483937
93,1.1,5,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: Is the radiographic transition zone in Hirschsprung's disease an indicator of the aganglionic section on the specimen? Answer: Yes, the transition zone seen on radiographs typically correlates with the level of aganglionosis on the specimen.",4.73719454713706e-08,0.20242006469838802,0.16117927887408404,0.003626852929563752,0.13538246964892497,0.13527575442247655,0.003621603081905747,0.05998473093019996,0.0849609375,4.737194547137081e-08,0.019851258254085735,0.029384756657483937
93,1.1,6,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: Does the radiographic transition zone in Hirschsprung's disease reflect the extent of aganglionosis in the analyzed tissue specimen? Answer: Yes, the transition zone usually aligns with the aganglionic segment found on the specimen.",9.47438909427412e-08,0.180787465276941,0.18783880739795913,0.007253705859127511,0.07475784783248951,0.13527575442247655,0.007243206163811494,0.002535626051133555,0.0849609375,9.474389094274162e-08,0.08438977939165726,0.029384756657483937
93,1.1,7,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: In Hirschsprung's disease cases, can the radiographic transition zone be used to determine the level of aganglionosis on pathology specimens? Answer: Yes, it generally corresponds with the level of aganglionosis seen on the specimen.",7.10579182070559e-08,0.13032925777351023,0.13070329588651272,0.005440279394345632,0.021511666431370813,0.07492195629552548,0.005432404622858621,0.014108626521551315,0.053743455710197695,7.105791820705622e-08,0.05159995656866556,0.029384756657483937
93,1.1,8,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: Is there a relationship between the radiographic transition zone and the level of aganglionosis in Hirschsprung's disease tissue specimens? Answer: Yes, the radiographic transition zone typically matches the extent of aganglionosis in the specimen.",7.10579182070559e-08,0.04878253064881033,0.07542496784682956,0.005440279394345632,0.020497253602564935,0.045275754422476513,0.005432404622858621,0.014108626521551315,0.053743455710197695,7.105791820705622e-08,0.05159995656866556,0.029384756657483937
93,1.1,9,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: Does the level of aganglionosis found on Hirschsprung's disease specimens correlate with the radiographic transition zone? Answer: Yes, the radiographic transition zone commonly reflects the level of aganglionosis seen on tissue specimens.",1.184298636784265e-07,0.024583767280860425,0.06722061252484524,0.009067132323909391,0.09114836930014425,0.03961248911635408,0.009054007704764368,0.0815352609114548,0.051667239521403084,1.1842986367842703e-07,0.11829133106733902,0.029384756657483937
93,1.1,10,ai,"Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Yes, the radiographic transition zone in Hirschsprung's disease typically correlates with the level of aganglionosis observed on the specimen.","Question: In Hirschsprung's disease, is the position of the radiographic transition zone consistent with the area of aganglionosis on the specimen? Answer: Yes, the transition zone detected radiographically usually correlates with the aganglionic level in the specimen.",2.36859727356853e-08,0.2327914089049572,0.16274892309865116,0.0018134264647818726,0.16437000652217648,0.13527575442247655,0.0018108015409528735,0.08983769407988174,0.0849609375,2.3685972735685406e-08,0.010920400412667952,0.029384756657483937
94,1.1,1,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer serve as a novel diagnostic indicator for acute appendicitis? Answer: Elevated D-dimer levels should not be used as a diagnostic marker for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,1.1,2,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a viable new diagnostic tool for acute appendicitis? Answer: Increased D-dimer levels are not reliable as a diagnostic parameter for acute appendicitis.,7.10579182070559e-08,0.12420106510601148,0.004605653180613213,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,1.1,3,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer become a diagnostic criterion for acute appendicitis? Answer: High D-dimer levels should not be considered diagnostic for acute appendicitis.,1.421158364141118e-07,0.26598420988005955,0.010517751479289968,0.010880558788691277,0.26236426446749217,0.0,0.010864809245717241,0.27443684570175986,0.0,1.4211583641411228e-07,0.28768207245178035,0.0
94,1.1,4,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer be utilized as a new diagnostic parameter in acute appendicitis? Answer: Raised D-dimer values should not be treated as diagnostic for acute appendicitis.,4.73719454713706e-08,0.025616805539096177,0.03698224852071005,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,1.1,5,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is it possible for D-dimer to be a new diagnostic marker for acute appendicitis? Answer: Elevated levels of D-dimer are not indicative for diagnosing acute appendicitis.,2.36859727356853e-08,0.013603907614186284,0.03698224852071005,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
94,1.1,6,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Might D-dimer become a new diagnostic parameter for detecting acute appendicitis? Answer: Increased D-dimer levels do not qualify as a diagnostic parameter for acute appendicitis.,4.73719454713706e-08,0.13652035442868815,0.04241283654545255,0.003626852929563759,0.13780497272019776,0.04158790170132326,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
94,1.1,7,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer act as a new diagnostic factor for acute appendicitis? Answer: Higher D-dimer levels should not be regarded as diagnostic for acute appendicitis.,7.10579182070559e-08,0.12420106510601148,0.004605653180613213,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,1.1,8,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Could D-dimer be adopted as a novel diagnostic parameter for acute appendicitis? Answer: Elevated D-dimer concentrations should not be used to diagnose acute appendicitis.,7.10579182070559e-08,0.06643880005935099,0.03698224852071005,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
94,1.1,9,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Is D-dimer a potential new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer should not be considered a diagnostic tool for acute appendicitis.,9.47438909427412e-08,0.1692720823529248,0.006406181231356084,0.007253705859127518,0.16705408466316696,0.0,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
94,1.1,10,human,Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Increased D-dimer levels should not be considered as a diagnostic parameter in diagnosis of acute appendicitis.,Question: Can D-dimer levels be used as a help in diagnosing acute appendicitis? Answer: Raised D-dimer levels should not serve as a diagnostic parameter for acute appendicitis.,2.36859727356853e-08,0.09303412016426726,0.039406640368178834,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
95,1.1,1,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Is endometrial polyp formation linked to elevated levels of vascular endothelial growth factor and transforming growth factor-beta1? Answer: The analysis showed higher TGF-β1 and VEGF expression in polyps versus normal endometrial tissue nearby. This indicates these cytokines could contribute to the development of endometrial polyps. Additionally, a strong correlation was found between steroid receptor presence and expression of VEGF and TGF-β1.",4.737194547137081e-08,0.07776249977541827,0.07877526753864447,0.0036268529295637453,0.01043023635331597,0.016124697661918846,0.003621603081905733,0.03333642026759165,0.0,4.737194547137081e-08,0.03390155167568043,0.0
95,1.1,2,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Does the formation of endometrial polyps associate with increased expression of VEGF and TGF-β1? Answer: There was an observed increase in TGF-β1 and VEGF levels in polyps compared to the adjacent normal endometrial tissues, suggesting a role for these cytokines in polyp development. Moreover, steroid receptor expression significantly correlated with the levels of VEGF and TGF-β1.",1.6580180914979784e-07,0.05727018655988214,0.0431099726140903,0.012693985253473108,0.12264696536330622,0.0020508853284789547,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
95,1.1,3,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Are higher expressions of vascular endothelial growth factor and transforming growth factor-beta1 involved in endometrial polyp formation? Answer: Increased expression of TGF-β1 and VEGF were noted in polyps relative to normal surrounding endometrial tissues, implying that these cytokines may play a role in forming endometrial polyps. A significant association was also found between steroid receptors and VEGF, TGF-β1 expressions.",9.474389094274162e-08,0.04442607950782662,0.07877526753864447,0.0072537058591274906,0.0443317880289964,0.016124697661918846,0.007243206163811466,0.0678225963387602,0.0,9.474389094274162e-08,0.06899287148694988,0.0
95,1.1,4,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Is there a relationship between endometrial polyp formation and enhanced expression of TGF-β1 and VEGF? Answer: The study found elevated levels of TGF-β1 and VEGF in polyps compared to normal endometrial tissue adjacent to the polyps, indicating that these cytokines may contribute to polyp formation. Additionally, steroid receptor expression significantly correlated with VEGF and TGF-β1 expression.",1.6580180914979784e-07,0.05727018655988214,0.0431099726140903,0.012693985253473108,0.12264696536330622,0.0020508853284789547,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
95,1.1,5,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Does increased expression of vascular endothelial growth factor and transforming growth factor-beta1 correlate with endometrial polyp formation? Answer: Polyps showed higher expressions of TGF-β1 and VEGF than adjacent normal endometrium, suggesting these cytokines might influence endometrial polyp formation. Furthermore, significant correlations were found between steroid receptor expression and VEGF and TGF-β1 levels.",2.6054570009253947e-07,0.135186659705691,0.04037526753864446,0.0199476911126006,0.17294916585109021,0.016124697661918846,0.019918816950481533,0.19885085874516495,0.0,2.6054570009253947e-07,0.20252426411147262,0.0
95,1.1,6,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Is the formation of endometrial polyps associated with increased levels of VEGF and TGF-β1? Answer: Findings revealed higher expression of TGF-β1 and VEGF in polyps compared to neighboring normal endometrial tissue, suggesting a possible role of these cytokines in polyp development. In addition, steroid receptor presence showed significant correlation with VEGF and TGF-β1 expression.",2.1317375462116866e-07,0.06979943563213364,0.06026334158634829,0.016320838183036854,0.13448288502329442,0.016124697661918846,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
95,1.1,7,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Are endometrial polyps linked with enhanced expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was greater TGF-β1 and VEGF expression in polyps compared to adjacent normal endometrium, implying these cytokines may be involved in polyp formation. Also, steroid receptor expression was significantly correlated with the expression of VEGF and TGF-β1.",2.1317375462116866e-07,0.06979943563213364,0.06026334158634829,0.016320838183036854,0.13448288502329442,0.016124697661918846,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
95,1.1,8,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Is overexpression of TGF-β1 and VEGF associated with endometrial polyp development? Answer: Elevated TGF-β1 and VEGF were detected in polyp tissues relative to nearby normal endometrium, indicating these cytokines might contribute to polyp formation. Moreover, steroid receptor levels significantly correlated with VEGF and TGF-β1 expression.",4.263475092423373e-07,0.28806195734401197,0.03442697116222479,0.03264167636607371,0.3520918546826062,0.0065902834089302635,0.0325944277371516,0.3496737484797481,0.0,4.263475092423373e-07,0.35667494393873156,0.0
95,1.1,9,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Does endometrial polyp formation show increased expression of TGF-β1 and vascular endothelial growth factor? Answer: Elevated TGF-β1 and VEGF were seen in polyps compared to the adjacent normal endometrial tissue, suggesting involvement of these cytokines in polyp formation. A significant correlation was also observed between steroid receptor expression and levels of VEGF and TGF-β1.",2.1317375462116866e-07,0.06979943563213364,0.06026334158634829,0.016320838183036854,0.13448288502329442,0.016124697661918846,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
95,1.1,10,human,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: There was increased expression of TGF-β1 and VEGF in polyps compared to adjacent normal endometrial tissue. It suggested that these cytokines might play a role in endometrial polyp formation. In addition, there was a significant correlation between steroid receptor expression and VEGF and TGF-β1 expression.","Question: Is there enhanced expression of transforming growth factor-beta1 and vascular endothelial growth factor related to endometrial polyp formation? Answer: Increased TGF-β1 and VEGF expression was found in polyps compared to adjacent normal endometrium, implying these cytokines may contribute to the formation of endometrial polyps. Additionally, steroid receptor expression was significantly linked with VEGF and TGF-β1 levels.",1.6580180914979784e-07,0.032514930111312346,0.06092402786922298,0.012693985253473108,0.09744161334294432,0.016124697661918846,0.012675610786670066,0.12188981760903506,0.0,1.6580180914979784e-07,0.12405264866997845,0.0
96,1.1,1,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is sternal fracture in growing children a rare and frequently missed fracture? Answer: Sternal fractures in growing children are uncommon and often go unnoticed. Diagnosing them can be difficult because of the cartilage-rich sternum in children. However, recognizing them early and managing them correctly is important.",9.474389094274162e-08,0.005025840701839535,0.05537700234669933,0.0072537058591274906,0.031089184732003172,0.038753339374150486,0.007243206163811466,0.02924911194296742,0.04158790170132326,9.474389094274162e-08,0.05945186131181712,0.0212665406427221
96,1.1,2,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper",Question: Are sternal fractures in growing children uncommon and frequently overlooked injuries? Answer: These fractures are rare in growing children and commonly missed during diagnosis due to the cartilaginous sternum. Early detection and appropriate treatment are critical.,3.3160361829959526e-07,0.26689098425559576,0.04340211029945748,0.025387970506946217,0.2912054819724008,0.032417370373035215,0.02535122157334014,0.2870782212450673,0.04158790170132326,3.316036182995957e-07,0.3241444155388993,0.0212665406427221
96,1.1,3,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper",Question: Is a sternal fracture an unusual and often ignored injury in children still growing? Answer: Sternal fractures are rare in growing children and tend to be overlooked because the sternum is mostly cartilage. Prompt identification and treatment are vital.,2.6054570009253936e-07,0.10983192318651191,0.09876543209876545,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.20252083321700365,0.04158790170132326,2.6054570009253947e-07,0.23713303854926915,0.0212665406427221
96,1.1,4,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Are sternal fractures in growing kids rare and usually overlooked? Answer: Such fractures are infrequent and often undetected in children because their sternum is cartilaginous, making diagnosis challenging. Early diagnosis and proper care are key.",3.5528959103528056e-07,0.21804550782674292,0.09876543209876545,0.027201396971728097,0.2805846085279411,0.060964083175803374,0.027162023114293013,0.3169311843947491,0.04158790170132326,3.552895910352811e-07,0.35491607420565296,0.0212665406427221
96,1.1,5,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Does a sternal fracture occur rarely and get frequently missed in growing children? Answer: Due to the cartilage composition of the child's sternum, sternal fractures are rare and often overlooked. Early recognition and proper management are essential.",3.0791764556390996e-07,0.16247565667193076,0.09876543209876545,0.023574544042164344,0.22342619468799274,0.060964083175803374,0.023540420032387266,0.2580906843718158,0.04158790170132326,3.079176455639103e-07,0.2942914523892175,0.0212665406427221
96,1.1,6,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Is a sternal fracture a seldom seen and neglected injury in growing children? Answer: In children, the cartilaginous sternum makes sternal fractures rare and hard to diagnose, often leading to missed cases. Nonetheless, early detection and treatment are important.",2.6054570009253936e-07,0.10983192318651191,0.09876543209876545,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.20252083321700365,0.04158790170132326,2.6054570009253947e-07,0.23713303854926915,0.0212665406427221
96,1.1,7,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Are sternal fractures rare and commonly missed in growing children? Answer: Because the sternum is largely cartilage in children, sternal fractures are uncommon and often not diagnosed promptly. Early identification and correct management are necessary.",3.5528959103528056e-07,0.25765391814445415,0.0702187192959973,0.027201396971728097,0.2805846085279411,0.060964083175803374,0.027162023114293013,0.3169311843947491,0.04158790170132326,3.552895910352811e-07,0.35491607420565296,0.0212665406427221
96,1.1,8,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper",Question: Is it true that sternal fractures in children who are still growing are rare and often overlooked? Answer: The cartilaginous nature of the sternum in kids makes these fractures rare and frequently missed. Identifying them early and managing properly is crucial.,2.1317375462116866e-07,0.09363356020013835,0.07439043209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.1498770997315848,0.04158790170132326,2.1317375462116866e-07,0.18306581727899296,0.0212665406427221
96,1.1,9,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Are sternal fractures in growing children an uncommon and overlooked type of fracture? Answer: These fractures are rare, largely because children's sternums are cartilaginous, which complicates diagnosis and often leads to them being overlooked. Timely identification and treatment are important.",2.3685972735685406e-07,0.08451411520222019,0.09876543209876545,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.17585258613484278,0.04158790170132326,2.3685972735685406e-07,0.20973406436115383,0.0212665406427221
96,1.1,10,ai,"Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: A sternal fracture in growing children is a rare type of fracture that is often overlooked. It can be challenging to diagnose due to the cartilaginous nature of the sternum in children. However, early identification and proper","Question: Do sternal fractures in children who are still developing happen rarely and often go unnoticed? Answer: Their rarity and the cartilage-based sternum in children cause sternal fractures to be easily missed, but early detection and appropriate care are essential.",2.6054570009253936e-07,0.1809239417054802,0.047633218804390004,0.0199476911126006,0.16935897341771655,0.060964083175803374,0.019918816950481533,0.20252083321700365,0.04158790170132326,2.6054570009253947e-07,0.23713303854926915,0.0212665406427221
97,1.1,1,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need fewer calories to keep their weight stable? Answer: The findings do not back the idea that African American women face a higher obesity risk due to needing fewer calories to maintain their weight.,7.10579182070559e-08,0.09474601728467036,0.008576706069585785,0.005440279394345625,0.13194264838430625,0.033531397991038235,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,1.1,2,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the calorie requirement to maintain weight lower for African American women? Answer: The evidence does not confirm that African American women are more prone to obesity because they require fewer calories for weight maintenance.,0.0,0.11882523095313324,0.08383622164052006,0.0,0.1223200906870483,0.08740894901144641,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,1.1,3,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are fewer calories required by African American women to sustain their weight? Answer: The data presented does not support the notion that African American women have an increased obesity risk linked to a lower caloric need for weight maintenance.,9.47438909427412e-08,0.1955552073921072,0.061250721148912765,0.0072537058591274975,0.1970642952414865,0.061112382174339036,0.00724320616381148,0.19842819124561784,0.06035379812695108,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,1.1,4,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women have a reduced calorie requirement for weight maintenance? Answer: These findings do not uphold the claim that African American women are at higher obesity risk because they need fewer calories to maintain weight.,4.73719454713706e-08,0.13906866209485091,0.05850538342288004,0.003626852929563752,0.1409703278292218,0.05965384697063009,0.003621603081905747,0.14285834009080567,0.06035379812695108,4.737194547137081e-08,0.10394632060143305,0.031217481789802305
97,1.1,5,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is it true that African American women require fewer calories to keep their weight? Answer: Results indicate there is no support for the view that African American women are more susceptible to obesity due to a lower caloric need.,9.47438909427412e-08,0.16000919813262326,0.03599404555439932,0.0072537058591274975,0.1605828646856997,0.03493981320897727,0.00724320616381148,0.16096077608021542,0.03334762528744492,9.474389094274162e-08,0.1611047344413814,0.031217481789802305
97,1.1,6,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women need to consume fewer calories to maintain their current weight? Answer: This research does not support the belief that African American women are more likely to be obese because of a reduced caloric need.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.17102921705750251,0.06035379812695108,7.105791820705622e-08,0.13293385747468456,0.031217481789802305
97,1.1,7,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Are calorie requirements for maintaining weight lower in African American women? Answer: The outcomes do not endorse the idea that African American women’s obesity risk is due to requiring fewer calories.,9.47438909427412e-08,0.007646388672773341,0.08016071222106602,0.007253705859127518,0.00284305226695869,0.08740894901144641,0.007243206163811494,0.04519389141213459,0.06035379812695108,9.474389094274162e-08,0.09020969383952471,0.031217481789802305
97,1.1,8,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require less energy intake to maintain body weight? Answer: The results do not validate the perspective that African American women face greater obesity risk from needing fewer calories for maintenance.,2.36859727356853e-08,0.04789937727289306,0.053789184443288215,0.0018134264647818796,0.050458207503430774,0.05713551151144641,0.0018108015409528735,0.0532461814011187,0.06035379812695108,2.3685972735685406e-08,0.01157300047041776,0.031217481789802305
97,1.1,9,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Is the need for calories to maintain weight lesser for African American women? Answer: The findings disprove the premise that African American women are at elevated risk of obesity on account of needing fewer calories.,0.0,0.11882523095313324,0.08383622164052006,0.0,0.1223200906870483,0.08740894901144641,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305
97,1.1,10,human,Question: Do African American women require fewer calories to maintain weight? Answer: These results do not support the view that AA women are at greater risk for obesity because they require fewer calories to maintain weight.,Question: Do African American women require fewer calories in order to keep their weight steady? Answer: There is no evidence from these results supporting that African American women have increased obesity risk because of lower calorie needs.,2.36859727356853e-08,0.10958816484199163,0.05701961264398024,0.0018134264647818796,0.11169921724258858,0.058862236208678254,0.0018108015409528735,0.11387080321755416,0.06035379812695108,2.3685972735685406e-08,0.07409335745175127,0.031217481789802305
98,1.1,1,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,"Is there satisfaction among UK radiologists with the training and support provided for suspected child abuse cases? Currently, there is scarce research focused precisely on UK radiologists' contentment with their training and support in suspected child abuse. More research is essential to collect thorough information and feedback from these professionals about their experiences and satisfaction in this domain.",2.3685972735685406e-08,0.0685129982306747,0.035958392071425545,0.0018134264647818726,0.04367395309483202,0.018460615083159496,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
98,1.1,2,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Are UK radiologists content with the training and support they receive for suspected child abuse cases? Available research on UK radiologists' satisfaction regarding their training and support in suspected child abuse is limited. Additional studies are necessary to obtain detailed data and radiologists' feedback about their experiences and level of satisfaction.,1.4211583641411244e-07,0.10045595195374757,0.009032442807732091,0.010880558788691236,0.12168562639213665,0.004430562630850447,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
98,1.1,3,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Do UK radiologists feel satisfied with the training and support related to suspected child abuse? There is a lack of extensive research concerning UK radiologists' satisfaction with the training and support they get in suspected child abuse. Further investigations are required to gather comprehensive feedback and data about their experiences and satisfaction.,1.1842986367842703e-07,0.10566098764247611,0.008453379498506108,0.009067132323909363,0.1280771374307954,0.023443690743118445,0.009054007704764333,0.15374719176466423,0.040742417383431435,1.1842986367842703e-07,0.12797203516756062,0.020823902218198284
98,1.1,4,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Are radiologists in the UK satisfied with the training and support they receive for managing suspected child abuse? Limited studies specifically address UK radiologists' satisfaction in this area. More detailed research is needed to understand their experiences and satisfaction levels thoroughly.,3.789755637709665e-07,0.21269595437836575,0.08842752787389466,0.029014823436509962,0.2933608350621033,0.03631185475258099,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
98,1.1,5,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,"What is the level of satisfaction among UK radiologists with the training and support for suspected child abuse? Research focusing on this exact satisfaction is minimal. To fully understand UK radiologists' experiences and satisfaction, further studies must be conducted.",4.263475092423371e-07,0.26398924876591545,0.08842752787389466,0.03264167636607371,0.34600456854752215,0.03631185475258099,0.0325944277371516,0.40546510810816505,0.0,4.263475092423373e-07,0.41494385206270756,0.0
98,1.1,6,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,How satisfied are UK radiologists with the training and support they receive regarding suspected child abuse cases? Research specifically examining their satisfaction is limited at present. Additional studies are required to compile comprehensive data and gather feedback from radiologists about their satisfaction and experiences.,3.079176455639103e-07,0.17261469654571382,0.06518489748840714,0.023574544042164344,0.21925286290837986,0.03631185475258099,0.023540420032387266,0.27541197985996746,0.0,3.079176455639103e-07,0.2814124594381848,0.0
98,1.1,7,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Do UK radiologists feel adequately supported and trained in cases of suspected child abuse? There is restricted research assessing their satisfaction with training and support. More extensive research is necessary to obtain comprehensive insights and feedback from radiologists about their satisfaction.,3.789755637709665e-07,0.21269595437836575,0.08842752787389466,0.029014823436509962,0.2933608350621033,0.03631185475258099,0.028972824655245866,0.35139788683788886,0.0,3.789755637709665e-07,0.3593740009078954,0.0
98,1.1,8,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Are UK radiologists happy with the training/support they acquire for suspected child abuse? Current research in this specific area is limited. Thorough studies are needed to collect complete data and feedback on radiologists' satisfaction and experiences.,4.97405427449393e-07,0.3462273470028885,0.08842752787389466,0.03808195576041933,0.4305619565755858,0.03631185475258099,0.03802683236001021,0.4924764850977952,0.0,4.974054274493935e-07,0.5045560107523945,0.0
98,1.1,9,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,Is the satisfaction level of UK radiologists regarding training and support in suspected child abuse well documented? Very limited data exists on this topic. More research is needed to accumulate detailed feedback and experiences from UK radiologists.,4.737194547137077e-07,0.31805647003619164,0.08842752787389466,0.03626852929563745,0.4015744197023343,0.03631185475258099,0.03621603081905734,0.4626235219481134,0.0,4.737194547137081e-07,0.47378435208564085,0.0
98,1.1,10,ai,Question: Are UK radiologists satisfied with the training and support received in suspected child abuse? Answer: There is limited research available specifically on the satisfaction of UK radiologists with training and support in suspected child abuse. Further studies are needed to gather comprehensive data and feedback from radiologists regarding their experiences and satisfaction levels in this area.,"Have UK radiologists expressed satisfaction with the specialized training and support for suspected child abuse? Research directly investigating this satisfaction is limited, indicating a need for additional studies to gather comprehensive data and radiologists’ feedback.",5.210914001850783e-07,0.37521488387614,0.08842752787389466,0.03989538222520121,0.4604149197252676,0.03631185475258099,0.039837633900963086,0.5232481437645489,0.0,5.210914001850789e-07,0.5363047090669744,0.0
99,1.1,1,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: Enhancing hospital efficiency by reducing the length of stay seems not to increase readmission rates or the number of physician visits within 30 days post-discharge. Further research is necessary to determine ideal lengths of stay and expected readmission rates.,9.474389094274162e-08,0.07459489795819252,0.0013226814394396817,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
99,1.1,2,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is early discharge from Winnipeg hospitals detrimental to care quality? Answer: Shortening hospital stays to improve efficiency does not appear to raise readmission rates or physician visits within 30 days after discharge. Additional research is required to find optimal stay durations and anticipated readmission rates.,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
99,1.1,3,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does releasing patients sooner from Winnipeg hospitals harm the quality of care? Answer: Reducing length of hospital stays to boost efficiency does not seem to increase the frequency of readmissions or physician consultations within 30 days after discharge. Research is needed to establish the best lengths of stay and expected rates of readmission.,9.474389094274162e-08,0.04843840057857163,0.01753826530612245,0.0072537058591274906,0.07410797215372167,0.0,0.007243206163811466,0.07550755250814589,0.0,9.474389094274162e-08,0.07696104113612989,0.0
99,1.1,4,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does early discharge at Winnipeg hospitals adversely affect patient care quality? Answer: Efforts to improve hospital efficiency by minimizing length of stay do not appear to cause higher rates of readmission or more physician visits within 30 days post-discharge. More research is needed to identify optimal hospital stays and expected readmission numbers.,1.1842986367842703e-07,0.06748659554926473,0.01753826530612245,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
99,1.1,5,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is the quality of care compromised by earlier discharges from Winnipeg hospitals? Answer: Improving efficiency through shorter hospital stays does not seem to lead to an increase in readmissions or physician visits within 30 days after discharge. Further studies are necessary to ascertain ideal lengths of stay and readmission expectations.,1.6580180914979784e-07,0.10670730870254719,0.01753826530612245,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
99,1.1,6,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does faster patient discharge from Winnipeg hospitals impact care quality negatively? Answer: Enhancing hospital efficiency by cutting down length of stay does not appear to raise readmission rates or physician visit counts within 30 days post-hospitalization. Additional research is required to establish optimal stay lengths and expected readmissions.,2.1317375462116866e-07,0.14752930322280156,0.01753826530612245,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
99,1.1,7,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does expediting discharges in Winnipeg hospitals reduce quality of care? Answer: Making hospital stays shorter to improve efficiency does not appear to lead to increased rates of readmission or physician visits within 30 days after discharge. Further investigation is needed to define the best stay durations and anticipated readmission levels.,1.6580180914979784e-07,0.10670730870254719,0.01753826530612245,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
99,1.1,8,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does discharging patients sooner from Winnipeg hospitals worsen quality of care? Answer: Reducing hospital length of stay to improve efficiency does not seem to boost readmission rates or number of physician visits within 30 days after discharge. More research is needed to determine optimal stay lengths and readmission expectations.,1.8948778188548325e-07,0.1269100160200658,0.01753826530612245,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
99,1.1,9,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Is quality of care at Winnipeg hospitals affected by earlier patient discharge? Answer: Efforts to increase hospital efficiency by shortening length of stay appear not to cause higher readmission rates or increased physician visits within 30 days post-discharge. Additional research is necessary to identify optimal lengths of stay and anticipated readmission rates.,1.1842986367842703e-07,0.09414610249387811,0.001685110318637259,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
99,1.1,10,human,Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: Improving hospital efficiency by shortening length of stay does not appear to result in increased rates of readmission or numbers of physician visits within 30 days after discharge from hospital. Research is needed to identify optimal lengths of stay and expected readmission rates.,Question: Does shortening hospital stays in Winnipeg negatively influence care quality? Answer: Improving efficiency by decreasing length of stay doesn’t seem to cause increased readmission or doctor visits within 30 days after discharge. Research is still needed to find the best lengths of stay and expected readmission rates.,2.3685972735685406e-07,0.1980783371253132,0.003728275336599654,0.018134264647818726,0.19671029424605502,0.0,0.018108015409528666,0.20067069546215155,0.0,2.3685972735685406e-07,0.2047944126460135,0.0
100,1.1,1,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is there a first night effect on sleep bruxism? Evidence indicates that individuals might show increased tooth grinding and clenching during the first night in a new setting or when monitored for sleep bruxism. Nonetheless, further studies are required to better comprehend this effect.",4.026615365066519e-07,0.2180336117674475,0.11255983875031497,0.030828249901291835,0.2458817672413427,0.06743801652892563,0.030783626196198732,0.27516606309453007,0.05157024793388431,4.026615365066519e-07,0.305529906312898,0.035041322314049606
100,1.1,2,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Does sleep bruxism exhibit a first night effect? Research suggests that on the first night in a new environment or with a sleep monitoring device, people may experience heightened grinding and clenching of teeth. Still, additional research is needed to clarify this phenomenon.",4.263475092423373e-07,0.2423317140287593,0.11200710923098393,0.03264167636607371,0.2699793188204027,0.06743801652892563,0.0325944277371516,0.29985867568490177,0.05157024793388431,4.263475092423373e-07,0.33084771429718973,0.035041322314049606
100,1.1,3,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.",Is there a first night phenomenon impacting sleep bruxism? Findings imply that increased tooth grinding and clenching can occur on the first night in unfamiliar surroundings or with the use of sleep monitoring equipment. More investigation is necessary to fully understand this.,4.500334819780227e-07,0.2672343145980176,0.11142746913580248,0.03445510283085558,0.2946719314107744,0.06743801652892563,0.034405229278104466,0.3251764836691935,0.05157024793388431,4.500334819780227e-07,0.3568232007004477,0.035041322314049606
100,1.1,4,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.",Is sleep bruxism influenced by a first night effect? Some evidence points to increased grinding and clenching during the first night in a novel environment or when using sleep trackers. Further research is essential to fully elucidate this phenomenon.,5.210914001850787e-07,0.3458895945434355,0.10950590229869511,0.0398953822252012,0.372633472880485,0.06743801652892563,0.039837633900963065,0.40521919134272766,0.05157024793388431,5.210914001850789e-07,0.43906129893742074,0.035041322314049606
100,1.1,5,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Does the first night effect affect sleep bruxism? Data suggests that people may experience more intense teeth grinding and clenching on their first night in a new setting or while using a sleep monitoring device, although more research is needed to understand this better.",4.026615365066519e-07,0.2180336117674475,0.11255983875031497,0.030828249901291835,0.2458817672413427,0.06743801652892563,0.030783626196198732,0.27516606309453007,0.05157024793388431,4.026615365066519e-07,0.305529906312898,0.035041322314049606
100,1.1,6,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.",Is there a first night effect related to sleep bruxism? There is some indication that increased tooth grinding and clenching occurs during the first night in a new environment or when a monitoring device is used. Additional studies are needed to fully grasp this effect.,3.789755637709665e-07,0.19431137982122637,0.11308748806495338,0.029014823436509962,0.22235126983114828,0.06743801652892563,0.028972824655245866,0.25106851151547005,0.05157024793388431,3.789755637709665e-07,0.2808372937225263,0.035041322314049606
100,1.1,7,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Can sleep bruxism be impacted by a first night effect? Evidence supports the possibility that individuals might grind and clench their teeth more intensely on the first night in unfamiliar surroundings or during monitored sleep, yet more research is needed.",4.974054274493934e-07,0.3189786868438751,0.11017920043774154,0.038081955760419325,0.3459652257983241,0.06743801652892563,0.0380268323600102,0.37782021715461234,0.05157024793388431,4.974054274493935e-07,0.4108904219707239,0.035041322314049606
100,1.1,8,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is a first night effect present in sleep bruxism? Research suggests heightened tooth grinding and clenching during the initial night in a new environment or with sleep monitoring devices, but further research is still required to understand it completely.",5.210914001850787e-07,0.30940816398764914,0.1358024691358025,0.0398953822252012,0.372633472880485,0.06743801652892563,0.039837633900963065,0.40521919134272766,0.05157024793388431,5.210914001850789e-07,0.43906129893742074,0.035041322314049606
100,1.1,9,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Is there a first night effect on the behavior of sleep bruxism? Some evidence shows people may grind or clench their teeth more on the first night in novel surroundings or when being monitored for sleep bruxism, though more studies are needed for full understanding.",3.789755637709665e-07,0.22581806984667852,0.0904509952129,0.029014823436509962,0.22235126983114828,0.06743801652892563,0.028972824655245866,0.25106851151547005,0.05157024793388431,3.789755637709665e-07,0.2808372937225263,0.035041322314049606
100,1.1,10,ai,"Question: Is there a first night effect on sleep bruxism? Answer: There is evidence to suggest that there may be a first night effect on sleep bruxism, where individuals may experience increased tooth grinding and clenching during the first night in a new environment or when using a sleep monitoring device. However, more research is needed to fully understand this phenomenon.","Does sleep bruxism show a first night effect? Studies suggest that tooth grinding and clenching increase on the first night in new environments or with sleep monitoring devices, but additional research is necessary to comprehend this fully.",5.684633456564493e-07,0.4019835619557002,0.10804736709498616,0.04352223515476494,0.42820332403529715,0.06743801652892563,0.043459236982868805,0.462377605182676,0.05157024793388431,5.684633456564497e-07,0.497901798960354,0.035041322314049606
101,1.1,1,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Grandmultiparous women exhibited higher rates of maternal and neonatal complications, including increased neonatal mortality, even after adjusting for confounding variables, indicating they require more attentive monitoring than typical multiparous patients during labor and delivery.",4.737194547137081e-08,0.0814401065775443,0.024375,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
101,1.1,2,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity independently raise the risk of negative perinatal outcomes? Women who are grandmultiparous face elevated maternal and neonatal morbidity and mortality risks, despite control for confounders, highlighting the necessity for more careful surveillance than that given to regular multiparous women during labor and delivery.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,1.1,3,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity a standalone risk factor for poor perinatal outcomes? Evidence shows grandmultiparous women have greater maternal and neonatal morbidity as well as increased neonatal mortality after accounting for confounders, implying the need for heightened vigilance during labor and delivery compared to other multiparous patients.",7.105791820705622e-08,0.10442962480224383,0.024375,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,1.1,4,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does being grandmultiparous independently increase the risk of adverse perinatal outcomes? Research indicates these women experience increased maternal and neonatal health issues and higher neonatal death rates, even controlling for other variables, suggesting a need for stricter observation than with normal multiparous patients in labor and delivery.",1.1842986367842703e-07,0.14888138737307655,0.024375,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
101,1.1,5,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent predictor of negative perinatal outcomes? Findings reveal that grandmultiparous women display increased maternal and neonatal morbidity and neonatal mortality rates after adjustment for confounders, recommending closer monitoring than standard multiparous cases during labor and childbirth.",7.1057918207056e-08,0.07865527994541788,0.0019215668371073726,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
101,1.1,6,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Could grandmultiparity be considered an independent risk factor for adverse perinatal events? Studies show grandmultiparous women have elevated maternal and neonatal morbidity and neonatal mortality despite controlling for confounders, indicating the importance of more intensive observation compared to regular multiparous patients during labor and delivery.",7.105791820705622e-08,0.07292293477679124,0.0016600189291508909,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
101,1.1,7,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is there an independent risk linked to grandmultiparity for unfavorable perinatal outcomes? Grandmultiparous women are at higher risk of maternal and neonatal complications including neonatal deaths even when adjusting for confounders, thus warranting more careful monitoring during labor and delivery than other multiparous women.",4.737194547137081e-08,0.0814401065775443,0.024375,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
101,1.1,8,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Does grandmultiparity on its own increase adverse perinatal outcomes? Data demonstrates that grandmultiparous women suffer increased maternal and neonatal morbidity and neonatal mortality after controlling confounders, suggesting these women need closer monitoring in labor and delivery than typical multiparous counterparts.",4.7371945471370706e-08,0.051744372245857484,0.0012482686980609496,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
101,1.1,9,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity independently associated with poor perinatal outcomes? Grandmultiparous women had higher maternal and neonatal morbidity as well as neonatal mortality rates, controlling for confounders, which implies the need for heightened observation compared with usual multiparous cases during labor and delivery.",2.3685972735685406e-08,0.009119444997918169,0.024375,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
101,1.1,10,human,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Grandmultiparous women had increased maternal and neonatal morbidity, and neonatal mortality even after controlling for confounders, suggesting a need for closer observation than regular multiparous patients during labor and delivery.","Is grandmultiparity an independent factor contributing to adverse perinatal results? Evidence shows an increase in maternal and neonatal morbidity and neonatal deaths among grandmultiparous women even after adjusting for confounding factors, suggesting they should be observed more closely than regular multiparous women when in labor and delivery.",1.1842986367842703e-07,0.1187445534356879,0.002646604938271603,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
102,1.1,1,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Question: Are doctors adequately supporting family caregivers of the frail elderly? Answer: Possible reasons for this dissatisfaction are discussed. Physicians might lack interest in assisting caregivers; even if willing to counsel them, they might receive insufficient compensation for the typical sessions required by caregivers; and they function as professional caregivers to family caregivers.",1.4211583641411244e-07,0.08529766504913106,0.017236072637734686,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
102,1.1,2,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Question: Do physicians fulfill the needs of family caregivers looking after frail elderly patients? Answer: Several hypotheses explain this dissatisfaction. Doctors may not be keen on helping caregivers; even if open to counseling caregivers, the payment for such sessions may be inadequate; and they act as professional supporters for family caregivers.",1.8948778188548325e-07,0.12451837820241352,0.017236072637734686,0.014507411718254981,0.15123096972392336,0.0,0.014486412327622933,0.1541506798272585,0.0,1.8948778188548325e-07,0.15718558352241319,0.0
102,1.1,3,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Question: Are medical doctors addressing the needs of family members caring for frail elderly individuals? Answer: The causes of this frustration are suggested. Physicians might be unmotivated to support caregivers; even if they offer counseling, the typical reimbursement may be low for sessions involving caregivers; and they serve as formal caregivers to family caregivers.",1.1842986367842703e-07,0.06624947007843796,0.017236072637734686,0.009067132323909363,0.09180754925312229,0.0,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
102,1.1,4,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Question: Are physicians effectively meeting the requirements of family caregivers of frail elderly patients? Answer: Hypotheses regarding this dissatisfaction are provided. Doctors might not be interested in assisting caregivers; even with a willingness to counsel caregivers, their remuneration for usual caregiver counseling sessions could be low; and they also act as professional caregivers to family caregivers.",7.105791820705622e-08,0.02920819839808786,0.017236072637734686,0.005440279394345618,0.05406722127027486,0.0,0.0054324046228586,0.05505977718302857,0.0,7.105791820705622e-08,0.056089466651043196,0.0
102,1.1,5,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers",Question: Are doctors providing adequate support to guardians of frail elderly family members? Answer: Possible reasons for the dissatisfaction include: physicians’ lack of interest in assisting caregivers; poor payment even if they do provide counseling; and their professional role includes caring for family caregivers themselves.,3.316036182995957e-07,0.2523517497122971,0.017236072637734686,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
102,1.1,6,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers",Question: Do physicians meet the needs of family caregivers for frail elderly folks? Answer: Proposed reasons for this unhappiness are that doctors may be uninterested in aiding caregivers; they may be poorly compensated for the counseling typically given to caregivers; and they take on the role of professional caregivers to these family caregivers.,1.4211583641411244e-07,0.11195717199374444,0.001987302987025024,0.010880558788691236,0.11122563511022499,0.0,0.0108648092457172,0.11332868530700413,0.0,1.4211583641411244e-07,0.11551288712184427,0.0
102,1.1,7,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers","Question: Are family caregivers of frail elderly patients adequately supported by physicians? Answer: The lack of satisfaction may stem from several reasons: physicians possibly being disinterested in helping caregivers; even when counseling is provided, it might not be well compensated; and the physicians functioning as professional caregivers to the family caregivers themselves.",1.6580180914979784e-07,0.13189799328113327,0.0023639273622653063,0.012693985253473108,0.13102826240640475,0.0,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
102,1.1,8,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers",Question: Are physicians responsive to the needs of family members caring for frail elderly individuals? Answer: Suggested causes for this discomfort include physician disinterest in assisting caregivers; insufficient payment for common counseling sessions for caregivers; and their professional engagement as caregivers to family caregivers.,3.552895910352811e-07,0.27534126793699665,0.017236072637734686,0.02720139697172809,0.3053816495511823,0.0,0.027162023114293,0.3117796240308417,0.0,3.552895910352811e-07,0.3184537311185349,0.0
102,1.1,9,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers",Question: Are doctors accommodating the needs of family caregivers of frail elderly patients? Answer: The dissatisfaction may be due to physicians' lack of interest in supporting caregivers; poor remuneration for counseling sessions typical for caregivers; and physicians acting as professional caregivers to those family caregivers.,3.316036182995957e-07,0.2523517497122971,0.017236072637734686,0.025387970506946217,0.2818511521409879,0.0,0.025351221573340132,0.2876820724517817,0.0,3.316036182995957e-07,0.2937611185281632,0.0
102,1.1,10,human,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: Hypotheses for this discontent are presented. Physicians may be uninterested in helping caregivers; even if they were receptive to counseling caregivers, they could be poorly remunerated for the types of counseling sessions that are usual for caregivers; and being a professional caregiver to family caregivers",Question: Are the needs of family caregivers of frail elderly persons being addressed by physicians? Answer: Hypotheses explaining the discontent involve physicians possibly being uninterested in helping caregivers; they may receive inadequate compensation for caregiver counseling; and they function in a professional caregiver capacity toward family caregivers.,2.8423167282822487e-07,0.2078999871414644,0.017236072637734686,0.02176111757738247,0.23638877806423064,0.0,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
103,1.1,1,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does airway surgery reduce serum lipid levels in patients with obstructive sleep apnea? Answer: Some limited evidence indicates that airway surgery might lower serum lipid levels in obstructive sleep apnea patients; however, more research is necessary to confirm this relationship.",9.474389094274162e-08,0.016543454740694408,0.050390526581002765,0.0072537058591274906,0.024705934398959073,0.08473338203067934,0.007243206163811466,0.028470153877695914,0.0905770635500365,9.474389094274162e-08,0.0325940762930772,0.09642074506939374
103,1.1,2,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Can airway surgery decrease serum lipid levels in obstructive sleep apnea sufferers? Answer: There is sparse evidence suggesting airway surgery could reduce serum lipid levels in patients with obstructive sleep apnea, though additional studies are required to verify the link.",9.474389094274162e-08,0.016543454740694408,0.050390526581002765,0.0072537058591274906,0.024705934398959073,0.08473338203067934,0.007243206163811466,0.028470153877695914,0.0905770635500365,9.474389094274162e-08,0.0325940762930772,0.09642074506939374
103,1.1,3,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Is there an effect of airway surgery on serum lipid levels in obstructive sleep apnea patients? Answer: Limited data suggest that airway surgery may have a lowering effect on serum lipid levels in obstructive sleep apnea, but further investigation is needed to confirm this effect.",2.3685972735685406e-08,0.05888058654813566,0.02256249786259021,0.0018134264647818726,0.058892490579285806,0.024097022018019942,0.0018108015409528666,0.05960792541276172,0.024828922957821048,2.3685972735685406e-08,0.06032475613794075,0.02541482790963044
103,1.1,4,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does undergoing airway surgery impact serum lipid levels in individuals with obstructive sleep apnea? Answer: While some limited research points to a potential reduction in serum lipid levels following airway surgery in obstructive sleep apnea patients, more evidence is needed to draw definitive conclusions.",0.0,0.1260267601018077,0.0828395061728395,0.0,0.16119701873487102,0.11262296493956728,0.0,0.16503504299046368,0.11687363038714388,0.0,0.13524823035315947,0.09642074506939374
103,1.1,5,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Is serum lipid level reduction seen after airway surgery in obstructive sleep apnea patients? Answer: There is minimal evidence implying that airway surgery might lower serum lipid levels in obstructive sleep apnea patients, yet further research is essential to establish a definite link.",2.3685972735685406e-08,0.06786698324404661,0.05857357819500024,0.0018134264647818726,0.10389190787546676,0.08836559532505478,0.0018108015409528666,0.10712543382311379,0.09249863038714387,2.3685972735685406e-08,0.11055561776278777,0.09642074506939374
103,1.1,6,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Can airway surgery in obstructive sleep apnea patients lead to decreased serum lipid levels? Answer: Current limited evidence hints at the possibility that airway surgery reduces serum lipid levels in these patients, but extensive research is still required.",1.4211583641411222e-07,0.03248718490016822,0.12037037037037035,0.010880558788691236,0.04315421943250852,0.1358655953250548,0.0108648092457172,0.010884363163206068,0.11687363038714388,1.4211583641411244e-07,0.022975774861734966,0.09642074506939374
103,1.1,7,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does surgery on the airway influence serum lipid levels in obstructive sleep apnea cases? Answer: Limited studies suggest airway surgery may lower serum lipid levels in patients with obstructive sleep apnea, but additional investigation is necessary for confirmation.",1.4211583641411222e-07,0.0404756762114058,0.06903327779913708,0.010880558788691236,0.0317806108982972,0.08198804430464662,0.0108648092457172,0.027623813534568775,0.08911852834632755,1.4211583641411244e-07,0.022975774861734966,0.09642074506939374
103,1.1,8,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Is there a connection between airway surgery and serum lipid levels among obstructive sleep apnea patients? Answer: Although evidence is scant, airway surgery might reduce serum lipid levels in this patient group, warranting further research for clarity.",1.6580180914979753e-07,0.033620446566628104,0.09238967918322015,0.012693985253473108,0.022752931453381642,0.10811049328423847,0.012675610786670066,0.017286513803490777,0.11687363038714388,1.6580180914979784e-07,0.05196331173498647,0.09642074506939374
103,1.1,9,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Does airway surgery have an effect on lipid profiles in obstructive sleep apnea patients? Answer: Preliminary findings indicate that airway surgery could decrease serum lipid levels, yet more research is needed to solidify this connection.",2.1317375462116813e-07,0.016396462542942913,0.14429279337007134,0.01632083818303686,0.04140316859555515,0.1358655953250548,0.016297213868575813,0.07612701382642406,0.11687363038714388,2.1317375462116866e-07,0.11258793355142194,0.09642074506939374
103,1.1,10,ai,"Question: Does airway surgery lower serum lipid levels in obstructive sleep apnea patients? Answer: There is limited evidence suggesting that airway surgery may lower serum lipid levels in obstructive sleep apnea patients, but further research is needed to establish a clear connection between the two.","Question: Are serum lipid levels decreased by airway surgery in individuals with obstructive sleep apnea? Answer: Some limited evidence supports the notion that airway surgery may reduce serum lipid levels in obstructive sleep apnea patients, though additional studies are necessary to confirm this.",4.737194547137081e-08,0.07350547017635156,0.07865668068807498,0.0036268529295637453,0.11199631590430092,0.11149059532505479,0.003621603081905733,0.11624487882103196,0.11687363038714388,4.737194547137081e-08,0.08523780977849604,0.09642074506939374
104,1.1,1,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the use of audits to detect maternal mortality merely a matter of disparity between wealthy and impoverished areas? The answer is no; audits play a critical role in recognizing maternal mortality across various settings regardless of economic status. While economic conditions influence healthcare access and outcomes, audit processes are essential for uncovering systemic problems in both affluent and underprivileged regions.",3.079176455639103e-07,0.08462555447858167,0.185246400700138,0.0235745440421644,0.0704285617740883,0.18311533888228299,0.02354042003238728,0.03206640580705589,0.16202240735420861,3.079176455639103e-07,0.007401922626254276,0.13888888888888895
104,1.1,2,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Does auditing maternal mortality differ only between rich and poor contexts? Auditing for maternal mortality cannot be reduced to just economic disparities. Though socioeconomic status impacts healthcare availability and maternal outcomes, audits are indispensable tools for revealing and addressing systemic healthcare flaws in diverse resource settings.",6.632072365991914e-07,0.21075815331275338,0.17969753566895338,0.05077594101389249,0.22291924821336861,0.18311533888228299,0.05070244314668028,0.2671764890458008,0.16202240735420861,6.632072365991914e-07,0.3127835721774366,0.13888888888888895
104,1.1,3,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the identification of maternal mortality through audit solely a difference tied to wealth? Identifying maternal mortality via audits transcends the simplistic rich-poor dichotomy. Socioeconomic factors do play a role in healthcare access and maternal health, yet audit methodologies help pinpoint systemic challenges in both economically advantaged and disadvantaged environments.",5.684633456564497e-07,0.12308552526973449,0.18150897391505072,0.043522235154765,0.13590787122373937,0.18311533888228299,0.04345923698286881,0.17822900302930522,0.16202240735420861,5.684633456564497e-07,0.22181179397170991,0.13888888888888895
104,1.1,4,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is auditing maternal mortality just a distinction between rich and poor settings? The use of audits to identify maternal mortality involves more than just economic differences. Though socioeconomic status affects healthcare and maternal outcomes, audit procedures assist in detecting and tackling systemic issues universally, both in wealthy and impoverished locations.",5.684633456564497e-07,0.12308552526973449,0.18150897391505072,0.043522235154765,0.13590787122373937,0.18311533888228299,0.04345923698286881,0.17822900302930522,0.16202240735420861,5.684633456564497e-07,0.22181179397170991,0.13888888888888895
104,1.1,5,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the application of audit to detect maternal mortality only a reflection of economic disparities? Auditing to identify maternal mortality is not merely about contrasting rich and poor. Although economic status influences healthcare quality and maternal outcomes, audits are valuable for revealing systemic deficiencies in all resource levels.",6.158352911278206e-07,0.1659621247194738,0.18064173882788417,0.047149088084328744,0.1784674856425359,0.18311533888228299,0.047080840064774546,0.22171411496904359,0.16202240735420861,6.158352911278206e-07,0.26626355654254263,0.13888888888888895
104,1.1,6,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is maternal mortality audit a question of rich versus poor contexts only? The role of audits in maternal mortality identification surpasses a mere contrast between economic backgrounds. Socioeconomic factors do shape healthcare access, but audits highlight systemic issues across both affluent and poor settings.",7.105791820705622e-07,0.25765338977826513,0.17866564908511876,0.054402793943456235,0.26943926384826256,0.18311533888228299,0.05432404622858601,0.31480453803505526,0.16202240735420861,7.105791820705622e-07,0.3615737363468683,0.13888888888888895
104,1.1,7,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the use of audits for identifying maternal mortality just a division between rich and poor areas? No, audits serve a more comprehensive function. While socioeconomic influences affect maternal health and healthcare access, auditing uncovers systemic problems for both wealthier and poorer environments.",7.342651548062476e-07,0.24894448344148534,0.20190827947060627,0.05621622040823811,0.2935368154273226,0.18311533888228299,0.05613484776953888,0.33949715062542696,0.16202240735420861,7.342651548062476e-07,0.38689154433116,0.13888888888888895
104,1.1,8,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is auditing maternal mortality simply distinguished by economic richness or poverty? The identification of maternal mortality through audits is not restricted to income disparities. Socioeconomic status impacts health outcomes, but audits are essential in detecting systemic challenges in settings with varying resources.",7.57951127541933e-07,0.3068540926088352,0.17753327947060626,0.05802964687301998,0.31822942801769427,0.18311533888228299,0.057945649310491745,0.3648149586097187,0.16202240735420861,7.57951127541933e-07,0.412867030734418,0.13888888888888895
104,1.1,9,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the auditing process for maternal mortality identification only about differences between the rich and the poor? Auditing for maternal mortality involves more complexity than economic divides. Economic factors influence healthcare accessibility and outcomes, but audits help address systemic issues universally.",7.816371002776184e-07,0.36704936566691115,0.15204678362573093,0.05984307333780185,0.3790932452614699,0.15749207018422204,0.05975645085144461,0.39079044501297666,0.16202240735420861,7.816371002776184e-07,0.43953527781657886,0.13888888888888895
104,1.1,10,ai,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: The use of audit to identify maternal mortality in different settings is not just a difference between the rich and the poor. While socioeconomic factors can influence access to healthcare and overall maternal health outcomes, audit processes can help identify and address systemic issues in both resource-rich and resource-poor settings.","Is the differentiation in maternal mortality audit only a matter of wealth? Using audits to track maternal mortality is broader than just a rich versus poor comparison. Socioeconomic conditions affect healthcare and maternal results, but audits can detect systemic faults regardless of economic status.",7.105791820705622e-07,0.25765338977826513,0.17866564908511876,0.054402793943456235,0.26943926384826256,0.18311533888228299,0.05432404622858601,0.31480453803505526,0.16202240735420861,7.105791820705622e-07,0.3615737363468683,0.13888888888888895
105,1.1,1,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,The study of gender differences following injury and hemorrhagic shock indicates that hormonal variations might play a key role.,8.526950184846725e-07,0.9189074640784964,0.12675418741511993,0.06528335273214754,1.0324525799774227,0.07496876301541025,0.06518885547430332,1.0986764755078067,0.057476051645147866,8.526950184846743e-07,1.1694109468723153,0.039150354019158694
105,1.1,2,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Research into gender dimorphism after trauma and hemorrhagic shock implicates hormones as a possible cause.,9.474389094274139e-07,1.170221892359403,0.12675418741511993,0.07253705859127504,1.3007165665721017,0.07496876301541025,0.07243206163811482,1.386358547959587,0.057476051645147866,9.474389094274157e-07,1.4795658751761551,0.039150354019158694
105,1.1,3,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Differences between genders in response to injury and hemorrhagic shock appear linked to hormonal factors.,9.474389094274139e-07,1.170221892359403,0.12675418741511993,0.07253705859127504,1.3007165665721017,0.07496876301541025,0.07243206163811482,1.386358547959587,0.057476051645147866,9.474389094274157e-07,1.4795658751761551,0.039150354019158694
105,1.1,4,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Hormonal disparities could be responsible for gender-specific outcomes observed after injury and hemorrhagic shock.,9.711248821630993e-07,1.2443298645131242,0.12675418741511993,0.07435048505605692,1.380759274245638,0.07496876301541025,0.0742428631790677,1.4733699249492171,0.057476051645147866,9.71124882163101e-07,1.5748760549804803,0.039150354019158694
105,1.1,5,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,"After injury and hemorrhagic shock, hormonal differences seem to underlie the observed gender dimorphism.",9.711248821630993e-07,1.2443298645131242,0.12675418741511993,0.07435048505605692,1.380759274245638,0.07496876301541025,0.0742428631790677,1.4733699249492171,0.057476051645147866,9.71124882163101e-07,1.5748760549804803,0.039150354019158694
105,1.1,6,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,The observed gender dimorphism post-injury and hemorrhagic shock raises questions about the influence of hormones.,9.474389094274139e-07,1.170221892359403,0.12675418741511993,0.07253705859127504,1.3007165665721017,0.07496876301541025,0.07243206163811482,1.386358547959587,0.057476051645147866,9.474389094274157e-07,1.4795658751761551,0.039150354019158694
105,1.1,7,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Hormones may explain the gender-related variations seen after injury and hemorrhagic shock.,1.01849682763447e-06,1.4113839491762907,0.12675418741511993,0.07797733798562068,1.5630808310395934,0.07496876301541025,0.07786446626097344,1.6740406204113683,0.057476051645147866,1.0184968276344718e-06,1.79801960629469,0.039150354019158694
105,1.1,8,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,"Gender dimorphism following injury and hemorrhagic shock is characterized by hormonal differences, warranting further investigation.",9.474389094274139e-07,1.170221892359403,0.12675418741511993,0.07253705859127504,1.3007165665721017,0.07496876301541025,0.07243206163811482,1.386358547959587,0.057476051645147866,9.474389094274157e-07,1.4795658751761551,0.039150354019158694
105,1.1,9,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,The role of hormones is crucial in understanding gender differences observed after hemorrhagic shock and injury.,9.237529366917285e-07,1.101229020872451,0.12675418741511993,0.07072363212649316,1.2266085944183804,0.07496876301541025,0.07062126009716195,1.3063158402860506,0.057476051645147866,9.237529366917304e-07,1.392554498186525,0.039150354019158694
105,1.1,10,ai,Question: Characterization of the gender dimorphism after injury and hemorrhagic shock: are hormonal differences responsible? Answer: The characterization of gender dimorphism after injury and hemorrhagic shock suggests that hormonal differences may be responsible. Further research is needed to fully understand the role of hormones in these conditions and their impact on outcomes and treatment strategies.,Further studies are necessary to clarify how hormonal differences contribute to gender-specific responses to injury and hemorrhagic shock.,8.763809912203578e-07,0.9760658779184452,0.12675418741511993,0.06709677919692941,1.0930772017938577,0.07496876301541025,0.0669996570152562,1.1632149966453773,0.057476051645147866,8.763809912203596e-07,1.2384038183592674,0.039150354019158694
106,1.1,1,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the impact of MPH programs on strengthening health systems in low- and middle-income countries? The programs had a significant influence across various levels; graduates were seen as valuable contributors to their workplaces and frequently held sway at the national level. Many reported outcomes aligned with the goals of public health education. The qualitative study provided deeper insights into the influence of graduates.,9.474389094274162e-08,0.0615578929994296,0.0,0.0072537058591274906,0.06252035698133263,0.0,0.007243206163811466,0.06351340572232633,0.0,9.474389094274162e-08,0.06453852113757197,0.0
106,1.1,2,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs contribute to health system strengthening in low- and middle-income countries? They have a notable impact on multiple levels; graduates are viewed as important contributors in their workplaces and often play influential roles nationally. The results largely correspond with objectives of public health training. The qualitative research offered a detailed understanding of graduates' effects.,2.6054570009253947e-07,0.1793409286558152,0.0,0.0199476911126006,0.18232155679395312,0.0,0.019918816950481533,0.1854032233313614,0.0,2.6054570009253947e-07,0.18859116980755042,0.0
106,1.1,3,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What is the role of MPH programs in enhancing health systems in low- and middle-income countries? Substantial impact was found at numerous levels; graduates were often seen as key contributors within their workplaces with influence extending to the national sphere. Many effects matched public health education aims. The qualitative approach revealed a more comprehensive understanding of graduates' impacts.,2.3685972735685406e-07,0.16164135155641457,0.0,0.018134264647818726,0.16430305129127465,0.0,0.018108015409528666,0.16705408466316563,0.0,2.3685972735685406e-07,0.16989903679539609,0.0
106,1.1,4,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What effects do MPH programs have on strengthening health systems in low- and middle-income countries? There was significant impact observed at various levels; graduates were perceived as valuable assets to their workplaces and sometimes had influence on the national stage. Much of the described impact aligned with the aims of public health education. The qualitative study uncovered a deeper perspective on graduates' influence.,1.1842986367842703e-07,0.07755823434587317,0.0,0.009067132323909363,0.07878087785311383,0.0,0.009054007704764333,0.08004270767353727,0.0,1.1842986367842703e-07,0.08134563945395268,0.0
106,1.1,5,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,To what extent do MPH programs impact health systems strengthening in low- and middle-income countries? The impact was considerable across several levels; graduates were recognized for meaningful contributions at their workplaces and frequently had influence at the national level. Many of the outcomes were consistent with public health education goals. The qualitative research provided richer insight into the impact of graduates.,1.6580180914979784e-07,0.13345296318752986,0.016661878770468257,0.012693985253473108,0.11211729812070548,0.0,0.012675610786670066,0.1139442593492177,0.0,1.6580180914979784e-07,0.11583181552512123,0.0
106,1.1,6,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How do MPH programs affect health system strengthening in low- and middle-income countries? Impact was notable on multiple levels; graduates were believed to contribute significantly to their workplaces and often exerted influence nationally. The impact largely reflected the objectives of public health education. Qualitative methods offered more detailed understanding of graduates’ contributions.,3.789755637709665e-07,0.27286698666663955,0.0,0.029014823436509962,0.2776317365982788,0.0,0.028972824655245866,0.2825669717850099,0.0,3.789755637709665e-07,0.28768207245178035,0.0
106,1.1,7,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What influence do MPH programs have on health system fortification in low- and middle-income countries? There was considerable impact at varying levels; graduates were considered capable of significant contributions at their workplaces and often held influence nationally. Much of the described impact aligned with public health educational goals. The qualitative study revealed more profound insights into graduates’ impact.,2.3685972735685406e-07,0.16164135155641457,0.0,0.018134264647818726,0.16430305129127465,0.0,0.018108015409528666,0.16705408466316563,0.0,2.3685972735685406e-07,0.16989903679539609,0.0
106,1.1,8,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,How significant is the impact of MPH programs on health system strengthening in low- and middle-income countries? They generated marked impact at many levels; graduates were seen as valuable contributors in their workplaces and frequently influenced national health policies. Most effects aligned with public health education intents. The qualitative analysis gave deeper understanding of graduate influence.,2.8423167282822487e-07,0.19735943415849366,0.0,0.02176111757738247,0.20067069546214888,0.0,0.0217296184914344,0.20409535634351572,0.0,2.8423167282822487e-07,0.20763936477824352,0.0
106,1.1,9,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,In what ways do MPH programs contribute to health system strengthening in low- and middle-income contexts? Notable impact was evident at numerous levels; graduates were perceived as key contributors within workplaces and often influenced at the national level. Much impact corresponded with public health education aims. Qualitative findings afforded deeper insights into the graduates’ impact.,3.079176455639103e-07,0.21570857282668943,0.0,0.023574544042164344,0.21936282847430322,0.0,0.023540420032387266,0.22314355131420882,0.0,3.079176455639103e-07,0.22705745063534621,0.0
106,1.1,10,human,Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: There was considerable impact at many levels; graduates were perceived to be able to contribute significantly to their workplaces and often had influence at the national level. Much of the impact described was in line with public health educational aims. The qualitative method study revealed more in-depth understanding of graduates' impact as,What has been the impact of MPH programs on strengthening health systems in low- and middle-income countries? Impact was significant at multiple levels; graduates frequently contributed meaningfully to their workplaces and held sway at national levels. The majority of outcomes aligned with public health educational missions. Qualitative studies provided a richer understanding of graduates’ impact.,3.079176455639103e-07,0.21570857282668943,0.0,0.023574544042164344,0.21936282847430322,0.0,0.023540420032387266,0.22314355131420882,0.0,3.079176455639103e-07,0.22705745063534621,0.0
107,1.1,1,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Could neoadjuvant chemotherapy alter the extent of lymphadenectomy in cervical cancer? No, the occurrence and location of lymph node metastases (LNM) are not changed by neoadjuvant chemotherapy (NACT), and patients who do not respond clinically have more affected lymph nodes. Therefore, a thorough and systemic lymphadenectomy should be conducted in patients undergoing NACT followed by surgery.",1.4211583641411244e-07,0.11859925675699046,0.002223722565157755,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
107,1.1,2,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is it possible for neoadjuvant chemotherapy to change the scope of lymphadenectomy in cervical cancer? The frequency and anatomical distribution of lymph node metastases (LNM) remain unaffected by neoadjuvant chemotherapy, and patients not responding clinically exhibit a higher number of involved lymph nodes. Hence, an extensive and systemic lymphadenectomy is recommended in patients treated with both NACT and surgery.",2.1317375462116866e-07,0.19691443409130027,0.020399305555555556,0.016320838183036854,0.17185025692665912,0.0,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
107,1.1,3,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can neoadjuvant chemotherapy influence the extent of lymphadenectomy in the treatment of cervical cancer? The prevalence and location of lymph node metastases are not altered by neoadjuvant chemotherapy, while clinically non-responding patients have more lymph nodes involved. Thus, patients receiving NACT plus surgery require a comprehensive systemic lymphadenectomy.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,1.1,4,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Does neoadjuvant chemotherapy modify the lymphadenectomy range in cervical cancer treatment? No modification occurs in the frequency or topographical distribution of lymph node metastases due to NACT, and those who do not respond clinically present with increased lymph node involvement. Consequently, a systemic and broad lymphadenectomy should be performed after NACT and surgery.",7.105791820705622e-08,0.06105563518169577,0.0011759299307958458,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
107,1.1,5,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can the extent of lymph node removal be adjusted by neoadjuvant chemotherapy in cervical cancer? Neither the occurrence nor the anatomical distribution of lymph node metastases changes with NACT, while clinical non-responders have more lymph nodes affected. Therefore, extensive systemic lymphadenectomy is advised for patients treated with neoadjuvant chemotherapy followed by surgery.",4.737194547137081e-08,0.013249670855492557,0.03819444444444445,0.0036268529295637453,0.013096107297856374,0.019991670137442734,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
107,1.1,6,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is lymphadenectomy extent affected by neoadjuvant chemotherapy in cervical cancer cases? The frequency and locations of lymph node metastases remain unchanged with NACT, and patients without clinical response show more involved lymph nodes. Thus, an extensive and systemic lymphadenectomy is necessary in patients treated with NACT plus surgery.",4.737194547137081e-08,0.013380974745060836,0.020399305555555556,0.0036268529295637453,0.04255961441879652,0.0,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
107,1.1,7,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Could neoadjuvant chemotherapy impact the scope of lymphadenectomy performed in cervical cancer? The distribution and frequency of lymph node metastases do not change with NACT, and clinical non-responders demonstrate higher numbers of involved lymph nodes. Therefore, a systemic and thorough lymphadenectomy is essential after NACT and surgery.",7.105791820705622e-08,0.034887179966024195,0.020399305555555556,0.005440279394345618,0.06453852113757153,0.0,0.0054324046228586,0.06595796779179608,0.0,7.105791820705622e-08,0.06744128079553224,0.0
107,1.1,8,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Is it feasible for neoadjuvant chemotherapy to influence the range of lymphadenectomy in cervical cancer treatment protocols? Clinical data show no change in the frequency or distribution of lymph node metastases with NACT, and non-responding patients have a greater lymph node involvement. Accordingly, a comprehensive systemic lymphadenectomy should be carried out following NACT and surgery.",1.1842986367842703e-07,0.09978335231063973,0.001887379603259371,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
107,1.1,9,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Does neoadjuvant chemotherapy alter lymphadenectomy extent in cervical cancer management? The prevalence and anatomical spread of lymph node metastases remain unaffected by NACT, with clinical non-responders having more involved lymph nodes. Hence, systemic and extensive lymphadenectomy is recommended for patients receiving NACT combined with surgery.",1.1842986367842703e-07,0.07933894253685692,0.020399305555555556,0.009067132323909363,0.11000089521432876,0.0,0.009054007704764333,0.11247798342669002,0.0,1.1842986367842703e-07,0.11506932978478668,0.0
107,1.1,10,human,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The frequency and topographic distribution of LNM are not modified by NACT, and clinical non-responders showed more involved LNs. A systemic and extensive lymphadenectomy should be performed in patients treated with NACT plus surgery regardless","Can the scope of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Both the frequency and location of lymph node metastases are not changed by NACT, and patients who do not respond clinically have increased lymph node involvement, indicating that systemic and extensive lymphadenectomy should be performed concurrently with NACT and surgery.",7.105791820705622e-08,0.06105563518169577,0.0011759299307958458,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
108,1.1,1,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are doctors effectively addressing the needs of family caregivers for the frail elderly? The issue remains controversial, with some asserting that medical professionals fall short in supporting caregivers, while others contend that measures to enhance caregiver education and support are underway.",4.263475092423373e-07,0.2042521680214615,0.1184159938485198,0.03264167636607371,0.23356389948175948,0.10380622837370242,0.0325944277371516,0.26398924876591545,0.08842752787389466,4.263475092423373e-07,0.29559386450679836,0.07227989234909649
108,1.1,2,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Do physicians meet the requirements of family caregivers caring for frail elderly individuals? Opinions differ, as some maintain that healthcare providers are insufficiently supporting these caregivers, whereas others feel improvements in caregiver training and resource availability are being implemented.",4.737194547137079e-07,0.2555454624090112,0.1184159938485198,0.03626852929563745,0.2862076329671783,0.10380622837370242,0.03621603081905733,0.31805647003619164,0.08842752787389466,4.737194547137081e-07,0.35116371566161053,0.07227989234909649
108,1.1,3,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Is the medical community satisfying the needs of family caregivers for frail seniors? This is debatable; some claim there’s a lack of adequate support from doctors, while others affirm that steps are being taken to offer better education and resources to caregivers.",4.026615365066519e-07,0.1795595554310898,0.1184159938485198,0.030828249901291835,0.20824609149746776,0.10380622837370242,0.030783626196198732,0.23801376236265748,0.08842752787389466,4.026615365066519e-07,0.2689256174246375,0.07227989234909649
108,1.1,4,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are family caregivers of the frail elderly receiving adequate support from physicians? The answer is contested—some suggest healthcare providers are not doing enough, but others see ongoing efforts to provide caregivers with improved resources and education.",5.447773729207638e-07,0.33778356064598425,0.1184159938485198,0.04170880868998308,0.370765020995242,0.10380622837370242,0.041648435441915946,0.40506784702582177,0.08842752787389466,5.447773729207643e-07,0.4407758743512975,0.07227989234909649
108,1.1,5,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are physicians fulfilling the needs of family members who care for frail elderly patients? This remains a topic of debate, with arguments that physicians neglect adequate support, contrasted by views that enhancements in caregiver education and resources are progressing.",4.737194547137079e-07,0.2555454624090112,0.1184159938485198,0.03626852929563745,0.2862076329671783,0.10380622837370242,0.03621603081905733,0.31805647003619164,0.08842752787389466,4.737194547137081e-07,0.35116371566161053,0.07227989234909649
108,1.1,6,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Is the care provided by physicians sufficient to meet the needs of family caregivers for the frail elderly? Opinions vary; some argue healthcare workers fall short in support, but others believe there are improvements in educating and resourcing caregivers.",4.737194547137079e-07,0.2555454624090112,0.1184159938485198,0.03626852929563745,0.2862076329671783,0.10380622837370242,0.03621603081905733,0.31805647003619164,0.08842752787389466,4.737194547137081e-07,0.35116371566161053,0.07227989234909649
108,1.1,7,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Do healthcare providers properly address family caregivers’ needs for the frail elderly? There is controversy, with some insisting support is lacking, while others point to advancements in caregiver education and resource provision.",6.39521263863505e-07,0.45914441765025105,0.1184159938485198,0.048962514549110596,0.495928163949249,0.10380622837370242,0.04889164160572744,0.5342795785058287,0.08842752787389466,6.39521263863506e-07,0.5743072669758198,0.07227989234909649
108,1.1,8,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are physicians adequately supporting family caregivers of the frail elderly? The discussion is ongoing, with some views criticizing insufficient support and others noting positive strides in caregiver education and resource implementation.",6.632072365991903e-07,0.49193424047324275,0.1184159938485198,0.050775941013892475,0.5298297156249308,0.10380622837370242,0.050702443146680314,0.5693708983170978,0.08842752787389466,6.632072365991914e-07,0.6106749111466945,0.07227989234909649
108,1.1,9,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Is the support from physicians meeting the needs of family caregivers of frail elderly individuals? Debate persists: some argue caregivers are underserved, whereas others recognize efforts to bolster education and resources for these caregivers.",5.921493183921344e-07,0.39662406066891753,0.1184159938485198,0.04533566161954684,0.43138964281167747,0.10380622837370242,0.04527003852382169,0.4675882040071553,0.08842752787389466,5.921493183921352e-07,0.505314395488869,0.07227989234909649
108,1.1,10,ai,"Question: Are physicians meeting the needs of family caregivers of the frail elderly? Answer: There is ongoing debate on whether physicians are adequately addressing the needs of family caregivers of the frail elderly. While some argue that healthcare providers are not doing enough to support caregivers, others believe that efforts are being made to improve caregiver education and resources.","Are family caregivers of the frail elderly getting the help they need from physicians? This question sparks differing opinions, with some believing healthcare providers are falling short and others seeing ongoing initiatives to improve caregiver support and education.",4.974054274493932e-07,0.2822137094911721,0.1184159938485198,0.038081955760419325,0.31360660715529365,0.10380622837370242,0.0380268323600102,0.3462273470028885,0.08842752787389466,4.974054274493935e-07,0.38015125253486204,0.07227989234909649
109,1.1,1,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain linked to poorer health-related quality of life half a year later? Our findings indicate neck pain is connected to reduced physical HRQoL, but not mental HRQoL. The analysis implies that neck pain might contribute to future declines in physical HRQoL at the population level.",2.3685972735685406e-08,0.03596060530495038,0.04203858239209045,0.0018134264647818726,0.008157927218613636,0.021728395061728398,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
109,1.1,2,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does neck pain correlate with diminished health-related quality of life six months afterward? We discovered that neck pain negatively affects physical health-related quality of life, yet it does not impact mental HRQoL. Our study suggests neck pain could be a factor in subsequent poor physical HRQoL in the population.",2.3685972735685406e-08,0.023743314157161244,0.0027823840449829884,0.0018134264647818726,0.02214741445367352,0.00046185441900629606,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
109,1.1,3,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,Is there an association between neck pain and worsened health-related quality of life after six months? Results showed that neck pain is adversely linked to physical HRQoL but not mental HRQoL. The data suggest that neck pain may lead to poorer physical HRQoL down the line for the general population.,4.737194547137081e-08,0.04694271428006891,0.005449458833269916,0.0036268529295637453,0.04381531583285447,0.0009044928435301136,0.003621603081905733,0.04348511193973836,0.0,4.737194547137081e-08,0.04445176257083272,0.0
109,1.1,4,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does suffering from neck pain predict lower health-related quality of life six months later? We found a negative relationship between neck pain and physical HRQoL, with no effect on mental HRQoL. The analysis indicates that neck pain may contribute to future poor physical HRQoL in the population.",2.3685972735685406e-08,0.03596060530495038,0.04203858239209045,0.0018134264647818726,0.008157927218613636,0.021728395061728398,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
109,1.1,5,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is neck pain a factor in reduced health-related quality of life half a year later? Evidence showed neck pain was negatively associated with physical but not mental health-related quality of life, implying it might influence future physical HRQoL detrimentally in the population.",1.4211583641411244e-07,0.10889626972287303,0.05816687615825879,0.010880558788691236,0.14428246746576612,0.003255168383373523,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
109,1.1,6,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is health-related quality of life worse six months later in people experiencing neck pain? Our findings show that neck pain correlates negatively with physical HRQoL but not with mental HRQoL, suggesting neck pain can be a predictor of future poor physical HRQoL in the community.",7.105791820705622e-08,0.00014409020504624337,0.08553008367579952,0.005440279394345618,0.0373044468581436,0.021728395061728398,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
109,1.1,7,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Can neck pain impact health-related quality of life negatively six months afterward? The study revealed a negative link between neck pain and physical health-related quality of life, however no link with mental HRQoL, suggesting potential future physical HRQoL decline due to neck pain.",1.1842986367842703e-07,0.0823835711732217,0.05987564043893871,0.009067132323909363,0.1187445534356879,0.002646604938271603,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
109,1.1,8,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is post-six-month health-related quality of life affected by neck pain? According to our data, neck pain harmed physical HRQoL but had no effect on mental HRQoL, indicating neck pain could contribute to future physical HRQoL problems within the population.",2.1317375462116844e-07,0.15640886504749751,0.07841242179623287,0.016320838183036854,0.1875866499074803,0.021728395061728398,0.0162972138685758,0.22314355131420927,0.0,2.1317375462116866e-07,0.2288415724288484,0.0
109,1.1,9,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Does neck pain result in a lower health-related quality of life six months later? The research revealed neck pain is associated negatively with physical but not mental HRQoL, suggesting it may play a role in declining physical HRQoL over time in the population.",1.1842986367842703e-07,0.016369553977034546,0.10708619769388346,0.009067132323909363,0.08493249584739804,0.021728395061728398,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
109,1.1,10,human,Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: We found that neck pain was negatively associated with physical but not mental HRQoL. Our analysis suggests that neck pain may be a contributor of future poor physical HRQoL in the population. Raising,"Is there a negative association between neck pain and health-related quality of life six months later? Findings indicated neck pain impacts physical health-related quality of life adversely while leaving mental HRQoL unaffected, suggesting it might affect future physical HRQoL deterioration in the population.",1.1842986367842703e-07,0.11539057977131417,0.03669873211393751,0.009067132323909363,0.15255661102397777,0.026923807436627943,0.009054007704764333,0.15244039468437975,0.02498356344510192,1.1842986367842703e-07,0.12062798778861739,0.0
110,1.1,1,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: What is the clinical significance of bile duct sludge, and how does it compare to bile duct stones? Answer: The results suggest that symptomatic bile duct sludge (BDS) has a clinical significance similar to common bile duct (CBD) stones. Bile duct sludge appears to represent an early phase of choledocholithiasis.",1.6580180914979784e-07,0.10779290426414478,0.22359836084338722,0.012693985253473108,0.1918729753679349,0.02710069444444446,0.012675610786670066,0.19144100179187307,0.024375,1.6580180914979784e-07,0.16126814759612174,0.0
110,1.1,2,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: How does the clinical importance of bile duct sludge differ from that of bile duct stones? Answer: The evidence shows that symptomatic BDS shares a clinical impact comparable to CBD stones, with bile duct sludge likely being an initial stage of choledocholithiasis.",2.3685972735685406e-08,0.005348759277950421,0.020083102493074767,0.0018134264647818726,0.025707649559455703,0.0011522024983563264,0.0018108015409528666,0.009119444997918169,0.024375,2.3685972735685406e-08,0.02531780798429173,0.0
110,1.1,3,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,Question: Is the clinical significance of bile duct sludge distinct from bile duct stones? Answer: Findings reveal that symptomatic BDS has clinical relevance akin to CBD stones and that bile duct sludge may be an early form of choledocholithiasis.,1.1842986367842682e-07,0.07346235541057267,0.03138730284357505,0.009067132323909363,0.09820510360836066,0.02049382716049385,0.009054007704764333,0.09624107065990772,0.024375,1.1842986367842703e-07,0.13353139262452274,0.0
110,1.1,4,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: What distinguishes the clinical significance of bile duct sludge from bile duct stones? Answer: Data indicates that symptomatic BDS and CBD stones have similar clinical significance, with bile duct sludge representing an early phase of choledocholithiasis.",1.6580180914979742e-07,0.13437479777313532,0.023646818219973526,0.012693985253473108,0.15591594991548163,0.018953287197231855,0.012675610786670073,0.15339948449985608,0.024375,1.6580180914979784e-07,0.19237189264745602,0.0
110,1.1,5,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: The clinical relevance of bile duct sludge: is it different compared to bile duct stones? Answer: The study suggests that symptomatic BDS is clinically as significant as CBD stones, while bile duct sludge appears to be an early stage of choledocholithiasis.",4.737194547137081e-08,0.04535126620401719,0.06696325314480002,0.0036268529295637453,0.017223853026752334,0.047500000000000014,0.003621603081905733,0.01619836298637356,0.024375,4.737194547137081e-08,0.051293294387549704,0.0
110,1.1,6,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: Does bile duct sludge have a different clinical significance than bile duct stones? Answer: The findings demonstrate that symptomatic bile duct sludge shares clinical significance with CBD stones, with bile duct sludge likely marking the initial stage of choledocholithiasis.",9.474389094274152e-08,0.1865115732334255,0.22428706607754714,0.0072537058591274906,0.12080199046617457,0.06052469135802464,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
110,1.1,7,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: In terms of clinical significance, how does bile duct sludge compare with bile duct stones? Answer: The research indicates that symptomatic BDS is similarly significant clinically as CBD stones, with bile duct sludge serving as an early form of choledocholithiasis.",7.105791820705622e-08,0.0506657210679613,0.012576519270886682,0.005440279394345618,0.07918597347650769,0.003632213294375436,0.0054324046228586,0.042173849389631535,0.024375,7.105791820705622e-08,0.07796154146971057,0.0
110,1.1,8,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: Is the clinical impact of bile duct sludge distinct from that of bile duct stones? Answer: Evidence points out that symptomatic BDS has a clinical impact comparable to CBD stones, with bile duct sludge being an early stage in the development of choledocholithiasis.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0
110,1.1,9,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: Are bile duct sludge and bile duct stones clinically different in significance? Answer: The findings indicate that symptomatic BDS and CBD stones share similar clinical importance, with bile duct sludge functioning as an initial stage of choledocholithiasis.",1.4211583641411212e-07,0.10346071005114421,0.02762415052382361,0.010880558788691236,0.1266448393288484,0.019744897959183685,0.0108648092457172,0.12441194762660457,0.024375,1.4211583641411244e-07,0.16251892949777424,0.0
110,1.1,10,human,Question: The clinical significance of bile duct sludge: is it different from bile duct stones? Answer: The findings indicate that the clinical significance of symptomatic BDS is similar to that of CBD stones. Bile duct sludge seems to be an early stage of choledocholithiasis.,"Question: How significant is bile duct sludge clinically compared to bile duct stones? Answer: The results affirm that symptomatic BDS bears clinical significance akin to that of CBD stones, and bile duct sludge likely represents an early stage of choledocholithiasis.",9.474389094274152e-08,0.044327536195488904,0.034953062480763186,0.0072537058591274906,0.07055087191658371,0.02120343316289264,0.007243206163811466,0.0688420964717924,0.024375,9.474389094274162e-08,0.10536051565782589,0.0
111,1.1,1,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,"Does a previous benign prostate biopsy forecast results for patients receiving radical perineal prostatectomy? Evidence is limited, implying such biopsies might not strongly predict outcomes.",4.026615365066502e-07,0.332645890826623,0.14204081632653065,0.030828249901291918,0.44941316110079566,0.07450693937180423,0.030783626196198823,0.536973183511845,0.025623268698060954,4.026615365066519e-07,0.5930637220029649,0.0
111,1.1,2,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Can a history of benign prostate biopsy predict outcomes after radical perineal prostatectomy? Current evidence is sparse and suggests it may not be a strong indicator.,3.789755637709649e-07,0.2918238963063682,0.14204081632653065,0.02901482343651004,0.406853546682,0.07450693937180423,0.02897282465524595,0.4925214209410109,0.025623268698060954,3.789755637709665e-07,0.5465437063680709,0.0
111,1.1,3,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Is outcome prediction for radical perineal prostatectomy influenced by prior benign prostate biopsy? Limited data indicates it might not be a reliable predictor.,4.500334819780208e-07,0.4196572678162527,0.14204081632653065,0.03445510283085568,0.5403849393065236,0.07450693937180423,0.03440522927810457,0.6322833633161702,0.025623268698060954,4.500334819780226e-07,0.6931471805599463,0.0
111,1.1,4,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Does having a prior benign prostate biopsy affect outcome predictions for patients undergoing radical perineal prostatectomy? Evidence suggests this is likely not a strong predictor.,4.026615365066502e-07,0.332645890826623,0.14204081632653065,0.030828249901291918,0.44941316110079566,0.07450693937180423,0.030783626196198823,0.536973183511845,0.025623268698060954,4.026615365066519e-07,0.5930637220029649,0.0
111,1.1,5,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Can prior benign prostate biopsy results predict the success of radical perineal prostatectomy? The evidence is limited and suggests weak predictive value.,4.737194547137061e-07,0.4661772834511466,0.14204081632653065,0.03626852929563756,0.5891751034759549,0.07450693937180423,0.03621603081905744,0.6835766577037203,0.025623268698060954,4.7371945471370796e-07,0.7472144018302216,0.0
111,1.1,6,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Does a history of benign prostate biopsy serve as a predictor for radical perineal prostatectomy outcomes? Available data is scarce and suggests it may not be predictive.,3.552895910352796e-07,0.2526031831530857,0.14204081632653065,0.02720139697172816,0.3660315521617452,0.07450693937180423,0.027162023114293075,0.4499618065222153,0.025623268698060954,3.552895910352811e-07,0.5020919437972369,0.0
111,1.1,7,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Is there evidence that a previous benign prostate biopsy predicts outcomes for patients treated with radical perineal prostatectomy? It appears to be limited and not strongly predictive.,3.552895910352796e-07,0.2526031831530857,0.14204081632653065,0.02720139697172816,0.3660315521617452,0.07450693937180423,0.027162023114293075,0.4499618065222153,0.025623268698060954,3.552895910352811e-07,0.5020919437972369,0.0
111,1.1,8,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Does undergoing a benign prostate biopsy earlier assist in predicting outcomes for radical perineal prostatectomy? Limited evidence suggests it may not be a strong predictor.,4.026615365066502e-07,0.332645890826623,0.14204081632653065,0.030828249901291918,0.44941316110079566,0.07450693937180423,0.030783626196198823,0.536973183511845,0.025623268698060954,4.026615365066519e-07,0.5930637220029649,0.0
111,1.1,9,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Can prior benign prostate biopsy results determine the prognosis of radical perineal prostatectomy? Existing evidence is limited and shows weak predictive strength.,4.737194547137061e-07,0.4661772834511466,0.14204081632653065,0.03626852929563756,0.5891751034759549,0.07450693937180423,0.03621603081905744,0.6835766577037203,0.025623268698060954,4.7371945471370796e-07,0.7472144018302216,0.0
111,1.1,10,ai,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: There is limited evidence to suggest that a prior benign prostate biopsy may not be a strong predictor of outcome for patients undergoing radical perineal prostatectomy.,Is prior benign prostate biopsy a reliable indicator of outcome for radical perineal prostatectomy patients? The evidence is limited and indicates it may not be a strong predictor.,3.316036182995943e-07,0.21486285517023873,0.14204081632653065,0.02538797050694628,0.32681083900846275,0.07450693937180423,0.025351221573340202,0.4091398120019605,0.025623268698060954,3.316036182995957e-07,0.45953232937844124,0.0
112,1.1,1,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: Should second-look laparotomy remain a practice? Answer: Second-look laparotomy does not improve overall or disease-free survival. Tumor grade stands as the sole independent prognostic factor for patient survival.,1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,1.1,2,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For Thai women with advanced epithelial ovarian carcinoma, is second-look laparotomy still recommended? Answer: Second-look laparotomy fails to positively affect overall or disease-free survival rates. Tumor grade is the only independent predictor of survival.",1.658018091497972e-07,0.22798490565049567,0.029384756657483937,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
112,1.1,3,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy still be offered for advanced epithelial ovarian carcinoma in Thai women? Answer: The procedure does not provide benefits in terms of overall or disease-free survival; tumor grade remains the only independent prognostic indicator.,1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,1.1,4,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: Advanced epithelial ovarian carcinoma in Thai women: Is the use of second-look laparotomy justified? Answer: The second-look laparotomy does not improve overall survival or disease-free survival, with tumor grade being the only independent survival predictor.",1.421158364141119e-07,0.19783241553260567,0.02854671280276816,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
112,1.1,5,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In cases of advanced epithelial ovarian carcinoma among Thai women, should second-look laparotomy be continued? Answer: Second-look laparotomy does not favorably impact either overall or disease-free survival. Tumor grade is the only independent prognostic variable influencing survival.",9.474389094274131e-08,0.1401215692254847,0.027006172839506164,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
112,1.1,6,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: For Thai women suffering from advanced epithelial ovarian carcinoma, should second-look laparotomy be maintained? Answer: The second-look laparotomy shows no benefit in improving survival rates overall or disease-free. Tumor grade alone serves as the independent prognostic factor for survival.",4.7371945471370706e-08,0.08555642983414735,0.025623268698060954,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
112,1.1,7,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy be performed for advanced epithelial ovarian carcinoma in Thai women? Answer: This laparotomy does not enhance overall or disease-free survival. The only independent survival predictor identified is tumor grade.,2.131737546211678e-07,0.2478361639045814,0.0,0.01632083818303688,0.25489224962878954,0.0,0.016297213868575834,0.2623642644674895,0.0,2.1317375462116866e-07,0.2702903297399133,0.0
112,1.1,8,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Advanced epithelial ovarian carcinoma in Thai women: is continuing second-look laparotomy advisable? Answer: There is no improvement in overall or disease-free survival due to second-look laparotomy. Tumor grade is the exclusive independent prognostic factor for survival.,1.1842986367842661e-07,0.1300531282481976,0.0,0.009067132323909363,0.13353139262452274,0.0,0.00905400770476434,0.13720112151348252,0.0,1.1842986367842703e-07,0.14107859825990632,0.0
112,1.1,9,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,Question: Should second-look laparotomy continue to be a treatment option for advanced epithelial ovarian carcinoma in Thai women? Answer: Second-look laparotomy does not positively affect overall or disease-free survival rates. Tumor grade remains the single independent prognostic variable for survival.,4.7371945471370706e-08,0.08555642983414735,0.025623268698060954,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
112,1.1,10,human,Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The second-look laparotomy doesn't have a favorable impact on overall and disease-free survival. Tumor grade is the only independent prognostic variable for survival of the patients.,"Question: In Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy still be utilized? Answer: This surgery does not influence overall survival or disease-free survival in a beneficial way. Tumor grade is the only independent prognostic factor for patient outcomes.",2.3685972735685406e-08,0.0246926125903717,0.0,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
113,1.1,1,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is it possible to confidently rule out aspiration after an acute stroke using only bedside assessment? Answer: Bedside assessment by itself might not be trustworthy enough to exclude aspiration after an acute stroke. Further evaluations like swallow tests or imaging are often required for an accurate diagnosis of aspiration in stroke patients.,2.8423167282822487e-07,0.355672538773637,0.06497292794668887,0.02176111757738247,0.3205375296233335,0.0372385348697302,0.0217296184914344,0.3196738195909341,0.032477465665026406,2.8423167282822487e-07,0.31836980063180365,0.027006172839506164
113,1.1,2,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Can aspiration be reliably excluded after an acute stroke through bedside assessment alone? Answer: Relying solely on bedside assessment may not be sufficient to reliably exclude aspiration following an acute stroke. Additional diagnostic tests such as swallowing evaluations or imaging studies are needed for accurate determination.,1.4211583641411244e-07,0.2527750696403661,0.07906054983977061,0.010880558788691236,0.24973887141912732,0.0763888888888889,0.0108648092457172,0.2195663353034485,0.05246913580246914,1.4211583641411244e-07,0.18774961821473912,0.027006172839506164
113,1.1,3,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Does bedside assessment alone effectively rule out aspiration post-acute stroke? Answer: Bedside assessment alone may not be dependable in excluding aspiration after an acute stroke, and further testing such as swallow assessments or imaging might be necessary for confirmation.",2.36859727356853e-08,0.07687696863672544,0.07131676629746128,0.0018134264647818726,0.0441811108194079,0.05009232205178152,0.0018108015409528666,0.04629461402941226,0.05246913580246914,2.3685972735685406e-08,0.010068440977287096,0.027006172839506164
113,1.1,4,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Is bedside evaluation enough to exclude aspiration after an acute stroke? Answer: Bedside evaluation by itself may not reliably exclude aspiration following acute stroke; other procedures like swallowing tests or imaging may be essential to confirm diagnosis.,7.10579182070559e-08,0.020390423339469166,0.06857142857142856,0.005440279394345618,0.026595320104918052,0.0763888888888889,0.0054324046228586,0.009275237125399904,0.05246913580246914,7.105791820705622e-08,0.047089972862661256,0.027006172839506164
113,1.1,5,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Can aspiration be accurately ruled out following acute stroke with bedside assessment? Answer: Bedside assessment alone may fail to reliably exclude aspiration in patients after acute stroke, thus additional tests such as swallow assessments or imaging are typically required for precise diagnosis.",4.737194547137081e-08,0.22207695930941718,0.12244897959183673,0.0036268529295637453,0.15664844835311564,0.0763888888888889,0.003621603081905733,0.12425615549912283,0.05246913580246914,4.737194547137081e-08,0.09011114865082126,0.027006172839506164
113,1.1,6,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Is it reliable to exclude aspiration post-acute stroke by bedside assessment only? Answer: Bedside assessment may not reliably exclude aspiration after an acute stroke, and further diagnostic evaluations such as swallowing studies or imaging tests may be needed.",4.73719454713706e-08,0.04903063964086263,0.06997984378936759,0.0036268529295637453,0.053994294293033374,0.0763888888888889,0.003621603081905733,0.01889563984129694,0.05246913580246914,4.737194547137081e-08,0.01810243598940975,0.027006172839506164
113,1.1,7,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,Question: Can the presence of aspiration after acute stroke be ruled out reliably using just bedside assessment? Answer: Using only bedside assessment might not reliably exclude aspiration after an acute stroke; additional testing like swallowing evaluations or imaging may be necessary for accurate diagnosis.,7.105791820705622e-08,0.2133680529726374,0.09920634920634921,0.005440279394345618,0.18074599993217566,0.0763888888888889,0.0054324046228586,0.14894876808949453,0.05246913580246914,7.105791820705622e-08,0.11542895663511299,0.027006172839506164
113,1.1,8,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Is bedside assessment sufficient to exclude aspiration following acute stroke? Answer: Bedside assessment alone might not be sufficient to exclude aspiration after acute stroke, requiring additional diagnostic tools such as swallow evaluations or imaging studies to ensure accuracy.",4.73719454713706e-08,0.02393222147071139,0.018642751218134315,0.0036268529295637453,0.02094053603777235,0.022511337868480717,0.003621603081905733,0.019612536856477902,0.02471403376165281,4.737194547137081e-08,0.01810243598940975,0.027006172839506164
113,1.1,9,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Does bedside assessment on its own reliably exclude aspiration after acute stroke? Answer: Bedside assessment on its own may not consistently rule out aspiration post-acute stroke, necessitating supplementary tests like swallow studies or imaging for a definitive diagnosis.",4.73719454713706e-08,0.02393222147071139,0.0186427512181343,0.0036268529295637453,0.05840795120317521,0.004060938100730452,0.003621603081905733,0.058120713554252745,0.002894185996838834,4.737194547137081e-08,0.05771084630712098,0.001540539963261995
113,1.1,10,ai,Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment alone may not reliably exclude aspiration following acute stroke. Additional tests such as swallow evaluations or imaging studies may be necessary to accurately diagnose aspiration in stroke patients.,"Question: Can bedside evaluation by itself rule out aspiration following an acute stroke reliably? Answer: Bedside evaluation alone may not reliably rule out aspiration in the aftermath of an acute stroke, so further assessments such as swallowing tests or imaging procedures are often needed.",7.105791820705622e-08,0.11664984173171522,0.030404272162513887,0.005440279394345618,0.14773899133408408,0.05259352898407034,0.0054324046228586,0.14894876808949453,0.05246913580246914,7.105791820705622e-08,0.11542895663511299,0.027006172839506164
114,1.1,1,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the Catholic bishops' boycott call influence polio vaccination rates in Kenya in 2015? Yes, the boycott urged by the Catholic bishops affected polio vaccination coverage in Kenya in 2015.",2.842316728282237e-07,0.09793250339694559,0.11432448979591839,0.02176111757738252,0.02495450752790207,0.19976871220980968,0.021729618491434455,0.047810696789956086,0.20999999999999996,2.8423167282822487e-07,0.12411960781439779,0.1748178980228928
114,1.1,2,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Was polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' call for a boycott? Indeed, the Catholic bishops' boycott call impacted polio vaccination coverage in Kenya in 2015.",2.605457000925384e-07,0.19628662065569102,0.03700426295281811,0.01994769111260064,0.179368943978095,0.0705034515788083,0.01991881695048158,0.15997459131049796,0.10439999999999992,2.6054570009253947e-07,0.18906775102561735,0.10121789802289281
114,1.1,3,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the Catholic bishops' boycott request affect 2015 polio vaccination coverage in Kenya? Yes, the boycott urged by the Catholic bishops did influence polio vaccination rates in Kenya in 2015.",2.842316728282237e-07,0.002325995733505337,0.1801373841717757,0.02176111757738252,0.024556005369237077,0.23543400713436385,0.021729618491434455,0.047810696789956086,0.20999999999999996,2.8423167282822487e-07,0.12411960781439779,0.1748178980228928
114,1.1,4,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","In 2015, did the boycott called by the Catholic bishops affect Kenya's polio vaccination coverage? Yes, the Catholic bishops' boycott call had an effect on Kenya's polio vaccination coverage in that year.",2.368597273568531e-07,0.025814367610554445,0.15306122448979587,0.01813426464781876,0.0473390648188583,0.20214030915576695,0.018108015409528708,0.0236482671921876,0.20999999999999996,2.3685972735685406e-07,0.050011635660676124,0.1748178980228928
114,1.1,5,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Was there an impact on polio vaccination coverage in Kenya during 2015 due to the Catholic bishops' boycott call? Yes, the boycott called by the Catholic bishops did affect vaccination rates in Kenya in 2015.",1.658018091497972e-07,0.17079847943492377,0.19013073979591835,0.012693985253473122,0.18885905666051306,0.23543400713436385,0.012675610786670087,0.12208834000544089,0.20999999999999996,1.6580180914979784e-07,0.051771058649266344,0.1748178980228928
114,1.1,6,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the Catholic bishops' boycott announcement in 2015 impact the polio vaccination coverage in Kenya? Yes, the boycott call from the Catholic bishops had an impact on polio vaccination coverage in Kenya in 2015.",1.894877818854825e-07,0.05445656327419757,0.12981842558664364,0.014507411718255002,0.07144400042376509,0.17321178491214162,0.01448641232762296,0.045620468751510046,0.17777777777777776,1.8948778188548325e-07,0.018981235826274645,0.1748178980228928
114,1.1,7,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did Kenya's polio vaccination coverage in 2015 suffer due to the boycott by Catholic bishops? Yes, the boycott urged by Catholic bishops did affect polio vaccine coverage in Kenya in 2015.",2.605457000925384e-07,0.011447372506371956,0.1499590576971529,0.01994769111260064,0.05964732518050608,0.23543400713436385,0.01991881695048158,0.011443052619081406,0.20999999999999996,2.6054570009253947e-07,0.0863792798315508,0.1748178980228928
114,1.1,8,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","In 2015, did the Catholic bishops' boycott affect polio vaccination coverage in Kenya? Yes, their call for boycott impacted the polio vaccination coverage in Kenya that year.",3.552895910352796e-07,0.17587582170273475,0.1353029397014004,0.02720139697172816,0.19967622882735903,0.15603892206820125,0.027162023114293075,0.22335599749300084,0.1684120982986767,3.552895910352811e-07,0.2467219299067307,0.1748178980228928
114,1.1,9,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Did the call for a boycott by Catholic bishops impact Kenya's polio vaccination coverage in 2015? Yes, the Catholic bishops' boycott call influenced the polio vaccination coverage in Kenya during 2015.",2.605457000925384e-07,0.011447372506371956,0.1499590576971529,0.01994769111260064,0.03595918248293417,0.1668469015102212,0.01991881695048158,0.060953565516220554,0.1743347050754458,2.6054570009253947e-07,0.0863792798315508,0.1748178980228928
114,1.1,10,ai,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: Yes, the call for boycott by the Catholic bishops did have an impact on the polio vaccination coverage in Kenya in 2015.","Was polio vaccination coverage influenced in Kenya in 2015 by the boycotting call from the Catholic bishops? Yes, the boycott by the Catholic bishops did affect the vaccination coverage against polio in Kenya in 2015.",1.658018091497972e-07,0.04847838874787547,0.10603721274478878,0.012693985253473122,0.1468501366265773,0.20516056963436385,0.012675610786670087,0.12208834000544089,0.20999999999999996,1.6580180914979784e-07,0.051771058649266344,0.1748178980228928
115,1.1,1,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Is transgastric endoscopic splenectomy achievable? Answer: Performing transgastric endoscopic splenectomy in a pig model seems technically viable. Further long-term survival studies are scheduled.,0.0,0.060273667874777725,0.0427793707014486,0.0,0.06301338005090429,0.04535147392290251,0.0,0.0,0.0,0.0,0.0,0.0
115,1.1,2,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Can transgastric endoscopic splenectomy be done? Answer: Transgastric endoscopic splenectomy has been shown to be technically feasible in a porcine model. Additional experiments focusing on long-term survival are planned.,1.421158364141118e-07,0.1964687742686615,0.025198675872076533,0.010880558788691277,0.19165154391974948,0.035665294924554176,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
115,1.1,3,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is it possible to perform a transgastric endoscopic splenectomy? Answer: In a pig model, transgastric endoscopic splenectomy appears to be technically achievable. Plans for more long-term survival experiments are underway.",1.658018091497971e-07,0.27976702157045397,0.010094731773469215,0.012693985253473157,0.27625337662815763,0.0,0.012675610786670115,0.28768207245178257,0.0,1.658018091497978e-07,0.30010459245033916,0.0
115,1.1,4,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Transgastric endoscopic splenectomy: is it doable? Answer: The procedure seems technically feasible when tested in a porcine model. More long-term survival research is intended.,2.36859727356853e-08,0.1028332822935738,0.04338842975206613,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
115,1.1,5,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,Question: Question: Could transgastric endoscopic splenectomy be performed? Answer: It appears technically possible to carry out transgastric endoscopic splenectomy in a pig model. Further long-term studies are planned.,9.47438909427412e-08,0.11792784675589152,0.030211570247933854,0.007253705859127518,0.11373507077394018,0.03840000000000001,0.007243206163811494,0.17435338714477844,0.0,9.474389094274157e-08,0.1823215567939549,0.0
115,1.1,6,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is transgastric endoscopic splenectomy feasible? Answer: This approach is technically achievable in a porcine model, with additional long-term survival experiments planned.",4.73719454713706e-08,0.030698110330949824,0.04338842975206613,0.003626852929563759,0.09531017980432521,0.0,0.003621603081905747,0.10008345855698142,0.0,4.7371945471370706e-08,0.10536051565782545,0.0
115,1.1,7,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can transgastric endoscopic splenectomy be technically accomplished? Answer: Evidence from a porcine model suggests feasibility, and more long-term survival trials are in preparation.",0.0,0.06027366787477817,0.04338842975206613,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
115,1.1,8,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Question: Is transgastric endoscopic splenectomy possible? Answer: It has demonstrated technical feasibility in a pig model, with further long-term survival experiments forthcoming.",2.36859727356853e-08,0.015821905303944117,0.04338842975206613,0.0018134264647818796,0.04652001563489394,0.0,0.0018108015409528735,0.04879016416943127,0.0,2.3685972735685353e-08,0.05129329438755015,0.0
115,1.1,9,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Is performing transgastric endoscopic splenectomy practicable? Answer: The procedure looks technically feasible in the porcine model, with plans for continued long-term survival studies.",0.0,0.06027366787477817,0.04338842975206613,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
115,1.1,10,human,Question: Transgastric endoscopic splenectomy: is it possible? Answer: Transgastric endoscopic splenectomy in a porcine model appears technically feasible. Additional long-term survival experiments are planned.,"Question: Can the transgastric endoscopic approach to splenectomy be performed? Answer: In a pig model, it appears technically feasible, and additional long-term survival experiments are expected.",4.73719454713706e-08,0.14365527681382861,0.04338842975206613,0.003626852929563759,0.08701137698962969,0.0,0.003621603081905747,0.090971778205728,0.0,4.737194547137076e-08,0.09531017980432521,0.0
116,1.1,1,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux have a role in perioperative bridging? Answer: The use of fondaparinux for perioperative bridge therapy is not yet established, and there are significant limitations that prevent it from being a standard bridging option.",2.36859727356853e-08,0.04884547642885284,0.055363321799307974,0.0018134264647818796,0.010620873444459722,0.02854671280276816,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
116,1.1,2,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux used in perioperative bridge therapy? Answer: Fondaparinux’s role in perioperative bridging is currently unproven, with notable restrictions limiting its routine use as a bridging agent.",2.131737546211677e-07,0.2620099546532644,0.018381073278597927,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
116,1.1,3,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Can fondaparinux be used for perioperative bridging? Answer: The application of fondaparinux in perioperative bridging remains unclear, and it has important limitations that restrict its routine employment.",2.131737546211677e-07,0.2106657190562311,0.055363321799307974,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
116,1.1,4,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is there a role for fondaparinux in perioperative bridge therapy? Answer: Fondaparinux’s role in perioperative bridging therapy is not established, and it has key limitations that hinder its use as a standard bridging drug.",4.73719454713706e-08,0.020915424006748395,0.025978565141824037,0.003626852929563759,0.019232089705222055,0.02854671280276816,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
116,1.1,5,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux serve in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been defined, and certain critical limitations prevent its routine use.",2.131737546211677e-07,0.2620099546532644,0.018381073278597927,0.016320838183036916,0.2576431131502197,0.02854671280276816,0.016297213868575862,0.3074846997479619,0.0,2.1317375462116866e-07,0.3184537311185349,0.0
116,1.1,6,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux suitable for use as a perioperative bridging agent? Answer: Its role in perioperative bridge therapy has yet to be established, with notable constraints limiting its routine application.",1.658018091497971e-07,0.13920675507408742,0.055363321799307974,0.012693985253473157,0.18353514099649804,0.02854671280276816,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
116,1.1,7,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Can fondaparinux play a part in perioperative bridging? Answer: The role fondaparinux plays in perioperative bridging is not clearly established, alongside some important limitations that affect its routine use.",1.658018091497971e-07,0.18701000890580755,0.020924546289103882,0.012693985253473157,0.18353514099649804,0.02854671280276816,0.012675610786670115,0.23052365861183244,0.0,1.6580180914979784e-07,0.23841102344499765,0.0
116,1.1,8,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Is fondaparinux considered for perioperative bridging? Answer: The role of fondaparinux is not yet confirmed in perioperative bridging therapy, and it faces significant limitations for regular bridging use.",1.894877818854824e-07,0.17429807488535642,0.055363321799307974,0.014507411718255037,0.21990278516737272,0.02854671280276816,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
116,1.1,9,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.",Question: Is there a function for fondaparinux in perioperative bridging? Answer: Fondaparinux’s role in perioperative bridging therapy remains unestablished and is limited by some important constraints regarding routine use.,1.894877818854824e-07,0.22380858778249557,0.019698026874753798,0.014507411718255037,0.21990278516737272,0.02854671280276816,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
116,1.1,10,human,"Question: Is there a role for fondaparinux in perioperative bridging? Answer: The role of fondaparinux in perioperative bridge therapy has not been established, and there are some important limitations to its use as a routine bridging agent.","Question: Does fondaparinux have a place in perioperative bridging therapy? Answer: Currently, its role in perioperative bridge therapy is not established, and there are considerable restrictions on its routine use as a bridging agent.",7.10579182070559e-08,0.05200394362801619,0.025089884299307974,0.005440279394345639,0.05000374837197574,0.02854671280276816,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
117,1.1,1,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.","Do individuals with episodic migraines focus specifically on visual cues related to headaches? People suffering from episodic migraines might show a selective focus on visual stimuli associated with headaches, as their brains prioritize these relevant signals due to their condition. This selective attention can influence how migraines are perceived and experienced.",4.737194547137081e-08,0.07201361764545178,0.02229166666666664,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
117,1.1,2,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.",Are episodic migraine sufferers particularly attentive to visual stimuli linked to headaches? Those with episodic migraines may direct their attention more to headache-related visual stimuli because their brains emphasize processing stimuli relevant to the migraine condition. This bias in attention may affect the way migraines are felt and experienced.,0.0,0.057762265046662264,0.04139832000402392,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
117,1.1,3,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.","Do those who experience episodic migraines pay special attention to visual headache-related cues? Episodic migraine patients might have an attentional bias favoring headache-related visuals, since their brains prioritize these stimuli relevant to their condition, which contributes to how migraines are sensed and interpreted.",1.4211583641411244e-07,0.04688799505453023,0.06222222222222221,0.010880558788691236,0.13657553500575004,0.0,0.0108648092457172,0.13976194237515838,0.0,1.4211583641411244e-07,0.1431008436406751,0.0
117,1.1,4,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.","Is there selective attention toward headache-related visual stimuli in people with episodic migraines? Episodic migraineurs may demonstrate selective focus on such visual stimuli because their brains prioritize their processing as they are pertinent to their condition, influencing migraine perception and experience.",1.8948778188548325e-07,0.13033551825195833,0.037238658777120286,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
117,1.1,5,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.","Do episodic migraine patients specifically focus on headache-related visual information? People with episodic migraines may selectively attend to visual cues tied to headaches due to their brain's prioritization of these condition-relevant stimuli, which can contribute to how they perceive and experience migraines.",1.6580180914979784e-07,0.07098554663359025,0.06222222222222221,0.012693985253473108,0.16126814759612174,0.0,0.012675610786670066,0.1650797503594501,0.0,1.6580180914979784e-07,0.16907633004393308,0.0
117,1.1,6,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.","Do episodic migraine sufferers selectively concentrate on headache-related visual stimuli? Those with episodic migraines might exhibit selective attention to headache-related visuals, as their brains put priority on processing these stimuli relevant to their health, affecting migraine perception and experience.",2.3685972735685385e-07,0.14697145361151165,0.06222222222222221,0.018134264647818726,0.2392296890658323,0.0,0.018108015409528666,0.24512245803298427,0.0,2.3685972735685406e-07,0.2513144282809061,0.0
117,1.1,7,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.","Are headache-related visual stimuli selectively attended to by individuals with episodic migraines? Episodic migraineurs may show a bias in attention towards these visuals because their brains prioritize such relevant stimuli, playing a role in how migraines are experienced and perceived.",2.1317375462116855e-07,0.12099596720825367,0.06222222222222221,0.016320838183036854,0.21256144198367144,0.0,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
117,1.1,8,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.","Do episodic migraineurs tend to focus selectively on headache-related visual stimuli? Their brains may prioritize these stimuli due to their importance to the condition, causing a selective attentional bias that influences the perception and experience of migraines.",2.8423167282822445e-07,0.20103867488178784,0.06222222222222221,0.02176111757738247,0.2947995402206445,0.0,0.021729618491434406,0.3022808718729326,0.0,2.8423167282822487e-07,0.3101549283038394,0.0
117,1.1,9,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.","Do people with episodic migraines display selective attention to visuals related to headaches? Episodic migraineurs might selectively process headache-associated visual cues as their brains prioritize stimuli pertinent to their condition, impacting migraine experience and perception.",3.3160361829959505e-07,0.2581970887217362,0.06222222222222221,0.02538797050694623,0.35364004024357776,0.0,0.025351221573340153,0.3629054936893681,0.0,3.316036182995957e-07,0.3726752852851729,0.0
117,1.1,10,ai,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: Episodic migraineurs may exhibit selective attention towards headache-related visual stimuli, as their brains may prioritize processing of such stimuli due to their relevance to their condition. This attentional bias can contribute to the perception and experience of migraines.","Is selective attention to headache-related visual stimuli present in episodic migraine sufferers? Those with episodic migraines may attend more to these visuals because their brains focus on processing stimuli relevant to their condition, thereby affecting how migraines are perceived and experienced.",1.8948778188548325e-07,0.09567815922396194,0.06222222222222221,0.014507411718254981,0.18658595558041347,0.0,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
118,1.1,1,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does a surgeon's prior experience affect their capability to perform transurethral resection of the prostate? Yes, a surgeon's capability to carry out transurethral resection of the prostate is shaped by their previous experience. Experience helps the surgeon acquire the skills, knowledge, and expertise necessary to perform the operation effectively and reduce risks of complications.",4.737194547137081e-08,0.10848396828626639,0.08982722482709384,0.0036268529295637453,0.16566183611309127,0.13721983471074375,0.003621603081905733,0.1436034558342696,0.12657283950617287,4.737194547137081e-08,0.12073632851439697,0.113421550094518
118,1.1,2,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is there an impact of a surgeon's past experience on their proficiency in performing transurethral resection of the prostate? Indeed, the proficiency in performing transurethral resection of the prostate is influenced by the surgeon's previous experience. Such experience enables the development of vital skills, knowledge, and expertise essential for successful surgery and the prevention of complications.",0.0,0.15123211212216958,0.09373460535305166,0.0,0.12836058899258163,0.08399134658079789,0.0,0.10462598951848268,0.07120407649076262,0.0,0.07997852083383927,0.055945498449370135
118,1.1,3,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does prior surgical experience influence the ability to conduct transurethral resection of the prostate? Yes, the capability to perform transurethral resection of the prostate is impacted by the surgeon's previous experience, which fosters the acquisition of necessary skills, knowledge, and expertise to carry out the procedure successfully and avoid complications.",1.4211583641411244e-07,0.10207617215597198,0.14022574916600294,0.010880558788691236,0.08117587728211939,0.1340319330094205,0.0108648092457172,0.05961204249022334,0.12490629886345075,1.4211583641411244e-07,0.037354719575346085,0.113421550094518
118,1.1,4,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is a surgeon's expertise in transurethral resection of the prostate dependent on their earlier experience? Yes, performing transurethral resection of the prostate successfully is dependent on the surgeon's earlier experience, which builds crucial skills, knowledge, and expertise to minimize complications.",3.789755637709664e-07,0.2190373611559071,0.07575730639024927,0.029014823436509962,0.20412100052008375,0.09725248777196827,0.028972824655245866,0.2250568522017362,0.09229528848576468,3.789755637709665e-07,0.24627591515541303,0.08566644805370167
118,1.1,5,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does prior experience affect a surgeon’s ability to perform transurethral resection of the prostate? Indeed, the surgeon’s ability to perform transurethral resection of the prostate is significantly affected by their prior experience, as it cultivates the skills, knowledge, and expertise necessary to execute the procedure safely and effectively.",1.8948778188548325e-07,0.061190732210822496,0.056814832341806315,0.014507411718254981,0.08444247571434849,0.04811983471074377,0.014486412327622933,0.10841015153593503,0.03679783950617285,1.8948778188548325e-07,0.13312380309729566,0.023421550094518004
118,1.1,6,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the skill to perform a transurethral resection of the prostate influenced by how experienced the surgeon is? Yes, this skill is indeed shaped by the surgeon’s previous experience, which helps them gain the expertise, knowledge, and practical skills crucial for the operation and minimizing complications.",2.3685972735685406e-07,0.1017935287821885,0.20118983234180632,0.018134264647818726,0.05192676533915197,0.17561983471074377,0.018108015409528666,0.0001601811784062157,0.14617283950617285,2.3685972735685406e-07,0.053617058630380576,0.113421550094518
118,1.1,7,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does a surgeon's previous experience impact their ability to execute transurethral resection of the prostate? Absolutely, previous experience influences the surgeon’s capacity to successfully execute transurethral resection of the prostate by enabling the development of vital skills, knowledge, and expertise that reduce surgical complications.",2.8423167282822487e-07,0.10486586402943932,0.08692390436396706,0.02176111757738247,0.09361427609002071,0.10461391755098047,0.0217296184914344,0.11509198298742795,0.09752063700781652,2.8423167282822487e-07,0.13706458182780867,0.08843798664941607
118,1.1,8,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the ability to carry out transurethral resection of the prostate linked to the surgeon’s historical experience? Yes, this ability is linked to historical experience, which equips the surgeon with the skills, knowledge, and expertise indispensable for successful procedure performance and fewer complications.",3.079176455639103e-07,0.0002063513028547348,0.17739447243698775,0.023574544042164344,0.018690801874801988,0.17561983471074377,0.023540420032387266,0.07216048040121992,0.14617283950617285,3.079176455639103e-07,0.12772503078410402,0.113421550094518
118,1.1,9,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Does the surgeon’s prior experience have a role in performing transurethral resection of the prostate? Yes, prior experience plays a key role in a surgeon’s ability to perform this procedure successfully, allowing for the accumulation of necessary skills, knowledge, and expertise that help avoid complications.",2.6054570009253947e-07,0.016307292879226054,0.1558383584189038,0.0199476911126006,0.028937247114452447,0.17561983471074377,0.019918816950481533,0.023370316231788202,0.14617283950617285,2.6054570009253947e-07,0.0777146102094406,0.113421550094518
118,1.1,10,ai,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: Yes, the ability to perform transurethral resection of the prostate is influenced by the surgeon's previous experience. Experience allows the surgeon to develop skills, knowledge, and expertise, which are crucial for successfully performing the procedure and minimizing complications.","Is the competence for performing transurethral resection of the prostate influenced by the surgeon’s past experience? Yes, the surgeon’s competence is influenced by past experience, which helps them develop the essential skills, knowledge, and expertise to conduct the procedure effectively and minimize risks.",3.079176455639103e-07,0.033213359900947204,0.1536898323418063,0.023574544042164344,0.018690801874801988,0.17561983471074377,0.023540420032387266,0.07216048040121992,0.14617283950617285,3.079176455639103e-07,0.12772503078410402,0.113421550094518
119,1.1,1,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living situation, and mortality: is the relationship influenced by gender? Answer: The link between marital status, living arrangement, and mortality might differ based on gender. Additional studies are necessary to identify the exact differences and contributing factors.",9.474389094274152e-08,0.0720122768419631,0.018242786705624542,0.0072537058591274906,0.10355788051467618,0.002501206932288818,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
119,1.1,2,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Does gender affect the relationship between marital status, living arrangements, and mortality? Answer: The connection between marital status, living arrangement, and mortality could vary with gender, requiring further research to understand the specific contributing elements.",1.8948778188548272e-07,0.22795907391635906,0.015585937500000008,0.014507411718254988,0.2598488121938143,0.034798390095181445,0.014486412327622947,0.25907342527176347,0.0302734375,1.8948778188548325e-07,0.2231435513142097,0.0
119,1.1,3,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: How do marital status and living arrangements influence mortality, and does this differ by gender? Answer: The association of marital status and living arrangements with mortality may be gender-specific, making further investigation essential to uncover precise distinctions and involved factors.",7.105791820705622e-08,0.11423188645069127,0.029390432098765476,0.005440279394345618,0.14773899133408408,0.05259352898407034,0.0054324046228586,0.14894876808949453,0.05246913580246914,7.105791820705622e-08,0.11542895663511299,0.027006172839506164
119,1.1,4,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Marital status, living arrangements, and mortality: is there a gender-related variation in their association? Answer: Gender might alter the relationship between marital status, living setup, and mortality; thus, more research is needed to pinpoint particular variations and their causes.",9.474389094274152e-08,0.0720122768419631,0.018242786705624542,0.0072537058591274906,0.10355788051467618,0.002501206932288818,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
119,1.1,5,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Is the relationship between marital status, living arrangements, and mortality different for males and females? Answer: There may be gender-based differences in how marital status and living arrangements relate to mortality, highlighting the need for further study to clarify specific factors.",4.737194547137081e-08,0.04909016225166862,0.06937499999999999,0.0036268529295637453,0.015783155571340135,0.023795359904818555,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
119,1.1,6,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Does the marital status and living arrangement impact on mortality differ across genders? Answer: Mortality's association with marital status and living arrangements might be influenced by gender, necessitating more research to detail this relationship.",2.1317375462116802e-07,0.2604414705235256,0.01803394901144642,0.016320838183036868,0.29217288828666854,0.036558438222132526,0.01629721386857582,0.291157862689579,0.031217481789802305,2.1317375462116866e-07,0.25489224962878954,0.0
119,1.1,7,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Question: Do marital status and living conditions correlate with mortality differently for each gender? Answer: The association between these factors and mortality could depend on gender, and further exploration is required to understand these nuances.",1.8948778188548272e-07,0.10913384296322581,0.06937499999999999,0.014507411718254988,0.17830208506911438,0.023795359904818555,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
119,1.1,8,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Are the effects of marital status and living arrangements on mortality subject to gender differences? Answer: There is a possibility that gender affects the link between marital status, living setup, and mortality, warranting further research to explain the distinctions.",9.474389094274152e-08,0.0009202583229948047,0.06937499999999999,0.0072537058591274906,0.06707644995888984,0.023795359904818555,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
119,1.1,9,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: How does gender influence the association between marital status, living situation, and mortality? Answer: The relationship linking marital status, living arrangements, and mortality may vary by gender; thus, additional inquiry is crucial to identify specific factors.",1.6580180914979742e-07,0.15797931939207865,0.014011678200692018,0.012693985253473108,0.1889229585135741,0.004751352897949604,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
119,1.1,10,ai,"Question: Marital status, living arrangement and mortality: does the association vary by gender? Answer: The association between marital status, living arrangement, and mortality may vary depending on gender. Further research is needed to determine the specific differences and factors that contribute to these variations.","Question: Does gender moderate the association between marital status, living arrangements, and mortality? Answer: The connection between marital status, living arrangement, and mortality might be moderated by gender, meaning further investigation is important to discern particular differences and contributors.",1.1842986367842682e-07,0.13634003639361314,0.008992346938775514,0.009067132323909363,0.16867952737185643,0.030082191115589622,0.009054007704764333,0.16856130494597243,0.02775510204081633,1.1842986367842703e-07,0.13353139262452274,0.0
120,1.1,1,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: How does living in an urban area influence non-communicable disease risk in Thailand: Is timing a factor? Answer: Urban living correlated with higher behavioral and physiological risk factors, but this doesn't necessarily lead directly to increased biological risks. These biological risks probably stem from a complex interplay between prolonged exposure and early life conditions.",2.1317375462116866e-07,0.088136662631074,0.0475,0.016320838183036854,0.1568424714929706,0.0,0.0162972138685758,0.1596301455918825,0.0,2.1317375462116866e-07,0.16251892949777424,0.0
120,1.1,2,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does the timing of urban living affect the risk of non-communicable diseases in Thailand? Answer: Urban living is linked to heightened behavioral and physiological risk factors. However, these do not straightforwardly increase biological risk factors, which likely arise from a complex combination of long-term exposure and early life influences.",3.316036182995957e-07,0.2135921327402306,0.027100694444444445,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
120,1.1,3,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: In Thailand, does the timing of urban residency impact non-communicable disease risk? Answer: Urbanicity increases behavioral and physiological risks, though these effects don't directly boost biological risk factors. Such biological risks likely result from a complex interaction of chronic exposure and early life stages.",4.500334819780227e-07,0.2929310752770875,0.0475,0.03445510283085558,0.3659342693515293,0.0,0.034405229278104466,0.3732042458899425,0.0,4.500334819780227e-07,0.3807724955177916,0.0
120,1.1,4,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does living in an urban environment at different times influence non-communicable disease risk in Thailand? Answer: Urbanicity associates with greater behavioral and physiological risk factors. These associations don't necessarily cause immediate biological risk increases, as these risks probably emerge from a complex interplay of long-term exposure and early life events.",3.079176455639103e-07,0.1650977037672039,0.0475,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
120,1.1,5,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Is the timing of urban dwelling relevant to non-communicable disease risks in Thailand? Answer: Behavioral and physiological risk factors rise with urban living, but this may not directly translate to increased biological risk factors. Those biological risks likely result from a complex interaction between prolonged exposure and early developmental periods.",3.079176455639103e-07,0.1650977037672039,0.0475,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
120,1.1,6,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: How does the timing of urban residence affect non-communicable disease risk in Thailand? Answer: Urban living correlates with higher behavioral and physiological risk factors, yet these may not directly lead to biological risk factors, which are probably the product of complex, long-term exposure and early life factors.",3.789755637709665e-07,0.2564687321899699,0.026233459357277895,0.029014823436509962,0.29849298855599704,0.0,0.028972824655245866,0.30421137440299084,0.0,3.789755637709665e-07,0.3101549283038376,0.0
120,1.1,7,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does timing in urban exposure change non-communicable disease risks in Thailand? Answer: There is a link between urbanicity and elevated behavioral and physiological risk factors. Nonetheless, these factors may not directly cause heightened biological risk which likely arises from a complex interaction of long-term exposure and early life periods.",3.316036182995957e-07,0.1853004110847225,0.0475,0.025387970506946217,0.2559333741372005,0.0,0.025351221573340132,0.2607262624632525,0.0,3.316036182995957e-07,0.2657031657330049,0.0
120,1.1,8,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: In Thailand, is the timing of urban living important for non-communicable disease risk? Answer: Urban environments are associated with increased behavioral and physiological risks; however, these do not automatically increase biological risk factors due to a complex interplay of long-term exposures and early life.",4.500334819780227e-07,0.2929310752770875,0.0475,0.03445510283085558,0.3659342693515293,0.0,0.034405229278104466,0.3732042458899425,0.0,4.500334819780227e-07,0.3807724955177916,0.0
120,1.1,9,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does when one lives in an urban setting affect risk for non-communicable diseases in Thailand? Answer: Urbanicity increases behavioral and physiological risk factors, but this doesn't always result in greater biological risks, which probably develop from a complex combination of long-term exposure and early life experiences.",4.026615365066519e-07,0.24847931270625478,0.0475,0.030828249901291835,0.32047189527477205,0.0,0.030783626196198732,0.32668423025504856,0.0,4.026615365066519e-07,0.33314444652853714,0.0
120,1.1,10,human,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Urbanicity was associated with increases in behavioral and physiological risk factors. However, these associations may not translate directly into increases in biological risk factors. It is likely that these biological risk factors were results of a complex interaction between both long term accumulation of exposure and early life","Question: Does the timing of urban living affect non-communicable disease risk in Thailand? Answer: There is an association between urban life and increased behavioral and physiological risk elements, though these may not directly push biological risk factors up, likely due to a complex interaction of prolonged exposure and early life influences.",3.079176455639103e-07,0.1650977037672039,0.0475,0.023574544042164344,0.23531408693446476,0.0,0.023540420032387266,0.23967285326541932,0.0,3.079176455639103e-07,0.24419696051204154,0.0
121,1.1,1,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does sex impact the effectiveness of intravenous thrombolysis in ischemic stroke? A study found that sex does not seem to affect the response to intravenous thrombolysis in ischemic stroke, with men and women exhibiting comparable recanalization rates and functional outcomes after treatment.",1.1842986367842703e-07,0.005547664987933576,0.07455685044647327,0.009067132323909363,0.0022585055630583994,0.08031601894802412,0.009054007704764333,0.0013594530791576354,0.0861453046089739,1.1842986367842703e-07,0.005343659020720537,0.09204470742932283
121,1.1,2,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is the response to intravenous thrombolysis in ischemic stroke affected by sex? According to research, sex does not appear to influence outcomes, as both males and females had similar recanalization and functional recovery following the therapy.",2.6054570009253894e-07,0.062335497437957965,0.1472715318869165,0.019947691112600606,0.09546271700483855,0.13017751479289946,0.019918816950481547,0.13014862232452273,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
121,1.1,3,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does gender affect how patients respond to intravenous thrombolysis for ischemic stroke? Studies indicate that sex is not a factor, with equal recanalization rates and functional results observed in both men and women treated with this method.",2.3685972735685364e-07,0.03416462047126112,0.1472715318869165,0.018134264647818726,0.06647518013158704,0.13017751479289946,0.018108015409528673,0.10029565917484096,0.11176857330703485,2.3685972735685406e-07,0.13573493923918578,0.09204470742932283
121,1.1,4,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is there a difference in intravenous thrombolysis response in ischemic stroke between sexes? Evidence shows that sex does not modify treatment response, with similar success and functional outcome for male and female patients.",3.3160361829959484e-07,0.15194765612764494,0.1472715318869165,0.025387970506946245,0.18783603713585384,0.13017751479289946,0.025351221573340167,0.22545880212884795,0.11176857330703485,3.316036182995957e-07,0.26494667071919276,0.09204470742932283
121,1.1,5,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does sex determine the effectiveness of intravenous thrombolysis in ischemic stroke? Research suggests there is no difference, as males and females achieved comparable recanalization and functional improvement post-treatment.",4.5003348197802134e-07,0.3218466929230419,0.1472715318869165,0.03445510283085564,0.363726703599518,0.13017751479289946,0.034405229278104535,0.40778035892280284,0.11176857330703485,4.500334819780227e-07,0.4541886703577207,0.09204470742932283
121,1.1,6,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Are the outcomes of intravenous thrombolysis in ischemic stroke influenced by sex? Findings reveal no sex-based variation, with similar rates of vessel reopening and functional recovery in both sexes.",4.2634750924233604e-07,0.28547904875216723,0.1472715318869165,0.03264167636607376,0.325986375616671,0.13017751479289946,0.03259442773715166,0.3685596457695204,0.11176857330703485,4.263475092423373e-07,0.4133666758374659,0.09204470742932283
121,1.1,7,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Do males and females respond differently to intravenous thrombolysis in ischemic stroke? The data indicates that sex does not impact treatment response, with equivalent recanalization and functional outcomes.",4.5003348197802134e-07,0.3218466929230419,0.1472715318869165,0.03445510283085564,0.363726703599518,0.13017751479289946,0.034405229278104535,0.40778035892280284,0.11176857330703485,4.500334819780227e-07,0.4541886703577207,0.09204470742932283
121,1.1,8,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.",Is the sex of a patient relevant to their recovery after intravenous thrombolysis for ischemic stroke? Studies show that sex does not alter the response; both genders have similar recanalization success and neurological outcomes.,3.0791764556390954e-07,0.12117599746089125,0.1472715318869165,0.023574544042164365,0.156087338821274,0.13017751479289946,0.023540420032387294,0.19266897930585625,0.11176857330703485,3.079176455639103e-07,0.231045119043511,0.09204470742932283
121,1.1,9,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Does intravenous thrombolysis work equally well for ischemic stroke patients regardless of sex? Research reports no significant sex differences, showing comparable recanalization and functional results between males and females.",4.2634750924233604e-07,0.28547904875216723,0.1472715318869165,0.03264167636607376,0.325986375616671,0.13017751479289946,0.03259442773715166,0.3685596457695204,0.11176857330703485,4.263475092423373e-07,0.4133666758374659,0.09204470742932283
121,1.1,10,ai,"Question: Does sex influence the response to intravenous thrombolysis in ischemic stroke? Answer: Sex does not appear to influence the response to intravenous thrombolysis in ischemic stroke, according to a study. Both males and females showed similar rates of recanalization and functional outcome after receiving this treatment.","Is the effectiveness of intravenous thrombolysis in ischemic stroke patients influenced by their sex? Evidence confirms that sex does not affect therapeutic response, with both male and female patients experiencing similar recovery rates and functional outcomes.",2.6054570009253894e-07,0.062335497437957965,0.1472715318869165,0.019947691112600606,0.09546271700483855,0.13017751479289946,0.019918816950481547,0.13014862232452273,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
122,1.1,1,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is beta-endorphin deficiency responsible for anxiety caused by withdrawal in alcoholism?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,1.1,2,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Could a lack of beta-endorphins contribute to withdrawal anxiety in alcoholism?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,1.1,3,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Does anxiety during alcohol withdrawal result from decreased beta-endorphins?,5.921493183921331e-07,1.2910392596848363,0.09000000000000004,0.045335661619546955,1.4331823561744184,0.06222222222222223,0.04527003852382183,1.5975085623177407,0.0322222222222222,5.921493183921343e-07,1.7917594692280545,0.0
122,1.1,4,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is depressive anxiety in alcoholic withdrawal linked to insufficient beta-endorphins?,5.684633456564478e-07,1.1732562240284525,0.09000000000000004,0.043522235154765075,1.2996509635498965,0.06222222222222223,0.043459236982868965,1.4433578824904818,0.0322222222222222,5.684633456564489e-07,1.6094379124341,0.0
122,1.1,5,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Might a deficiency in beta-endorphins underlie withdrawal anxiety in those with alcoholism?,5.210914001850771e-07,0.9725855285663014,0.09000000000000004,0.03989538222520132,1.0765074122356868,0.06222222222222223,0.03983763390096322,1.1920434542095761,0.0322222222222222,5.210914001850783e-07,1.3217558399823193,0.0
122,1.1,6,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is the anxiety observed during alcohol withdrawal due to beta-endorphin shortage?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,1.1,7,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Can beta-endorphin deficiency be a factor in alcoholism withdrawal anxiety?,5.684633456564478e-07,1.1732562240284525,0.09000000000000004,0.043522235154765075,1.2996509635498965,0.06222222222222223,0.043459236982868965,1.4433578824904818,0.0322222222222222,5.684633456564489e-07,1.6094379124341,0.0
122,1.1,8,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is withdrawal-related anxiety in alcoholics connected to low beta-endorphin levels?,5.684633456564478e-07,1.1732562240284525,0.09000000000000004,0.043522235154765075,1.2996509635498965,0.06222222222222223,0.043459236982868965,1.4433578824904818,0.0322222222222222,5.684633456564489e-07,1.6094379124341,0.0
122,1.1,9,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Does the anxiety from alcohol withdrawal stem from a beta-endorphin deficit?,5.447773729207624e-07,1.0678957083706266,0.09000000000000004,0.041708808689983196,1.1818679278935127,0.06222222222222223,0.041648435441916085,1.30982648986596,0.0322222222222222,5.447773729207636e-07,1.4552872326068411,0.0
122,1.1,10,ai,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Withdrawal-induced anxiety in alcoholism may be associated with a beta-endorphin deficiency. Beta-endorphins are natural peptides that play a role in regulating mood and,Is a decrease in beta-endorphins involved in the anxiety associated with alcohol withdrawal?,4.974054274493918e-07,0.8855741515766713,0.09000000000000004,0.03808195576041945,0.9811972324313616,0.06222222222222223,0.03802683236001034,1.0866829385517502,0.0322222222222222,4.974054274493929e-07,1.2039728043259355,0.0
123,1.1,1,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: How well are patients at high risk for falls prepared for discharge after rehabilitation? Answer: It's uncertain if such patients receive adequate preparation for discharge. More assessment is required to confirm adherence to guidelines.,3.5528959103528046e-07,0.13912600025040112,0.15704937537180244,0.027201396971728103,0.20140665430142457,0.12244897959183676,0.02716202311429302,0.2664292000916175,0.08436992969172526,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
123,1.1,2,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Are patients prone to falls sufficiently prepared for discharge home post-rehabilitation? Answer: There is a lack of clarity regarding the adequacy of discharge preparation for these patients. Further investigation is necessary to evaluate compliance with guidelines.,3.0791764556390986e-07,0.08196758641045276,0.15704937537180244,0.023574544042164344,0.14256615427849129,0.12244897959183676,0.023540420032387273,0.20580457827518206,0.08436992969172526,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
123,1.1,3,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Do we follow guidelines in preparing high fall-risk patients for discharge after rehab? Answer: It remains unclear if these patients are properly prepared for going home. Additional evaluation is needed to confirm guideline adherence.,3.5528959103528046e-07,0.13912600025040112,0.15704937537180244,0.027201396971728103,0.20140665430142457,0.12244897959183676,0.02716202311429302,0.2664292000916175,0.08436992969172526,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
123,1.1,4,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Is discharge preparation for patients susceptible to falls after rehab in line with recommendations? Answer: The adequacy of preparation for discharge among these patients is uncertain. More research is required to assess conformity with guidelines.,3.3160361829959516e-07,0.14974687369486084,0.12850266256903428,0.025387970506946224,0.1715536911517428,0.12244897959183676,0.025351221573340146,0.23565754142486384,0.08436992969172526,3.316036182995957e-07,0.30263182581459036,0.043388429752066124
123,1.1,5,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: How effectively are patients with a high risk of falls prepared for home discharge following rehabilitation? Answer: Uncertainty exists about whether such patients are adequately prepared. Further evaluation should determine if current practices meet established standards.,3.0791764556390986e-07,0.08196758641045276,0.15704937537180244,0.023574544042164344,0.14256615427849129,0.12244897959183676,0.023540420032387273,0.20580457827518206,0.08436992969172526,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
123,1.1,6,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Are rehabilitation discharge protocols for patients at high fall risk being properly met? Answer: It is unclear if preparation before discharge sufficiently follows guidelines. A thorough evaluation is needed.,4.7371945471370696e-07,0.29819069488008987,0.15704937537180244,0.0362685292956375,0.36570970559270055,0.12244897959183676,0.03621603081905739,0.4363282368870145,0.08436992969172526,4.737194547137081e-07,0.5102711905928343,0.043388429752066124
123,1.1,7,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Do current practices ensure that patients vulnerable to falls are well-prepared for discharge after rehab? Answer: The effectiveness of preparation is uncertain and requires further review to verify guideline adherence.,4.5003348197802166e-07,0.2642891432044081,0.15704937537180244,0.03445510283085562,0.33061838578143155,0.12244897959183676,0.034405229278104514,0.3999605927161398,0.08436992969172526,4.500334819780227e-07,0.47253086260998733,0.043388429752066124
123,1.1,8,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,Question: Is there compliance with guidelines when preparing fall-risk patients for discharge after rehabilitation? Answer: It's not clear if these patients receive adequate support upon discharge. More assessment must be conducted.,4.5003348197802166e-07,0.2642891432044081,0.15704937537180244,0.03445510283085562,0.33061838578143155,0.12244897959183676,0.034405229278104514,0.3999605927161398,0.08436992969172526,4.500334819780227e-07,0.47253086260998733,0.043388429752066124
123,1.1,9,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,"Question: To what extent are high fall-risk patients prepared for discharge post-rehab according to guidelines? Answer: Adequacy of discharge preparation remains uncertain, necessitating additional evaluation.",5.921493183921335e-07,0.4874326945186178,0.15704937537180244,0.0453356616195469,0.5624199998387551,0.12244897959183676,0.045270038523821755,0.6411226495330284,0.08436992969172526,5.921493183921352e-07,0.7238452908908952,0.043388429752066124
123,1.1,10,ai,Question: Preparing patients at high risk of falls for discharge home after rehabilitation: Do we meet the guidelines? Answer: It is unclear whether patients at high risk of falls are adequately prepared for discharge home after rehabilitation. Further evaluation is needed to determine if current practices align with established guidelines.,"Question: Are high fall-risk patients adequately readied for home discharge after rehabilitation in accordance with guidelines? Answer: There is uncertainty about whether current preparation practices fully comply with established guidelines, warranting further examination.",4.0266153650665106e-07,0.19975062206683658,0.15704937537180244,0.030828249901291863,0.2639270112827581,0.12244897959183676,0.030783626196198767,0.33096772122918905,0.08436992969172526,4.026615365066519e-07,0.40107189862784365,0.043388429752066124
124,1.1,1,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage an effective method for managing postoperative cerebrospinal fluid fistula following spine surgery? Lumbar drainage appears to be both effective and safe for preventing CSF fistulas especially in cases of significant dural tears and in patients who are debilitated or have undergone irradiation, as well as for treating existing CSF leaks.",2.8423167282822487e-07,0.2703621165508747,0.005760187820342211,0.02176111757738247,0.26826398659468076,0.0,0.0217296184914344,0.27443684570175897,0.0,2.8423167282822487e-07,0.2809023854664012,0.0
124,1.1,2,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage effectively treat postoperative CSF fistulas after spine surgery? Evidence suggests that lumbar drainage is a safe and effective approach for preventing CSF fistulas in patients with large dural tears and those who are debilitated or irradiated, and it also aids in resolving CSF leaks.",1.4211583641411244e-07,0.11414563352837703,0.018404866306964203,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
124,1.1,3,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage prevent and treat cerebrospinal fluid fistulas after spine surgery? Lumbar drainage seems to safely and effectively prevent CSF fistulas in cases involving large dural tears and patients with weakened or irradiated tissue, and it is useful for treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,1.1,4,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a reliable and safe option for addressing postoperative cerebrospinal fluid fistula after spine surgery? It appears to be effective in both preventing CSF fistulas in patients with major dural tears and compromised health or irradiation, and in managing CSF leaks.",4.737194547137081e-08,0.0834475231974281,0.02498356344510192,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,1.1,5,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does the use of lumbar drainage improve outcomes for postoperative CSF fistula following spine surgery? Lumbar drainage is considered safe and effective for preventing CSF fistulas in large dural tear cases and in debilitated or irradiated patients, as well as for treating CSF leaks.",7.105791820705622e-08,0.07473861686064831,0.0017409330596143968,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
124,1.1,6,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage beneficial in preventing and treating cerebrospinal fluid fistula after spinal surgery? Lumbar drainage has shown to be a safe and effective measure for CSF fistula prevention in large dural tears and patients with frail or irradiated tissue, and it helps in treating CSF leaks.",1.4211583641411244e-07,0.14428246746576612,0.003255168383373523,0.010880558788691236,0.1431008436406751,0.0,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
124,1.1,7,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"How effective is lumbar drainage in managing postoperative CSF fistula after spine surgery? Lumbar drainage appears to be a safe and effective technique both in preventing CSF fistulas, particularly with large dural tears and weakened or irradiated patients, and in treating CSF leaks.",4.737194547137081e-08,0.05044051459933652,0.0011882035402833654,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
124,1.1,8,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Is lumbar drainage a safe and efficient treatment for cerebrospinal fluid fistula post spinal surgery? It seems to be both effective and safe in preventing CSF fistulas in large dural tear cases and debilitated or irradiated patients, as well as in the treatment of CSF leaks.",1.1842986367842703e-07,0.15244039468437975,0.02498356344510192,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
124,1.1,9,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Does lumbar drainage effectively prevent and treat postoperative cerebrospinal fluid fistulas following spine surgery? Lumbar drainage is likely a safe and effective intervention for preventing CSF fistulas in cases of significant dural tears and in debilitated or irradiated patients, and it treats CSF leaks.",7.105791820705622e-08,0.07473861686064831,0.0017409330596143968,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
124,1.1,10,human,Question: Is lumbar drainage of postoperative cerebrospinal fluid fistula after spine surgery effective? Answer: Lumbar drainage seems to be effective and safe both in preventing CSF fistula in cases of large dural tears and debilitated/irradiated patients and in treating CSF leaks.,"Can lumbar drainage securely and effectively handle postoperative CSF fistula after spine surgery? Lumbar drainage seems to work well both in preventing CSF fistulas in patients with large dural tears or who are debilitated/irradiated, and in treating CSF leaks.",4.73719454713706e-08,0.053117365915339665,0.0013130033920054525,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
125,1.1,1,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does using a neuroendoscope at the same time affect the rate of ventriculoperitoneal shunt infections? The concurrent use of a neuroendoscope does not significantly impact the frequency of ventriculoperitoneal shunt infections.,9.47438909427412e-08,0.10316769299515194,0.13163456790123454,0.007253705859127518,0.1170474549258258,0.1623067866199734,0.007243206163811494,0.0830771013004612,0.1508916323731139,9.474389094274162e-08,0.003992819662763214,0.09566326530612247
125,1.1,2,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Is the incidence of ventriculoperitoneal shunt infection affected by simultaneous neuroendoscope usage? Employing a neuroendoscope simultaneously does not notably alter the incidence of ventriculoperitoneal shunt infections.,2.131737546211677e-07,0.16233152546599738,0.07620498866213149,0.016320838183036916,0.19767808602096704,0.07429658253834079,0.016297213868575862,0.23418052869514927,0.06472383191959917,2.1317375462116866e-07,0.27180061235968145,0.050311791383219964
125,1.1,3,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does simultaneous neuroendoscope use influence ventriculoperitoneal shunt infection rates? Using a neuroendoscope at the same time does not significantly change the rate of ventriculoperitoneal shunt infection.,2.131737546211677e-07,0.004023797868390577,0.19046944444444444,0.016320838183036916,0.02439129088098202,0.1967455621301775,0.016297213868575862,0.11363319294559338,0.1508916323731139,2.1317375462116866e-07,0.20878723230877716,0.09566326530612247
125,1.1,4,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Is there a significant effect on ventriculoperitoneal shunt infection by using a neuroendoscope simultaneously? The simultaneous application of a neuroendoscope shows no meaningful effect on ventriculoperitoneal shunt infection occurrence.,1.421158364141118e-07,0.07474830686550504,0.060267674858223014,0.010880558788691277,0.060640962015697575,0.08737056213017749,0.010864809245717241,0.09766889863171402,0.07450274348422502,1.4211583641411244e-07,0.13640563524368776,0.05573270975056691
125,1.1,5,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does concurrent utilization of a neuroendoscope impact ventriculoperitoneal shunt infection incidence? The use of a neuroendoscope alongside does not significantly impact the occurrence of ventriculoperitoneal shunt infections.,1.894877818854824e-07,0.06126075620121041,0.11697844990548205,0.014507411718255037,0.03902107080552231,0.15681500657462194,0.014486412327622988,0.07107357852679774,0.1508916323731139,1.8948778188548325e-07,0.1643354697379431,0.09566326530612247
125,1.1,6,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does employing a neuroendoscope at the time of the procedure affect the incidence of ventriculoperitoneal shunt infection? The concurrent use of a neuroendoscope does not importantly influence ventriculoperitoneal shunt infection rates.,9.47438909427412e-08,0.14937750503248148,0.16407346938775513,0.007253705859127518,0.16485070875754593,0.1967455621301775,0.007243206163811494,0.0830771013004612,0.1508916323731139,9.474389094274162e-08,0.003992819662763214,0.09566326530612247
125,1.1,7,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does the simultaneous operation of a neuroendoscope change the likelihood of ventriculoperitoneal shunt infection? Simultaneous neuroendoscope operation does not substantially affect ventriculoperitoneal shunt infection incidence.,2.36859727356853e-07,0.039108687253729624,0.18881209829867673,0.018134264647818796,0.06695090529977765,0.1967455621301775,0.018108015409528735,0.15808495551642743,0.1508916323731139,2.3685972735685406e-07,0.2553072479436711,0.09566326530612247
125,1.1,8,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Is the rate of ventriculoperitoneal shunt infection influenced by the simultaneous use of a neuroendoscope? There is no significant influence from using a neuroendoscope simultaneously on ventriculoperitoneal shunt infection frequency.,1.184298636784265e-07,0.11228906976801856,0.16181289437585733,0.009067132323909398,0.08024887604913777,0.16108026720562332,0.009054007704764368,0.04670945712958652,0.1508916323731139,1.1842986367842703e-07,0.0417331476456102,0.09566326530612247
125,1.1,9,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Does performing procedures with a neuroendoscope simultaneously alter ventriculoperitoneal shunt infection occurrence? The simultaneous use of a neuroendoscope does not cause a significant change in ventriculoperitoneal shunt infection rates.,1.421158364141118e-07,0.024272718928772363,0.12479999999999997,0.010880558788691277,0.04204750917836897,0.15976331360946744,0.010864809245717241,0.00896912914673953,0.1508916323731139,1.4211583641411244e-07,0.08095386079889266,0.09566326530612247
125,1.1,10,ai,Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: The simultaneous use of a neuroendoscope does not have a significant influence on the incidence of ventriculoperitoneal shunt infection.,Is the frequency of ventriculoperitoneal shunt infection affected when a neuroendoscope is used simultaneously? Using a neuroendoscope at the same time does not significantly affect the incidence of ventriculoperitoneal shunt infection.,9.47438909427412e-08,0.10316769299515194,0.13163456790123454,0.007253705859127518,0.1170474549258258,0.1623067866199734,0.007243206163811494,0.0830771013004612,0.1508916323731139,9.474389094274162e-08,0.003992819662763214,0.09566326530612247
126,1.1,1,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
126,1.1,2,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can automatic transmissions enhance driving performance in elderly drivers? Answer: It is suggested that older drivers consider switching to an automatic transmission to help preserve safe driving and ensure good transport mobility.,7.10579182070559e-08,0.05000374837197574,0.02854671280276816,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,1.1,3,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Is driving behavior better in older drivers with automatic transmissions? Answer: Older drivers may benefit from using automatic transmissions to support safer driving practices and maintain quality transport mobility.,1.421158364141118e-07,0.19624707501694916,0.005892062707435933,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,1.1,4,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,"Question: Does using automatic transmission promote safer driving among older adults? Answer: For older drivers, transitioning to an automatic transmission can be advisable to sustain driving safety and overall transport mobility.",1.184298636784265e-07,0.1607520815468768,0.0047469851758287565,0.009067132323909398,0.15906469462968875,0.0,0.009054007704764368,0.16430305129127598,0.0,1.1842986367842703e-07,0.16989903679539697,0.0
126,1.1,5,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can switching to automatic transmission improve the driving habits of senior drivers? Answer: Older drivers might be encouraged to adopt automatic transmissions to help uphold safe driving and improve transport mobility quality.,7.10579182070559e-08,0.05000374837197574,0.02854671280276816,0.005440279394345639,0.09237332013101529,0.0,0.005432404622858621,0.09531017980432521,0.0,7.105791820705622e-08,0.09844007281325329,0.0
126,1.1,6,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Does an automatic transmission positively impact the driving behavior of elderly drivers? Answer: It is often recommended that older drivers switch to automatic transmissions to maintain safe driving and enhance their transport mobility.,4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
126,1.1,7,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Will automatic transmission help improve driving safety in older drivers? Answer: Older individuals might consider automatic transmissions as a way to maintain safer driving conditions and better transport mobility.,1.421158364141118e-07,0.14844382118522903,0.02854671280276816,0.010880558788691277,0.19415601444095776,0.0,0.010864809245717241,0.20067069546215066,0.0,1.4211583641411244e-07,0.20763936477824396,0.0
126,1.1,8,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Is the use of automatic transmissions beneficial to driving behavior among older drivers? Answer: Switching to automatic transmission might be advised for seniors to help keep their driving safe and their transport mobility high-quality.,2.36859727356853e-08,0.010620873444459722,0.02854671280276816,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
126,1.1,9,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,"Question: Does automatic transmission make driving easier and safer for older drivers? Answer: As a measure to promote safer driving and maintain transport mobility, older drivers may be recommended to switch to automatic transmission.",4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
126,1.1,10,human,Question: Does automatic transmission improve driving behavior in older drivers? Answer: Switching to automatic transmission may be recommended for older drivers as a means to maintain safe driving and thereby the quality of their transport mobility.,Question: Can older drivers improve their safety and transport mobility by using automatic transmissions? Answer: Switching to automatic transmission can be a helpful recommendation for senior drivers to preserve safe driving practices and sustain their mobility quality.,2.36859727356853e-08,0.06777928728440807,0.02854671280276816,0.0018134264647818796,0.028987536873251507,0.0,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
127,1.1,1,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does anemia before surgery have a negative impact on the results of colon and rectal surgeries? This extensive analysis of a multicenter database indicates that severe, moderate, and even mild anemia prior to surgery independently increases the risk of complications and extends hospital stays following colon surgery.",4.737194547137081e-08,0.07595845259628531,0.02271498107084911,0.0036268529295637453,0.04546237407675724,0.0,0.003621603081905733,0.04652001563489394,0.0,4.737194547137081e-08,0.047628048989254435,0.0
127,1.1,2,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Is preoperative anemia linked to worse outcomes in colon and rectal surgery? According to this large multicenter database study, the presence of severe, moderate, or mild anemia before surgery is an independent predictor of complications and prolonged hospitalization post colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,1.1,3,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does having anemia before colon or rectal surgery affect surgical outcomes adversely? This broad multicenter database analysis reveals that any degree of preoperative anemia—severe, moderate, or mild—is an independent risk factor for complications and longer hospital stays after colon surgery.",1.1842986367842692e-07,0.0891212977631648,0.02271498107084911,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,1.1,4,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does anemia prior to colon and rectal surgery negatively influence surgical outcomes? Evidence from this large multicenter database shows that severe, moderate, and even mild preoperative anemia independently increase complication risks and prolong hospital admission after colon surgery.",1.6580180914979753e-07,0.14176503124858364,0.02271498107084911,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
127,1.1,5,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Is preoperative anemia a detrimental factor for outcomes in colon and rectal surgeries? This extensive study utilizing a large multicenter database suggests that severe, moderate, and mild anemia before surgery is independently associated with higher complication rates and extended hospital stays following colon surgery.",2.3685972735685406e-08,0.008517171800753065,0.02271498107084911,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
127,1.1,6,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does pre-surgical anemia impair colon and rectal surgery results? Findings from this large multicenter database analysis indicate that severe, moderate, and mild anemia before surgery is an independent factor increasing complications and hospitalization duration after colon surgery.",1.8948778188548283e-07,0.16916400543669896,0.02271498107084911,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
127,1.1,7,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does the presence of anemia before colon or rectal surgery negatively affect surgical outcomes? This study of a large multicenter database demonstrates that mild, moderate, and severe preoperative anemia independently contribute to complications and lengthier hospital stays post colon surgery.",1.1842986367842692e-07,0.0891212977631648,0.02271498107084911,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
127,1.1,8,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Is preoperative anemia linked to poorer colon and rectal surgery outcomes? Analysis of this large multicenter database finds that severe, moderate, and mild anemia prior to surgery independently raises the risk of complications and longer hospitalization following colon surgery.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
127,1.1,9,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does anemia before undergoing colon and rectal surgery worsen patient outcomes? According to this analysis of a large multicenter database, any level of preoperative anemia—severe, moderate, or mild—is an independent risk factor for complications and extended hospital stays after colon surgery.",9.474389094274162e-08,0.06380348977887307,0.02271498107084911,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
127,1.1,10,human,Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: This large multicenter database analysis suggests that the presence of severe and moderate and even mild preoperative anemia is an independent risk factor for complications and a longer hospital stay after colon surgery.,"Does preoperative anemia adversely influence outcomes in colon and rectal surgery? This large-scale multicenter database analysis indicates that severe, moderate, and even mild anemia before surgery independently increases the risk of complications and lengthens hospital stays following colon surgery.",1.4211583641411222e-07,0.11509678416642277,0.02271498107084911,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
128,1.1,1,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of having preeclampsia predict maternal and neonatal adverse outcomes? Answer: The initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia is not a predictive indicator for maternal and neonatal adverse outcomes.,4.737194547137081e-08,0.09300961162067889,0.006803840877915079,0.0036268529295637453,0.09784243133245818,0.03020211726730243,0.003621603081905733,0.10304207538179488,0.05982461355529137,4.737194547137081e-08,0.10864615733962157,0.08346189164370979
128,1.1,2,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Is the first urinary albumin/creatinine ratio (ACR) measurement in women suspected of preeclampsia predictive of maternal and neonatal complications? Answer: The initial urinary albumin/creatinine ratio (ACR) in suspected preeclamptic women does not predict maternal and neonatal complications.,1.6580180914979753e-07,0.17500493333163547,0.10136022162208497,0.012693985253473108,0.1903853488738365,0.16607986169674488,0.012675610786670066,0.20716114466353908,0.2187779007525232,1.6580180914979784e-07,0.1847210913830435,0.23222222222222216
128,1.1,3,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Can the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia serve as a prognostic marker for adverse maternal and neonatal outcomes? Answer: The first urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia cannot be used as a prognostic marker for adverse maternal and neonatal outcomes.,9.474389094274162e-08,0.1894081195723487,0.0147377251754357,0.0072537058591274906,0.18909542106028843,0.012565320245745387,0.007243206163811466,0.18855771666965326,0.03181440947365871,9.474389094274162e-08,0.18776418431322295,0.04472222222222216
128,1.1,4,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Is the initial urinary albumin/creatinine ratio (ACR) a useful prognostic factor for adverse outcomes in mothers and newborns among women with suspected preeclampsia? Answer: The initial urinary albumin/creatinine ratio (ACR) is not a useful prognostic factor for maternal and neonatal adverse outcomes in women with suspected preeclampsia.,7.105791820705622e-08,0.21812857706366096,0.002963010428088053,0.005440279394345618,0.2798008315636449,0.0646485219361668,0.0054324046228586,0.34405127647105793,0.13794961355529137,7.105791820705622e-08,0.3480301306087865,0.16440544649348923
128,1.1,5,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Does the first measurement of urinary albumin/creatinine ratio (ACR) in women suspected of having preeclampsia predict poor maternal and neonatal outcomes? Answer: The first urinary albumin/creatinine ratio (ACR) measurement in women suspected of preeclampsia does not predict adverse maternal and neonatal outcomes.,4.737194547137081e-08,0.19203063741495807,0.03484905168406843,0.0036268529295637453,0.2669027192739093,0.12912572436381958,0.003621603081905733,0.31098622954977895,0.19746311771041603,4.737194547137081e-08,0.321922212896526,0.23222222222222216
128,1.1,6,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia indicative of future maternal and neonatal adverse outcomes? Answer: The first urinary albumin/creatinine ratio (ACR) in such women is not indicative of potential maternal and neonatal adverse outcomes.,9.474389094274162e-08,0.09372996034838721,0.010973936899862813,0.0072537058591274906,0.13713052182430685,0.07782605229591841,0.007243206163811466,0.14660050043928985,0.11876630317879919,9.474389094274162e-08,0.15687623391489858,0.15177239523260283
128,1.1,7,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Can the initial urinary albumin/creatinine ratio (ACR) in suspected preeclamptic women forecast maternal and neonatal adverse events? Answer: The initial urinary albumin/creatinine ratio (ACR) in these women does not forecast maternal and neonatal adverse events.,2.1317375462116813e-07,0.08931194517327468,0.006803840877915024,0.01632083818303686,0.07743544337158514,0.035706738316628545,0.016297213868575813,0.06412446524529969,0.07448510738245184,2.1317375462116866e-07,0.04919032557337921,0.10977324263038545
128,1.1,8,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Is the first urinary albumin/creatinine ratio (ACR) test in women thought to have preeclampsia a reliable prognostic factor for maternal and neonatal risks? Answer: The first urinary albumin/creatinine ratio (ACR) test is not a reliable prognostic factor for maternal or neonatal risks in women suspected of preeclampsia.,7.105791820705622e-08,0.24762420176833944,0.007890036673105394,0.005440279394345618,0.2798008315636449,0.0646485219361668,0.0054324046228586,0.28243819375461765,0.09704760524504208,7.105791820705622e-08,0.285016750557884,0.12045364891518731
128,1.1,9,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Does the initial urinary albumin/creatinine ratio (ACR) in women suspected of preeclampsia predict poor outcomes for mother and child? Answer: The first urinary albumin/creatinine ratio (ACR) in these women is not predictive of poor maternal or neonatal outcomes.,1.4211583641411222e-07,0.2430845340176626,0.12938993074838254,0.010880558788691236,0.22090660765906778,0.16827466280629905,0.0108648092457172,0.19792407855239746,0.1919612917559834,1.4211583641411244e-07,0.17410021793858377,0.203675509419454
128,1.1,10,ai,Question: Is the first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia a prognostic factor for maternal and neonatal adverse outcome? Answer: The first urinary albumin/creatinine ratio (ACR) in women with suspected preeclampsia is not a prognostic factor for maternal and neonatal adverse outcome.,Question: Is the first urinary albumin/creatinine ratio (ACR) considered a prognostic indicator for adverse maternal and neonatal outcomes in women suspected of preeclampsia? Answer: The first urinary albumin/creatinine ratio (ACR) is not considered a prognostic indicator for maternal and neonatal adverse outcomes in women with suspected preeclampsia.,4.737194547137081e-08,0.18828665181746107,0.005554988719971954,0.0036268529295637453,0.25179455805739215,0.06122448979591841,0.003621603081905733,0.31807767728283975,0.13555604024825652,4.737194547137081e-08,0.3228424712195208,0.16284722222222217
129,1.1,1,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: In the preoperative staging of patients with colorectal carcinoma liver metastases, does PET/CT offer more than multidetector CT? Answer: PET/CT imaging delivers extra, valuable details for preoperative staging over multidetector CT alone in patients with liver metastases from colorectal carcinoma.",1.6580180914979784e-07,0.03487775668999049,0.13088642659279776,0.012693985253473108,0.045878087202273043,0.1472715318869165,0.012675610786670066,0.015762918105385992,0.13017751479289946,1.6580180914979784e-07,0.01573827114677684,0.11176857330703485
129,1.1,2,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: For preoperative staging of liver metastases in colorectal carcinoma patients, does PET/CT provide added insights beyond multidetector CT? Answer: PET/CT has been shown to yield additional and important information compared to multidetector CT alone for staging liver metastases preoperatively in colorectal carcinoma cases.",9.474389094274162e-08,0.07979492508468766,0.1113729224376731,0.0072537058591274906,0.08697905075790491,0.12347617198209794,0.007243206163811466,0.0917488250833074,0.13017751479289946,9.474389094274162e-08,0.06222327032293373,0.11176857330703485
129,1.1,3,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: Regarding the preoperative staging of colorectal carcinoma liver metastases, is PET/CT superior to multidetector CT? Answer: PET/CT imaging offers supplementary valuable information during the preoperative staging of these patients beyond what multidetector CT can provide.",2.8423167282822434e-07,0.1481641488316714,0.0957869849376731,0.02176111757738248,0.17286976143590937,0.0886777818869165,0.021729618491434413,0.16732460018845607,0.09990407729289946,2.8423167282822487e-07,0.16092028099127598,0.11176857330703485
129,1.1,4,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: In staging liver metastases from colorectal carcinoma before surgery, does PET/CT contribute more than multidetector CT? Answer: Compared to multidetector CT alone, PET/CT imaging adds significant and useful information for preoperative staging of colorectal carcinoma patients with liver metastases.",1.8948778188548314e-07,0.043328657502208934,0.15512465373961215,0.014507411718254981,0.01990260079901507,0.1472715318869165,0.014486412327622933,0.010905328976774875,0.13017751479289946,1.8948778188548325e-07,0.04313724533489216,0.11176857330703485
129,1.1,5,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: Does PET/CT improve preoperative staging for patients with colorectal carcinoma liver metastases compared to multidetector CT? Answer: Yes, PET/CT provides additional valuable data that multidetector CT alone does not offer in preoperative staging of these patients.",2.6054570009253904e-07,0.03967621760961615,0.15299282039685677,0.0199476911126006,0.062335497437957965,0.1472715318869165,0.01991881695048154,0.09546271700483855,0.13017751479289946,2.6054570009253947e-07,0.1301486223245223,0.11176857330703485
129,1.1,6,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: For patients with liver metastases of colorectal carcinoma, does PET/CT add valuable information when used for preoperative staging alongside multidetector CT? Answer: PET/CT has been found to supply extra, important details for preoperative staging beyond those gleaned from multidetector CT alone.",1.4211583641411244e-07,0.06126097215977655,0.13209571993931676,0.010880558788691236,0.03653853615856839,0.12228796844181458,0.0108648092457172,0.04173840450864397,0.13017751479289946,1.4211583641411244e-07,0.010929975935384029,0.11176857330703485
129,1.1,7,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Question: Is there an added benefit of PET/CT over multidetector CT in the preoperative staging of liver metastases from colorectal carcinoma? Answer: PET/CT imaging contributes further valuable insights that enhance preoperative staging compared to relying solely on multidetector CT.,1.8948778188548314e-07,0.043328657502208934,0.15512465373961215,0.014507411718254981,0.01990260079901507,0.1472715318869165,0.014486412327622933,0.010905328976774875,0.13017751479289946,1.8948778188548325e-07,0.04313724533489216,0.11176857330703485
129,1.1,8,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: Question: In preoperative staging of colorectal carcinoma liver metastases, what extra value does PET/CT have over multidetector CT? Answer: PET/CT has demonstrated the ability to provide additional important information beyond that acquired through multidetector CT alone.",2.6054570009253904e-07,0.001168040911841306,0.1807479224376731,0.0199476911126006,0.062335497437957965,0.1472715318869165,0.01991881695048154,0.09546271700483855,0.13017751479289946,2.6054570009253947e-07,0.1301486223245223,0.11176857330703485
129,1.1,9,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,Question: Can PET/CT offer more useful information than multidetector CT in the preoperative staging of liver metastases due to colorectal carcinoma? Answer: PET/CT imaging proves to add beneficial and relevant data for staging before surgery that multidetector CT by itself lacks.,1.6580180914979784e-07,0.0695351157179882,0.15576435899257118,0.012693985253473108,0.045878087202273043,0.1472715318869165,0.012675610786670066,0.015762918105385992,0.13017751479289946,1.6580180914979784e-07,0.01573827114677684,0.11176857330703485
129,1.1,10,ai,Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT imaging has been found to provide additional and valuable information for preoperative staging of patients with liver metastases of colorectal carcinoma when compared to multidetector CT alone.,"Question: Question: When staging liver metastases from colorectal carcinoma preoperatively, does PET/CT give additional advantages compared to multidetector CT? Answer: PET/CT imaging does provide added valuable details, enhancing the preoperative staging process more than multidetector CT alone.",2.6054570009253904e-07,0.001168040911841306,0.1807479224376731,0.0199476911126006,0.062335497437957965,0.1472715318869165,0.01991881695048154,0.09546271700483855,0.13017751479289946,2.6054570009253947e-07,0.1301486223245223,0.11176857330703485
130,1.1,1,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the long-term importance of postictal psychotic episodes II? Do they predict interictal psychotic episodes? A history of PIPE could pose a risk for IPE development, but multivariate analysis shows it is not an independent predictor.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,1.1,2,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How significant are postictal psychotic episodes II in the long term? Can they forecast interictal psychotic episodes? While a history of PIPE may increase risk for IPE, multivariate analysis indicates it's not an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,1.1,3,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the lasting significance of postictal psychotic episodes II? Are they indicative of future interictal psychotic episodes? Having PIPE may raise the risk for IPE, but it does not independently predict it according to multivariate analysis.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
130,1.1,4,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What long-term role do postictal psychotic episodes II play? Do they predict interictal psychotic episodes? There is a possible risk from PIPE history for IPE, but multivariate analysis shows it's not an independent predictor.",2.8423167282822413e-07,0.3101549283038394,0.0,0.021761117577382492,0.31845373111853537,0.0,0.021729618491434427,0.32721291120841567,0.0,2.8423167282822487e-07,0.33647223662121295,0.0
130,1.1,5,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","How does a history of postictal psychotic episodes II impact long-term outcomes? Is it predictive of interictal psychotic episodes? History of PIPE may be a risk factor for IPE, but multivariate analysis reveals it is not independently predictive.",1.8948778188548293e-07,0.23321199229149636,0.027006172839506164,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
130,1.1,6,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the prognostic value of postictal psychotic episodes II over time? Are they predictive of interictal psychotic episodes? PIPE history may indicate risk for IPE, yet multivariate analysis finds it isn't an independent predictor.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
130,1.1,7,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Do postictal psychotic episodes II have long-term predictive value for interictal psychotic episodes? A history of PIPE might increase IPE risk, but it is not independently predictive on multivariate analysis.",3.7897556377096533e-07,0.43936665978384637,0.0,0.02901482343651001,0.45198512374305766,0.0,0.02897282465524592,0.4653632496892328,0.0,3.789755637709665e-07,0.4795730802618854,0.0
130,1.1,8,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Are long-term outcomes of postictal psychotic episodes II indicative of interictal psychotic episodes? PIPE history may be a risk factor for IPE, though multivariate analysis shows no independent predictive value.",3.7897556377096533e-07,0.43936665978384637,0.0,0.02901482343651001,0.45198512374305766,0.0,0.02897282465524592,0.4653632496892328,0.0,3.789755637709665e-07,0.4795730802618854,0.0
130,1.1,9,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","What is the enduring clinical significance of postictal psychotic episodes II? Can they foretell interictal psychotic episodes? Although PIPE history may risk IPE, multivariate analysis does not support it as an independent predictor.",3.0791764556390943e-07,0.3409265869705931,0.0,0.023574544042164372,0.3502024294331152,0.0,0.0235404200323873,0.36000273403140737,0.0,3.079176455639103e-07,0.3703737882968947,0.0
130,1.1,10,human,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: A history of PIPE may be a risk factor for the development of IPE. Yet, the disappearance of significance on multivariate analysis indicates that it is not an independent predictor.","Is the presence of postictal psychotic episodes II a predictor for interictal psychotic episodes in the long term? While PIPE history may increase risk for IPE, multivariate analysis suggests it is not an independent predictor.",2.6054570009253883e-07,0.32107532871650735,0.029384756657483937,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
131,1.1,1,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
131,1.1,2,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can previous benign prostate biopsy serve as a predictor for outcomes in patients undergoing radical perineal prostatectomy? Answer: Having a prior benign prostate biopsy might independently correlate with better surgical and biochemical results post-prostatectomy. Further research is required to validate these observations.,2.3685972735685406e-08,0.059519707147746015,0.025214681440443212,0.0018134264647818726,0.06019527305807593,0.025486495844875334,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,1.1,3,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is a history of benign prostate biopsy indicative of outcomes following radical perineal prostatectomy? Answer: Prior benign prostate biopsy could be independently linked to improved surgical and biochemical outcomes after prostatectomy. More studies are necessary to confirm this association.,4.7371945471370706e-08,0.019666266328761672,0.021582468146067776,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,1.1,4,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does undergoing a benign prostate biopsy before radical perineal prostatectomy predict patient outcomes? Answer: A history of benign prostate biopsy may independently predict more favorable surgical and biochemical outcomes following prostatectomy. Additional investigations are needed to corroborate these results.,4.7371945471370706e-08,0.019666266328761672,0.021582468146067776,0.0036268529295637453,0.01846000688734195,0.02356492900776796,0.003621603081905733,0.017097724225934918,0.025623268698060954,4.737194547137081e-08,0.05406722127027619,0.0
131,1.1,5,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Can a previous benign prostate biopsy forecast the results of radical perineal prostatectomy? Answer: Prior benign prostate biopsy might be independently associated with enhanced surgical and biochemical outcomes post-prostatectomy. Further studies are essential to verify these findings.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,1.1,6,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Is the outcome of radical perineal prostatectomy influenced by a previous benign prostate biopsy? Answer: Having a prior benign prostate biopsy may independently relate to superior surgical and biochemical outcomes after prostatectomy. More research is required to confirm this relationship.,2.3685972735685406e-08,0.04208620114650197,0.047731117995341306,0.0018134264647818726,0.043996910071702366,0.049861495844875335,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
131,1.1,7,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,Question: Does a benign prostate biopsy before radical perineal prostatectomy affect patient outcomes? Answer: Prior benign prostate biopsy might independently be linked to better surgical and biochemical outcomes following prostatectomy. Additional studies are necessary to validate these findings.,9.474389094274131e-08,0.07615281162601795,0.01883713042003505,0.0072537058591274906,0.07455397429960664,0.022106393804059005,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
131,1.1,8,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,"Question: Can prior benign prostate biopsy independently predict surgical and biochemical outcomes after radical perineal prostatectomy? Answer: A history of benign prostate biopsy may be independently associated with improved outcomes post-prostatectomy, although further studies are needed to substantiate this.",7.1057918207056e-08,0.047512595324624485,0.020245545637974087,0.005440279394345618,0.046114238579118894,0.02285532300536917,0.0054324046228586,0.04449669841405024,0.025623268698060954,7.105791820705622e-08,0.08223809823697303,0.0
131,1.1,9,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,"Question: Is prior benign prostate biopsy an independent factor in predicting outcomes for patients treated with radical perineal prostatectomy? Answer: Prior benign biopsy of the prostate may correlate with more favorable surgical and biochemical post-prostatectomy outcomes, but further research is needed for confirmation.",2.3685972735685406e-08,0.09252671574583848,0.04891932153562467,0.0018134264647818726,0.0940073306463658,0.049861495844875335,0.0018108015409528666,0.06086381724377565,0.025623268698060954,2.3685972735685406e-08,0.025975486403257975,0.0
131,1.1,10,human,Question: Does prior benign prostate biopsy predict outcome for patients treated with radical perineal prostatectomy? Answer: A prior benign prostate biopsy may be independently associated with more favorable surgical and biochemical outcomes after prostatectomy. Additional studies are needed to confirm these findings.,"Question: Does a prior benign prostate biopsy influence the prognosis of patients undergoing radical perineal prostatectomy? Answer: A history of benign prostate biopsy may be independently linked with better surgical and biochemical postoperative outcomes, necessitating additional studies to confirm these findings.",2.3685972735685406e-08,0.007428842118504253,0.02285318559556789,0.0018134264647818726,0.008450900812218443,0.02423822714681438,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
132,1.1,1,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Can neoadjuvant chemotherapy alter the extent of lymphadenectomy in cervical cancer? Answer: Neoadjuvant chemotherapy might change the scope of lymphadenectomy in cervical cancer. Nevertheless, additional studies are necessary to identify the best method and assess the advantages and possible risks of this change.",1.4211583641411244e-07,0.06153574581640475,0.046844181459566064,0.010880558788691236,0.08402087972738315,0.035144628099173555,0.0108648092457172,0.11139634318468294,0.01809413580246913,1.4211583641411244e-07,0.13976194237515838,0.0
132,1.1,2,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Is it possible for neoadjuvant chemotherapy to modify the extent of lymphadenectomy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer may be influenced by neoadjuvant chemotherapy, but more research is required to establish the optimal strategy and evaluate its benefits and risks.",9.474389094274162e-08,0.04114846354284962,0.029513888888888895,0.0072537058591274906,0.09751360699811418,0.007355371900826427,0.007243206163811466,0.1266744478480617,0.02690586419753086,9.474389094274162e-08,0.1569857954019107,0.047500000000000014
132,1.1,3,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Does neoadjuvant chemotherapy have the potential to modify lymphadenectomy extent in cervical cancer? Answer: Neoadjuvant chemotherapy could potentially adjust the extent of lymphadenectomy in cervical cancer. Still, further investigation is needed to determine the ideal approach as well as the associated benefits and risks.",1.1842986367842703e-07,0.027398007345286413,0.0935374149659864,0.009067132323909363,0.0055236348789953205,0.08264462809917357,0.009054007704764333,0.05348673401733306,0.04246913580246913,1.1842986367842703e-07,0.11506932978478668,0.0
132,1.1,4,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Could neoadjuvant chemotherapy affect the extent of lymphadenectomy in cervical cancer? Answer: The extent of lymphadenectomy might be altered by neoadjuvant chemotherapy in cervical cancer cases; however, more studies are required to define the best practice and assess possible benefits and risks.",1.6580180914979784e-07,0.12114367122916647,0.022015258501745016,0.012693985253473108,0.10972852928683885,0.03399242560081723,0.012675610786670066,0.13693425721476116,0.01748557235736721,1.6580180914979784e-07,0.1650797503594501,0.0
132,1.1,5,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Can the scope of lymphadenectomy be changed by neoadjuvant chemotherapy in cervical cancer? Answer: Neoadjuvant chemotherapy could modify the scope of lymphadenectomy in cervical cancer, but additional research is necessary to determine the optimal method and evaluate the potential benefits and risks involved.",1.4211583641411244e-07,0.09377514956337896,0.024622960911049638,0.010880558788691236,0.08402087972738315,0.035144628099173555,0.0108648092457172,0.11139634318468294,0.01809413580246913,1.4211583641411244e-07,0.13976194237515838,0.0
132,1.1,6,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Is the extent of lymphadenectomy in cervical cancer modifiable by neoadjuvant chemotherapy? Answer: The extent of lymphadenectomy in cervical cancer possibly could be modified by neoadjuvant chemotherapy, although further studies are essential to optimize the approach and assess potential risks and benefits.",1.6580180914979784e-07,0.1871576884253514,0.021111111111111136,0.012693985253473108,0.21116470205170845,0.03695413733292524,0.012675610786670066,0.24090633429875297,0.05629629629629632,1.6580180914979784e-07,0.2717177781379023,0.0763888888888889
132,1.1,7,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Might neoadjuvant chemotherapy influence the degree of lymphadenectomy performed for cervical cancer? Answer: The degree of lymphadenectomy in cervical cancer might be influenced by neoadjuvant chemotherapy; however, further research is required to find the best approach and to examine the benefits and risks.",1.4211583641411244e-07,0.029296342069431436,0.0695138888888889,0.010880558788691236,0.08402087972738315,0.035144628099173555,0.0108648092457172,0.11139634318468294,0.01809413580246913,1.4211583641411244e-07,0.13976194237515838,0.0
132,1.1,8,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Could neoadjuvant chemotherapy potentially change the extent of lymphadenectomy in cervical cancer? Answer: It is possible that neoadjuvant chemotherapy could alter the extent of lymphadenectomy in cervical cancer, yet further studies must explore the optimal strategy alongside the benefits and potential hazards.",1.6580180914979784e-07,0.15415067982725894,2.7755575615628914e-17,0.012693985253473108,0.17735264446341859,0.013776116970220173,0.012675610786670066,0.2062489752707557,0.032037803569335103,1.6580180914979784e-07,0.2361717688784184,0.05113221329437545
132,1.1,9,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Is it feasible for neoadjuvant chemotherapy to modify lymphadenectomy extent in cervical cancer? Answer: Modification of lymphadenectomy extent by neoadjuvant chemotherapy in cervical cancer is feasible, but more evidence is needed to finalize the best technique and weigh the pros and cons.",1.6580180914979784e-07,0.055129654032981534,0.0678829717291256,0.012693985253473108,0.042104414110259114,0.08264462809917357,0.012675610786670066,0.10227689818676478,0.04246913580246913,1.6580180914979784e-07,0.1650797503594501,0.0
132,1.1,10,ai,"Question: Could the extent of lymphadenectomy be modified by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy in cervical cancer could potentially be modified by neoadjuvant chemotherapy. However, further research is needed to determine the optimal approach and to evaluate the benefits and potential risks of this modification.","Question: Can lymphadenectomy extent be adjusted by neoadjuvant chemotherapy in cervical cancer? Answer: The extent of lymphadenectomy may be adjusted by neoadjuvant chemotherapy in cervical cancer treatment, though additional research is essential to define the optimal approach and assess associated benefits and risks.",1.6580180914979784e-07,0.15415067982725894,2.7755575615628914e-17,0.012693985253473108,0.21116470205170845,0.03695413733292524,0.012675610786670066,0.24090633429875297,0.05629629629629632,1.6580180914979784e-07,0.2717177781379023,0.0763888888888889
133,1.1,1,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is there an important link between environmental factors and primary systemic vasculitis (PSV)? This study has, for the first time, found a strong connection between farming and PSV. Additionally, the findings confirm earlier reports linking PSV with exposure to silica, solvents, and allergies.",1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
133,1.1,2,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Do environmental factors play a crucial role in primary systemic vasculitis? A novel significant association between farming and PSV has been discovered, along with reinforcing earlier findings that connect PSV to silica, solvents, and allergies.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
133,1.1,3,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental elements significant in primary systemic vasculitis? This research reveals a newly identified significant correlation between farming and PSV and also corroborates previous links with silica, solvents, and allergic conditions.",9.47438909427412e-08,0.125163142954007,0.0,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
133,1.1,4,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is primary systemic vasculitis influenced by environmental factors? For the first time, a noteworthy association between farming and PSV has been reported, supporting earlier evidence connecting PSV with exposure to silica, solvents, and allergies.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,1.1,5,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Does primary systemic vasculitis have connections to environmental factors? Significant ties to farming have been found for the first time, alongside validation of earlier associations with silica exposure, solvents, and allergic reactions.",7.10579182070559e-08,0.09237332013101529,0.0,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
133,1.1,6,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","How important are environmental exposures in primary systemic vasculitis? A significant new link between farming and PSV has been observed, along with support for prior findings associating PSV with silica, solvents, and allergies.",4.73719454713706e-08,0.060624621816435464,0.0,0.003626852929563759,0.06252035698133351,0.0,0.003621603081905747,0.06453852113757153,0.0,4.737194547137081e-08,0.06669137449867346,0.0
133,1.1,7,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Are environmental aspects key in primary systemic vasculitis? This is the first significant documentation of an association with farming, along with continued support for previously known links to silica, solvents, and allergies.",7.10579182070559e-08,0.09237332013101529,0.0,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
133,1.1,8,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Is there a meaningful connection between environmental factors and primary systemic vasculitis? Farming has been significantly linked to PSV for the first time, and previous relationships with silica, solvents, and allergies have been confirmed.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
133,1.1,9,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","What is the role of environmental factors in primary systemic vasculitis? A first-time significant association has been established between farming and PSV, further supporting prior connections to silica, solvents, and allergy.",9.47438909427412e-08,0.125163142954007,0.0,0.007253705859127518,0.12921173148000697,0.0,0.007243206163811494,0.1335313926245223,0.0,9.474389094274162e-08,0.13815033848081715,0.0
133,1.1,10,human,"Question: Are environmental factors important in primary systemic vasculitis? Answer: A significant association between farming and PSV has been identified for the first time. Results also support previously reported associations with silica, solvents, and allergy.","Can environmental factors be linked to primary systemic vasculitis? A major new association with farming has been identified, validating earlier reports of relations to silica, solvents, and allergic conditions.",1.421158364141118e-07,0.19415601444095776,0.0,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
134,1.1,1,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program decrease disability among the elderly? Research specifically linking the program to reduced disability in older adults is limited. Yet, by offering financial assistance, the program can ease economic hardships and enhance access to healthcare and services, possibly improving health results for seniors.",4.026615365066519e-07,0.20826600999930278,0.07148018944051217,0.030828249901291835,0.22647464030752618,0.06320022981901754,0.030783626196198732,0.2757527223354206,0.0322222222222222,4.026615365066519e-07,0.30395809318750944,0.016388888888888897
134,1.1,2,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Can the Supplemental Security Income program cut down disability rates in elderly populations? Although direct studies are sparse, the program's financial support may reduce economic stress and increase availability of healthcare, potentially leading to healthier outcomes for elderly individuals.",6.158352911278203e-07,0.39133182727829574,0.09274673008323427,0.04714908808432869,0.4441981241523951,0.06320022981901754,0.04708084006477453,0.49889627364962985,0.0322222222222222,6.158352911278206e-07,0.5327996656163578,0.016388888888888897
134,1.1,3,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Is there a reduction in disability among the elderly because of the Supplemental Security Income program? Limited research examines this directly, but by providing monetary assistance, the program may relieve financial burdens and improve access to medical care, which could promote better health in older adults.",4.500334819780227e-07,0.22225549723436266,0.09274673008323427,0.03445510283085558,0.2709264028783589,0.06320022981901754,0.034405229278104466,0.3212150964121778,0.0322222222222222,4.500334819780227e-07,0.3504781088224034,0.016388888888888897
134,1.1,4,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program help lower disability levels in older adults? Direct evidence is scarce, yet the financial aid it offers can mitigate economic difficulties and improve healthcare access, possibly enhancing health among the elderly.",6.63207236599191e-07,0.44539904854857193,0.09274673008323427,0.050775941013892434,0.4997679753072073,0.06320022981901754,0.05070244314668027,0.5560546874895782,0.0322222222222222,6.632072365991914e-07,0.5916401656392911,0.016388888888888897
134,1.1,5,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program impact disability reduction for elderly individuals? Direct research is limited, but the program’s financial assistance helps ease economic challenges and improve access to healthcare, which may contribute to better health outcomes for seniors.",6.158352911278203e-07,0.39133182727829574,0.09274673008323427,0.04714908808432869,0.4441981241523951,0.06320022981901754,0.04708084006477453,0.49889627364962985,0.0322222222222222,6.158352911278206e-07,0.5327996656163578,0.016388888888888897
134,1.1,6,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Upstream question: Does the Supplemental Security Income program diminish disability among the elderly? There is little direct research, but financial support provided may alleviate economic hardships and increase access to care, supporting improved elderly health.",7.105791820705615e-07,0.5025574623885203,0.09274673008323427,0.05440279394345619,0.5586084753301406,0.06320022981901754,0.05432404622858602,0.6166793093060137,0.0322222222222222,7.105791820705622e-07,0.6541605226206246,0.016388888888888897
134,1.1,7,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does receiving Supplemental Security Income lead to less disability in the elderly? Research on this direct effect is minimal; however, the financial support helps relieve economic pressure and may improve access to health services, indirectly benefiting older adults’ health.",6.158352911278203e-07,0.39133182727829574,0.09274673008323427,0.04714908808432869,0.4441981241523951,0.06320022981901754,0.04708084006477453,0.49889627364962985,0.0322222222222222,6.158352911278206e-07,0.5327996656163578,0.016388888888888897
134,1.1,8,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program reduce disability rates among older people? Although evidence is limited, financial assistance from the program can help lessen economic difficulties and boost healthcare access, which might indirectly enhance elderly health.",6.868932093348762e-07,0.4735699255152688,0.09274673008323427,0.05258936747867431,0.5287555121804588,0.06320022981901754,0.052513244687633145,0.58590765063926,0.0322222222222222,6.868932093348768e-07,0.6224118243060448,0.016388888888888897
134,1.1,9,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Is there evidence that the Supplemental Security Income program reduces disability in elderly populations? Research is scarce on direct effects, but the financial aid offered could reduce economic strain and improve healthcare access, potentially leading to better health among older adults.",5.684633456564497e-07,0.34003853289074604,0.09274673008323427,0.04352223515476494,0.3915543906669763,0.06320022981901754,0.0434592369828688,0.44482905237935366,0.0322222222222222,5.684633456564497e-07,0.47722981446154566,0.016388888888888897
134,1.1,10,ai,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: There is limited research on the direct impact of the Supplemental Security Income program on reducing disability in the elderly. However, providing financial support through the program can alleviate economic challenges and potentially improve access to healthcare and resources, which may indirectly contribute to better health outcomes for older individuals.","Does the Supplemental Security Income program contribute to lowering disability in the elderly? Direct studies are rare, but by providing economic support, the program can reduce financial challenges and improve access to healthcare resources, which may positively impact seniors’ health outcomes.",5.684633456564497e-07,0.34003853289074604,0.09274673008323427,0.04352223515476494,0.3915543906669763,0.06320022981901754,0.0434592369828688,0.44482905237935366,0.0322222222222222,5.684633456564497e-07,0.47722981446154566,0.016388888888888897
135,1.1,1,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in",Is primary angioplasty a viable alternative to thrombolysis? Primary angioplasty is viewed as a better option than thrombolysis for treating heart attacks. It is a safer and more effective procedure that opens blocked arteries using a balloon catheter.,1.4211583641411212e-07,0.12327081072079071,0.01939477897489004,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
135,1.1,2,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Can primary angioplasty replace thrombolysis? Yes, primary angioplasty is regarded as a superior treatment for heart attacks compared to thrombolysis. It safely and effectively opens clogged arteries with a balloon catheter.",3.079176455639092e-07,0.3417337385747885,0.01310725383579929,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
135,1.1,3,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in",Is primary angioplasty an acceptable substitute for thrombolysis? Primary angioplasty is considered more effective and safer than thrombolysis in treating heart attacks by using a balloon catheter to clear blocked arteries.,3.079176455639092e-07,0.3417337385747885,0.01310725383579929,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
135,1.1,4,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Does primary angioplasty serve as an alternative to thrombolysis? Indeed, primary angioplasty is preferred over thrombolysis because it is a safer and more effective method to open blocked arteries during a heart attack.",2.605457000925386e-07,0.274307104184885,0.0151834700245939,0.019947691112600627,0.30368241379822125,0.0,0.019918816950481567,0.31237468504215293,0.0,2.6054570009253947e-07,0.321583624127463,0.0
135,1.1,5,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty a better alternative than thrombolysis? It is, as primary angioplasty outperforms thrombolysis in heart attack treatment by safely opening obstructed arteries through a balloon catheter.",3.789755637709651e-07,0.4522286777923177,0.00941870329368616,0.029014823436510025,0.4795730802618854,0.0,0.028972824655245935,0.49469624183610783,0.0,3.789755637709665e-07,0.5108256237659909,0.0
135,1.1,6,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in",Could primary angioplasty be used instead of thrombolysis? Primary angioplasty is accepted as a superior approach than thrombolysis since it more effectively and safely opens blocked arteries in heart attack patients.,3.079176455639092e-07,0.3417337385747885,0.01310725383579929,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
135,1.1,7,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Is primary angioplasty accepted as an alternative to thrombolysis? Yes, it is a superior, safer, and more effective method to treat heart attacks by opening blocked arteries with a balloon catheter.",3.079176455639092e-07,0.29552392653745896,0.046400951814396206,0.023574544042164386,0.3703737882968947,0.0,0.023540420032387314,0.3813675565291037,0.0,3.079176455639103e-07,0.3930425881096067,0.0
135,1.1,8,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in","Can primary angioplasty be considered over thrombolysis? It is considered superior, providing a safer, more effective way to open arterial blockages during heart attack treatment.",4.50033481978021e-07,0.5186674778516687,0.046400951814396206,0.03445510283085566,0.6021754023542183,0.0,0.034405229278104556,0.6225296133459923,0.0,4.500334819780227e-07,0.6443570163905146,0.0
135,1.1,9,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in",Is primary angioplasty preferable to thrombolysis? Primary angioplasty is generally recognized as a better option due to its effectiveness and safety in clearing blocked arteries with a balloon catheter.,3.552895910352798e-07,0.4140273109215489,0.01073565688984203,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
135,1.1,10,ai,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Primary angioplasty is considered a superior alternative to thrombolysis for the treatment of heart attacks. It is a more effective and safer procedure that involves opening blocked arteries with a balloon catheter, resulting in",Is primary angioplasty a better choice than thrombolysis? It is deemed a safer and more effective treatment for heart attacks since it opens blocked arteries via a balloon catheter.,3.552895910352798e-07,0.3645167980244097,0.046400951814396206,0.027201396971728145,0.4418327522790384,0.0,0.02716202311429306,0.45547552868282537,0.0,3.552895910352811e-07,0.47000362924573613,0.0
136,1.1,1,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Recovery outcome measures must acknowledge the impact of culture, beliefs, and attitudes since they significantly affect an individual's recovery process.",4.026615365066502e-07,0.5235554291963456,0.08264462809917354,0.030828249901291953,0.6253678932755373,0.02854671280276816,0.030783626196198847,0.6931471805599458,0.0,4.0266153650665164e-07,0.7239188392266991,0.0
136,1.1,2,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Incorporating culture, attitudes, and faith into recovery outcome assessments is essential due to their pivotal role in personal recovery journeys.",4.026615365066502e-07,0.5235554291963456,0.08264462809917354,0.030828249901291953,0.6253678932755373,0.02854671280276816,0.030783626196198847,0.6931471805599458,0.0,4.0266153650665164e-07,0.7239188392266991,0.0
136,1.1,3,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Culture, attitudes, and faith should be factored into recovery outcome measures, as they deeply influence an individual's path to recovery.",4.026615365066502e-07,0.5235554291963456,0.08264462809917354,0.030828249901291953,0.6253678932755373,0.02854671280276816,0.030783626196198847,0.6931471805599458,0.0,4.0266153650665164e-07,0.7239188392266991,0.0
136,1.1,4,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","The role of culture, attitudes, and faith is crucial in recovery, thus these aspects deserve inclusion in outcome measures.",4.2634750924233556e-07,0.5776226504666209,0.08264462809917354,0.03264167636607383,0.6825263071154861,0.02854671280276816,0.032594427737151724,0.7537718023763809,0.0,4.26347509242337e-07,0.7884573603642697,0.0
136,1.1,5,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Measuring recovery outcomes requires consideration of cultural background, personal attitudes, and faith because they are vital to recovery.",4.500334819780209e-07,0.6347810643065697,0.08264462809917354,0.034455102830855705,0.7431509289319211,0.02854671280276816,0.03440522927810459,0.8183103235139515,0.0,4.5003348197802235e-07,0.8574502318512218,0.0
136,1.1,6,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Assessing recovery outcomes should incorporate culture, attitudes, and faith because these elements shape the individual's recovery experience.",4.7371945471370627e-07,0.6954056861230047,0.08264462809917354,0.03626852929563758,0.8076894500694918,0.02854671280276816,0.03621603081905747,0.8873031950009036,0.0,4.737194547137077e-07,0.931558204004943,0.0
136,1.1,7,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Recovery measures ought to reflect the influences of culture, faith, and attitudes given their importance in recovery.",4.7371945471370627e-07,0.6954056861230047,0.08264462809917354,0.03626852929563758,0.8076894500694918,0.02854671280276816,0.03621603081905747,0.8873031950009036,0.0,4.737194547137077e-07,0.931558204004943,0.0
136,1.1,8,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","It is important for recovery outcome evaluations to consider culture, attitudes, and faith as key factors affecting recovery.",4.500334819780209e-07,0.6347810643065697,0.08264462809917354,0.034455102830855705,0.7431509289319211,0.02854671280276816,0.03440522927810459,0.8183103235139515,0.0,4.5003348197802235e-07,0.8574502318512218,0.0
136,1.1,9,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","There is value in factoring culture, attitudes, and faith into recovery outcomes since they significantly inform the recovery path.",4.2634750924233556e-07,0.5776226504666209,0.08264462809917354,0.03264167636607383,0.6825263071154861,0.02854671280276816,0.032594427737151724,0.7537718023763809,0.0,4.26347509242337e-07,0.7884573603642697,0.0
136,1.1,10,ai,"Question: Recovery Outcome Measures: Is There a Place for Culture, Attitudes, and Faith? Answer: Yes, recovery outcome measures should consider the influence of culture, attitudes, and faith as they play a significant role in an individual's journey","Acknowledging culture, attitudes, and faith in recovery outcome measures is necessary because these dimensions profoundly impact recovery.",4.7371945471370627e-07,0.6954056861230047,0.08264462809917354,0.03626852929563758,0.8076894500694918,0.02854671280276816,0.03621603081905747,0.8873031950009036,0.0,4.737194547137077e-07,0.931558204004943,0.0
137,1.1,1,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is cholecystectomy truly an indication for performing a concomitant splenectomy in cases of mild hereditary spherocytosis? The decision to carry out concomitant splenectomy in mild hereditary spherocytosis remains controversial. Although cholecystectomy might be essential for addressing gallstones, the necessity of splenectomy is influenced by patient-specific factors like spleen condition.",1.1842986367842703e-07,0.02879531593649931,0.04914038529249026,0.009067132323909363,0.0027057931470175767,0.0737990999186179,0.009054007704764333,0.005544733264369217,0.07786328655500228,1.1842986367842703e-07,0.0221828539906328,0.05975554549569943
137,1.1,2,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Does cholecystectomy warrant a simultaneous splenectomy in patients with mild hereditary spherocytosis? The requirement for concomitant splenectomy in mild hereditary spherocytosis is debated within the medical community. While cholecystectomy treats gallstones, the decision to remove the spleen depends on individual clinical considerations.",2.8423167282822487e-07,0.1674049777466693,0.06271040501635614,0.02176111757738247,0.12906672974442568,0.09506564056134,0.0217296184914344,0.1595350170950809,0.07786328655500228,2.8423167282822487e-07,0.19125918403456588,0.05975554549569943
137,1.1,3,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is performing a concomitant splenectomy along with cholecystectomy justified in mild hereditary spherocytosis? Medical experts continue to discuss the indications for simultaneous splenectomy in this condition. Cholecystectomy addresses gallstones, but splenectomy necessity is determined by specific patient characteristics.",3.789755637709662e-07,0.20243501663017183,0.11136260751471248,0.029014823436509962,0.23442724540225157,0.09506564056134,0.028972824655245866,0.2677486017353119,0.07786328655500228,3.789755637709665e-07,0.3024848191447904,0.05975554549569943
137,1.1,4,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Should cholecystectomy be combined with splenectomy in mild hereditary spherocytosis? The indication for a combined splenectomy remains under debate. While cholecystectomy is required to manage gallstones, splenectomy depends on patient-specific factors such as the condition of the spleen.",3.789755637709662e-07,0.20243501663017183,0.11136260751471248,0.029014823436509962,0.23442724540225157,0.09506564056134,0.028972824655245866,0.2677486017353119,0.07786328655500228,3.789755637709665e-07,0.3024848191447904,0.05975554549569943
137,1.1,5,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Can cholecystectomy alone indicate the need for concurrent splenectomy in mild hereditary spherocytosis? The role of concomitant splenectomy in mild hereditary spherocytosis is controversial. Cholecystectomy may be needed for gallstones; however, splenectomy decisions are based on individual spleen-related factors.",3.552895910352809e-07,0.2852110612153713,0.03299526057593698,0.02720139697172809,0.281963101544942,0.04118808954093182,0.027162023114293,0.2780859014663899,0.05010818451418596,3.552895910352811e-07,0.2734972822715389,0.05975554549569943
137,1.1,6,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is a concomitant splenectomy an appropriate indicator alongside cholecystectomy in mild hereditary spherocytosis? Opinions vary on the need for simultaneous splenectomy. Cholecystectomy is performed to treat gallstones, but splenectomy is considered depending on spleen-specific clinical elements.",4.263475092423368e-07,0.258004867784984,0.11136260751471248,0.032641676366073714,0.2915856592421999,0.09506564056134,0.03259442773715161,0.3265891017582452,0.07786328655500228,4.263475092423373e-07,0.3631094409612259,0.05975554549569943
137,1.1,7,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Does mild hereditary spherocytosis require splenectomy alongside cholecystectomy? The potential need for concomitant splenectomy is a debated topic. Even though cholecystectomy treats gallstones, splenectomy is decided based on particular factors related to the spleen.",4.737194547137074e-07,0.358854287841853,0.08108917001471248,0.036268529295637474,0.3522102810586354,0.09506564056134,0.03621603081905736,0.3891094587395787,0.07786328655500228,4.737194547137081e-07,0.4276479620987974,0.05975554549569943
137,1.1,8,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen",Is splenectomy indicated together with cholecystectomy in mild hereditary spherocytosis cases? This indication remains contentious among clinicians. Cholecystectomy is often performed due to gallstones; splenectomy consideration depends on individual patient spleen status.,5.21091400185078e-07,0.3793657247892508,0.11136260751471248,0.03989538222520123,0.4167488021962069,0.09506564056134,0.03983763390096311,0.45580083323825216,0.07786328655500228,5.210914001850789e-07,0.4966408335857482,0.05975554549569943
137,1.1,9,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","In mild hereditary spherocytosis, is it necessary to do a splenectomy when performing cholecystectomy? The indication for concurrent splenectomy is still debated. Although cholecystectomy addresses gallstones, splenectomy reliance on specific spleen factors guides the decision.",4.500334819780221e-07,0.2869924046582355,0.11136260751471248,0.034455102830855594,0.3214386223918817,0.09506564056134,0.034405229278104486,0.35736076042499887,0.07786328655500228,4.500334819780227e-07,0.3948581392758057,0.05975554549569943
137,1.1,10,ai,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The indication for concomitant splenectomy in mild hereditary spherocytosis is still a subject of debate among medical professionals. While cholecystectomy may be necessary to treat gallstones in these patients, the need for splenectomy depends on individual factors such as spleen","Is concomitant splenectomy justified alongside cholecystectomy in mild hereditary spherocytosis? The clinical decision is debated. While cholecystectomy may be required for gallstone treatment, splenectomy is based on individual patient-related spleen conditions.",5.447773729207633e-07,0.4121555476122425,0.11136260751471248,0.04170880868998311,0.4506503538718887,0.09506564056134,0.04164843544191598,0.49089215304952116,0.07786328655500228,5.447773729207643e-07,0.5330084777566229,0.05975554549569943
138,1.1,1,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is it appropriate to perform aneurysm repair in patients aged 80 or older following aneurysmal subarachnoid hemorrhage? The choice should depend on the patient's individual conditions, general health, and weighing the benefits against the risks, with careful evaluation by a healthcare provider.",2.8423167282822487e-07,0.07362436519046911,0.12901701323251416,0.02176111757738247,0.10240722279981229,0.113421550094518,0.0217296184914344,0.13235277472018137,0.09688090737240077,2.8423167282822487e-07,0.16353329681216788,0.07939508506616257
138,1.1,2,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","For patients 80 years or older who have experienced aneurysmal subarachnoid hemorrhage, should aneurysm repair be carried out? Decisions must consider patient-specific factors, overall wellness, and the risk-benefit balance, under a thorough medical assessment.",4.737194547137074e-07,0.29068887042829683,0.12901701323251416,0.036268529295637474,0.325550774114022,0.113421550094518,0.03621603081905736,0.36192721636467917,0.09688090737240077,4.737194547137081e-07,0.3999220748763994,0.07939508506616257
138,1.1,3,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Should elderly patients aged 80+ undergo aneurysm repair after aneurysmal subarachnoid hemorrhage? This decision requires evaluation of the patient's health status, personalized circumstances, and potential advantages versus associated risks by medical professionals.",5.21091400185078e-07,0.35320922740963034,0.12901701323251416,0.03989538222520123,0.3900892952515935,0.113421550094518,0.03983763390096311,0.42861859086335263,0.09688090737240077,5.210914001850789e-07,0.4689149463633502,0.07939508506616257
138,1.1,4,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is aneurysm repair warranted for individuals aged 80 or more after a subarachnoid hemorrhage due to aneurysm? The repairing decision hinges on personalized patient factors, their general health, and the benefit-risk assessment conducted by healthcare experts.",4.263475092423368e-07,0.23184837040536355,0.12901701323251416,0.032641676366073714,0.26492615229758654,0.113421550094518,0.03259442773715161,0.29940685938334566,0.09688090737240077,4.263475092423373e-07,0.3353835537388279,0.07939508506616257
138,1.1,5,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is surgery for aneurysm repair justified in those 80 years old or older post-aneurysmal subarachnoid hemorrhage? It should be decided based on the patient’s health conditions, benefit and risk considerations, and carefully assessed by clinicians.",4.500334819780221e-07,0.26083590727861505,0.12901701323251416,0.034455102830855594,0.2947791154472683,0.113421550094518,0.034405229278104486,0.33017851805009935,0.09688090737240077,4.500334819780227e-07,0.3671322520534077,0.07939508506616257
138,1.1,6,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","In patients aged 80 and above with aneurysmal subarachnoid hemorrhage, is aneurysm repair recommended? Determining this requires individualized evaluation of health status and weighing potential benefits against risks with expert medical judgment.",5.21091400185078e-07,0.35320922740963034,0.12901701323251416,0.03989538222520123,0.3900892952515935,0.113421550094518,0.03983763390096311,0.42861859086335263,0.09688090737240077,5.210914001850789e-07,0.4689149463633502,0.07939508506616257
138,1.1,7,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","For patients aged 80 or older after aneurysmal subarachnoid hemorrhage, does aneurysm repair make sense? The decision depends on individual health factors, overall patient condition, and a thorough risk-benefit analysis by healthcare professionals.",4.974054274493927e-07,0.3214605290950505,0.12901701323251416,0.03808195576041935,0.3572994724286018,0.113421550094518,0.03802683236001023,0.39471703918767087,0.09688090737240077,4.974054274493935e-07,0.4338236265520812,0.07939508506616257
138,1.1,8,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is it advisable to proceed with aneurysm repair for patients over 80 following an aneurysmal subarachnoid hemorrhage? Such decisions should incorporate personal patient health, potential advantages, and risks after a complete medical assessment.",4.974054274493927e-07,0.3214605290950505,0.12901701323251416,0.03808195576041935,0.3572994724286018,0.113421550094518,0.03802683236001023,0.39471703918767087,0.09688090737240077,4.974054274493935e-07,0.4338236265520812,0.07939508506616257
138,1.1,9,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Should elderly patients aged 80 and above be considered for aneurysm repair after aneurysmal subarachnoid hemorrhage? This choice relies on thorough evaluation of each patient’s health, balancing the possible benefits and risks with expert clinical insight.",4.263475092423368e-07,0.23184837040536355,0.12901701323251416,0.032641676366073714,0.26492615229758654,0.113421550094518,0.03259442773715161,0.29940685938334566,0.09688090737240077,4.263475092423373e-07,0.3353835537388279,0.07939508506616257
138,1.1,10,ai,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: The decision to repair aneurysms in patients aged 80 or older after aneurysmal subarachnoid hemorrhage should be based on individual patient factors, overall health, and potential benefits versus risks. A thorough assessment by a healthcare professional is","Is aneurysm repair appropriate for patients 80 years or older post-aneurysmal subarachnoid hemorrhage? The choice should be personalized, factoring in the patient's health and a careful analysis of the risks versus benefits by healthcare practitioners.",4.500334819780221e-07,0.26083590727861505,0.12901701323251416,0.034455102830855594,0.2947791154472683,0.113421550094518,0.034405229278104486,0.33017851805009935,0.09688090737240077,4.500334819780227e-07,0.3671322520534077,0.07939508506616257
139,1.1,1,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does blood pressure vary in treated hypertensive patients based on whether the measurement is taken by a nurse or a physician? Systolic blood pressure readings taken by nurses are significantly lower than those taken by physicians and closely match ambulatory blood pressure monitoring, making nurse measurements preferable both for diagnosis and for assessing blood pressure control.",4.263475092423373e-07,0.25862340164366104,0.06665039062500006,0.03264167636607376,0.22991980740511764,0.041587901701323246,0.03259442773715161,0.27286269079736636,0.014081632653061225,4.263475092423373e-07,0.2972515234679305,0.0
139,1.1,2,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In treated hypertensive patients, does blood pressure change depending on whether it is measured by a nurse or a physician? Nurse-measured systolic blood pressure values are significantly lower than those measured by physicians and almost identical to ambulatory monitoring results, suggesting nurse measurements are advisable for diagnosis and monitoring control levels.",5.447773729207643e-07,0.24863964115671155,0.14341905381944445,0.041708808689983126,0.32708355585876614,0.041587901701323246,0.041648435441915946,0.3719535934415963,0.014081632653061225,5.447773729207643e-07,0.3983476403393005,0.0
139,1.1,3,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Is there a difference in blood pressure readings in treated hypertensive patients when measured by a nurse compared to a physician? Systolic blood pressure recorded by the nurse tends to be significantly lower than readings from the physician and closely aligns with ambulatory blood pressure monitoring, indicating nurse assessments are beneficial for diagnosis and control evaluation.",4.263475092423373e-07,0.15780199356221436,0.10930190556581527,0.03264167636607376,0.22991980740511764,0.041587901701323246,0.03259442773715161,0.27286269079736636,0.014081632653061225,4.263475092423373e-07,0.2972515234679305,0.0
139,1.1,4,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","For treated hypertensive patients, does blood pressure assessment depend on whether a nurse or physician conducts the measurement? Systolic BP taken by nurses is notably lower than that recorded by physicians and approximates ambulatory blood pressure values, supporting the use of nurse measurements for both diagnosis and monitoring control.",5.921493183921352e-07,0.2628909937555006,0.1625257071568017,0.04533566161954687,0.36875625225933506,0.041587901701323246,0.04527003852382168,0.4145132078603928,0.014081632653061225,5.921493183921352e-07,0.44183275227903884,0.0
139,1.1,5,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Does the blood pressure of treated hypertensive patients differ when taken by a nurse versus a physician? Nurse-measured systolic blood pressure is significantly less than physician-measured values and nearly matches ambulatory BP monitoring, showing that nurse assessments are advantageous for diagnosing and managing blood pressure.",6.868932093348768e-07,0.35252792824725177,0.1606346283041509,0.05258936747867436,0.45770373827583066,0.041587901701323246,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
139,1.1,6,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","In hypertensive patients undergoing treatment, does who measures blood pressure—nurse or physician—affect the readings? Systolic BP taken by nurses is considerably lower than physician measurements and similar to ambulatory monitoring, making nurse measurement optimal for diagnosis and blood pressure control evaluation.",7.816371002776184e-07,0.41633141802612483,0.183349609375,0.05984307333780185,0.5553422078397485,0.041587901701323246,0.05975645085144461,0.6055684446231009,0.014081632653061225,7.816371002776184e-07,0.6375773294051328,0.0
139,1.1,7,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Is the blood pressure reading in treated hypertensive patients influenced by whether a nurse or physician performs the measurement? The systolic BP recorded by nurses is significantly lower than those of physicians and closely aligns with ambulatory BP monitoring, validating the nurse measurement for diagnosis and treatment control purposes.",5.921493183921352e-07,0.23400986123216994,0.183349609375,0.04533566161954687,0.36875625225933506,0.041587901701323246,0.04527003852382168,0.4145132078603928,0.014081632653061225,5.921493183921352e-07,0.44183275227903884,0.0
139,1.1,8,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Among patients receiving hypertension treatment, does measuring blood pressure by a nurse versus a physician change the results? Nurse-measured systolic BP is significantly lower and nearly equal to ambulatory BP levels compared to physician readings, implying nurse measurements are preferred for diagnosis and monitoring control.",6.868932093348768e-07,0.3210212382217992,0.183349609375,0.05258936747867436,0.45770373827583066,0.041587901701323246,0.052513244687633145,0.5054849860661195,0.014081632653061225,6.868932093348768e-07,0.5349231753450505,0.0
139,1.1,9,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","For patients treated for hypertension, is blood pressure affected by measurement taken by a nurse or a physician? Nurse measures show significantly lower systolic readings than physician measures and closely match ambulatory BP monitoring, making nurse readings beneficial for diagnosis and control assessment.",7.342651548062476e-07,0.3675412538566931,0.183349609375,0.05621622040823811,0.5053317872650851,0.041587901701323246,0.05613484776953888,0.5542751502355512,0.014081632653061225,7.342651548062476e-07,0.584933595919714,0.0
139,1.1,10,human,"Question: Does blood pressure change in treated hypertensive patients depending on whether it is measured by a physician or a nurse? Answer: Systolic BP measured by the nurse in treated hypertensive patients is significantly lower than the readings obtained by the physician, and are almost identical to ambulatory BP monitoring. Blood pressure determination by the nurse is desirable not only for diagnosis but also to evaluate the level of control of blood pressure during","Do blood pressure values change in treated hypertensive patients depending on whether a nurse or physician measures them? Nurse-recorded systolic BP is significantly lower than physician measurements and almost identical to ambulatory BP, suggesting nurse assessments are ideal for diagnosing and evaluating control.",7.342651548062476e-07,0.3675412538566931,0.183349609375,0.05621622040823811,0.5053317872650851,0.041587901701323246,0.05613484776953888,0.5542751502355512,0.014081632653061225,7.342651548062476e-07,0.584933595919714,0.0
140,1.1,1,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the application of audits to detect maternal mortality merely reflecting economic disparities between wealthy and impoverished settings? Answer: Variations in maternal mortality extend beyond the economic divide between rich and poor. Recognizing the scale of maternal mortality and mobilizing political commitment are crucial. However, there is no universal solution to lowering maternal mortality, and the process of problem identification must be tailored.",2.3685972735685406e-07,0.09752013428466189,0.03303581142844919,0.018134264647818782,0.11102355727318969,0.027755102040816333,0.01810801540952868,0.13228074017617697,0.014081632653061225,2.3685972735685406e-07,0.15415067982725894,0.0
140,1.1,2,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does auditing to identify maternal mortality simply highlight the economic gap between affluent and poor areas? Answer: Maternal mortality differences involve more factors than just wealth inequality. It's essential to acknowledge the severity of maternal deaths and foster strong political will to address these issues. Still, no single solution fits all, and identifying problems requires context-specific approaches.",3.789755637709665e-07,0.16960967565654617,0.07999633677000212,0.029014823436510018,0.2128062515831317,0.027755102040816333,0.02897282465524588,0.23582141911701626,0.014081632653061225,3.789755637709665e-07,0.25951119548508306,0.0
140,1.1,3,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is maternal mortality identification through audit only differentiating between rich and poor environments? Answer: The disparity in maternal mortality transcends economic status. Understanding the extent of the issue and generating political resolve are vital. Nonetheless, reducing maternal mortality demands multiple strategies, and problem identification is not one-size-fits-all.",6.158352911278206e-07,0.408316576715571,0.010621021829210986,0.047149088084328744,0.40951654582918673,0.027755102040816333,0.047080840064774546,0.4364921145791678,0.014081632653061225,6.158352911278206e-07,0.46430560813109656,0.0
140,1.1,4,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does using audits to find maternal mortality simply reflect the divide between wealthy and poor settings? Answer: Maternal mortality differences go beyond economic lines. Recognizing the breadth of the issue and strong political commitment are key. There is no single approach for reduction, and the identification of problems needs to be contextually informed.",4.737194547137081e-07,0.24420457361473868,0.07867365533056245,0.03626852929563751,0.2869142237368534,0.027755102040816333,0.036216030819057346,0.31132897162516215,0.014081632653061225,4.737194547137081e-07,0.33647223662121295,0.0
140,1.1,5,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the audit process for maternal mortality just a way to differentiate between the affluent and the poor? Answer: Maternal mortality disparity is more complex than economic contrast alone. Grasping the magnitude and committing politically are important for tackling this issue. No single solution suffices, and problem identification strategies must vary.",5.210914001850789e-07,0.2836965994378131,0.07793460207612458,0.039895382225201254,0.32613493689013584,0.027755102040816333,0.03983763390096308,0.3513343062388605,0.014081632653061225,5.210914001850789e-07,0.3772942311414673,0.0
140,1.1,6,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is auditing maternal mortality solely distinguishing between rich and poor areas? Answer: Differences in maternal mortality surpass wealth differences. Acknowledging the problem scale and harnessing solid political will are critical. Yet, no single method exists to decrease maternal mortality universally, and problem identification should be specific to settings.",5.921493183921352e-07,0.38580224692110443,0.012468439505236156,0.04533566161954687,0.38801034060822337,0.027755102040816333,0.04527003852382168,0.4145132078603928,0.014081632653061225,5.921493183921352e-07,0.44183275227903884,0.0
140,1.1,7,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Does maternal mortality identification by audit only show differences between economic classes? Answer: Maternal mortality disparities are not just about riches and poverty. Understanding the magnitude and political dedication is essential. There is no general solution for lowering mortality, and problems must be identified specifically.",6.632072365991914e-07,0.41248404137513894,0.07532385827447169,0.05077594101389249,0.45396830840001945,0.027755102040816333,0.05070244314668028,0.48195448865592505,0.014081632653061225,6.632072365991914e-07,0.5108256237659905,0.0
140,1.1,8,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the use of audit in identifying maternal mortality merely exposing the gap between wealthy and poor populations? Answer: Maternal mortality gaps involve more than economic differences. Recognizing the severity and political will to address it are crucial. Still, no one-size-fits-all solution exists, and problem identification must be tailored.",5.684633456564497e-07,0.32481141333212005,0.07713529652056902,0.043522235154765,0.3669569314103902,0.027755102040816333,0.04345923698286881,0.39300700263942945,0.014081632653061225,5.684633456564497e-07,0.41985384556026384,0.0
140,1.1,9,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is auditing to track maternal mortality simply indicating a divide between rich and poor settings? Answer: Differences in maternal mortality extend beyond economic distinctions. Acknowledging their magnitude and developing strong political will is key. However, reducing maternal mortality demands varied solutions, and problem identification must adapt accordingly.",6.158352911278206e-07,0.408316576715571,0.010621021829210986,0.047149088084328744,0.40951654582918673,0.027755102040816333,0.047080840064774546,0.4364921145791678,0.014081632653061225,6.158352911278206e-07,0.46430560813109656,0.0
140,1.1,10,human,"Question: The use of audit to identify maternal mortality in different settings: is it just a difference between the rich and the poor? Answer: Differences in maternal mortality are more than just differences between the rich and poor. Acknowledging the magnitude of maternal mortality and harnessing a strong political will to tackle the issues are important factors. However, there is no single, general solution to reduce maternal mortality, and identification of problems needs to","Question: Is the application of audit methods in maternal mortality just a reflection of socioeconomic disparity? Answer: The variation in maternal mortality is more than a wealth issue. Recognizing the problem scale and maintaining political determination are vital. There is no universal fix, and the identification of problems requires targeted approaches.",5.447773729207643e-07,0.3317687588038889,0.05760404652056901,0.041708808689983126,0.37462936586316253,0.007355796485260777,0.041648435441915946,0.3719535934415963,0.014081632653061225,5.447773729207643e-07,0.3983476403393005,0.0
141,1.1,1,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,"Is it possible for a single-level measurement of visceral adipose tissue area to represent the total visceral adipose tissue volume? Measuring VAT area at a single level, 3 cm above the lower edge of the L3 vertebra, is achievable and correlates with variations in VAT volume and body weight. New insights show that VAT area on a CT slice 3 cm above...",7.105791820705622e-08,0.15976084040369454,0.10914915358571867,0.005440279394345618,0.1254722031843163,0.05311384212664815,0.0054324046228586,0.10169626606770876,0.03566529492455417,7.105791820705622e-08,0.07831517733430982,0.0181755829903978
141,1.1,2,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can the measurement of visceral adipose tissue (VAT) area at one level accurately represent the entire VAT volume? Measuring VAT area at a single slice 3 cm above the lower border of the L3 vertebra is practical and can reflect changes in VAT volume and body weight. Recent findings indicate that VAT area at a CT section 3 cm above...,2.3685972735685406e-08,0.09097778282382007,0.05334375857338822,0.0018134264647818726,0.06687230369558028,0.03533694538691232,0.0018108015409528666,0.04288913629268265,0.01812702961843172,2.3685972735685406e-08,0.043223857523040365,0.0181755829903978
141,1.1,3,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Does measuring visceral adipose tissue area at a single anatomical level correspond to visceral adipose tissue volume? VAT area measurement taken 3 cm above the lower margin of vertebra L3 is feasible and reflects alterations in VAT volume and body weight. Advances reveal that VAT area on a CT slice 3 cm above...,1.4211583641411244e-07,0.015602784696485017,0.09801111111111109,0.010880558788691236,0.04112406266969293,0.050175720897116416,0.0108648092457172,0.06381817240986454,0.03566529492455417,1.4211583641411244e-07,0.09030753510148237,0.0181755829903978
141,1.1,4,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can a single-level measurement of visceral adipose tissue area represent the visceral adipose tissue volume? Measuring the VAT area at one level 3 cm above the lower margin of L3 vertebra is possible and corresponds to changes in VAT volume and body weight. New knowledge suggests that VAT area on a CT slice 3 cm above...,7.105791820705622e-08,0.0463033016515646,0.10212010765090349,0.005440279394345618,0.017544475746639865,0.051263794944820223,0.0054324046228586,0.005549264285888977,0.03566529492455417,7.105791820705622e-08,0.030884114630681303,0.0181755829903978
141,1.1,5,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,"Is a single-level visceral adipose tissue area measurement an accurate proxy for the total VAT volume? It is feasible to measure VAT area 3 cm above the lower border of the L3 vertebra, which can reflect changes in VAT volume and body weight. Progress in understanding shows VAT area at a CT slice 3 cm above...",7.105791820705622e-08,0.09671400569228839,0.13808814524741897,0.005440279394345618,0.04321659354515672,0.06977572089711641,0.0054324046228586,0.005549264285888977,0.03566529492455417,7.105791820705622e-08,0.030884114630681303,0.0181755829903978
141,1.1,6,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can visceral adipose tissue volume be represented by a visceral adipose tissue area measurement at a single level? Measurement of VAT area at a single level 3 cm above the lower margin of L3 is achievable and reflects changes in VAT volume and body weight. Advances disclose that VAT area on CT at 3 cm above...,7.105791820705622e-08,0.004107402389158743,0.06694477301124531,0.005440279394345618,0.008127642051876993,0.032793472376406355,0.0054324046228586,0.005549264285888977,0.03566529492455417,7.105791820705622e-08,0.030884114630681303,0.0181755829903978
141,1.1,7,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Is the area of visceral adipose tissue measured at one level sufficient to represent VAT volume? Measuring VAT area at 3 cm above the lower edge of the L3 vertebra is feasible and signifies VAT volume and body weight changes. Knowledge advances indicate VAT area on CT slice 3 cm above...,1.8948778188548325e-07,0.0036372445161094724,0.13446944444444442,0.014507411718254981,0.05394715490849178,0.06977572089711641,0.014486412327622933,0.1046401669301189,0.03566529492455417,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
141,1.1,8,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Can the measurement of VAT area at a single point represent the total volume of visceral adipose tissue? VAT area measured 3 cm above L3 lower boundary is possible and correlates with changes in VAT volume and body weight. Advances in understanding reveal VAT area at a CT slice 3 cm above...,1.6580180914979784e-07,0.07455382217442885,0.03404083175803399,0.012693985253473108,0.08919622203576871,0.029845165341560842,0.012675610786670066,0.11231260138289123,0.015265989368998614,1.6580180914979784e-07,0.11092682230421813,0.0181755829903978
141,1.1,9,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,Does a single-level visceral adipose tissue area measurement reflect visceral adipose tissue volume? VAT area at 3 cm above the lower margin of L3 vertebra is measurable and can mirror changes in VAT volume and body weight. Recent knowledge improvements focus on VAT area from a CT slice 3 cm above...,1.8948778188548325e-07,0.059089018960905015,0.09500491493383739,0.014507411718254981,0.08223887656399986,0.049376415341560856,0.014486412327622933,0.1046401669301189,0.03566529492455417,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
141,1.1,10,human,Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: VAT area measurement at a single level 3 cm above the lower margin of the L3 vertebra is feasible and can reflect changes in VAT volume and body weight. Advances in knowledge: As VAT area at a CT slice 3cm above,"Can VAT area measurement from a single level be indicative of overall visceral adipose tissue volume? Measuring VAT area 3 cm above the L3 vertebra lower margin is feasible, able to reflect variations in VAT volume and body weight. Scientific progress highlights VAT area at a CT slice 3 cm above...",1.8948778188548325e-07,0.04182809461379833,0.07209126301493884,0.014507411718254981,0.05394715490849178,0.06977572089711641,0.014486412327622933,0.1046401669301189,0.03566529492455417,1.8948778188548325e-07,0.1319802315020513,0.0181755829903978
142,1.1,1,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Does the menopausal transition influence quality of life? Yes, it can impact quality of life because of symptoms like hot flashes, mood swings, sleep disruptions, and decreased sexual desire. However, the extent of the effect varies among women.",9.474389094274131e-08,0.004873338872325217,0.06941457222988758,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
142,1.1,2,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Is quality of life affected by menopausal transition? Yes, symptoms such as hot flashes, mood changes, sleep problems, and lower sexual desire during menopausal transition can affect quality of life, though the degree differs for every woman.",1.1842986367842661e-07,0.03331307459281296,0.06866564302857742,0.009067132323909363,0.06421667456852864,0.049861495844875335,0.00905400770476434,0.10165511225399859,0.025623268698060954,1.1842986367842703e-07,0.14107859825990632,0.0
142,1.1,3,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Does going through menopause change a woman's quality of life? Yes, menopausal transition may influence quality of life due to symptoms like hot flashes, mood swings, sleep disturbances, and reduced sexual drive, but the impact is different for each individual woman.",2.3685972735685406e-08,0.07589825873479139,0.07143718162429183,0.0018134264647818726,0.043996910071702366,0.049861495844875335,0.0018108015409528666,0.00957052285622595,0.025623268698060954,2.3685972735685406e-08,0.026668247082160867,0.0
142,1.1,4,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Can menopausal transition affect quality of life? Yes, it can, as symptoms including hot flashes, mood fluctuations, sleep issues, and diminished sexual desire often influence quality of life, with the degree of effect varying from woman to woman.",9.474389094274131e-08,0.004873338872325217,0.06941457222988758,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
142,1.1,5,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Is the quality of life affected during the menopausal transition? Yes, common symptoms such as hot flashes, mood swings, sleep problems, and lower sexual interest can impact quality of life, though the consequences differ among women.",1.421158364141119e-07,0.0625841851794462,0.06787403226662558,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,1.1,6,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Does menopausal transition have an impact on quality of life? Yes, symptoms like hot flashes, mood alterations, sleep disturbances, and decreased sexual desire can affect quality of life during this phase, but the effect varies for each woman.",9.474389094274131e-08,0.004873338872325217,0.06941457222988758,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
142,1.1,7,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Can the quality of life change during menopausal transition? Yes, due to symptoms such as hot flashes, mood swings, trouble sleeping, and lessened sexual desire, quality of life can be affected, with individual variation among women.",1.421158364141119e-07,0.10219259549715698,0.03948777904551864,0.010880558788691243,0.13397757500412988,0.0204767391873914,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,1.1,8,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Does the transition into menopause influence a woman's quality of life? Yes, because symptoms including hot flashes, mood swings, disturbed sleep, and reduced sexual desire may affect quality of life, though the impact varies by individual.",1.421158364141119e-07,0.0625841851794462,0.06787403226662558,0.010880558788691243,0.09320421144178015,0.049861495844875335,0.010864809245717214,0.13150807540368037,0.025623268698060954,1.4211583641411244e-07,0.17185025692666,0.0
142,1.1,9,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Is life quality impacted by menopausal transition? Yes, menopausal transition symptoms like hot flashes, mood swings, sleep troubles, and decreased sexual desire can influence quality of life, but the extent varies from woman to woman.",1.658018091497972e-07,0.05196331173498647,0.09642074506939374,0.012693985253473122,0.12305717459146193,0.049861495844875335,0.012675610786670087,0.16227973407043406,0.025623268698060954,1.6580180914979784e-07,0.20359895524123983,0.0
142,1.1,10,ai,"Question: Does menopausal transition affect the quality of life? Answer: Yes, menopausal transition can affect the quality of life due to symptoms such as hot flashes, mood swings, sleep disturbances, and reduced sexual desire. However, the impact varies for each woman, and","Does transitioning through menopause affect quality of life? Yes, it can lead to symptoms such as hot flashes, mood swings, sleep disturbances, and a drop in sexual desire, causing variations in quality of life depending on the woman.",9.474389094274131e-08,0.004873338872325217,0.06941457222988758,0.0072537058591274906,0.0360457976018318,0.049861495844875335,0.007243206163811466,0.07266757538074708,0.025623268698060954,9.474389094274162e-08,0.11122563511022454,0.0
143,1.1,1,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the prognosis of low-tone sudden deafness? Does it always lead to Meniere's disease? We conclude that not all patients with low-tone sudden deafness experience endolymphatic hydrops, even with vertigo attacks at onset, and that electrocochleography is a helpful prognostic tool.",1.1842986367842703e-07,0.08860771949829882,0.019013429752066123,0.009067132323909363,0.08697649429816368,0.02221074380165289,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
143,1.1,2,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness inevitably develop into Meniere's disease? Our findings indicate that not all low-tone sudden deafness patients suffer from endolymphatic hydrops, even if they had vertigo at onset, and that electrocochleography serves as a useful prognostic instrument.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,1.1,3,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is the progression from low-tone sudden deafness to Meniere's disease inevitable? The conclusion is that endolymphatic hydrops is not present in all low-tone sudden deafness cases, even when vertigo attacks occur initially, and that electrocochleography can effectively predict outcomes.",1.8948778188548304e-07,0.20374442999950348,0.009080706050403016,0.014507411718254981,0.20240545093327666,0.004795429037853273,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
143,1.1,4,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Regarding low-tone sudden deafness, does it inevitably progress to Meniere's disease? We find that endolymphatic hydrops does not affect all patients with low-tone sudden deafness, even those with initial vertigo, and electrocochleography is a valuable prognostic tool.",2.3685972735685364e-07,0.26186514355375623,0.01197489204724185,0.018134264647818726,0.26011629724039764,0.006335969001115268,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
143,1.1,5,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness always lead to Meniere's disease? The conclusion is that not every patient with low-tone sudden deafness experiences endolymphatic hydrops, despite vertigo attacks at onset, and electrocochleography is useful for prognosis.",3.0791764556390954e-07,0.35587800721570906,0.016965368374884958,0.023574544042164365,0.35344174439737097,0.009006737988149414,0.023540420032387294,0.3502024294331152,0.0,3.079176455639103e-07,0.36000273403140737,0.0
143,1.1,6,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is Meniere's disease the inevitable outcome for low-tone sudden deafness? We conclude that endolymphatic hydrops is not present in all such patients even when vertigo occurs initially, and electrocochleography is a reliable tool for prognosis.",2.8423167282822424e-07,0.2420072039981549,0.043388429752066124,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
143,1.1,7,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Does low-tone sudden deafness necessarily progress to Meniere's disease? Our study suggests that not all cases involve endolymphatic hydrops, even with vertigo at onset, and that electrocochleography is a practical prognostic measure.",3.5528959103528014e-07,0.3343805241291702,0.043388429752066124,0.027201396971728124,0.3746585667499449,0.02221074380165289,0.02716202311429304,0.41689380393178865,0.0,3.552895910352811e-07,0.42899560551835814,0.0
143,1.1,8,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"What is the likelihood that low-tone sudden deafness progresses to Meniere's disease? Findings show that endolymphatic hydrops does not affect all low-tone sudden deafness patients, even those with vertigo initially, and electrocochleography is a useful means for prognosis.",2.1317375462116834e-07,0.23238464630089695,0.010489121268342054,0.016320838183036854,0.2308451866537644,0.005544358239163438,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
143,1.1,9,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Is progression to Meniere's disease certain in low-tone sudden deafness? We determined that not all patients have endolymphatic hydrops at onset, even with vertigo present, and that electrocochleography provides useful prognostic information.",3.5528959103528014e-07,0.3343805241291702,0.043388429752066124,0.027201396971728124,0.3746585667499449,0.02221074380165289,0.02716202311429304,0.41689380393178865,0.0,3.552895910352811e-07,0.42899560551835814,0.0
143,1.1,10,human,Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: We conclude that not all low-tone sudden deafness (SD) patients suffered from endolymphatic hydrops even if they had vertigo attack at the onset and that electrocochleography (ECochG) was a useful prognostic tool.,"Will low-tone sudden deafness inevitably result in Meniere's disease? Our conclusion is that endolymphatic hydrops is not universal among these patients despite vertigo attacks at onset, and electrocochleography proves valuable for prognosis.",3.5528959103528014e-07,0.3343805241291702,0.043388429752066124,0.027201396971728124,0.3746585667499449,0.02221074380165289,0.02716202311429304,0.41689380393178865,0.0,3.552895910352811e-07,0.42899560551835814,0.0
144,1.1,1,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Is there a connection between a resident's leadership abilities and their technical skill ratings? Answer: No direct correlation exists between a resident's leadership abilities and their technical skill ratings. Leadership and technical skills are separate attributes that both play roles in overall competence, but one doesn't inherently affect the other.",4.737194547137081e-08,0.0032026948761529894,0.015873015873015872,0.0036268529295637453,0.06788248107395178,0.07535583103764922,0.003621603081905733,0.13072718072118983,0.12244897959183676,4.737194547137081e-08,0.10399301158365404,0.10487528344671203
144,1.1,2,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.",Question: Are a resident's leadership skills related to their technical skill ratings? Answer: There is no direct relationship between a resident’s leadership capabilities and their technical skill evaluations. These are distinct qualities contributing independently to overall proficiency.,2.8423167282822445e-07,0.18051062771224968,0.11470470541157635,0.02176111757738247,0.24592107642432026,0.03498634504847149,0.021729618491434406,0.3022808718729326,0.0,2.8423167282822487e-07,0.3101549283038394,0.0
144,1.1,3,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Do leadership skills in residents correspond with their technical skill ratings? Answer: No, leadership skills and technical skill ratings in residents do not show a direct correlation. Both are important but separate competencies that do not necessarily influence one another.",1.8948778188548325e-07,0.1367631947708623,0.07130259511211885,0.014507411718254981,0.09809908146637802,0.06353305785123965,0.014486412327622933,0.19105523676270808,0.0,1.8948778188548325e-07,0.19574457712609394,0.0
144,1.1,4,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Does a resident's leadership skill have any bearing on their technical skill ratings? Answer: There is no direct linkage between leadership skills and technical ratings for residents. While both contribute to overall skill, they remain independent in their influence.",2.1317375462116855e-07,0.023451566643165833,0.17006802721088432,0.016320838183036854,0.124074567869636,0.06353305785123965,0.0162972138685758,0.21772348384486895,0.0,2.1317375462116866e-07,0.22314355131420927,0.0
144,1.1,5,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.",Question: Is there a relationship between residents’ leadership skills and their technical skill scores? Answer: Residents’ leadership skills and technical skill scores do not directly correlate. They represent different attributes that independently contribute to competency.,3.3160361829959505e-07,0.3237461424060468,0.05451247165532873,0.02538797050694623,0.3491710061974147,0.0031792597242885703,0.025351221573340153,0.4062271924743657,0.031217481789802305,3.316036182995957e-07,0.3726752852851729,0.0
144,1.1,6,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.",Question: Are ratings of technical skills associated with a resident's leadership skills? Answer: There is no direct association between leadership skills and technical skill ratings for residents. Both are distinct yet vital components of overall capability.,3.0791764556390975e-07,0.13166515128339684,0.17006802721088432,0.02357454404216435,0.23530020297986054,0.06353305785123965,0.02354042003238728,0.3321338350226144,0.0,3.079176455639103e-07,0.3409265869705931,0.0
144,1.1,7,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.","Question: Do technical skill ratings reflect a resident’s leadership abilities? Answer: No, there is no direct connection between a resident’s leadership abilities and their assessed technical skills. These skills stand as separate factors contributing uniquely to overall performance.",2.6054570009253915e-07,0.1510301304593904,0.11619047619047615,0.0199476911126006,0.21664996583768703,0.035777955810423326,0.019918816950481533,0.2732933349996811,0.0,2.6054570009253947e-07,0.2803019651541576,0.0
144,1.1,8,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.",Question: Does a resident’s ability to lead relate to their technical skill evaluation? Answer: Leadership ability and technical skill evaluations in residents are not directly connected. They are separate traits that both impact overall competency.,3.3160361829959505e-07,0.20142605171899808,0.14068327055340038,0.02538797050694623,0.2651531661295423,0.06353305785123965,0.025351221573340153,0.3629054936893681,0.0,3.316036182995957e-07,0.3726752852851729,0.0
144,1.1,9,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.",Question: Are a resident’s leadership qualities linked to their technical skill ratings? Answer: There is no direct link between a resident’s leadership qualities and their technical skill ratings. Both qualities contribute differently to the total measure of competency.,2.6054570009253915e-07,0.2634323759555981,0.03823208971088432,0.0199476911126006,0.2936663192332367,0.01911157024793389,0.019918816950481533,0.31290174531739234,0.02854671280276816,2.6054570009253947e-07,0.2803019651541576,0.0
144,1.1,10,ai,"Question: Do resident's leadership skills relate to ratings of technical skill? Answer: There is no direct correlation between a resident's leadership skills and their ratings of technical skill. Leadership skills and technical skills are distinct qualities that contribute to overall competency, but one does not necessarily impact the other.",Question: Is there a direct correlation between leadership and technical skills in residents? Answer: Leadership and technical skills for residents are distinct without a direct correlation; each independently affects overall skill level.,4.0266153650665095e-07,0.43190270004506903,0.043867752862461834,0.03082824990129187,0.4528829700085266,0.0027934727610052223,0.030783626196198774,0.5091488203343415,0.03443877551020409,4.026615365066519e-07,0.4744579795951154,0.0
145,1.1,1,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Are student examiners suitable substitutes for faculty in an undergraduate medical emergency OSCE if they are well-trained and competent?,6.395212638635038e-07,0.5466122355755174,0.23140495867768596,0.048962514549110686,0.6359093896075247,0.20761245674740483,0.04889164160572752,0.6984567597310134,0.19463667820069208,6.395212638635056e-07,0.7655633483964164,0.1799307958477509
145,1.1,2,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Can properly trained student examiners effectively replace faculty in an undergraduate OSCE on medical emergencies?,7.342651548062453e-07,0.797926663856424,0.23140495867768596,0.05621622040823819,0.9041733762022037,0.20761245674740483,0.05613484776953902,0.9861388321827937,0.19463667820069208,7.342651548062471e-07,1.0757182767002562,0.1799307958477509
145,1.1,3,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"Might student examiners act as reasonable substitutes for faculty during an undergraduate OSCE involving medical emergencies, provided they receive adequate training?",5.92149318392133e-07,0.44125171991769196,0.23140495867768596,0.04533566161954693,0.5246837544973006,0.20761245674740483,0.04527003852382178,0.5806737240746296,0.19463667820069208,5.921493183921349e-07,0.6404002054424107,0.1799307958477509
145,1.1,4,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Is it acceptable for student examiners to stand in for faculty in an undergraduate OSCE on medical emergencies given sufficient training and capability?,5.447773729207624e-07,0.34594154011336675,0.23140495867768596,0.04170880868998317,0.42460029594031923,0.20761245674740483,0.041648435441916036,0.47531320841680413,0.19463667820069208,5.447773729207642e-07,0.5291745703321866,0.1799307958477509
145,1.1,5,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Do adequately trained student examiners serve as reasonable substitutes for faculty members in undergraduate medical emergencies OSCEs?,6.868932093348744e-07,0.6643952712319012,0.23140495867768596,0.05258936747867443,0.7610725325615304,0.20761245674740483,0.05251324468763327,0.8319881523555361,0.19463667820069208,6.868932093348764e-07,0.9086641920370897,0.1799307958477509
145,1.1,6,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"With proper training and expertise, can student examiners reasonably substitute for faculty in undergraduate OSCEs on medical emergencies?",6.632072365991891e-07,0.6037706494154662,0.23140495867768596,0.05077594101389256,0.6965340114239598,0.20761245674740483,0.050702443146680404,0.762995280868584,0.19463667820069208,6.63207236599191e-07,0.8345562198833685,0.1799307958477509
145,1.1,7,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Are student examiners who are properly trained a good substitute for faculty during an undergraduate medical emergency OSCE?,6.632072365991891e-07,0.6037706494154662,0.23140495867768596,0.05077594101389256,0.6965340114239598,0.20761245674740483,0.050702443146680404,0.762995280868584,0.19463667820069208,6.63207236599191e-07,0.8345562198833685,0.1799307958477509
145,1.1,8,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Could student examiners replace faculty reasonably in an undergraduate OSCE on medical emergencies if trained adequately?,7.105791820705599e-07,0.7289337923694719,0.23140495867768596,0.05440279394345631,0.8300654040484825,0.20761245674740483,0.05432404622858615,0.9060961245092574,0.19463667820069208,7.105791820705618e-07,0.9887068997106261,0.1799307958477509
145,1.1,9,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,"When properly trained, can student examiners function as effective substitutes for faculty in an undergraduate OSCE focused on medical emergencies?",6.158352911278184e-07,0.4925450143052421,0.23140495867768596,0.04714908808432881,0.578750975767576,0.20761245674740483,0.04708084006477466,0.6378321379145784,0.19463667820069208,6.158352911278203e-07,0.7010248272588457,0.1799307958477509
145,1.1,10,ai,Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: Student examiners may be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies as long as they have been properly trained and have a good,Is the substitution of faculty by properly trained student examiners reasonable in an undergraduate OSCE on medical emergencies?,6.632072365991891e-07,0.6037706494154662,0.23140495867768596,0.05077594101389256,0.6965340114239598,0.20761245674740483,0.050702443146680404,0.762995280868584,0.19463667820069208,6.63207236599191e-07,0.8345562198833685,0.1799307958477509
146,1.1,1,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policies could be a powerful tool for boosting public health, particularly for individuals with lower incomes. Although the results are strong, additional studies are necessary to verify their accuracy. Future work should explore various income support programs and a wider array of related factors.",9.474389094274162e-08,0.06598257776373995,0.0010408155303573991,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
146,1.1,2,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Providing income support may be an important strategy to enhance population health, especially among low-income groups. While the findings are compelling, more research is needed to confirm their robustness. Future investigations should consider multiple forms of income support policies and examine a broader spectrum of issues.",9.474389094274162e-08,0.06598257776373995,0.0010408155303573991,0.0072537058591274906,0.06559728248581642,0.0,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
146,1.1,3,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Policies that support income may serve as a critical mechanism to improve health outcomes for the public, particularly those with less income. Despite strong findings, further validation is required. Upcoming studies should analyze different income support policies along with a more extensive set of variables.",1.1842986367842703e-07,0.059684790061456106,0.015621063240110858,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
146,1.1,4,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income assistance programs might be an effective lever to improve the health of populations, particularly low-income individuals. Though the evidence is solid, it is essential to conduct additional analyses to verify the findings. Future research should review a variety of income policies and examine a broader range of factors.",2.3685972735685406e-08,0.005912492424360316,0.015621063240110858,0.0018134264647818726,0.01600034134644357,0.0,0.0018108015409528666,0.016260520871781203,0.0,2.3685972735685406e-08,0.01652930195121094,0.0
146,1.1,5,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support could represent a vital tool for enhancing the health of populations, notably those with lower incomes. Even with robust findings, confirmation through further analysis is necessary. Research going forward should cover diverse income support policies and broader related parameters.",2.1317375462116866e-07,0.15509440075506564,0.0025545197502869436,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
146,1.1,6,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may offer a meaningful intervention to improve overall health, particularly among economically disadvantaged groups. Although the outcomes are reliable, they warrant additional validation. Future studies are encouraged to assess various income support schemes and a wider array of associated aspects.",1.6580180914979784e-07,0.11849191983648222,0.001917202066011597,0.012693985253473108,0.11778303565638559,0.0,0.012675610786670066,0.1198011998126205,0.0,1.6580180914979784e-07,0.12188981760903506,0.0
146,1.1,7,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Supporting income could be a significant approach to improving population health, especially for those earning less. The present findings are persuasive, yet further research is advised to confirm these results. Future analysis should include multiple types of income support and a wider scope of factors.",1.1842986367842703e-07,0.059684790061456106,0.015621063240110858,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
146,1.1,8,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support might be a new and effective way to enhance public health, particularly for lower-income populations. While the data is strong, more studies are required to validate these conclusions. Continued research should explore various income support policies and encompass a broader range of considerations.",1.1842986367842703e-07,0.08318130465670848,0.0013230509097107834,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
146,1.1,9,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support initiatives may constitute a crucial lever to boost community health, especially for those with limited financial resources. Even though findings are convincing, confirmation through further investigation is needed. Future work should survey multiple income support options and incorporate a broader set of factors.",1.1842986367842703e-07,0.08318130465670848,0.0013230509097107834,0.009067132323909363,0.08269171584511614,0.0,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
146,1.1,10,human,"Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Income support policy may be a significant new lever for improving population health, especially that of lower-income persons. Even though the findings are robust, further analyses are needed to confirm their reliability. Future research should examine a variety of different income support policies, as well as whether a broader range","Question: Upstream solutions: does the supplemental security income program reduce disability in the elderly? Answer: Financial assistance programs might play a key role in raising population health standards, notably among lower-income groups. Despite strong evidence, ongoing research is essential to affirm these findings. Future studies should focus on examining a wider variety of income support policies and related dimensions.",1.4211583641411244e-07,0.07677922342075583,0.015621063240110858,0.010880558788691236,0.10008345855698497,0.0,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
147,1.1,1,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone correspond to the level of aganglionosis in Hirschsprung's disease specimens? The correlation between the radiographic transition zone on contrast enema and the aganglionosis length is low. Systematic preoperative biopsy is advised.,4.73719454713706e-08,0.02452542144633485,0.02155880538337923,0.003626852929563752,0.10019696426687341,0.03083864795918367,0.003621603081905747,0.10084942005686903,0.0302734375,4.737194547137081e-08,0.060624621816435464,0.0
147,1.1,2,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is there a correlation between the radiographic transition zone and the aganglionosis level in Hirschsprung's disease? The link between the transition zone seen on contrast enema and aganglionosis length is weak; systematic preoperative biopsy is necessary.,4.73719454713706e-08,0.015082988871376823,0.04958677685950413,0.003626852929563752,0.01865023714217351,0.02775510204081633,0.003621603081905747,0.058840500022933284,0.0,4.737194547137081e-08,0.060624621816435464,0.0
147,1.1,3,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the radiographic transition zone align with the aganglionosis level in Hirschsprung’s disease specimens? The correlation between contrast enema transition zone and aganglionosis length remains minimal. Preoperative biopsy should be systematic.,1.658018091497971e-07,0.1060606823577892,0.07322604490478232,0.01269398525347315,0.17771493177186226,0.02775510204081633,0.012675610786670115,0.22314355131420927,0.0,1.6580180914979784e-07,0.23052365861183244,0.0
147,1.1,4,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is the radiographic transition zone correlated with the level of aganglionosis identified in Hirschsprung's disease samples? The association between transition zone on contrast enema and aganglionosis length is low; systematic preoperative biopsy is recommended.,9.47438909427412e-08,0.006549610550070195,0.07624630538337923,0.007253705859127511,0.07927485895860897,0.02775510204081633,0.007243206163811494,0.1213608570042668,0.0,9.474389094274162e-08,0.125163142954007,0.0
147,1.1,5,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Does the location of the radiographic transition zone on contrast enema match the level of aganglionosis on the Hirschsprung’s specimen? The correlation remains low and systematic preoperative biopsy is essential.,1.894877818854824e-07,0.09375242199614142,0.10651974288337923,0.01450741171825503,0.21280625158313127,0.02775510204081633,0.014486412327622988,0.25951119548508395,0.0,1.8948778188548325e-07,0.2682639865946794,0.0
147,1.1,6,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Is there a significant correlation between the radiographic transition zone on contrast enema and the aganglionosis length in Hirschsprung’s disease? The relationship is weak, indicating that systematic preoperative biopsy is important.",1.658018091497971e-07,0.05985087032045966,0.10651974288337923,0.01269398525347315,0.17771493177186226,0.02775510204081633,0.012675610786670115,0.22314355131420927,0.0,1.6580180914979784e-07,0.23052365861183244,0.0
147,1.1,7,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Does the radiographic transition zone correspond well with the aganglionosis length on specimens in Hirschsprung’s disease? The correlation is low, thus systematic preoperative biopsy is advised.",2.842316728282236e-07,0.24217242711441456,0.10651974288337923,0.021761117577382548,0.3669569314103902,0.02775510204081633,0.021729618491434483,0.41985384556026384,0.0,2.8423167282822487e-07,0.4353180712578464,0.0
147,1.1,8,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Does the radiographic transition zone found on contrast enema reliably indicate the level of aganglionosis in Hirschsprung's disease specimens? The correlation remains weak, emphasizing the need for systematic preoperative biopsy.",1.894877818854824e-07,0.09375242199614142,0.10651974288337923,0.01450741171825503,0.21280625158313127,0.02775510204081633,0.014486412327622988,0.25951119548508395,0.0,1.8948778188548325e-07,0.2682639865946794,0.0
147,1.1,9,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,Is the radiographic transition zone on angiogram indicative of aganglionosis extent in Hirschsprung’s disease? Correlation is low and systematic preoperative biopsy is recommended.,3.552895910352795e-07,0.37000579862429905,0.10651974288337923,0.027201396971728187,0.5004883240349138,0.02775510204081633,0.027162023114293103,0.5596157879354231,0.0,3.55289591035281e-07,0.5819215454497217,0.0
147,1.1,10,human,Question: Does the radiographic transition zone correlate with the level of aganglionosis on the specimen in Hirschsprung's disease? Answer: Correlation between level of radiographic transition zone on contrast enema and length of aganglionosis remains low. Systematic preoperative biopsy,"Does the level of the radiographic transition zone on contrast enema accurately reflect the aganglionosis extent in Hirschsprung's disease specimens? Correlation stays low, making systematic preoperative biopsy necessary.",2.36859727356853e-07,0.1652113859782851,0.10651974288337923,0.01813426464781879,0.28691422373685294,0.02775510204081633,0.018108015409528735,0.3364722366212134,0.0,2.3685972735685406e-07,0.3483066942682167,0.0
148,1.1,1,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures in growing children are uncommon and frequently missed injuries; they usually result from age-specific traumatic events. Ultrasound is effective for detecting these fractures, while X-rays are preferred for assessing dislocation severity.",4.2634750924233646e-07,0.418561215406021,0.01999167013744273,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
148,1.1,2,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In children, isolated sternal fractures are rare and often go unnoticed; these fractures commonly arise from trauma linked to their age group. Ultrasonography serves as a helpful diagnostic method, with radiographs being ideal to determine the dislocation's magnitude.",3.0791764556390996e-07,0.27337920556152184,0.01999167013744273,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
148,1.1,3,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Fractures of the sternum in growing children are infrequent and often overlooked, typically caused by trauma associated with their age. Ultrasonography is valuable for identifying fractures, and radiography is the preferred technique to evaluate the extent of dislocation.",3.0791764556390996e-07,0.27337920556152184,0.01999167013744273,0.023574544042164344,0.30830135965451655,0.0,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
148,1.1,4,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Growing children rarely sustain isolated sternal fractures, which are often missed; these injuries usually stem from typical age-related trauma. Ultrasounds aid diagnosis, whereas radiographic imaging is best for visualizing the degree of dislocation.",4.2634750924233646e-07,0.418561215406021,0.01999167013744273,0.032641676366073735,0.4578330936254802,0.0,0.032594427737151634,0.47000362924573613,0.0,4.263475092423373e-07,0.48285177172358473,0.0
148,1.1,5,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Isolated sternal fractures in children are an uncommon and frequently under-recognized injury, generally resulting from trauma specific to the child's age. Ultrasound is a useful tool to detect such fractures, with X-rays preferred to assess dislocation extent.",3.3160361829959526e-07,0.30077817974963716,0.01999167013744273,0.025387970506946217,0.3364722366212134,0.0,0.02535122157334014,0.34484048629172914,0.0,3.316036182995957e-07,0.35364004024357776,0.0
148,1.1,6,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Sternal fractures occurring in growing children are rare and often overlooked, commonly caused by age-related traumatic incidents. Ultrasonography helps detect fractures, while radiography is optimal for showing the dislocation's severity.",4.974054274493924e-07,0.5170012882192743,0.01999167013744273,0.038081955760419374,0.5596157879354227,0.0,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
148,1.1,7,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In pediatric populations, isolated sternal fractures are rare and commonly missed, arising from trauma typical of their developmental stage. Ultrasonography can effectively detect these fractures, and radiographic evaluation is the standard for determining dislocation extent.",3.7897556377096586e-07,0.3579365935895855,0.01999167013744273,0.029014823436509976,0.3953127366441467,0.0,0.028972824655245887,0.4054651081081646,0.0,3.789755637709665e-07,0.41616039722491127,0.0
148,1.1,8,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Fractures of the sternum in children are infrequent and often neglected in diagnosis; they are typically a result of trauma consistent with the child's age. Ultrasound imaging is useful to detect fractures, while radiography provides the best visualization of dislocation.",2.6054570009253936e-07,0.220735472076103,0.01999167013744273,0.0199476911126006,0.25423413838424036,0.0,0.019918816950481533,0.26028309826366547,0.0,2.6054570009253947e-07,0.26662866325394763,0.0
148,1.1,9,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"Rare and often overlooked, sternal fractures in growing children usually derive from common traumatic incidents depending on their age. Ultrasonography functions as a helpful diagnostic tool, with radiography being the preferred method to visualize dislocation extent.",3.5528959103528056e-07,0.328949056716334,0.01999167013744273,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
148,1.1,10,human,Question: Sternal fracture in growing children : A rare and often overlooked fracture? Answer: Isolated sternal fractures in childhood are often due to typical age-related traumatic incidents. Ultrasonography is a useful diagnostic tool for fracture detection and radiography is the method of choice for visualization of the extent of the dislocation.,"In childhood, isolated sternal fractures are uncommon and frequently underdiagnosed, often arising from trauma indicative of the child's age bracket. Ultrasound is beneficial for detecting fractures; however, radiography remains the choice technique for assessing dislocation degree.",3.5528959103528056e-07,0.328949056716334,0.01999167013744273,0.027201396971728097,0.3654597734944649,0.0,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
149,1.1,1,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole be a novel risk factor for pathological gambling? Answer: Adverse drug reactions were compared with previously published case reports. The dopamine partial agonist action of aripiprazole might account for the development of pathological gambling.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,1.1,2,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is aripiprazole a potential new risk factor for pathological gambling? Answer: Side effects were reviewed alongside existing case reports. The mechanism of aripiprazole as a dopamine partial agonist could explain the emergence of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,1.1,3,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Might aripiprazole represent a newly identified risk factor for pathological gambling? Answer: Drug adverse reactions were matched with earlier documented cases. The dopamine partial agonist properties of aripiprazole might clarify the onset of pathological gambling.,4.73719454713706e-08,0.058840500022933284,0.0,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,1.1,4,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole induce pathological gambling as a novel risk factor? Answer: Observed adverse drug reactions were compared with published case reports. Aripiprazole's mechanism as a dopamine partial agonist could justify the occurrence of pathological gambling.,4.73719454713706e-08,0.019232089705222055,0.02854671280276816,0.003626852929563759,0.060624621816435464,0.0,0.003621603081905747,0.06252035698133351,0.0,4.737194547137081e-08,0.06453852113757153,0.0
149,1.1,5,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is pathological gambling a possible side effect linked to aripiprazole? Answer: Adverse drug reactions were cross-checked with previously documented case reports. Aripiprazole’s dopamine partial agonist mechanism might explain pathological gambling episodes.,4.73719454713706e-08,0.10723952992068453,0.0322222222222222,0.003626852929563759,0.06453852113757153,0.0,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
149,1.1,6,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Can aripiprazole be considered a fresh risk factor for pathological gambling? Answer: The adverse reactions to the drug were analyzed alongside known case reports. The dopamine partial agonist activity of aripiprazole could explain pathological gambling onset.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,1.1,7,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Does aripiprazole pose a new risk for developing pathological gambling? Answer: The reported adverse drug events were correlated with published case studies. The dopamine partial agonist effect of aripiprazole may underlie pathological gambling.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
149,1.1,8,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Could aripiprazole’s dopamine partial agonist mechanism increase risk for pathological gambling? Answer: Drug side effects were examined in light of existing case reports. This mechanism can explain pathological gambling manifestation.,7.10579182070559e-08,0.09531017980432521,0.0,0.005440279394345639,0.09844007281325329,0.0,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
149,1.1,9,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,Question: Is there evidence of aripiprazole as a new risk factor for pathological gambling? Answer: Adverse reactions to the drug aligned with already published case reports. The partial dopamine agonism of aripiprazole might contribute to pathological gambling.,7.10579182070559e-08,0.048503200291855286,0.02775510204081633,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
149,1.1,10,human,Question: Aripiprazole: a new risk factor for pathological gambling? Answer: Adverse drug reactions were confronted with other already published case reports. Dopamine partial agonist mechanism of aripiprazole could explain the occurrence of pathological gambling.,"Question: Might aripiprazole’s pharmacology indicate a new risk factor for pathological gambling? Answer: Adverse drug reactions were compared with prior case reports, suggesting that its dopamine partial agonist profile could explain pathological gambling occurrence.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
150,1.1,1,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Do statins given before surgery lower the risk of atrial fibrillation following coronary artery bypass surgery?,2.605457000925386e-07,0.4967273230300453,0.03840000000000001,0.01994769111260066,0.5798184952529417,0.0,0.019918816950481606,0.6131044728864081,0.0,2.60545700092539e-07,0.6505875661411489,0.0
150,1.1,2,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Is preoperative use of statins effective in decreasing atrial fibrillation after coronary artery bypass grafting?,2.8423167282822397e-07,0.5657201945169974,0.03840000000000001,0.021761117577382538,0.6539264674066629,0.0,0.02172961849143448,0.6931471805599445,0.0,2.8423167282822434e-07,0.737598943130779,0.0
150,1.1,3,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Does the administration of statins prior to surgery help reduce atrial fibrillation post coronary artery bypass graft?,2.3685972735685327e-07,0.43218880189247466,0.03840000000000001,0.018134264647818785,0.5108256237659896,0.0,0.018108015409528732,0.5389965007326869,0.0,2.3685972735685364e-07,0.5705448584676125,0.0
150,1.1,4,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Can taking statins before coronary artery bypass grafting diminish the occurrence of atrial fibrillation?,3.0791764556390933e-07,0.6398281666707186,0.03840000000000001,0.023574544042164414,0.7339691750801993,0.0,0.023540420032387353,0.7801585575495746,0.0,3.079176455639097e-07,0.8329091229351042,0.0
150,1.1,5,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Is there evidence that starting statins before surgery reduces atrial fibrillation incidence after coronary artery bypass?,2.605457000925386e-07,0.4967273230300453,0.03840000000000001,0.01994769111260066,0.5798184952529417,0.0,0.019918816950481606,0.6131044728864081,0.0,2.60545700092539e-07,0.6505875661411489,0.0
150,1.1,6,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Do patients on statins before coronary artery bypass have a lower rate of atrial fibrillation post-operation?,2.605457000925386e-07,0.4967273230300453,0.03840000000000001,0.01994769111260066,0.5798184952529417,0.0,0.019918816950481606,0.6131044728864081,0.0,2.60545700092539e-07,0.6505875661411489,0.0
150,1.1,7,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Does the use of preoperative statins have a role in preventing atrial fibrillation after coronary artery bypass surgery?,2.1317375462116791e-07,0.37156418007603964,0.03840000000000001,0.01632083818303691,0.446287102628419,0.0,0.01629721386857586,0.4700036292457348,0.0,2.1317375462116828e-07,0.49643688631389127,0.0
150,1.1,8,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Are preoperative statins associated with a reduction in atrial fibrillation after coronary artery bypass grafting?,2.8423167282822397e-07,0.5657201945169974,0.03840000000000001,0.021761117577382538,0.6539264674066629,0.0,0.02172961849143448,0.6931471805599445,0.0,2.8423167282822434e-07,0.737598943130779,0.0
150,1.1,9,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Is the incidence of atrial fibrillation after coronary artery bypass grafting decreased by preoperative statin therapy?,2.605457000925386e-07,0.4967273230300453,0.03840000000000001,0.01994769111260066,0.5798184952529417,0.0,0.019918816950481606,0.6131044728864081,0.0,2.60545700092539e-07,0.6505875661411489,0.0
150,1.1,10,ai,Question: Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Answer: There is evidence that preoperative statin use may reduce the incidence of atrial fibrillation,Does preoperative statin treatment potentially reduce the risk of atrial fibrillation following coronary artery bypass surgery?,2.605457000925386e-07,0.4967273230300453,0.03840000000000001,0.01994769111260066,0.5798184952529417,0.0,0.019918816950481606,0.6131044728864081,0.0,2.60545700092539e-07,0.6505875661411489,0.0
151,1.1,1,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are there discrepancies in reporting and interpreting red blood cell morphology between clinical pathologists and clinicians? Significant differences exist regarding the clinical importance of some RBC-M terminology between clinicians and clinical pathologists. Adding interpretive remarks on CBC reports is the most effective method to guarantee that RBC-M alterations are understood as intended by clinical pathologists. Reviewing reporting methods is necessary to enhance them.,0.0,0.022359586469676174,0.016124697661918843,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
151,1.1,2,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is a discordance present between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology? There are notable differences in how clinicians and clinical pathologists view the clinical relevance of certain RBC-M terms. Including explanatory comments on CBC reports is the best approach to ensure RBC-M changes are properly interpreted as the clinical pathologist intended. Reporting approaches should be evaluated carefully for improvements.,4.737194547137081e-08,0.011573000470415096,0.03121748178980229,0.0036268529295637453,0.03226086221822477,0.0,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
151,1.1,3,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Do clinical pathologists and clinicians differ in their reporting and interpretation of red blood cell morphology? Important disagreements about the clinical significance of specific RBC-M terms exist between these two groups. The clearest way to make sure RBC-M changes are interpreted correctly by clinicians is the addition of interpretive commentary on CBC reports. Reporting protocols must be critically reviewed to achieve improvements.,2.3685972735685406e-08,0.016260520871781203,0.0,0.0018134264647818726,0.01652930195121094,0.0,0.0018108015409528666,0.01680711831638071,0.0,2.3685972735685406e-08,0.01709443335929972,0.0
151,1.1,4,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there a lack of agreement between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Clinicians and clinical pathologists differ significantly regarding the clinical relevance of some RBC-M terminology. The inclusion of interpretive notes on CBC reports ensures RBC-M changes are read as clinical pathologists intend. Reporting practices need critical examination to enhance quality.,1.1842986367842703e-07,0.14190481661412635,0.07140495867768595,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
151,1.1,5,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are reporting and interpretation of red blood cell morphology consistent between clinical pathologists and clinicians? Marked differences exist concerning the clinical relevance of certain RBC-M terms from the perspectives of clinicians and clinical pathologists. The clearest method to ensure proper interpretation of RBC-M changes is adding interpretive comments to CBC reports. Reporting practices should undergo critical scrutiny for improvements.,9.474389094274162e-08,0.09059300141453264,0.017236072637734686,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
151,1.1,6,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there discord between clinicians and clinical pathologists in reporting and interpreting red blood cell morphology? Substantial differences about the clinical importance of some RBC-M terms arise between the two groups. Including interpretative comments on CBC reports guarantees RBC-M changes are comprehended in the way clinical pathologists intend. Reporting procedures ought to be critically reviewed to foster enhancement.,1.1842986367842703e-07,0.10840407091439896,0.017538265306122455,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
151,1.1,7,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are clinical pathologists and clinicians in agreement when reporting and interpreting red blood cell morphology? Significant discrepancies between clinicians and CPs exist regarding the clinical relevance of various RBC-M terms. Adding interpretive notes to CBC reports is the simplest way to ensure RBC-M modifications are interpreted as intended by CPs. Reporting habits should be critically analyzed to improve.,1.1842986367842703e-07,0.0840831172105414,0.0,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
151,1.1,8,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Do clinical pathologists and clinicians have differing interpretations and reports regarding red blood cell morphology? Critical differences exist between clinicians and clinical pathologists on meaningfulness of certain RBC-M terminology. The most straightforward way to ensure intended interpretation by CPs is to include interpretive remarks on CBC reports. Examination of reporting practices is essential for improvement.,1.8948778188548325e-07,0.16382245627933312,0.01851192595229618,0.014507411718254981,0.1405819506211894,0.0,0.014486412327622933,0.14310084364067155,0.0,1.8948778188548325e-07,0.14571181118139354,0.0
151,1.1,9,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Is there disagreement in how clinical pathologists and clinicians report and interpret red blood cell morphology? Important distinctions about clinical relevance of specific RBC-M terms exist between the two groups. Incorporating interpretive comments within CBC reports ensures RBC-M alterations are decoded as CPs intend. Reporting practices warrant rigorous scrutiny for betterment.,2.8423167282822487e-07,0.21511137961694615,0.0,0.02176111757738247,0.21905356606268356,0.0,0.0217296184914344,0.22314355131420838,0.0,2.8423167282822487e-07,0.22738984219566083,0.0
151,1.1,10,human,Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: Important differences about the clinical relevance of certain RBC-M terms exist between clinicians and CPs. Inclusion of interpretive comments on CBC reports is the clearest way to ensure that RBC-M changes are interpreted as intended by the CP. Reporting practices should be examined critically to improve,Are differences present in reporting and interpreting red blood cell morphology by clinical pathologists compared to clinicians? There are essential differences regarding clinical significance of some RBC-M terms between the two disciplines. Including interpretive comments on CBC reports is the clearest approach to guarantee RBC-M results are understood as clinical pathologists mean. Reporting methods should be critically inspected for improvements.,7.105791820705622e-08,0.07309345573462522,0.01694411414982164,0.005440279394345618,0.05043085362689137,0.0,0.0054324046228586,0.05129329438754926,0.0,7.105791820705622e-08,0.05218575317056917,0.0
152,1.1,1,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Do viral infections contribute to benign paroxysmal positional vertigo? The exact cause of BPPV remains unclear, but viral infections are generally not considered a direct factor. Instead, BPPV typically arises from inner ear issues, such as...",3.7897556377096597e-07,0.2801747696781236,0.0683341945696326,0.02901482343650997,0.3579365935895855,0.019991670137442734,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
152,1.1,2,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Is there a connection between viral infections and benign paroxysmal positional vertigo? The precise cause of BPPV is not entirely known; however, viral infections are usually not seen as a primary cause. BPPV mainly results from inner ear disorders like...",2.8423167282822477e-07,0.1678987839796653,0.07125763867433982,0.02176111757738247,0.24671095847936098,0.019991670137442734,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
152,1.1,3,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Can viral infections lead to benign paroxysmal positional vertigo? While the exact cause of BPPV isn't completely understood, viral infections are not thought to directly cause it. Usually, BPPV is caused by inner ear problems, including...",3.7897556377096597e-07,0.2801747696781236,0.0683341945696326,0.02901482343650997,0.3579365935895855,0.019991670137442734,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
152,1.1,4,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Are viral infections involved in causing benign paroxysmal positional vertigo? The exact cause of BPPV is still not fully clear, but viral infections are generally not implicated. Instead, BPPV typically stems from inner ear complications such as...",3.5528959103528067e-07,0.25090365909149037,0.06912580533158444,0.02720139697172809,0.328949056716334,0.019991670137442734,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
152,1.1,5,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Do viral infections play a role in benign paroxysmal positional vertigo? The cause of BPPV is not definitively known, but viral infections are not believed to have a direct impact. BPPV commonly results from inner ear disturbances like...",3.3160361829959537e-07,0.22246392337100263,0.0698747345328946,0.025387970506946217,0.30077817974963716,0.019991670137442734,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
152,1.1,6,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Is benign paroxysmal positional vertigo caused by viral infections? Although the precise cause of BPPV is unknown, viral infections are not considered a direct cause. BPPV is mainly due to issues in the inner ear, including...",3.7897556377096597e-07,0.2801747696781236,0.0683341945696326,0.02901482343650997,0.3579365935895855,0.019991670137442734,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
152,1.1,7,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Could viral infections be responsible for benign paroxysmal positional vertigo? The underlying cause of BPPV hasn't been fully established, but viral infections typically are not directly linked. Inner ear problems typically cause BPPV, such as...",4.0266153650665127e-07,0.3103272597960136,0.06749615071491682,0.03082824990129185,0.3877895567392673,0.019991670137442734,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
152,1.1,8,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Might viral infections contribute to benign paroxysmal positional vertigo? The exact cause of BPPV remains uncertain, yet viral infections are generally not viewed as a direct cause. Problems within the inner ear, like..., are common causes of BPPV.",3.3160361829959537e-07,0.22246392337100263,0.0698747345328946,0.025387970506946217,0.30077817974963716,0.019991670137442734,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
152,1.1,9,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Does benign paroxysmal positional vertigo result from viral infections? The definitive cause of BPPV isn't fully understood, and viral infections are typically excluded as a direct factor. BPPV usually originates from inner ear abnormalities such as...",3.7897556377096597e-07,0.24056635936041237,0.09688090737240077,0.02901482343650997,0.3579365935895855,0.019991670137442734,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
152,1.1,10,ai,"Question: Do viral infections have a role in benign paroxysmal positional vertigo? Answer: The exact cause of benign paroxysmal positional vertigo (BPPV) is not fully understood, but viral infections are not believed to have a direct role in its development. BPPV is typically caused by problems in the inner ear, such as","Are viral infections a direct cause of benign paroxysmal positional vertigo? The main cause of BPPV is not completely known, but viral infections are not considered a direct cause. BPPV arises most commonly from inner ear issues including...",3.3160361829959537e-07,0.2973987537018088,0.01643108038278142,0.025387970506946217,0.30077817974963716,0.019991670137442734,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
153,1.1,1,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Is there a role for polymorphisms in beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the newborn (TTN)? Answer: The involvement of polymorphisms in beta-adrenergic receptor genes in TTN is presently being explored.,7.10579182070559e-08,0.02284635128504764,0.04053185339345593,0.005440279394345632,0.055504686964177985,0.02229082997222246,0.005432404622858621,0.053717036839262544,0.0257154842340728,7.105791820705622e-08,0.05159995656866556,0.029384756657483937
153,1.1,2,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Could polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes influence transient tachypnea of the newborn (TTN)? Answer: The potential role of these genetic polymorphisms in TTN is under current investigation.,1.658018091497971e-07,0.0311258520269857,0.12279371097041461,0.01269398525347315,0.10069857837631258,0.08264462809917354,0.012675610786670115,0.14392673067878725,0.056932966023875105,1.6580180914979784e-07,0.1897502950494827,0.029384756657483937
153,1.1,3,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Transient tachypnea of the newborn (TTN) and its connection to polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: Research is ongoing to understand the impact of these polymorphisms in TTN.,1.658018091497971e-07,0.0311258520269857,0.12279371097041461,0.01269398525347315,0.10069857837631258,0.08264462809917354,0.012675610786670115,0.14392673067878725,0.056932966023875105,1.6580180914979784e-07,0.1897502950494827,0.029384756657483937
153,1.1,4,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Is transient tachypnea of the newborn (TTN) associated with polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: Studies are currently assessing the role of these genetic variants in TTN.,1.894877818854824e-07,0.01881759166533792,0.15608740894901152,0.01450741171825503,0.13578989818758158,0.08264462809917354,0.014486412327622988,0.18029437484966193,0.056932966023875105,1.8948778188548325e-07,0.2274906230323297,0.029384756657483937
153,1.1,5,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Are polymorphisms in beta-adrenergic receptor (ADRB) encoding genes implicated in transient tachypnea of the newborn (TTN)? Answer: The contribution of these polymorphisms to TTN is being investigated.,2.36859727356853e-07,0.0902765556474816,0.15608740894901152,0.01813426464781879,0.20989787034130325,0.08264462809917354,0.018108015409528735,0.2572554159857914,0.056932966023875105,2.3685972735685406e-07,0.30753333070586697,0.029384756657483937
153,1.1,6,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: What role do polymorphisms in beta-adrenergic receptor (ADRB) genes have in transient tachypnea of the newborn (TTN)? Answer: This role is actively being researched.,3.079176455639089e-07,0.20805959130386587,0.15608740894901152,0.023574544042164428,0.33250019243363615,0.08264462809917354,0.023540420032387356,0.3850887874956759,0.056932966023875105,3.079176455639103e-07,0.4410647233303906,0.029384756657483937
153,1.1,7,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Can polymorphisms in beta-adrenergic receptor (ADRB) encoding genes affect transient tachypnea of the newborn (TTN)? Answer: Their role is currently a subject of scientific study.,2.842316728282236e-07,0.16723759678361105,0.15608740894901152,0.021761117577382548,0.2899405780148405,0.08264462809917354,0.021729618491434483,0.3406370249248418,0.056932966023875105,2.8423167282822487e-07,0.39454470769549665,0.029384756657483937
153,1.1,8,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Investigating the role of polymorphisms in beta-adrenergic receptor (ADRB) encoding genes in transient tachypnea of the newborn (TTN). Answer: These polymorphisms are being examined for their relevance to TTN.,1.894877818854824e-07,0.01881759166533792,0.15608740894901152,0.01450741171825503,0.13578989818758158,0.08264462809917354,0.014486412327622988,0.18029437484966193,0.056932966023875105,1.8948778188548325e-07,0.2274906230323297,0.029384756657483937
153,1.1,9,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms in beta-adrenergic receptor (ADRB) encoding genes? Answer: The involvement of such polymorphisms is under current research.,2.842316728282236e-07,0.16723759678361105,0.15608740894901152,0.021761117577382548,0.2899405780148405,0.08264462809917354,0.021729618491434483,0.3406370249248418,0.056932966023875105,2.8423167282822487e-07,0.39454470769549665,0.029384756657483937
153,1.1,10,ai,Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: The role of polymorphisms in beta-adrenergic receptor encoding genes in transient tachypnea of the newborn (TTN) is currently being,Question: Exploring whether polymorphisms in beta-adrenergic receptor (ADRB) encoding genes play a role in transient tachypnea of the newborn (TTN). Answer: This is an area of ongoing study.,2.36859727356853e-07,0.0902765556474816,0.15608740894901152,0.01813426464781879,0.20989787034130325,0.08264462809917354,0.018108015409528735,0.2572554159857914,0.056932966023875105,2.3685972735685406e-07,0.30753333070586697,0.029384756657483937
154,1.1,1,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's doctors view body image differently? Answer: Studies indicate that parents, their kids, and the children's physicians might have distinct views on body image. Elements like cultural influences, individual prejudices, and medical knowledge play roles in these differing perceptions. More research is required to understand fully.",2.3685972735685406e-08,0.10721085565545785,0.08894330103645848,0.0018134264647818726,0.10966845598042951,0.09162848812994588,0.0018108015409528666,0.08557779454778913,0.07496876301541025,2.3685972735685406e-08,0.060560434976737465,0.057476051645147866
154,1.1,2,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: do parents, their children, and their children's healthcare providers have differing views on body image? Answer: Evidence suggests that parents, their offspring, and pediatric doctors often perceive body image in diverse ways. Various factors including societal norms, personal attitudes, and clinical expertise affect these perspectives. Additional investigation is necessary to clarify these differences.",0.0,0.12602676010180858,0.08927964399835686,0.0,0.12836058899258385,0.09162848812994588,0.0,0.10462598951848223,0.07496876301541025,0.0,0.07997852083384016,0.057476051645147866
154,1.1,3,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception: are there differences in body image perception among parents, their children, and their children’s physicians? Answer: Research shows that parents, children, and the children’s doctors may each perceive body image uniquely. These discrepancies can result from social, personal, and professional factors. Further studies are needed to explore this comprehensively.",9.474389094274162e-08,0.021360074864225087,0.06830487296959598,0.0072537058591274906,0.05139954785645395,0.09162848812994588,0.007243206163811466,0.026154374076988063,0.07496876301541025,9.474389094274162e-08,6.418683969666716e-05,0.057476051645147866
154,1.1,4,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Question: Do parents, their children, and their children’s doctors perceive body image differently? Answer: Research suggests that perceptions of body image can vary between parents, their children, and the children’s physicians due to societal influences, personal biases, and medical expertise. More research is warranted to fully understand these differences.",1.4211583641411244e-07,0.07744766162170569,0.026467572667767003,0.010880558788691236,0.047184711710462235,0.05004058642862262,0.0108648092457172,0.04501394702825934,0.05370222237268815,1.4211583641411244e-07,0.04262380125849319,0.057476051645147866
154,1.1,5,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Question: Are body image perceptions different among parents, their children, and the children’s medical practitioners? Answer: Findings imply that these groups might see body image in varying ways because of cultural pressures, individual perspectives, and professional backgrounds. There is a need for further study to deepen our understanding.",1.6580180914979784e-07,0.013781194725740242,0.08663132477055638,0.012693985253473108,0.010475855861633576,0.09162848812994588,0.012675610786670066,0.03702452754454422,0.07496876301541025,1.6580180914979784e-07,0.06460270797726819,0.057476051645147866
154,1.1,6,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Question: Do parents, their offspring, and their children's physicians differ in how they view body image? Answer: Studies suggest variations in how these groups perceive body image, influenced by society, subjective biases, and clinical experience. Continued research is essential to gain more insight.",2.8423167282822487e-07,0.12714036116371252,0.08421259660326713,0.02176111757738247,0.1229538392883236,0.09162848812994588,0.0217296184914344,0.1520938573293309,0.07496876301541025,2.8423167282822487e-07,0.18238574363365156,0.057476051645147866
154,1.1,7,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Body perception question: Is body image seen differently by parents, their children, and their children’s doctors? Answer: Research indicates that there can be differing perceptions among these groups due to societal norms, personal beliefs, and medical knowledge. Further research is necessary to clarify these distinctions.",2.3685972735685406e-07,0.04943858333998108,0.10745522698875466,0.018134264647818726,0.07643382365342966,0.09162848812994588,0.018108015409528666,0.10446580834007646,0.07496876301541025,2.3685972735685406e-07,0.13359557946421985,0.057476051645147866
154,1.1,8,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Question: How do parents, their children, and their children’s healthcare providers perceive body image? Answer: There is evidence that these groups hold different views, shaped by cultural, individual, and medical factors. More extensive research is needed for a deeper understanding.",3.552895910352811e-07,0.16722161899636445,0.10745522698875466,0.02720139697172809,0.19706181144204704,0.09162848812994588,0.027162023114293,0.2280797643072523,0.07496876301541025,3.552895910352811e-07,0.26034728510336214,0.057476051645147866
154,1.1,9,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Question: Does body image perception differ among parents, their children, and the children’s medical professionals? Answer: Studies reveal that body image perceptions do differ, influenced by societal norms, personal biases, and medical expertise. Further inquiry is required to explore these variations.",3.316036182995957e-07,0.17634106399428262,0.08308022698875467,0.025387970506946217,0.1717440034577553,0.09162848812994588,0.025351221573340132,0.20210427790399432,0.07496876301541025,3.316036182995957e-07,0.23367903802120127,0.057476051645147866
154,1.1,10,ai,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Research suggests that parents, their children, and their children's physicians may have different perceptions of body image. Factors such as societal influences, personal biases, and medical expertise can contribute to these varying perceptions. Further studies are needed to gain a","Question: Question: Are perceptions of body image different among parents, their children, and the children’s physicians? Answer: Research points to varying perceptions among these parties, affected by social influence, personal viewpoints, and clinical knowledge. Additional research is needed to fully comprehend these differences.",3.079176455639103e-07,0.11843145482693274,0.10745522698875466,0.023574544042164344,0.1470513908673836,0.09162848812994588,0.023540420032387266,0.1767864699197026,0.07496876301541025,3.079176455639103e-07,0.2077035516179433,0.057476051645147866
155,1.1,1,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is there a link between neck pain and poorer health-related quality of life six months afterward? Yes, neck pain is linked to a decline in health-related quality of life six months later. Research indicates that ongoing neck pain can lead to diminished physical capabilities and a lower overall quality of life.",7.105791820705622e-08,0.16585613039785319,0.0738693625598387,0.005440279394345618,0.16096985256122354,0.06628387756592884,0.0054324046228586,0.16273437171689764,0.06795529257067724,7.105791820705622e-08,0.16450016850969806,0.06929943750456571
155,1.1,2,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Does neck pain correlate with a worse health-related quality of life half a year later? Indeed, neck pain is connected with a poorer health-related quality of life six months down the line. Studies have demonstrated that chronic neck pain often causes reduced physical function and an overall decrease in life quality.",7.105791820705622e-08,0.2317728677179396,0.1600793286399347,0.005440279394345618,0.2175532958722397,0.10652911450348507,0.0054324046228586,0.2204966367635599,0.10935361257470118,7.105791820705622e-08,0.22349141791905502,0.11176857330703485
155,1.1,3,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain tied to a more negative health-related quality of life six months later? Yes, experiencing neck pain is associated with worse health-related quality of life after six months. Evidence shows that persistent neck pain contributes to decreased physical functioning and a diminished overall quality of life.",0.0,0.1474781235233924,0.10081585402574889,0.0,0.15068416968694542,0.10388310213485037,0.0,0.15403270679109937,0.10796677099124657,0.0,0.15753345012725894,0.11176857330703485
155,1.1,4,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.",Is there an association between neck pain and a decline in health-related quality of life six months later? Neck pain is indeed associated with poorer health-related quality of life after six months. Research has found that persistent neck pain can impair physical functioning and reduce overall life quality.,0.0,0.18810668745710402,0.1708081380700428,0.0,0.15068416968694542,0.10388310213485037,0.0,0.15403270679109937,0.10796677099124657,0.0,0.15753345012725894,0.11176857330703485
155,1.1,5,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Does neck pain impact health-related quality of life adversely six months later? Yes, neck pain is linked to worse health-related quality of life over six months. Studies confirm that ongoing neck pain leads to decreased physical functioning and an overall worsening of quality of life.",7.105791820705622e-08,0.06793563573026962,0.085075322321398,0.005440279394345618,0.0790377492722425,0.10087058007252028,0.0054324046228586,0.08283936806427583,0.10638215488808091,7.105791820705622e-08,0.08691588291330499,0.11176857330703485
155,1.1,6,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.",Is neck pain related to a lower health-related quality of life half a year later? Neck pain is associated with worse health-related quality of life six months later. Evidence suggests that persistent neck pain results in diminished physical functioning and reduced quality of life overall.,7.105791820705622e-08,0.024536942437441756,0.007743667090513939,0.005440279394345618,0.034629784042371714,0.02789653188691646,0.0054324046228586,0.08283936806427583,0.10638215488808091,7.105791820705622e-08,0.08691588291330499,0.11176857330703485
155,1.1,7,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain connected to reduced health-related quality of life six months after? Yes, there is an association between neck pain and a poorer health-related quality of life six months afterward. Research demonstrates ongoing neck pain can lower physical functionality and overall quality of life.",7.105791820705622e-08,0.004922255679364884,0.039351851851851805,0.005440279394345618,0.014558941778294532,0.055226824457593665,0.0054324046228586,0.016825350868088673,0.05917159763313616,7.105791820705622e-08,0.01929176773672525,0.06311637080867852
155,1.1,8,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Does experiencing neck pain affect health-related quality of life negatively six months later? It does, as neck pain is linked with worse quality of life six months following onset. Studies indicate persistent neck pain leads to declines in physical function and overall life quality.",9.474389094274162e-08,0.08440468397526679,0.1564049622105948,0.0072537058591274906,0.08697905075790491,0.12347617198209794,0.007243206163811466,0.0917488250833074,0.13017751479289946,9.474389094274162e-08,0.06222327032293329,0.11176857330703485
155,1.1,9,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Can neck pain lead to a decline in health-related quality of life after six months? Yes, neck pain is associated with a deterioration in health-related quality of life six months later. Research points out that continuous neck pain reduces physical functioning and overall life satisfaction.",7.105791820705622e-08,0.07982763899764622,0.13770690126876636,0.005440279394345618,0.04679834552526785,0.0778965318869165,0.0054324046228586,0.04983235946618336,0.08267751479289945,7.105791820705622e-08,0.05310382532501512,0.08739357330703484
155,1.1,10,ai,"Question: Is neck pain associated with worse health-related quality of life 6 months later? Answer: Yes, neck pain is associated with worse health-related quality of life 6 months later. Studies have shown that persistent neck pain can result in decreased physical functioning and overall reduced quality of life.","Is neck pain associated with poorer health-related quality of life six months subsequent? Indeed, neck pain correlates with worse health-related quality of life half a year later. Studies have shown persistent neck pain diminishes physical abilities and overall quality of life.",1.6580180914979784e-07,0.048656958742802736,0.06032669058908974,0.012693985253473108,0.02521393131669525,0.09613931859254105,0.012675610786670066,0.02071851245040035,0.10388094795579209,1.6580180914979784e-07,0.015738271146777283,0.11176857330703485
156,1.1,1,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG used as a surrogate tracer to assess tumor hypoxia? No, (18)F-FDG does not serve as a surrogate tracer for tumor hypoxia; instead, it measures glucose metabolism in tumors rather than oxygen levels.",0.0,0.14188276445830983,0.1569135802469136,0.0,0.08664339756999295,0.060226757369614504,0.0,0.08943834587870292,0.06344104308390028,0.0,0.09241962407465909,0.06632653061224487
156,1.1,2,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Does (18)F-FDG act as a surrogate tracer for tumor hypoxia? No, (18)F-FDG is not suitable as a surrogate tracer for tumor hypoxia since it reflects glucose metabolism, not oxygen concentrations in tumors.",4.73719454713706e-08,0.01820669711797196,0.09158813645993139,0.003626852929563759,0.07609097414690291,0.007728535201062703,0.003621603081905747,0.07594361717577991,0.006407740611037299,4.737194547137081e-08,0.07559427320657042,0.004679386547518455
156,1.1,3,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG a tracer for detecting tumor hypoxia? No, (18)F-FDG is not used to detect tumor hypoxia; it is employed to quantify tumor glucose metabolism and not oxygen levels.",1.184298636784265e-07,0.10360647326884198,0.24691358024691362,0.009067132323909398,0.0033877583445902637,0.12244897959183673,0.009054007704764368,0.0417331476456102,0.09566326530612247,1.1842986367842703e-07,0.08990193271929581,0.06632653061224487
156,1.1,4,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Can (18)F-FDG be used as a surrogate marker for tumor hypoxia? No, (18)F-FDG is not a surrogate marker for tumor hypoxia but rather an indicator of glucose metabolism in tumors, not oxygenation.",4.73719454713706e-08,0.026512475821379056,0.12071330589849114,0.003626852929563759,0.029881162109573367,0.023683547493071277,0.003621603081905747,0.028140363344059782,0.02707615968197981,4.737194547137081e-08,0.026083760309430826,0.030661235687690698
156,1.1,5,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG a tracer to evaluate tumor hypoxia? No, (18)F-FDG does not evaluate tumor hypoxia; it is utilized to measure glucose metabolism within tumors, not their oxygen status.",1.421158364141118e-07,0.01589459350093403,0.20993133172620357,0.010880558788691277,0.034352569638256725,0.12244897959183673,0.010864809245717241,0.08095386079889266,0.09566326530612247,1.4211583641411244e-07,0.13072392723955062,0.06632653061224487
156,1.1,6,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Does (18)F-FDG indicate tumor hypoxia? No, (18)F-FDG cannot indicate tumor hypoxia as it is designed to assess glucose metabolism in tumors instead of oxygen levels.",2.131737546211677e-07,0.10830647160507745,0.20532567854559036,0.016320838183036916,0.15695489173058963,0.12244897959183673,0.016297213868575862,0.20878723230877716,0.09566326530612247,2.1317375462116866e-07,0.26425531986407425,0.06632653061224487
156,1.1,7,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG employed to measure tumor hypoxia? No, (18)F-FDG is not used for tumor hypoxia measurement but for evaluating glucose metabolism in tumors.",2.605457000925383e-07,0.13755558354804664,0.24691358024691362,0.019947691112600675,0.24792666993631762,0.12244897959183673,0.01991881695048161,0.30409741211310237,0.09566326530612247,2.6054570009253936e-07,0.36433877842105566,0.06632653061224487
156,1.1,8,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG a surrogate tracer for assessing tumor oxygen levels? No, (18)F-FDG cannot substitute as a tracer for tumor oxygen levels; it measures glucose metabolic activity in tumors.",1.421158364141118e-07,0.03544964209609924,0.17331358024691362,0.010880558788691277,0.034352569638256725,0.12244897959183673,0.010864809245717241,0.08095386079889266,0.09566326530612247,1.4211583641411244e-07,0.13072392723955062,0.06632653061224487
156,1.1,9,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG suitable to measure tumor hypoxia? No, (18)F-FDG is not appropriate for measuring tumor hypoxia; it detects glucose metabolism instead of hypoxic conditions.",2.36859727356853e-07,0.09310382097721259,0.24691358024691362,0.018134264647818796,0.20140665430142368,0.12244897959183673,0.018108015409528735,0.2553072479436711,0.09566326530612247,2.36859727356854e-07,0.3130454840335055,0.06632653061224487
156,1.1,10,ai,"Question: Is (18)F-FDG a surrogate tracer to measure tumor hypoxia? Answer: No, (18)F-FDG is not a surrogate tracer to measure tumor hypoxia. It is used to measure glucose metabolism in tumors, not oxygen levels.","Is (18)F-FDG a proxy tracer to gauge tumor hypoxia? No, (18)F-FDG serves as a proxy for tumor glucose metabolism rather than hypoxia or oxygen concentration.",2.131737546211677e-07,0.10830647160507745,0.20532567854559036,0.016320838183036916,0.15695489173058963,0.12244897959183673,0.016297213868575862,0.20878723230877716,0.09566326530612247,2.1317375462116866e-07,0.26425531986407425,0.06632653061224487
157,1.1,1,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Does pain represent a clinically relevant issue in general adult psychiatry? Evidence suggests that pain is a notable clinical concern in psychiatric patients, often underestimated in psychiatric practice. Patients in general adult psychiatry exhibit unique risk factors distinct from clinical subpopulations in other specialties.",2.1317375462116866e-07,0.2067832932949485,0.011898948354852126,0.016320838183036854,0.19998078066414937,0.004195359904818563,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
157,1.1,2,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain considered an important clinical problem in general adult psychiatry? Research shows that pain is a significant clinical challenge among psychiatric patients and appears to be overlooked within psychiatry. Those treated in general adult psychiatry have particular risk factors different from those seen in other clinical subgroups.,1.1842986367842703e-07,0.08010884544688679,0.015006915842678735,0.009067132323909363,0.10613882779771977,0.0021283950617284053,0.009054007704764333,0.10536051565782589,0.0,1.1842986367842703e-07,0.107630664192365,0.0
157,1.1,3,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a significant clinical issue within the realm of general adult psychiatry? Findings indicate that pain is a major clinical problem for psychiatric patients, often underestimated by psychiatric professionals. Patients in general adult psychiatry display specific risk profiles differing from other clinical subpopulations.",2.1317375462116866e-07,0.14230448580099964,0.03423342125966034,0.016320838183036854,0.1669737720660578,0.019599999999999992,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
157,1.1,4,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Does pain constitute a clinically meaningful problem in general adult psychiatry? Studies reveal that pain is a substantial clinical concern in psychiatric patients, which tends to be underestimated in psychiatric care. Patients under general adult psychiatry possess distinct risk factors unlike those of other clinical groups.",1.6580180914979784e-07,0.12621579069370759,0.013127755268728183,0.012693985253473108,0.12045375643116385,0.019599999999999992,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
157,1.1,5,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a clinically noteworthy problem in the field of general adult psychiatry? Evidence reveals pain as a considerable clinical difficulty among psychiatric patients that is often underappreciated in psychiatric settings. Patients managed by general adult psychiatry are marked by specific risk factors not seen in other clinical subpopulations.,9.474389094274162e-08,0.028945319363027355,0.03665214942694958,0.0072537058591274906,0.05449578863936777,0.019599999999999992,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
157,1.1,6,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is the problem of pain clinically relevant in general adult psychiatry? Research has found that pain can pose a significant clinical problem in psychiatric patients and is frequently underestimated within psychiatry. The patients treated in general adult psychiatry have particular risk factors that distinguish them from other clinical subpopulations.,9.474389094274162e-08,0.05782645188635849,0.015888149943824606,0.0072537058591274906,0.08399141334404625,0.0016665406427221093,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
157,1.1,7,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain an important clinical problem in general adult psychiatry? The evidence points to pain being a significant clinical issue in psychiatric patients, one that is underestimated by psychiatric specialists. Patients within general adult psychiatry exhibit unique risk factors different from those in other specialties' clinical subgroups.",1.4211583641411244e-07,0.07276063519588183,0.03574765658341947,0.010880558788691236,0.09798090057910613,0.019599999999999992,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
157,1.1,8,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain a clinically relevant concern in general adult psychiatry? Data confirms that pain is a significant clinical problem in psychiatric patients, often underestimated in the psychiatric field. The patients seen in general adult psychiatry present with risk factors specific and distinct from those seen in other clinical cohorts.",9.474389094274162e-08,0.08670758440968962,0.004746170577074341,0.0072537058591274906,0.08399141334404625,0.0016665406427221093,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
157,1.1,9,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,"Is pain recognized as a clinically significant issue in general adult psychiatry? Findings demonstrate that pain is an important clinical problem in the psychiatric population, frequently underestimated by psychiatry professionals. Patients examined in general adult psychiatry show particular risk factors different from other clinical populations.",1.8948778188548325e-07,0.15008894388023064,0.012124577722245372,0.014507411718254981,0.17568267840283758,0.0036426303854875317,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
157,1.1,10,human,Question: Is pain a clinically relevant problem in general adult psychiatry? Answer: We found evidence that pain can be a significant clinical problem in psychiatric patients which seems to be underestimated in psychiatry. The investigated patients in general adult psychiatry are characterized by specific risk factors different from clinical subpopulations of other disciplines.,Is pain a pertinent clinical problem in general adult psychiatry? Studies indicate that pain can be a substantial clinical concern for psychiatric patients and tends to be undervalued in psychiatric practice. The individuals treated in general adult psychiatry possess risk factors specific and unlike those of other clinical subpopulations.,9.474389094274162e-08,0.05782645188635849,0.015888149943824606,0.0072537058591274906,0.08399141334404625,0.0016665406427221093,0.007243206163811466,0.08338160893905089,0.0,9.474389094274162e-08,0.08515780834030728,0.0
158,1.1,1,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Are clinical predictors sufficient for identifying cervical spine fractures in elderly patients suffering from blunt trauma with low-energy mechanism? The sufficiency of clinical predictors for these fractures is...,1.658018091497971e-07,0.12586574141463203,0.2060733070348455,0.012693985253473157,0.097660336826491,0.21760000000000002,0.012675610786670115,0.05639181356344958,0.20160000000000003,1.6580180914979784e-07,0.012381663498906903,0.18239999999999998
158,1.1,2,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Do clinical predictors adequately detect cervical spine fractures in geriatric blunt trauma patients under low-energy mechanisms? The adequacy of such predictors is...,3.079176455639089e-07,0.07410445126924259,0.24305555555555555,0.023574544042164434,0.16470392764100117,0.21760000000000002,0.023540420032387356,0.21804503213831028,0.20160000000000003,3.079176455639101e-07,0.27530040895287344,0.18239999999999998
158,1.1,3,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Is the use of clinical predictors reliable for cervical spine fractures in elderly patients injured by low-energy blunt trauma? The reliability of these predictors is...,2.36859727356853e-07,0.05942694135528104,0.24305555555555555,0.018134264647818796,0.024941985265841904,0.21760000000000002,0.018108015409528735,0.07144155794643492,0.20160000000000003,2.3685972735685406e-07,0.12114972912561672,0.18239999999999998
158,1.1,4,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Are clinical predictors effective in diagnosing cervical spine fractures in older patients with blunt trauma caused by low-energy mechanisms? The effectiveness of these predictors is...,2.36859727356853e-07,0.05942694135528104,0.24305555555555555,0.018134264647818796,0.024941985265841904,0.21760000000000002,0.018108015409528735,0.07144155794643492,0.20160000000000003,2.3685972735685406e-07,0.12114972912561672,0.18239999999999998
158,1.1,5,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Can clinical predictors accurately identify cervical spine fractures in geriatric patients experiencing blunt trauma with a low-energy mechanism? The accuracy of the predictors is...,2.605457000925383e-07,0.016867326936485405,0.24305555555555555,0.019947691112600675,0.06939374783667596,0.21760000000000002,0.01991881695048161,0.11796157358132886,0.20160000000000003,2.605457000925394e-07,0.169939893295048,0.18239999999999998
158,1.1,6,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,How sufficient are clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy injury mechanisms? The sufficiency is...,3.3160361829959426e-07,0.12289461543867386,0.24305555555555555,0.025387970506946314,0.21599722202855132,0.21760000000000002,0.02535122157334023,0.2721122534085856,0.20160000000000003,3.316036182995955e-07,0.33245882279282224,0.18239999999999998
158,1.1,7,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Are clinical predictors dependable for assessing cervical spine fractures in elderly patients with low-energy blunt trauma? The dependability is...,3.7897556377096496e-07,0.2282551310964993,0.24305555555555555,0.02901482343651007,0.3272228571387754,0.21760000000000002,0.028972824655245973,0.3898952890649694,0.20160000000000003,3.789755637709662e-07,0.4576219657468279,0.18239999999999998
158,1.1,8,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Do clinical predictors provide an adequate assessment for cervical spine fractures in elderly blunt trauma patients with low-energy impact? This adequacy is...,3.079176455639089e-07,0.07410445126924259,0.24305555555555555,0.023574544042164434,0.16470392764100117,0.21760000000000002,0.023540420032387356,0.21804503213831028,0.20160000000000003,3.079176455639101e-07,0.27530040895287344,0.18239999999999998
158,1.1,9,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Are clinical predictors appropriate for identifying cervical spine fractures among geriatric blunt trauma patients with low-energy forces? The appropriateness is...,3.552895910352796e-07,0.174187909826224,0.24305555555555555,0.027201396971728194,0.2700644432988266,0.21760000000000002,0.0271620231142931,0.3292706672485344,0.20160000000000003,3.5528959103528083e-07,0.39308344460925726,0.18239999999999998
158,1.1,10,ai,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: The adequacy of clinical predictors for cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism is,Is the evaluation by clinical predictors adequate for cervical spine fractures in elderly blunt trauma patients with low-energy injuries? The adequacy of evaluation is...,2.605457000925383e-07,0.016867326936485405,0.24305555555555555,0.019947691112600675,0.06939374783667596,0.21760000000000002,0.01991881695048161,0.11796157358132886,0.20160000000000003,2.605457000925394e-07,0.169939893295048,0.18239999999999998
159,1.1,1,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Is there variation in interfractional motion of the prostate bed target, as defined by RTOG consensus, between the superior and inferior parts of the clinical target volume (CTV) when monitored using daily CT on rails? Answer: No significant differences in motion were observed between the superior (SUP-CTV) and inferior (INF-CTV) regions. The existing uniform planning target volume (PTV) margins sufficiently cover both areas of the CTV.",2.1317375462116866e-07,0.06129061931953128,0.08829201101928374,0.016320838183036854,0.1524632300533657,0.002470380294421492,0.0162972138685758,0.15154989812720032,0.0,2.1317375462116866e-07,0.15415067982725983,0.0
159,1.1,2,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the interfractional motion of the prostate bed target differ in the superior compared to the inferior portions of the clinical target volume based on RTOG consensus and daily CT on rails imaging? Answer: There is no statistically significant difference in motion between the superior CTV (SUP-CTV) and inferior CTV (INF-CTV). Current uniform planning target volume margins effectively encompass both regions.,9.474389094274162e-08,0.04828609254385885,0.014007429172276202,0.0072537058591274906,0.09374812793551968,0.017851239669421492,0.007243206163811466,0.07020425867324764,0.0,9.474389094274162e-08,0.07145896398214369,0.0
159,1.1,3,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using the RTOG consensus definitions and daily CT on rails, is there a difference in interfractional motion between the superior and inferior segments of the prostate bed clinical target volume? Answer: No statistically significant motion difference exists between the superior part of the CTV (SUP-CTV) and the inferior part (INF-CTV). Uniform planning target volume margins currently in use are adequate for coverage.",1.1842986367842703e-07,0.06564626520922978,0.013220671365927417,0.009067132323909363,0.0875512928191915,0.001462350780532598,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
159,1.1,4,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the prostate bed target exhibit different interfractional movements in its superior versus inferior clinical target volume portions according to RTOG criteria and daily CT on rails? Answer: The motion differences between the superior CTV and inferior CTV are not statistically significant. Uniform planning target volume margins are sufficient for both portions.,1.1842986367842703e-07,0.06982514879001966,0.01581794668928989,0.009067132323909363,0.06877080156225457,0.017851239669421492,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
159,1.1,5,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: According to RTOG guidelines and daily CT on rails, is there a distinction in interfractional motion between the upper and lower parts of the prostate bed clinical target volume? Answer: Analysis shows no significant motion difference between SUP-CTV and INF-CTV. The standardized planning target volume margins currently applied adequately cover both sections.",1.1842986367842703e-07,0.04316564184540628,0.0350413223140496,0.009067132323909363,0.06877080156225457,0.017851239669421492,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
159,1.1,6,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: When assessing prostate bed target interfractional motion using daily CT on rails and RTOG consensus definitions, does motion differ between the superior and inferior clinical target volumes? Answer: There are no statistically meaningful differences in motion between the superior and inferior CTV areas. The uniform planning target volume margins in place are appropriate for both.",4.737194547137081e-08,0.08789758327581021,0.03723857003504689,0.0036268529295637453,0.08862874111785413,0.037512082129886465,0.003621603081905733,0.08935426643959143,0.03767781622452902,4.737194547137081e-08,0.06439983492746082,0.01922337562475971
159,1.1,7,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Is there a disparity in interfractional motion between the superior and inferior portions of the prostate bed clinical target volume as defined by RTOG consensus and observed with daily CT on rails? Answer: No significant motion differences were identified between SUP-CTV and INF-CTV. The uniform planning target volume margins remain adequate for the entire CTV.,4.737194547137081e-08,0.012281527214724974,0.016865739323651797,0.0036268529295637453,0.01161238772230444,0.017851239669421492,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
159,1.1,8,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,Question: Does the interfractional motion of the prostate bed clinical target volume differ across its superior and inferior sections based on RTOG consensus and daily CT on rails observation? Answer: Statistical analysis reveals no significant differences in motion between superior and inferior CTV areas. Current uniform planning target volume margins sufficiently encompass both.,1.1842986367842703e-07,0.12314416267924644,0.022434729331098267,0.009067132323909363,0.09595304393715409,0.0017487603305785006,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
159,1.1,9,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: Using daily CT on rails and RTOG consensus standards, does the motion of the prostate bed clinical target volume differ between its upper and lower parts? Answer: No statistically significant motion variance exists between SUP-CTV and INF-CTV. The uniform planning target volume margins currently used are adequate for comprehensive coverage.",1.6580180914979784e-07,0.11011224222108673,0.015049652176606865,0.012693985253473108,0.10877613617595294,0.017851239669421492,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
159,1.1,10,human,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: There are no statistically apparent motion differences between SUP-CTV and INF-CTV. Current uniform planning target volume (PTV) margins are adequate to cover both portions of the CTV.,"Question: According to RTOG consensus criteria, does interfractional motion vary between the superior and inferior segments of the prostate bed clinical target volume when monitored by daily CT on rails? Answer: There are no statistically detectable motion differences between the superior and inferior CTV portions. Uniform planning target volume margins effectively cover both regions.",9.474389094274162e-08,0.15489993377281586,0.05827464990817261,0.0072537058591274906,0.12933123653899203,0.03962481197572637,0.007243206163811466,0.12987203725794538,0.039150354019158694,9.474389094274162e-08,0.10468692835852789,0.019991670137442734
160,1.1,1,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Are serum quantitative hCG results being reported correctly by laboratories? It's essential that laboratories report serum quantitative hCG results accurately to provide dependable diagnostic data. Implementing regular quality control and following established guidelines and protocols can help maintain accurate reporting.,7.105791820705611e-08,0.08172497413789692,0.0053829717291255935,0.005440279394345618,0.0813246529129148,0.003816933304112799,0.0054324046228586,0.08077159760711661,0.0020226093944042435,7.105791820705622e-08,0.08004270767353416,0.0
160,1.1,2,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Do laboratories correctly report serum quantitative hCG findings? Accurate reporting of serum quantitative hCG results by laboratories is vital for trustworthy diagnostic information. Consistent quality control and strict adherence to protocols and guidelines support precise reporting.,1.6580180914979731e-07,0.16251735163509773,0.014072951135888197,0.012693985253473115,0.16036079047391594,0.019267445840872404,0.01267561078667008,0.15771453361945964,0.02498356344510192,1.6580180914979784e-07,0.19782574332991798,0.0
160,1.1,3,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Is the reporting of serum quantitative hCG by laboratories accurate? Laboratories must report serum quantitative hCG results accurately to guarantee reliable diagnostic outcomes. Maintaining accuracy is possible through routine quality controls and compliance with recognized standards and procedures.,1.1842986367842671e-07,0.10266551017566927,0.017128366139355124,0.009067132323909363,0.1009371897693927,0.02089710045754001,0.009054007704764333,0.09887403359652636,0.02498356344510192,1.1842986367842703e-07,0.13720112151348252,0.0
160,1.1,4,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Are labs providing accurate serum quantitative hCG reports? Precise reporting of serum quantitative hCG results by laboratories is critical for valid diagnostic interpretations. Ensuring accuracy requires ongoing quality assurance and conformity to accepted protocols and guidelines.,1.6580180914979731e-07,0.16251735163509773,0.014072951135888197,0.012693985253473115,0.16036079047391594,0.019267445840872404,0.01267561078667008,0.15771453361945964,0.02498356344510192,1.6580180914979784e-07,0.19782574332991798,0.0
160,1.1,5,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Do laboratories reliably report serum quantitative hCG data? Accurate reporting of serum quantitative hCG is crucial for dependable diagnostics. Laboratories can achieve this accuracy by performing regular quality control checks and following established protocols and guidelines.,1.6580180914979731e-07,0.16251735163509773,0.014072951135888197,0.012693985253473115,0.16036079047391594,0.019267445840872404,0.01267561078667008,0.15771453361945964,0.02498356344510192,1.6580180914979784e-07,0.19782574332991798,0.0
160,1.1,6,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Are serum quantitative hCG results accurately reported in laboratories? It is important that laboratories report serum quantitative hCG results with precision for dependable diagnostic information. Regular quality controls and strict adherence to standardized guidelines and protocols help ensure this accuracy.,7.105791820705611e-08,0.08172497413789692,0.0053829717291255935,0.005440279394345618,0.0813246529129148,0.003816933304112799,0.0054324046228586,0.08077159760711661,0.0020226093944042435,7.105791820705622e-08,0.08004270767353416,0.0
160,1.1,7,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Do laboratories report serum quantitative hCG results with accuracy? Accurate lab reporting of serum quantitative hCG measurements is essential to provide reliable diagnostic data. This can be ensured by routine quality control and adherence to guidelines and protocols.,1.1842986367842671e-07,0.10266551017566927,0.017128366139355124,0.009067132323909363,0.1009371897693927,0.02089710045754001,0.009054007704764333,0.09887403359652636,0.02498356344510192,1.1842986367842703e-07,0.13720112151348252,0.0
160,1.1,8,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Are laboratories correctly documenting serum quantitative hCG levels? Proper reporting of serum quantitative hCG by laboratories is critical to ensure valid diagnostic results. Regular quality checks and following established procedures and protocols are key.,2.1317375462116791e-07,0.22615887109048138,0.01065211903281222,0.016320838183036875,0.22353374751299926,0.017434720708554036,0.016297213868575827,0.22023489060079315,0.02498356344510192,2.1317375462116866e-07,0.2623642644674895,0.0
160,1.1,9,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Is there accurate reporting of serum quantitative hCG values in laboratories? Laboratories reporting serum quantitative hCG results must ensure precision to maintain trust in diagnostic information. This accuracy can be safeguarded through consistent quality assurance and compliance with guidelines.,9.474389094274141e-08,0.07402529387427581,0.01853678135729416,0.0072537058591274906,0.07249745404890495,0.021646029658850176,0.007243206163811466,0.07070315662982951,0.02498356344510192,9.474389094274162e-08,0.10821358464023101,0.0
160,1.1,10,ai,Question: Are laboratories reporting serum quantitative hCG results correctly? Answer: It is crucial for laboratories to accurately report serum quantitative hCG results to ensure reliable diagnostic information. Regular quality control measures and adherence to established guidelines and protocols can help ensure accurate reporting.,Do laboratories provide accurate serum quantitative hCG results? Ensuring precise reporting of serum quantitative hCG by laboratories is vital for reliable diagnosis. This can be achieved through continual quality control measures and strict adherence to established protocols and guidelines.,9.474389094274141e-08,0.07402529387427581,0.01853678135729416,0.0072537058591274906,0.07249745404890495,0.021646029658850176,0.007243206163811466,0.07070315662982951,0.02498356344510192,9.474389094274162e-08,0.10821358464023101,0.0
161,1.1,1,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,"Question: Hepatorenal syndrome: are we overlooking some prognostic indicators? Answer: Recent studies indicate there may be unknown prognostic markers for hepatorenal syndrome, calling for further investigation to enhance knowledge and treatment.",3.7897556377096544e-07,0.4274440148269396,0.0,0.029014823436510004,0.43936665978384637,0.0,0.028972824655245914,0.45198512374305766,0.0,3.789755637709665e-07,0.4653632496892328,0.0
161,1.1,2,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: could there be undiscovered prognostic factors? Answer: Evidence suggests additional prognostic factors for hepatorenal syndrome might exist and require further research to better understand and treat the condition.,3.7897556377096544e-07,0.4274440148269396,0.0,0.029014823436510004,0.43936665978384637,0.0,0.028972824655245914,0.45198512374305766,0.0,3.789755637709665e-07,0.4653632496892328,0.0
161,1.1,3,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,"Question: Hepatorenal syndrome: might some prognostic factors be missed? Answer: Current findings imply there may be prognostic factors for hepatorenal syndrome not yet identified, necessitating more studies to improve management.",4.0266153650665074e-07,0.5091488203343415,0.03443877551020409,0.030828249901291883,0.4744579795951154,0.0,0.030783626196198788,0.48835276791393234,0.0,4.026615365066519e-07,0.5031035776720798,0.0
161,1.1,4,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,Question: Hepatorenal syndrome: are there prognostic factors we've yet to identify? Answer: Ongoing research highlights possible unknown prognostic determinants in hepatorenal syndrome that warrant deeper exploration for improved outcomes.,4.2634750924233604e-07,0.4964368863138904,0.0,0.03264167636607376,0.5108256237659901,0.0,0.03259442773715166,0.5260930958967793,0.0,4.263475092423373e-07,0.5423242908253623,0.0
161,1.1,5,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,"Question: Hepatorenal syndrome: might we be neglecting prognostic factors? Answer: Emerging data suggests additional prognostic factors might exist for hepatorenal syndrome, emphasizing the need for further study to enhance care.",4.0266153650665074e-07,0.4613455665026214,0.0,0.030828249901291883,0.4744579795951154,0.0,0.030783626196198788,0.48835276791393234,0.0,4.026615365066519e-07,0.5031035776720798,0.0
161,1.1,6,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,"Question: Hepatorenal syndrome: are additional prognostic factors being overlooked? Answer: Research to date suggests some prognostic indicators for hepatorenal syndrome remain undiscovered, requiring more investigation to advance treatment strategies.",4.2634750924233604e-07,0.4964368863138904,0.0,0.03264167636607376,0.5108256237659901,0.0,0.03259442773715166,0.5260930958967793,0.0,4.263475092423373e-07,0.5423242908253623,0.0
161,1.1,7,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,"Question: Hepatorenal syndrome: could we be missing prognostic indicators? Answer: There is a possibility that unknown prognostic factors for hepatorenal syndrome exist, and more research is needed to clarify and improve patient management.",3.3160361829959484e-07,0.3629054936893681,0.0,0.025387970506946245,0.3726752852851729,0.0,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
161,1.1,8,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,"Question: Hepatorenal syndrome: is there a gap in identifying prognostic factors? Answer: Studies imply additional prognostic factors could be present but unidentified in hepatorenal syndrome, so further research is essential.",4.0266153650665074e-07,0.4613455665026214,0.0,0.030828249901291883,0.4744579795951154,0.0,0.030783626196198788,0.48835276791393234,0.0,4.026615365066519e-07,0.5031035776720798,0.0
161,1.1,9,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,"Question: Hepatorenal syndrome: are some prognostic factors yet to be found? Answer: The current research landscape suggests potential prognostic factors for hepatorenal syndrome remain to be discovered, necessitating additional studies for better management.",3.3160361829959484e-07,0.44954889125936237,0.06222222222222223,0.025387970506946245,0.3726752852851729,0.0,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
161,1.1,10,ai,Question: Hepatorenal syndrome: are we missing some prognostic factors? Answer: Current research suggests that there may be additional prognostic factors for hepatorenal syndrome that have not yet been identified. Further studies are needed to explore these potential factors and improve the understanding and management of this condition.,"Question: Hepatorenal syndrome: are we failing to recognize all prognostic factors? Answer: It's suggested that undiscovered prognostic factors for hepatorenal syndrome exist, highlighting the need for further research to improve understanding and treatment.",3.3160361829959484e-07,0.3629054936893681,0.0,0.025387970506946245,0.3726752852851729,0.0,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
162,1.1,1,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does cup-cage reconstruction employing oversized cups ensure initial stability in THA for patients with osteoporotic acetabular fractures? Most acetabular components in this group showed stability even though only a minimal contact surface was achieved with the pelvic bone. However, 3 out of 10 implants migrated beyond thresholds associated with future loosening.",2.3685972735685406e-08,0.019802627296179764,0.0,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
162,1.1,2,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In the context of THA for osteoporotic acetabular fractures, does using oversized cups in cup-cage reconstruction offer initial stability? The majority of acetabular components remained stable despite limited contact area between the component and pelvic bone, although 3 of 10 moved beyond limits that indicate potential loosening later.",9.474389094274162e-08,0.0816780310142673,0.0,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
162,1.1,3,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Is initial stability achieved with cup-cage reconstruction using oversized cups in THA for osteoporotic acetabular fractures? Most acetabular components in this cohort were stable despite small bone-component contact, but 3 out of 10 showed migration exceeding predictive limits for loosening.",2.8423167282822477e-07,0.26826398659468076,0.0,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
162,1.1,4,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does oversized cup-cage reconstruction provide initial stability in THA treating osteoporotic acetabular fractures? Despite a small contact surface between acetabular component and pelvic bone, most components remained stable, though 3/10 migrated beyond limits linked to future loosening.",3.5528959103528067e-07,0.3483066942682149,0.0,0.02720139697172809,0.356674943938732,0.0,0.027162023114293006,0.3654597734944649,0.0,3.552895910352811e-07,0.3746934494414109,0.0
162,1.1,5,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In treating osteoporotic acetabular fractures with THA, does the use of cup-cage reconstruction with oversized cups guarantee initial stability? Most acetabular parts were stable in this group despite minimal pelvic bone contact, but 3 in 10 displaced beyond migration thresholds predicting loosening.",2.3685972735685406e-07,0.21825356602001733,0.0,0.018134264647818726,0.22314355131420927,0.0,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
162,1.1,6,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Can initial stability be achieved in THA for osteoporotic acetabular fractures by using oversized cups in cup-cage reconstruction? The majority had stable acetabular components despite limited contact with pelvic bone, with 3 of 10 migrating past loosening-prediction limits.",3.3160361829959537e-07,0.3209077200800996,0.0,0.025387970506946217,0.32850406697203516,0.0,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
162,1.1,7,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does the application of oversized cups in cup-cage reconstruction provide initial stability during THA for osteoporotic acetabular fractures? Most components were stable despite small component-to-bone contact, though 3 of 10 migrated beyond thresholds forecasting loosening.",4.0266153650665127e-07,0.4054651081081633,0.0,0.03082824990129185,0.4155154439616653,0.0,0.030783626196198753,0.42608439531090037,0.0,4.026615365066519e-07,0.43721380642274443,0.0
162,1.1,8,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"In THA for osteoporotic acetabular fractures, is initial stability attained through oversized cups in cup-cage reconstruction? While most acetabular implants were stable despite minimal contact surface, 3 of 10 moved beyond migration limits predictive of loosening.",3.7897556377096597e-07,0.37647757123491177,0.0,0.02901482343650997,0.3856624808119835,0.0,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
162,1.1,9,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"When performing cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures, is initial stability ensured? Most acetabular elements remained stable despite limited pelvic bone contact area, though 3 out of 10 migrated beyond limits associated with future loosening.",2.8423167282822477e-07,0.26826398659468076,0.0,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
162,1.1,10,human,Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: The majority of acetabular components in this cohort were stable despite the small contact surface achieved between the component and pelvic bone. Three of 10 migrated in excess of the limits that predict later loosening,"Does cup-cage reconstruction using oversized cups deliver initial stability in THA for osteoporotic acetabular fractures? Despite small contact surfaces between component and pelvic bone, most components were stable, but 3 in every 10 migrated beyond thresholds that indicate later loosening.",2.8423167282822477e-07,0.26826398659468076,0.0,0.02176111757738247,0.27443684570175897,0.0,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
163,1.1,1,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a connection between cervical cord plaques and discopathy in multiple sclerosis patients? The study indicates a potential correlation between cervical discopathy and MS plaques in the cervical region.,2.36859727356853e-08,0.035494993470072345,0.0011450775316071762,0.0018134264647818796,0.035091319811269006,0.0,0.0018108015409528735,0.03636764417087468,0.0,2.3685972735685406e-08,0.03774032798284699,0.0
163,1.1,2,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Does cervical cord plaque relate to discopathy in multiple sclerosis? The data suggests a possible link between cervical MS plaques and discopathy.,2.131737546211677e-07,0.3104651319014038,0.033293697978596916,0.016320838183036916,0.37156355643248284,0.0,0.016297213868575862,0.387765531008764,0.0,2.131737546211685e-07,0.4054651081081646,0.0
163,1.1,3,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there an association between cervical cord plaques and cervical discopathy in MS patients? Study findings imply a possible correlation.,2.605457000925384e-07,0.4105485904583852,0.033293697978596916,0.019947691112600675,0.4769240720903083,0.0,0.019918816950481606,0.4989911661189881,0.0,2.605457000925392e-07,0.5232481437645484,0.0
163,1.1,4,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques correlated with discopathy in multiple sclerosis individuals? The research suggests a potential association.,3.3160361829959447e-07,0.5823988473850443,0.033293697978596916,0.025387970506946304,0.6592456288842627,0.0,0.025351221573340226,0.6931471805599458,0.0,3.3160361829959526e-07,0.7308875085427924,0.0
163,1.1,5,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Can cervical cord plaques be related to discopathy in multiple sclerosis cases? The study data points toward a possible connection.,2.605457000925384e-07,0.4105485904583852,0.033293697978596916,0.019947691112600675,0.4769240720903083,0.0,0.019918816950481606,0.4989911661189881,0.0,2.605457000925392e-07,0.5232481437645484,0.0
163,1.1,6,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any link between cervical plaques and discopathy in patients with multiple sclerosis? The analysis suggests a possible relation.,2.605457000925384e-07,0.4105485904583852,0.033293697978596916,0.019947691112600675,0.4769240720903083,0.0,0.019918816950481606,0.4989911661189881,0.0,2.605457000925392e-07,0.5232481437645484,0.0
163,1.1,7,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Do cervical cord plaques have any relation to cervical discopathy in MS patients? The results indicate a possible correlation.,2.8423167282822376e-07,0.4646158117286605,0.033293697978596916,0.02176111757738255,0.5340824859302571,0.0,0.02172961849143448,0.5596157879354231,0.0,2.8423167282822456e-07,0.5877866649021191,0.0
163,1.1,8,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there a relationship between cervical cord plaques and discopathy in multiple sclerosis patients? The data implies a potential association.,2.605457000925384e-07,0.4105485904583852,0.033293697978596916,0.019947691112600675,0.4769240720903083,0.0,0.019918816950481606,0.4989911661189881,0.0,2.605457000925392e-07,0.5232481437645484,0.0
163,1.1,9,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Are cervical cord plaques connected to cervical discopathy in multiple sclerosis? The study suggests a possible correlation.,3.3160361829959447e-07,0.5823988473850443,0.033293697978596916,0.025387970506946304,0.6592456288842627,0.0,0.025351221573340226,0.6931471805599458,0.0,3.3160361829959526e-07,0.7308875085427924,0.0
163,1.1,10,human,Question: Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Answer: The study data suggests a possible correlation between cervical discopathy and cervical MS plaque.,Is there any association between cervical plaques and discopathy in individuals with multiple sclerosis? The evidence suggests a possible link.,2.605457000925384e-07,0.4105485904583852,0.033293697978596916,0.019947691112600675,0.4769240720903083,0.0,0.019918816950481606,0.4989911661189881,0.0,2.605457000925392e-07,0.5232481437645484,0.0
164,1.1,1,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to perform aneurysm repair in patients aged 80 or older after aneurysmal subarachnoid hemorrhage? The study shows that repairing ruptured aneurysms in the elderly yields a better prognosis than conservative treatment, supporting the recommendation to not hesitate in offering definitive surgery to elderly aSAH patients.",1.4211583641411244e-07,0.06783131708282175,0.03767781622452902,0.010880558788691236,0.12260232209233335,0.0,0.0108648092457172,0.12516314295400566,0.0,1.4211583641411244e-07,0.1278333715098836,0.0
164,1.1,2,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should aneurysm repair be performed on patients who are 80 years or older following aneurysmal subarachnoid hemorrhage? Findings indicate that elderly patients have a better outcome with repaired ruptured aneurysms compared to conservative management, suggesting surgery should be offered without hesitation.",3.079176455639103e-07,0.2290994646789435,0.03767781622452902,0.023574544042164344,0.28768207245178345,0.0,0.023540420032387266,0.29423947299793873,0.0,3.079176455639103e-07,0.30110509278391984,0.0
164,1.1,3,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair justified in patients aged 80+ after an aneurysmal subarachnoid hemorrhage? This study found superior prognosis with surgical repair over conservative treatment in the elderly, implying that definitive surgery should be recommended.",4.737194547137074e-07,0.4214713573263995,0.03767781622452902,0.036268529295637474,0.48550781578170144,0.0,0.03621603081905736,0.49783842823917857,0.0,4.737194547137081e-07,0.5108256237659905,0.0
164,1.1,4,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Does aneurysm repair benefit patients aged 80 or older after an aneurysmal subarachnoid hemorrhage? Results reveal that elderly patients fare better with repaired ruptured aneurysms than with conservative therapy, thus surgery is advisable.",4.974054274493927e-07,0.4522430159931532,0.03767781622452902,0.03808195576041935,0.5172565140962813,0.0,0.03802683236001023,0.5306282510621703,0.0,4.974054274493935e-07,0.5447271754416723,0.0
164,1.1,5,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is surgery for aneurysm repair warranted for patients aged 80 and above after aneurysmal subarachnoid hemorrhage? Evidence from the study suggests a better prognosis in elderly patients undergoing repair as opposed to conservative treatment, supporting the offer of surgery.",3.552895910352809e-07,0.2803927590664932,0.03767781622452902,0.02720139697172809,0.3403258059372023,0.0,0.027162023114293,0.3483066942682149,0.0,3.552895910352811e-07,0.356674943938732,0.0
164,1.1,6,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Can patients aged 80 or older with aneurysmal subarachnoid hemorrhage be justified to receive aneurysm repair? The study reports enhanced prognosis after surgery versus conservative care in elderly, recommending definitive surgical intervention.",5.21091400185078e-07,0.483991714307733,0.03767781622452902,0.03989538222520123,0.550046336919273,0.0,0.03983763390096311,0.564529802737852,0.0,5.210914001850789e-07,0.5798184952529413,0.0
164,1.1,7,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Should elderly patients, 80 years or older, with aneurysmal subarachnoid hemorrhage undergo aneurysm repair? The data indicate a better outcome when the ruptured aneurysm is repaired rather than treated conservatively, so surgery should be considered.",4.500334819780221e-07,0.39161839417671773,0.03767781622452902,0.034455102830855594,0.45473615711494775,0.0,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
164,1.1,8,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is aneurysm repair advisable in patients aged above 80 following aneurysmal subarachnoid hemorrhage? According to the study, surgical repair in elderly patients leads to better prognosis than conservative management, indicating surgery should be offered confidently.",4.500334819780221e-07,0.39161839417671773,0.03767781622452902,0.034455102830855594,0.45473615711494775,0.0,0.034405229278104486,0.46608972992459874,0.0,4.500334819780227e-07,0.4780358009429988,0.0
164,1.1,9,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Is it appropriate to recommend aneurysm repair to octogenarians after aneurysmal subarachnoid hemorrhage? The research confirms that elderly patients have improved prognosis with surgical repair compared to non-surgical treatment, advocating definitive surgery.",5.21091400185078e-07,0.483991714307733,0.03767781622452902,0.03989538222520123,0.550046336919273,0.0,0.03983763390096311,0.564529802737852,0.0,5.210914001850789e-07,0.5798184952529413,0.0
164,1.1,10,human,"Question: Is aneurysm repair justified for the patients aged 80 or older after aneurysmal subarachnoid hemorrhage? Answer: Better prognosis was obtained when ruptured aneurysm was repaired in the elderly than it was treated conservatively. From the results of this study, we should not hesitate to offer the definitive surgery for the elderly with aSAH.","Do patients aged 80 or older benefit from aneurysm repair after aneurysmal subarachnoid hemorrhage? Study results show that elderly patients have a better prognosis with repaired ruptured aneurysms than conservative treatment, hence definitive surgery should be provided.",4.026615365066515e-07,0.3344599803367694,0.03767781622452902,0.030828249901291835,0.39589565709201446,0.0,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
165,1.1,1,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do individuals with episodic migraines pay specific attention to visual stimuli related to headaches? Answer: Based on the large sample size and previous pilot testing of the images shown, the findings indicate that episodic migraine patients do not show differential attention to headache-related facial stimuli. Considering limited evidence for attentional biases in chronic headache groups, these results...",2.1317375462116866e-07,0.2341727007927945,0.04468395691609976,0.016320838183036854,0.20469971372977014,0.0212665406427221,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
165,1.1,2,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are episodic migraine sufferers particularly attentive to headache-associated visual cues? Answer: The analysis, supported by a substantial sample size and earlier pilot studies of the images, suggests that those with episodic migraines do not selectively focus on headache-related facial images. In light of only modest evidence for such attentional biases in chronic headache populations, these findings...",1.8948778188548325e-07,0.24079407739725145,0.06222222222222222,0.014507411718254981,0.18668120822709167,0.0212665406427221,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
165,1.1,3,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do migraine patients with episodic occurrences exhibit selective attention toward headache-related visual stimuli? Answer: Given the extensive sample and prior pilot validation of stimuli, data suggest that episodic migraineurs do not differentially attend to headache-linked facial cues. Considering the limited yet present attentional bias evidence in chronic headache sufferers, these results...",7.105791820705622e-08,0.14726801938642708,0.06222222222222222,0.005440279394345618,0.09137102842276601,0.0212665406427221,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
165,1.1,4,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these",Question: Is selective attention to headache-related visual stimuli observed in episodic migraine patients? Answer: Results derived from a large sample and pilot-tested images show no differential attention by episodic migraineurs toward headache-related facial stimuli. Modest evidence for attentional biases in chronic headaches should be considered alongside these findings...,2.3685972735685406e-08,0.06558998837215979,0.06222222222222222,0.0018134264647818726,0.007989419483715121,0.0212665406427221,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
165,1.1,5,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do people with episodic migraines specifically focus on visual stimuli related to headaches? Answer: Taking into account the large participant group and the prior screening of images, results suggest episodic migraine sufferers do not display selective attention to headache-associated facial stimuli. These findings come amidst only slight evidence of attentional bias in chronic headache cohorts...",1.6580180914979784e-07,0.22277557189457298,0.06222222222222222,0.012693985253473108,0.1683320695588959,0.0212665406427221,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
165,1.1,6,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Are episodic migraine patients prone to focusing selectively on headache-related visual facial stimuli? Answer: The large sample size and early pilot testing of presented images indicate that episodic migraineurs do not uniquely attend to headache-related facial stimuli. Given that evidence of attentional biases is modest among chronic headache patients, these findings...",7.105791820705622e-08,0.14726801938642708,0.06222222222222222,0.005440279394345618,0.09137102842276601,0.0212665406427221,0.0054324046228586,0.06317890162153228,0.0,7.105791820705622e-08,0.06453852113757153,0.0
165,1.1,7,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do those with episodic migraines direct selective attention to headache-linked visual stimuli? Answer: Large sample results paired with confirmed pilot testing of images suggest episodic migraine sufferers do not preferentially attend to headache-related facial stimuli. With only modest attentional bias observed in chronic headache cases, these results...",2.3685972735685406e-08,0.06558998837215979,0.06222222222222222,0.0018134264647818726,0.007989419483715121,0.0212665406427221,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
165,1.1,8,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Does selective attention to headache-associated face stimuli occur in episodic migraineurs? Answer: Based on results from a significant sample and validated image set, episodic migraineurs appear not to attend differently to headache-related facial cues. Noting only moderate evidence for attentional biases in chronic headache groups, these findings...",2.3685972735685406e-08,0.06558998837215979,0.06222222222222222,0.0018134264647818726,0.007989419483715121,0.0212665406427221,0.0018108015409528666,0.021978906718775004,0.0,2.3685972735685406e-08,0.022472855852057716,0.0
165,1.1,9,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Is there selective attentional focus on headache-related visual images among people with episodic migraine? Answer: Findings from a robustly sized sample and prior pilot image evaluations imply episodic migraineurs do not show distinct attentional preference to headache-specific facial stimuli. Considering modest attentional bias evidence in chronic headache populations, these data...",4.737194547137081e-08,0.12746539209024732,0.06222222222222222,0.0036268529295637453,0.0711683211052474,0.0212665406427221,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
165,1.1,10,human,"Question: Do episodic migraineurs selectively attend to headache-related visual stimuli? Answer: In light of the large sample size and prior pilot testing of presented images, results suggest that episodic migraineurs do not differentially attend to headache-related facial stimuli. Given modest evidence of attentional biases among chronic headache samples, these","Question: Do episodic migraineurs show a selective focus on headache-associated visual stimuli? Answer: The evidence, accounting for a large sample and previously validated stimuli, indicates no differential attention among episodic migraine patients toward headache-related facial images. Appreciating modest bias findings in chronic headache samples, the results...",7.105791820705622e-08,0.022104876432421428,0.06222222222222222,0.005440279394345618,0.0364623430871176,0.0212665406427221,0.0054324046228586,0.06744128079553224,0.0,7.105791820705622e-08,0.06899287148695166,0.0
166,1.1,1,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does Kenya's distribution of health care benefits align with the principles of universal coverage? Currently, it does not completely adhere to these principles. Despite attempts to broaden access to health services, substantial gaps remain, especially impacting vulnerable groups and residents of remote regions.",4.263475092423373e-07,0.10252097773341928,0.17409412744689712,0.03264167636607371,0.15249674584413953,0.1476,0.0325944277371516,0.2042521680214615,0.11841599384851978,4.263475092423373e-07,0.25788485318561616,0.0869082840236687
166,1.1,2,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the allocation of health care benefits in Kenya consistent with universal coverage principles? The answer is no, not entirely. Although there have been initiatives to increase health service accessibility, major coverage gaps still exist, notably among vulnerable populations and those living in isolated areas.",3.789755637709665e-07,0.05600096209852534,0.17409412744689712,0.029014823436509962,0.10486869685488509,0.1476,0.028972824655245866,0.1554620038520298,0.11841599384851978,3.789755637709665e-07,0.20787443261095273,0.0869082840236687
166,1.1,3,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does the way health care benefits are distributed in Kenya satisfy universal coverage principles? Not fully. Efforts to enhance access to health care have progressed, yet significant coverage disparities persist, particularly for marginalized groups and people in hard-to-reach locations.",5.210914001850787e-07,0.23908586684618705,0.14779756060978974,0.0398953822252012,0.2551508999042218,0.1476,0.039837633900963065,0.3096126836792874,0.11841599384851978,5.210914001850789e-07,0.36609843782584717,0.0869082840236687
166,1.1,4,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does Kenya's health care benefit distribution uphold the universal coverage principles? It falls short. While progress has been made to broaden health service access, notable deficiencies in coverage remain for vulnerable and remote communities.",6.395212638635052e-07,0.343683034550307,0.17409412744689712,0.04896251454911058,0.40033290974872093,0.1476,0.048891641605727426,0.45914441765025105,0.11841599384851978,6.39521263863506e-07,0.5202491176531057,0.0869082840236687
166,1.1,5,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is universal coverage realized through the distribution of health care benefits in Kenya? The distribution does not entirely fulfill this ideal. Although access to health services has been expanded, considerable gaps still affect vulnerable populations and those in distant areas.",4.974054274493934e-07,0.21217495914662665,0.14847085874883617,0.038081955760419325,0.22848265282206093,0.1476,0.0380268323600102,0.2822137094911721,0.11841599384851978,4.974054274493935e-07,0.3379275608591503,0.0869082840236687
166,1.1,6,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does the current distribution of health care benefits in Kenya achieve universal coverage goals? Not completely. Efforts to increase accessibility have been undertaken, but coverage significantly lacks for vulnerable groups and remote populations.",6.632072365991905e-07,0.3744546932170607,0.17409412744689712,0.05077594101389246,0.43208160806330076,0.1476,0.0507024431466803,0.49193424047324275,0.11841599384851978,6.632072365991914e-07,0.5541506693287874,0.0869082840236687
166,1.1,7,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Is the health care benefits system in Kenya universally inclusive as per coverage principles? No, it presently does not. Despite work to extend health service reach, important coverage gaps remain, particularly for the at-risk and isolated communities.",5.684633456564493e-07,0.2566716575606769,0.17409412744689712,0.04352223515476494,0.31072075105903396,0.1476,0.043459236982868805,0.36677109751923576,0.11841599384851978,5.684633456564497e-07,0.42493893784878045,0.0869082840236687
166,1.1,8,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Does Kenya's distribution model for health benefits meet universal coverage standards? It partially meets, but not fully. While there have been steps to augment health care access, vulnerable and geographically remote populations continue to face considerable coverage shortages.",5.44777372920764e-07,0.22927268337256157,0.17409412744689712,0.04170880868998307,0.2825498740923371,0.1476,0.04164843544191593,0.33778356064598425,0.11841599384851978,5.447773729207643e-07,0.3950859746990987,0.0869082840236687
166,1.1,9,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","In Kenya, does the distribution of health care benefits conform to the universal coverage principles? It does not entirely. Although access to services has been improved, there are still key gaps in reaching vulnerable and remote people.",5.684633456564493e-07,0.2566716575606769,0.17409412744689712,0.04352223515476494,0.31072075105903396,0.1476,0.043459236982868805,0.36677109751923576,0.11841599384851978,5.684633456564497e-07,0.42493893784878045,0.0869082840236687
166,1.1,10,ai,"Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The distribution of health care benefits in Kenya does not fully meet the principles of universal coverage. While efforts have been made to expand access to health services, there are still significant gaps in coverage, particularly for vulnerable populations and those in remote areas.","Are the health care benefits distributed in Kenya in accordance with universal coverage principles? The distribution is inadequate to fully meet these principles. Efforts to broaden health care accessibility exist, yet distinct coverage gaps remain for vulnerable and remote groups.",4.974054274493934e-07,0.21217495914662665,0.14847085874883617,0.038081955760419325,0.22848265282206093,0.1476,0.0380268323600102,0.2822137094911721,0.11841599384851978,4.974054274493935e-07,0.3379275608591503,0.0869082840236687
167,1.1,1,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Can a new surgical method for the temporomandibular joint enhance accessibility and lower the risk of complications?,7.579511275419307e-07,0.8098009634347991,0.19390581717451527,0.05802964687302005,0.9061324029704196,0.16305062458908606,0.05794564931049187,1.008763063249503,0.1275,7.579511275419326e-07,1.1184869668759037,0.08804283164782867
167,1.1,2,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Is it possible that an innovative surgical technique for the temporomandibular joint can improve access and decrease complications?,7.342651548062454e-07,0.7491763416183641,0.19390581717451527,0.05621622040823818,0.841593881832849,0.16305062458908606,0.056134847769539004,0.9397701917625509,0.1275,7.342651548062472e-07,1.0443789947221824,0.08804283164782867
167,1.1,3,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Could a novel approach to surgery on the temporomandibular joint offer better access and minimize complications?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
167,1.1,4,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Does a new surgical strategy for treating the temporomandibular joint improve visibility and reduce complication rates?,7.816371002776161e-07,0.8743394845723698,0.19390581717451527,0.05984307333780193,0.9751252744573717,0.16305062458908606,0.05975645085144475,1.0828710354032243,0.1275,7.81637100277618e-07,1.19852967454944,0.08804283164782867
167,1.1,5,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Can adopting a novel surgical procedure for the temporomandibular joint lead to improved access and fewer complications?,7.579511275419307e-07,0.8098009634347991,0.19390581717451527,0.05802964687302005,0.9061324029704196,0.16305062458908606,0.05794564931049187,1.008763063249503,0.1275,7.579511275419326e-07,1.1184869668759037,0.08804283164782867
167,1.1,6,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Is a novel temporomandibular joint surgical approach capable of enhancing surgical access while reducing the chance of complications?,7.342651548062454e-07,0.7491763416183641,0.19390581717451527,0.05621622040823818,0.841593881832849,0.16305062458908606,0.056134847769539004,0.9397701917625509,0.1275,7.342651548062472e-07,1.0443789947221824,0.08804283164782867
167,1.1,7,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Might a new surgical technique for the temporomandibular joint allow for improved access and reduced post-operative complications?,7.579511275419307e-07,0.8098009634347991,0.19390581717451527,0.05802964687302005,0.9061324029704196,0.16305062458908606,0.05794564931049187,1.008763063249503,0.1275,7.579511275419326e-07,1.1184869668759037,0.08804283164782867
167,1.1,8,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Could applying an innovative surgical approach to the temporomandibular joint result in better access and less tissue trauma?,7.342651548062454e-07,0.7491763416183641,0.19390581717451527,0.05621622040823818,0.841593881832849,0.16305062458908606,0.056134847769539004,0.9397701917625509,0.1275,7.342651548062472e-07,1.0443789947221824,0.08804283164782867
167,1.1,9,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Is there potential in a novel temporomandibular joint surgery method to facilitate easier access and minimize complications?,7.579511275419307e-07,0.8098009634347991,0.19390581717451527,0.05802964687302005,0.9061324029704196,0.16305062458908606,0.05794564931049187,1.008763063249503,0.1275,7.579511275419326e-07,1.1184869668759037,0.08804283164782867
167,1.1,10,ai,"Question: Can a Novel Surgical Approach to the Temporomandibular Joint Improve Access and Reduce Complications? Answer: Yes, a novel surgical approach to the temporomandibular joint has the potential to improve access and reduce complications by providing better visualization, precise instrumentation, and less tissue trauma. However, more research and clinical",Can the use of a novel surgical approach for the temporomandibular joint improve operative access and reduce adverse outcomes?,7.105791820705601e-07,0.6920179277784153,0.19390581717451527,0.054402793943456304,0.780969260016414,0.16305062458908606,0.05432404622858612,0.8752316706249803,0.1275,7.105791820705619e-07,0.9753861232352303,0.08804283164782867
168,1.1,1,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Does head positioning affect anterior chamber depth in pseudoexfoliation syndrome? Answer: Limited evidence indicates that head positioning might impact anterior chamber depth in pseudoexfoliation syndrome. Additional studies are required to validate these observations and quantify the relationship.,1.8948778188548293e-07,0.22904894616200888,0.0224609375,0.014507411718254981,0.2216751554791192,0.014827852370440611,0.014486412327622933,0.22059006734562248,0.010532014209478899,1.8948778188548325e-07,0.2190754486314641,0.005589396752665381
168,1.1,2,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Is anterior chamber depth in pseudoexfoliation syndrome influenced by head positioning? Answer: Some limited evidence suggests head positioning could alter anterior chamber depth in pseudoexfoliation syndrome, though more research is necessary to confirm this and assess the degree of influence.",1.1842986367842703e-07,0.10237976497727308,0.010609567901234546,0.009067132323909363,0.13274594549071272,0.008572113160155964,0.009054007704764333,0.13209800958480056,0.006068183988072934,1.1842986367842703e-07,0.13121211220645312,0.003210812934687609
168,1.1,3,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Can head positioning change anterior chamber depth in patients with pseudoexfoliation syndrome? Answer: Preliminary findings show limited evidence that head positioning may affect anterior chamber depth in pseudoexfoliation syndrome; however, further investigation is needed to establish the strength of this association.",9.474389094274162e-08,0.07430594662807266,0.012954254930606257,0.0072537058591274906,0.07010482778396288,0.017955279883857596,0.007243206163811466,0.06870567132945338,0.020777683116335252,9.474389094274162e-08,0.06707644995888984,0.023795359904818555
168,1.1,4,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Does the position of the head impact anterior chamber depth in pseudoexfoliation syndrome cases? Answer: There is scarce evidence suggesting a possible effect of head positioning on anterior chamber depth among pseudoexfoliation syndrome patients, but further studies are essential to confirm and clarify this effect.",0.0,0.061613082716439393,0.04304846938775511,0.0,0.06301338005090429,0.04510179465788382,0.0,0.06447880749394841,0.046400951814396206,0.0,0.03300700859809158,0.023795359904818555
168,1.1,5,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Is anterior chamber depth in pseudoexfoliation syndrome dependent on head positioning? Answer: Research thus far provides limited proof that head positioning might influence anterior chamber depth in pseudoexfoliation syndrome; further research is necessary to verify and understand the extent.,1.4211583641411233e-07,0.13125217388751276,0.008150510204081599,0.010880558788691236,0.16152769578287884,0.010550571210042575,0.0108648092457172,0.16073822588619402,0.007476599206011972,1.4211583641411244e-07,0.15965184792694087,0.003959742135997774
168,1.1,6,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Could head posture influence the anterior chamber depth in pseudoexfoliation syndrome? Answer: Evidence is limited but indicates that head posture may have an effect on anterior chamber depth in pseudoexfoliation syndrome. More comprehensive studies are required to affirm the relationship and its magnitude.,4.737194547137081e-08,0.052626686020529334,0.004890927977839257,0.0036268529295637453,0.0510209713528158,0.0031891414310303706,0.003621603081905733,0.05077335667188576,0.002251250683960135,4.737194547137081e-08,0.05044051459933652,0.0011882035402833654
168,1.1,7,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Does altering head position impact anterior chamber depth in pseudoexfoliation syndrome? Answer: Existing limited evidence hints that changes in head position might affect anterior chamber depth in pseudoexfoliation syndrome; further research is needed for confirmation and detailed understanding.,1.6580180914979763e-07,0.19745077603176808,0.01918331037649218,0.012693985253473108,0.19115389669388794,0.012633051260886416,0.012675610786670066,0.1902187231390533,0.008962369984911768,1.6580180914979784e-07,0.1889229585135741,0.004751352897949604
168,1.1,8,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,Question: Is there an effect of head positioning on anterior chamber depth in pseudoexfoliation syndrome? Answer: The evidence is limited but suggests that head positioning could influence anterior chamber depth in patients with pseudoexfoliation syndrome. Additional research is needed to confirm and quantify this effect.,2.3685972735685406e-08,0.005533090837231747,0.019375000000000003,0.0018134264647818726,0.0070517443577089445,0.021415823914336725,0.0018108015409528666,0.007941301485662411,0.02260559190957765,2.3685972735685406e-08,0.008909457019031564,0.023795359904818555
168,1.1,9,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: In pseudoexfoliation syndrome, does head alignment influence anterior chamber depth? Answer: There is minimal evidence proposing that head alignment might impact anterior chamber depth in pseudoexfoliation syndrome, though more research is required to validate and determine the extent of this influence.",9.474389094274162e-08,0.07430594662807266,0.012954254930606257,0.0072537058591274906,0.03544746875596516,0.04283321228363101,0.007243206163811466,0.03315966206996945,0.046400951814396206,9.474389094274162e-08,0.06707644995888984,0.023795359904818555
168,1.1,10,ai,Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: There is limited evidence suggesting that head positioning may have an influence on anterior chamber depth in pseudoexfoliation syndrome. Further research is needed to confirm these findings and determine the extent of the relationship.,"Question: Does the orientation of the head affect anterior chamber depth in patients with pseudoexfoliation syndrome? Answer: Limited data suggests that head orientation may have some effect on anterior chamber depth in pseudoexfoliation syndrome, but further studies are necessary to establish and clarify the relationship.",2.3685972735685406e-08,0.03703978086268389,0.04155822427126707,0.0018134264647818726,0.0070517443577089445,0.021415823914336725,0.0018108015409528666,0.007941301485662411,0.02260559190957765,2.3685972735685406e-08,0.008909457019031564,0.023795359904818555
169,1.1,1,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there a link between the CYP2D6*4 allele and breast cancer risk? The CYP2D6*4 poor metabolisers might reduce activation of procarcinogens, potentially offering protection against carcinogens.",9.47438909427412e-08,0.20387177956306823,0.03993055555555556,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,1.1,2,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does the CYP2D6*4 allele influence breast cancer risk? Reduced biotransformation of procarcinogens in CYP2D6*4 poor metabolisers may provide a protective effect against carcinogens.,1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,1.1,3,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there an association between breast cancer risk and the CYP2D6*4 allele? Poor metaboliser status with CYP2D6*4 could lead to lowered procarcinogen activation, possibly protecting against cancer-causing agents.",4.73719454713706e-08,0.07145896398214369,0.0,0.003626852929563759,0.07410797215372167,0.0,0.003621603081905747,0.07696104113612945,0.0,4.737194547137081e-08,0.08004270767353727,0.0
169,1.1,4,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,CYP2D6*4 allele and its impact on breast cancer: is there any connection? A decreased conversion of procarcinogens by CYP2D6*4 poor metabolisers might confer protection from carcinogens.,9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,1.1,5,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"What is the relation between CYP2D6*4 allele and breast cancer risk? CYP2D6*4 poor metabolisers may have less transformation of procarcinogens, resulting in protective effects against carcinogens.",9.47438909427412e-08,0.14842000511827314,0.0,0.007253705859127518,0.15415067982725894,0.0,0.007243206163811494,0.1603426500751799,0.0,9.474389094274162e-08,0.16705408466316696,0.0
169,1.1,6,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Regarding CYP2D6*4 allele and breast cancer, is there any association? Lower procarcinogen metabolism in CYP2D6*4 poor metabolisers could impart a protective role versus carcinogens.",1.421158364141118e-07,0.23180161405732358,0.0,0.010880558788691277,0.24116205681688863,0.0,0.010864809245717241,0.2513144282809079,0.0,1.4211583641411238e-07,0.26236426446749217,0.0
169,1.1,7,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Does carrying the CYP2D6*4 allele affect breast cancer risk? Reduced activation of procarcinogens in CYP2D6*4 poor metabolisers might protect against cancer-causing substances.,1.894877818854824e-07,0.3227733922630516,0.0,0.014507411718255037,0.33647223662121384,0.0,0.014486412327622988,0.3513978868378893,0.0,1.894877818854831e-07,0.3677247801253176,0.0
169,1.1,8,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,Is breast cancer risk linked to the CYP2D6*4 allele? The decreased procarcinogen transformation by CYP2D6*4 poor metabolisers may offer some protection from carcinogens.,1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,1.1,9,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Is there any correlation between the CYP2D6*4 allele and breast cancer? CYP2D6*4 poor metabolisers possibly decrease procarcinogen activation, leading to a protective effect.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
169,1.1,10,human,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: A possible decreased transformation of procarcinogens by CYP2D6*4 poor metabolisers could result in a protective effect against carcinogens.,"Regarding breast cancer risk, does the CYP2D6*4 allele have a role? CYP2D6*4 poor metabolisers might exhibit reduced procarcinogen biotransformation, offering protection against carcinogens.",1.658018091497971e-07,0.27625337662815763,0.0,0.012693985253473157,0.28768207245178257,0.0,0.012675610786670115,0.30010459245033916,0.0,1.6580180914979774e-07,0.3136575588550423,0.0
170,1.1,1,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott call impact the polio vaccination coverage in Kenya in 2015? The boycott call did not significantly influence the campaign, but if repeated, it might have an effect.",2.368597273568531e-07,0.049333182496734906,0.30774317570165316,0.01813426464781876,0.12289022915156567,0.20987654320987656,0.018108015409528708,0.21175717855331744,0.1051862673484295,2.3685972735685406e-07,0.3053816495511823,0.0
170,1.1,2,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was the polio vaccination coverage in Kenya in 2015 affected by the Catholic bishops' boycott call? The campaign was not notably impacted, though future repeated calls could make a difference.",2.842316728282237e-07,0.07130538405605735,0.33996539792387537,0.02176111757738252,0.19188310063851644,0.20987654320987656,0.021729618491434455,0.2832161425354611,0.1051862673484295,2.8423167282822487e-07,0.37948962170490397,0.0
170,1.1,3,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott urged by Catholic bishops influence polio vaccination coverage in Kenya during 2015? No significant effect was observed, but repeated calls in the future could have consequences.",3.07917645563909e-07,0.10639670386732636,0.33996539792387537,0.0235745440421644,0.22825074480939112,0.20987654320987656,0.02354042003238733,0.3209564705183081,0.1051862673484295,3.079176455639103e-07,0.41871033485818643,0.0
170,1.1,4,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","In 2015, did the Catholic bishops' call for a boycott affect Kenya's polio vaccination coverage? The campaign remained largely unaffected, yet future repeals might cause issues.",3.789755637709649e-07,0.2197253891743305,0.33996539792387537,0.02901482343651004,0.3460337804657754,0.20987654320987656,0.02897282465524595,0.443558792610641,0.1051862673484295,3.789755637709665e-07,0.5465437063680709,0.0
170,1.1,5,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the 2015 boycott call by Catholic bishops impact polio vaccination rates in Kenya? It did not affect the campaign much, but a similar call repeated later could.",3.316036182995943e-07,0.14276434803820104,0.33996539792387537,0.02538797050694628,0.2659910727922381,0.20987654320987656,0.025351221573340202,0.3601771836715906,0.1051862673484295,3.316036182995957e-07,0.45953232937844124,0.0
170,1.1,6,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was Kenya's polio vaccination program in 2015 hindered by the Catholic bishops' boycott call? The call did not significantly affect the coverage, but repeated future calls might.",3.552895910352796e-07,0.18050467602104803,0.33996539792387537,0.02720139697172816,0.30521178594552056,0.20987654320987656,0.027162023114293075,0.4009991781918454,0.1051862673484295,3.552895910352811e-07,0.5020919437972369,0.0
170,1.1,7,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the Catholic bishops' boycott request affect Kenya’s polio vaccination coverage in 2015? It did not have a major effect, although future repeated boycott calls could cause problems.",3.316036182995943e-07,0.14276434803820104,0.33996539792387537,0.02538797050694628,0.2659910727922381,0.20987654320987656,0.025351221573340202,0.3601771836715906,0.1051862673484295,3.316036182995957e-07,0.45953232937844124,0.0
170,1.1,8,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Was the call for boycott by Catholic bishops influential on polio vaccination coverage in Kenya in 2015? It had no significant impact, but if repeated, it might do so.",3.07917645563909e-07,0.10639670386732636,0.33996539792387537,0.0235745440421644,0.22825074480939112,0.20987654320987656,0.02354042003238733,0.3209564705183081,0.1051862673484295,3.079176455639103e-07,0.41871033485818643,0.0
170,1.1,9,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","In 2015, did the Catholic bishops' boycott call affect the polio vaccine coverage in Kenya? The impact was minimal, but a reiterated boycott could pose risks later.",3.552895910352796e-07,0.18050467602104803,0.33996539792387537,0.02720139697172816,0.30521178594552056,0.20987654320987656,0.027162023114293075,0.4009991781918454,0.1051862673484295,3.552895910352811e-07,0.5020919437972369,0.0
170,1.1,10,human,"Question: Did the call for boycott by the Catholic bishops affect the polio vaccination coverage in Kenya in 2015? Answer: The call for boycott did not affect the campaign significantly. However, if the call for boycott is repeated in future it could","Did the boycott call from Catholic bishops affect the 2015 polio vaccination campaign in Kenya? There was no significant effect, but repeat calls might influence it in the future.",3.07917645563909e-07,0.10639670386732636,0.33996539792387537,0.0235745440421644,0.22825074480939112,0.20987654320987656,0.02354042003238733,0.3209564705183081,0.1051862673484295,3.079176455639103e-07,0.41871033485818643,0.0
171,1.1,1,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The stretch-sensitive KCNQ1 mutation might suggest a link between genetic and environmental influences in atrial fibrillation development.,9.000669639560431e-07,0.8986401303022116,0.25170068027210885,0.06891020566171129,1.0529897334129457,0.14617283950617282,0.06881045855620907,1.1788888542431035,0.09506564056134,9.00066963956045e-07,1.285329548138089,0.05859375
171,1.1,2,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,"This mutation in KCNQ1, sensitive to stretch, could connect genetic and environmental factors in causing atrial fibrillation.",9.000669639560431e-07,0.8986401303022116,0.25170068027210885,0.06891020566171129,1.0529897334129457,0.14617283950617282,0.06881045855620907,1.1788888542431035,0.09506564056134,9.00066963956045e-07,1.285329548138089,0.05859375
171,1.1,3,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,A connection between genetic and environmental factors in atrial fibrillation may be indicated by the stretch-sensitive KCNQ1 mutation.,8.763809912203578e-07,0.8380155084857766,0.25170068027210885,0.06709677919692941,0.988451212275375,0.14617283950617282,0.0669996570152562,1.1098959827561514,0.09506564056134,8.763809912203596e-07,1.2112215759843679,0.05859375
171,1.1,4,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The development of atrial fibrillation could be linked to both genetics and environment through the stretch-sensitive KCNQ1 mutation.,8.763809912203578e-07,0.8380155084857766,0.25170068027210885,0.06709677919692941,0.988451212275375,0.14617283950617282,0.0669996570152562,1.1098959827561514,0.09506564056134,8.763809912203596e-07,1.2112215759843679,0.05859375
171,1.1,5,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The stretch-sensitive KCNQ1 mutation potentially bridges genetic and environmental contributions to atrial fibrillation pathogenesis.,9.711248821630993e-07,1.1062794950804555,0.25170068027210885,0.07435048505605692,1.2761332847271554,0.14617283950617282,0.0742428631790677,1.4200509110599913,0.09506564056134,9.71124882163101e-07,1.5476938126055808,0.05859375
171,1.1,6,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Genetic and environmental elements might be connected in atrial fibrillation by the presence of the stretch-sensitive KCNQ1 mutation.,8.763809912203578e-07,0.8380155084857766,0.25170068027210885,0.06709677919692941,0.988451212275375,0.14617283950617282,0.0669996570152562,1.1098959827561514,0.09506564056134,8.763809912203596e-07,1.2112215759843679,0.05859375
171,1.1,7,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,The role of the stretch-sensitive KCNQ1 mutation may link genetic predisposition and environmental triggers in atrial fibrillation.,9.000669639560431e-07,0.8986401303022116,0.25170068027210885,0.06891020566171129,1.0529897334129457,0.14617283950617282,0.06881045855620907,1.1788888542431035,0.09506564056134,9.00066963956045e-07,1.285329548138089,0.05859375
171,1.1,8,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,"This KCNQ1 mutation, sensitive to stretch, may highlight the interplay between genetic and environmental factors in atrial fibrillation.",8.763809912203578e-07,0.8380155084857766,0.25170068027210885,0.06709677919692941,0.988451212275375,0.14617283950617282,0.0669996570152562,1.1098959827561514,0.09506564056134,8.763809912203596e-07,1.2112215759843679,0.05859375
171,1.1,9,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Stretch-sensitivity in the KCNQ1 mutation could represent a genetic-environmental factor interaction relevant to atrial fibrillation.,9.474389094274139e-07,1.0321715229267343,0.25170068027210885,0.07253705859127504,1.196090577053619,0.14617283950617282,0.07243206163811482,1.3330395340703611,0.09506564056134,9.474389094274157e-07,1.4523836328012556,0.05859375
171,1.1,10,ai,Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: The stretch-sensitive KCNQ1 mutation may indicate a connection between genetic and environmental factors in the development of atrial fibrillation. Further research is needed to fully understand the role of this mutation in the pathogenesis of the condition.,Further research is essential to elucidate the stretch-sensitive KCNQ1 mutation's involvement in the genetic and environmental basis of atrial fibrillation.,8.290090457489871e-07,0.7267898733755525,0.25170068027210885,0.06346992626736567,0.8706681766189912,0.14617283950617282,0.06337805393335046,0.9847328398021458,0.09506564056134,8.29009045748989e-07,1.0776901833598451,0.05859375
172,1.1,1,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Is decompressive surgery beneficial for managing spinal cord sarcoidosis with compressive cervical myelopathy? It is generally effective in alleviating symptoms caused by this condition, but outcomes vary based on several factors.",2.605457000925384e-07,0.21093851227728289,0.07271468144044323,0.01994769111260064,0.321583624127463,0.0,0.01991881695048158,0.3313571359544403,0.0,2.6054570009253947e-07,0.341749293722057,0.0
172,1.1,2,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Does decompressive surgery work for spinal cord sarcoidosis accompanied by compressive cervical myelopathy? The procedure often helps reduce symptoms, though its success is influenced by multiple variables.",3.552895910352796e-07,0.3540393559179553,0.07271468144044323,0.02720139697172816,0.47000362924573613,0.0,0.027162023114293075,0.4855078157816992,0.0,3.552895910352811e-07,0.5020919437972369,0.0
172,1.1,3,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Can decompressive surgery effectively treat spinal cord sarcoidosis with compressive cervical myelopathy? It tends to relieve symptoms, but the degree of success depends on different factors.",3.789755637709649e-07,0.3932600690712378,0.07271468144044323,0.02901482343651004,0.5108256237659909,0.0,0.02897282465524595,0.5280674302004948,0.0,3.789755637709665e-07,0.5465437063680709,0.0
172,1.1,4,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Is decompressive surgery a valid treatment for spinal cord sarcoidosis presenting with compressive cervical myelopathy? It frequently alleviates associated symptoms, but various factors affect the surgical results.",3.552895910352796e-07,0.3540393559179553,0.07271468144044323,0.02720139697172816,0.47000362924573613,0.0,0.027162023114293075,0.4855078157816992,0.0,3.552895910352811e-07,0.5020919437972369,0.0
172,1.1,5,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","How effective is decompressive surgery for spinal cord sarcoidosis involving compressive cervical myelopathy? It is often successful in symptom relief, although its efficacy depends on several conditions.",3.552895910352796e-07,0.3540393559179553,0.07271468144044323,0.02720139697172816,0.47000362924573613,0.0,0.027162023114293075,0.4855078157816992,0.0,3.552895910352811e-07,0.5020919437972369,0.0
172,1.1,6,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Does surgery to decompress the spine effectively address spinal cord sarcoidosis with compressive cervical myelopathy? It often successfully mitigates symptoms, but outcomes rely on various influencing factors.",3.552895910352796e-07,0.3540393559179553,0.07271468144044323,0.02720139697172816,0.47000362924573613,0.0,0.027162023114293075,0.4855078157816992,0.0,3.552895910352811e-07,0.5020919437972369,0.0
172,1.1,7,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Is decompressive spinal surgery an effective option for spinal cord sarcoidosis with compressive cervical myelopathy? It typically eases symptoms, but success rates vary depending on a range of factors.",3.07917645563909e-07,0.27993138376423365,0.07271468144044323,0.0235745440421644,0.3930425881096067,0.0,0.02354042003238733,0.40546510810816194,0.0,3.079176455639103e-07,0.41871033485818643,0.0
172,1.1,8,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","To what extent does decompressive surgery help in spinal cord sarcoidosis when compressive cervical myelopathy is present? It usually provides symptomatic relief, but its success is contingent upon multiple circumstances.",2.842316728282237e-07,0.24484006395296465,0.07271468144044323,0.02176111757738252,0.356674943938732,0.0,0.021729618491434455,0.36772478012531495,0.0,2.8423167282822487e-07,0.37948962170490397,0.0
172,1.1,9,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Is surgical decompression helpful in treating spinal cord sarcoidosis with compressive cervical myelopathy? It tends to be successful in symptom management, though diverse factors impact the overall outcome.",3.316036182995943e-07,0.31629902793510833,0.07271468144044323,0.02538797050694628,0.43078291609245367,0.0,0.025351221573340202,0.4446858212614444,0.0,3.316036182995957e-07,0.45953232937844124,0.0
172,1.1,10,ai,"Question: Is decompressive surgery effective for spinal cord sarcoidosis accompanied with compressive cervical myelopathy? Answer: Decompressive surgery is often effective in relieving the symptoms of compressive cervical myelopathy caused by spinal cord sarcoidosis. However, the success of the surgery depends on various","Can decompressive surgery effectively ease symptoms in spinal cord sarcoidosis complicated by compressive cervical myelopathy? It is often beneficial, but the surgery’s success is subject to various considerations.",3.316036182995943e-07,0.31629902793510833,0.07271468144044323,0.02538797050694628,0.43078291609245367,0.0,0.025351221573340202,0.4446858212614444,0.0,3.316036182995957e-07,0.45953232937844124,0.0
173,1.1,1,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Does premature aging occur among Indigenous Australians? The evidence from this study on specific conditions does not strongly support the notion that Indigenous people age prematurely. The present emphasis and kind of services offered by the aged care sector may be inadequate.,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
173,1.1,2,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Is there premature aging in Indigenous Australians? This research examining certain isolated conditions does not substantiate the claim that Indigenous Australians age early. The existing focus and scope of aged care services might not align with their needs.,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
173,1.1,3,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Do Indigenous Australians experience early aging? The study of various distinct conditions does not offer strong support for the idea that Indigenous people age prematurely. Current aged care services and their focus may be insufficient.,1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
173,1.1,4,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Are Indigenous Australians subject to premature aging? Findings from a study of specific health issues suggest there is limited support for the idea that Indigenous Australians age prematurely. The aged care sector’s present priorities and services may not fully meet their requirements.,2.3685972735685406e-08,0.057909609167349885,0.024375,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
173,1.1,5,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Is premature aging a phenomenon among Indigenous Australians? This analysis of distinct medical conditions does not strongly validate the theory of premature aging in Indigenous populations. The current approach and services in aged care might not be adequate.,1.1842986367842671e-07,0.1642191208045447,0.027006172839506164,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
173,1.1,6,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Do Indigenous Australians age faster than others? Research looking into a series of particular conditions does not strongly back the assumption that Indigenous people age prematurely. The focus and services in the aged care system as they stand may not be suitable.,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
173,1.1,7,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Is the notion that Indigenous Australians age prematurely supported by evidence? This study on selected conditions finds little support for that idea. The way aged care services are currently provided might not appropriately address their needs.,1.6580180914979731e-07,0.18232155679395445,0.0,0.012693985253473115,0.18721154208814594,0.0,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
173,1.1,8,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Do Indigenous Australians experience accelerated aging? The evidence from a range of specific conditions analyzed in this research provides little support for that claim. The aged care sector’s current focus and services could be misaligned with their needs.,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
173,1.1,9,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Are premature aging patterns evident in Indigenous Australians? The research into separate conditions offers minimal backing for the theory that Indigenous peoples age early. Present aged care services might not be targeting their needs effectively.,1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
173,1.1,10,human,Question: Do Indigenous Australians age prematurely? Answer: The idea that Indigenous people age prematurely is not well supported by this study of a series of discrete conditions. The current focus and type of services provided by the aged care sector may not be,Does research confirm premature aging in Indigenous Australians? This study of various distinct health conditions does not provide strong evidence for premature aging. The aged care sector’s existing services and focus may not be adequately tailored to Indigenous peoples.,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
174,1.1,1,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it possible to maintain a zero central line-associated bloodstream infection rate? Consistent high-quality training, adherence to evidence-based protocols, and meticulous documentation contribute to significant decreases in CLABSIs. Careful organization helps understand a unit's capacity to manage peak demands and maintain outstanding performance over time.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,1.1,2,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can a zero rate of central line-associated bloodstream infections be maintained sustainably? Factors such as superior training, rigorous adherence to evidence-based guidelines, and detailed documentation correlate with notable reductions in CLABSIs. Thoughtful organizational strategies may enhance comprehension of a unit's ability to meet high demand periods and sustain exceptional performance long-term.",4.737194547137081e-08,0.03922071315328246,0.0,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
174,1.1,3,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining a zero central line-associated bloodstream infection rate feasible? High-level training, strict following of evidence-backed guidelines, and comprehensive documentation are linked with marked declines in CLABSIs. Strategic organizing might improve understanding of a unit’s capacity to manage peak workloads and maintain durable exceptional outcomes.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,1.1,4,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Could zero incidence of central line-associated bloodstream infections be sustainably achieved? High-quality education, compliance with proven guidelines, and precise documentation are associated with substantial reduction in CLABSIs. Deliberate organization may lead to improved insight into how a unit handles peak challenges and sustains excellent long-term performance.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,1.1,5,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is a zero central line-associated bloodstream infection rate maintainable over time? Intensive training, stringent compliance with evidence-based standards, and thorough recording practices are associated with significant drops in CLABSIs. Careful structural organization could foster better awareness of a unit's ability to weather peak demands and preserve superior performance for the long haul.",2.3685972735685406e-08,0.019418085857102696,0.0,0.0018134264647818726,0.019802627296179764,0.0,0.0018108015409528666,0.02020270731751861,0.0,2.3685972735685406e-08,0.02061928720273576,0.0
174,1.1,6,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is it sustainable to have zero central line-associated bloodstream infections? High-caliber training, strict observance of guidelines grounded in evidence, and detailed documentation contribute significantly to lowering CLABSIs. Mindful organization may help grasp what underpins a unit's capability to manage peak periods and uphold exceptional long-term results.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,1.1,7,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is maintaining a zero rate of central line-associated bloodstream infections achievable in the long term? Effective training, adherence to evidence-based protocols, and accurate documentation strongly correlate with reduced CLABSI rates. Thoughtful unit organization can enhance understanding of handling peak load and sustaining extraordinary performance over time.",1.6580180914979784e-07,0.14458122881110835,0.0,0.012693985253473108,0.14763599880606337,0.0,0.012675610786670066,0.15082288973458313,0.0,1.6580180914979784e-07,0.15415067982725894,0.0
174,1.1,8,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Can zero CLABSI rates be sustained sustainable? Excellence in training, rigorous guideline adherence grounded in research, and comprehensive documentation are linked to major CLABSI reductions. Organized approaches are key to appreciating a unit's preparedness for peak demands and maintaining high performance forward.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
174,1.1,9,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is a sustainable zero central line-associated bloodstream infection rate possible? Quality training, full compliance with evidence-based recommendations, and consistent documentation are connected with significant CLABSI reductions. Mindful planning and organization aid deeper understanding of a unit's readiness to handle peak demands while sustaining high performance.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
174,1.1,10,human,"Question: Is zero central line-associated bloodstream infection rate sustainable? Answer: High-quality training, strict compliance with evidence-based guidelines, and thorough documentation is associated with significant reductions in CLABSIs. Mindful organizing may lead to a better understanding of what goes into a unit's ability to handle peak demands and sustain extraordinary performance in the long-term.","Is sustaining zero central line-associated bloodstream infections feasible? Comprehensive, high-quality training, strict guideline compliance, and thorough documentation are related to marked CLABSI decreases. Thoughtful organizational strategies help elucidate how a unit maintains peak demand capacities and long-term exceptional service.",3.316036182995955e-07,0.31365755885504143,0.0,0.025387970506946217,0.3209077200800996,0.0,0.025351221573340132,0.32850406697203516,0.0,3.316036182995957e-07,0.3364722366212134,0.0
175,1.1,1,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does pretreatment with estradiol and antagonist before microdose leuprolide in IVF enhance outcomes for poor responders compared to oral contraceptive pills?,8.053230730133017e-07,0.6851863594280867,0.20408163265306117,0.06165649980258378,0.8166009553487159,0.14617283950617285,0.06156725239239758,0.9542339329068095,0.07638888888888888,8.053230730133036e-07,1.0714300462932096,0.019599999999999992
175,1.1,2,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,"In IVF, does using estradiol and antagonist prior to microdose leuprolide improve results in poor responders versus using oral contraceptive pills?",8.053230730133017e-07,0.6851863594280867,0.20408163265306117,0.06165649980258378,0.8166009553487159,0.14617283950617285,0.06156725239239758,0.9542339329068095,0.07638888888888888,8.053230730133036e-07,1.0714300462932096,0.019599999999999992
175,1.1,3,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does administering estradiol and antagonist before microdose leuprolide treatment in IVF lead to better outcomes in poor responders than oral contraceptive pills?,7.816371002776164e-07,0.6363961952586554,0.20408163265306117,0.0598430733378019,0.7653076609611658,0.14617283950617285,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,1.0142716324532608,0.019599999999999992
175,1.1,4,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Is the IVF outcome improved in poor responders when pretreated with estradiol and antagonist before microdose leuprolide compared to oral contraceptive pills?,7.816371002776164e-07,0.6363961952586554,0.20408163265306117,0.0598430733378019,0.7653076609611658,0.14617283950617285,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,1.0142716324532608,0.019599999999999992
175,1.1,5,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does pretreatment involving estradiol and antagonists prior to microdose leuprolide yield better IVF results in poor responders than oral contraceptive pill use?,7.816371002776164e-07,0.6363961952586554,0.20408163265306117,0.0598430733378019,0.7653076609611658,0.14617283950617285,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,1.0142716324532608,0.019599999999999992
175,1.1,6,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,"In IVF protocols, does pretreatment with estradiol and antagonist ahead of microdose leuprolide enhance outcomes in poor responders over oral contraceptive pills?",7.816371002776164e-07,0.6363961952586554,0.20408163265306117,0.0598430733378019,0.7653076609611658,0.14617283950617285,0.05975645085144471,0.9001667116365342,0.07638888888888888,7.816371002776182e-07,1.0142716324532608,0.019599999999999992
175,1.1,7,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does starting with estradiol and antagonist treatment before microdose leuprolide improve IVF success rates in poor responders relative to oral contraceptive pill pretreatment?,7.579511275419311e-07,0.5898761796237615,0.20408163265306117,0.05802964687302002,0.7165174967917345,0.14617283950617285,0.057945649310491835,0.848873417248984,0.07638888888888888,7.579511275419329e-07,0.9602044111829855,0.019599999999999992
175,1.1,8,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Is the use of estradiol and antagonist prior to microdose leuprolide more effective than oral contraceptive pills in improving IVF outcomes for poor responders?,7.342651548062458e-07,0.5454244170529274,0.20408163265306117,0.05621622040823814,0.6699974811568405,0.14617283950617285,0.05613484776953896,0.8000832530795527,0.07638888888888888,7.342651548062476e-07,0.9089111167954353,0.019599999999999992
175,1.1,9,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does pretreating with estradiol and antagonist before microdose leuprolide in IVF result in superior outcomes for poor responders compared to oral contraceptive pills?,7.579511275419311e-07,0.5898761796237615,0.20408163265306117,0.05802964687302002,0.7165174967917345,0.14617283950617285,0.057945649310491835,0.848873417248984,0.07638888888888888,7.579511275419329e-07,0.9602044111829855,0.019599999999999992
175,1.1,10,ai,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: The study aims to determine whether pretreatment with estradiol and antagonist prior to microdose leuprolide in IVF improves outcomes in poor responders compared to oral contraceptive pill.,Does the use of estradiol and antagonist pretreatment before microdose leuprolide in IVF improve outcomes for poor responders relative to oral contraceptive pills?,7.579511275419311e-07,0.5898761796237615,0.20408163265306117,0.05802964687302002,0.7165174967917345,0.14617283950617285,0.057945649310491835,0.848873417248984,0.07638888888888888,7.579511275419329e-07,0.9602044111829855,0.019599999999999992
176,1.1,1,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does preoperative platelet count serve as a prognostic indicator in esophageal squamous cell carcinoma? It's found that preoperative platelet levels predict long-term survival in ESCC, particularly for patients with positive lymph nodes. A cutoff value of 205 (×10(9)/L) platelet count appears optimal for survival prediction in ESCC cases.",7.105791820705622e-08,0.028227745859835007,0.10074074074074077,0.005440279394345618,0.006595458310516555,0.040742417383431435,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
176,1.1,2,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count a prognostic factor in esophageal squamous cell carcinoma? The data suggest that preoperative platelet count can forecast long-term outcomes in ESCC, especially in patients with nodal involvement. We identified 205 (×10(9)/L) as the ideal threshold for predicting survival in ESCC.",1.6580180914979784e-07,0.06620729824125204,0.0968089247288137,0.012693985253473108,0.1305742451143348,0.01694705747861288,0.012675610786670066,0.1576289442035832,0.0,1.6580180914979784e-07,0.16126814759612174,0.0
176,1.1,3,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can preoperative platelet count predict outcomes in esophageal squamous cell carcinoma? Yes, it is a prognostic factor for long-term survival in ESCC, notably in nodal-positive patients. A platelet count of 205 (×10(9)/L) seems to be the best cutoff for survival prediction.",2.3685972735685406e-07,0.10870651135492615,0.118226313098108,0.018134264647818726,0.17167520866996666,0.040742417383431435,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
176,1.1,4,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is platelet count before surgery a prognostic marker for esophageal squamous cell carcinoma? Preoperative platelet count is indeed predictive of long-term survival in ESCC cases, particularly among patients with lymph node positivity. The value of 205 (×10(9)/L) is suggested as the optimal survival prediction cutoff.",1.4211583641411244e-07,0.0102456625480567,0.1204948954723608,0.010880558788691236,0.0740367391060488,0.040742417383431435,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
176,1.1,5,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does the platelet count prior to surgery influence prognosis in esophageal squamous cell carcinoma? Preoperative platelet counts are predictive of survival in ESCC, especially in nodal-positive individuals. The optimal cutoff for platelet count to predict survival is 205 (×10(9)/L).",2.8423167282822466e-07,0.16182387727026581,0.11691330970610253,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,1.1,6,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is there prognostic value in preoperative platelet counts for patients with esophageal squamous cell carcinoma? Yes, it associates with long-term survival outcomes, prominently in patients with nodal metastases. The suggested cutoff is 205 (×10(9)/L) platelet count.",3.5528959103528056e-07,0.24718895526916373,0.11466316374044175,0.027201396971728097,0.3088763301834492,0.040742417383431435,0.027162023114293013,0.3746934494414109,0.0,3.552895910352811e-07,0.38441169891033145,0.0
176,1.1,7,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Can the platelet count before surgery be used as a prognostic factor in esophageal squamous cell carcinoma? Preoperative platelet counts predict long-term survival, particularly among those with positive lymph nodes. The cutoff point of 205 (×10(9)/L) is considered ideal for survival forecasting.",2.1317375462116866e-07,0.04935653973655807,0.1432098765432099,0.016320838183036854,0.14635740068567493,0.040742417383431435,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
176,1.1,8,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Does measuring platelet count before surgery provide prognostic information in esophageal squamous cell carcinoma? Preoperative platelet count is a significant prognostic factor for survival, with emphasis on node-positive patients. The suggested cutoff for this prognostic marker is 205 (×10(9)/L).",2.8423167282822466e-07,0.16182387727026581,0.11691330970610253,0.02176111757738247,0.2243189421553855,0.040742417383431435,0.0217296184914344,0.2876820724517808,0.0,2.8423167282822487e-07,0.2947995402206445,0.0
176,1.1,9,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is preoperative platelet count useful as a prognostic indicator in esophageal squamous cell carcinoma? It predicts long-term survival, particularly in patients who have positive lymph node involvement. The optimal platelet count cutoff is 205 (×10(9)/L) for predicting survival.",3.0791764556390996e-07,0.18947810896204276,0.11620370370370374,0.023574544042164344,0.2517179163435008,0.040742417383431435,0.023540420032387266,0.31585294941847764,0.0,3.079176455639103e-07,0.323787077093896,0.0
176,1.1,10,human,"Question: Preoperative platelet count in esophageal squamous cell carcinoma: is it a prognostic factor? Answer: Preoperative platelet count is a predictive factor for long-term survival in ESCC, especially in nodal-positive patients. We conclude that 205 (×10(9)/L) may be the optimum cutoff point for platelet count in predicting survival in ESCC patients.","Is the platelet count before surgery a reliable prognostic factor in esophageal squamous cell carcinoma? Yes, it effectively predicts long-term survival in ESCC, especially in cases with nodal positivity. A platelet count of 205 (×10(9)/L) is proposed as the best cutoff for predicting patient survival.",1.4211583641411244e-07,0.0102456625480567,0.1204948954723608,0.010880558788691236,0.0740367391060488,0.040742417383431435,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
177,1.1,1,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is splenectomy truly necessary alongside cholecystectomy in cases of mild hereditary spherocytosis? The recommendation to conduct a simultaneous splenectomy for children with mild HS undergoing cholecystectomy due to symptomatic gallstones should be reconsidered. In the contemporary context of minimally invasive surgery, the indication for splenectomy in these children warrants independent evaluation.",7.105791820705622e-08,0.030073190501009428,0.09639999999999999,0.005440279394345618,0.03276391352618768,0.01922337562475971,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
177,1.1,2,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy warrant a concurrent splenectomy in children with mild hereditary spherocytosis? Revisiting the suggestion to perform a splenectomy during cholecystectomy in pediatric patients with mild HS and symptomatic gallstones is needed. In the age of minimal access surgery, the decision to do splenectomy should depend on its individual justification.",9.474389094274162e-08,0.018421238472017265,0.07600069444444443,0.0072537058591274906,0.05338320072892344,0.01922337562475971,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
177,1.1,3,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is a splenectomy truly indicated alongside cholecystectomy in mild hereditary spherocytosis cases? The guidance to perform concomitant splenectomy in children with mild HS undergoing cholecystectomy for gallstones requires reassessment. Given the advances in minimally invasive surgery, the need for splenectomy should be evaluated on its own basis.",1.6580180914979784e-07,0.05330841843804146,0.09639999999999999,0.012693985253473108,0.11792172186649497,0.01922337562475971,0.012675610786670066,0.14763599880606337,0.0,1.6580180914979784e-07,0.15082288973458313,0.0
177,1.1,4,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should splenectomy be performed simultaneously with cholecystectomy in children with mild hereditary spherocytosis? The current advice to conduct a combined splenectomy in mild HS kids having cholecystectomy for symptomatic gallstones merits reexamination. With modern minimal access surgery, splenectomy necessity should be judged independently.",2.6054570009253947e-07,0.14428019664376812,0.09639999999999999,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,1.1,5,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is it necessary to do splenectomy concurrently with cholecystectomy in mild hereditary spherocytosis? The recommendation to carry out splenectomy together with cholecystectomy in children with mild HS treated for symptomatic gallstones should be reconsidered. In the era of minimal access procedures, the indication for splenectomy should be considered on its own merits.",4.737194547137081e-08,0.03167090932750982,0.037806249999999986,0.0036268529295637453,0.04028709343106707,0.0007682945126830237,0.003621603081905733,0.04000533461369837,0.0,4.737194547137081e-08,0.04082199452025437,0.0
177,1.1,6,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does mild hereditary spherocytosis require splenectomy during cholecystectomy for symptomatic gallstones? The notion of a concomitant splenectomy in mild HS pediatric patients undergoing cholecystectomy needs review. In times of minimally invasive surgery, the decision to remove the spleen should be individually justified.",2.8423167282822487e-07,0.16837774822282814,0.09639999999999999,0.02176111757738247,0.23570475752287834,0.01922337562475971,0.0217296184914344,0.26826398659468076,0.0,2.8423167282822487e-07,0.27443684570175897,0.0
177,1.1,7,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Is a simultaneous splenectomy justified when performing cholecystectomy in children with mild hereditary spherocytosis? Advice to do splenectomy alongside cholecystectomy in mild HS kids with symptomatic gallstones should be reconsidered. With minimal invasive surgical options available, necessity of splenectomy should be individually evaluated.",2.6054570009253947e-07,0.21029421383995217,0.04889999999999998,0.0199476911126006,0.21101214493250664,0.01922337562475971,0.019918816950481533,0.24294617861038903,0.0,2.6054570009253947e-07,0.248461359298501,0.0
177,1.1,8,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Should children with mild hereditary spherocytosis undergoing cholecystectomy for gallstones routinely have a splenectomy? The recommendation for concurrent splenectomy needs to be revisited. Presently, minimal access surgery requires splenectomy decisions to be made on their own merits.",4.026615365066515e-07,0.3369390531688006,0.06864489795918366,0.030828249901291835,0.3692361501474011,0.01922337562475971,0.03078362619619874,0.4054651081081633,0.0,4.026615365066519e-07,0.4155154439616653,0.0
177,1.1,9,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.",Is concomitant splenectomy needed during cholecystectomy in mild hereditary spherocytosis cases? It is advisable to reexamine the proposal of performing spleen removal in kids with mild HS having cholecystectomy for symptomatic gallstones. Modern minimal access surgical techniques call for separate assessment of splenectomy necessity.,2.3685972735685406e-07,0.1207496992335737,0.09639999999999999,0.018134264647818726,0.18691459335344662,0.01922337562475971,0.018108015409528666,0.21825356602001733,0.0,2.3685972735685406e-07,0.22314355131420927,0.0
177,1.1,10,human,"Question: Is cholecystectomy really an indication for concomitant splenectomy in mild hereditary spherocytosis? Answer: The advice to perform a concomitant splenectomy in children with mild HS undergoing cholecystectomy for symptomatic gallstones needs revisiting. In the era of minimal access surgery, the need for splenectomy in such children should be judged on its own merits.","Does cholecystectomy indicate that splenectomy should be done at the same time in mild hereditary spherocytosis? The current advice for splenectomy accompanying cholecystectomy in children with mild HS and symptomatic gallstones should be reviewed. In the context of minimal access surgery, the need for splenectomy should be decided independently.",1.1842986367842703e-07,0.1371743371076639,0.03169917355371904,0.009067132323909363,0.10393223463143508,0.0020431650179623916,0.009054007704764333,0.10318423623523065,0.0,1.1842986367842703e-07,0.10536051565782589,0.0
178,1.1,1,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Does measuring visceral adipose tissue area at one level accurately estimate its total volume? Measuring visceral adipose tissue area at a single level might give an approximation of its volume but does not precisely represent the whole volume. For a more complete evaluation, multiple level measurements or other imaging methods are necessary.",1.6580180914979784e-07,0.04619256020958984,0.33770487805086735,0.012693985253473108,0.023043227961276003,0.1796636404648661,0.012675610786670066,0.0946302753481989,0.027463444698091283,1.6580180914979784e-07,0.09307303128979472,0.030691990647773226
178,1.1,2,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Can the area measurement of visceral adipose tissue at a single level reflect its total volume? Measuring the area of visceral adipose tissue at one level can estimate the volume but may not fully capture the entire volume. To assess it comprehensively, measurements at multiple levels or additional imaging techniques are required.",1.6580180914979784e-07,0.04619256020958984,0.33770487805086735,0.012693985253473108,0.004682659261121991,0.1993031800353292,0.012675610786670066,0.06633855369269082,0.04768511049046322,1.6580180914979784e-07,0.06419189876646358,0.0514559901308982
178,1.1,3,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Is a one-level measurement of visceral adipose tissue area sufficient to represent its volume? While a single-level visceral adipose tissue area measurement offers an estimate of volume, it may not be fully accurate. Comprehensive evaluation demands multiple site measurements or supplementary imaging tools.",3.789755637709665e-07,0.11107326815114682,0.36357986826350486,0.029014823436509962,0.17821473297210222,0.21040652303267232,0.028972824655245866,0.24735331340636213,0.06344396442879274,3.789755637709665e-07,0.24295013102137952,0.07227989234909649
178,1.1,4,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Does a single-level measurement of visceral adipose tissue area correlate with its total volume? The area measured at one level can approximate visceral adipose tissue volume but might not reflect the actual entire volume accurately. Thoroughness involves several level measurements or enhanced imaging methods.,3.552895910352811e-07,0.05300055244062207,0.38818483360887196,0.02720139697172809,0.11950007481455405,0.23526336562621009,0.027162023114293,0.18800334178799405,0.08842752787389466,3.552895910352811e-07,0.2176323230370878,0.07227989234909649
178,1.1,5,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Can one-level visceral adipose tissue area measurement stand for the entire volume? Area measurement at a single layer can estimate visceral adipose tissue volume but may lack accuracy for the total volume. A more detailed assessment requires several levels of measurement or other imaging approaches.,3.316036182995957e-07,0.09155898682378316,0.3445857854232681,0.025387970506946217,0.09520197255324225,0.23581609514554114,0.025351221573340132,0.16390579020893403,0.08842752787389466,3.316036182995957e-07,0.1929397104467161,0.07227989234909649
178,1.1,6,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Is measuring visceral adipose tissue area at a single point enough to infer total volume? Estimating visceral adipose tissue volume by measuring area at one level can be indicative but not definitely representative of the whole volume. Multiple measurements or additional imaging techniques aid in a better evaluation.,2.6054570009253947e-07,0.011938866955786498,0.3710527275720285,0.0199476911126006,0.025658121948124446,0.23733033046930024,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
178,1.1,7,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Does a single slice measure of visceral adipose tissue area represent its full volume? Such a measure might estimate the visceral adipose tissue volume to some extent but does not precisely reflect the overall volume. For a fuller understanding, more levels of measurement or further imaging are necessary.",2.6054570009253947e-07,0.04143449166046498,0.392116649620799,0.0199476911126006,0.025658121948124446,0.23733033046930024,0.019918816950481533,0.09491291872198238,0.08842752787389466,2.6054570009253947e-07,0.12232214323276214,0.07227989234909649
178,1.1,8,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.","Can the visceral adipose tissue area found in one cross-section indicate its volume? Measuring the area at a single point might provide an approximate volume of visceral adipose tissue, yet it may not completely represent the entire volume. Multiple locations or advanced imaging techniques improve accuracy.",3.079176455639103e-07,0.02613408777186388,0.41237504162161526,0.023574544042164344,0.039973050581568526,0.25905872553102866,0.023540420032387266,0.14037529279873961,0.08842752787389466,3.079176455639103e-07,0.16884215886765608,0.07227989234909649
178,1.1,9,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Is a single-level visceral adipose tissue area measurement a reliable volume indicator? This approach may help estimate visceral adipose tissue volume but it isn't fully reliable to reflect total volume. More comprehensive analysis requires multiple points or additional imaging methods.,4.500334819780226e-07,0.15725223302955982,0.3834535721288927,0.03445510283085558,0.22305795532923023,0.23276215869392128,0.034405229278104466,0.2906574958480763,0.08842752787389466,4.500334819780227e-07,0.3229928386949137,0.07227989234909649
178,1.1,10,ai,"Question: Visceral adipose tissue area measurement at a single level: can it represent visceral adipose tissue volume? Answer: Visceral adipose tissue area measurement at a single level may provide an estimate of visceral adipose tissue volume, but it may not accurately represent the entire volume. Multiple level measurements or additional imaging techniques are needed for a more comprehensive assessment.",Can measuring visceral adipose tissue area at just one level serve as a proxy for volume? It can provide an estimation of visceral adipose tissue volume but often falls short of representing the entire volume precisely. A comprehensive assessment involves multiple measurements or further imaging methods.,3.079176455639103e-07,0.004672453586355818,0.39023748904684846,0.023574544042164344,0.07147974060702111,0.23634374446017956,0.023540420032387266,0.14037529279873961,0.08842752787389466,3.079176455639103e-07,0.16884215886765608,0.07227989234909649
179,1.1,1,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermotherapy enable locoregional opening of the rodent blood-brain barrier for paclitaxel, proposing a novel adjuvant glioma treatment approach? Answer: LITT facilitates local passage of chemotherapy drugs into brain tissue, presenting potential advantages for brain tumor therapy.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
179,1.1,2,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can Nd:YAG laser-induced thermo therapy create a locoregional opening in the rodent blood-brain barrier to deliver paclitaxel, offering a new adjuvant treatment for glioma? Answer: LITT allows chemotherapeutic agents to locally penetrate brain tissue, which may benefit brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,1.1,3,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is locoregional disruption of the rodent blood-brain barrier by Nd:YAG laser-induced thermo therapy a promising adjuvant for glioma therapy with paclitaxel? Answer: LITT causes localized passage of chemotherapy drugs into brain tissue, which is potentially useful for treating brain tumors.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,1.1,4,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does Nd:YAG laser-induced thermotherapy enable targeted opening of the rodent blood-brain barrier for paclitaxel, presenting a new concept in glioma therapy? Answer: LITT induces local entry of chemotherapeutic agents into cerebral tissue, making it a potential strategy for brain tumor treatment.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
179,1.1,5,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Could Nd:YAG laser-induced thermo therapy open the rodent blood-brain barrier locoregionally to enhance paclitaxel delivery as a novel glioma adjuvant? Answer: LITT facilitates selective penetration of chemotherapy drugs into brain tissue, which might improve brain tumor therapy outcomes.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
179,1.1,6,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is Nd:YAG laser-induced thermotherapy effective in locally opening the blood-brain barrier in rodents to allow paclitaxel passage for glioma treatment? Answer: LITT promotes locoregional chemotherapeutic agent delivery into brain tissue, signifying potential for brain tumor management.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
179,1.1,7,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Can the rodent blood-brain barrier be opened locoregionally for paclitaxel delivery via Nd:YAG laser-induced thermo therapy as an adjunct glioma treatment? Answer: LITT generates local passage for chemotherapeutics into the brain, a technique potentially valuable in brain tumor therapy.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
179,1.1,8,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Does the application of Nd:YAG laser-induced thermotherapy cause localized opening of the rodent blood-brain barrier, supporting paclitaxel’s use as adjuvant glioma treatment? Answer: LITT induces regional entry of chemotherapy drugs into brain tissue, potentially benefiting brain tumor treatment.",1.6580180914979763e-07,0.16907633004393308,0.0,0.012693985253473108,0.17327172127403623,0.0,0.012675610786670066,0.17768117723745203,0.0,1.6580180914979784e-07,0.18232155679395445,0.0
179,1.1,9,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: How does Nd:YAG laser-induced thermo therapy induce locoregional blood-brain barrier opening for paclitaxel use in rodent brains, forming a new glioma adjuvant approach? Answer: It allows chemotherapy drugs to locally enter brain tissue through LITT, promising for brain tumor treatment.",1.1842986367842703e-07,0.11778303565638337,0.0,0.009067132323909363,0.12062798778861739,0.0,0.009054007704764333,0.12361395596717584,0.0,1.1842986367842703e-07,0.1267517056391423,0.0
179,1.1,10,human,Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: LITT induces a locoregional passage of chemotherapeutic agents into the brain tissue. This is of potential interest for the treatment of brain tumors.,"Question: Is the locoregional opening of the rodent blood-brain barrier by Nd:YAG laser-induced thermo therapy a viable novel method for administering paclitaxel in glioma therapy? Answer: LITT promotes localized chemotherapeutic agent passage into brain tissue, offering new potentials in brain tumor treatment.",9.474389094274162e-08,0.09309042306601167,0.0,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
180,1.1,1,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Does consulting a geriatric oncologist lead to changes in cancer treatment plans for elderly patients?,8.526950184846723e-07,1.023432690811307,0.17132659131469363,0.06528335273214755,1.128828889060534,0.13888888888888887,0.06518885547430335,1.2418886985032351,0.10275824770146022,8.526950184846741e-07,1.3637654547976519,0.06353305785123965
180,1.1,2,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Can a geriatric oncology consultation alter the cancer treatment approach for older adults?,9.000669639560429e-07,1.1775833706385646,0.17132659131469363,0.0689102056617113,1.2958829737237005,0.13888888888888887,0.0688104585562091,1.4242102552971905,0.10275824770146022,9.000669639560448e-07,1.564436150259803,0.06353305785123965
180,1.1,3,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Is the cancer treatment plan for elderly patients modified after a geriatric oncology consultation?,8.763809912203576e-07,1.0975406629650282,0.17132659131469363,0.06709677919692943,1.2088715967340704,0.13888888888888887,0.06699965701525623,1.3289000754928653,0.10275824770146022,8.763809912203594e-07,1.459075634601977,0.06353305785123965
180,1.1,4,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Does a geriatric oncology consultation influence adjustments to cancer therapy for elderly patients?,9.000669639560429e-07,1.1775833706385646,0.17132659131469363,0.0689102056617113,1.2958829737237005,0.13888888888888887,0.0688104585562091,1.4242102552971905,0.10275824770146022,9.000669639560448e-07,1.564436150259803,0.06353305785123965
180,1.1,5,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Are cancer treatment plans revised for elderly patients following a geriatric oncology consultation?,9.000669639560429e-07,1.1775833706385646,0.17132659131469363,0.0689102056617113,1.2958829737237005,0.13888888888888887,0.0688104585562091,1.4242102552971905,0.10275824770146022,9.000669639560448e-07,1.564436150259803,0.06353305785123965
180,1.1,6,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Can the cancer treatment regimen for older patients be changed through a geriatric oncology consultation?,8.526950184846723e-07,1.023432690811307,0.17132659131469363,0.06528335273214755,1.128828889060534,0.13888888888888887,0.06518885547430335,1.2418886985032351,0.10275824770146022,8.526950184846741e-07,1.3637654547976519,0.06353305785123965
180,1.1,7,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Does consulting with a geriatric oncologist affect the cancer treatment strategy for elderly patients?,8.763809912203576e-07,1.0975406629650282,0.17132659131469363,0.06709677919692943,1.2088715967340704,0.13888888888888887,0.06699965701525623,1.3289000754928653,0.10275824770146022,8.763809912203594e-07,1.459075634601977,0.06353305785123965
180,1.1,8,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Is there a modification in cancer treatment plans for seniors after geriatric oncology consultation?,8.763809912203576e-07,1.0975406629650282,0.17132659131469363,0.06709677919692943,1.2088715967340704,0.13888888888888887,0.06699965701525623,1.3289000754928653,0.10275824770146022,8.763809912203594e-07,1.459075634601977,0.06353305785123965
180,1.1,9,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Does a specialized geriatric oncology consultation impact cancer treatment decisions for older patients?,9.000669639560429e-07,1.1775833706385646,0.17132659131469363,0.0689102056617113,1.2958829737237005,0.13888888888888887,0.0688104585562091,1.4242102552971905,0.10275824770146022,9.000669639560448e-07,1.564436150259803,0.06353305785123965
180,1.1,10,ai,"Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: Yes, a geriatric oncology consultation can modify the cancer treatment plan for elderly patients. This specialized consultation takes into consideration the unique needs and circumstances of older adults, such as their overall health, comorbidities, and functional",Can a geriatric oncology consultation lead to changes in the therapeutic plan for cancer among elderly individuals?,8.053230730133015e-07,0.8899012981867842,0.17132659131469363,0.061656499802583795,0.9857280454198607,0.13888888888888887,0.0615672523923976,1.0877380186759775,0.10275824770146022,8.053230730133034e-07,1.1967113701344854,0.06353305785123965
181,1.1,1,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be effectively applied in community palliative care? Answer: Yes, an advance care planning model is practical for community palliative care services. Incorporating quality audit processes is vital for the Model, with documented advance care planning discussions serving as a key outcome metric.",2.3685972735685406e-08,0.02581872693514109,0.005231632956573529,0.0018134264647818726,0.024313062569826904,0.0029052904738603447,0.0018108015409528666,0.023318321560436672,0.0009598666243535586,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
181,1.1,2,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it possible to implement an advance care planning model in community palliative care? Answer: Implementing an advance care planning model in community palliative care services is feasible. Quality audits play a critical role in the Model, with the documentation of advance care planning conversations recognized as an important measure of outcomes.",1.1842986367842703e-07,0.06977087715433594,0.014143117901568247,0.009067132323909363,0.03457106748274752,0.04544868911752034,0.009054007704764333,0.028344162262276207,0.05441713572234577,1.1842986367842703e-07,0.025970467595785696,0.058272673250138546
181,1.1,3,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is an advance care planning model workable in community palliative care settings? Answer: An advance care planning model can be successfully utilized within community palliative care services. Quality audit procedures are integral to the Model, with documented discussions on advance care planning being a significant outcome indicator.",0.0,0.029495624704679813,0.021239727153188726,0.0,0.030136833937389973,0.022072759303999184,0.0,0.0,0.0,0.0,0.0,0.0
181,1.1,4,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can community palliative care services adopt an advance care planning model effectively? Answer: Yes, community palliative care services can adopt an advance care planning model. Quality audit mechanisms are crucial components of the Model, and documentation of advance care planning conversations is identified as an essential outcome measure.",2.3685972735685406e-08,0.031943538111521175,0.03570389546351088,0.0018134264647818726,0.034678186839530056,0.03991927923261315,0.0018108015409528666,0.0068185123769524125,0.020551649540292066,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
181,1.1,5,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the adoption of an advance care planning model viable in community palliative care? Answer: The adoption of an advance care planning model is viable for community palliative care services. Quality audit processes form a fundamental part of the Model, with the documentation of advance care planning discussions viewed as a key outcome metric.",1.6580180914979784e-07,0.0914709573796979,0.022153925619834702,0.012693985253473108,0.08060472431616938,0.03870842602951699,0.012675610786670066,0.0728967768044817,0.05071734418492031,1.6580180914979784e-07,0.07041371933191609,0.05514830548415317
181,1.1,6,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the use of an advance care planning model achievable in community palliative care? Answer: Using an advance care planning model in community palliative care services is achievable. Quality audits represent an essential element of the Model, with advance care planning discussion documentation as a primary outcome metric.",2.3685972735685406e-08,0.0030624055881909307,0.015625,0.0018134264647818726,0.005182562134851576,0.0187074829931973,0.0018108015409528666,0.023318321560436672,0.0009598666243535586,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
181,1.1,7,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Does an advance care planning model work in community palliative care? Answer: An advance care planning model is functional within community palliative care services. The Model fundamentally includes quality audit procedures, and establishing documentation of advance care planning discussions is a critical outcome measure.",7.105791820705622e-08,0.08155355311389778,0.017129747991234345,0.005440279394345618,0.07664516186971415,0.00953991063881171,0.0054324046228586,0.07339380596669631,0.003151703623580332,7.105791820705622e-08,0.07292293477679124,0.0016600189291508909
181,1.1,8,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is the implementation of an advance care planning model possible in community palliative care? Answer: Implementing an advance care planning model is possible in community palliative care services. Quality audit strategies are a key aspect of the Model, and documenting advance care planning discussions is regarded as an important outcome metric.",9.474389094274162e-08,0.04525356598139352,0.0192304421768707,0.0072537058591274906,0.038483618125984,0.029436292423305366,0.007243206163811466,0.06189572609022287,0.01661578679938369,9.474389094274162e-08,0.08963693449175114,0.0018910788526508258
181,1.1,9,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Can an advance care planning model be integrated into community palliative care? Answer: Integrating an advance care planning model into community palliative care services is feasible. Quality audit processes are an indispensable part of the Model, with documentation of advance care planning discussions established as a fundamental outcome measure.",4.737194547137081e-08,0.02271710745488864,0.010235350981558533,0.0036268529295637453,0.019175244203657016,0.015483027535874605,0.003621603081905733,0.046106945246820796,0.0018791605739505515,4.737194547137081e-08,0.04582161865889667,0.0009865860091207122
181,1.1,10,human,Question: Is an advance care planning model feasible in community palliative care? Answer: An advance care planning model is feasible for community palliative care services. Quality audit processes are an essential component of the Model with documentation of advance care planning discussion established as an important outcome measure.,"Question: Is it feasible to introduce an advance care planning model in community palliative care? Answer: Introducing an advance care planning model in community palliative care services is feasible. Quality audits are a crucial element of the Model, and documenting advance care planning discussions is considered a vital outcome measure.",4.737194547137081e-08,0.005574614200619443,0.02999999999999997,0.0036268529295637453,0.038587020843004805,0.05657603116598614,0.003621603081905733,0.042379928867214645,0.060526987070292346,4.737194547137081e-08,0.04458888315327014,0.06345281938266564
182,1.1,1,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Does central venous pressure serve as a predictor for fluid responsiveness? Numerous studies indicate that central venous pressure (CVP) is an unreliable indicator of fluid responsiveness, with other measures like stroke volume variation (SVV) and pulse pressure being more effective.",9.47438909427412e-08,0.11633838675668473,0.005800752729499654,0.0072537058591274975,0.11551756811678793,0.0030881898203765634,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
182,1.1,2,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Can central venous pressure predict how a patient will respond to fluids? Research consistently shows that central venous pressure (CVP) is not a reliable predictor of fluid responsiveness, whereas parameters such as stroke volume variation (SVV) and pulse pressure are more useful.",1.421158364141119e-07,0.16981671067373671,0.008280763525518764,0.010880558788691243,0.1686349340321276,0.004401193212382016,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
182,1.1,3,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Is fluid responsiveness predicted accurately by central venous pressure? Evidence from several studies reveals that central venous pressure (CVP) poorly predicts fluid responsiveness, and alternative indicators like stroke volume variation (SVV) and pulse pressure provide better assessments.",2.36859727356853e-08,0.06887952090434402,0.029177863983058775,0.0018134264647818796,0.06976090043560124,0.029384756657483937,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
182,1.1,4,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Does measuring central venous pressure help in anticipating fluid responsiveness? Central venous pressure (CVP) has been demonstrated in many studies to be a weak predictor for fluid responsiveness, with other variables like stroke volume variation (SVV) and pulse pressure offering superior prediction.",1.421158364141119e-07,0.16981671067373671,0.008280763525518764,0.010880558788691243,0.1686349340321276,0.004401193212382016,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
182,1.1,5,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Is fluid responsiveness assessment reliable using central venous pressure? Studies have found central venous pressure (CVP) to be a poor predictor of fluid responsiveness, while other parameters such as stroke volume variation (SVV) and pulse pressure have greater predictive accuracy.",9.47438909427412e-08,0.1518843960161691,0.03130969732581415,0.0072537058591274975,0.15199899867257427,0.029384756657483937,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
182,1.1,6,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Can central venous pressure predict fluid responsiveness effectively? Central venous pressure (CVP) is shown by multiple studies to be a poor marker for fluid responsiveness, with stroke volume variation (SVV) and pulse pressure being more reliable indicators.",2.36859727356853e-08,0.030371344206569173,0.0015696442245671308,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
182,1.1,7,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure",Is fluid responsiveness well indicated by central venous pressure? Research highlights that central venous pressure (CVP) alone is an inadequate predictor for fluid responsiveness; more effective parameters include stroke volume variation (SVV) and pulse pressure.,2.36859727356853e-08,0.009455920199820778,0.027548209366391168,0.0018134264647818796,0.010920400412667952,0.029384756657483937,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
182,1.1,8,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Does central venous pressure accurately forecast fluid responsiveness? Numerous scientific investigations demonstrate central venous pressure (CVP) is insufficient as a predictor of fluid responsiveness, recommending other measures like stroke volume variation (SVV) and pulse pressure.",2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
182,1.1,9,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Is central venous pressure a dependable predictor of fluid responsiveness? Evidence suggests that central venous pressure (CVP) lacks accuracy in predicting fluid responsiveness, whereas parameters such as stroke volume variation (SVV) and pulse pressure are more informative.",2.36859727356853e-08,0.030371344206569173,0.0015696442245671308,0.0018134264647818796,0.030152490117890007,0.0008380438547157774,0.0018108015409528735,0.029852963149681777,0.0,2.3685972735685406e-08,0.030771658666753687,0.0
182,1.1,10,ai,"Question: Does the central venous pressure predict fluid responsiveness? Answer: Central venous pressure (CVP) is a poor predictor of fluid responsiveness. Multiple studies have shown that other parameters such as stroke volume variation (SVV), pulse pressure","Can central venous pressure be used to predict fluid responsiveness? Studies indicate central venous pressure (CVP) poorly predicts fluid responsiveness, with alternative parameters like stroke volume variation (SVV) and pulse pressure providing better predictive value.",2.36859727356853e-08,0.031317443362529396,0.0016607839761248952,0.0018134264647818796,0.031088519621267796,0.0008886808425160632,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
183,1.1,1,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is it required to routinely place a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis?,6.632072365991897e-07,0.39995679100889703,0.23268698060941817,0.05077594101389252,0.47014450829637733,0.21301775147928995,0.050702443146680355,0.5437216798458517,0.1875,6.632072365991914e-07,0.6209640871431414,0.15704937537180247
183,1.1,2,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Should a nasobiliary drainage tube be routinely inserted after endoscopic removal of stones from the common bile duct in patients with choledocholithiasis-induced cholangitis?,7.105791820705603e-07,0.4869681679985267,0.23268698060941817,0.054402793943456276,0.5611162865021053,0.21301775147928995,0.0543240462285861,0.639031859650177,0.1875,7.105791820705621e-07,0.7210475457001229,0.15704937537180247
183,1.1,3,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is the routine insertion of a nasobiliary drainage tube necessary after endoscopic clearance of the common bile duct for cholangitis patients with choledocholithiasis?,7.105791820705603e-07,0.4869681679985267,0.23268698060941817,0.054402793943456276,0.5611162865021053,0.21301775147928995,0.0543240462285861,0.639031859650177,0.1875,7.105791820705621e-07,0.7210475457001229,0.15704937537180247
183,1.1,4,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Does routine placement of a nasobiliary drainage tube after endoscopic clearance of the common bile duct remain necessary in cases of cholangitis caused by choledocholithiasis?,6.632072365991897e-07,0.39995679100889703,0.23268698060941817,0.05077594101389252,0.47014450829637733,0.21301775147928995,0.050702443146680355,0.5437216798458517,0.1875,6.632072365991914e-07,0.6209640871431414,0.15704937537180247
183,1.1,5,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is it standard practice to insert a nasobiliary drainage tube after endoscopic stone clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis?,6.86893209334875e-07,0.44251640542769266,0.23268698060941817,0.0525893674786744,0.5145962708672114,0.21301775147928995,0.05251324468763323,0.5902416954807457,0.1875,6.868932093348768e-07,0.6697542513125727,0.15704937537180247
183,1.1,6,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is the nasobiliary drainage tube routinely placed after the endoscopic clearance of the common bile duct in patients with cholangitis due to choledocholithiasis?,7.105791820705603e-07,0.4869681679985267,0.23268698060941817,0.054402793943456276,0.5611162865021053,0.21301775147928995,0.0543240462285861,0.639031859650177,0.1875,7.105791820705621e-07,0.7210475457001229,0.15704937537180247
183,1.1,7,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is it common or necessary to insert a nasobiliary drainage tube routinely post endoscopic clearance of the common bile duct in choledocholithiasis-induced cholangitis?,7.105791820705603e-07,0.4869681679985267,0.23268698060941817,0.054402793943456276,0.5611162865021053,0.21301775147928995,0.0543240462285861,0.639031859650177,0.1875,7.105791820705621e-07,0.7210475457001229,0.15704937537180247
183,1.1,8,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is there a necessity for routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients suffering from choledocholithiasis-induced cholangitis?,6.395212638635044e-07,0.3591347964886422,0.23268698060941817,0.04896251454911064,0.4275848938775817,0.21301775147928995,0.04889164160572748,0.4992699172750177,0.1875,6.39521263863506e-07,0.5744440715082475,0.15704937537180247
183,1.1,9,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is continuous placement of a nasobiliary drainage tube necessary after endoscopic clearance of the common bile duct in patients with cholangitis from choledocholithiasis?,7.105791820705603e-07,0.4869681679985267,0.23268698060941817,0.054402793943456276,0.5611162865021053,0.21301775147928995,0.0543240462285861,0.639031859650177,0.1875,7.105791820705621e-07,0.7210475457001229,0.15704937537180247
183,1.1,10,ai,Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: There is no consensus on the routine insertion of a nasobiliary drainage tube after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis. The decision,Is the routine use of nasobiliary drainage tubes after endoscopic removal of common bile duct stones in choledocholithiasis-associated cholangitis patients warranted?,7.579511275419309e-07,0.5822783478028519,0.23268698060941817,0.058029646873020035,0.6611997450590867,0.21301775147928995,0.05794564931049185,0.7443923753080024,0.1875,7.579511275419328e-07,0.832273180810347,0.15704937537180247
184,1.1,1,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Is the length of psychological treatment for depression linked to the likelihood of returning for treatment? Findings indicate that extended treatment durations might reduce the chance of returning to mental health services for certain patients. Yet, the study’s design limits causal conclusions. More research, ideally randomized controlled trials, is necessary to establish if trends toward lower intensity treatments are related.",1.4211583641411244e-07,0.05636352391809929,0.029101671490136743,0.010880558788691236,0.0984400728132524,0.0,0.0108648092457172,0.10008345855698497,0.0,1.4211583641411244e-07,0.10178269430994202,0.0
184,1.1,2,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Does the duration of psychological therapy for depression influence the rate of returning to treatment? Results imply that longer therapy may help prevent patients from coming back to mental health care in specific groups. Still, due to study design limitations, no cause-and-effect relationship can be concluded. Additional studies, preferably randomized controlled trials, are required to explore whether lower intensity treatment trends correlate.",9.474389094274162e-08,0.00046941094474473033,0.046045785639958384,0.0072537058591274906,0.06453852113757197,0.0,0.007243206163811466,0.06559728248581642,0.0,9.474389094274162e-08,0.06669137449867257,0.0
184,1.1,3,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Is there a connection between how long psychological treatment for depression lasts and the likelihood of returning for care? Data suggest that longer treatment durations could prevent some groups from needing repeat mental health treatment. However, the study design does not allow for causal claims. Further investigation, preferably through randomized controlled trials, is needed to clarify if lower intensity treatments affect return rates.",7.105791820705622e-08,0.016729931816525934,0.046045785639958384,0.005440279394345618,0.04800921918636103,0.0,0.0054324046228586,0.04879016416943571,0.0,7.105791820705622e-08,0.04959694113937285,0.0
184,1.1,4,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Does the period of psychological treatment for depression affect the risk of patients returning to treatment? Evidence suggests extended treatment might reduce re-entry into mental health care among some populations. Nonetheless, the study’s methodology prevents establishing causality. More rigorous research, such as randomized control trials, is necessary to understand if decreased treatment intensity plays a role.",2.3685972735685406e-07,0.10307126799609456,0.046045785639958384,0.018134264647818726,0.16989903679539609,0.0,0.018108015409528666,0.17284281283941416,0.0,2.3685972735685406e-07,0.1758906664636637,0.0
184,1.1,5,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Is a longer psychological treatment period for depression connected to reduced likelihood of returning to treatment? The findings propose that longer therapies may prevent some patients from re-engaging with mental health services. However, due to study design constraints, we cannot infer causation. Future research, ideally RCTs, should determine if lower intensity care trends have an impact.",2.3685972735685406e-07,0.10307126799609456,0.046045785639958384,0.018134264647818726,0.16989903679539609,0.0,0.018108015409528666,0.17284281283941416,0.0,2.3685972735685406e-07,0.1758906664636637,0.0
184,1.1,6,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Does extending the duration of psychological treatment for depression relate to a lower chance of patients returning for treatment? Results indicate longer treatment might avoid repeat mental health visits in certain cohorts. The design of the study, however, limits causal interpretation. Further randomized studies are needed to assess the association with lower intensity treatments.",2.8423167282822487e-07,0.14011253967644466,0.046045785639958384,0.02176111757738247,0.20763936477824352,0.0,0.0217296184914344,0.21130909366720996,0.0,2.8423167282822487e-07,0.21511137961694615,0.0
184,1.1,7,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Is the length of treatment for depression psychological therapy associated with return rates? Outcomes suggest prolonged treatment could discourage some groups from revisiting mental health care. Still, no causal link can be established because of study design. More studies, preferably randomized controlled trials, are required to evaluate if lower intensity treatments influence recidivism.",3.079176455639103e-07,0.15916073464713776,0.046045785639958384,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
184,1.1,8,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Does treatment length for psychological depression therapy affect patient return to care? The research implies treatment extension may help prevent returns to mental health support in some groups. However, causal conclusions are not possible because of study design. Additional research using randomized control trials is needed to explore links with treatment intensity trends.",3.079176455639103e-07,0.15916073464713776,0.046045785639958384,0.023574544042164344,0.22705745063534621,0.0,0.023540420032387266,0.23111172096338972,0.0,3.079176455639103e-07,0.23531408693446476,0.0
184,1.1,9,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Is the duration of depression psychological therapy related to subsequent returns to treatment? The evidence hints at longer therapy preventing mental health care returns in certain demographics. Yet, study design restricts causal deduction. More detailed randomized controlled trials are necessary to determine associations with lower intensity treatment trends.",4.263475092423373e-07,0.26025685151850775,0.046045785639958384,0.03264167636607371,0.33024168687057687,0.0,0.0325944277371516,0.3364722366212156,0.0,4.263475092423373e-07,0.34294475112682976,0.0
184,1.1,10,human,"Question: Is duration of psychological treatment for depression related to return into treatment? Answer: The results suggest that a longer duration of treatment may prevent return into mental health care in some groups. However, because of the design of the study, no causal inference can be drawn. Further research, preferably in a RCT, is needed to determine whether the trend towards lower intensity treatments is associated","Is a longer duration of psychological treatment for depression connected to less frequent returns to mental health care? The findings support the idea that extended treatment can reduce re-treatment in some groups. However, no causal claims can be made due to study methodology. Further research, preferably through randomized controlled trials, is essential to understand the impact of treatment intensity changes.",1.4211583641411244e-07,0.03286700932284692,0.046045785639958384,0.010880558788691236,0.0984400728132524,0.0,0.0108648092457172,0.10008345855698497,0.0,1.4211583641411244e-07,0.10178269430994202,0.0
185,1.1,1,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is it possible to predict discordance in TEOAE and AABR results in newborns? Discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not consistently predictable because it depends on factors like gestational age, middle ear fluid presence, and individual differences in auditory maturation.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
185,1.1,2,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can discordance in TEOAE and AABR findings be forecasted in newborns? The discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results among newborns is not always predictable due to influences like gestational age, middle ear fluid, and variability in the development of the auditory system.",1.4211583641411244e-07,0.11859925675699046,0.002223722565157755,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
185,1.1,3,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is it foreseeable to have discordance in TEOAE and AABR outcomes in newborns? Newborn discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results cannot reliably be predicted, as it is affected by several factors including gestational age, the existence of middle ear fluid, and individual maturation of the auditory pathways.",2.3685972735685406e-08,0.0068562133521661295,0.0181755829903978,0.0018134264647818726,0.018692133012154333,0.0,0.0018108015409528666,0.0190481949706931,0.0,2.3685972735685406e-08,0.019418085857102696,0.0
185,1.1,4,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can one anticipate differences between TEOAE and AABR test results in newborns? Variability in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcome discordance in newborns is not always foreseeable, as it depends on factors such as gestational maturity, middle ear fluid, and individual variations in auditory system development.",9.474389094274162e-08,0.050302200487784,0.0181755829903978,0.0072537058591274906,0.07696104113612989,0.0,0.007243206163811466,0.07847161544149417,0.0,9.474389094274162e-08,0.08004270767353683,0.0
185,1.1,5,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is discordance in TEOAE and AABR outcomes among newborns predictable? The variation or discordance found in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) measurements in newborns is not always predictable, influenced by gestational age, presence of middle ear fluid, and individual auditory maturation differences.",1.8948778188548325e-07,0.1319802315020513,0.0181755829903978,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
185,1.1,6,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can we predict when discordance occurs in TEOAE and AABR outcomes in newborns? Predicting discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) results in newborns is unreliable because it varies with gestational age, middle ear fluid presence, and maturation variability of the auditory systems.",1.6580180914979784e-07,0.11092682230421813,0.0181755829903978,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
185,1.1,7,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is it possible to foresee discordance in TEOAE and AABR results in newborn infants? Discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) assessments in newborns cannot always be predicted due to factors like gestational age, the presence of middle ear fluid, and auditory maturation variability.",1.4211583641411244e-07,0.09030753510148237,0.0181755829903978,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
185,1.1,8,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Are discordant TEOAE and AABR newborn results predictable? The discordance seen in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes of newborns lacks consistent predictability because of influences such as gestational age differences, middle ear fluid, and individual auditory developmental variability.",2.6054570009253947e-07,0.19793819929384737,0.0181755829903978,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
185,1.1,9,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Is predicting TEOAE and AABR discordance in newborns feasible? Discordance between Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) in newborns cannot be reliably forecasted, as it depends largely on factors including gestational age, middle ear effusion, and individual auditory maturation variations.",2.6054570009253947e-07,0.22944488931929996,0.004539398080451309,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
185,1.1,10,ai,"Question: Is discordance in TEOAE and AABR outcomes predictable in newborns? Answer: Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes in newborns is not always predictable, as it can vary depending on various factors such as gestational age, presence of middle ear fluid, and individual variability in auditory system maturation.","Can discordant results in TEOAE and AABR testing for newborns be foreseen? Discordance in Transient Evoked Otoacoustic Emissions (TEOAE) and Automated Auditory Brainstem Response (AABR) outcomes among newborns is not always predictable, with variability arising from gestational maturity, presence of middle ear fluid, and individual differences in auditory system development.",1.4211583641411244e-07,0.09030753510148237,0.0181755829903978,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
186,1.1,1,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Does laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Answer: Limited evidence indicates that laparoscopic cholecystectomy might influence peri-sinusoidal cell activity. More studies are required to thoroughly comprehend the impact of this surgery on liver function.,1.184298636784265e-07,0.1121098208597302,0.017795138888888895,0.009067132323909377,0.10459716770411998,0.026296566837107373,0.009054007704764354,0.14518200984449914,0.0,1.1842986367842703e-07,0.14953173397096364,0.0
186,1.1,2,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Is peri-sinusoidal cell activity altered by laparoscopic cholecystectomy? Answer: There is some limited proof suggesting laparoscopic cholecystectomy could impact peri-sinusoidal cell activity. Further investigation is necessary to fully understand this procedure's effects on liver function.,9.47438909427412e-08,0.04118396717949002,0.047842176086120736,0.0072537058591274975,0.0747442045544382,0.026296566837107373,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
186,1.1,3,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Does undergoing laparoscopic cholecystectomy change peri-sinusoidal cell activity? Answer: Evidence is limited but suggests a possible influence of laparoscopic cholecystectomy on peri-sinusoidal cell activity. Additional research is essential to clearly define its role in liver function.,7.10579182070559e-08,0.050421033290631634,0.02102556708958092,0.005440279394345618,0.04575666768118669,0.026296566837107373,0.005432404622858607,0.08455738802806367,0.0,7.105791820705622e-08,0.08701137698963013,0.0
186,1.1,4,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Can laparoscopic cholecystectomy modify peri-sinusoidal cell activity? Answer: Current evidence is scarce but points towards a potential effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity. More research is required for a comprehensive understanding of its effects on liver function.,0.0,0.035546009259483924,0.025256675594513445,0.0,0.03648143055578634,0.026296566837107373,0.0,0.0,0.0,0.0,0.0,0.0
186,1.1,5,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Is there an effect of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Answer: The evidence is limited but suggests laparoscopic cholecystectomy may affect peri-sinusoidal cell activity. Further detailed research is needed to determine the procedure's impact on liver function.,2.36859727356853e-08,0.0076996802636211115,0.023919753086419755,0.0018134264647818726,0.009813183473625475,0.026296566837107373,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
186,1.1,6,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Question: Does laparoscopic cholecystectomy have an impact on peri-sinusoidal cell activity? Answer: Although evidence is limited, it indicates that laparoscopic cholecystectomy might influence peri-sinusoidal cell activity. More extensive research is necessary to fully understand its effect on liver function.",2.36859727356853e-08,0.0076996802636211115,0.023919753086419755,0.0018134264647818726,0.009813183473625475,0.026296566837107373,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
186,1.1,7,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Is peri-sinusoidal cell activity influenced by laparoscopic cholecystectomy? Answer: Limited data suggests laparoscopic cholecystectomy could alter peri-sinusoidal cell activity. Additional research is needed to elucidate the full implications for liver function.,1.894877818854824e-07,0.1676555868053966,0.044166666666666694,0.014507411718255016,0.1999073475084452,0.026296566837107373,0.014486412327622974,0.24362208265775243,0.0,1.8948778188548325e-07,0.2513144282809061,0.0
186,1.1,8,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Does the process of laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Answer: There is minimal evidence suggesting the surgery may impact peri-sinusoidal cell activity. Further investigation is crucial to accurately assess its effects on liver function.,9.47438909427412e-08,0.04118396717949002,0.047842176086120736,0.0072537058591274975,0.0747442045544382,0.026296566837107373,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
186,1.1,9,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,"Question: Might laparoscopic cholecystectomy affect peri-sinusoidal cell activity? Answer: Some limited evidence suggests it might, but more research is required to clearly understand its influence on liver function.",2.842316728282236e-07,0.26108675234686274,0.0763888888888889,0.021761117577382534,0.3430081911491176,0.026296566837107373,0.02172961849143447,0.39204208777602556,0.0,2.8423167282822487e-07,0.40546510810816505,0.0
186,1.1,10,ai,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: There is limited evidence to suggest that laparoscopic cholecystectomy may influence peri-sinusoidal cell activity. Further research is needed to fully understand the potential impact of this surgical procedure on liver function.,Question: Does laparoscopic cholecystectomy influence the activity of peri-sinusoidal cells? Answer: Sparse evidence hints that laparoscopic cholecystectomy may affect peri-sinusoidal cell activity. In-depth research is necessary to fully grasp its impact on liver function.,1.421158364141118e-07,0.10242497691864783,0.046115451388888895,0.010880558788691257,0.13536882637087366,0.026296566837107373,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
187,1.1,1,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does a reimbursement model based on case-mix encourage the advancement of process-oriented healthcare delivery? Case-mix based reimbursement incentivizes healthcare providers to deliver efficient and effective care by tying payments to patient complexity and outcomes, prompting improvements in care processes, coordination, and quality to achieve proper reimbursement.",3.552895910352811e-07,0.12594773032112672,0.11463154147383414,0.02720139697172809,0.17586523701119683,0.08401920438957468,0.027162023114293,0.2275380141052752,0.051570247933884296,3.552895910352811e-07,0.2567397421434663,0.035041322314049606
187,1.1,2,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Can case-mix reimbursement promote the evolution of process-centered care delivery? By linking reimbursement to patient complexity and outcomes, case-mix based payment motivates healthcare organizations to enhance their procedures, coordination, and care quality to secure appropriate reimbursements.",5.921493183921346e-07,0.3772621586020328,0.11463154147383414,0.04533566161954682,0.43369434631329673,0.08401920438957468,0.04527003852382168,0.49223056833235734,0.051570247933884296,5.921493183921352e-07,0.5286734576271077,0.035041322314049606
187,1.1,3,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Is process-focused care delivery fostered by case-mix based reimbursement schemes? Case-mix reimbursement encourages providers to focus on effective and efficient care by associating payments with patient complexity and results, thus driving improvements in healthcare processes and quality.",5.684633456564493e-07,0.349091281635336,0.11463154147383414,0.04352223515476494,0.4047068094400452,0.08401920438957468,0.043459236982868805,0.46237760518267557,0.051570247933884296,5.684633456564497e-07,0.497901798960354,0.035041322314049606
187,1.1,4,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does the use of case-mix based reimbursement spur growth in process-oriented care delivery? By rewarding providers according to patient complexity and outcomes, case-mix reimbursement incentivizes the improvement of care coordination, processes, and quality to obtain fitting payments.",5.684633456564493e-07,0.349091281635336,0.11463154147383414,0.04352223515476494,0.4047068094400452,0.08401920438957468,0.043459236982868805,0.46237760518267557,0.051570247933884296,5.684633456564497e-07,0.497901798960354,0.035041322314049606
187,1.1,5,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","To what extent does case-mix reimbursement stimulate process-based healthcare delivery? Tying reimbursement to patient complexity and outcomes encourages healthcare providers to develop better processes and quality care, ensuring appropriate reimbursement under case-mix payment models.",6.395212638635052e-07,0.4361026586249661,0.11463154147383414,0.04896251454911058,0.4943189681297322,0.08401920438957468,0.048891641605727426,0.5547509253136909,0.051570247933884296,6.39521263863506e-07,0.5932119787646792,0.035041322314049606
187,1.1,6,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does linking reimbursement to case-mix factors encourage process-oriented healthcare delivery? Case-mix reimbursement links payment to patient complexity and outcomes, motivating providers to improve care quality, coordination, and efficiency as a pathway to receive adequate compensation.",6.158352911278199e-07,0.40624969547528433,0.11463154147383414,0.0471490880843287,0.4635473094629785,0.08401920438957468,0.04708084006477455,0.523002226999111,0.051570247933884296,6.158352911278206e-07,0.5604221559416875,0.035041322314049606
187,1.1,7,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","How does case-mix based reimbursement affect process-oriented healthcare delivery development? By incentivizing effective and efficient care through reimbursement tied to patient complexity and outcomes, healthcare entities are driven to enhance processes, coordination, and quality.",6.395212638635052e-07,0.4361026586249661,0.11463154147383414,0.04896251454911058,0.4943189681297322,0.08401920438957468,0.048891641605727426,0.5547509253136909,0.051570247933884296,6.39521263863506e-07,0.5932119787646792,0.035041322314049606
187,1.1,8,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Is the progression of process-oriented care delivery enhanced by case-mix reimbursement policies? Because reimbursement aligns with patient complexity and outcomes, healthcare providers are motivated to optimize processes, coordination, and quality to meet reimbursement criteria.",6.395212638635052e-07,0.4361026586249661,0.11463154147383414,0.04896251454911058,0.4943189681297322,0.08401920438957468,0.048891641605727426,0.5547509253136909,0.051570247933884296,6.39521263863506e-07,0.5932119787646792,0.035041322314049606
187,1.1,9,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","Does case-mix dependent reimbursement encourage process-oriented care delivery improvements? Linking payments to patient complexity and treatment outcomes stimulates providers to refine processes, improve coordination, and elevate care quality to gain proper reimbursement.",6.868932093348758e-07,0.4986230156062996,0.11463154147383414,0.05258936747867434,0.5588574892673037,0.08401920438957468,0.05251324468763317,0.6214422998123643,0.051570247933884296,6.868932093348768e-07,0.66220485025163,0.035041322314049606
187,1.1,10,ai,"Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: Case-mix based reimbursement can stimulate the development of process-oriented care delivery by incentivizing healthcare providers to focus on delivering efficient and effective care. By linking reimbursement to patient complexity and outcomes, healthcare organizations are encouraged to improve their processes, coordination, and quality of care to receive appropriate reimbursement.","In what way does case-mix based reimbursement influence the development of process-oriented care? Case-mix reimbursement incentivizes healthcare providers to focus on efficient and effective care delivery by connecting payments to patient complexity and clinical results, promoting better processes and quality care.",4.737194547137081e-07,0.2437307659775101,0.11463154147383414,0.03626852929563745,0.2964932247998142,0.08401920438957468,0.03621603081905733,0.351151970072451,0.051570247933884296,4.737194547137081e-07,0.3834914477826086,0.035041322314049606
188,1.1,1,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Does bedside assessment reliably exclude aspiration after an acute stroke? Bedside swallowing assessment does not have sufficient sensitivity to serve as a screening tool for acute stroke patients, although videofluoroscopy as a gold standard raises some concerns.",9.47438909427412e-08,0.07455397429960664,0.022106393804059005,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
188,1.1,2,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Can aspiration be reliably ruled out by bedside assessment following an acute stroke? Bedside evaluation of swallowing lacks adequate sensitivity for use as a stroke screening method, though the use of videofluoroscopy as the gold standard has its issues.",4.73719454713706e-08,0.018021423668444392,0.049861495844875335,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
188,1.1,3,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Is bedside assessment a reliable method to exclude aspiration after an acute stroke? Bedside swallowing tests are not sensitive enough to function as a screening method in acute stroke cases, despite concerns regarding videofluoroscopy as a reference standard.",7.10579182070559e-08,0.046114238579118894,0.022855323005369167,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
188,1.1,4,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Can bedside assessment effectively exclude aspiration in acute stroke patients? The sensitivity of bedside swallowing assessments is insufficient for stroke screening, but the application of videofluoroscopy as the gold standard is questioned.",2.131737546211677e-07,0.18557753157279544,0.049861495844875335,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
188,1.1,5,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Does bedside assessment have the reliability to exclude aspiration following acute stroke? Bedside swallowing assessments lack the required sensitivity for screening acute stroke patients, though videofluoroscopy as a definitive test is controversial.",2.131737546211677e-07,0.18557753157279544,0.049861495844875335,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
188,1.1,6,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Is it possible to exclude aspiration by bedside assessment after an acute stroke? Bedside swallowing evaluations do not possess enough sensitivity to be considered reliable screening tools in acute stroke, while videofluoroscopy as the gold standard remains debated.",7.10579182070559e-08,0.008646823413716476,0.049861495844875335,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
188,1.1,7,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Can aspiration be ruled out by bedside assessment in acute stroke cases? Bedside assessments of swallowing are insufficiently sensitive for stroke screening, yet videofluoroscopy's status as a gold standard is problematic.",2.36859727356853e-07,0.21836735439578714,0.049861495844875335,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
188,1.1,8,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Is bedside swallowing assessment a dependable method to rule out aspiration after acute stroke? It lacks adequate sensitivity for acute stroke screening, although concerns exist about videofluoroscopy as the gold standard.",2.36859727356853e-07,0.21836735439578714,0.049861495844875335,0.018134264647818768,0.29626581614317127,0.0,0.018108015409528715,0.3053816495511823,0.0,2.3685972735685406e-07,0.3150810466398961,0.0
188,1.1,9,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Can bedside swallowing assessment reliably preclude aspiration following an acute stroke? Bedside tests do not reach the sensitivity needed for screening in acute stroke, with videofluoroscopy as a gold standard also contested.",2.131737546211677e-07,0.18557753157279544,0.049861495844875335,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
188,1.1,10,human,"Question: Can bedside assessment reliably exclude aspiration following acute stroke? Answer: Bedside assessment of swallowing lacks the necessary sensitivity to be used as a screening instrument in acute stroke, but there are concerns about the use of videofluoroscopy as a gold","Is bedside assessment sufficient to exclude aspiration after an acute stroke? It lacks the sensitivity necessary for screening in acute stroke patients, and videofluoroscopy’s role as the gold standard is also questioned.",2.131737546211677e-07,0.18557753157279544,0.049861495844875335,0.01632083818303689,0.2623642644674895,0.0,0.01629721386857584,0.2702903297399133,0.0,2.1317375462116866e-07,0.27871340246902143,0.0
189,1.1,1,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Patients on aromatase inhibitors (AIs) who develop osteoporosis have a higher risk of musculoskeletal symptoms and bone fractures. Using calcium or bisphosphonates alongside reduces the chance of osteoporosis and related symptoms. Those treated with tamoxifen before AIs are less prone to AI-induced musculoskeletal issues. We advise...,2.8423167282822487e-07,0.21206782436037308,0.01753826530612245,0.02176111757738247,0.24116205681688774,0.0,0.0217296184914344,0.2461330695389088,0.0,2.8423167282822487e-07,0.25131442828090744,0.0
189,1.1,2,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Those undergoing aromatase inhibitor therapy who develop osteoporosis face increased likelihood of musculoskeletal symptoms and fractures. Co-treatment with calcium or bisphosphonates can lower these risks. Previous tamoxifen use before AIs also decreases occurrence of musculoskeletal symptoms. Our recommendation is...,4.500334819780225e-07,0.4176255849600925,0.008758301530984922,0.03445510283085558,0.41443377809092397,0.0,0.034405229278104466,0.4238142467763608,0.0,4.500334819780227e-07,0.4336359850748619,0.0
189,1.1,3,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Osteoporosis raises the risk of musculoskeletal symptoms and fractures in patients treated with aromatase inhibitors. Supplementing treatment with calcium or bisphosphonates reduces these complications. Patients using tamoxifen prior to AIs show lower rates of musculoskeletal symptoms. We suggest...,4.737194547137078e-07,0.44527981665186944,0.009467907533383713,0.03626852929563745,0.4418327522790393,0.0,0.03621603081905733,0.45198512374305766,0.0,4.737194547137081e-07,0.4626235219481134,0.0
189,1.1,4,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,"Musculoskeletal symptoms and bone fractures are more common in patients on AIs who develop osteoporosis. Concurrent medication with calcium or bisphosphonates diminishes this risk. Additionally, those who had tamoxifen before AIs are less likely to experience these symptoms. We recommend...",4.263475092423372e-07,0.3551686680010482,0.01753826530612245,0.03264167636607371,0.3877655310087631,0.0,0.0325944277371516,0.3964152725882455,0.0,4.263475092423373e-07,0.40546510810816505,0.0
189,1.1,5,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,AI patients developing osteoporosis are more vulnerable to musculoskeletal symptoms and bone fractures. Co-administration of calcium or bisphosphonates can alleviate this. Prior tamoxifen therapy reduces the incidence of musculoskeletal problems during AI treatment. Our advice is...,5.210914001850784e-07,0.4633822526412792,0.01753826530612245,0.039895382225201205,0.49899116611898764,0.0,0.03983763390096308,0.5108256237659909,0.0,5.210914001850789e-07,0.5232481437645489,0.0
189,1.1,6,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Those receiving AIs and developing osteoporosis face heightened risks of musculoskeletal symptoms and fractures. The use of calcium or bisphosphonates alongside AIs lowers these chances. Tamoxifen pre-treatment is associated with fewer AI-related musculoskeletal symptoms. We propose...,5.210914001850784e-07,0.4633822526412792,0.01753826530612245,0.039895382225201205,0.49899116611898764,0.0,0.03983763390096308,0.5108256237659909,0.0,5.210914001850789e-07,0.5232481437645489,0.0
189,1.1,7,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,"In patients on aromatase inhibitors, osteoporosis increases the risk of musculoskeletal symptoms and bone fractures. Combining calcium or bisphosphonates therapy reduces these risks. Prior tamoxifen therapy before AIs lessens musculoskeletal symptom development. We recommend...",5.68463345656449e-07,0.5222227526642125,0.01753826530612245,0.043522235154764964,0.5596157879354231,0.0,0.043459236982868826,0.5733459807473245,0.0,5.684633456564497e-07,0.5877866649021204,0.0
189,1.1,8,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Osteoporosis in AI-treated patients leads to more musculoskeletal symptoms and bone fractures. Co-prescribing calcium or bisphosphonates reduces this risk. Those who had tamoxifen before AIs show fewer AI-related musculoskeletal issues. Our recommendation is...,5.921493183921343e-07,0.5529944113309662,0.01753826530612245,0.045335661619546844,0.5913644862500029,0.0,0.0452700385238217,0.6061358035703162,0.0,5.921493183921352e-07,0.6216882165778022,0.0
189,1.1,9,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,Patients treated with aromatase inhibitors who develop osteoporosis are at greater risk for musculoskeletal symptoms and fractures. Using calcium or bisphosphonates as co-medication reduces this risk. Previous tamoxifen use is linked to reduced AI-related musculoskeletal symptoms. We advise...,4.737194547137078e-07,0.407812401486467,0.01753826530612245,0.03626852929563745,0.4418327522790393,0.0,0.03621603081905733,0.45198512374305766,0.0,4.737194547137081e-07,0.4626235219481134,0.0
189,1.1,10,human,Question: Aromatase inhibitor-related musculoskeletal symptoms: is preventing osteoporosis the key to eliminating these symptoms? Answer: Patients on AIs who develop osteoporosis are at increased risk of musculoskeletal symptoms and bone fracture. Comedication with Ca/Bis reduces the likelihood for osteoporosis and musculoskeletal symptoms. Patients who received tamoxifen before AIs were less likely to develop AI-related musculoskeletal symptoms. We recommend,The risk of musculoskeletal symptoms and fractures increases in AI patients who have osteoporosis. Supplementing with calcium or bisphosphonates lowers osteoporosis and associated symptoms. Prior tamoxifen treatment decreases musculoskeletal symptoms related to AIs. Our recommendation is...,5.210914001850784e-07,0.5029906629589904,0.011008447496645708,0.039895382225201205,0.49899116611898764,0.0,0.03983763390096308,0.5108256237659909,0.0,5.210914001850789e-07,0.5232481437645489,0.0
190,1.1,1,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are the elevated depression rates in women due to differences in symptom reporting? Answer: Men and women in this community sample exhibited similar depressive symptom patterns. No proof that depressive symptom presentation varies by gender was observed.,7.10579182070559e-08,0.08077159760711661,0.0020226093944042504,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
190,1.1,2,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Do higher depression rates in women result from differing symptom reportings? Answer: Both men and women in this community sample reported comparable depressive symptom patterns. No indication of gender-based differences in symptom presentation was found.,1.184298636784265e-07,0.09887403359652636,0.024983563445101917,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,1.1,3,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the greater prevalence of depression among women explained by reporting differences in symptoms? Answer: Men and women from this community sample showed alike depressive symptom patterns. There was no evidence that the way depressive symptoms present differs between genders.,0.0,0.03465735902799638,0.024983563445101917,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
190,1.1,4,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Could increased depression rates in women be due to varied symptom reporting? Answer: In this community sample, men and women reported similar depressive symptom patterns. No evidence emerged that depressive symptom presentation differs across genders.",1.184298636784265e-07,0.13848244391423759,0.0035631493576662454,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
190,1.1,5,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are the higher depression statistics in women attributable to differences in symptom reporting? Answer: Men and women in the community sample reported analogous depressive symptom patterns. No indication of gender differences in symptom presentation was detected.,9.47438909427412e-08,0.1477195100253792,0.030379758354206057,0.0072537058591274906,0.14782199495794224,0.02854671280276816,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
190,1.1,6,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Does differential symptom reporting explain why depression rates are higher in women? Answer: Men and women in this community sample displayed similar depressive symptom patterns. No proof was found that depressive symptom presentations depend on gender.,9.47438909427412e-08,0.10921133332760435,0.0027715385957144123,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
190,1.1,7,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Is the increased depression rate in women due to differences in symptom reporting? Answer: Participants from both genders reported similar depressive symptom patterns in this community sample. No evidence supported gender differences in the way depressive symptoms are presented.,2.36859727356853e-08,0.02620645821577927,0.0006397052529590365,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
190,1.1,8,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are the higher instances of depression among women explained by differential symptom reporting? Answer: Men and women in this community showed comparable depressive symptom patterns. No signs indicated that symptom presentation differs by gender.,1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,1.1,9,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,"Question: Might differential symptom reporting account for the greater depression rate in women? Answer: Both men and women in this community sample reported similar depressive symptoms, with no evidence suggesting gender influences depressive symptom expression.",1.421158364141118e-07,0.12786157046977786,0.024983563445101917,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
190,1.1,10,human,Question: Are higher rates of depression in women accounted for by differential symptom reporting? Answer: Men and women in this community sample reported similar patterns of depressive symptoms. No evidence that the presentation of depressive symptoms differs by gender was found.,Question: Are elevated female depression rates due to differences in how symptoms are reported? Answer: This community sample demonstrated that men and women report depressive symptoms similarly. No evidence indicated differences in symptom presentation related to gender.,9.47438909427412e-08,0.10921133332760435,0.0027715385957144123,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
191,1.1,1,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can an advance care planning model be implemented in community palliative care? Answer: Yes, an advance care planning model is practical in community palliative care. It assists individuals in making choices about their future medical care and guarantees their preferences are honored, even if they cannot express them.",2.3685972735685406e-08,0.054235986990596174,0.021926020408163244,0.0018134264647818726,0.05420787608919353,0.022709189879958278,0.0018108015409528666,0.05412486291865637,0.022938100860178764,2.3685972735685406e-08,0.023173004519290608,0.0005042372691962185
191,1.1,2,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is it possible to apply an advance care planning model in community palliative care? Answer: Yes, implementing an advance care planning model in community palliative care is feasible. This model supports individuals in planning their future health decisions and ensures that their wishes are followed if they are unable to communicate.",9.474389094274162e-08,0.09787170732271777,0.0105940082644628,0.0072537058591274906,0.06771045529160835,0.010689475469638735,0.007243206163811466,0.0361188241374264,0.034396609883622836,9.474389094274162e-08,0.0029935369217577446,0.059929647028324456
191,1.1,3,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can an advance care planning approach be used in community palliative care? Answer: Yes, the advance care planning approach is achievable in community palliative care. It enables individuals to decide on their future treatment and ensures respect for their preferences when communication is impossible.",7.105791820705622e-08,0.017022044986306106,0.03260642669296515,0.005440279394345618,0.01347532234951121,0.03770411957168354,0.0054324046228586,0.009580256010384147,0.04253117070742633,7.105791820705622e-08,0.03911087718850137,0.02271498107084911
191,1.1,4,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is the use of an advance care planning model viable in community palliative care? Answer: Yes, an advance care planning model can be effectively used in community palliative care. It aids people in making informed decisions about their healthcare and safeguards their wishes even if they're unable to convey them.",7.105791820705622e-08,0.10198945331645026,0.026606404958677735,0.005440279394345618,0.10069618468644448,0.026091465250695875,0.0054324046228586,0.0991958801655688,0.02473862891092163,7.105791820705622e-08,0.06796903311257019,0.0014484404281270083
191,1.1,5,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Could an advance care planning model be integrated into community palliative care? Answer: Yes, integrating an advance care planning model within community palliative care is feasible. It empowers individuals to make future healthcare decisions and ensures their preferences are maintained if they cannot communicate.",7.105791820705622e-08,0.017022044986306106,0.03260642669296515,0.005440279394345618,0.01347532234951121,0.03770411957168354,0.0054324046228586,0.042587264608476616,0.018826530612244874,7.105791820705622e-08,0.07292293477679124,0.0016600189291508909
191,1.1,6,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is an advance care planning model suitable for community palliative care settings? Answer: Yes, an advance care planning model fits well within community palliative care. It helps patients plan their healthcare ahead of time and confirms their wishes are respected, even without direct communication.",7.105791820705622e-08,0.017022044986306106,0.03260642669296515,0.005440279394345618,0.01347532234951121,0.03770411957168354,0.0054324046228586,0.042587264608476616,0.018826530612244874,7.105791820705622e-08,0.07292293477679124,0.0016600189291508909
191,1.1,7,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can an advance care planning framework be applied in community palliative care? Answer: Yes, applying an advance care planning framework in community palliative care is feasible. It allows individuals to pre-determine their health choices and ensures these preferences are honored if unable to communicate them.",4.737194547137081e-08,0.02185498715630807,0.01419748520710054,0.0036268529295637453,0.01979435298569765,0.017079119571683538,0.003621603081905733,0.017521557496046558,0.019925578797848682,4.737194547137081e-08,0.04802033420753293,0.0010803788339694455
191,1.1,8,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is it feasible to establish an advance care planning model in community palliative care? Answer: Yes, establishing an advance care planning model in a community palliative care context is feasible. This approach helps people decide on future healthcare plans and makes sure their preferences are respected despite communication barriers.",4.737194547137081e-08,0.07839173940027022,0.02431010005408331,0.0036268529295637453,0.07771925401241653,0.024434491472509964,0.003621603081905733,0.04741786190036201,0.0027934727610052362,4.737194547137081e-08,0.015684784721507583,0.020673448681217014
191,1.1,9,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Is an advance care planning strategy workable in the context of community palliative care? Answer: Yes, an advance care planning strategy is workable in community palliative care. It supports individuals in making decisions about upcoming medical care and guarantees their wishes are upheld if they can't communicate.",0.0,0.02949562470467848,0.019449360499702542,0.0,0.06027366787477728,0.042179173654971786,0.0,0.030806541358219697,0.021978234235825206,0.0,0.0,0.0
191,1.1,10,ai,"Question: Is an advance care planning model feasible in community palliative care? Answer: Yes, an advance care planning model is feasible in community palliative care. It helps individuals make decisions about their future healthcare and ensures their preferences are respected, even if they are unable to communicate them","Question: Can the advance care planning model be effectively used in community palliative care? Answer: Yes, the advance care planning model can be effectively used in community palliative care. It helps patients plan ahead for their healthcare and ensures their treatment preferences are acknowledged even if they become unable to communicate.",7.105791820705622e-08,0.018811791649256726,0.02695159131469363,0.005440279394345618,0.01582101971992067,0.03180976931720533,0.0054324046228586,0.012552482595575398,0.03643171708921533,7.105791820705622e-08,0.008977783703213227,0.04081807678039054
192,1.1,1,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: is it advisable to keep performing second-look laparotomy? Answer: The choice to proceed with second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women requires careful assessment of its advantages and associated risks.,2.3685972735685406e-08,0.0387049953876728,0.04104583009674459,0.0018134264647818726,0.005784950117757592,0.02122448979591833,0.0018108015409528666,0.02878175029216612,0.001978458049886611,2.3685972735685406e-08,0.028640216301393462,0.001408415217939038
192,1.1,2,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","Question: Regarding advanced epithelial ovarian carcinoma in Thai women, should second-look laparotomy still be offered? Answer: Offering second-look laparotomy to Thai women with advanced epithelial ovarian carcinoma demands a thoughtful evaluation of its benefits versus potential harms.",1.1842986367842661e-07,0.047401431921267445,0.05411980968858132,0.009067132323909363,0.03946141811995929,0.06551601356796163,0.00905400770476434,0.07133645729738003,0.047004132231404955,1.1842986367842703e-07,0.06811573714833319,0.05246913580246914
192,1.1,3,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","Question: For Thai women with advanced epithelial ovarian carcinoma, should second-look laparotomy remain a treatment option? Answer: Deciding on second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women necessitates balancing the potential gains against the risks involved.",9.474389094274131e-08,0.01583941160366331,0.05697506680520209,0.0072537058591274906,0.029418102784384725,0.0946938775510204,0.007243206163811466,0.001575556861778793,0.0763888888888889,9.474389094274162e-08,0.03826277399865141,0.05246913580246914
192,1.1,4,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: is continuation of second-look laparotomy justified? Answer: The decision to continue offering second-look laparotomy in this group must consider both its possible benefits and the associated risks.,1.658018091497972e-07,0.00869949746753429,0.13411005303109738,0.012693985253473122,0.01908509750747056,0.12244897959183673,0.012675610786670087,0.09118771555146576,0.0763888888888889,1.6580180914979784e-07,0.1306360941296667,0.05246913580246914
192,1.1,5,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Should second-look laparotomy still be presented as an option for Thai women with advanced epithelial ovarian carcinoma? Answer: Offering second-look laparotomy should be done with careful consideration of the advantages as well as the risks for advanced epithelial ovarian carcinoma in Thai women.,4.737194547137081e-08,0.18759424086636134,0.09411980968858133,0.0036268529295637453,0.1890699507113256,0.09865361968701818,0.003621603081905733,0.15664844835311564,0.0763888888888889,4.737194547137081e-08,0.12425615549912283,0.05246913580246914
192,1.1,6,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: to persist or cease offering second-look laparotomy? Answer: It is important to evaluate the benefits and risks when deciding whether to offer second-look laparotomy in Thai women with advanced epithelial ovarian carcinoma.,4.7371945471370706e-08,0.08003595476491432,0.08710592079969243,0.0036268529295637453,0.08551207019664941,0.09615241275472936,0.003621603081905733,0.053994294293033374,0.0763888888888889,4.737194547137081e-08,0.01889563984129694,0.05246913580246914
192,1.1,7,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Is second-look laparotomy advisable for advanced epithelial ovarian carcinoma in Thai women anymore? Answer: The decision should hinge on a thorough comparison of the potential benefits against the dangers involved.,2.605457000925384e-07,0.07569028192412297,0.16349480968858132,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.22471910817598806,0.0763888888888889,2.6054570009253947e-07,0.26878643261048385,0.05246913580246914
192,1.1,8,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","Question: For Thai women diagnosed with advanced epithelial ovarian carcinoma, should second-look laparotomy continue? Answer: The decision to offer this procedure should be made after carefully weighing its potential benefits and associated risks.",2.131737546211678e-07,0.011151760786551446,0.16349480968858132,0.01632083818303688,0.08160545448880407,0.12244897959183673,0.016297213868575834,0.1557262366890373,0.0763888888888889,2.1317375462116866e-07,0.19732746862834016,0.05246913580246914
192,1.1,9,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and",Question: Advanced epithelial ovarian carcinoma in Thai women: should the practice of second-look laparotomy be maintained? Answer: Maintaining this practice should involve careful deliberation on the procedure’s risks and expected benefits.,2.605457000925384e-07,0.07569028192412297,0.16349480968858132,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.22471910817598806,0.0763888888888889,2.6054570009253947e-07,0.26878643261048385,0.05246913580246914
192,1.1,10,ai,"Question: Advanced epithelial ovarian carcinoma in Thai women: should we continue to offer second-look laparotomy? Answer: The decision to offer second-look laparotomy for advanced epithelial ovarian carcinoma in Thai women should be carefully considered, weighing the potential benefits against the risks and","Question: In cases of advanced epithelial ovarian carcinoma among Thai women, is the use of second-look laparotomy still appropriate? Answer: Choosing to proceed with second-look laparotomy needs a balanced consideration of its potential advantages and possible dangers.",1.1842986367842661e-07,0.06812309817205753,0.135739707647765,0.009067132323909363,0.03975540251546272,0.12244897959183673,0.00905400770476434,0.0305630937350303,0.0763888888888889,1.1842986367842703e-07,0.06811573714833319,0.05246913580246914
193,1.1,1,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea impact aerobic fitness? Indeed, obstructive sleep apnea can influence aerobic capacity. It involves repeated breathing interruptions during sleep, which lower oxygen availability to the body. This condition may cause fatigue, diminished endurance, and reduced aerobic efficiency. Addressing sleep apnea through treatment can enhance aerobic fitness.",1.4211583641411244e-07,0.051604948990287,0.04437500000000004,0.010880558788691236,0.09732694178750068,0.01641127558180693,0.0108648092457172,0.12260232209233335,0.0,1.4211583641411244e-07,0.12516314295400566,0.0
193,1.1,2,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Is aerobic fitness affected by obstructive sleep apnea? Yes, obstructive sleep apnea can impair aerobic fitness. This disorder causes frequent breathing pauses at night, decreasing oxygen delivery to the body. As a result, individuals may experience tiredness, lowered stamina, and poorer aerobic function. Managing sleep apnea can lead to better aerobic performance.",7.105791820705622e-08,0.025017346266535956,0.09244791666666666,0.005440279394345618,0.03368180058713266,0.017686146087086296,0.0054324046228586,0.05942342047080107,0.0,7.105791820705622e-08,0.06062462181643413,0.0
193,1.1,3,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Can obstructive sleep apnea negatively influence aerobic fitness? Yes, it can. Obstructive sleep apnea is marked by multiple sleep-time breathing interruptions, causing less oxygen to reach the body. This leads to tiredness, lessened endurance, and compromised aerobic ability. Treating the condition can improve aerobic fitness.",2.3685972735685406e-07,0.10408530546573314,0.10569019274376416,0.018134264647818726,0.189018206846292,0.014435185839041506,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
193,1.1,4,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does having obstructive sleep apnea reduce aerobic fitness? Yes, it does. The condition features recurrent episodes of stopped breathing during sleep, which lowers oxygen supply to bodily tissues. This often results in fatigue, decreased endurance, and impaired aerobic capacity. Appropriate treatment can help restore aerobic fitness.",2.1317375462116866e-07,0.018599069562770687,0.15104166666666666,0.016320838183036854,0.13378928487461828,0.03767781622452903,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
193,1.1,5,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Is there a connection between obstructive sleep apnea and aerobic fitness? Yes, obstructive sleep apnea affects aerobic fitness through repeated nighttime breathing interruptions that diminish oxygen flow to the body. This causes fatigue, reduces stamina, and weakens aerobic performance. Treatment can aid in recovering aerobic fitness.",2.1317375462116866e-07,0.08021215227921008,0.10669337029024697,0.016320838183036854,0.16529597490007086,0.01496283515367992,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
193,1.1,6,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Can aerobic fitness suffer due to obstructive sleep apnea? Yes, aerobic fitness can be adversely affected by obstructive sleep apnea, which is characterized by recurring breathing cessations during sleep, leading to less oxygen for the body. This results in fatigue, lowered endurance, and impaired aerobic ability, but treatment can improve fitness.",9.474389094274162e-08,0.03130967165025966,0.11111111111111109,0.0072537058591274906,0.026158620682253275,0.03767781622452903,0.007243206163811466,0.08004270767353683,0.0,9.474389094274162e-08,0.0816780310142673,0.0
193,1.1,7,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Does obstructive sleep apnea have an impact on aerobic fitness? It does. The condition causes repeated breathing breaks during sleep, reducing oxygen supply to the body, which in turn can cause tiredness, decreased stamina, and poorer aerobic performance. Treating sleep apnea can enhance aerobic fitness levels.",2.1317375462116866e-07,0.049405610920990384,0.12883092286501377,0.016320838183036854,0.13378928487461828,0.03767781622452903,0.0162972138685758,0.1900436028878656,0.0,2.1317375462116866e-07,0.19415601444095731,0.0
193,1.1,8,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Will obstructive sleep apnea affect a person's aerobic fitness? Yes, it can. This disorder involves repeated interruptions in breathing during sleep and causes a drop in oxygen levels, which may result in fatigue, reduced endurance, and lowered aerobic capacity. Effective treatment can support improvements in aerobic fitness.",1.8948778188548325e-07,0.0033798371560043172,0.15104166666666666,0.014507411718254981,0.11131642902256056,0.03767781622452903,0.014486412327622933,0.16705408466316607,0.0,1.8948778188548325e-07,0.1706255170307629,0.0
193,1.1,9,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Is aerobic fitness compromised by obstructive sleep apnea? Yes, obstructive sleep apnea disrupts breathing repeatedly during sleep, leading to decreased oxygenation of the body. This condition can cause symptoms like fatigue and reduced endurance, impairing aerobic fitness. With treatment, aerobic fitness can improve.",2.8423167282822487e-07,0.1536059582459064,0.10354166666666664,0.02176111757738247,0.20440685208857223,0.03767781622452903,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
193,1.1,10,ai,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Yes, obstructive sleep apnea can affect aerobic fitness. It is characterized by repeated interruptions in breathing during sleep, leading to decreased oxygen supply to the body. This can result in fatigue, reduced endurance, and impaired aerobic performance. Treatment of sleep apnea can help improve aerobic fitness.","Can obstructive sleep apnea lead to decreased aerobic fitness? Yes, it can. The sleep disorder causes frequent breathing interruptions at night that reduce oxygen supply, resulting in fatigue, diminished endurance, and lowered aerobic function. Treating the apnea can help restore aerobic fitness.",3.079176455639103e-07,0.11168949262878236,0.15104166666666666,0.023574544042164344,0.22909946467894393,0.03767781622452903,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
194,1.1,1,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is advanced age a contraindication for GERD laparoscopic surgery? Advanced age alone does not disqualify patients from GERD laparoscopic surgery, but the choice should be individualized based on the patient's general health and other factors.",1.8948778188548261e-07,0.1278207778014422,0.05827988038714388,0.014507411718254995,0.11562833247295812,0.07271468144044323,0.014486412327622954,0.1538288332582156,0.049861495844875335,1.8948778188548325e-07,0.19402843238501388,0.025623268698060954
194,1.1,2,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Does old age serve as a contraindication for GERD laparoscopic surgery? Being elderly is not automatically a contraindication to GERD laparoscopic surgery; the decision depends on the patient's overall health status.,2.842316728282238e-07,0.26385681770540836,0.050547099774899004,0.021761117577382513,0.2448400639529651,0.07271468144044323,0.021729618491434448,0.2873602258827379,0.049861495844875335,2.8423167282822487e-07,0.33217877086583103,0.025623268698060954
194,1.1,3,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is being advanced in age a reason to avoid GERD laparoscopic surgery? Advanced age is not necessarily a barrier to GERD laparoscopic surgery, but decisions need to consider the patient's overall health condition individually.",2.1317375462116791e-07,0.11813593386035981,0.08660019288714388,0.016320838183036875,0.1463999911397118,0.07271468144044323,0.016297213868575827,0.18557753157279544,0.049861495844875335,2.1317375462116866e-07,0.22681825520800558,0.025623268698060954
194,1.1,4,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is advanced age a limiting factor for GERD laparoscopic surgery? Advanced age by itself is not a contraindication for the procedure, though patient-specific health evaluations are crucial to the decision.",3.079176455639091e-07,0.25314199913815116,0.08243485487693979,0.023574544042164393,0.2799313837642341,0.07271468144044323,0.02354042003238732,0.3237278700536126,0.049861495844875335,3.079176455639103e-07,0.369919098848678,0.025623268698060954
194,1.1,5,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Does the elderly status contraindicate GERD laparoscopic surgery? Age in itself isn’t a contraindication to GERD laparoscopic surgery; decisions should be personalized according to the patient’s overall health.,3.552895910352797e-07,0.328141944885608,0.07989138186643382,0.027201396971728152,0.35403935591795577,0.07271468144044323,0.02716202311429307,0.40068891118974204,0.049861495844875335,3.552895910352811e-07,0.4499618065222153,0.025623268698060954
194,1.1,6,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is older age a contraindication to undergoing GERD laparoscopic surgery? Advanced age does not automatically exclude patients from GERD laparoscopic surgery, but the decision must be individualized based on health conditions.",2.842316728282238e-07,0.21764700566807882,0.08357993240854697,0.021761117577382513,0.2448400639529651,0.07271468144044323,0.021729618491434448,0.2873602258827379,0.049861495844875335,2.8423167282822487e-07,0.33217877086583103,0.025623268698060954
194,1.1,7,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Is GERD laparoscopic surgery contraindicated in elderly patients? Being of advanced age is not by itself a contraindication to this surgery; individual overall health must guide the treatment choice.,3.316036182995944e-07,0.24043006511770004,0.11687363038714388,0.025387970506946272,0.3162990279351088,0.07271468144044323,0.025351221573340195,0.3614681980364596,0.049861495844875335,3.316036182995957e-07,0.4091398120019605,0.025623268698060954
194,1.1,8,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Is there a contraindication to GERD laparoscopic surgery related to advanced age? Advanced age alone does not exclude the patient from surgery, but the decision should be customized to the patient’s health profile.",2.3685972735685321e-07,0.10689867249317775,0.11687363038714388,0.018134264647818754,0.17814868945429163,0.07271468144044323,0.0181080154095287,0.21836735439578714,0.049861495844875335,2.3685972735685406e-07,0.26071980688368734,0.025623268698060954
194,1.1,9,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any",Is advanced age a disqualifying factor for GERD laparoscopic surgery? Older age is not necessarily contraindicated for GERD laparoscopic surgery; surgical candidacy depends on the patient’s overall health assessment.,3.316036182995944e-07,0.3394510909119788,0.04586771322738055,0.025387970506946272,0.36764326353214205,0.03573243291973318,0.025351221573340195,0.3614681980364596,0.049861495844875335,3.316036182995957e-07,0.4091398120019605,0.025623268698060954
194,1.1,10,ai,"Question: Is the advanced age a contraindication to GERD laparoscopic surgery? Answer: Advanced age is not necessarily a contraindication to GERD laparoscopic surgery. However, the decision to undergo surgery should be made on an individual basis, considering the patient's overall health and any","Can elderly patients safely undergo GERD laparoscopic surgery? Advanced age is not inherently a contraindication to GERD laparoscopic surgery, but individual health considerations are important for the decision.",3.552895910352797e-07,0.328141944885608,0.07989138186643382,0.027201396971728152,0.35403935591795577,0.07271468144044323,0.02716202311429307,0.40068891118974204,0.049861495844875335,3.552895910352811e-07,0.4499618065222153,0.025623268698060954
195,1.1,1,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Korean individuals? Both hsCRP concentrations and carotid intima-media thickness showed a strong correlation with standard factors.,2.36859727356853e-08,0.04082199452025481,0.0,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,1.1,2,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"In healthy Koreans, is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis? The levels of hsCRP and carotid IMT were highly correlated with conventional markers.",4.73719454713706e-08,0.026723693784310498,0.03840000000000001,0.003626852929563759,0.08338160893905044,0.0,0.003621603081905747,0.08701137698962969,0.0,4.737194547137081e-08,0.090971778205728,0.0
195,1.1,3,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Does high-sensitivity C-reactive protein relate to carotid atherosclerosis in healthy Korean people? Both hsCRP values and carotid intima-media thickness had a strong relationship with traditional indicators.,2.36859727356853e-08,0.04082199452025481,0.0,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,1.1,4,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"Among healthy Koreans, is high-sensitivity C-reactive protein connected to carotid atherosclerosis? There was a strong correlation between hsCRP levels and carotid IMT with established risk factors.",2.36859727356853e-08,0.04082199452025481,0.0,0.0018134264647818796,0.04255961441879563,0.0,0.0018108015409528735,0.04445176257083405,0.0,2.3685972735685406e-08,0.04652001563489394,0.0
195,1.1,5,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean subjects? Both hsCRP and carotid intima-media thickness exhibited a strong correlation with conventional parameters.,7.10579182070559e-08,0.06643880005935099,0.03698224852071005,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
195,1.1,6,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"In healthy Korean adults, is high-sensitivity C-reactive protein associated with carotid atherosclerosis? Both hsCRP measures and the carotid IMT showed strong associations with known factors.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
195,1.1,7,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"For healthy Koreans, does high-sensitivity C-reactive protein correlate with carotid atherosclerosis? Levels of hsCRP and carotid intima-media thickness were strongly associated with traditional measures.",2.36859727356853e-08,0.04255961441879563,0.0,0.0018134264647818796,0.04445176257083405,0.0,0.0018108015409528735,0.04652001563489394,0.0,2.3685972735685353e-08,0.04879016416943127,0.0
195,1.1,8,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,Is high-sensitivity C-reactive protein correlated with carotid atherosclerosis in a healthy Korean cohort? Both hsCRP and carotid IMT were strongly linked to conventional risk factors.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
195,1.1,9,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"Among healthy individuals in Korea, does high-sensitivity C-reactive protein relate to carotid atherosclerosis? There was a notable correlation between hsCRP and carotid intima-media thickness with routine clinical metrics.",7.10579182070559e-08,0.11778303565638426,0.0,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
195,1.1,10,human,Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Both hsCRP levels and the carotid IMT were strongly correlated with conventional,"In the context of healthy Koreans, is high-sensitivity C-reactive protein associated with carotid atherosclerosis? Both hsCRP levels and carotid IMT strongly correlated with conventional determinants.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
196,1.1,1,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,Is fondaparinux useful for perioperative bridging? Fondaparinux proves effective in perioperative bridging among high thromboembolic risk patients due to its safety and user-friendliness.,3.316036182995942e-07,0.4539683084000199,0.02775510204081633,0.025387970506946314,0.5108256237659918,0.0,0.02535122157334023,0.5306282510621716,0.0,3.316036182995956e-07,0.55206858230004,0.0
196,1.1,2,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Does fondaparinux have a role in perioperative bridging? It has demonstrated efficacy in perioperative bridging in patients with elevated thromboembolism risk, combined with a favorable safety profile and simplicity of administration.",1.421158364141118e-07,0.19002319213351004,0.005538595937780586,0.010880558788691277,0.18805223150294026,0.0,0.010864809245717241,0.19415601444095776,0.0,1.4211583641411244e-07,0.20067069546215066,0.0
196,1.1,3,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Can fondaparinux be used in perioperative bridging? Studies show fondaparinux effectively bridges perioperative periods for high-risk patients, with advantages in safety and ease of use.",2.842316728282236e-07,0.3669569314103902,0.02775510204081633,0.021761117577382555,0.41985384556026384,0.0,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
196,1.1,4,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"What is fondaparinux’s role in perioperative bridging? Fondaparinux is effective for bridging high-risk thromboembolism patients during perioperative care, offering a safe and easy treatment option.",2.842316728282236e-07,0.3669569314103902,0.02775510204081633,0.021761117577382555,0.41985384556026384,0.0,0.021729618491434483,0.4353180712578464,0.0,2.8423167282822487e-07,0.45198512374305855,0.0
196,1.1,5,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Is fondaparinux part of perioperative bridging? Fondaparinux is proven to be an effective agent for this purpose in patients at high risk, noted for its safety and straightforward application.",1.894877818854824e-07,0.21280625158313127,0.02775510204081633,0.014507411718255037,0.25951119548508395,0.0,0.014486412327622988,0.2682639865946794,0.0,1.8948778188548325e-07,0.2776317365982801,0.0
196,1.1,6,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,How does fondaparinux fit into perioperative bridging? It's effective for patients prone to thromboembolic events perioperatively and is favored for its safety and ease of use.,2.605457000925383e-07,0.3261349368901354,0.02775510204081633,0.019947691112600675,0.3772942311414682,0.0,0.01991881695048161,0.39086630868701233,0.0,2.6054570009253947e-07,0.4054651081081646,0.0
196,1.1,7,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,Can fondaparinux be used for perioperative bridging? This anticoagulant shows effectiveness in high-risk patients while maintaining a good safety record and ease of handling.,3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
196,1.1,8,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Does fondaparinux serve a function in perioperative bridging? Indeed, it's effective for high thromboembolic risk patients, with a sound safety profile and simple administration.",3.079176455639089e-07,0.40951654582918584,0.02775510204081633,0.023574544042164434,0.4643056081310979,0.0,0.023540420032387356,0.4818380868927403,0.0,3.0791764556391023e-07,0.5007752879124898,0.0
196,1.1,9,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,What role does fondaparinux play in perioperative bridging? It is an effective medication for high-risk patients offering benefits in safety and usability.,3.552895910352795e-07,0.5004883240349138,0.02775510204081633,0.027201396971728194,0.5596157879354231,0.0,0.027162023114293103,0.5819215454497217,0.0,3.5528959103528093e-07,0.6061358035703153,0.0
196,1.1,10,ai,Question: Is there a role for fondaparinux in perioperative bridging? Answer: Fondaparinux has been shown to be effective in perioperative bridging for patients at high risk of thromboembolic events. Its safety profile and ease of use make,"Is fondaparinux indicated for perioperative bridging? Fondaparinux has proven effective in patients at high thromboembolism risk, combining safety and user convenience.",3.7897556377096486e-07,0.5492784882043451,0.02775510204081633,0.029014823436510073,0.6109090823229733,0.0,0.028972824655245977,0.635988766719997,0.0,3.789755637709663e-07,0.6632942174102641,0.0
197,1.1,1,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Are environmental factors significant in primary systemic vasculitis? Yes, environmental elements are implicated in its onset and progression, including exposure to various agents.",2.842316728282236e-07,0.3537713441331465,0.05859375,0.021761117577382555,0.45198512374305855,0.0,0.021729618491434483,0.47000362924573613,0.0,2.8423167282822477e-07,0.48954822531870645,0.0
197,1.1,2,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Do environmental factors matter in primary systemic vasculitis? Indeed, research indicates they contribute to both the development and course of the disease through exposures.",2.605457000925383e-07,0.30931958156231243,0.05859375,0.019947691112600675,0.4054651081081646,0.0,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
197,1.1,3,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Is there an impact of environmental factors on primary systemic vasculitis? Yes, such factors influence the condition’s emergence and advancement and may involve exposure to certain triggers.",1.894877818854824e-07,0.18671725946997952,0.05859375,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
197,1.1,4,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Can environmental factors affect primary systemic vasculitis? Yes, these factors have a recognized role in the disease’s initiation and progression, often related to exposure to specific environmental agents.",1.658018091497971e-07,0.14897693148713254,0.05859375,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
197,1.1,5,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Are environmental influences important in primary systemic vasculitis? Yes, they are involved in causing and exacerbating the disease, including through exposure to harmful elements.",2.605457000925383e-07,0.30931958156231243,0.05859375,0.019947691112600675,0.4054651081081646,0.0,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
197,1.1,6,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Do environmental factors play a role in primary systemic vasculitis? Yes, they contribute to the disease’s development and worsening, typically involving exposure to environmental substances.",2.36859727356853e-07,0.2667599671435168,0.05859375,0.018134264647818796,0.36101334553733055,0.0,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
197,1.1,7,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Is there a connection between environmental factors and primary systemic vasculitis? Yes, environmental exposures are linked to the pathogenesis and progression of the condition.",2.605457000925383e-07,0.30931958156231243,0.05859375,0.019947691112600675,0.4054651081081646,0.0,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
197,1.1,8,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","How important are environmental factors for primary systemic vasculitis? They are considered important as they have been found to be involved in the initiation and development, with exposure being a key aspect.",7.10579182070559e-08,0.010826593006315388,0.05859375,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
197,1.1,9,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Are environmental factors relevant to primary systemic vasculitis? Yes, they play a role in the disease's onset and development, particularly regarding certain exposures.",2.842316728282236e-07,0.3537713441331465,0.05859375,0.021761117577382555,0.45198512374305855,0.0,0.021729618491434483,0.47000362924573613,0.0,2.8423167282822477e-07,0.48954822531870645,0.0
197,1.1,10,ai,"Question: Are environmental factors important in primary systemic vasculitis? Answer: Yes, environmental factors have been found to play a role in the development and progression of primary systemic vasculitis. These factors can include exposure to","Do environmental factors influence primary systemic vasculitis? Yes, environmental conditions have been associated with the disease’s emergence and progression, including exposure to various agents.",2.605457000925383e-07,0.30931958156231243,0.05859375,0.019947691112600675,0.4054651081081646,0.0,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
198,1.1,1,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does menopausal transition influence quality of life? This longitudinal research revealed no notable impact of menopausal transition on quality of life in Taiwanese women. The reduction in role limitations caused by emotional issues was associated with vasomotor symptoms.,9.474389094274131e-08,0.10996486921430826,0.005225348522051837,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
198,1.1,2,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does experiencing menopausal transition alter quality of life? The longitudinal study showed that menopausal transition did not significantly affect quality of life among Taiwanese women. Decreased role limitations from emotional problems were linked to vasomotor symptoms.,1.421158364141119e-07,0.16981671067373671,0.008280763525518764,0.010880558788691243,0.16251892949777424,0.0,0.010864809245717214,0.1670540846631643,0.0,1.4211583641411244e-07,0.17185025692666,0.0
198,1.1,3,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,"Is quality of life affected by menopausal transition? In this longitudinal study, menopausal transition had no significant effect on the quality of life of Taiwanese women. The drop in role limitations due to emotional problems correlated with vasomotor symptoms.",7.1057918207056e-08,0.0813246529129148,0.003816933304112799,0.005440279394345618,0.11542895663511299,0.027006172839506164,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
198,1.1,4,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does going through menopausal transition impact quality of life? This longitudinal study concluded that menopausal transition did not significantly influence quality of life in Taiwanese women. The decline in role restrictions related to emotional issues was tied to vasomotor symptoms.,4.7371945471370706e-08,0.053478323917051984,0.0024800107960191095,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,1.1,5,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the menopausal transition have an effect on quality of life? Findings from this longitudinal study indicated no significant effect of menopausal transition on the quality of life among Taiwanese women. The decline in role limitations from emotional problems was associated with vasomotor symptoms.,4.737194547137081e-08,0.05077335667188576,0.002251250683960135,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
198,1.1,6,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is the quality of life influenced by menopausal transition? This longitudinal research found no important effect of menopausal transition on quality of life in Taiwanese women. Reduced role limitations due to emotional problems were connected to vasomotor symptoms.,9.474389094274131e-08,0.10996486921430826,0.005225348522051837,0.0072537058591274906,0.14386869235560074,0.02775510204081633,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
198,1.1,7,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does transitioning through menopause impact quality of life? The longitudinal study showed no significant effect of menopausal transition on the quality of life among Taiwanese women. The decrease in role limitations caused by emotional problems was linked to vasomotor symptoms.,4.7371945471370706e-08,0.017932314657567616,0.023028933800295387,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,1.1,8,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is the quality of life changed by menopausal transition? This longitudinal study reported no meaningful effect of menopausal transition on quality of life among Taiwanese women. The reduction in role limitations due to emotional issues was related to vasomotor symptoms.,4.7371945471370706e-08,0.053478323917051984,0.0024800107960191095,0.0036268529295637453,0.08777472494333605,0.026296566837107373,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
198,1.1,9,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Is there an impact of menopausal transition on quality of life? The longitudinal study discovered no significant effect of menopausal transition on quality of life in Taiwanese women. The decline in the role restrictions resulting from emotional problems was associated with vasomotor symptoms.,2.3685972735685406e-08,0.07331337623482392,0.06822142788878754,0.0018134264647818726,0.11055561776278777,0.09642074506939374,0.0018108015409528666,0.07865426909969919,0.07450693937180423,2.3685972735685406e-08,0.04511653211571032,0.05113221329437545
198,1.1,10,human,Question: Does menopausal transition affect the quality of life? Answer: This longitudinal study found no significant effect of menopausal transition on quality of life among Taiwanese women. The decline in the role limitations due to emotional problems was related to vasomotor symptoms.,Does the menopausal transition modify quality of life? Results of this longitudinal study showed no significant influence of menopausal transition on the quality of life of Taiwanese women. The diminished role limitations related to emotional problems were linked to vasomotor symptoms.,2.3685972735685406e-08,0.02638321546978606,0.0012092933465189942,0.0018134264647818726,0.02531780798429173,0.0,0.0018108015409528666,0.025975486403257975,0.0,2.3685972735685406e-08,0.026668247082160867,0.0
199,1.1,1,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity a separate risk factor for negative perinatal results? Indeed, grandmultiparity, which means having five or more children, is recognized as an independent risk factor for adverse perinatal outcomes such as preterm birth and low birth weight.",9.474389094274131e-08,0.025283361138851657,0.08816326530612248,0.0072537058591274906,0.029418102784384725,0.0946938775510204,0.007243206163811466,0.03397045239770513,0.1012244897959184,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
199,1.1,2,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Does grandmultiparity independently increase the risk for adverse perinatal outcomes? Yes, having given birth to at least five children classifies as grandmultiparity, known to be an independent risk factor for poor perinatal outcomes including preterm birth and low birth weight.",4.7371945471370706e-08,0.15286192495507622,0.14204081632653065,0.0036268529295637453,0.12199350075243576,0.12244897959183673,0.003621603081905733,0.0895403035525173,0.1012244897959184,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
199,1.1,3,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is giving birth to five or more children an independent risk factor for adverse perinatal outcomes? Yes, grandmultiparity is considered an independent risk factor linked to negative outcomes like preterm delivery and low birth weight.",1.658018091497972e-07,0.10665928724545459,0.05463186731508424,0.012693985253473122,0.10310293757534295,0.06209518146488565,0.012675610786670087,0.09896340507697943,0.07000700800611609,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,1.1,4,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Can grandmultiparity be considered an independent risk factor for poor perinatal outcomes? Affirmative, grandmultiparity, defined by having five or more births, has been identified as a standalone risk factor for adverse outcomes such as premature birth and low birth weight.",4.7371945471370706e-08,0.08176990643610793,0.0909086030321552,0.0036268529295637453,0.08551207019664941,0.09615241275472936,0.003621603081905733,0.0895403035525173,0.1012244897959184,4.737194547137081e-08,0.05537707039708417,0.0783673469387755
199,1.1,5,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity independently associated with increased adverse perinatal risks? Yes, having five or more children is linked independently to higher risks like preterm birth and low birth weight in perinatal outcomes.",2.605457000925384e-07,0.10950233951241328,0.14204081632653065,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.18917309891650413,0.1012244897959184,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
199,1.1,6,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Does grandmultiparity serve as an independent risk factor for unfavorable perinatal results? Indeed, grandmultiparity—birth of five or more children—is independently connected to bad perinatal outcomes including prematurity and low birth weight.",2.605457000925384e-07,0.10950233951241328,0.14204081632653065,0.01994769111260064,0.14829682898747754,0.12244897959183673,0.01991881695048158,0.18917309891650413,0.1012244897959184,2.6054570009253947e-07,0.23230500205469662,0.0783673469387755
199,1.1,7,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity classified as an independent risk factor for adverse outcomes during the perinatal period? Yes, this condition, characterized by 5 or more childbirths, increases the risk of adverse outcomes such as preterm birth and low birth weight.",9.474389094274131e-08,0.06275077630425496,0.11503464348702448,0.0072537058591274906,0.06792627948215957,0.12244897959183673,0.007243206163811466,0.03397045239770513,0.1012244897959184,9.474389094274162e-08,0.0017813434428641806,0.0783673469387755
199,1.1,8,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is having five or more children (grandmultiparity) an independent risk factor for negative perinatal outcomes? Yes, it has been established as an independent risk factor contributing to issues like preterm birth and low birth weight.",1.658018091497972e-07,0.10665928724545459,0.05463186731508424,0.012693985253473122,0.10310293757534295,0.06209518146488565,0.012675610786670087,0.09896340507697943,0.07000700800611609,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,1.1,9,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Is grandmultiparity an independent contributor to the risk of adverse perinatal events? Yes, defined as childbirths numbering five or more, grandmultiparity independently raises the likelihood of adverse outcomes including preterm birth and low birth weight.",1.658018091497972e-07,0.025112560120756022,0.11265605966904671,0.012693985253473122,0.01908509750747056,0.12244897959183673,0.012675610786670087,0.05564170629198184,0.1012244897959184,1.6580180914979784e-07,0.09415466357387947,0.0783673469387755
199,1.1,10,ai,"Question: Is grandmultiparity an independent risk factor for adverse perinatal outcomes? Answer: Yes, grandmultiparity (defined as giving birth to 5 or more children) has been identified as an independent risk factor for adverse perinatal outcomes, including preterm birth, low birth weight, and","Does grandmultiparity independently raise the risk of poor perinatal outcomes? Yes, as defined by delivering five or more children, grandmultiparity is an independent risk factor linked to adverse outcomes like preterm birth and low birth weight.",1.421158364141119e-07,0.044648340314845214,0.14204081632653065,0.010880558788691243,0.010767865642211216,0.12244897959183673,0.010864809245717214,0.024870047625228153,0.1012244897959184,1.4211583641411244e-07,0.062405965259299645,0.0783673469387755
200,1.1,1,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: How accurate is the current basal metabolic rate (BMR) estimation method for the Chinese population? Answer: Presently, the Singapore equation, which was recently developed, is considered the most precise for predicting BMR in Chinese individuals and is suitable for use.",1.421158364141118e-07,0.16251892949777424,0.0,0.01088055878869125,0.1670540846631643,0.0,0.01086480924571722,0.17185025692666,0.0,1.4211583641411244e-07,0.17693070815907896,0.0
200,1.1,2,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Are the existing equations for estimating basal metabolic rate valid for Chinese individuals? Answer: So far, the newly created Singapore equation provides the most accurate BMR predictions for the Chinese population and is applicable to them.",4.73719454713706e-08,0.05715841383994835,0.0,0.003626852929563759,0.058840500022933284,0.0,0.003621603081905747,0.060624621816435464,0.0,4.737194547137081e-08,0.06252035698133351,0.0
200,1.1,3,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for",Question: Can current prediction formulas estimate basal metabolic rate in Chinese people effectively? Answer: The newest Singapore equation is the most reliable and precise BMR prediction formula for Chinese subjects and is currently applicable.,2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
200,1.1,4,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Is the basal metabolic rate estimation equation used in Chinese populations accurate? Answer: Up until now, the Singapore equation, recently developed, has proven to be the most accurate for predicting BMR in the Chinese group and is applicable for their use.",1.658018091497972e-07,0.18721154208814594,0.0,0.012693985253473122,0.19237189264745602,0.0,0.012675610786670087,0.19782574332991798,0.0,1.6580180914979784e-07,0.20359895524123983,0.0
200,1.1,5,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: How well do current BMR prediction equations apply to Chinese individuals? Answer: The most accurate basal metabolic rate prediction for Chinese individuals to date is the newly developed Singapore equation, making it applicable.",2.36859727356853e-08,0.029852963149681777,0.0,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
200,1.1,6,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Are the existing basal metabolic rate estimation models suitable for Chinese individuals? Answer: The Singapore equation, newly devised, remains the most precise BMR predictor for the Chinese population and is suitable for use.",2.36859727356853e-08,0.07186188318361753,0.0302734375,0.0018134264647818796,0.030771658666753687,0.0,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
200,1.1,7,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Does the current method of estimating basal metabolic rate work for Chinese people? Answer: The most accurate equation for predicting BMR in Chinese individuals thus far is the newly developed Singapore equation, which is applicable.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
200,1.1,8,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: To what extent are the present BMR prediction equations usable for Chinese? Answer: The Singapore equation, developed recently, is currently the most accurate basal metabolic rate estimation for the Chinese population and is applicable.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
200,1.1,9,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: Do the existing BMR prediction formulas apply effectively to Chinese populations? Answer: As of now, the Singapore equation, a recent development, is the most accurate prediction tool for basal metabolic rate in Chinese individuals and can be applied.",9.47438909427412e-08,0.11122563511022454,0.0,0.007253705859127504,0.11441035117774545,0.0,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
200,1.1,10,human,"Question: Estimation of basal metabolic rate in Chinese: are the current prediction equations applicable? Answer: To date, the newly developed Singapore equation is the most accurate BMR prediction equation in Chinese and is applicable for","Question: How does the newly developed Singapore equation perform in estimating basal metabolic rate for Chinese individuals? Answer: To date, this equation is the most accurate for predicting BMR among the Chinese population and is applicable.",2.36859727356853e-08,0.028987536873251507,0.0,0.0018134264647818796,0.029852963149681777,0.0,0.0018108015409528735,0.030771658666753687,0.0,2.3685972735685406e-08,0.031748698314579826,0.0
201,1.1,1,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it essential to routinely place a nasobiliary drainage tube following endoscopic clearance of the common bile duct in patients with cholangitis caused by choledocholithiasis? The routine use of an ENBD tube did not enhance the clinical outcome, despite prolonged procedure times and greater patient discomfort, making the insertion unnecessary.",7.105791820705622e-08,0.05942342047080107,0.0,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
201,1.1,2,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Should a nasobiliary drainage tube be routinely inserted after endoscopic common bile duct clearance in patients with cholangitis due to choledocholithiasis? Routine ENBD tube placement showed no clinical benefit and only resulted in longer procedures and more discomfort, thus it is not required.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,1.1,3,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is the routine insertion of a nasobiliary drainage tube necessary after clearing the common bile duct endoscopically in cases of choledocholithiasis-induced cholangitis? Using an ENBD tube routinely did not improve clinical progress and caused additional procedure time and patient discomfort, so it is unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,1.1,4,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Does routinely placing a nasobiliary drainage tube after endoscopic clearance of the common bile duct improve outcomes in choledocholithiasis-related cholangitis? Routine insertion did not benefit the clinical course and caused longer procedures and discomfort, making it unnecessary.",3.789755637709661e-07,0.3677247801253176,0.0,0.029014823436509962,0.37647757123491177,0.0,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
201,1.1,5,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it required to routinely insert a nasobiliary drainage tube after endoscopic removal of choledocholithiasis in patients with cholangitis? Routine ENBD insertion did not improve patient outcomes and increased procedure duration and discomfort, so it is unnecessary.",3.789755637709661e-07,0.3677247801253176,0.0,0.029014823436509962,0.37647757123491177,0.0,0.028972824655245873,0.3856624808119835,0.0,3.789755637709665e-07,0.3953127366441467,0.0
201,1.1,6,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is routine nasobiliary drainage tube insertion after endoscopic common bile duct clearance essential in cholangitis caused by choledocholithiasis? Routine use of the ENBD tube failed to improve clinical results and only extended procedure time and patient discomfort, making it unnecessary.",3.079176455639102e-07,0.28768207245178345,0.0,0.023574544042164344,0.29423947299793873,0.0,0.023540420032387266,0.30110509278391984,0.0,3.079176455639103e-07,0.30830135965451655,0.0
201,1.1,7,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","After endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis, is it necessary to place a nasobiliary drainage tube routinely? Routinely inserted ENBD tubes did not enhance the clinical course but caused longer procedures and discomfort, so they are unnecessary.",2.3685972735685406e-07,0.21357410029806,0.0,0.018134264647818726,0.21825356602001733,0.0,0.018108015409528666,0.22314355131420927,0.0,2.3685972735685406e-07,0.22825865198098239,0.0
201,1.1,8,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Must a nasobiliary drainage tube be routinely inserted after endoscopic clearance of the common bile duct in patients with choledocholithiasis-related cholangitis? Routine ENBD tube insertion offers no clinical advantage and leads to increased procedure time and patient discomfort, thus it is unnecessary.",2.6054570009253947e-07,0.23767165187712003,0.0,0.0199476911126006,0.24294617861038903,0.0,0.019918816950481533,0.248461359298501,0.0,2.6054570009253947e-07,0.25423413838424036,0.0
201,1.1,9,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is the routine use of nasobiliary drainage tubes necessary after endoscopic clearance of the common bile duct in patients suffering from cholangitis due to choledocholithiasis? Routine ENBD tube insertion did not improve the clinical outcome despite increasing procedure time and discomfort, making it unnecessary.",2.1317375462116866e-07,0.1900436028878656,0.0,0.016320838183036854,0.19415601444095731,0.0,0.0162972138685758,0.19845093872383757,0.0,2.1317375462116866e-07,0.20294084399669066,0.0
201,1.1,10,human,"Question: Is it necessary to insert a nasobiliary drainage tube routinely after endoscopic clearance of the common bile duct in patients with choledocholithiasis-induced cholangitis? Answer: A routinely inserted ENBD tube did not improve the clinical course, despite patients having to endure increased procedure time and discomfort, and the insertion would therefore be unnecessary.","Is it justified to routinely insert a nasobiliary drainage tube following endoscopic clearance of the common bile duct in choledocholithiasis-associated cholangitis? The routine insertion of an ENBD tube did not benefit the clinical course but added to procedure time and patient discomfort, rendering it unnecessary.",1.8948778188548325e-07,0.16705408466316607,0.0,0.014507411718254981,0.1706255170307629,0.0,0.014486412327622933,0.17435338714477755,0.0,1.8948778188548325e-07,0.17824823140631896,0.0
202,1.1,1,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Pap smears showing glandular cell abnormalities are frequently identified as abnormal during rapid prescreening (RPS), yielding a sensitivity of 36.4% at the AGC threshold. Notably, RPS can detect some cases of AGC on Pap smears.",4.0266153650665127e-07,0.2592941287088686,0.14035916824196598,0.03082824990129185,0.3323377822944722,0.05975554549569943,0.030783626196198753,0.36950095199988464,0.040742417383431435,4.026615365066519e-07,0.40833267389941375,0.020823902218198284
202,1.1,2,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Rapid prescreening (RPS) commonly flags Pap smears with glandular cell abnormalities as abnormal, achieving a sensitivity of 36.4% at the AGC threshold. Crucially, RPS successfully detects some AGC instances in Pap smears.",4.7371945471370717e-07,0.3516674488398839,0.14035916824196598,0.03626852929563749,0.4276479620987974,0.05975554549569943,0.036216030819057374,0.46794102481313793,0.040742417383431435,4.737194547137081e-07,0.5101153682093562,0.020823902218198284
202,1.1,3,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","In Pap smears, glandular cell abnormalities are often detected by rapid prescreening, which results in a sensitivity rate of 36.4% at the AGC threshold. Most importantly, RPS identifies some AGC cases on these smears.",4.2634750924233657e-07,0.28914709185855036,0.14035916824196598,0.03264167636607373,0.3631094409612259,0.05975554549569943,0.03259442773715163,0.40124965031446447,0.040742417383431435,4.263475092423373e-07,0.44112249672240544,0.020823902218198284
202,1.1,4,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Pap smears containing glandular cell abnormalities are frequently picked up as abnormal through rapid prescreening, showing a sensitivity of 36.4% with respect to the AGC threshold. Significantly, several AGC cases are found during this screening.",4.0266153650665127e-07,0.2592941287088686,0.14035916824196598,0.03082824990129185,0.3323377822944722,0.05975554549569943,0.030783626196198753,0.36950095199988464,0.040742417383431435,4.026615365066519e-07,0.40833267389941375,0.020823902218198284
202,1.1,5,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Rapid prescreening detects abnormalities in Pap smears with glandular cell changes in many cases, giving a sensitivity of 36.4% at the AGC threshold. Importantly, it identifies certain AGC cases on Pap smears.",4.7371945471370717e-07,0.3516674488398839,0.14035916824196598,0.03626852929563749,0.4276479620987974,0.05975554549569943,0.036216030819057374,0.46794102481313793,0.040742417383431435,4.737194547137081e-07,0.5101153682093562,0.020823902218198284
202,1.1,6,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Pap smears with glandular abnormalities are often detected as abnormal by rapid prescreening, which has a sensitivity of 36.4% at the AGC threshold. Importantly, some AGC cases are identified during Pap smear screening.",4.5003348197802187e-07,0.31991875052530405,0.14035916824196598,0.03445510283085561,0.3948581392758057,0.05975554549569943,0.0344052292781045,0.43403947313745617,0.040742417383431435,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
202,1.1,7,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Glandular cell abnormalities in Pap smears are frequently flagged as abnormal by rapid prescreening, resulting in a sensitivity of 36.4% at the AGC threshold. Notably, RPS detects some AGC cases on Pap smears.",4.5003348197802187e-07,0.31991875052530405,0.14035916824196598,0.03445510283085561,0.3948581392758057,0.05975554549569943,0.0344052292781045,0.43403947313745617,0.040742417383431435,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
202,1.1,8,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Rapid prescreening often identifies Pap smears with glandular cell abnormalities as abnormal, reaching a sensitivity of 36.4% at the AGC threshold. Crucially, some cases of AGC are discovered in Pap smears by RPS.",4.5003348197802187e-07,0.36324044931030164,0.10914168645216368,0.03445510283085561,0.3948581392758057,0.05975554549569943,0.0344052292781045,0.43403947313745617,0.040742417383431435,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
202,1.1,9,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Pap smear samples with glandular cell abnormalities are often marked as abnormal by rapid prescreening, which achieves 36.4% sensitivity at the AGC threshold. Most importantly, RPS detects some AGC cases in these samples.",4.5003348197802187e-07,0.31991875052530405,0.14035916824196598,0.03445510283085561,0.3948581392758057,0.05975554549569943,0.0344052292781045,0.43403947313745617,0.040742417383431435,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
202,1.1,10,human,"Question: Pap smears with glandular cell abnormalities: Are they detected by rapid prescreening? Answer: Pap smears with glandular cell abnormalities are often flagged as abnormal by RPS, and this results in a sensitivity of 36.4% (at the AGC threshold). Most importantly, some cases of AGC are detected on Pap smears by RPS","Rapid prescreening frequently detects glandular cell abnormalities in Pap smears as abnormal, yielding a sensitivity rate of 36.4% at the AGC threshold. Importantly, several AGC cases are identified in Pap smears using RPS.",4.5003348197802187e-07,0.40656214809529834,0.07813694601974375,0.03445510283085561,0.4395773122151567,0.027533323273477232,0.0344052292781045,0.43403947313745617,0.040742417383431435,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
204,1.1,1,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does using cup-cage reconstruction with oversized cups offer initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures? Current evidence indicates it can, but more studies are required to confirm its long-term effectiveness.",4.2634750924233657e-07,0.19067788988374712,0.16836734693877556,0.03264167636607373,0.2799317792940319,0.1177685950413223,0.03259442773715163,0.3729579286589564,0.060964083175803374,4.263475092423373e-07,0.44112249672240544,0.020823902218198284
204,1.1,2,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is initial stability achieved in THA for osteoporotic acetabular fractures through cup-cage reconstruction employing oversized cups? Present data suggest it can provide such stability, though additional research is needed for comprehensive understanding.",4.7371945471370717e-07,0.25319824686508063,0.16836734693877556,0.03626852929563749,0.3444703004316034,0.1177685950413223,0.036216030819057374,0.43964930315762984,0.060964083175803374,4.737194547137081e-07,0.5101153682093562,0.020823902218198284
204,1.1,3,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Can cup-cage reconstruction with oversized cups ensure early stability in total hip arthroplasty for patients with osteoporotic acetabular fractures? Evidence so far supports this, yet more investigation is necessary for evaluating long-term results.",4.5003348197802187e-07,0.2214495485505008,0.16836734693877556,0.03445510283085561,0.31168047760861173,0.1177685950413223,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
204,1.1,4,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does the use of oversized cups in cup-cage reconstruction yield initial stability during THA in cases of osteoporotic acetabular fractures? Research to date suggests yes, but further studies are essential to assess sustained outcomes.",4.2634750924233657e-07,0.19067788988374712,0.16836734693877556,0.03264167636607373,0.2799317792940319,0.1177685950413223,0.03259442773715163,0.3729579286589564,0.060964083175803374,4.263475092423373e-07,0.44112249672240544,0.020823902218198284
204,1.1,5,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is initial mechanical stability provided by cup-cage reconstruction with oversized cups in THA for osteoporotic acetabular fractures? Current findings imply it does, though continued research is needed to verify its long-term success.",4.7371945471370717e-07,0.25319824686508063,0.16836734693877556,0.03626852929563749,0.3444703004316034,0.1177685950413223,0.036216030819057374,0.43964930315762984,0.060964083175803374,4.737194547137081e-07,0.5101153682093562,0.020823902218198284
204,1.1,6,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does cup-cage reconstruction utilizing oversized cups provide primary stability in total hip arthroplasty for osteoporotic acetabular fractures? Existing evidence supports this, while further investigation remains necessary to ascertain long-term efficacy.",5.210914001850778e-07,0.3198896213637541,0.16836734693877556,0.03989538222520125,0.4134631719185542,0.1177685950413223,0.03983763390096312,0.5111082671397735,0.060964083175803374,5.210914001850789e-07,0.5842233403630779,0.020823902218198284
204,1.1,7,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","In cases of osteoporotic acetabular fractures, does THA using cup-cage reconstruction with oversized cups achieve initial stability? Current research points towards yes, but more studies are required to fully understand the long-term impact.",4.5003348197802187e-07,0.2214495485505008,0.16836734693877556,0.03445510283085561,0.31168047760861173,0.1177685950413223,0.0344052292781045,0.4057477514819481,0.060964083175803374,4.500334819780227e-07,0.4750240483980872,0.020823902218198284
204,1.1,8,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Does initial stability in total hip arthroplasty for osteoporotic acetabular fractures result from cup-cage reconstruction with oversized cups? Available evidence indicates it might, although further research is needed to confirm permanent effectiveness.",4.7371945471370717e-07,0.25319824686508063,0.16836734693877556,0.03626852929563749,0.3444703004316034,0.1177685950413223,0.036216030819057374,0.43964930315762984,0.060964083175803374,4.737194547137081e-07,0.5101153682093562,0.020823902218198284
204,1.1,9,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Can THA for osteoporotic acetabular fractures attain early stability via cup-cage reconstruction with oversized cups? Present evidence suggests it can, yet more research is essential to evaluate its long-range outcomes.",5.210914001850778e-07,0.3198896213637541,0.16836734693877556,0.03989538222520125,0.4134631719185542,0.1177685950413223,0.03983763390096312,0.5111082671397735,0.060964083175803374,5.210914001850789e-07,0.5842233403630779,0.020823902218198284
204,1.1,10,ai,"Question: Does cup-cage reconstruction with oversized cups provide initial stability in THA for osteoporotic acetabular fractures? Answer: Current evidence suggests that cup-cage reconstruction with oversized cups can provide initial stability in total hip arthroplasty (THA) for osteoporotic acetabular fractures. However, further research is needed to fully understand its effectiveness and long-term outcomes.","Is the initial stability in total hip arthroplasty for osteoporotic acetabular fractures guaranteed by cup-cage reconstruction with oversized cups? Current data suggest it provides stability, but further scientific study is necessary for long-term evaluation.",4.2634750924233657e-07,0.19067788988374712,0.16836734693877556,0.03264167636607373,0.2799317792940319,0.1177685950413223,0.03259442773715163,0.3729579286589564,0.060964083175803374,4.263475092423373e-07,0.44112249672240544,0.020823902218198284
205,1.1,1,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Question: Is imaging necessary to diagnose appendicitis in children? Answer: Yes, diagnosing appendicitis in children generally requires imaging. Common methods are ultrasound and computed tomography (CT) scans. These help visualize the inflamed appendix for a precise diagnosis.",1.8948778188548283e-07,0.14465880208356952,0.040061673687916605,0.014507411718254981,0.14137324671020046,0.046400951814396206,0.01448641232762294,0.17830208506911438,0.023795359904818555,1.8948778188548325e-07,0.21706450523782772,0.0
205,1.1,2,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.",Question: Do children need imaging to diagnose appendicitis? Answer: Imaging is usually essential to diagnose appendicitis in children. Ultrasound and CT scans are common techniques that enable clear visualization of the inflamed appendix for accurate diagnosis.,2.1317375462116813e-07,0.17392991267020275,0.03927006292596477,0.01632083818303686,0.17036078358345197,0.046400951814396206,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
205,1.1,3,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Question: Is imaging used to diagnose appendicitis in kids? Answer: Yes, medical imaging such as ultrasound and CT scans is commonly needed to confirm appendicitis in children by showing the inflamed appendix.",3.0791764556390933e-07,0.30040153229610933,0.03559455350651073,0.02357454404216438,0.29552392653745896,0.046400951814396206,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
205,1.1,4,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Question: Should imaging be performed to diagnose appendicitis in pediatric patients? Answer: Yes, imaging studies like ultrasound and CT scans are typically required to identify an inflamed appendix and establish a diagnosis in children.",2.605457000925387e-07,0.1931620023754248,0.06781677572873293,0.01994769111260062,0.23098540539988743,0.046400951814396206,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
205,1.1,5,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Question: Is it required to use imaging for appendicitis diagnosis in children? Answer: Imaging, often through ultrasound and CT scans, is required to detect appendicitis by clearly visualizing the inflamed appendix in pediatric patients.",2.605457000925387e-07,0.23517092240936055,0.03754333822873293,0.01994769111260062,0.23098540539988743,0.046400951814396206,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
205,1.1,6,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Question: Do we rely on imaging to diagnose appendicitis in children? Answer: Yes, imaging techniques such as ultrasound and CT scans are commonly utilized to detect the inflamed appendix and provide a definitive diagnosis for children.",2.1317375462116813e-07,0.13432150235249152,0.06781677572873293,0.01632083818303686,0.17036078358345197,0.046400951814396206,0.016297213868575813,0.20815504821879616,0.023795359904818555,2.1317375462116866e-07,0.2478361639045814,0.0
205,1.1,7,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Question: Is imaging a necessary step in diagnosing appendicitis for children? Answer: Yes, diagnostic imaging including ultrasound and computed tomography scans are typically needed to view the inflamed appendix and accurately diagnose appendicitis in children.",2.3685972735685343e-07,0.16330903922574302,0.06781677572873293,0.01813426464781874,0.20021374673313375,0.046400951814396206,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
205,1.1,8,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Question: Are imaging studies needed for appendicitis diagnosis in children? Answer: Yes, imaging with ultrasound and CT helps clinicians to locate the inflamed appendix and make an accurate diagnosis in pediatric appendicitis cases.",2.84231672828224e-07,0.2672553598271761,0.036599293938930626,0.0217611175773825,0.26273410371446726,0.046400951814396206,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
205,1.1,9,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Question: Must we use imaging to identify appendicitis in children? Answer: Indeed, imaging methods, particularly ultrasound and CT scans, are standard practice for confirming appendicitis by visualizing the inflamed appendix in children.",3.0791764556390933e-07,0.2556823593567583,0.06781677572873293,0.02357454404216438,0.29552392653745896,0.046400951814396206,0.023540420032387308,0.33736677969880313,0.023795359904818555,3.079176455639103e-07,0.3813675565291037,0.0
205,1.1,10,ai,"Question: Do we need imaging to diagnose appendicitis in children? Answer: Yes, imaging is typically required to diagnose appendicitis in children. Common imaging techniques include ultrasound and computed tomography (CT) scans. These tests help to visualize the inflamed appendix and provide a more accurate diagnosis.","Question: Is the use of imaging techniques required to diagnose appendicitis in children? Answer: Yes, to diagnose appendicitis in children accurately, imaging tools such as ultrasound and CT scans are usually employed to detect the inflamed appendix.",1.8948778188548283e-07,0.2216751554791192,0.014827852370440611,0.014507411718254981,0.22059006734562248,0.010532014209478899,0.01448641232762294,0.2190754486314641,0.005589396752665381,1.8948778188548325e-07,0.21706450523782772,0.0
206,1.1,1,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Does cognitive ability predict how well listeners with normal hearing and cognition recognize frequency compressed speech? Research confirms that cognitive function influences recognition of frequency compressed speech among listeners with normal hearing and cognition.,2.1317375462116791e-07,0.08812956240754843,0.08224452632249571,0.016320838183036875,0.0734927419649627,0.10940170741676575,0.016297213868575827,0.06707172328351385,0.12329072532699169,2.1317375462116866e-07,0.059752011688430695,0.1376047395214031
206,1.1,2,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Is there a predictive relationship between cognitive function and frequency compressed speech recognition in individuals with normal hearing and cognition? Yes, evidence indicates cognitive function contributes to predicting speech recognition in such listeners.",2.3685972735685321e-07,0.03882171725961259,0.13618146970864917,0.018134264647818754,0.01999551686390255,0.1699262152777778,0.0181080154095287,0.010423200227803076,0.1875,2.3685972735685406e-07,0.04744375132678291,0.1708984375
206,1.1,3,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Can cognitive function indicate how frequently listeners with normal hearing and cognition recognize frequency compressed speech? Studies affirm that cognitive abilities do impact recognition of frequency compressed speech in these individuals.,2.842316728282238e-07,0.019604954079522674,0.1956345018132865,0.021761117577382513,0.041967718423225,0.2021484375,0.021729618491434448,0.07941607171475384,0.1875,2.8423167282822487e-07,0.1189027153089266,0.1708984375
206,1.1,4,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Does cognitive function serve as a predictor for recognition of frequency compressed speech in listeners with normal hearing and cognitive function? Research verifies cognitive function's role in predicting speech recognition performance in these listeners.,2.1317375462116791e-07,0.12191503776213208,0.22892819979188342,0.016320838183036875,0.05647235439002829,0.2021484375,0.016297213868575827,0.022366622595188623,0.1875,2.1317375462116866e-07,0.01354219965110115,0.1708984375
206,1.1,5,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Is frequency compressed speech recognition in listeners who have normal hearing and cognition predicted by cognitive function? Yes, scientific studies demonstrate cognitive function's influence on speech recognition accuracy in this group.",2.842316728282238e-07,0.019604954079522674,0.1956345018132865,0.021761117577382513,0.041967718423225,0.2021484375,0.021729618491434448,0.07941607171475384,0.1875,2.8423167282822487e-07,0.1189027153089266,0.1708984375
206,1.1,6,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Does cognitive function forecast frequency compressed speech recognition ability in listeners with normal hearing and normal cognitive status? Research results suggest cognitive abilities do predict speech recognition in such individuals.,3.079176455639091e-07,0.05509994754959502,0.1944894242816793,0.023574544042164393,0.077059038234494,0.2021484375,0.02354042003238732,0.11578371588562852,0.1875,3.079176455639103e-07,0.1566430432917736,0.1708984375
206,1.1,7,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Is there an association between cognitive function and the recognition of frequency compressed speech among listeners with typical hearing and cognition? Studies indicate cognitive function plays a predictive role in speech recognition for these listeners.,1.8948778188548261e-07,0.11099463734946413,0.19954344313439948,0.014507411718254995,0.08724401305678198,0.2021484375,0.014486412327622954,0.05411532090976845,0.1875,1.8948778188548325e-07,0.01924762317189055,0.1708984375
206,1.1,8,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Can cognitive performance predict how well listeners with normal hearing and cognition recognize frequency compressed speech? Evidence shows that cognitive function is a key factor in anticipation of speech recognition capabilities in this population.,2.1317375462116791e-07,0.12191503776213208,0.22892819979188342,0.016320838183036875,0.05647235439002829,0.2021484375,0.016297213868575827,0.022366622595188623,0.1875,2.1317375462116866e-07,0.01354219965110115,0.1708984375
206,1.1,9,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.","Does cognitive ability predict frequency compressed speech recognition effectiveness in normal hearing and cognitive listeners? Yes, scientific data supports that cognitive function is predictive of speech recognition in these listeners.",3.079176455639091e-07,0.05509994754959502,0.1944894242816793,0.023574544042164393,0.077059038234494,0.2021484375,0.02354042003238732,0.11578371588562852,0.1875,3.079176455639103e-07,0.1566430432917736,0.1708984375
206,1.1,10,ai,"Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: Yes, studies have shown that cognitive function does play a role in predicting frequency compressed speech recognition in listeners with normal hearing and normal cognition.",Is cognitive function a predictor of frequency compressed speech recognition in listeners maintaining normal hearing and cognition? Research consistently finds cognitive function to influence recognition performance in such listeners.,3.316036182995944e-07,0.09189852642628304,0.19326290486732925,0.025387970506946272,0.11342668240536868,0.2021484375,0.025351221573340195,0.1535240438684755,0.1875,3.316036182995957e-07,0.19586375644505605,0.1708984375
207,1.1,1,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are Biochemical Markers of Bone Turnover Reflective of Bone Histomorphometry in 370 Postmenopausal Women? Bone turnover markers showed a significant yet moderate correlation with bone turnover characteristics assessed in iliac cancellous bone. The iliac crest bone might not be fully representative.,4.73719454713706e-08,0.05745399337060908,0.006949210655774363,0.0036268529295637453,0.05264373348541884,0.0,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
207,1.1,2,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Do Biochemical Markers of Bone Turnover Correspond to Bone Histomorphometry Findings in 370 Postmenopausal Women? Bone turnover markers were notably but only modestly linked with bone turnover metrics measured in iliac cancellous bone. The iliac crest bone could be an incomplete proxy.,7.1057918207056e-08,0.11881362161458986,0.03557595030122497,0.005440279394345618,0.07796154146971057,0.0,0.0054324046228586,0.08004270767353416,0.0,7.105791820705622e-08,0.08223809823697303,0.0
207,1.1,3,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Can Biochemical Markers of Bone Turnover Accurately Represent Bone Histomorphometry in 370 Postmenopausal Women? There was a significant yet modest association between bone turnover markers and turnover parameters in iliac cancellous bone. The iliac crest bone may not fully reflect the overall bone state.,1.1842986367842682e-07,0.21458853188136562,0.11226757369614512,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
207,1.1,4,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are Biochemical Markers of Bone Turnover Indicative of Bone Histomorphometry in 370 Postmenopausal Women? Bone turnover markers demonstrated significant but modest correlations with bone turnover parameters in iliac cancellous bone. The iliac crest bone might not be entirely representative.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,1.1,5,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"Do Bone Turnover Biochemical Markers Mirror Bone Histomorphometry in 370 Postmenopausal Women? Bone turnover markers were significantly but modestly associated with turnover parameters measured in iliac cancellous bone, suggesting the iliac crest bone may not fully represent bone histomorphometry.",0.0,0.08673254910537764,0.10921363724452526,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
207,1.1,6,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Are Bone Turnover Markers Biochemically Representative of Bone Histomorphometry in 370 Postmenopausal Women? Bone turnover markers had a significant yet modest link with bone turnover metrics in iliac cancellous bone. The iliac crest sample may not be completely representative.,0.0,0.0,0.0,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0,0.0,0.0,0.0
207,1.1,7,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,Can Bone Turnover Biochemical Markers Serve as Reliable Indicators of Bone Histomorphometry in 370 Postmenopausal Women? There was a notable but only moderate association between biochemical markers and bone turnover parameters in iliac cancellous bone. The iliac crest may not fully represent bone characteristics.,1.1842986367842682e-07,0.18234912813439141,0.08910925226723643,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
207,1.1,8,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"Do Biochemical Markers of Bone Turnover Accurately Reflect Bone Histomorphometry in 370 Postmenopausal Women? Bone turnover markers were significantly but modestly correlated with iliac cancellous bone turnover parameters. Thus, the iliac crest bone may not be entirely representative.",2.36859727356853e-08,0.007469060524830873,0.02448979591836732,0.0018134264647818726,0.02739897418811532,0.0,0.0018108015409528666,0.028170876966696845,0.0,2.3685972735685406e-08,0.028987536873251507,0.0
207,1.1,9,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"Are Biochemical Markers for Bone Turnover Valid Proxies for Bone Histomorphometry in 370 Postmenopausal Women? Bone turnover markers were significantly linked, though only modestly, to bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not completely reflect the bone turnover state.",1.4211583641411222e-07,0.11228400372577818,0.10448979591836735,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
207,1.1,10,human,Question: Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women? Answer: Bone turnover markers were significantly but modestly associated with bone turnover parameters measured in iliac cancellous bone. The iliac crest bone may not,"Is There a Significant Relationship Between Biochemical Bone Turnover Markers and Bone Histomorphometry in 370 Postmenopausal Women? Bone turnover markers showed a significant but modest association with parameters from iliac cancellous bone samples. Therefore, the iliac crest may not adequately represent overall bone turnover.",1.1842986367842682e-07,0.15010972438741677,0.06613520408163265,0.009067132323909363,0.0937446970410507,0.023795359904818555,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
208,1.1,1,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Hypotension in coronary disease patients: can severe drops in blood pressure lead to myocardial ischemic events? In patients with ischemic heart disease and hypotension, both symptomatic and silent ischemia happened in a time-related manner with hypotension, especially diastolic pressure, indicating that coronary disease patients might be vulnerable to ischemic events.",4.737194547137081e-08,0.05069168075518826,0.10001717248880848,0.0036268529295637453,0.014629779924541175,0.039930555555555566,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
208,1.1,2,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Does profound hypotension cause myocardial ischemic events in patients with coronary disease? Observations show that in ischemic heart disease patients with low blood pressure, symptomatic and silent ischemia occurred temporally associated with hypotension, particularly with diastolic pressure, implying susceptibility to ischemic events.",2.3685972735685406e-07,0.13307688658391248,0.09604147804436403,0.018134264647818726,0.16769177686941372,0.039930555555555566,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
208,1.1,3,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In patients with coronary disease, can significant hypotensive episodes trigger myocardial ischemic events? Evidence suggests that ischemic heart disease patients with hypotension experience symptomatic and silent ischemia in temporal relation to hypotension, mainly diastolic hypotension, indicating an increased risk of ischemic events.",2.3685972735685406e-07,0.13307688658391248,0.09604147804436403,0.018134264647818726,0.16769177686941372,0.039930555555555566,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
208,1.1,4,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Can profound hypotensive episodes cause myocardial ischemic events in patients with coronary disease? Studies indicate that ischemic heart disease patients who develop hypotension face both symptomatic and silent ischemia temporally linked to hypotensive episodes, especially involving diastolic pressure, pointing to heightened risk.",2.3685972735685406e-07,0.09926482899562261,0.12041647804436403,0.018134264647818726,0.16769177686941372,0.039930555555555566,0.018108015409528666,0.22825865198098239,0.0,2.3685972735685406e-07,0.2336148511815046,0.0
208,1.1,5,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Are myocardial ischemic events caused by severe hypotension in coronary disease patients? Clinical data reveal that among ischemic heart disease patients, symptomatic and silent ischemia coincide temporally with hypotension, notably diastolic hypotension, suggesting a vulnerability to ischemic events.",3.3160361829959537e-07,0.20191898305570488,0.12041647804436403,0.025387970506946217,0.2730522925272396,0.039930555555555566,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
208,1.1,6,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Does profound hypotension induce myocardial ischemic events in patients with coronary artery disease? Observations in ischemic heart disease patients show symptomatic and silent ischemia aligns temporally with hypotension, particularly diastolic pressure, indicating these patients may be prone to ischemic incidents.",2.8423167282822477e-07,0.14927524957028604,0.12041647804436403,0.02176111757738247,0.21898507125696343,0.039930555555555566,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
208,1.1,7,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","In coronary disease patients, can significant hypotension result in myocardial ischemic events? Findings demonstrate that both symptomatic and silent ischemia follow hypotensive events in ischemic heart disease, especially with low diastolic pressures, suggesting increased ischemic risk.",3.7897556377096597e-07,0.25748883421051705,0.12041647804436403,0.02901482343650997,0.33021070636718797,0.039930555555555566,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
208,1.1,8,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Is there a causal link between profound hypotension and myocardial ischemic events in coronary disease patients? Evidence shows symptomatic and silent ischemia in ischemic heart disease occurs temporally alongside hypotension, mainly diastolic, hinting at susceptibility in these patients.",3.3160361829959537e-07,0.20191898305570488,0.12041647804436403,0.025387970506946217,0.2730522925272396,0.039930555555555566,0.025351221573340132,0.3364722366212134,0.0,3.316036182995957e-07,0.34484048629172914,0.0
208,1.1,9,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Can large drops in blood pressure lead to myocardial ischemic incidents in patients with coronary disease? Data suggest that ischemic heart disease patients experience symptomatic and silent ischemia in time association with hypotension, particularly diastolic, indicating a likelihood of ischemia.",2.8423167282822477e-07,0.14927524957028604,0.12041647804436403,0.02176111757738247,0.21898507125696343,0.039930555555555566,0.0217296184914344,0.2809023854664012,0.0,2.8423167282822487e-07,0.2876820724517808,0.0
208,1.1,10,human,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: In patients with ischaemic heart disease and hypotension, symptomatic and silent ischaemia occurred in a temporally causal relation with hypotension, particularly for diastolic pressures, suggesting that patients with coronary disease may be susceptible to ischaemic events","Are myocardial ischemic events temporally related to profound hypotension in coronary disease patients? Findings reveal symptomatic and silent ischemia in ischemic heart disease occur coincident with hypotension, notably during diastolic hypotension, suggesting vulnerability to ischemic events.",3.7897556377096597e-07,0.25748883421051705,0.12041647804436403,0.02901482343650997,0.33021070636718797,0.039930555555555566,0.02897282465524588,0.3953127366441467,0.0,3.789755637709665e-07,0.4054651081081646,0.0
209,1.1,1,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive functioning predict how well listeners with normal hearing and cognition recognize frequency compressed speech? The connection between cognitive function and recognition of frequency compressed speech amidst noise was not statistically meaningful. Results might differ with different participants.,9.474389094274141e-08,0.10355788051467618,0.002501206932288818,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
209,1.1,2,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is cognitive function a predictor of the ability to recognize frequency compressed speech in individuals with normal hearing and cognition? There was no significant statistical correlation between cognitive ability and recognizing frequency compressed speech in noisy conditions. The findings could vary with another participant pool.,4.737194547137081e-08,0.014993045843371355,0.044021415823914375,0.0036268529295637453,0.016850758504693975,0.046400951814396206,0.003621603081905733,0.015783155571340135,0.023795359904818555,4.737194547137081e-08,0.05001042057466343,0.0
209,1.1,3,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,"Can cognitive performance forecast recognition of frequency compressed speech in normal hearing, cognitively typical listeners? Cognitive function did not significantly correlate with recognition scores of frequency compressed speech in noise. Different participants might yield different outcomes.",1.6580180914979731e-07,0.30774818946670734,0.08858757453846966,0.012693985253473115,0.30953163277519424,0.08740894901144641,0.01267561078667008,0.2763897327153284,0.06035379812695108,1.6580180914979784e-07,0.24114744211491557,0.031217481789802305
209,1.1,4,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognition influence recognition frequency of compressed speech in listeners with normal hearing and typical cognitive status? There was no statistically significant relationship found between cognitive function and frequency compressed speech-in-noise recognition. Alternate participant groups might show different results.,9.474389094274141e-08,0.06707644995888984,0.023795359904818555,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
209,1.1,5,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is there a link between cognitive function and frequency compressed speech recognition in those with normal hearing and cognition? The study found no statistically relevant association between cognitive abilities and recognizing frequency compressed speech amid noise. Results might change with different participants.,2.3685972735685406e-08,0.09252671574583848,0.04891932153562467,0.0018134264647818726,0.05934997161836808,0.02498356344510192,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
209,1.1,6,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive function serve as an indicator for recognition ability of frequency compressed speech among listeners with normal cognition and hearing? No statistically significant relationship was identified between cognition and frequency compressed speech recognition in noise. Outcome variations might exist with alternate subjects.,0.0,0.06601401719618716,0.047210557254944746,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0
209,1.1,7,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,"Does the level of cognitive functioning predict recognition of frequency compressed speech in noise among normal hearing, neurotypical listeners? Cognitive function was not significantly related statistically to the ability to understand frequency compressed speech in noisy environments. Different participant characteristics could affect findings.",0.0,0.06601401719618716,0.047210557254944746,0.0,0.06762411517657974,0.04865220249835634,0.0,0.03465735902799638,0.02498356344510192,0.0,0.0,0.0
209,1.1,8,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is recognition of frequency compressed speech in normal hearing individuals predicted by cognitive function? There was no statistically significant evidence to support a connection between cognitive ability and speech recognition of frequency compressed speech in noise. Different findings may arise with another participant sample.,2.3685972735685406e-08,0.10465951272658458,0.0904705680730207,0.0018134264647818726,0.10793048281331119,0.0941828254847645,0.0018108015409528666,0.0767435601744979,0.07271468144044323,2.3685972735685406e-08,0.043996910071702366,0.049861495844875335
209,1.1,9,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Does cognitive ability determine frequency compressed speech-in-noise recognition in individuals with normal hearing and cognition? The connection between cognitive ability and recognition performance of frequency compressed speech in noise was statistically non-significant. Findings may vary with different subjects.,1.1842986367842671e-07,0.16867952737185643,0.030082191115589622,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
209,1.1,10,human,Question: Does cognitive function predict frequency compressed speech recognition in listeners with normal hearing and normal cognition? Answer: The relationship between cognitive functioning and recognition of frequency compressed speech-in-noise was not statistically significant. The findings may have been different if the participants had,Is there an association between cognitive functioning and recognition of frequency compressed speech under noisy conditions in listeners with normal hearing and cognition? No statistically significant correlation was discovered. Different participants might yield alternate results.,1.8948778188548261e-07,0.17830208506911438,0.023795359904818555,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
210,1.1,1,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is the heightened neutrophil migration following significant trauma a contributing cause to acute respiratory distress syndrome? Answer: The findings show that severe blunt trauma boosts the migratory ability of circulating neutrophils. This effect appears within 2 hours of admission and could,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,1.1,2,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could enhanced neutrophil migration after major trauma play a role in the development of acute respiratory distress syndrome? Answer: Data suggest that major blunt trauma increases the migratory capabilities of circulating neutrophils. This enhancement is evident within 2 hours of hospital admission and might,4.737194547137081e-08,0.04652001563489394,0.0,0.0036268529295637453,0.047628048989254435,0.0,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
210,1.1,3,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does increased neutrophil migratory activity post-major trauma contribute to the onset of acute respiratory distress syndrome? Answer: Evidence shows that severe blunt trauma augments the migration potential of circulating neutrophils. This phenomenon is noticeable within 2 hours following admission and may,2.3685972735685406e-08,0.024097551579060017,0.0,0.0018134264647818726,0.0246926125903717,0.0,0.0018108015409528666,0.02531780798429173,0.0,2.3685972735685406e-08,0.025975486403257975,0.0
210,1.1,4,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is neutrophil migration acceleration after significant trauma involved in acute respiratory distress syndrome’s etiology? Answer: Findings indicate that major blunt trauma elevates the migratory function of circulating neutrophils. This occurs within 2 hours after admission and possibly,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
210,1.1,5,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: How does increased neutrophil migratory activity after major trauma relate to acute respiratory distress syndrome? Answer: The data reveal that serious blunt trauma heightens the migratory capability of circulating neutrophils. This is observed within 2 hours upon admission and might,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
210,1.1,6,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Question: Could the raised neutrophil migratory activity following major trauma contribute to acute respiratory distress syndrome? Answer: These results demonstrate that significant blunt trauma enhances the movement ability of circulating neutrophils. This effect is apparent within 2 hours of admission and might,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
210,1.1,7,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Does augmented neutrophil migration after major trauma factor into acute respiratory distress syndrome's development? Answer: These data indicate that serious blunt trauma improves the migratory properties of circulating neutrophils. This is evident within 2 hours of admission and potentially,7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
210,1.1,8,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Could increased neutrophil migratory response post-major trauma be a factor in acute respiratory distress syndrome pathogenesis? Answer: The data suggest that blunt trauma significantly increases circulating neutrophil migration. This is seen within 2 hours of admission and may,9.474389094274141e-08,0.10008345855698142,0.0,0.0072537058591274906,0.10265415406008227,0.0,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
210,1.1,9,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,Question: Is the enhanced neutrophil migration following major trauma implicated in the cause of acute respiratory distress syndrome? Answer: Findings suggest blunt trauma boosts the migrating ability of circulating neutrophils. This happens within 2 hours of hospital admission and possibly,7.105791820705611e-08,0.07410797215372344,0.0,0.005440279394345618,0.0759859069779214,0.0,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
210,1.1,10,human,Question: Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome? Answer: These data indicate that major blunt trauma enhances the migratory capacity of circulating neutrophils. This is manifest within 2 hrs of admission and may,"Question: Question: Does major blunt trauma-induced neutrophil migration enhancement contribute to acute respiratory distress syndrome? Answer: The evidence shows that major blunt trauma increases the migratory capacity of circulating neutrophils, noticeable within 2 hours after admission and may",1.1842986367842671e-07,0.1642191208045447,0.027006172839506164,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
211,1.1,1,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.",MPH programs play a crucial role in health system strengthening in low- and middle-income countries by providing students with vital public health knowledge and skills to tackle healthcare issues.,9.237529366917296e-07,0.7897242667608424,0.05946082136558325,0.07072363212649309,0.8518089559881594,0.0302734375,0.07062126009716185,0.894963126318463,0.015380859375,9.237529366917308e-07,0.9400072584914714,0.0
211,1.1,2,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","Graduates of MPH programs in low- and middle-income countries actively enhance health systems by applying their expertise in policy-making, program execution, and research.",1.0658687731058414e-06,1.030886323577731,0.05946082136558325,0.08160419091518437,1.1031233842690673,0.0302734375,0.08148606934287911,1.1573273907859551,0.015380859375,1.065868773105843e-06,1.2144441041932312,0.0
211,1.1,3,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.",The impact of MPH programs in low- and middle-income countries is notable as they prepare students with essential tools for improving health systems and addressing healthcare challenges.,9.711248821631002e-07,0.8638322389145641,0.05946082136558325,0.07435048505605685,0.9287699971242889,0.0302734375,0.07424286317906761,0.9750058339920002,0.015380859375,9.711248821631017e-07,1.0233888674305218,0.0
211,1.1,4,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","In low- and middle-income countries, MPH programs significantly contribute to strengthening health systems through education that empowers students with public health competencies.",1.0895547458415266e-06,1.077406339212625,0.05946082136558325,0.08341761737996625,1.1519135484384986,0.0302734375,0.08329687088383197,1.2086206851735053,0.015380859375,1.0895547458415285e-06,1.2685113254635065,0.0
211,1.1,5,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","By equipping students with necessary public health skills, MPH programs help strengthen health systems and improve health outcomes in low- and middle-income countries.",1.0658687731058414e-06,1.030886323577731,0.05946082136558325,0.08160419091518437,1.1031233842690673,0.0302734375,0.08148606934287911,1.1573273907859551,0.015380859375,1.065868773105843e-06,1.2144441041932312,0.0
211,1.1,6,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","MPH programs influence health system development in low- and middle-income countries by fostering graduates' capacity to contribute to policy, programming, and research.",1.0895547458415266e-06,1.077406339212625,0.05946082136558325,0.08341761737996625,1.1519135484384986,0.0302734375,0.08329687088383197,1.2086206851735053,0.015380859375,1.0895547458415285e-06,1.2685113254635065,0.0
211,1.1,7,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.",The contribution of MPH programs to health system strengthening in low- and middle-income countries is evident in graduates’ abilities to address local healthcare challenges.,1.0421828003701562e-06,0.986434561006897,0.05946082136558325,0.07979076445040248,1.0566033686341734,0.0302734375,0.07967526780192623,1.1085372266165239,0.015380859375,1.0421828003701579e-06,1.163150809805681,0.0
211,1.1,8,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.",Health system strengthening in low- and middle-income countries is supported by MPH programs that train students in public health knowledge and practical skills.,1.0658687731058414e-06,1.030886323577731,0.05946082136558325,0.08160419091518437,1.1031233842690673,0.0302734375,0.08148606934287911,1.1573273907859551,0.015380859375,1.065868773105843e-06,1.2144441041932312,0.0
211,1.1,9,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.","In low- and middle-income countries, MPH graduates help enhance health systems by developing policies, implementing programs, and conducting research.",1.1606126640485828e-06,1.2315570190398817,0.05946082136558325,0.08885789677431188,1.3144324779362728,0.0302734375,0.08872927550669059,1.3804709421001644,0.015380859375,1.1606126640485847e-06,1.450832882257461,0.0
211,1.1,10,ai,"Question: Impact of MPH programs: contributing to health system strengthening in low- and middle-income countries? Answer: MPH programs in low- and middle-income countries have a significant impact on health system strengthening. These programs equip students with essential public health knowledge, skills, and tools to address healthcare challenges. Graduates can contribute to policy development, program implementation, and research, ultimately improving health outcomes and strengthening health systems in these countries.",The role of MPH programs in low- and middle-income countries involves preparing students to effectively contribute to stronger health systems and better health outcomes.,1.0421828003701562e-06,0.986434561006897,0.05946082136558325,0.07979076445040248,1.0566033686341734,0.0302734375,0.07967526780192623,1.1085372266165239,0.015380859375,1.0421828003701579e-06,1.163150809805681,0.0
212,1.1,1,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a connection between transient tachypnea of the newborn (TTN) and polymorphisms in beta-adrenergic receptor (ADRB) genes? Answer: We find that being homozygous for beta1Gly49 and having the TACC haplotype in the ADRB2 gene, both representing loss-of-function mutations, could increase risk for TTN.",1.6580180914979753e-07,0.17327172127403623,0.0,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
212,1.1,2,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) involve polymorphisms within beta-adrenergic receptor (ADRB) encoding genes? Answer: Our study indicates that beta1Gly49 homozygosity and the TACC haplotype in the ADRB2 gene, both loss-of-function variants, may contribute to a predisposition to TTN.",7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,1.1,3,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Could polymorphisms in beta-adrenergic receptor (ADRB) genes influence transient tachypnea of the newborn (TTN)? Answer: We conclude that the loss-of-function beta1Gly49 homozygous genotype and the ADRB2 gene TACC haplotype might predispose newborns to TTN.,7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
212,1.1,4,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Is there a role for ADRB gene polymorphisms in the development of transient tachypnea of the newborn (TTN)? Answer: The data suggest homozygosity for beta1Gly49 and the presence of the ADRB2 TACC haplotype, both loss-of-function genetic alterations, increase susceptibility to TTN.",9.474389094274131e-08,0.0688420964717924,0.024375,0.0072537058591274906,0.10536051565782589,0.0,0.007243206163811466,0.10821358464023101,0.0,9.474389094274162e-08,0.11122563511022454,0.0
212,1.1,5,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Are polymorphisms in beta-adrenergic receptor (ADRB) genes linked to transient tachypnea of the newborn (TTN)? Answer: Evidence points to beta1Gly49 homozygosity and the TACC haplotype of the ADRB2 gene, as loss-of-function variants, possibly predisposing individuals to TTN.",0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
212,1.1,6,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: What is the potential role of beta-adrenergic receptor gene polymorphisms in transient tachypnea of the newborn (TTN)? Answer: It appears that homozygosity for beta1Gly49 and carrying the loss-of-function TACC haplotype in the ADRB2 gene may increase the risk of TTN.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
212,1.1,7,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Do polymorphisms in the beta-adrenergic receptor genes contribute to transient tachypnea of the newborn (TTN)? Answer: Our findings indicate beta1Gly49 homozygosity alongside the ADRB2 TACC haplotype, both loss-of-function mutations, are associated with an increased TTN predisposition.",2.36859727356853e-08,0.02739897418811532,0.0,0.0018134264647818726,0.028170876966696845,0.0,0.0018108015409528735,0.028987536873251507,0.0,2.3685972735685406e-08,0.029852963149681777,0.0
212,1.1,8,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Can loss-of-function polymorphisms in the ADRB gene affect transient tachypnea of the newborn (TTN)? Answer: We conclude that beta1Gly49 homozygosity and the TACC haplotype in ADRB2 possibly predispose infants to TTN.,1.421158364141118e-07,0.17693070815907896,0.0,0.01088055878869127,0.18232155679395534,0.0,0.010864809245717241,0.18805223150294026,0.0,1.4211583641411244e-07,0.19415601444095776,0.0
212,1.1,9,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.",Question: Is transient tachypnea of the newborn (TTN) linked to polymorphisms in beta-adrenergic receptor genes? Answer: We indicate that both loss-of-function genetic alterations beta1Gly49 homozygosity and the ADRB2 TACC haplotype may predispose newborns to TTN.,7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
212,1.1,10,human,"Question: Transient tachypnea of the newborn (TTN): a role for polymorphisms in the beta-adrenergic receptor (ADRB) encoding genes? Answer: We conclude that beta1Gly49 homozygosity and TACC haplotype of ADRB2 gene, both loss-of-function genetic variations, may predispose to TTN.","Question: Does transient tachypnea of the newborn (TTN) involve loss-of-function polymorphisms in ADRB genes? Answer: The study concludes that beta1Gly49 homozygosity and the TACC haplotype of ADRB2, both loss-of-function, may increase the likelihood of TTN.",7.10579182070559e-08,0.08455738802806367,0.0,0.005440279394345632,0.08701137698963013,0.0,0.005432404622858621,0.08961215868968697,0.0,7.105791820705622e-08,0.09237332013101529,0.0
213,1.1,1,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Diagnostic features of childhood bipolar I disorder: Does the 'Treatment of Early Age Mania (TEAM)' sample apply broadly? The RCT sample's generalizability was confirmed, as just 7.8% of Phenomenology participants didn't meet RCT criteria. However, since RCT subjects exhibited more severe symptoms, it's uncertain if RCT treatment results can be extended to children with milder mania.",2.1317375462116866e-07,0.0649065005572087,0.1451222789572694,0.016320838183036854,0.15415067982725983,0.0,0.0162972138685758,0.1568424714929706,0.0,2.1317375462116866e-07,0.1596301455918825,0.0
213,1.1,2,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Questioning the diagnostic traits of child bipolar I disorder: Is the sample from the 'Treatment of Early Age Mania (TEAM)' study generalizable? Support for RCT sample generalization exists, with only 7.8% of Phenomenology cases excluded by RCT criteria. Still, due to greater severity in RCT subjects, applicability of treatment outcomes to less severe pediatric mania remains unclear.",1.8948778188548325e-07,0.04688799505453023,0.1451222789572694,0.014507411718254981,0.13580154115906407,0.0,0.014486412327622933,0.13815033848081626,0.0,1.8948778188548325e-07,0.1405819506211894,0.0
213,1.1,3,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Diagnostic markers of pediatric bipolar I disorder: does the TEAM study sample extend to a wider population? Generalization was backed as only 7.8% of Phenomenology subjects failed to meet RCT inclusion. Nevertheless, given increased illness severity in RCT participants, the relevance of treatment results for children with mild mania is uncertain.",3.316036182995957e-07,0.16021668036153436,0.1451222789572694,0.025387970506946217,0.25131442828090833,0.0,0.025351221573340132,0.2559333741372005,0.0,3.316036182995957e-07,0.2607262624632525,0.0
213,1.1,4,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Regarding childhood bipolar I disorder characteristics: does the 'Treatment of Early Age Mania (TEAM)' sample generalize to broader cases? Evidence supports generalization since merely 7.8% of Phenomenology subjects didn't fit RCT criteria. However, because RCT subjects were more severely affected, the extrapolation of RCT treatment findings to less severe mania in children is questionable.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,1.1,5,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Child bipolar I disorder diagnostic features: can findings from the 'Treatment of Early Age Mania (TEAM)' sample be generalized? The generalization is supported as only 7.8% of Phenomenology subjects were excluded by RCT standards. Still, due to increased severity in RCT participants, it's unclear if treatment data can apply to children with milder mania.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,1.1,6,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Does the 'Treatment of Early Age Mania' sample generalize to child bipolar I disorder diagnostics? Generalization was confirmed since just 7.8% of Phenomenology participants fell outside RCT parameters. However, RCT subjects were notably more severely ill, raising uncertainties about applicability of treatments to children with less severe manic states.",3.789755637709665e-07,0.20103867488178873,0.1451222789572694,0.029014823436509962,0.29298712468147725,0.0,0.028972824655245866,0.29849298855599704,0.0,3.789755637709665e-07,0.30421137440299084,0.0
213,1.1,7,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","In child bipolar I disorder: are diagnostic criteria from the 'Treatment of Early Age Mania (TEAM)' sample generalizable? The data supports generalization as only 7.8% of Phenomenology subjects did not meet RCT criteria. Yet, given RCT subjects’ higher illness severity, the relevance of treatments to children with less severe mania isn't clear.",3.079176455639103e-07,0.1404140530653546,0.1451222789572694,0.023574544042164344,0.23111172096338972,0.0,0.023540420032387266,0.23531408693446476,0.0,3.079176455639103e-07,0.23967285326541932,0.0
213,1.1,8,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Examining child bipolar I disorder diagnosis: does the TEAM sample generalize? Generalization is supported by the fact that only 7.8% of Phenomenology subjects failed RCT criteria. But because subjects in the RCT were more severely ill, whether treatment results apply to children with less severe mania is uncertain.",4.026615365066519e-07,0.2220920840796219,0.1451222789572694,0.030828249901291835,0.3144933299024406,0.0,0.030783626196198732,0.32047189527477205,0.0,4.026615365066519e-07,0.32668423025504856,0.0
213,1.1,9,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Diagnostic features of bipolar I disorder in children: does the Treatment of Early Age Mania (TEAM) study sample generalize? Generalization was supported as only 7.8% of Phenomenology subjects did not satisfy RCT inclusion criteria. However, due to greater severity in RCT subjects, treatment outcomes may not be fully applicable to kids with milder mania.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
213,1.1,10,human,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: Generalization of the RCT sample was supported, because only 7.8% of Phenomenology subjects did not fit the RCT criteria. Nevertheless, because the RCT subjects were more severely ill, it is unclear if treatment findings from the RCT will be applicable to children with less severe mania.","Child bipolar I disorder diagnostic traits: is the 'Treatment of Early Age Mania' (TEAM) sample representative? Support for generalization exists because only 7.8% of Phenomenology participants did not meet RCT criteria. Nonetheless, as the RCT group was more severely ill, whether the observed treatment effects generalize to children with lower severity mania is uncertain.",2.6054570009253947e-07,0.1019477722375588,0.1451222789572694,0.0199476911126006,0.19189100781010726,0.0,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
214,1.1,1,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy effective for gallbladder carcinoma? Its effectiveness depends on factors like cancer stage and the patient's general health, offering symptom relief.",4.974054274493917e-07,0.45965527783640026,0.13296398891966763,0.038081955760419416,0.5412000473473504,0.09204470742932283,0.038026832360010296,0.5941261547656675,0.0710059171597633,4.974054274493935e-07,0.6502156779737378,0.04865220249835634
214,1.1,2,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Does external palliative radiotherapy work well for gallbladder carcinoma? Effectiveness varies with cancer progression and patient health, providing symptom management.",5.92149318392133e-07,0.6507105145991097,0.13296398891966763,0.045335661619546934,0.741870742809501,0.09204470742932283,0.04527003852382179,0.8054352484328731,0.0710059171597633,5.921493183921349e-07,0.8733592292879471,0.04865220249835634
214,1.1,3,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"How effective is external palliative radiotherapy for gallbladder carcinoma? Its success relies on cancer stage and patient condition, helping alleviate symptoms.",5.684633456564476e-07,0.5994172202115595,0.13296398891966763,0.043522235154765054,0.6878035215392257,0.09204470742932283,0.043459236982868917,0.7482768345929243,0.0710059171597633,5.684633456564495e-07,0.812734607471512,0.04865220249835634
214,1.1,4,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Can external palliative radiotherapy be effective in treating gallbladder carcinoma? Effectiveness depends on the cancer’s stage and the patient’s overall health, potentially relieving symptoms.",4.974054274493917e-07,0.45965527783640026,0.13296398891966763,0.038081955760419416,0.5412000473473504,0.09204470742932283,0.038026832360010296,0.5941261547656675,0.0710059171597633,4.974054274493935e-07,0.6502156779737378,0.04865220249835634
214,1.1,5,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy beneficial for gallbladder carcinoma? The benefit varies based on cancer severity and patient health, offering symptom relief.",5.684633456564476e-07,0.5994172202115595,0.13296398891966763,0.043522235154765054,0.6878035215392257,0.09204470742932283,0.043459236982868917,0.7482768345929243,0.0710059171597633,5.684633456564495e-07,0.812734607471512,0.04865220249835634
214,1.1,6,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Does external palliative radiotherapy help with gallbladder carcinoma? Its impact varies with disease stage and patient health, aiming to ease symptoms.",5.684633456564476e-07,0.5994172202115595,0.13296398891966763,0.043522235154765054,0.6878035215392257,0.09204470742932283,0.043459236982868917,0.7482768345929243,0.0710059171597633,5.684633456564495e-07,0.812734607471512,0.04865220249835634
214,1.1,7,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"What is the efficacy of external palliative radiotherapy for gallbladder carcinoma? It depends on cancer stage and patient status, providing symptom alleviation.",5.447773729207623e-07,0.5506270560421282,0.13296398891966763,0.041708808689983175,0.6365102271516756,0.09204470742932283,0.04164843544191604,0.694209613322649,0.0710059171597633,5.447773729207641e-07,0.7555761936315633,0.04865220249835634
214,1.1,8,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy a useful treatment for gallbladder carcinoma? Its effectiveness fluctuates with cancer stage and patient health, helping reduce symptoms.",5.447773729207623e-07,0.5506270560421282,0.13296398891966763,0.041708808689983175,0.6365102271516756,0.09204470742932283,0.04164843544191604,0.694209613322649,0.0710059171597633,5.447773729207641e-07,0.7555761936315633,0.04865220249835634
214,1.1,9,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"How well does external palliative radiotherapy work for gallbladder carcinoma? Effectiveness is influenced by cancer phase and patient health, offering symptom relief.",5.447773729207623e-07,0.5506270560421282,0.13296398891966763,0.041708808689983175,0.6365102271516756,0.09204470742932283,0.04164843544191604,0.694209613322649,0.0710059171597633,5.447773729207641e-07,0.7555761936315633,0.04865220249835634
214,1.1,10,ai,Question: Is external palliative radiotherapy for gallbladder carcinoma effective? Answer: The effectiveness of external palliative radiotherapy for gallbladder carcinoma can vary depending on factors such as the stage of the cancer and the overall health of the patient. It can provide relief from symptoms and,"Is external palliative radiotherapy effective in managing gallbladder carcinoma? Its effectiveness varies with the stage of cancer and patient health, providing relief from symptoms.",4.974054274493917e-07,0.45965527783640026,0.13296398891966763,0.038081955760419416,0.5412000473473504,0.09204470742932283,0.038026832360010296,0.5941261547656675,0.0710059171597633,4.974054274493935e-07,0.6502156779737378,0.04865220249835634
215,1.1,1,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: Is assessing antral follicles a superior predictor of IVF success compared to age and FSH? Answer: The success of in vitro fertilization is closely linked to maternal age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Among these, antral follicle assessment predicts IVF outcomes better than age or FSH levels.",1.6580180914979784e-07,0.042309626114174215,0.14506172839506165,0.012693985253473108,0.030985269338878574,0.0652508464142813,0.012675610786670066,0.1009477426513139,0.016661878770468257,1.6580180914979784e-07,0.12629372532429084,0.0
215,1.1,2,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: Can antral follicle evaluation more accurately predict IVF results compared to age and FSH? Answer: In vitro fertilization results are strongly associated with a woman’s age, basal cycle day 3 follicle count, stimulated hormone levels, and antral follicle assessment. Antral follicle count serves as a better predictor than age or FSH.",2.6054570009253947e-07,0.07261682664820457,0.08327063083568853,0.0199476911126006,0.10794631047500847,0.0652508464142813,0.019918816950481533,0.17941935809280807,0.016661878770468257,2.6054570009253947e-07,0.20633643299782767,0.0
215,1.1,3,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: Is antral follicle counting a more reliable indicator of IVF outcomes than age and FSH levels? Answer: IVF success is strongly correlated with maternal age, basal cycle day 3 follicles, stimulated hormone, and antral follicle assessment. Among these parameters, antral follicle assessment is superior for predicting IVF outcomes compared to age or FSH.",2.1317375462116866e-07,0.05786839217079898,0.06683731138545951,0.016320838183036854,0.068725597321726,0.0652508464142813,0.0162972138685758,0.1394140234791097,0.016661878770468257,2.1317375462116866e-07,0.1655144384775733,0.0
215,1.1,4,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: Does antral follicle evaluation outperform age and FSH as a predictor for IVF outcome? Answer: The effectiveness of in vitro fertilization correlates closely with maternal age, basal cycle day 3 follicle number, stimulated hormone, and antral follicle count. Antral follicle count was shown to be a better predictor than age or FSH.",2.3685972735685406e-07,0.05195596670889824,0.0848373113854595,0.018134264647818726,0.0881436831788287,0.0652508464142813,0.018108015409528666,0.15921665077528946,0.016661878770468257,2.3685972735685406e-07,0.1857171457950919,0.0
215,1.1,5,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: How does antral follicle assessment compare to age and FSH in forecasting IVF success? Answer: IVF outcome has a strong relationship with maternal age, basal cycle day 3 follicle counts, stimulated hormones, and antral follicle counts. Antral follicle evaluation was found to surpass both age and FSH as a predictor.",2.8423167282822487e-07,0.1491637134346715,0.04036396544973167,0.02176111757738247,0.15644073944803516,0.04485154085872575,0.0217296184914344,0.20003864529554383,0.016661878770468257,2.8423167282822487e-07,0.22738984219566083,0.0
215,1.1,6,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: Is assessing antral follicles a more accurate measure for predicting IVF outcome than age and FSH hormone levels? Answer: The outcome of in vitro fertilization is connected to maternal age, basal cycle day 3 follicles, stimulated hormone, and antral follicle counts. Assessment of antral follicles provided better prediction than either age or FSH levels.",1.8948778188548325e-07,0.023493721667823486,0.1447253854331633,0.014507411718254981,0.04967740235103291,0.0652508464142813,0.014486412327622933,0.119995937622007,0.016661878770468257,1.8948778188548325e-07,0.14571181118139354,0.0
215,1.1,7,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: Can the antral follicle count better predict IVF success than age and FSH levels? Answer: IVF outcomes are strongly linked to factors such as maternal age, basal cycle day 3 follicles, stimulated hormone, and antral follicle count. The antral follicle count is a superior predictor compared to age or FSH.",2.8423167282822487e-07,0.14916371343467194,0.04036396544973167,0.02176111757738247,0.1847324611035428,0.02450842903084987,0.0217296184914344,0.22891977781887451,0.0041620234477300275,2.8423167282822487e-07,0.22738984219566083,0.0
215,1.1,8,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: Is antral follicle count a stronger predictor of IVF outcomes than age and follicle-stimulating hormone? Answer: In vitro fertilization success is correlated with maternal age, basal cycle day 3 follicle count, stimulated hormone, and antral follicle assessment, with antral follicle count being a better predictor than age or FSH.",3.079176455639103e-07,0.17184332915555522,0.03780521262002737,0.023574544042164344,0.17764943751859352,0.04442694419608302,0.023540420032387266,0.221092054493377,0.016661878770468257,3.079176455639103e-07,0.2488960474166242,0.0
215,1.1,9,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: Does antral follicle measurement provide a more accurate prediction of IVF outcomes relative to age and FSH? Answer: IVF success is linked to maternal age, basal cycle day 3 follicles, stimulated hormones, and antral follicle count, with antral follicle evaluation proving a better predictor than age or FSH.",3.316036182995957e-07,0.13728046423180063,0.07817114881457105,0.025387970506946217,0.169821714193096,0.0652508464142813,0.025351221573340132,0.24259825971434035,0.016661878770468257,3.316036182995957e-07,0.2708749541353992,0.0
215,1.1,10,human,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: In vitro fertilization outcome is strongly correlated with both maternal ages, basal cycle, day 3 follicle, stimulated hormone, and antral follicle assessment. Antral follicle assessment was a better predictor of in vitro fertilization outcome than were age or follicle stimulated hormone. Antral","Question: Is antral follicle assessment a more effective predictor of IVF outcome than either age or follicle-stimulating hormone? Answer: Outcomes of in vitro fertilization closely correlate with maternal age, basal cycle day 3 follicle counts, stimulated hormone levels, and antral follicle analysis, where antral follicle assessment outperforms age and FSH as predictors.",2.6054570009253947e-07,0.09979906902310365,0.0629768947187928,0.0199476911126006,0.13567219769740646,0.04525917627683857,0.019918816950481533,0.17941935809280807,0.016661878770468257,2.6054570009253947e-07,0.20633643299782767,0.0
216,1.1,1,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: Can stroke patients reliably report their home blood pressure readings? Answer: These elderly stroke patients were capable of accurately recording their blood pressures at home. Any bias found was minimal and unlikely to impact treatment decisions. Given that blood pressure readings taken in a GP's office often do not reflect true blood pressure, GPs might consider using home measurements for hypertension management.",1.1842986367842703e-07,0.03936394427118994,0.0322222222222222,0.009067132323909363,0.08552217343816082,0.0,0.009054007704764333,0.08701137698962835,0.0,1.1842986367842703e-07,0.08855339734144341,0.0
216,1.1,2,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: Are home blood pressure readings reported by stroke patients dependable? Answer: This group of elderly stroke patients demonstrated reliable home blood pressure monitoring. The small bias observed is unlikely to influence clinical management. Considering that blood pressure measured in GP clinics may not represent true BP, GPs may want to rely more on home readings when managing hypertension.",2.3685972735685406e-08,0.08723628467165057,0.10562414266117966,0.0018134264647818726,0.006621376604456941,0.017538265306122455,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
216,1.1,3,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: Do stroke patients provide consistent home blood pressure readings? Answer: Elderly stroke patients in this study could reliably measure their BP at home. The minor bias detected would probably not affect their treatment plans. Since blood pressure from GP appointments often inaccurately reflects a patient's true BP, utilizing home BP readings could be beneficial for GPs handling hypertension cases.",4.737194547137081e-08,0.012506853119336192,0.033856571252693125,0.0036268529295637453,0.03509131981126945,0.0,0.003621603081905733,0.03571808260207909,0.0,4.737194547137081e-08,0.036367644170874236,0.0
216,1.1,4,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: Is it reliable to trust stroke patients' home blood pressure reports? Answer: Elderly stroke patients were able to record accurate blood pressure readings at home with minimal bias, unlikely to alter management approaches. Due to the poor representation of true BP by GP clinic readings, GPs may consider incorporating home monitoring for hypertension treatment.",7.105791820705622e-08,0.07973933906879171,0.01851192595229618,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
216,1.1,5,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: Are blood pressure readings taken at home by stroke patients dependable? Answer: The elderly group of stroke patients reliably logged their blood pressures at home. The slight bias seen was unlikely to affect clinical decisions. Since BP readings in GP settings often do not reflect actual BP, home readings might be a better option for GPs managing hypertension.",2.3685972735685406e-08,0.006509884203991234,0.017236072637734686,0.0018134264647818726,0.01769957709940062,0.0,0.0018108015409528666,0.018018505502678472,0.0,2.3685972735685406e-08,0.018349138668195764,0.0
216,1.1,6,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: Can stroke patients' reports of home blood pressure be trusted? Answer: This set of elderly stroke patients successfully recorded reliable blood pressures at home. The relatively small bias should not impact treatment. As blood pressure taken during GP visits commonly misrepresents true BP, GPs might prefer home BP monitoring when treating hypertension.",1.1842986367842703e-07,0.11846705619773568,0.01922337562475971,0.009067132323909363,0.09352605801082436,0.0,0.009054007704764333,0.09531017980432566,0.0,1.1842986367842703e-07,0.0971637484536485,0.0
216,1.1,7,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: How reliable are home blood pressure readings reported by stroke patients? Answer: Elderly stroke patients documented them reliably with minimal bias, unlikely to influence care management. Given that BP readings collected at GPs are often poor indicators of real BP, doctors could consider home measurements for managing hypertension.",2.1317375462116866e-07,0.17185025692665912,0.0,0.016320838183036854,0.17520408902509166,0.0,0.0162972138685758,0.17869178874337655,0.0,2.1317375462116866e-07,0.18232155679395579,0.0
216,1.1,8,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: Are self-reported home BP readings from stroke patients accurate? Answer: In this study, elderly stroke patients accurately recorded their blood pressure at home. Any bias was minor and unlikely to affect clinical management. Since GP readings frequently underestimate true BP, home measurement could be helpful for GPs managing hypertensive patients.",1.6580180914979784e-07,0.15875414962880274,0.019991670137442734,0.012693985253473108,0.13353139262452274,0.0,0.012675610786670066,0.13613217432458002,0.0,1.6580180914979784e-07,0.13883644485421742,0.0
216,1.1,9,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: Do stroke patients provide reliable home blood pressure data? Answer: This elderly stroke patient group consistently recorded blood pressures at home with minimal bias, unlikely to impact treatment. Because BP results from GP offices often do not reflect actual levels, GPs might consider home monitoring as a tool in hypertension management.",1.4211583641411244e-07,0.11122563511022499,0.0,0.010880558788691236,0.11332868530700413,0.0,0.0108648092457172,0.11551288712184427,0.0,1.4211583641411244e-07,0.11778303565638426,0.0
216,1.1,10,human,"Question: Are stroke patients' reports of home blood pressure readings reliable? Answer: This group of elderly stroke patients were able to record their BPs reliably at home. Any bias was small and would be unlikely to affect management. Since BP readings in a GP surgery are often a poor indication of true BP, GPs might consider using hypertensive","Question: Is the blood pressure data reported at home by stroke patients accurate? Answer: Elderly stroke patients were able to record their blood pressure reliably at home, with any bias too slight to affect clinical decisions. Since GP surgery readings often fail to indicate true BP, GPs might want to use home BP readings for managing hypertension.",2.3685972735685406e-08,0.06721008999654021,0.03566529492455417,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
217,1.1,1,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","In patients with myelomeningocele, whether to perform untethering before scoliosis surgery hinges on the severity of cord tethering, neurological symptoms, and treatment objectives. Consultation with specialists is crucial.",5.44777372920763e-07,0.5052825905342249,0.07939508506616258,0.04170880868998313,0.5771403167781286,0.040742417383431435,0.041648435441916,0.652325186039691,0.0,5.447773729207643e-07,0.6720937713621127,0.0
217,1.1,2,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","For myelomeningocele patients, deciding if untethering is needed before scoliosis correction depends on tethered cord severity, neurological signs, and treatment goals, requiring careful clinical evaluation.",6.158352911278189e-07,0.6230656261906091,0.07939508506616258,0.04714908808432877,0.6997426388704615,0.040742417383431435,0.04708084006477462,0.7801585575495755,0.0,6.158352911278206e-07,0.8056251639866363,0.0
217,1.1,3,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","The necessity of untethering a patient with myelomeningocele prior to scoliosis correction varies based on the extent of tethered cord involvement, neurological symptoms presented, and intended treatment outcomes; expert consultation is advised.",4.5003348197802176e-07,0.3671322520534077,0.07939508506616258,0.034455102830855615,0.43403947313745617,0.040742417383431435,0.03440522927810451,0.5039051809214179,0.0,4.500334819780227e-07,0.5179430915348537,0.0
217,1.1,4,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Determining untethering prior to scoliosis surgery in myelomeningocele cases involves assessing cord tether severity, neurological status, and therapy aims, necessitating specialist input.",6.868932093348748e-07,0.7565970188151327,0.07939508506616258,0.05258936747867441,0.8395045812456208,0.040742417383431435,0.05251324468763324,0.9267620317414509,0.0,6.868932093348766e-07,0.959775843813893,0.0
217,1.1,5,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Before correcting scoliosis in myelomeningocele patients, untethering decisions rely on the degree of tethered cord, neurological manifestations, and desired treatment results, making professional medical advice important.",5.921493183921336e-07,0.5822436316703543,0.07939508506616258,0.04533566161954689,0.6571830244516659,0.040742417383431435,0.04527003852382175,0.7357067949787415,0.0,5.921493183921352e-07,0.7591051483517424,0.0
217,1.1,6,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","The choice to untether a myelomeningocele patient ahead of scoliosis correction is influenced by tethered cord severity, related neurological symptoms, and treatment goals, highlighting the importance of expert consultation.",5.210914001850777e-07,0.4689149463633502,0.07939508506616258,0.039895382225201254,0.5393999887952816,0.040742417383431435,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
217,1.1,7,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","In treating scoliosis in myelomeningocele patients, untethering is considered based on how severe the tethered cord is, neurological symptoms and what the treatment intends to achieve, necessitating specialist guidance.",5.210914001850777e-07,0.4689149463633502,0.07939508506616258,0.039895382225201254,0.5393999887952816,0.040742417383431435,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
217,1.1,8,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","Untethering prior to scoliosis correction in patients with myelomeningocele depends on factors like the seriousness of the tethered cord, neurological signs, and therapeutic aims, which requires consultation with healthcare professionals.",4.974054274493924e-07,0.4338236265520812,0.07939508506616258,0.038081955760419374,0.5030323446244069,0.040742417383431435,0.038026832360010254,0.5753641449035616,0.0,4.974054274493935e-07,0.5920510636885754,0.0
217,1.1,9,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","When managing scoliosis in myelomeningocele patients, deciding on untethering first depends on the severity of the tethered cord, associated neurological issues, and treatment goals, thus specialist consultation is essential.",5.210914001850777e-07,0.4689149463633502,0.07939508506616258,0.039895382225201254,0.5393999887952816,0.040742417383431435,0.03983763390096313,0.6131044728864086,0.0,5.210914001850789e-07,0.6312717768418579,0.0
217,1.1,10,ai,"Question: A patient with myelomeningocele: is untethering necessary prior to scoliosis correction? Answer: The decision to untether a patient with myelomeningocele prior to scoliosis correction depends on several factors including the severity of the tethered cord, the associated neurological symptoms, and the goals of treatment. It is important to consult with","The decision to untether before scoliosis surgery for myelomeningocele patients is contingent upon tethered cord severity, neurological symptoms present, and treatment objectives, underscoring the need for expert assessment.",5.44777372920763e-07,0.5052825905342249,0.07939508506616258,0.04170880868998313,0.5771403167781286,0.040742417383431435,0.041648435441916,0.652325186039691,0.0,5.447773729207643e-07,0.6720937713621127,0.0
218,1.1,1,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Reimplanting spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is a crucial step that helps maintain spinal cord blood flow, thereby lowering the chances of paraplegia and related issues.",6.868932093348756e-07,0.5258357921489245,0.11549875052061644,0.052589367478674355,0.5649210354361998,0.10380622837370242,0.05251324468763319,0.6552490553851111,0.0533997864008544,6.868932093348768e-07,0.7240312951906267,0.0181755829903978
218,1.1,2,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",The process of reattaching spinal cord arteries in thoracic and thoracoabdominal aneurysm surgeries is important for preserving spinal cord perfusion and preventing complications like paralysis.,8.053230730133021e-07,0.7250368030023928,0.10834962432949727,0.06165649980258375,0.7616313296822543,0.10380622837370242,0.061567252392397555,0.8600434680311251,0.0533997864008544,8.053230730133038e-07,0.9376053954886876,0.0181755829903978
218,1.1,3,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","In thoracic and thoracoabdominal aneurysm repair, it is important to reimplant the spinal cord arteries to sustain adequate blood circulation and minimize the risk of spinal cord injury.",7.342651548062462e-07,0.6008357378963813,0.11295527751011047,0.056216220408238114,0.6390290075899214,0.10380622837370242,0.056134847769538934,0.7322100965212406,0.0533997864008544,7.342651548062476e-07,0.804074002864164,0.0181755829903978
218,1.1,4,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",Reimplantation of spinal cord arteries is a vital procedure during thoracic and thoracoabdominal aneurysm surgery to ensure sufficient blood supply and reduce neurologic complications.,8.290090457489874e-07,0.709834152374528,0.14993752603082053,0.06346992626736564,0.8060830922530884,0.10380622837370242,0.06337805393335043,0.906563483666019,0.0533997864008544,8.290090457489892e-07,0.9863955596581189,0.0181755829903978
218,1.1,5,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","During thoracic and thoracoabdominal aneurysm repair, restoring the spinal cord arteries is critical to avoid ischemia and subsequent paraplegia.",9.474389094274141e-07,0.9549566104075127,0.14993752603082053,0.07253705859127503,1.0639122015551878,0.10380622837370242,0.07243206163811479,1.1784971991496596,0.0533997864008544,9.474389094274159e-07,1.2740776321098988,0.0181755829903978
218,1.1,6,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","Reimplanting the spinal cord arteries during these aneurysm procedures is essential, helping to maintain spinal perfusion and prevent serious neurologic outcomes.",9.000669639560433e-07,0.8495960947496872,0.14993752603082053,0.06891020566171127,0.9526865664449637,0.10380622837370242,0.06881045855620904,1.0607141634932757,0.0533997864008544,9.000669639560452e-07,1.1489144891558931,0.0181755829903978
218,1.1,7,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",The reattachment of spinal cord arteries in thoracic and thoracoabdominal aneurysm repair plays a key role in reducing risks such as spinal cord ischemia and subsequent paralysis.,7.579511275419315e-07,0.6405508441714218,0.11153752603082051,0.058029646873019994,0.6782497207432039,0.10380622837370242,0.05794564931049181,0.7730320910414954,0.0533997864008544,7.57951127541933e-07,0.8466336172829596,0.0181755829903978
218,1.1,8,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",Ensuring the reimplantation of spinal cord arteries during aneurysm surgery is fundamental to safeguarding spinal cord health and preventing complications like paraplegia.,8.76380991220358e-07,0.8668199477764409,0.10243752603082051,0.06709677919692938,0.9013932720574136,0.10380622837370242,0.06699965701525618,1.0066469422230004,0.0533997864008544,8.763809912203598e-07,1.0917560753159443,0.0181755829903978
218,1.1,9,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.",The spinal cord artery reimplantation in thoracic and thoracoabdominal aneurysm repair is not futile; it is fundamental to protecting the spinal cord from ischemic damage.,8.053230730133021e-07,0.7827990680490551,0.06729289793164699,0.06165649980258375,0.8219049975570325,0.060417798621636286,0.061567252392397555,0.8600434680311251,0.0533997864008544,8.053230730133038e-07,0.9376053954886876,0.0181755829903978
218,1.1,10,ai,"Question: Thoracic and thoracoabdominal aneurysm repair: is reimplantation of spinal cord arteries a waste of time? Answer: Reimplantation of spinal cord arteries during thoracic and thoracoabdominal aneurysm repair is not considered a waste of time. It is an essential procedure that helps to ensure adequate blood supply to the spinal cord, reducing the risk of paraplegia and other complications.","In surgeries for thoracic and thoracoabdominal aneurysms, reimplanting the spinal cord arteries is necessary to maintain blood flow and reduce paraplegia risk.",8.76380991220358e-07,0.800805930580256,0.14993752603082053,0.06709677919692938,0.9013932720574136,0.10380622837370242,0.06699965701525618,1.0066469422230004,0.0533997864008544,8.763809912203598e-07,1.0917560753159443,0.0181755829903978
219,1.1,1,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss program before surgery enhance the results of bariatric surgery? The medically supervised weight management protocol (MSWM) does not seem to offer extra advantages over the usual preoperative bariatric procedure regarding weight loss and most behavioral outcomes following LAGB in our patients.,2.3685972735685406e-08,0.0068185123769524125,0.020551649540292066,0.0018134264647818726,0.00833368550616198,0.02221074380165289,0.0018108015409528666,0.022989518224699523,0.0,2.3685972735685406e-08,0.023530497410194418,0.0
219,1.1,2,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is there an improvement in bariatric surgery outcomes when patients undergo a medically supervised weight loss program before surgery? Our data suggests that MSWM does not provide additional benefits compared to the standard preoperative bariatric protocol in terms of weight loss and key behavioral outcomes post-LAGB.,0.0,0.030806541358219697,0.02213755257476679,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
219,1.1,3,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Can preoperative medically supervised weight loss programs improve the outcomes of bariatric surgery? In our study, MSWM showed no extra benefit relative to the standard pre-op bariatric surgery approach concerning weight loss and most behavioral measures after LAGB.",1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
219,1.1,4,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,"Does participating in a medically supervised weight loss program before surgery positively influence bariatric surgery results? According to our findings, MSWM offers no greater advantage than the conventional preoperative bariatric protocol for weight loss and behavioral outcomes post-LAGB.",1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
219,1.1,5,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a preoperative medically supervised weight loss regimen improve the outcomes of bariatric surgery? MSWM does not appear to offer additional benefits compared to the traditional preoperative bariatric surgery routine concerning weight loss and majority of behavioral results after LAGB in our patient group.,4.737194547137081e-08,0.01608869510729205,0.02110566599093216,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
219,1.1,6,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is the outcome of bariatric surgery enhanced by engaging in a medically supervised weight loss program beforehand? Results indicate that MSWM doesn’t provide extra benefits over the standard preoperative bariatric surgery protocol with respect to weight loss and most behavioral outcomes post-LAGB.,9.474389094274162e-08,0.09910145552615202,0.004303906121936658,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
219,1.1,7,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does undergoing a medically supervised weight loss program prior to surgery improve bariatric surgery outcomes? Our patient data shows that MSWM does not yield any extra benefit compared to the standard pre-op bariatric surgery protocol in weight loss and behavioral outcomes after LAGB.,7.105791820705622e-08,0.07339380596669631,0.003151703623580332,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,1.1,8,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does a medically supervised weight loss intervention before bariatric surgery improve surgical outcomes? It appears that MSWM lacks added benefit beyond the usual standard preoperative bariatric protocol for weight loss and most behavioral outcomes after LAGB.,2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
219,1.1,9,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Is outcome improvement seen in bariatric surgery patients who participate in a medically supervised weight loss program preoperatively? MSWM seems not to provide further benefits over the standard preoperative bariatric surgery protocol in weight loss and behavioral outcomes following LAGB in our patients.,7.105791820705622e-08,0.07339380596669631,0.003151703623580332,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
219,1.1,10,human,Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: MSWM does not appear to confer additional benefit as compared to the standard preoperative bariatric surgery protocol in terms of weight loss and most behavioral outcomes after LAGB in our patient population.,Does participation in a preoperative medically supervised weight loss program enhance bariatric surgery outcomes? Our evidence indicates that MSWM fails to offer any significant advantage compared to the conventional preoperative bariatric surgery protocol regarding weight loss and most behavioral outcomes after LAGB.,9.474389094274162e-08,0.09910145552615202,0.004303906121936658,0.0072537058591274906,0.09531017980432566,0.0,0.007243206163811466,0.09763846956391786,0.0,9.474389094274162e-08,0.10008345855698142,0.0
220,1.1,1,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does receiving birth center care during a woman's first pregnancy influence her future reproductive outcomes? Answer: In Sweden, the type of care model, like birth center care, during a first pregnancy appears not to significantly impact later reproduction.",1.8948778188548304e-07,0.21008902661790163,0.013467401022063757,0.014507411718254981,0.19574457712609394,0.0,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
220,1.1,2,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Can care at a birth center during a woman’s first pregnancy affect her future fertility? Answer: Evidence from Sweden suggests that a woman’s choice of care model, including birth center care, in her initial pregnancy does not greatly influence her subsequent reproduction.",9.474389094274162e-08,0.0665752935897439,0.017399945916711734,0.0072537058591274906,0.09309042306601167,0.0,0.007243206163811466,0.09531017980432566,0.0,9.474389094274162e-08,0.09763846956391786,0.0
220,1.1,3,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does first pregnancy care at a birth center influence a woman's reproductive future? Answer: The model of care, such as birth center care during a woman's first pregnancy, does not seem to be a significant determinant of future reproduction in Sweden.",1.1842986367842703e-07,0.0922829431491996,0.016247743418355408,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,1.1,4,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Is there an effect of birth center care during the first pregnancy on later reproduction? Answer: Care models like birth center care during the first pregnancy do not appear to have a meaningful effect on subsequent reproduction in Sweden.,1.6580180914979774e-07,0.2879453041041877,0.08386038466180062,0.012693985253473108,0.35148348282286657,0.12855831037649218,0.012675610786670066,0.32314138193564723,0.10651974288337923,1.6580180914979784e-07,0.29320570733077655,0.08264462809917354
220,1.1,5,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does birth center care for a woman’s first pregnancy impact her later reproductive outcomes? Answer: In Sweden, birth center care during the initial pregnancy does not seem to be a critical factor influencing future reproduction.",2.6054570009253894e-07,0.2620996538229363,0.007966979892836644,0.019947691112600606,0.32107532871650735,0.029384756657483937,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
220,1.1,6,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Could birth center care during a first pregnancy influence future childbearing? Answer: The choice of birth center care in a first pregnancy does not seem to be an important influence on later reproduction among Swedish women.,2.3685972735685364e-07,0.30874466301191683,0.04447505408328825,0.018134264647818726,0.3305312489163281,0.056932966023875105,0.018108015409528673,0.2578291093020999,0.0,2.3685972735685406e-07,0.26469255422708216,0.0
220,1.1,7,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does the model of care during a woman's first pregnancy, for example birth center care, affect her subsequent reproduction? Answer: In Sweden, it seems that birth center care during the first pregnancy is not a significant factor in later reproductive behavior.",1.1842986367842703e-07,0.0922829431491996,0.016247743418355415,0.009067132323909363,0.11778303565638337,0.0,0.009054007704764333,0.12062798778861739,0.0,1.1842986367842703e-07,0.12361395596717584,0.0
220,1.1,8,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Can care during a first pregnancy at a birth center affect subsequent reproduction? Answer: Among women in Sweden, birth center care in the first pregnancy is apparently not a key factor affecting future reproductive patterns.",2.6054570009253894e-07,0.2620996538229363,0.007966979892836644,0.019947691112600606,0.2803019651541576,0.0,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
220,1.1,9,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.","Question: Does first pregnancy birth center care have any effect on future reproduction? Answer: The data from Sweden indicate that a woman’s model of care, such as birth center care during the first pregnancy, does not strongly affect later reproduction.",1.6580180914979774e-07,0.1457612670662516,0.013767732622336298,0.012693985253473108,0.20555776059971942,0.026296566837107373,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
220,1.1,10,human,"Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: A woman's model of care, such as birth center care, during her first pregnancy does not seem to be a sufficiently important factor to affect subsequent reproduction in Sweden.",Question: Is the choice of birth center care in the first pregnancy influential on a woman’s later reproduction? Answer: Birth center care during a woman’s first pregnancy does not seem to be an influential factor for subsequent reproduction in Sweden.,1.6580180914979774e-07,0.21685328558521944,0.03632454387920664,0.012693985253473108,0.20555776059971942,0.026296566837107373,0.012675610786670066,0.17327172127403623,0.0,1.6580180914979784e-07,0.17768117723745203,0.0
221,1.1,1,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does having anemia before surgery negatively impact outcomes in colon and rectal procedures? Answer: Yes, preoperative anemia is linked to greater complications and higher mortality in colon and rectal surgeries, such as more infections, extended hospitalization, and increased readmissions. Effective management and treatment are essential.",2.3685972735685406e-08,0.024573301853755503,0.0014902451164880426,0.0018134264647818726,0.007784458079231005,0.02210884353741497,0.0018108015409528666,0.008708906336779787,0.023242630385487524,2.3685972735685406e-08,0.024097551579060017,0.0
221,1.1,2,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Can preoperative anemia harm the results of colon and rectal surgeries? Answer: Indeed, anemia prior to surgery is associated with elevated risks of complications and death in colon and rectal operations, including increased infection rates, longer hospital stays, and greater chances of readmission. Proper treatment is critical.",7.105791820705622e-08,0.101486788458796,0.0253476399262638,0.005440279394345618,0.06954385060511781,0.0015142353237591263,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
221,1.1,3,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Is preoperative anemia detrimental to colon and rectal surgery outcomes? Answer: Yes, the presence of anemia before colon and rectal surgery correlates with higher complication rates and mortality, including more infections, prolonged hospitalization, and greater readmission frequency. Timely management improves outcomes.",7.105791820705622e-08,0.07753366990246713,0.004897905711710296,0.005440279394345618,0.10939597588864602,0.02661886545938781,0.0054324046228586,0.10965398141320737,0.025623268698060954,7.105791820705622e-08,0.0759859069779214,0.0
221,1.1,4,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does anemia before surgery worsen outcomes in colon and rectal procedures? Answer: Yes, preoperative anemia contributes to increased postoperative complications and mortality in colon and rectal surgeries, such as higher infection rates, longer stays in hospital, and more readmissions. Addressing anemia adequately is important.",0.0,0.0,0.0,0.0,0.032239403746974205,0.023158321428908682,0.0,0.03300700859809158,0.023795359904818555,0.0,0.0,0.0
221,1.1,5,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does pre-surgical anemia negatively influence the results of colon and rectal surgeries? Answer: Yes, patients with anemia before colon and rectal surgery exhibit higher incidences of complications and death, including increased infections, extended hospital duration, and elevated readmission rates. Proper anemia management is necessary.",0.0,0.031506690025452144,0.022465301805830437,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
221,1.1,6,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Is there an adverse effect of preoperative anemia on colon and rectal surgery outcomes? Answer: Yes, anemia before surgery is associated with worsened outcomes in colon and rectal surgery, including higher mortality, increased infections, longer hospital stays, and higher rates of hospital readmission. Effective treatment is needed.",7.105791820705622e-08,0.101486788458796,0.0253476399262638,0.005440279394345618,0.06954385060511781,0.0015142353237591263,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
221,1.1,7,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: How does preoperative anemia affect outcomes in colon and rectal surgery? Answer: Preoperative anemia negatively impacts outcomes, being linked to increased complications, mortality, infections, prolonged hospital stays, and higher readmission rates in colon and rectal surgeries. Managing anemia properly is essential.",7.105791820705622e-08,0.11134572749075655,0.028603969340660812,0.005440279394345618,0.10939597588864602,0.02661886545938781,0.0054324046228586,0.10965398141320737,0.025623268698060954,7.105791820705622e-08,0.0759859069779214,0.0
221,1.1,8,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Does anemia present prior to colon and rectal surgery affect postoperative results? Answer: Yes, preoperative anemia is tied to worse outcomes in these surgeries, with greater complication rates, mortality, infections, longer hospitalization, and more frequent readmissions. Timely treatment and management are important.",4.737194547137081e-08,0.048000054441462936,0.06781677572873293,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
221,1.1,9,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Will preoperative anemia impact the success of colon and rectal surgeries? Answer: Yes, having anemia before surgery is linked to increased complications and death, including infection, prolonged hospital stay, and higher likelihood of readmission. Appropriate management can mitigate these risks.",9.474389094274162e-08,0.0007901097279687797,0.06781677572873293,0.0072537058591274906,0.06539906581694366,0.023242630385487524,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
221,1.1,10,ai,"Question: Does preoperative anemia adversely affect colon and rectal surgery outcomes? Answer: Yes, preoperative anemia has been associated with increased complications and mortality rates in colon and rectal surgery, including higher rates of infection, longer hospital stays, and higher readmission rates. Proper management and treatment","Question: Is pre-surgical anemia associated with poorer outcomes in colon and rectal surgery? Answer: Yes, patients with anemia before surgery of the colon and rectum face heightened risk of postoperative complications, mortality, infections, longer hospital stays, and increased readmissions. Proper treatment is crucial.",4.737194547137081e-08,0.014993045843371355,0.044021415823914375,0.0036268529295637453,0.01538864524228023,0.023242630385487524,0.003621603081905733,0.048790164169431716,0.0,4.737194547137081e-08,0.05001042057466343,0.0
222,1.1,1,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Could Alveolar Macrophage Phagocytic Dysfunction in children suffering from Protracted Bacterial Bronchitis be a precursor to Bronchiectasis? Answer: The connection between Alveolar Macrophage Phagocytic Dysfunction in pediatric Protracted Bacterial Bronchitis cases and Bronchiectasis remains under investigation, with no conclusive results yet. More studies are required to clarify if a causal link exists.",7.105791820705622e-08,0.03600701188489408,0.059417956078321496,0.005440279394345618,0.0394895590485822,0.0658040102313872,0.0054324046228586,0.06937479908857291,0.0890864576769586,7.105791820705622e-08,0.07224189954137028,0.09302224453896245
222,1.1,2,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is there evidence that Alveolar Macrophage Phagocytic Dysfunction in kids with Protracted Bacterial Bronchitis leads to Bronchiectasis? Answer: Currently, the association between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and the development of Bronchiectasis is not definitively established, and further research is necessary.",2.1317375462116866e-07,0.13759610610148298,0.025567974285923,0.016320838183036854,0.13097732119692207,0.03429229678638948,0.0162972138685758,0.09752686805287203,0.06120023750378123,2.1317375462116866e-07,0.06232596496716036,0.09017891970903047
222,1.1,3,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Does Alveolar Macrophage Phagocytic Dysfunction act as an early indicator for Bronchiectasis in children with Protracted Bacterial Bronchitis? Answer: The potential role of Alveolar Macrophage Phagocytic Dysfunction in initiating Bronchiectasis among children with Protracted Bacterial Bronchitis is under ongoing study, with no firm conclusions at present. Additional investigations are needed to establish causality.",4.737194547137081e-08,0.058073264245543044,0.06147689865812701,0.0036268529295637453,0.06099858662683122,0.0672784078975006,0.003621603081905733,0.09026471607974873,0.08986665921335546,4.737194547137081e-08,0.12073632851439697,0.113421550094518
222,1.1,4,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in children having Protracted Bacterial Bronchitis a risk factor or precursor for Bronchiectasis? Answer: The link between Alveolar Macrophage Phagocytic Dysfunction seen in pediatric Protracted Bacterial Bronchitis and the onset of Bronchiectasis is being researched, and no definitive answer has been reached yet. Further studies are essential to understand if it causes Bronchiectasis.",7.105791820705622e-08,0.18565521093826343,0.08739984793147246,0.005440279394345618,0.18648130254683348,0.09119816098392036,0.0054324046228586,0.2134000023918028,0.11116577356309267,7.105791820705622e-08,0.21604650831872263,0.113421550094518
222,1.1,5,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Can Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis be considered a forerunner to Bronchiectasis? Answer: Research is ongoing into the relationship between Alveolar Macrophage Phagocytic Dysfunction in Protracted Bacterial Bronchitis among children and Bronchiectasis, with no clear evidence currently. More research is needed to determine any causal effects.",9.474389094274162e-08,0.013729728928828067,0.039058514437302294,0.0072537058591274906,0.01751235236241122,0.06427221172022692,0.007243206163811466,0.048040422904834124,0.08827459584908273,9.474389094274162e-08,0.05103320147081192,0.09259764787631972
222,1.1,6,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is there a causal relationship between Alveolar Macrophage Phagocytic Dysfunction and Bronchiectasis in children with Protracted Bacterial Bronchitis? Answer: At this time, the connection between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis has not been definitively proven, warranting further study.",2.3685972735685406e-07,0.225876047482513,0.014660493827160503,0.018134264647818726,0.1884576104105924,0.010703307866721856,0.018108015409528666,0.15495393118911105,0.03697230580319133,2.3685972735685406e-07,0.11963107582656463,0.06592155009451799
222,1.1,7,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Could dysfunction of Alveolar Macrophage phagocytosis in children with Protracted Bacterial Bronchitis initiate the development of Bronchiectasis? Answer: The potential causative association between this dysfunction and Bronchiectasis in such patients is still being explored, and currently, no definitive conclusion exists. More research is imperative.",2.6054570009253947e-07,0.028909968889407445,0.1728395061728395,0.0199476911126006,0.022406988482580825,0.14366729678638948,0.019918816950481533,0.04952681361140909,0.12901701323251416,2.6054570009253947e-07,0.0777146102094406,0.113421550094518
222,1.1,8,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction in pediatric Protracted Bacterial Bronchitis a possible precursor to Bronchiectasis? Answer: There is still ongoing research to clarify the relationship between Alveolar Macrophage Phagocytic Dysfunction in Protracted Bacterial Bronchitis in children and Bronchiectasis, and no conclusive evidence yet exists. Additional research is needed.",1.6580180914979784e-07,0.057365449260949664,0.05039052658100274,0.012693985253473108,0.051442001284799144,0.059297367094664225,0.012675610786670066,0.018828703280460157,0.08562858348044804,1.6580180914979784e-07,0.015430728501648616,0.09121080629286511
222,1.1,9,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Does Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis contribute to eventual Bronchiectasis? Answer: The association remains uncertain as studies are incomplete and no definite answer exists, requiring further scientific examination to determine causality.",4.500334819780223e-07,0.1717607265727441,0.1728395061728395,0.03445510283085558,0.2282590426867297,0.14366729678638948,0.03440522927810447,0.26083590727861505,0.12901701323251416,4.500334819780227e-07,0.2947791154472683,0.113421550094518
222,1.1,10,ai,Question: Is Alveolar Macrophage Phagocytic Dysfunction in Children With Protracted Bacterial Bronchitis a Forerunner to Bronchiectasis? Answer: The relationship between Alveolar Macrophage Phagocytic Dysfunction in children with Protracted Bacterial Bronchitis and Bronchiectasis is still being studied and there is no definitive answer at this time. Further research is needed to determine if there is a causal,"Question: Is Alveolar Macrophage Phagocytic Dysfunction found in children with Protracted Bacterial Bronchitis a precursor stage for Bronchiectasis? Answer: This possibility remains under investigation, with current evidence being insufficient and additional research necessary to confirm any direct causal relationship.",4.026615365066517e-07,0.11769350530246792,0.1728395061728395,0.030828249901291835,0.17268919153191753,0.14366729678638948,0.030783626196198732,0.2036774934386667,0.12901701323251416,4.026615365066519e-07,0.23593861542433503,0.113421550094518
223,1.1,1,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","In instances of metastatic carcinoma in the cervical nodes with an unidentified primary site in the head and neck, neck dissection might be required to excise the affected lymph nodes and identify the cancer's origin, aiding in treatment planning and improving prognosis.",7.105791820705622e-07,0.3486165956233451,0.1376474073542086,0.05440279394345621,0.34176953118801245,0.1516805515656421,0.054324046228586,0.3696326322183552,0.14076414823326625,7.105791820705622e-07,0.39844140941914663,0.1292731973570813
223,1.1,2,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","When cancer has metastasized to cervical lymph nodes from an unknown head and neck primary tumor, neck dissection may be needed to remove the involved nodes and locate the primary cancer site, which helps in deciding further therapy and enhancing patient recovery.",7.105791820705622e-07,0.31480453803505526,0.16202240735420861,0.05440279394345621,0.34176953118801245,0.1516805515656421,0.054324046228586,0.3696326322183552,0.14076414823326625,7.105791820705622e-07,0.39844140941914663,0.1292731973570813
223,1.1,3,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","For metastatic carcinoma spreading to cervical nodes from an unknown head and neck primary, performing neck dissection could be essential to eliminate the impacted lymph nodes and ascertain the original cancer site, thereby guiding treatment and boosting outcomes.",8.053230730133035e-07,0.41745869209513753,0.16202240735420861,0.0616564998025837,0.44713004684583835,0.1516805515656421,0.061567252392397465,0.4778462168585862,0.14076414823326625,8.053230730133038e-07,0.5096670445293712,0.1292731973570813
223,1.1,4,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Neck dissection is often considered necessary when metastatic carcinoma is found in cervical nodes without a known head and neck primary source, to remove affected nodes and identify the primary tumor, assisting in treatment choices and patient prognosis.",8.053230730133035e-07,0.41745869209513753,0.16202240735420861,0.0616564998025837,0.44713004684583835,0.1516805515656421,0.061567252392397465,0.4778462168585862,0.14076414823326625,8.053230730133038e-07,0.5096670445293712,0.1292731973570813
223,1.1,5,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","In cases where metastatic carcinoma involves cervical lymph nodes from an unknown head and neck primary, neck dissection may be performed to remove diseased nodes and find the primary cancer site, facilitating treatment decisions and better outcomes.",8.290090457489888e-07,0.44485766628325285,0.16202240735420861,0.06346992626736557,0.4753009238125352,0.1516805515656421,0.06337805393335033,0.5068337537318377,0.14076414823326625,8.290090457489892e-07,0.539520007679053,0.1292731973570813
223,1.1,6,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Metastatic cancer in cervical nodes from an unidentified head and neck primary site may necessitate neck dissection to excise affected lymph nodes and clarify the primary source, which is important for directing further treatment and improving patient results.",8.053230730133035e-07,0.41745869209513753,0.16202240735420861,0.0616564998025837,0.44713004684583835,0.1516805515656421,0.061567252392397465,0.4778462168585862,0.14076414823326625,8.053230730133038e-07,0.5096670445293712,0.1292731973570813
223,1.1,7,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","When metastatic carcinoma affects cervical nodes with an unknown head and neck primary tumor, neck dissection might be required for removal of involved nodes and determination of the primary cancer origin to guide therapy and enhance prognosis.",8.290090457489888e-07,0.44485766628325285,0.16202240735420861,0.06346992626736557,0.4753009238125352,0.1516805515656421,0.06337805393335033,0.5068337537318377,0.14076414823326625,8.290090457489892e-07,0.539520007679053,0.1292731973570813
223,1.1,8,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Performing neck dissection may be necessary in metastatic carcinoma involving cervical nodes with an unknown head and neck primary, to remove affected nodes and identify the primary site, helping guide treatment and patient outcomes.",9.000669639560447e-07,0.531869043272883,0.16202240735420861,0.06891020566171122,0.5649130825022222,0.1516805515656421,0.06881045855620896,0.599207073862853,0.14076414823326625,9.000669639560454e-07,0.6348301874833782,0.1292731973570813
223,1.1,9,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","In the presence of metastatic carcinoma in cervical lymph nodes from a head and neck primary site that is unknown, neck dissection may be needed to remove the affected lymph nodes and discover the cancer's origin, aiding treatment direction and improving patient prognosis.",6.868932093348768e-07,0.3237139950540868,0.13822704744939007,0.052589367478674334,0.31707691859764076,0.1516805515656421,0.05251324468763313,0.34431482423406345,0.14076414823326625,6.868932093348768e-07,0.37246592301588866,0.1292731973570813
223,1.1,10,ai,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In cases of metastatic carcinoma to the cervical nodes from an unknown head and neck primary site, a neck dissection may be necessary to remove the affected lymph nodes and determine the primary source of the cancer. This procedure can help guide further treatment decisions and improve patient outcomes.","Neck dissection may be indicated in metastatic carcinoma cases with cervical node involvement from an unknown head and neck primary tumor to remove affected lymph nodes and ascertain the primary source, which helps tailor subsequent therapy and enhances patient outcomes.",7.579511275419329e-07,0.3648149586097187,0.16202240735420861,0.05802964687301995,0.39306282557556216,0.1516805515656421,0.05794564931049173,0.422276365703774,0.14076414823326625,7.57951127541933e-07,0.4525086306894228,0.1292731973570813
224,1.1,1,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Is the 30-day and 1-year mortality rate following emergency general surgery laparotomies a significant concern requiring attention? Answer: Emergency laparotomy has a notably high mortality rate, particularly for patients over 70, highlighting the need for enhanced outcome improvements.",1.4211583641411222e-07,0.14660347419187536,0.0,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
224,1.1,2,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Are the 30-day and 1-year death rates after emergency general surgery laparotomies an issue that demands action? Answer: There is a considerable mortality risk with emergency laparotomy, especially among those older than 70 years, indicating that efforts to improve results must be intensified.",2.3685972735685406e-08,0.022989518224699523,0.0,0.0018134264647818726,0.023530497410194418,0.0,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
224,1.1,3,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Is there a worry about 30-day and 1-year mortality post-emergency general surgery laparotomies that calls for better interventions? Answer: Emergency laparotomy results in high mortality, notably for patients aged above 70, and further action is necessary to boost outcomes.",1.1842986367842692e-07,0.12062798778861739,0.0,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
224,1.1,4,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Does the 30-day and 1-year mortality following emergency general surgery laparotomies point to an area needing improvement? Answer: The mortality rate associated with emergency laparotomy is high, mainly among those over 70 years old, and improved outcomes must be pursued.",9.474389094274162e-08,0.09531017980432566,0.0,0.0072537058591274906,0.09763846956391786,0.0,0.007243206163811466,0.10008345855698142,0.0,9.474389094274162e-08,0.10265415406008227,0.0
224,1.1,5,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Are 30-day and 1-year mortality rates in emergency general surgery laparotomies a concern that requires enhancement efforts? Answer: Emergency laparotomy carries a significant mortality risk, especially in elderly patients over 70, and more should be done to improve survival.",1.1842986367842692e-07,0.12062798778861739,0.0,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
224,1.1,6,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Is the mortality at 30 days and one year after emergency general surgery laparotomies an issue necessitating improvements? Answer: Mortality following emergency laparotomy remains high, particularly in patients older than 70, signaling a demand for better outcome strategies.",1.4211583641411222e-07,0.14660347419187536,0.0,0.010880558788691236,0.1502822030493367,0.0,0.0108648092457172,0.1541506798272576,0.0,1.4211583641411244e-07,0.15822400521489444,0.0
224,1.1,7,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Is there cause for concern regarding 30-day and 1-year mortality rates in emergency general surgery laparotomies, and is improvement needed? Answer: Emergency laparotomy involves a high risk of death, especially for people aged over 70, thus necessitating efforts to enhance results.",7.105791820705622e-08,0.07061756721395396,0.0,0.005440279394345618,0.07232066157962613,0.0,0.0054324046228586,0.07410797215372344,0.0,7.105791820705622e-08,0.0759859069779214,0.0
224,1.1,8,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Should 30-day and 1-year mortality rates after emergency general surgery laparotomies prompt concern and a need for better care? Answer: The mortality rates in emergency laparotomy are elevated, particularly in the elderly above 70 years, advocating for targeted improvements.",1.1842986367842692e-07,0.1561739970481013,0.025623268698060954,0.009067132323909363,0.12361395596717584,0.0,0.009054007704764333,0.1267517056391423,0.0,1.1842986367842703e-07,0.1300531282481976,0.0
224,1.1,9,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Do 30-day and 1-year mortality rates in emergency general surgery laparotomies represent a concerning problem requiring action? Answer: Emergency laparotomy is associated with high mortality, mostly affecting patients older than 70, and focused improvements are essential.",1.8948778188548283e-07,0.20067069546215155,0.0,0.014507411718254981,0.20585205420414887,0.0,0.01448641232762294,0.21130909366720596,0.0,1.8948778188548325e-07,0.21706450523782772,0.0
224,1.1,10,human,"Question: 30-Day and 1-year mortality in emergency general surgery laparotomies: an area of concern and need for improvement? Answer: Emergency laparotomy carries a high rate of mortality, especially in those over the age of 70 years, and more needs to be done to improve outcomes,","Question: Is improving the outcomes of emergency general surgery laparotomies imperative due to high 30-day and 1-year mortality rates? Answer: Yes, emergency laparotomy carries significant mortality risk, especially in patients over 70, indicating the need for better outcomes.",1.6580180914979753e-07,0.17327172127403623,0.0,0.012693985253473108,0.17768117723745203,0.0,0.012675610786670066,0.18232155679395445,0.0,1.6580180914979784e-07,0.18721154208814594,0.0
225,1.1,1,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Does amblyopia cause permanent vision loss? Answer: If amblyopia is not treated for a long time, the vision loss can become permanent. However, early detection and timely treatment, particularly in children, significantly increase the likelihood of restoring vision and minimizing permanent loss.",2.3685972735685406e-08,0.008708906336779787,0.023242630385487524,0.0018134264647818726,0.024097551579060017,0.0,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
225,1.1,2,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Is visual impairment from amblyopia irreversible? Answer: Prolonged untreated amblyopia can lead to permanent visual impairment. Nevertheless, early diagnosis and prompt treatment, especially among pediatric patients, often improve vision and prevent enduring damage.",2.3685972735685332e-07,0.23245315048010795,0.023242630385487524,0.018134264647818747,0.2719337154836414,0.0,0.018108015409528694,0.27958486221916123,0.0,2.3685972735685406e-07,0.28768207245178123,0.0
225,1.1,3,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Can vision loss due to amblyopia be permanent? Answer: Vision loss from amblyopia may become permanent if it goes untreated for an extended duration. Early identification and treatment, especially in young children, can enhance vision recovery and lessen permanent visual impairment.",4.737194547137081e-08,0.0492007028305701,0.0011323696145124768,0.0036268529295637453,0.048790164169431716,0.0,0.003621603081905733,0.05001042057466343,0.0,4.737194547137081e-08,0.051293294387549704,0.0
225,1.1,4,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Does amblyopia result in lasting vision loss? Answer: Visual loss caused by amblyopia has the potential to be permanent if left untreated over a long period. With early detection and proper treatment, particularly in children, there is a greater possibility of visual improvement and reducing lasting vision loss.",1.1842986367842703e-07,0.11335916643797228,0.00241872816728924,0.009067132323909363,0.11247798342669002,0.0,0.009054007704764333,0.11506932978478668,0.0,1.1842986367842703e-07,0.11778303565638337,0.0
225,1.1,5,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Is the vision loss linked to amblyopia irreversible? Answer: Without timely intervention, the vision loss from amblyopia can become permanent. However, detecting the condition early and treating it promptly, especially in childhood, increases the chances of vision recovery and diminishes permanent loss.",2.3685972735685406e-08,0.05730511085940426,0.02425736961451249,0.0018134264647818726,0.057909609167349885,0.024375,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
225,1.1,6,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Can untreated amblyopia cause permanent vision deficits? Answer: Yes, if amblyopia remains untreated for a prolonged time, vision loss may become permanent. But early diagnosis and treatment, particularly among children, improve the chances of restoring vision and preventing permanent damage.",7.105791820705622e-08,0.04008125783265193,0.023242630385487524,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
225,1.1,7,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Is the visual loss in amblyopia permanent if not treated? Answer: The visual loss caused by amblyopia can become permanent if not treated for a long time. Early recognition and intervention, especially in children, improve outcomes and reduce the risk of lasting vision loss.",2.3685972735685406e-08,0.0707978381301353,0.06675736961451248,0.0018134264647818726,0.04094831008375399,0.046400951814396206,0.0018108015409528666,0.024097551579060017,0.0,2.3685972735685406e-08,0.0246926125903717,0.0
225,1.1,8,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Does amblyopia permanently damage vision? Answer: Vision loss from amblyopia can be permanent if untreated for extended periods, but early detection and treatment, especially in pediatric cases, can significantly improve vision and reduce permanent harm.",1.8948778188548272e-07,0.17361265045717467,0.023242630385487524,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
225,1.1,9,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Can amblyopia's visual impairment be reversed? Answer: Visual impairment due to amblyopia may be permanent if left untreated for lengthy time spans. Early detection and prompt treatment, particularly in children, increases the likelihood of vision restoration.",1.6580180914979742e-07,0.18394995018825266,0.004512471655328806,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
225,1.1,10,ai,"Question: Amblyopia: is visual loss permanent? Answer: Visual loss from amblyopia can be permanent if left untreated for a prolonged period. However, if detected early and treated promptly, especially in children, there is a higher chance of improving vision and reducing permanent visual loss.","Question: Is vision impairment from amblyopia enduring if not treated? Answer: Prolonged untreated amblyopia can cause lasting vision impairment; however, when identified and treated early, especially in children, the chances of improving vision and limiting permanence are higher.",1.4211583641411212e-07,0.1180427993023625,0.023242630385487524,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
226,1.1,1,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners reasonably serve as substitute examiners for faculty during an undergraduate OSCE on medical emergencies? It appears acceptable and justified to have medical students act as examiners in formative emergency medicine OSCE tests, though this may not be appropriate for summative assessments.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
226,1.1,2,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it reasonable for student examiners to act as substitutes for faculty in an undergraduate OSCE focused on medical emergencies? Encouraging medical students to serve as examiners in formative OSCEs on emergency medicine seems justifiable, but this may not extend to summative evaluation scenarios.",4.737194547137081e-08,0.04546237407675724,0.0,0.0036268529295637453,0.04652001563489394,0.0,0.003621603081905733,0.047628048989254435,0.0,4.737194547137081e-08,0.048790164169431716,0.0
226,1.1,3,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May student examiners logically replace faculty examiners in an undergraduate OSCE on medical emergencies? It seems both permissible and justified to allow medical students to officiate in formative emergency medicine OSCEs, but this practice might be unsuitable for summative assessments.",1.4211583641411233e-07,0.1431008436406751,0.0,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,1.1,4,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners acceptable substitutes for faculty in an undergraduate OSCE dealing with medical emergencies? Supporting medical students as examiners during formative OSCE tests in emergency medicine appears reasonable, though not necessarily for summative evaluations.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
226,1.1,5,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners serve as fair substitutes for faculty examiners in an undergraduate OSCE assessing medical emergencies? Using medical students as examiners in formative emergency medicine OSCE assessments is seemingly justified, but their role might be inappropriate for summative assessments.",1.4211583641411233e-07,0.17864685290015903,0.025623268698060954,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
226,1.1,6,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is it justified for medical students to act as substitute examiners for faculty in an undergraduate OSCE on medical emergencies? The evidence suggests it is allowable and appropriate for students to examine in formative emergency medicine testing, but less so for summative OSCEs.",7.105791820705622e-08,0.10199988008504324,0.023795359904818555,0.005440279394345618,0.07061756721395396,0.0,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
226,1.1,7,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Are student examiners a reasonable alternative to faculty examiners in an undergraduate OSCE regarding medical emergencies? Encouraging medical students to officiate in formative emergency medicine OSCEs is justified, although their involvement may not be suitable for summative assessments.",1.8948778188548293e-07,0.19574457712609394,0.0,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
226,1.1,8,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","May students substitute as examiners for faculty in an undergraduate OSCE on medical emergencies? It seems acceptable to have medical students participate as examiners in formative emergency medicine OSCEs, but not necessarily in summative assessment contexts.",2.3685972735685353e-07,0.29092283859861734,0.02854671280276816,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
226,1.1,9,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Is substituting student examiners for faculty in an undergraduate OSCE on medical emergencies a reasonable practice? Allowing medical students to officiate in formative emergency medicine OSCE assessments appears justified, whereas summative examination roles may not be appropriate.",2.1317375462116823e-07,0.22314355131420927,0.0,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
226,1.1,10,human,"Question: May student examiners be reasonable substitute examiners for faculty in an undergraduate OSCE on medical emergencies? Answer: It seems quite admissible and justified to encourage medical students to officiate as examiners in undergraduate emergency medicine OSCE formative testing, but not necessarily in summative assessment evaluations.","Can student examiners appropriately replace faculty in an undergraduate OSCE focused on medical emergencies? Encouraging their role in formative emergency medicine OSCE testing seems warranted, but their participation in summative assessments might not be advisable.",2.6054570009253883e-07,0.2803019651541576,0.0,0.019947691112600613,0.2876820724517817,0.0,0.019918816950481553,0.29546421289383584,0.0,2.6054570009253947e-07,0.30368241379822125,0.0
227,1.1,1,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae produce more noise than bubble CPAP in preterm infants? Answer: At the gas flow rates examined, HFNC are not louder than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,1.1,2,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae louder than bubble CPAP when used with preterm infants? Answer: At the studied gas flows, HFNC do not generate more noise than BCPAP for preterm infants.",9.47438909427412e-08,0.2408388096748837,0.07359999999999998,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,1.1,3,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is noise level higher with high flow nasal cannulae compared to bubble CPAP in preterm infants? Answer: For the gas flows investigated, HFNC are not noisier than BCPAP for preterm infants.",9.47438909427412e-08,0.2408388096748837,0.07359999999999998,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,1.1,4,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae make more noise than bubble CPAP in preterm infants? Answer: Based on the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.",7.10579182070559e-08,0.208048986851892,0.07359999999999998,0.005440279394345639,0.10919929196499067,0.0,0.005432404622858621,0.11332868530700413,0.0,7.105791820705622e-08,0.11778303565638426,0.0
227,1.1,5,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are the noise levels of high flow nasal cannulae greater than those of bubble CPAP in preterm infants? Answer: At the evaluated gas flows, HFNC do not produce more noise than BCPAP in preterm infants.",1.894877818854824e-07,0.32259125636143926,0.045053287197231826,0.014507411718255037,0.2682639865946794,0.0,0.014486412327622988,0.2776317365982801,0.0,1.8948778188548325e-07,0.28768207245178123,0.0
227,1.1,6,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Does the use of high flow nasal cannulae result in higher noise than bubble CPAP for preterm infants? Answer: Considering the tested gas flows, HFNC are not noisier than BCPAP for preterm infants.",1.421158364141118e-07,0.26135024662228146,0.043326562499999985,0.010880558788691277,0.20763936477824396,0.0,0.010864809245717241,0.2151113796169466,0.0,1.4211583641411244e-07,0.2231435513142097,0.0
227,1.1,7,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae noisier compared to bubble CPAP in preterm infants? Answer: With the gas flows studied, HFNC are not louder than BCPAP for preterm infants.",2.36859727356853e-08,0.13905611536494122,0.07359999999999998,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
227,1.1,8,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Do high flow nasal cannulae generate more noise than bubble CPAP in preterm infants? Answer: Based on the measured gas flow rates, HFNC are not noisier than BCPAP for preterm infants.",9.47438909427412e-08,0.2408388096748837,0.07359999999999998,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
227,1.1,9,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Is the noise from high flow nasal cannulae higher than that from bubble CPAP in preterm infants? Answer: At the specified gas flows, HFNC are not noisier than BCPAP for preterm infants.",1.184298636784265e-07,0.2725875079894635,0.07359999999999998,0.009067132323909398,0.17589066646366414,0.0,0.009054007704764368,0.1823215567939549,0.0,1.1842986367842703e-07,0.18924199963852795,0.0
227,1.1,10,human,"Question: Are high flow nasal cannulae noisier than bubble CPAP for preterm infants? Answer: At the gas flows studied, HFNC are not noisier than BCPAP for preterm infants.","Question: Are high flow nasal cannulae louder than bubble CPAP at the gas flows used for preterm infants? Answer: At the flows studied, HFNC are not noisier than BCPAP for preterm infants.",9.47438909427412e-08,0.15140046379618122,0.009390725326991672,0.007253705859127518,0.14310084364067244,0.0,0.007243206163811494,0.14842000511827314,0.0,9.474389094274162e-08,0.15415067982725894,0.0
228,1.1,1,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Does having both major depression and alcohol use disorder during adolescence result in worse outcomes for depression? When these two conditions co-occur, they can intensify each other and lengthen depressive episodes, leading to poorer depression outcomes, hence treatment must target both simultaneously for improved results.",3.552895910352811e-07,0.058382664034933196,0.1624323198667222,0.02720139697172809,0.10802987952597531,0.13440000000000002,0.027162023114293,0.15945592732803604,0.10380622837370242,3.552895910352811e-07,0.2127585982365634,0.07100591715976332
228,1.1,2,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","In adolescents, comorbid major depression and alcohol use disorder may cause poorer depression outcomes, as each condition can worsen the other and extend depressive episodes. Effective treatment should address both issues at once.",6.395212638635051e-07,0.37683639515346856,0.1624323198667222,0.04896251454911059,0.435242790734391,0.13440000000000002,0.04889164160572743,0.495928163949249,0.10380622837370242,6.39521263863506e-07,0.5590348349543981,0.07100591715976332
228,1.1,3,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.",The coexistence of major depression and alcohol use disorder in adolescents often results in a more severe prognosis for depression since both disorders can amplify symptoms and prolong episodes. Concurrent treatment of both conditions yields better outcomes.,5.447773729207639e-07,0.25905335949708475,0.1624323198667222,0.04170880868998307,0.3138819337301242,0.13440000000000002,0.04164843544191594,0.370765020995242,0.10380622837370242,5.447773729207643e-07,0.4298231034743911,0.07100591715976332
228,1.1,4,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.",Adolescent major depression paired with alcohol use disorder tends to produce worse depression outcomes due to mutual exacerbation and longer depressive periods. Therapy must simultaneously tackle both disorders for optimal recovery.,6.868932093348757e-07,0.4413749162910401,0.1624323198667222,0.05258936747867435,0.5019341652330644,0.13440000000000002,0.05251324468763318,0.5649210354361998,0.10380622837370242,6.868932093348768e-07,0.6304937989365418,0.07100591715976332
228,1.1,5,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","When major depression and alcohol use disorder are present together in adolescence, they can lead to more challenging depression outcomes because each condition worsens the other and prolongs symptoms. Comprehensive treatment addressing both disorders concurrently is crucial.",5.447773729207639e-07,0.25905335949708475,0.1624323198667222,0.04170880868998307,0.3138819337301242,0.13440000000000002,0.04164843544191594,0.370765020995242,0.10380622837370242,5.447773729207643e-07,0.4298231034743911,0.07100591715976332
228,1.1,6,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.",The combination of major depression and alcohol use disorder during adolescence can negatively impact depression outcomes by intensifying symptoms and extending depressive phases. Treatment should focus on both conditions simultaneously for improved efficacy.,6.395212638635051e-07,0.37683639515346856,0.1624323198667222,0.04896251454911059,0.435242790734391,0.13440000000000002,0.04889164160572743,0.495928163949249,0.10380622837370242,6.39521263863506e-07,0.5590348349543981,0.07100591715976332
228,1.1,7,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","In adolescents, the dual diagnosis of major depression and alcohol use disorder may result in poorer outcomes for depression, as the disorders can heighten each other's severity and prolong depressive episodes. Addressing both in treatment improves prognosis.",5.447773729207639e-07,0.25905335949708475,0.1624323198667222,0.04170880868998307,0.3138819337301242,0.13440000000000002,0.04164843544191594,0.370765020995242,0.10380622837370242,5.447773729207643e-07,0.4298231034743911,0.07100591715976332
228,1.1,8,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.",Major depression accompanied by alcohol use disorder in adolescent patients can lead to more adverse depression outcomes through mutual reinforcement and lengthening of depressive episodes. Simultaneous treatment is essential to improve outcomes.,6.632072365991904e-07,0.4085850934680484,0.1624323198667222,0.05077594101389247,0.4680326135573827,0.13440000000000002,0.05070244314668031,0.5298297156249308,0.10380622837370242,6.632072365991914e-07,0.5941261547656671,0.07100591715976332
228,1.1,9,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.",Comorbid major depression and alcohol use disorder in adolescence typically cause poorer depression outcomes because each can exacerbate the other's impact and extend the duration of depressive episodes. Optimizing treatment entails targeting both conditions together.,5.921493183921345e-07,0.3162117733370331,0.1624323198667222,0.04533566161954683,0.37272243375305747,0.13440000000000002,0.045270038523821686,0.43138964281167747,0.10380622837370242,5.921493183921352e-07,0.49234346045572464,0.07100591715976332
228,1.1,10,ai,"Question: Major depression and alcohol use disorder in adolescence: Does comorbidity lead to poorer outcomes of depression? Answer: Comorbidity of major depression and alcohol use disorder in adolescence can lead to poorer outcomes of depression, as the two conditions can exacerbate each other and prolong the duration of depressive episodes. Treatment should address both conditions simultaneously to achieve better outcomes.","Adolescents suffering from both major depression and alcohol use disorder often experience worsened depression outcomes due to reciprocal amplification of symptoms and longer depressive episodes, necessitating treatment that concurrently addresses both conditions.",6.632072365991904e-07,0.4085850934680484,0.1624323198667222,0.05077594101389247,0.4680326135573827,0.13440000000000002,0.05070244314668031,0.5298297156249308,0.10380622837370242,6.632072365991914e-07,0.5941261547656671,0.07100591715976332
229,1.1,1,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Hypotensive episodes in individuals with coronary artery disease may induce myocardial ischemic incidents due to significant blood pressure reduction that diminishes oxygen delivery to the heart, possibly leading to a heart attack.",4.7371945471370717e-07,0.3891094587395787,0.07786328655500228,0.03626852929563749,0.45537384932119496,0.039930555555555566,0.036216030819057374,0.49623274646864557,0.020399305555555556,4.737194547137081e-07,0.5389965007326869,0.0
229,1.1,2,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","In patients suffering from coronary disease, severe hypotension can cause myocardial ischemia by lowering the heart’s oxygen supply, which may result in ischemic events like heart attacks.",5.921493183921337e-07,0.5650001252032428,0.07786328655500228,0.045335661619546885,0.6376954061151499,0.039930555555555566,0.04527003852382174,0.6854747461071735,0.020399305555555556,5.921493183921352e-07,0.7357067949787415,0.0
229,1.1,3,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",Marked hypotensive events in those with coronary disease have the potential to initiate myocardial ischemia by causing a considerable drop in blood pressure and consequently less oxygen reaching the heart.,5.210914001850778e-07,0.45580083323825216,0.07786328655500228,0.03989538222520125,0.5243667208081457,0.039930555555555566,0.03983763390096312,0.5676917104507893,0.020399305555555556,5.210914001850789e-07,0.6131044728864086,0.0
229,1.1,4,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","For patients with coronary disease, profound episodes of low blood pressure can trigger myocardial ischemic events through reduced oxygen supply, and this can possibly lead to a heart attack.",5.447773729207631e-07,0.49089215304952116,0.07786328655500228,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6054320384336362,0.020399305555555556,5.447773729207643e-07,0.652325186039691,0.0
229,1.1,5,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Myocardial ischemia can occur in coronary disease patients during profound hypotensive events because the significant fall in blood pressure limits oxygen availability to cardiac tissue, potentially causing heart attacks.",5.447773729207631e-07,0.49089215304952116,0.07786328655500228,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6054320384336362,0.020399305555555556,5.447773729207643e-07,0.652325186039691,0.0
229,1.1,6,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Severe decreases in blood pressure in patients with coronary artery disease can reduce myocardial oxygen delivery, thus triggering ischemic events including heart attacks.",6.868932093348749e-07,0.7320542098664098,0.07786328655500228,0.052589367478674404,0.8120487932599283,0.039930555555555566,0.052513244687633236,0.8677963029011284,0.020399305555555556,6.868932093348767e-07,0.9267620317414509,0.0
229,1.1,7,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","In coronary disease patients, notable hypotensive episodes might result in myocardial ischemia by sharply lowering blood pressure and impairing the heart’s oxygen supply, which could lead to heart attack.",5.447773729207631e-07,0.49089215304952116,0.07786328655500228,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6054320384336362,0.020399305555555556,5.447773729207643e-07,0.652325186039691,0.0
229,1.1,8,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Profound hypotension in coronary diseased patients can induce myocardial ischemia by restricting oxygen flow due to decreased blood pressure, possibly precipitating heart attacks.",6.868932093348749e-07,0.7320542098664098,0.07786328655500228,0.052589367478674404,0.8120487932599283,0.039930555555555566,0.052513244687633236,0.8677963029011284,0.020399305555555556,6.868932093348767e-07,0.9267620317414509,0.0
229,1.1,9,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.","Coronary disease patients experiencing significant hypotensive events may face myocardial ischemia as a consequence of reduced oxygen delivery to the heart, increasing the risk of ischemic heart episodes.",5.684633456564484e-07,0.5272597972203958,0.07786328655500228,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6446527515869187,0.020399305555555556,5.684633456564497e-07,0.6931471805599458,0.0
229,1.1,10,ai,"Question: Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events? Answer: Hypotensive events in patients with coronary disease can potentially lead to myocardial ischemic events. Profound drops in blood pressure can decrease the oxygen supply to the heart, resulting in ischemia and potentially triggering a heart attack.",A critical drop in blood pressure in those with coronary artery disease can cause myocardial ischemic events by limiting oxygen supply to the heart and potentially causing heart attacks.,5.447773729207631e-07,0.49089215304952116,0.07786328655500228,0.041708808689983126,0.5607343649790204,0.039930555555555566,0.041648435441915994,0.6054320384336362,0.020399305555555556,5.447773729207643e-07,0.652325186039691,0.0
230,1.1,1,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using",Question: Is it advisable to screen HIV-positive patients for silent myocardial ischemia with gated myocardial perfusion SPECT? Answer: Male HIV-positive patients over 52 with at least two cardiovascular risk factors (CRFs) had about four times higher likelihood of positive SMI screening via myocardial SPECT compared to the general population. This could encourage doctors to recommend more routine SMI screening in these patients.,1.1842986367842703e-07,0.04021531192032057,0.02760458812982383,0.009067132323909363,0.037387496562156564,0.03073822121441168,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
230,1.1,2,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Question: Should clinicians screen HIV-infected individuals for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: In men infected with HIV older than 52 who have two or more cardiovascular risk factors, the chance of a positive SMI result on myocardial SPECT was approximately quadrupled relative to the general population. This finding suggests that systematic screening should be considered in these patients.",1.1842986367842703e-07,0.005236962214757668,0.060353798126951096,0.009067132323909363,0.037387496562156564,0.03073822121441168,0.009054007704764333,0.059684790061456106,0.015621063240110858,1.1842986367842703e-07,0.08269171584511614,0.0
230,1.1,3,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Question: Is it necessary to perform screening for silent myocardial ischemia by myocardial perfusion SPECT in HIV-infected patients? Answer: Among male HIV-infected patients above 52 years of age with at least two additional cardiovascular risk factors, myocardial SPECT screening revealed about fourfold greater positive SMI rates than those seen in the general population. Hence, physicians might be encouraged to conduct systematic SMI screening in these cases.",2.3685972735685406e-08,0.068750367937084,0.060353798126951096,0.0018134264647818726,0.027151024575415406,0.03073822121441168,0.0018108015409528666,0.005912492424360316,0.015621063240110858,2.3685972735685406e-08,0.01600034134644357,0.0
230,1.1,4,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Question: For male HIV patients over 52 with multiple cardiovascular risk factors, is screening with gated myocardial perfusion SPECT recommended for silent myocardial ischemia? Answer: Such patients showed about a fourfold increase in positive SMI detection using myocardial perfusion SPECT compared to the general population, providing a rationale for recommending more systematic screening.",3.316036182995957e-07,0.2077121972663516,0.021953798126951085,0.025387970506946217,0.22708866843483033,0.011138221214411683,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
230,1.1,5,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Question: Is gated myocardial perfusion SPECT a useful screening tool for silent myocardial ischemia in HIV+ male patients above 52 years with at least two cardiovascular risk factors? Answer: Screening these patients identified positive cases to a rate about four times higher than in the general population, highlighting a potential benefit for more routine SMI evaluation.",2.6054570009253947e-07,0.09830371672608162,0.060353798126951096,0.0199476911126006,0.14274801221998068,0.03073822121441168,0.019918816950481533,0.16693032041505385,0.015621063240110858,2.6054570009253947e-07,0.19189100781010726,0.0
230,1.1,6,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Question: Should HIV-positive males older than 52 years with multiple cardiovascular risk factors be systematically screened for silent myocardial ischemia using myocardial perfusion SPECT? Answer: Screening in this group resulted in approximately four times greater detection of positive SMI than the general population, supporting recommendations for systematic use of this screening method.",3.552895910352811e-07,0.17381126923422752,0.060353798126951096,0.02720139697172809,0.21970905335611057,0.03073822121441168,0.027162023114293,0.24540193585654801,0.015621063240110858,3.552895910352811e-07,0.2719337154836441,0.0
230,1.1,7,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Question: Does gated myocardial perfusion SPECT screening justify use in HIV-infected men aged over 52 with two or more cardiovascular risk factors to detect silent myocardial ischemia? Answer: Studies indicate that these patients have about fourfold higher positive SMI findings compared to the general population, reinforcing the need for systematic screening.",3.789755637709665e-07,0.19361389653040728,0.060353798126951096,0.029014823436509962,0.23991176067362918,0.03073822121441168,0.028972824655245866,0.2660212230592838,0.015621063240110858,3.789755637709665e-07,0.29298712468147725,0.0
230,1.1,8,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Question: Should patients infected with HIV and older than 52 years who have multiple cardiovascular risk factors be screened for silent myocardial ischemia using myocardial perfusion SPECT? Answer: These patients were about four times more likely to test positive for SMI than the general population, potentially prompting more consistent screening protocols.",3.789755637709665e-07,0.19361389653040728,0.060353798126951096,0.029014823436509962,0.23991176067362918,0.03073822121441168,0.028972824655245866,0.2660212230592838,0.015621063240110858,3.789755637709665e-07,0.29298712468147725,0.0
230,1.1,9,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Question: Is there a medical rationale for screening male HIV patients older than 52 years with two-plus cardiovascular risk factors for silent myocardial ischemia using gated myocardial perfusion SPECT? Answer: Positive SMI detection rates were roughly four times higher in this group compared to the general population, which may justify increased screening efforts.",3.316036182995957e-07,0.15439318337712482,0.060353798126951096,0.025387970506946217,0.1999064260599308,0.03073822121441168,0.025351221573340132,0.2251992285390294,0.015621063240110858,3.316036182995957e-07,0.25131442828090833,0.0
230,1.1,10,human,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: In male HIV-infected patients older than 52 years and with at least two other CRFs, screening for SMI using myocardial SPECT was about four times more likely to be positive than in the general population. This may motivate physicians to advise these patients to undergo more systematic screening for SMI using","Question: In the context of HIV-infected men aged over 52 with at least two other cardiovascular risk factors, should silent myocardial ischemia screening by gated myocardial perfusion SPECT be performed? Answer: This demographic showed about a fourfold increase in positive SMI results relative to general population rates, suggesting that physicians might encourage systematic SMI screening in them.",2.3685972735685406e-07,0.08028521122340315,0.060353798126951096,0.018134264647818726,0.12439887355178492,0.03073822121441168,0.018108015409528666,0.1482381874028995,0.015621063240110858,2.3685972735685406e-07,0.17284281283941416,0.0
231,1.1,1,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy less invasive compared to retropubic radical prostatectomy? Yes, it is typically regarded as less invasive than the retropubic method.",9.47438909427412e-08,0.13466064540605283,0.18063432052089884,0.007253705859127518,0.09637852790998469,0.17561983471074386,0.007243206163811494,0.007097042995488412,0.11342155009451795,9.474389094274162e-08,0.11890161269998334,0.03993055555555556
231,1.1,2,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Does robotically assisted laparoscopic radical prostatectomy present a less invasive option than retropubic radical prostatectomy? Yes, it is usually thought to be less invasive.",1.184298636784265e-07,0.14986329603391768,0.2222222222222221,0.009067132323909398,0.05192676533915064,0.17561983471074386,0.009054007704764368,0.05361705863038235,0.11342155009451795,1.1842986367842698e-07,0.1676917768694146,0.03993055555555556
231,1.1,3,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is the robotically assisted laparoscopic approach to radical prostatectomy less invasive than the retropubic approach? Yes, this minimally invasive technique is generally preferred for being less invasive.",4.73719454713706e-08,0.2724656181262506,0.2222222222222221,0.003626852929563759,0.17976013684903513,0.17561983471074386,0.003621603081905747,0.07991433399414127,0.11342155009451795,4.737194547137081e-08,0.027929834494255346,0.03993055555555556
231,1.1,4,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy considered less invasive relative to retropubic radical prostatectomy? Yes, it is commonly seen as the less invasive procedure.",1.184298636784265e-07,0.08958962815913951,0.17883379247015596,0.009067132323909398,0.05192676533915064,0.17561983471074386,0.009054007704764368,0.05361705863038235,0.11342155009451795,1.1842986367842698e-07,0.1676917768694146,0.03993055555555556
231,1.1,5,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is the robotically assisted laparoscopic method for radical prostatectomy less invasive than the retropubic method? Yes, it is often recognized as less invasive.",1.421158364141118e-07,0.10541153346308363,0.2222222222222221,0.010880558788691277,0.005406749704256697,0.17561983471074386,0.010864809245717241,0.10240722279981362,0.11342155009451795,1.4211583641411233e-07,0.21898507125696476,0.03993055555555556
231,1.1,6,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Does robotically assisted laparoscopic radical prostatectomy have a less invasive profile than retropubic radical prostatectomy? Yes, it is regarded as less invasive on average.",1.184298636784265e-07,0.08958962815913951,0.17883379247015596,0.009067132323909398,0.05192676533915064,0.17561983471074386,0.009054007704764368,0.05361705863038235,0.11342155009451795,1.1842986367842698e-07,0.1676917768694146,0.03993055555555556
231,1.1,7,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy believed to be less invasive relative to the retropubic surgery? Yes, it generally causes less tissue disruption.",1.421158364141118e-07,0.10541153346308363,0.2222222222222221,0.010880558788691277,0.005406749704256697,0.17561983471074386,0.010864809245717241,0.10240722279981362,0.11342155009451795,1.4211583641411233e-07,0.21898507125696476,0.03993055555555556
231,1.1,8,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is robotically assisted laparoscopic radical prostatectomy a less invasive procedure than retropubic radical prostatectomy? Yes, it is frequently considered less invasive.",1.8948778188548245e-07,0.010101353658758416,0.2222222222222221,0.014507411718255037,0.09467670885272472,0.17561983471074386,0.014486412327622988,0.20776773845763907,0.11342155009451795,1.8948778188548304e-07,0.33021070636718886,0.03993055555555556
231,1.1,9,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is the invasiveness of robotically assisted laparoscopic radical prostatectomy lower than that of retropubic radical prostatectomy? Yes, it is usually described as less invasive.",1.184298636784265e-07,0.14986329603391768,0.2222222222222221,0.009067132323909398,0.05192676533915064,0.17561983471074386,0.009054007704764368,0.05361705863038235,0.11342155009451795,1.1842986367842698e-07,0.1676917768694146,0.03993055555555556
231,1.1,10,ai,"Question: Is robotically assisted laparoscopic radical prostatectomy less invasive than retropubic radical prostatectomy? Answer: Yes, robotically assisted laparoscopic radical prostatectomy is generally considered to be less invasive than retropubic","Is the use of robotically assisted laparoscopic technique for radical prostatectomy less invasive compared to the retropubic approach? Yes, it is typically noted for being less invasive.",4.73719454713706e-08,0.2724656181262506,0.2222222222222221,0.003626852929563759,0.17976013684903513,0.17561983471074386,0.003621603081905747,0.07991433399414127,0.11342155009451795,4.737194547137081e-08,0.027929834494255346,0.03993055555555556
232,1.1,1,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study investigates the possibility of employing Nd:YAG laser-induced thermo therapy to locally disrupt the blood-brain barrier in rodents for enhanced drug delivery.,0.0,0.030806541358219697,0.02171630103558378,0.0,0.031506690025452144,0.022636492852053384,0.0,0.032239403746974205,0.023242630385487524,0.0,0.0,0.0
232,1.1,2,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: could this be a novel adjuvant glioma treatment? Answer: This research examines the use of Nd:YAG laser-induced thermo therapy to selectively open the blood-brain barrier in rodents, facilitating improved delivery of paclitaxel.",2.3685972735685406e-08,0.05479457033948698,0.02314288573111692,0.0018134264647818726,0.05467969454474275,0.023140730121249602,0.0018108015409528666,0.05522892197167373,0.023242630385487524,2.3685972735685406e-08,0.023530497410194418,0.0
232,1.1,3,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Can Nd:YAG laser-induced thermo therapy achieve locoregional opening of the rodent blood-brain barrier to improve paclitaxel delivery as a new adjuvant glioma therapy? Answer: The study assesses whether Nd:YAG laser-based thermo therapy can locally open the blood-brain barrier in rodents to enhance drug penetration.,2.3685972735685406e-08,0.03773992952991634,0.04269135772492618,0.0018134264647818726,0.04002386182620521,0.045351473922902494,0.0018108015409528666,0.008708906336779787,0.023242630385487524,2.3685972735685406e-08,0.024097551579060017,0.0
232,1.1,4,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Locoregional blood-brain barrier opening in rodents via Nd:YAG laser-induced thermo therapy for paclitaxel delivery: a novel glioma treatment approach? Answer: The work explores Nd:YAG laser thermo therapy's potential to transiently disrupt the blood-brain barrier in rodents, improving drug access.",1.4211583641411233e-07,0.05542068746728024,0.062419562949767714,0.010880558788691236,0.08359009414097063,0.045351473922902494,0.0108648092457172,0.1180427993023625,0.023242630385487524,1.4211583641411244e-07,0.1541506798272576,0.0
232,1.1,5,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Is locoregional opening of the rodent blood-brain barrier using Nd:YAG laser-induced thermo therapy a new concept for glioma adjuvant therapy? Answer: The research investigates how Nd:YAG laser-induced thermo therapy may locally open the blood-brain barrier in rodents to enhance paclitaxel delivery.,9.474389094274162e-08,0.10511248798629236,0.008377913421565075,0.0072537058591274906,0.10161151780941502,0.004510021921972841,0.007243206163811466,0.10094507507642758,0.00238063831257343,9.474389094274162e-08,0.10008345855698142,0.0
232,1.1,6,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Using Nd:YAG laser-induced thermo therapy to locally open the rodent blood-brain barrier for paclitaxel: a new adjuvant treatment strategy for glioma? Answer: This study tests the feasibility of Nd:YAG laser-induced thermo therapy to selectively open the blood-brain barrier in rodents enabling better drug delivery.,2.3685972735685406e-08,0.0882868305718909,0.04492115727183896,0.0018134264647818726,0.05669434941471785,0.0240235260770975,0.0018108015409528666,0.05730511085940426,0.02425736961451249,2.3685972735685406e-08,0.057909609167349885,0.024375
232,1.1,7,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel via Nd:YAG laser-induced thermo therapy as a novel adjuvant glioma therapy? Answer: This investigation focuses on Nd:YAG laser-induced thermo therapy to achieve localized blood-brain barrier opening in rodents to improve therapeutic delivery.,7.105791820705622e-08,0.07779474044644408,0.00613999383693585,0.005440279394345618,0.07522830233962896,0.003300728575453847,0.0054324046228586,0.07473861686064831,0.0017409330596143968,7.105791820705622e-08,0.07410797215372344,0.0
232,1.1,8,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Can Nd:YAG laser-induced thermo therapy serve as a locoregional method to open the blood-brain barrier in rodents for enhancing paclitaxel delivery in glioma treatment? Answer: The study explores this technique as a strategy to improve drug delivery by locally disrupting the blood-brain barrier.,4.737194547137081e-08,0.013284983862173139,0.04164187983343246,0.0036268529295637453,0.01649336441601079,0.045351473922902494,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
232,1.1,9,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery",Question: Locoregional disruption of the rodent blood-brain barrier via Nd:YAG laser-induced thermo therapy for improved paclitaxel therapy in glioma: a new conceptual approach? Answer: The research evaluates Nd:YAG laser thermo therapy for targeted blood-brain barrier opening to advance drug delivery in rodents.,9.474389094274162e-08,0.07130043039800293,0.015328150207385441,0.0072537058591274906,0.0669541587814173,0.020367910477800573,0.007243206163811466,0.06539906581694366,0.023242630385487524,9.474389094274162e-08,0.10008345855698142,0.0
232,1.1,10,ai,"Question: Locoregional opening of the rodent blood-brain barrier for paclitaxel using Nd:YAG laser-induced thermo therapy: a new concept of adjuvant glioma therapy? Answer: The study explores the potential of using Nd:YAG laser-induced thermo therapy to locally open the blood-brain barrier in rodents, allowing for better delivery","Question: Investigating locoregional opening of the blood-brain barrier in rodents using Nd:YAG laser-induced thermo therapy to improve paclitaxel delivery for glioma treatment: a new concept? Answer: This study examines Nd:YAG laser-induced thermo therapy's ability to locally open the blood-brain barrier, facilitating enhanced drug administration.",4.737194547137081e-08,0.01895441988480151,0.018667831647828675,0.0036268529295637453,0.01651364418208079,0.02155611401808394,0.003621603081905733,0.01538864524228023,0.023242630385487524,4.737194547137081e-08,0.048790164169431716,0.0
233,1.1,1,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young patients a unique clinical condition? Answer: Research is ongoing to find out if colorectal cancer in young patients represents a unique clinical entity. Some studies indicate differences in tumor characteristics and,7.10579182070559e-08,0.13336172156276183,0.03456747404844296,0.005440279394345618,0.13122744784045715,0.03401558750451271,0.005432404622858607,0.12863669998736116,0.03158757716049383,7.105791820705622e-08,0.12902029702356588,0.0302734375
233,1.1,2,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Could colorectal cancer in young patients be considered a separate clinical entity? Answer: Studies are currently being conducted to explore whether colorectal cancer among young individuals is a distinct clinical condition. Evidence points to variations in tumor features and,0.0,0.14218403703793658,0.09980925725349613,0.0,0.10944429166736036,0.0783673469387755,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
233,1.1,3,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in younger individuals a distinct clinical syndrome? Answer: Ongoing investigations aim to confirm if colorectal cancer in young people constitutes a distinct clinical entity. Findings from some studies reveal differences in tumor characteristics and,4.73719454713706e-08,0.02478334784960934,0.01891278306817784,0.0036268529295637453,0.021639282998465514,0.023004025139467532,0.003621603081905733,0.01810243598940975,0.027006172839506164,4.737194547137081e-08,0.05715841383994835,0.0
233,1.1,4,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Does colorectal cancer in young patients represent an independent clinical entity? Answer: There is active research to establish whether colorectal cancer seen in young patients is a separate clinical entity. Certain studies suggest that tumor characteristics differ and,2.36859727356853e-08,0.04231026822680217,0.047065179012781566,0.0018134264647818726,0.045308629419797075,0.05136117409926934,0.0018108015409528666,0.010068440977287096,0.027006172839506164,2.3685972735685406e-08,0.028170876966696845,0.0
233,1.1,5,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is early-onset colorectal cancer a distinct clinical condition? Answer: Researchers are examining whether colorectal cancer that develops in young patients should be classified as a separate clinical entity. Some research reports note differences in tumor characteristics and,4.73719454713706e-08,0.08761889764659925,0.0984263531120509,0.0036268529295637453,0.05537707039708417,0.0783673469387755,0.003621603081905733,0.01810243598940975,0.027006172839506164,4.737194547137081e-08,0.05715841383994835,0.0
233,1.1,6,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Could colorectal cancer occurring in young patients be a unique clinical form? Answer: Ongoing studies are investigating if colorectal cancer in younger patients can be identified as a distinct clinical entity. There is evidence of differing tumor characteristics and,0.0,0.14218403703793658,0.09980925725349613,0.0,0.10944429166736036,0.0783673469387755,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
233,1.1,7,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer among younger patients a separate clinical entity? Answer: There is continued scientific inquiry regarding whether colorectal cancer in young patients is a distinct clinical form. Some scientific work highlights variability in tumor characteristics and,4.73719454713706e-08,0.08761889764659925,0.0984263531120509,0.0036268529295637453,0.05537707039708417,0.0783673469387755,0.003621603081905733,0.01810243598940975,0.027006172839506164,4.737194547137081e-08,0.05715841383994835,0.0
233,1.1,8,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in young adults considered a distinct clinical entity? Answer: Research efforts are underway to determine if colorectal cancer in young adults is a separate clinical entity. Certain studies point toward differences in tumor characteristics and,2.36859727356853e-08,0.0058288376710153855,0.021626297577854642,0.0018134264647818726,0.029626200911009093,0.0020824800508438407,0.0018108015409528666,0.06694791241826259,0.02835714895980181,2.3685972735685406e-08,0.06777928728440807,0.02854671280276816
233,1.1,9,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Is colorectal cancer in the young a distinctive clinical condition? Answer: Current research is focused on understanding if colorectal cancer in young individuals is a distinctive clinical entity. Some studies suggest that tumors have different characteristics and,4.73719454713706e-08,0.02478334784960934,0.01891278306817784,0.0036268529295637453,0.021639282998465514,0.023004025139467532,0.003621603081905733,0.01810243598940975,0.027006172839506164,4.737194547137081e-08,0.05715841383994835,0.0
233,1.1,10,ai,Question: Colorectal cancer in young patients: is it a distinct clinical entity? Answer: There is ongoing research to determine if colorectal cancer in young patients is a distinct clinical entity. Some studies suggest there are differences in tumor characteristics and,Question: Can colorectal cancer in younger patients be regarded as a distinct clinical entity? Answer: Investigations are ongoing to ascertain if colorectal cancer in young patients should be considered a separate clinical entity. Some data suggest tumor characteristics differ and,0.0,0.10663802777845222,0.07430031265718162,0.0,0.07296286111157402,0.05207078010166813,0.0,0.03746741516540242,0.027006172839506164,0.0,0.0,0.0
234,1.1,1,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Can analyzing APC mutations aid in making treatment decisions for familial adenomatous polyposis? Yes, studying APC mutations can inform therapeutic strategies in individuals with familial adenomatous polyposis by revealing specific mutations that guide targeted therapies or surgical options.",4.500334819780224e-07,0.41510283907602075,0.00047776461955376104,0.03445510283085558,0.3986088947559989,0.0181755829903978,0.034405229278104466,0.4336359850748619,0.0,4.500334819780227e-07,0.44393138893595907,0.0
234,1.1,2,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Is APC mutation analysis useful for therapy planning in familial adenomatous polyposis? Indeed, APC mutation assessment helps tailor treatment approaches by identifying mutation specifics, which can influence choices like targeted drugs or surgery.",5.684633456564489e-07,0.5286717173747117,0.022182304611052105,0.04352223515476497,0.5481406287269626,0.0181755829903978,0.04345923698286883,0.5877866649021204,0.0,5.684633456564497e-07,0.6029960835656478,0.0
234,1.1,3,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Does APC mutation testing influence treatment choices in familial adenomatous polyposis? Yes, analyzing APC mutations assists in therapeutic decision-making by providing detailed mutation data to guide targeted or surgical treatments.",6.395212638635048e-07,0.5837900914029674,0.05339978640085441,0.04896251454911061,0.649923323036905,0.0181755829903978,0.048891641605727454,0.6931471805599458,0.0,6.39521263863506e-07,0.7121953755306385,0.0
234,1.1,4,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Can mutation analysis of APC impact therapy decisions for familial adenomatous polyposis patients? Yes, examining APC mutations offers essential insight that aids in selecting appropriate treatments, including targeted and surgical interventions.",6.158352911278195e-07,0.5498885397272857,0.05339978640085441,0.04714908808432873,0.614832003225636,0.0181755829903978,0.04708084006477458,0.6567795363890712,0.0,6.158352911278206e-07,0.6744550475477915,0.0
234,1.1,5,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Is it beneficial to analyze APC mutations when deciding therapies for familial adenomatous polyposis? Absolutely, APC mutation analysis contributes valuable information that supports personalized treatment strategies such as targeted therapy or surgery.",5.921493183921342e-07,0.517098716904294,0.05339978640085441,0.04533566161954685,0.5809304515499543,0.0181755829903978,0.04527003852382171,0.6216882165778022,0.0,5.921493183921352e-07,0.6380874033769168,0.0
234,1.1,6,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Does identifying APC mutations play a role in therapeutic choices for familial adenomatous polyposis? Yes, detecting specific APC gene mutations helps direct treatment options, from targeted therapies to surgical procedures.",6.395212638635048e-07,0.5837900914029674,0.05339978640085441,0.04896251454911061,0.649923323036905,0.0181755829903978,0.048891641605727454,0.6931471805599458,0.0,6.39521263863506e-07,0.7121953755306385,0.0
234,1.1,7,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Can evaluations of APC mutations guide therapeutic decisions in familial adenomatous polyposis? Yes, understanding the exact APC mutation enables more informed treatment planning, including targeted and surgical approaches.",6.868932093348754e-07,0.6552490553851111,0.05339978640085441,0.05258936747867437,0.7240312951906267,0.0181755829903978,0.0525132446876332,0.7701082216960753,0.0,6.868932093348768e-07,0.7922380832041758,0.0
234,1.1,8,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Is APC mutation analysis significant for making therapy decisions in familial adenomatous polyposis? Yes, APC mutation insights are useful in tailoring treatment, impacting decisions on targeted therapies and surgical methods.",6.395212638635048e-07,0.6315933452346876,0.018961010890650318,0.04896251454911061,0.649923323036905,0.0181755829903978,0.048891641605727454,0.6931471805599458,0.0,6.39521263863506e-07,0.7121953755306385,0.0
234,1.1,9,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Will APC mutation analysis influence the treatment plan for familial adenomatous polyposis? Yes, examining APC mutations can determine the best treatment options by revealing mutation details that guide targeted or surgical care.",5.921493183921342e-07,0.517098716904294,0.05339978640085441,0.04533566161954685,0.5809304515499543,0.0181755829903978,0.04527003852382171,0.6216882165778022,0.0,5.921493183921352e-07,0.6380874033769168,0.0
234,1.1,10,ai,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: Yes, APC mutation analysis can help in determining the appropriate therapeutic approach for individuals with familial adenomatous polyposis. It can provide valuable information about the specific mutation present, which can guide treatment decisions such as the use of targeted therapies or surgical interventions.","Does APC mutation identification assist in choosing therapies for familial adenomatous polyposis? Yes, mutation analysis of APC provides critical data that influences whether targeted treatments or surgery are most appropriate.",6.395212638635048e-07,0.5837900914029674,0.05339978640085441,0.04896251454911061,0.649923323036905,0.0181755829903978,0.048891641605727454,0.6931471805599458,0.0,6.39521263863506e-07,0.7121953755306385,0.0
235,1.1,1,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms important when selecting patients for phase I clinical trials? Answer: Older adults with more symptoms participating in PICT might trade quality of life for access to experimental treatments.,9.47438909427412e-08,0.14310084364067244,0.0,0.007253705859127518,0.14842000511827314,0.0,0.007243206163811494,0.15415067982725894,0.0,9.474389094274162e-08,0.1603426500751799,0.0
235,1.1,2,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Does symptom presence influence patient selection in phase I clinical trials? Answer: Older adults enrolled in PICT who have more symptoms may experience a decrease in quality of life due to participation in experimental treatments.,2.131737546211677e-07,0.29725152346793093,0.0,0.016320838183036916,0.3074846997479619,0.0,0.016297213868575862,0.3184537311185349,0.0,2.1317375462116866e-07,0.33024168687057687,0.0
235,1.1,3,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Should symptoms be taken into account for patient inclusion in phase I clinical trials? Answer: Older patients with a higher symptom burden in PICT might sacrifice their quality of life to receive experimental therapy.,1.894877818854824e-07,0.2682639865946794,0.0,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
235,1.1,4,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,"Question: Are patient symptoms a factor when considering candidates for phase I trials? Answer: In PICT, older adults presenting more symptoms may endure a reduction in quality of life for the chance of experimental treatment.",1.894877818854824e-07,0.2682639865946794,0.0,0.014507411718255037,0.2776317365982801,0.0,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
235,1.1,5,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms play a role in selecting patients for phase I clinical trials? Answer: Older adults with increased symptoms enrolled in PICT could compromise quality of life to pursue experimental treatments.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,1.1,6,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Is symptom evaluation important in choosing patients for phase I clinical trials? Answer: Older patients involved in PICT who report more symptoms may risk quality of life in exchange for experimental therapy.,1.421158364141118e-07,0.20763936477824396,0.0,0.010880558788691277,0.2151113796169466,0.0,0.010864809245717241,0.2231435513142097,0.0,1.4211583641411244e-07,0.23180161405732358,0.0
235,1.1,7,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: To what extent do symptoms affect patient considerations in phase I trials? Answer: Older adults participating in PICT with greater symptom severity might forgo quality of life for the benefit of experimental treatment.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
235,1.1,8,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Are symptoms relevant when determining eligibility for phase I clinical trials? Answer: Older individuals enrolled in PICT with a higher symptom load may sacrifice quality of life to undergo experimental treatments.,1.184298636784265e-07,0.17589066646366414,0.0,0.009067132323909398,0.1823215567939549,0.0,0.009054007704764368,0.18924199963852795,0.0,1.1842986367842703e-07,0.19671029424605457,0.0
235,1.1,9,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: How important are symptoms in selecting participants for phase I clinical trials? Answer: Older adult patients with more symptoms who join PICT might trade off their quality of life to receive experimental treatment.,1.658018091497971e-07,0.23841102344499765,0.0,0.012693985253473157,0.24686007793152642,0.0,0.012675610786670115,0.2559333741372014,0.0,1.6580180914979784e-07,0.26570316573300534,0.0
235,1.1,10,human,Question: Do symptoms matter when considering patients for phase I clinical trials? Answer: Older adults enrolled in PICT with more symptoms may sacrifice QOL for experimental treatment.,Question: Do symptoms influence the inclusion criteria for phase I clinical trial patients? Answer: Elderly patients in PICT experiencing more symptoms may sacrifice quality of life to access experimental therapy.,7.10579182070559e-08,0.10919929196499067,0.0,0.005440279394345639,0.11332868530700413,0.0,0.005432404622858621,0.11778303565638426,0.0,7.105791820705622e-08,0.1226023220923329,0.0
236,1.1,1,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon's prior experience affect their skill in performing transurethral resection of the prostate? The senior urologist resected tissue at a rate four times greater per unit time than less experienced surgeons, suggesting that surgeon experience could be key in lowering the risk of secondary TURP from recurring adenomas.",1.4211583641411244e-07,0.11551288712184427,0.0,0.010880558788691236,0.11778303565638426,0.0,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
236,1.1,2,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is surgical experience a factor in the ability to perform transurethral resection of the prostate efficiently? The senior urologist removed tissue at quadruple the rate of less experienced surgeons, indicating that experience may help minimize the chance of repeat TURP because of adenoma recurrence.",2.8423167282822487e-07,0.2461330695389088,0.0,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
236,1.1,3,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does prior surgical experience influence the proficiency in transurethral prostate resection? The senior urologist was able to excise tissue four times faster than less experienced counterparts, implying that greater experience might be crucial in reducing secondary TURP due to recurring adenomas.",3.552895910352811e-07,0.3184537311185349,0.0,0.02720139697172809,0.3254224004346309,0.0,0.027162023114293,0.33270575382573453,0.0,3.552895910352811e-07,0.3403258059372023,0.0
236,1.1,4,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the capacity to perform transurethral resection of the prostate affected by a surgeon’s past experience? Evidence shows that the senior urologist resected four times more tissue per time unit than juniors, suggesting that experience could be vital to lowering the risk of subsequent TURP caused by adenoma recurrence.",1.6580180914979784e-07,0.13613217432458002,0.0,0.012693985253473108,0.13883644485421742,0.0,0.012675610786670066,0.14165051706302645,0.0,1.6580180914979784e-07,0.14458122881110835,0.0
236,1.1,5,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","How does a surgeon’s experience impact their ability to conduct transurethral resection of the prostate? The senior urologist achieved four times the tissue resection rate compared to less experienced surgeons, indicating that experience may reduce the likelihood of secondary TURP from recurring adenomas.",3.079176455639103e-07,0.2696635669491032,0.0,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
236,1.1,6,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does the surgeon’s previous experience play a role in the performance of transurethral prostate resection? The senior urologist operated at four times the efficiency of their less experienced peers, which might mean that experience helps prevent secondary TURP due to reappearing adenomas.",3.316036182995957e-07,0.2937611185281632,0.0,0.025387970506946217,0.30010459245033916,0.0,0.025351221573340132,0.30673026742247655,0.0,3.316036182995957e-07,0.31365755885504143,0.0
236,1.1,7,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Is the effectiveness of transurethral resection of the prostate influenced by the surgeon's experience level? The senior urologist removed tissue four times more rapidly than inexperienced surgeons, suggesting experience could be essential in lowering the chance of repeat TURP arising from adenoma recurrence.",3.079176455639103e-07,0.2696635669491032,0.0,0.023574544042164344,0.27541197985996746,0.0,0.023540420032387266,0.2814124594381848,0.0,3.079176455639103e-07,0.28768207245178345,0.0
236,1.1,8,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","To what extent does a surgeon’s experience affect the execution of transurethral resection of the prostate? The senior urologist excised four times more tissue per time than junior surgeons, pointing to experience as a significant factor in reducing secondary TURP related to recurring adenomas.",2.8423167282822487e-07,0.2461330695389088,0.0,0.02176111757738247,0.25131442828090744,0.0,0.0217296184914344,0.2567198468478131,0.0,2.8423167282822487e-07,0.2623642644674917,0.0
236,1.1,9,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Does surgeon experience determine the skill in performing transurethral resection of the prostate? Senior surgeons resected tissue at a rate four times that of their less experienced counterparts, implying that experience may be important for decreasing the risk of secondary TURP due to adenoma recurrence.",2.6054570009253947e-07,0.22314355131420927,0.0,0.0199476911126006,0.22778393087071303,0.0,0.019918816950481533,0.2326222952687531,0.0,2.6054570009253947e-07,0.23767165187712003,0.0
236,1.1,10,human,"Question: Is the ability to perform transurethral resection of the prostate influenced by the surgeon's previous experience? Answer: The senior urologist was capable of resecting four times more tissue per time unit than the more inexperienced surgeons. Therefore, a surgeon's experience may be important to reduce the risk of secondary TURP due to recurring adenomas or","Can a surgeon’s previous experience impact their ability to perform transurethral prostate resection? The senior urologist removed tissue four times faster than less experienced surgeons, suggesting that experience could reduce the risk of subsequent TURP caused by recurring adenomas.",4.026615365066517e-07,0.3697470255060846,0.0,0.030828249901291835,0.37806613392004973,0.0,0.030783626196198732,0.3867729750960107,0.0,4.026615365066519e-07,0.39589565709201446,0.0
237,1.1,1,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does pretreating with estradiol and an antagonist before microdose leuprolide enhance IVF results in poor responders compared to using oral contraceptive pills?,7.816371002776164e-07,0.8161010198482703,0.09162848812994588,0.0598430733378019,0.9222466452388893,0.03767781622452902,0.05975645085144471,0.9801452324703743,0.01922337562475971,7.816371002776182e-07,1.0414538748281603,0.0
237,1.1,2,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does using estradiol plus antagonist pretreatment before microdose leuprolide improve IVF outcomes in poor responders as opposed to oral contraceptive pill pretreatment?,7.816371002776164e-07,0.8161010198482703,0.09162848812994588,0.0598430733378019,0.9222466452388893,0.03767781622452902,0.05975645085144471,0.9801452324703743,0.01922337562475971,7.816371002776182e-07,1.0414538748281603,0.0
237,1.1,3,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Is estradiol and antagonist pretreatment prior to microdose leuprolide more effective for IVF success in poor responders than oral contraceptive pills?,8.053230730133017e-07,0.8648911840177016,0.09162848812994588,0.06165649980258378,0.9735399396264395,0.03767781622452902,0.06156725239239758,1.0342124537406496,0.01922337562475971,8.053230730133036e-07,1.0986122886681091,0.0
237,1.1,4,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,"In poor responders undergoing IVF, does pretreatment with estradiol and antagonist before microdose leuprolide yield better outcomes than oral contraceptive pill pretreatment?",7.816371002776164e-07,0.8161010198482703,0.09162848812994588,0.0598430733378019,0.9222466452388893,0.03767781622452902,0.05975645085144471,0.9801452324703743,0.01922337562475971,7.816371002776182e-07,1.0414538748281603,0.0
237,1.1,5,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does estradiol plus antagonist pretreatment before microdose leuprolide enhance IVF outcomes in poor responders when compared to oral contraceptive pill use?,8.053230730133017e-07,0.8648911840177016,0.09162848812994588,0.06165649980258378,0.9735399396264395,0.03767781622452902,0.06156725239239758,1.0342124537406496,0.01922337562475971,8.053230730133036e-07,1.0986122886681091,0.0
237,1.1,6,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does administering estradiol and antagonist before microdose leuprolide improve IVF success rates in poor responders better than oral contraceptive pill pretreatment?,8.053230730133017e-07,0.8648911840177016,0.09162848812994588,0.06165649980258378,0.9735399396264395,0.03767781622452902,0.06156725239239758,1.0342124537406496,0.01922337562475971,8.053230730133036e-07,1.0986122886681091,0.0
237,1.1,7,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Is IVF success improved in poor responders by estradiol and antagonist pretreatment prior to microdose leuprolide as opposed to oral contraceptive pills?,7.816371002776164e-07,0.8161010198482703,0.09162848812994588,0.0598430733378019,0.9222466452388893,0.03767781622452902,0.05975645085144471,0.9801452324703743,0.01922337562475971,7.816371002776182e-07,1.0414538748281603,0.0
237,1.1,8,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does prior treatment with estradiol plus an antagonist before microdose leuprolide lead to better IVF results in poor responders than using oral contraceptive pills?,7.342651548062458e-07,0.7251292416425423,0.09162848812994588,0.05621622040823814,0.8269364654345641,0.03767781622452902,0.05613484776953896,0.8800617739133929,0.01922337562475971,7.342651548062476e-07,0.9360933591703349,0.0
237,1.1,9,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Is using estradiol and antagonist pretreatment before microdose leuprolide associated with improved IVF outcomes in poor responders compared to oral contraceptive pills?,7.816371002776164e-07,0.8161010198482703,0.09162848812994588,0.0598430733378019,0.9222466452388893,0.03767781622452902,0.05975645085144471,0.9801452324703743,0.01922337562475971,7.816371002776182e-07,1.0414538748281603,0.0
237,1.1,10,human,Question: Estradiol and Antagonist Pretreatment Prior to Microdose Leuprolide in in Vitro Fertilization. Does It Improve IVF Outcomes in Poor Responders as Compared to Oral Contraceptive Pill? Answer: E2+antag pretreatment does not appear to improve IVF outcomes in ML protocol when compared to the standard OCP in poor responders. Randomized trials with adequate power to,Does pretreatment with estradiol and antagonist before microdose leuprolide improve IVF outcomes for poor responders compared to standard oral contraceptive pills?,8.053230730133017e-07,0.8648911840177016,0.09162848812994588,0.06165649980258378,0.9735399396264395,0.03767781622452902,0.06156725239239758,1.0342124537406496,0.01922337562475971,8.053230730133036e-07,1.0986122886681091,0.0
238,1.1,1,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns typically causes less pain than conventional open surgery due to smaller incisions and less tissue trauma.,2.36859727356853e-08,0.0360227736709966,0.0035429153825620313,0.0018134264647818796,0.03594112077764278,0.0029165352228882196,0.0018108015409528735,0.035771101018948315,0.002117255939236562,2.3685972735685406e-08,0.035494993470072345,0.0011450775316071762
238,1.1,2,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Question: Is pain reduced in newborns undergoing minimal access major surgery? Answer: Compared to traditional open surgery, minimal access major surgery in newborns generally results in less pain because of smaller cuts and less invasive procedures.",7.10579182070559e-08,0.14407372287654097,0.03748804209183673,0.005440279394345639,0.1857574753867195,0.06627850864863853,0.005432404622858621,0.1877298038789843,0.06632653061224487,7.105791820705622e-08,0.14624332664497341,0.03443877551020409
238,1.1,3,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Question: Does minimal access major surgery lead to less pain for newborns? Answer: Yes, newborns experience less pain with minimal access major surgery than with traditional open surgery owing to smaller incisions and minimally invasive techniques.",7.10579182070559e-08,0.10446531255882974,0.010066045148548516,0.005440279394345639,0.14498411182436932,0.03706951530612247,0.005432404622858621,0.14572088384504855,0.036053093112244874,7.105791820705622e-08,0.14624332664497341,0.03443877551020409
238,1.1,4,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Question: Are newborns less likely to experience pain after minimal access major surgery? Answer: Minimal access major surgery causes less postoperative pain in newborns compared to open surgery because it involves smaller incisions and less tissue disruption.,9.47438909427412e-08,0.21405347740082137,0.06708565779252876,0.007253705859127518,0.2159099655046095,0.06711655250335431,0.007243206163811494,0.21758276702866608,0.06632653061224487,9.474389094274162e-08,0.1770149853117271,0.03443877551020409
238,1.1,5,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Question: Does minimal access surgery cause less pain in newborns? Answer: Minimal access surgery in newborns is linked to reduced pain versus traditional open procedures, primarily due to smaller surgical wounds.",4.73719454713706e-08,0.016328649927756622,0.05612244897959186,0.003626852929563759,0.019662890487660345,0.06122448979591838,0.003621603081905747,0.02342675258770832,0.06632653061224487,4.737194547137081e-08,0.02365571015042356,0.03443877551020409
238,1.1,6,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Question: Is newborn pain less with minimal access major surgery than with open surgery? Answer: Yes, pain is generally lower in newborns undergoing minimal access major surgery because of smaller incisions and less invasive approaches.",4.73719454713706e-08,0.1115913262693744,0.03504003058039032,0.003626852929563759,0.11266003573151506,0.03530946717917139,0.003621603081905747,0.11363644642723303,0.03510904882244257,4.737194547137081e-08,0.11449462833039359,0.03443877551020409
238,1.1,7,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,Question: Do newborns have less postoperative pain following minimal access major surgery? Answer: Newborns experience less pain after minimal access surgery than after traditional surgery because it uses smaller incisions and less tissue handling.,2.36859727356853e-08,0.16204953377280518,0.09217554209183673,0.0018134264647818796,0.16590621713263376,0.09566326530612247,0.0018108015409528735,0.1252094468976508,0.06632653061224487,2.3685972735685406e-08,0.08170480550740189,0.03443877551020409
238,1.1,8,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Question: Does minimal access surgery result in less pain for newborns? Answer: By making smaller incisions, minimal access surgery causes less pain in newborns compared to conventional open surgery.",9.47438909427412e-08,0.1087761361759525,0.016848979591836705,0.007253705859127518,0.055337055259796486,0.058681016785412425,0.007243206163811494,0.05068121956601335,0.06632653061224487,9.474389094274162e-08,0.10061675128655301,0.03443877551020409
238,1.1,9,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Question: Is the pain reduced during minimal access major surgery in newborns? Answer: Minimal access major surgery is associated with decreased pain in newborns compared to open surgery, due to the smaller incisions and less invasive methods used.",1.184298636784265e-07,0.2060665594882778,0.041999152602217385,0.009067132323909391,0.2066728993934679,0.0402999435068145,0.009054007704764368,0.20696189358420636,0.037779817809476715,1.1842986367842703e-07,0.20686794846140888,0.03443877551020409
238,1.1,10,ai,Question: Does minimal access major surgery in the newborn hurt less? Answer: Minimal access major surgery in newborns is associated with less pain compared to traditional open surgery. The smaller incisions and use,"Question: Are pain levels lower with minimal access major surgery in newborns? Answer: Yes, minimal access major surgery reduces pain in newborns relative to traditional open surgery, as it features smaller incisions and less disruption of tissues.",9.47438909427412e-08,0.17554530070304653,0.03980435149266319,0.007253705859127518,0.17630155518689872,0.03873029928224737,0.007243206163811494,0.17680940346631635,0.036941773954760934,9.474389094274162e-08,0.1770149853117271,0.03443877551020409
239,1.1,1,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Is there a link between angiotensin-converting enzyme-1 (ACE-1) gene polymorphisms and chronic kidney disease in patients with hypertension? Answer: Research indicates that specific ACE-1 gene polymorphisms might elevate the risk of chronic kidney disease in hypertensive individuals.,2.36859727356853e-08,0.10357504663219874,0.05405060708091009,0.0018134264647818726,0.06694791241826259,0.02835714895980181,0.0018108015409528666,0.06777928728440807,0.02854671280276816,2.3685972735685406e-08,0.028987536873251507,0.0
239,1.1,2,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Can ACE-1 gene polymorphism contribute to chronic kidney disease among those with high blood pressure? Answer: Evidence suggests that certain polymorphisms in the ACE-1 gene are associated with an increased risk of chronic kidney disease in patients who have hypertension.,4.73719454713706e-08,0.020284078415131912,0.022037803569335095,0.0036268529295637453,0.054565139391337336,0.0013829041414452105,0.003621603081905733,0.05406722127027619,0.0,4.737194547137081e-08,0.055569851154812167,0.0
239,1.1,3,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Does polymorphism in the ACE-1 gene affect the likelihood of chronic kidney disease in hypertensive patients? Answer: There is evidence that variations in the ACE-1 gene may raise the risk of chronic kidney disease among hypertensive patients.,2.36859727356853e-08,0.17850987696300225,0.10361827314654237,0.0018134264647818726,0.14396426581381272,0.08236882716049383,0.0018108015409528666,0.10738769760211886,0.056932966023875105,2.3685972735685406e-08,0.028987536873251507,0.0
239,1.1,4,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Are ACE-1 gene polymorphisms linked to chronic kidney disease in individuals with hypertension? Answer: Data support the idea that some ACE-1 gene polymorphisms can increase the risk of chronic kidney disease in those with hypertension.,7.10579182070559e-08,0.20731728871395516,0.08641975308641972,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.12902029702356588,0.0302734375,7.105791820705622e-08,0.08961215868968697,0.0
239,1.1,5,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Is chronic kidney disease risk among hypertensive patients influenced by ACE-1 gene polymorphisms? Answer: Studies show that certain ACE-1 gene polymorphisms may enhance susceptibility to chronic kidney disease in hypertensive patients.,1.658018091497971e-07,0.26479361294772064,0.04319412950365332,0.012693985253473143,0.2184629278539978,0.0062875251390907515,0.012675610786670108,0.2162231084696371,0.0,1.6580180914979784e-07,0.22314355131420927,0.0
239,1.1,6,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Does the presence of ACE-1 gene polymorphism lead to chronic kidney disease in patients with hypertension? Answer: Evidence points to some ACE-1 gene polymorphisms potentially increasing the risk of chronic kidney disease in hypertensive individuals.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.12863669998736116,0.03158757716049383,0.005432404622858614,0.12902029702356588,0.0302734375,7.105791820705622e-08,0.08961215868968697,0.0
239,1.1,7,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Do polymorphisms of the ACE-1 gene cause chronic kidney disease in hypertensive patients? Answer: There is indication that specific polymorphisms in the ACE-1 gene elevate the probability of chronic kidney disease among hypertensive patients.,9.47438909427412e-08,0.20135622824804988,0.06308641975308646,0.007253705859127504,0.16096077608021542,0.03334762528744492,0.007243206163811487,0.11778303565638382,0.0,9.474389094274162e-08,0.1213608570042668,0.0
239,1.1,8,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Is there an association between ACE-1 gene polymorphisms and chronic kidney disease in patients suffering from hypertension? Answer: Research suggests that certain ACE-1 gene polymorphisms may increase the likelihood of chronic kidney disease in hypertensive patients.,4.73719454713706e-08,0.17364524364757639,0.0828066186200074,0.0036268529295637453,0.136927666942543,0.05795476466049383,0.00362160308190574,0.09793177740229808,0.029384756657483937,4.737194547137081e-08,0.058840500022933284,0.0
239,1.1,9,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Can variations in the ACE-1 gene contribute to chronic kidney disease among hypertensive patients? Answer: Evidence exists that particular polymorphisms in the ACE-1 gene heighten the risk of chronic kidney disease in those with hypertension.,7.10579182070559e-08,0.2073172887139556,0.08641975308641972,0.005440279394345625,0.16941006354970956,0.060402776171940245,0.005432404622858614,0.12902029702356588,0.0302734375,7.105791820705622e-08,0.08961215868968697,0.0
239,1.1,10,ai,Question: Does angiotensin-converting enzyme-1 (ACE-1) gene polymorphism lead to chronic kidney disease among hypertensive patients? Answer: There is evidence suggesting that certain polymorphisms in the ACE-1 gene may increase the risk of developing chronic kidney disease in hypertensive patients.,Question: Do certain ACE-1 gene polymorphisms promote chronic kidney disease development in hypertensive individuals? Answer: Studies support the role of specific ACE-1 gene polymorphisms in increasing the risk of chronic kidney disease among patients with hypertension.,7.10579182070559e-08,0.16770887839624438,0.059913798640819076,0.005440279394345625,0.12863669998736116,0.03158757716049383,0.005432404622858614,0.08701137698963013,0.0,7.105791820705622e-08,0.08961215868968697,0.0
240,1.1,1,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does receiving birth center care in a woman’s first pregnancy influence her future reproductive outcomes? The effect of birth center care during an initial pregnancy on subsequent reproduction remains unclear. More studies are required to establish potential impacts.,2.1317375462116834e-07,0.02142680873917424,0.13019841683934344,0.016320838183036854,0.04600593850444534,0.12252190626943296,0.0162972138685758,0.071308122301589,0.11176857330703485,2.1317375462116866e-07,0.105881976089504,0.09204470742932283
240,1.1,2,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Is there an effect of birth center care during a woman's first pregnancy on her later reproductive history? Current evidence on how birth center care affects future pregnancies is limited. Further investigation is necessary to understand any possible connections.,1.8948778188548304e-07,0.007213407562219221,0.13160683205728246,0.014507411718254981,0.017566202783957596,0.12327083547074312,0.014486412327622933,0.04313724533489216,0.11176857330703485,1.8948778188548325e-07,0.0768944392162525,0.09204470742932283
240,1.1,3,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,How does birth center care in a first pregnancy affect a woman's future reproduction? The influence of such care on later reproductive events is not well-defined at this time. Additional research is needed to clarify any effects.,2.3685972735685364e-07,0.02610904740351616,0.1840759678597516,0.018134264647818726,0.035668638773367345,0.1502770083102493,0.018108015409528673,0.10029565917484051,0.11176857330703485,2.3685972735685406e-07,0.13573493923918578,0.09204470742932283
240,1.1,4,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does care at a birth center during a woman's first pregnancy impact her reproductive future? The relationship between birth center care and subsequent reproductive outcomes is insufficiently studied. More data are needed to ascertain any impacts.,2.6054570009253894e-07,0.04167023988089191,0.15552925505698345,0.019947691112600606,0.06465617564661885,0.1502770083102493,0.019918816950481547,0.1301486223245223,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
240,1.1,5,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Can birth center care in a woman's initial pregnancy affect her future fertility? There is a lack of comprehensive documentation on birth center care's influence on later reproduction. Continued research is essential to determine any effects.,2.6054570009253894e-07,0.04167023988089191,0.15552925505698345,0.019947691112600606,0.06465617564661885,0.1502770083102493,0.019918816950481547,0.1301486223245223,0.11176857330703485,2.6054570009253947e-07,0.16650659790593947,0.09204470742932283
240,1.1,6,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,What is the impact of birth center care during a first pregnancy on a woman's future reproductive choices? Documentation about this impact is currently inadequate. Further research needs to be conducted to validate any influences.,2.8423167282822424e-07,0.03104936643643219,0.1840759678597516,0.021761117577382486,0.09450913879630063,0.1502770083102493,0.02172961849143442,0.16092028099127598,0.11176857330703485,2.8423167282822487e-07,0.1982552962205193,0.09204470742932283
240,1.1,7,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does receiving care at a birth center during the first pregnancy affect a woman's subsequent reproduction? The impact remains poorly documented at present. Additional studies are required to explore this topic thoroughly.,3.5528959103528014e-07,0.12342268656744748,0.1840759678597516,0.027201396971728124,0.18981931860062584,0.1502770083102493,0.02716202311429304,0.25936035380452926,0.11176857330703485,3.552895910352811e-07,0.30003799053046176,0.09204470742932283
240,1.1,8,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Is the future reproductive performance of a woman affected by birth center care in her first pregnancy? There is insufficient evidence about any impact to date. Ongoing research is important to find out more.,3.0791764556390954e-07,0.06090232958611397,0.1840759678597516,0.023574544042164365,0.12528079746305432,0.1502770083102493,0.023540420032387294,0.1926689793058558,0.11176857330703485,3.079176455639103e-07,0.231045119043511,0.09204470742932283
240,1.1,9,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,Does birth center care in a woman's inaugural pregnancy have implications for her later reproductive outcomes? Such effects are not well recorded yet. More scientific inquiry is warranted to understand possible impacts.,3.5528959103528014e-07,0.12342268656744748,0.1840759678597516,0.027201396971728124,0.18981931860062584,0.1502770083102493,0.02716202311429304,0.25936035380452926,0.11176857330703485,3.552895910352811e-07,0.30003799053046176,0.09204470742932283
240,1.1,10,ai,Question: Does birth center care during a woman's first pregnancy have any impact on her future reproduction? Answer: The impact of birth center care during a woman's first pregnancy on her future reproduction is not yet well-documented. Further research is needed to determine if there are any,"How does birth center care during a woman’s first pregnancy influence her reproductive future? The impact is currently not well documented, making further research necessary to determine its significance.",4.2634750924233604e-07,0.22520538087738995,0.1840759678597516,0.03264167636607376,0.2951798342584513,0.1502770083102493,0.03259442773715166,0.36855964576951994,0.11176857330703485,4.263475092423373e-07,0.4133666758374659,0.09204470742932283
241,1.1,1,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Question: Is there a link between the CYP2D6*4 allele and breast cancer risk? Answer: Presently, no evidence supports a direct connection between the CYP2D6*4 allele and breast cancer risk.",2.36859727356853e-08,0.14094138186722205,0.06394710743801663,0.0018134264647818796,0.1445572834646227,0.07001983471074381,0.0018108015409528735,0.14832791234568576,0.07516033057851236,2.3685972735685406e-08,0.15225702259844365,0.07936859504132227
241,1.1,2,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Question: Does the CYP2D6*4 allele influence breast cancer risk? Answer: At this time, no data indicate a direct association between the CYP2D6*4 allele and the risk of breast cancer.",2.36859727356853e-08,0.057100669721332764,0.06339408284023663,0.0018134264647818796,0.0608196589235086,0.06861775147929,0.0018108015409528735,0.06494814321121956,0.07359999999999998,2.3685972735685406e-08,0.014098300735944314,0.03840000000000001
241,1.1,3,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Question: Is there any association between CYP2D6*4 allele and breast cancer risk? Answer: Currently, there is no proof of a direct relationship between the CYP2D6*4 allele and breast cancer risk.",0.0,0.0,0.0,0.0,8.881784197001252e-16,1.3877787807814457e-17,0.0,0.0,0.0,0.0,0.0,0.0
241,1.1,4,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,Question: Could the CYP2D6*4 allele affect breast cancer susceptibility? Answer: There is no current evidence that directly links the CYP2D6*4 allele to breast cancer risk.,1.184298636784265e-07,0.17131577945163246,0.01195102040816326,0.009067132323909398,0.10845242342941619,0.06221157024793391,0.009054007704764368,0.1021059414519474,0.07359999999999998,1.1842986367842703e-07,0.16025508640883412,0.03840000000000001
241,1.1,5,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Question: Is breast cancer risk associated with the CYP2D6*4 allele? Answer: At present, no evidence suggests a direct association between the CYP2D6*4 allele and breast cancer risk.",7.10579182070559e-08,0.024624304416563714,0.05801111111111108,0.005440279394345639,0.035202853384412425,0.10560000000000004,0.005432404622858621,0.015094564462317717,0.07359999999999998,7.105791820705622e-08,0.06928330820310613,0.03840000000000001
241,1.1,6,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,Question: Does carrying the CYP2D6*4 allele increase breast cancer risk? Answer: No direct evidence exists currently to indicate a relationship between the CYP2D6*4 allele and breast cancer risk.,4.73719454713706e-08,0.03427865544636299,0.025024999999999964,0.003626852929563759,0.02110455264846811,0.06720000000000004,0.003621603081905747,0.025727430057937095,0.07359999999999998,4.737194547137081e-08,0.026723693784310498,0.03840000000000001
241,1.1,7,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,Question: Is the CYP2D6*4 allele related to breast cancer risk? Answer: No current evidence points to a direct association between the CYP2D6*4 allele and the risk of breast cancer.,2.36859727356853e-08,0.057100669721332764,0.06339408284023663,0.0018134264647818796,0.0608196589235086,0.06861775147929,0.0018108015409528735,0.06494814321121956,0.07359999999999998,2.3685972735685406e-08,0.014098300735944314,0.03840000000000001
241,1.1,8,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Question: Are the CYP2D6*4 allele and breast cancer risk connected? Answer: As of now, no evidence shows a direct link between the CYP2D6*4 allele and breast cancer risk.",4.73719454713706e-08,0.13696712664042776,0.04121983471074389,0.003626852929563759,0.13885248901921043,0.043160330578512304,0.003621603081905747,0.14062789327645087,0.044168595041322284,4.737194547137081e-08,0.14224822387763325,0.04424462809917353
241,1.1,9,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,"Question: Is there any evidence linking the CYP2D6*4 allele to breast cancer risk? Answer: To date, there is no evidence that the CYP2D6*4 allele is directly associated with breast cancer risk.",2.36859727356853e-08,0.08648513089057364,0.03563456790123451,0.0018134264647818796,0.13581960467096543,0.07116122448979595,0.0018108015409528735,0.13905611536494122,0.07359999999999998,2.3685972735685406e-08,0.09105934187207376,0.03840000000000001
241,1.1,10,ai,Question: CYP2D6*4 allele and breast cancer risk: is there any association? Answer: There is currently no evidence to suggest a direct association between the CYP2D6*4 allele and breast cancer risk.,Question: Does the presence of the CYP2D6*4 allele correlate with breast cancer risk? Answer: There is currently no proof to suggest a direct correlation between the CYP2D6*4 allele and the risk of breast cancer.,9.47438909427412e-08,0.2364069067390151,0.07404620187304889,0.007253705859127518,0.23874123253094126,0.07438251821019773,0.007243206163811494,0.2408388096748837,0.07359999999999998,9.474389094274162e-08,0.1964198575298992,0.03840000000000001
242,1.1,1,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Does high-sensitivity C-reactive protein correlate with carotid atherosclerosis in healthy Koreans? Answer: Yes, there is a correlation between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans.",7.10579182070559e-08,0.26539771299785375,0.06659469816122848,0.005440279394345639,0.26401361979854343,0.08719573385609931,0.005432404622858621,0.2614217372178014,0.09303343336411202,7.105791820705622e-08,0.2655594270168935,0.09418282548476456
242,1.1,2,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is there a link between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Korean individuals? Answer: Yes, high-sensitivity C-reactive protein is linked to carotid atherosclerosis in healthy Koreans.",9.47438909427412e-08,0.31093397066819817,0.07208220773019536,0.007253705859127518,0.30767828265796915,0.09124228395061726,0.007243206163811494,0.30277521092665216,0.09456398891966755,9.474389094274162e-08,0.3063814215371483,0.09418282548476456
242,1.1,3,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein connected to carotid atherosclerosis among healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is connected to carotid atherosclerosis in healthy Koreans.",0.0,0.11552453009332453,0.048308715697457066,0.0,0.12054733574955545,0.07311728395061726,0.0,0.1260267601018077,0.08761251499676506,0.0,0.13202803439236988,0.09418282548476456
242,1.1,4,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Does high-sensitivity C-reactive protein have an association with carotid atherosclerosis in healthy Korean people? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Korean individuals.",9.47438909427412e-08,0.21191294487392076,0.01999231064975024,0.007253705859127518,0.20498981146390394,0.024997449239873404,0.007243206163811494,0.19613718314819995,0.019542438825149624,9.474389094274162e-08,0.19547787264755634,0.014787740418601966
242,1.1,5,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is there an association between high-sensitivity C-reactive protein and carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis among healthy Koreans.",7.10579182070559e-08,0.3680861841919185,0.13283953287197234,0.005440279394345639,0.3706516475769952,0.16221728395061724,0.005432404622858621,0.3168735116625965,0.13296398891966757,7.105791820705622e-08,0.2655594270168935,0.09418282548476456
242,1.1,6,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is high-sensitivity C-reactive protein related to carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is related to carotid atherosclerosis in healthy Koreans.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
242,1.1,7,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Do healthy Koreans show an association between high-sensitivity C-reactive protein and carotid atherosclerosis? Answer: Yes, healthy Koreans exhibit an association between high-sensitivity C-reactive protein and carotid atherosclerosis.",7.10579182070559e-08,0.11136500620675438,0.0015527801474182479,0.005440279394345639,0.10405657813086311,0.009382716049382706,0.005432404622858621,0.039614639438618315,0.05453601108033243,7.105791820705622e-08,0.03451036683024622,0.06581717451523547
242,1.1,8,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Are levels of high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, elevated high-sensitivity C-reactive protein levels are associated with carotid atherosclerosis in healthy Koreans.",9.47438909427412e-08,0.21191294487392076,0.01999231064975024,0.007253705859127518,0.20498981146390438,0.024997449239873404,0.007243206163811494,0.1961371831482004,0.019542438825149624,9.474389094274162e-08,0.19547787264755634,0.014787740418601966
242,1.1,9,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Is the presence of high-sensitivity C-reactive protein linked to carotid atherosclerosis in healthy Korean subjects? Answer: Yes, the presence of high-sensitivity C-reactive protein is linked to carotid atherosclerosis in healthy Korean subjects.",1.894877818854824e-07,0.21547924114345207,0.007218573703991343,0.014507411718255037,0.1973887714757243,0.0411182532394653,0.014486412327622988,0.17572638419524322,0.07875623792343267,1.8948778188548325e-07,0.21578515749682037,0.07074773007079102
242,1.1,10,ai,"Question: Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Answer: Yes, high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.","Question: Does the biomarker high-sensitivity C-reactive protein associate with carotid atherosclerosis in healthy Koreans? Answer: Yes, the biomarker high-sensitivity C-reactive protein is associated with carotid atherosclerosis in healthy Koreans.",9.47438909427412e-08,0.1624024319767816,0.002214532871972291,0.007253705859127518,0.1536455758668711,0.003464348702443998,0.007243206163811494,0.14281816925897362,0.015796341658844776,9.474389094274162e-08,0.19547787264755634,0.014787740418601966
243,1.1,1,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is fragility of the esophageal mucosa a diagnostic endoscopic feature unique to primary eosinophilic esophagitis? Primary eosinophilic esophagitis is marked by esophageal mucosa that easily tears from minor trauma during routine endoscopy. This 'crêpe-paper' appearance may help endoscopists recognize the disease when other signs are absent.,1.1842986367842703e-07,0.11152182392946974,0.004417740820864123,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
243,1.1,2,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other","Can fragile esophageal mucosa be considered a definitive endoscopic indicator of primary eosinophilic esophagitis? In primary eosinophilic esophagitis, the mucosa is delicate and tears easily with slight mechanical trauma during diagnostic endoscopy. This 'crêpe-paper' phenomenon can prompt endoscopists to suspect the disease even when other features are subtle.",7.105791820705622e-08,0.03591925397797047,0.018664014912833465,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
243,1.1,3,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other","Is the esophageal mucosa’s fragility a hallmark endoscopic sign for primary eosinophilic esophagitis? The mucosa in this condition is fragile and tears readily when minor trauma occurs during an otherwise routine endoscopy. Known as the 'crêpe-paper' sign, it may signal the presence of disease when other signs are not obvious.",2.3685972735685406e-08,0.035249067127276934,0.039930555555555566,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
243,1.1,4,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Does the fragility of the esophageal mucosa serve as a pathognomonic endoscopic marker for primary eosinophilic esophagitis? Patients with primary eosinophilic esophagitis have mucosa that is fragile and prone to tearing with minimal trauma during diagnostic endoscopy. This 'crêpe-paper' appearance can alert endoscopists to the diagnosis even if other signs are inconspicuous.,2.3685972735685406e-08,0.048072159366075784,0.020330555555555574,0.0018134264647818726,0.02020270731751861,0.0,0.0018108015409528666,0.02061928720273576,0.0,2.3685972735685406e-08,0.02105340919783316,0.0
243,1.1,5,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other","Is fragile esophageal mucosa an exclusive endoscopic sign of primary eosinophilic esophagitis? The disease involves esophageal mucosa that breaks easily with minor trauma during routine endoscopy, creating the characteristic 'crêpe-paper' sign that can aid in diagnosis when other indicators are not evident.",2.1317375462116866e-07,0.1768112218673319,0.015555555555555566,0.016320838183036854,0.20294084399669066,0.0,0.0162972138685758,0.20763936477824663,0.0,2.1317375462116866e-07,0.21256144198367144,0.0
243,1.1,6,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other","Can the 'crêpe-paper' fragility of the esophageal mucosa uniquely indicate primary eosinophilic esophagitis during endoscopy? The mucosa’s propensity to tear with minimal trauma during diagnostic endoscopy is characteristic, potentially guiding endoscopists to detect the disease in the absence of other signs.",2.3685972735685406e-07,0.16769177686941372,0.039930555555555566,0.018134264647818726,0.22825865198098239,0.0,0.018108015409528666,0.2336148511815046,0.0,2.3685972735685406e-07,0.2392296890658323,0.0
243,1.1,7,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is the fragility of the esophageal lining a definitive observed sign in primary eosinophilic esophagitis? This disease is defined by mucosa that tears easily under minor trauma during standard endoscopic examination. The resulting 'crêpe-paper' sign helps clinicians identify the condition when other findings are inconspicuous.,1.4211583641411244e-07,0.07238159706508807,0.039930555555555566,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
243,1.1,8,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other","Does the presence of 'crêpe-paper' fragility in the esophageal mucosa indicate primary eosinophilic esophagitis? In this condition, the mucosa of the esophagus is unusually fragile and tears under slight trauma during diagnostic endoscopy, serving as a helpful sign for endoscopists when other signs are not present.",1.1842986367842703e-07,0.04990874121303035,0.039930555555555566,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
243,1.1,9,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other",Is mucosal fragility of the esophagus a key endoscopic sign indicative of primary eosinophilic esophagitis? The fragile mucosa tears easily in response to minor trauma during diagnostic endoscopy characteristic of this condition. This 'crêpe-paper' sign may alert endoscopists to the diagnosis where other indicators may be missing.,9.474389094274162e-08,0.027929834494255346,0.039930555555555566,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
243,1.1,10,human,"Question: Fragility of the esophageal mucosa: a pathognomonic endoscopic sign of primary eosinophilic esophagitis? Answer: Primary eosinophilic esophagitis is characterized by fragile esophageal mucosa that readily tears in response to minor trauma during otherwise uneventful diagnostic endoscopy. This ""crêpe-paper"" sign may alert endoscopists to the presence of the disease when other","Could the fragile nature of the esophageal mucosa be a distinctive endoscopic hallmark of primary eosinophilic esophagitis? This condition results in mucosa that breaks upon slight trauma during routine diagnostic endoscopy, producing a 'crêpe-paper' sign that may alert clinicians to its presence despite the absence of other typical signs.",4.737194547137081e-08,0.014629779924541175,0.039930555555555566,0.0036268529295637453,0.04167269640056892,0.0,0.003621603081905733,0.04255961441879652,0.0,4.737194547137081e-08,0.04348511193973836,0.0
244,1.1,1,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does releasing patients earlier from Winnipeg hospitals negatively impact the quality of care? Answer: The consequences of earlier patient discharge from Winnipeg hospitals on care quality is a complicated topic needing more research. Although it could improve patient satisfaction and lower healthcare expenses, risks like insufficient follow-up and readmission exist.",1.6580180914979784e-07,0.06487526833191071,0.0469777284681131,0.012693985253473108,0.08755734493432188,0.033000480845298844,0.012675610786670066,0.08572147028385668,0.03631185475258099,1.6580180914979784e-07,0.11316432705570056,0.01851192595229618
244,1.1,2,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Is early discharge of patients from Winnipeg hospitals harmful to the quality of care? Answer: The effect of early discharge from Winnipeg hospitals on care quality is multifaceted and calls for additional study. It might boost patient satisfaction and cut costs, but also raises concerns about poor follow-up and possible readmissions.",1.4211583641411244e-07,0.07116759371563441,0.028314534023668667,0.010880558788691236,0.06678880318369318,0.03340811626341167,0.0108648092457172,0.06510218308112092,0.03631185475258099,1.4211583641411244e-07,0.0921109178578674,0.01851192595229618
244,1.1,3,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Does early patient discharge in Winnipeg hospitals reduce care quality? Answer: The influence of discharging patients sooner in Winnipeg hospitals on care quality is complex and requires further examination. While it may enhance patient happiness and decrease healthcare costs, hazards such as inadequate ongoing care and hospital readmission need consideration.",1.6580180914979784e-07,0.06487526833191071,0.0469777284681131,0.012693985253473108,0.08755734493432188,0.033000480845298844,0.012675610786670066,0.08572147028385668,0.03631185475258099,1.6580180914979784e-07,0.11316432705570056,0.01851192595229618
244,1.1,4,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission",Question: Are patients discharged earlier from Winnipeg hospitals receiving lower quality of care? Answer: The impact of expediting patient discharge in Winnipeg hospitals on care standards is intricate and needs more analysis. Early discharge might increase satisfaction and lower costs but also risks insufficient follow-up and more readmissions.,2.3685972735685406e-07,0.10079452230988117,0.06564174338094657,0.018134264647818726,0.12244452490034607,0.0533997864008544,0.018108015409528666,0.1502599914214282,0.03631185475258099,2.3685972735685406e-07,0.17912229484749664,0.01851192595229618
244,1.1,5,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Could earlier discharges from Winnipeg hospitals compromise the quality of care? Answer: Assessing how early patient discharge affects care quality in Winnipeg hospitals is complicated and warrants deeper study. Although it may improve patient satisfaction rates and reduce costs, it might also cause gaps in follow-up care and raise readmission rates.",1.4211583641411244e-07,0.016803108965834923,0.06730828402366867,0.010880558788691236,0.039062915961295186,0.0533997864008544,0.0108648092457172,0.06510218308112092,0.03631185475258099,1.4211583641411244e-07,0.0921109178578674,0.01851192595229618
244,1.1,6,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission",Question: Does earlier release of patients from Winnipeg hospitals affect care quality negatively? Answer: The consequences of earlier release from Winnipeg hospitals for care quality are complex and need further investigation. Early discharge offers potential benefits like higher patient satisfaction and cost savings but presents risks like poor follow-up and readmission.,1.6580180914979784e-07,0.12032704277670625,0.007513198957506087,0.012693985253473108,0.08755734493432188,0.033000480845298844,0.012675610786670066,0.08572147028385668,0.03631185475258099,1.6580180914979784e-07,0.11316432705570056,0.01851192595229618
244,1.1,7,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: What is the effect of discharging patients earlier from Winnipeg hospitals on care quality? Answer: The relationship between earlier patient discharge in Winnipeg hospitals and quality of care is complicated and requires more research. Potential advantages include improved patient satisfaction and lower healthcare costs, but possible risks consist of insufficient follow-up and readmissions.",9.474389094274162e-08,0.022688916857239505,0.06804733727810654,0.0072537058591274906,0.0001577971919872745,0.0533997864008544,0.007243206163811466,0.02509684846742255,0.03631185475258099,9.474389094274162e-08,0.051288923337613035,0.01851192595229618
244,1.1,8,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission",Question: Does discharging patients sooner from Winnipeg hospitals impact quality of care adversely? Answer: Understanding the impact of earlier patient discharge in Winnipeg hospitals on care quality is challenging and needs further study. Early discharge might promote patient satisfaction and reduce expenses but may also lead to inadequate follow-up and increased readmissions.,1.4211583641411244e-07,0.016803108965834923,0.06730828402366867,0.010880558788691236,0.039062915961295186,0.0533997864008544,0.0108648092457172,0.06510218308112092,0.03631185475258099,1.4211583641411244e-07,0.0921109178578674,0.01851192595229618
244,1.1,9,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission","Question: Is the quality of care affected when patients are discharged earlier from Winnipeg hospitals? Answer: The effects of early discharge on care quality in Winnipeg hospitals are multifactorial and need deeper study. While benefits such as increased patient satisfaction and decreased costs exist, risks like poor follow-up and readmissions must be considered.",1.1842986367842703e-07,0.029797219266167296,0.08690828402366867,0.009067132323909363,0.01926028866511542,0.0533997864008544,0.009054007704764333,0.044899475763602315,0.03631185475258099,1.1842986367842703e-07,0.07149163065513164,0.01851192595229618
244,1.1,10,ai,"Question: Discharging patients earlier from Winnipeg hospitals: does it adversely affect quality of care? Answer: The impact of discharging patients earlier from Winnipeg hospitals on the quality of care is a complex issue that requires further investigation. While it may lead to increased patient satisfaction and reduced healthcare costs, potential risks such as inadequate follow-up care and readmission",Question: Does releasing patients earlier from Winnipeg hospitals have a negative effect on quality of care? Answer: The influence of earlier patient discharge from Winnipeg hospitals on the quality of care is complex and calls for more investigation. Early discharge may enhance patient satisfaction and reduce healthcare costs but also carries risks like insufficient follow-up care and hospital readmission.,2.3685972735685406e-08,0.06729163048357689,0.03533803608978437,0.0018134264647818726,0.067644392741252,0.03586152109473195,0.0018108015409528666,0.06842920954340181,0.03631185475258099,2.3685972735685406e-08,0.04402125646671262,0.01851192595229618
245,1.1,1,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a relationship between androgens and sexual desire in women? This study found that both FT and androstenedione showed a statistically significant correlation with sexual desire among the total cohort of women. However, ADT-G did not show a stronger correlation than circulating androgens, so it is not better for assessing sexual desire compared to measuring circulating androgens using mass spectrometry.",9.474389094274162e-08,0.17193751259790124,0.07782354340071347,0.0072537058591274906,0.12061496271397099,0.036311854752580995,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
245,1.1,2,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does sexual desire in women correlate with androgens? According to the current study, FT and androstenedione were significantly linked with sexual desire across the entire female cohort. ADT-G's correlation with sexual desire was not stronger than that of the circulating androgens, indicating that it is not a superior measurement compared to mass spectrometry of circulating androgens.",2.3685972735685406e-08,0.054727091366691294,0.052774556213017756,0.0018134264647818726,0.00638944757401072,0.01779992880028481,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
245,1.1,3,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgens associated with sexual desire in women? In this study, a statistically significant association was found between sexual desire and both FT and androstenedione in the overall group of women. ADT-G’s correlation with sexual desire was not greater than that of circulating androgens, so it doesn’t outperform the measurement of circulating androgens by mass spectrometry.",2.3685972735685406e-08,0.0295217393463294,0.034104421376393745,0.0018134264647818726,0.00638944757401072,0.017799928800284814,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
245,1.1,4,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there evidence of a correlation between androgens and women's sexual desire? The present research demonstrated a significant statistical correlation of FT and androstenedione with sexual desire in the full sample of women. ADT-G did not exhibit a stronger correlation with sexual desire than circulating androgens, and thus it is not a superior method to measuring circulating androgens via mass spectrometry.",9.474389094274162e-08,0.18065831499397644,0.11230630202140313,0.0072537058591274906,0.09711844811871861,0.019367740602759354,0.007243206163811466,0.07145896398214369,0.0,9.474389094274162e-08,0.07275935428242919,0.0
245,1.1,5,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Do androgens correlate with sexual desire in women? This study revealed that FT and androstenedione levels had significant correlations with sexual desire within the total female cohort. ADT-G did not show a stronger association than circulating androgens, meaning it is not a better tool than measuring circulating androgens using mass spectrometry.",1.4211583641411244e-07,0.010905204207444008,0.10566944444444447,0.010880558788691236,0.09339390473662901,0.01591254919702544,0.0108648092457172,0.11778303565638426,0.0,1.4211583641411244e-07,0.12014431184206309,0.0
245,1.1,6,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is sexual desire in women correlated to androgens? The study found statistically distinct correlations between sexual desire and levels of FT and androstenedione in women. ADT-G was not more strongly correlated with sexual desire than circulating androgens and thus is not preferable over measuring these androgens by mass spectrometry.,1.8948778188548325e-07,0.06493869232465954,0.060533837429111614,0.014507411718254981,0.10677487948168984,0.036311854752580995,0.014486412327622933,0.16034265007518078,0.0,1.8948778188548325e-07,0.16362942378180145,0.0
245,1.1,7,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Are androgen levels connected to sexual desire in women? The study indicated a significant statistical link between sexual desire and both FT and androstenedione among women as a whole. ADT-G did not correlate stronger with sexual desire than circulating androgens, so it is not superior to measuring androgens in the circulation using mass spectrometry.",7.105791820705622e-08,0.04062987711596211,0.0687064975009612,0.005440279394345618,0.005678762610319854,0.036311854752580995,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
245,1.1,8,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.",Is there a link between female sexual desire and androgens? Findings from this study reveal FT and androstenedione have statistically significant correlations with sexual desire in the full female cohort. ADT-G showed no stronger correlations than circulating androgens and therefore is not a better measure than circulating androgen measurement by mass spectrometry.,1.1842986367842703e-07,0.009984712783731808,0.10644964598084133,0.009067132323909363,0.044899475763602315,0.036311854752580995,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
245,1.1,9,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Does female sexual desire correlate with androgens? The current investigation showed FT and androstenedione were significantly correlated with sexual desire across the entire group of women. ADT-G did not show a stronger correlation than circulating androgens, and thus does not surpass the accuracy of mass spectrometry measurements of circulating androgens.",1.6580180914979784e-07,0.003947858735675158,0.12520069444444448,0.012693985253473108,0.08572147028385668,0.036311854752580995,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
245,1.1,10,human,"Question: Is there a correlation between androgens and sexual desire in women? Answer: In the present study, FT and androstenedione were statistically significantly correlated with sexual desire in the total cohort of women. ADT-G did not correlate more strongly than circulating androgens with sexual desire and is therefore not superior to measuring circulating androgens by mass spectrometry.","Is there a correlation between androgens and women's sexual drive? The present study detected statistically significant associations of FT and androstenedione to sexual desire throughout the total cohort of women. No stronger correlation for ADT-G compared to circulating androgens was found, indicating it isn’t superior to mass spectrometry methods for measuring circulating androgens.",9.474389094274162e-08,0.083767283390634,0.14560000000000003,0.0072537058591274906,0.02509684846742255,0.036311854752580995,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
246,1.1,1,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Does engaging in a preoperative medically supervised weight loss program enhance the success of bariatric surgery? Answer: Research indicates that such a program before surgery can lead to better bariatric surgery results. It assists patients in losing weight, lowering surgical complications, and promoting long-term health benefits.",2.3685972735685406e-08,0.20681815486809407,0.13017751479289946,0.0018134264647818726,0.1800063059793171,0.11176857330703485,0.0018108015409528666,0.1519471332125959,0.09204470742932283,2.3685972735685406e-08,0.12255152320447316,0.0710059171597633
246,1.1,2,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Can a medically supervised weight loss program before surgery improve the effectiveness of bariatric surgery? Answer: Evidence shows that participation in a preoperative medically supervised weight loss regimen can result in improved bariatric surgery outcomes. It aids in weight reduction, decreases surgical risks, and supports long-term success.",4.737194547137081e-08,0.139837485975022,0.06664445694165981,0.0036268529295637453,0.14171154482331438,0.06838014355496873,0.003621603081905733,0.14361344770643392,0.06983396362766994,4.737194547137081e-08,0.14554104142917268,0.0710059171597633
246,1.1,3,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Is a preoperative medically supervised weight loss program beneficial for bariatric surgery results? Answer: Studies suggest that undergoing a medically supervised weight loss plan before bariatric surgery can improve surgical outcomes by facilitating weight loss, minimizing operative risks, and enhancing long-term prognosis.",7.105791820705622e-08,0.016181657730003796,0.03599468930813496,0.005440279394345618,0.019291767736725696,0.06311637080867852,0.0054324046228586,0.02197959438027386,0.06706114398422092,7.105791820705622e-08,0.024913053640555294,0.0710059171597633
246,1.1,4,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Do bariatric surgery outcomes benefit from preoperative medically supervised weight loss programs? Answer: There is supportive evidence that such programs prior to surgery can enhance outcomes by helping patients lose weight, reduce surgical risks, and improve long-term results.",1.6580180914979763e-07,0.015762918105385992,0.13017751479289946,0.012693985253473108,0.01573827114677684,0.11176857330703485,0.012675610786670066,0.04872356224955565,0.09204470742932283,1.6580180914979784e-07,0.08330053099967571,0.0710059171597633
246,1.1,5,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Does completing a medically supervised weight loss program before bariatric surgery improve patient outcomes? Answer: Evidence indicates that patients who complete a supervised weight loss program before surgery tend to have better bariatric surgical outcomes, including weight loss, reduced risk during surgery, and improved long-term health.",2.3685972735685406e-08,0.08627081911853862,0.044009714339384706,0.0018134264647818726,0.08758668190465801,0.045442042694789964,0.0018108015409528666,0.08893375316169116,0.04669323350642034,2.3685972735685406e-08,0.09031211945749895,0.04776328677427578
246,1.1,6,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Can bariatric surgery outcomes be improved by a preoperative medically supervised weight loss program? Answer: Research supports that engaging in a medically supervised preoperative weight loss program can lead to better surgical results by aiding weight loss, lowering surgical risk, and improving long-term outcomes.",2.3685972735685406e-08,0.09935301224635662,0.08482604086999697,0.0018134264647818726,0.13454393190255987,0.11176857330703485,0.0018108015409528666,0.10542711757770196,0.09204470742932283,2.3685972735685406e-08,0.07492347421521872,0.0710059171597633
246,1.1,7,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Are bariatric surgery results better when preceded by a medically supervised weight loss program? Answer: Data suggests that a supervised preoperative weight loss program can enhance the effectiveness of bariatric surgery via weight loss, risk reduction, and long-term improvement.",1.4211583641411233e-07,0.029353614010324325,0.07904530149852401,0.010880558788691236,0.010929975935384029,0.11176857330703485,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
246,1.1,8,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Does a preoperative weight loss program under medical supervision positively affect bariatric surgery outcomes? Answer: There is evidence that such medically supervised programs before surgery can improve bariatric outcomes by promoting weight loss, minimizing surgical complications, and supporting long-term well-being.",1.1842986367842703e-07,0.0670562124929357,0.13017751479289946,0.009067132323909363,0.036905462338642,0.11176857330703485,0.009054007704764333,0.005343659020720537,0.09204470742932283,1.1842986367842703e-07,0.02773067984486355,0.0710059171597633
246,1.1,9,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: Is there an advantage to medically supervised weight loss before undergoing bariatric surgery? Answer: Yes, evidence suggests that a medically supervised weight loss effort before surgery can improve outcomes by reducing surgical risks, achieving weight loss, and enhancing long-term results.",1.1842986367842703e-07,0.036915864591055225,0.05567057542109523,0.009067132323909363,0.03418655618032629,0.0606363600126594,0.009054007704764333,0.031137771535065806,0.06574814059221545,1.1842986367842703e-07,0.02773067984486355,0.0710059171597633
246,1.1,10,ai,"Question: Does a preoperative medically supervised weight loss program improve bariatric surgery outcomes? Answer: There is evidence to suggest that a preoperative medically supervised weight loss program can improve outcomes for bariatric surgery. It can help patients achieve weight loss, reduce surgical risks, and improve long-term","Question: How does a preoperative medically supervised weight loss program impact bariatric surgery outcomes? Answer: It appears that such programs can improve outcomes by aiding in weight reduction, decreasing surgical risk, and contributing to better long-term health following bariatric surgery.",1.4211583641411233e-07,0.04173840450864397,0.13017751479289946,0.010880558788691236,0.010929975935384029,0.11176857330703485,0.0108648092457172,0.02132458806144033,0.09204470742932283,1.4211583641411244e-07,0.05512965403297887,0.0710059171597633
247,1.1,1,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" sample represent child bipolar I disorder accurately? The TEAM sample might not be generalizable to every child diagnosed with bipolar I disorder. Each individual's diagnostic traits can differ, and more studies are required to assess if TEAM's observations fit the wider population.",3.552895910352811e-07,0.05708516358707261,0.14407203655907605,0.02720139697172809,0.095896336293817,0.12429752066115701,0.027162023114293,0.14282926451697886,0.09566326530612247,3.552895910352811e-07,0.19132791941405936,0.06525084641428129
247,1.1,2,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Are the diagnostic characteristics of child bipolar I disorder found in the ""Treatment of Early Age Mania (TEAM)"" sample applicable generally? It is possible that the TEAM sample does not reflect all child bipolar I disorder cases. Variations exist among individuals, necessitating additional research to confirm if TEAM's results extend to a larger group.",2.6054570009253947e-07,0.02879131862893214,0.10807134211463157,0.0199476911126006,0.06917264250950694,0.085897520661157,0.019918816950481533,0.08833347587761109,0.07606326530612248,2.6054570009253947e-07,0.10794631047500847,0.06525084641428129
247,1.1,3,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Can findings from the ""Treatment of Early Age Mania (TEAM)"" sample about child bipolar I disorder be generalized? The sample may not be representative of all children with bipolar I disorder. There is individual variability in diagnostic features, so further investigation is essential to validate broader applicability.",4.263475092423373e-07,0.12210917749048544,0.1427429470529032,0.03264167636607371,0.16043485743138852,0.12429752066115701,0.0325944277371516,0.20878723230877494,0.09566326530612247,4.263475092423373e-07,0.2587692002095916,0.06525084641428129
247,1.1,4,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Is the ""Treatment of Early Age Mania (TEAM)"" sample a generalizable representation of child bipolar I disorder's diagnostic features? It might not cover all cases, as diagnostic traits can vary by individual. More research is required to establish if its findings hold true across a wider demographic.",4.263475092423373e-07,0.0919723435530968,0.1644713421146316,0.03264167636607371,0.16043485743138852,0.12429752066115701,0.0325944277371516,0.20878723230877494,0.09566326530612247,4.263475092423373e-07,0.2587692002095916,0.06525084641428129
247,1.1,5,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Do the diagnostic traits of child bipolar I disorder indicated by the ""Treatment of Early Age Mania (TEAM)"" sample apply broadly? Possibly not, since individual differences exist, and the TEAM sample might not be comprehensive. Further studies are vital to determine if the results extrapolate to a broader population.",3.789755637709665e-07,0.04941272913430028,0.1644713421146316,0.029014823436509962,0.11694974549165016,0.12429752066115701,0.028972824655245866,0.16433546973794222,0.09566326530612247,3.789755637709665e-07,0.21330682613283436,0.06525084641428129
247,1.1,6,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Are child bipolar I disorder characteristics from the ""Treatment of Early Age Mania (TEAM)"" study broadly applicable? The sample may lack generalizability due to variability among patients, indicating a need for additional research to confirm wider relevance of the findings.",5.92149318392135e-07,0.2570520939125469,0.1644713421146316,0.045335661619546816,0.3295111874753216,0.12429752066115701,0.045270038523821665,0.38205895358281117,0.09566326530612247,5.921493183921352e-07,0.4364503774470436,0.06525084641428129
247,1.1,7,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","To what extent do the diagnostic features of child bipolar I disorder found in the ""Treatment of Early Age Mania (TEAM)"" sample generalize? The sample might not be universally representative, as individuals differ diagnostically. Subsequent research is necessary to verify if these findings can be generalized.",4.500334819780227e-07,0.1139512502718718,0.1644713421146316,0.03445510283085558,0.18290771328344624,0.12429752066115701,0.034405229278104466,0.23177675053347446,0.09566326530612247,4.500334819780227e-07,0.282299697619786,0.06525084641428129
247,1.1,8,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Does the ""Treatment of Early Age Mania (TEAM)"" dataset generalize across cases of child bipolar I disorder? It may not, given the variation in diagnostic characteristics among individuals. More research is needed to determine if TEAM's conclusions apply to the wider population.",5.447773729207643e-07,0.20704167333788348,0.1644713421146316,0.04170880868998307,0.2782178930877719,0.12429752066115701,0.04164843544191593,0.3294152200973923,0.09566326530612247,5.447773729207643e-07,0.38238315617676744,0.06525084641428129
247,1.1,9,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Can the ""Treatment of Early Age Mania (TEAM)"" sample's diagnostic characteristics of child bipolar I disorder be generalized? It's uncertain, as individual differences exist and the sample alone may not represent all cases. Further investigation is required to assess generalizability.",5.92149318392135e-07,0.2570520939125469,0.1644713421146316,0.045335661619546816,0.3295111874753216,0.12429752066115701,0.045270038523821665,0.38205895358281117,0.09566326530612247,5.921493183921352e-07,0.4364503774470436,0.06525084641428129
247,1.1,10,ai,"Question: Diagnostic characteristics of child bipolar I disorder: does the ""Treatment of Early Age Mania (team)"" sample generalize? Answer: The ""Treatment of Early Age Mania (TEAM)"" sample may not generalize to all cases of child bipolar I disorder. Diagnostic characteristics may vary among individuals, and further research is needed to determine if the findings of the TEAM sample can be applied to a broader population.","Is it appropriate to generalize the ""Treatment of Early Age Mania (TEAM)"" sample's diagnostic findings on child bipolar I disorder? This sample might not capture all manifestations, given individual variability; thus, more research is needed to confirm generalizability.",6.395212638635056e-07,0.30969582739796575,0.1644713421146316,0.04896251454911056,0.3835784087455978,0.12429752066115701,0.0488916416057274,0.43762880473762333,0.09566326530612247,6.39521263863506e-07,0.493608791286992,0.06525084641428129
248,1.1,1,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are elevated carotid artery pulsatility and resistance indexes early indicators of vascular abnormalities in young obese males? Yes, increased carotid artery pulsatility and resistance indexes may signal early vascular abnormalities in young obese men, suggesting a higher risk for future cardiovascular diseases.",2.6054570009253947e-07,0.19540657989175747,0.02007378472222221,0.0199476911126006,0.1865430256824725,0.03224919651056016,0.019918816950481533,0.17665842059434134,0.045894065363136616,2.6054570009253947e-07,0.16563637846304502,0.060521541950113375
248,1.1,2,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Do increased carotid artery pulsatility and resistance indexes serve as early signs of vascular issues in young obese males? Indeed, these elevated indexes can reflect early vascular abnormalities, indicating a potential elevated risk for cardiovascular conditions later in life.",3.316036182995955e-07,0.032916031424930825,0.2222222222222222,0.025387970506946217,0.02190305395620218,0.19937500000000002,0.025351221573340132,0.07897108197045499,0.1713265913146937,3.316036182995957e-07,0.1384301850326577,0.1388888888888889
248,1.1,3,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Is a rise in carotid artery pulsatility and resistance indexes an early marker of vascular problems in young obese males? Yes, the increased indexes point to early vascular abnormalities, which may elevate the risk of cardiovascular diseases in young obese men.",2.8423167282822487e-07,0.014894607756486433,0.17236072637734687,0.02176111757738247,0.00480532973026726,0.17375173130193908,0.0217296184914344,0.024903860700178804,0.1713265913146937,2.8423167282822487e-07,0.08286033387784553,0.1388888888888889
248,1.1,4,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Can higher carotid artery pulsatility and resistance indexes be early signs of vascular abnormalities in young obese males? Yes, such increases are indicative of early vascular changes, potentially placing young obese males at greater risk for future cardiovascular disease.",3.316036182995955e-07,0.0035653991308555177,0.19592565538511483,0.025387970506946217,0.02190305395620218,0.19937500000000002,0.025351221573340132,0.07897108197045499,0.1713265913146937,3.316036182995957e-07,0.1384301850326577,0.1388888888888889
248,1.1,5,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are increased carotid artery pulsatility and resistance indexes early signs of vascular dysfunction in young obese males? Yes, raised pulsatility and resistance indexes in the carotid artery can signify early vascular dysfunction, signaling a longer-term risk of cardiovascular disease for young obese men.",2.3685972735685406e-07,0.03203555300855143,0.10534859183507833,0.018134264647818726,0.013126984927300356,0.1507227975016437,0.018108015409528666,0.008267925340625482,0.14634302786959177,2.3685972735685406e-07,0.030216600392426685,0.1388888888888889
248,1.1,6,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Do young obese males with increased carotid artery pulsatility and resistance indexes show early vascular abnormalities? Yes, heightened carotid artery pulsatility and resistance indexes can reflect early signs of vascular abnormalities and a higher likelihood of cardiovascular disease later on.",3.079176455639102e-07,0.11883852846923171,0.09678969627066517,0.023574544042164344,0.14116052909718846,0.0955687716262976,0.023540420032387266,0.16397435327854826,0.09087676432507434,3.079176455639103e-07,0.18727566146151053,0.08352556708958092
248,1.1,7,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are carotid artery pulsatility and resistance indexes elevated in the early stages of vascular abnormalities among young obese males? Yes, increased values of these indexes in young obese males may represent preliminary vascular abnormalities and raise the possibility of future cardiovascular problems.",2.6054570009253947e-07,0.04127782322627249,0.17357001972386588,0.0199476911126006,0.05605848751350839,0.19937500000000002,0.019918816950481533,0.001071625703079171,0.1713265913146937,2.6054570009253947e-07,0.05619208679568466,0.1388888888888889
248,1.1,8,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Is the elevation of carotid artery pulsatility and resistance indexes an early indicator of vascular abnormalities in young obese males? Yes, early vascular abnormalities can be detected by increased carotid artery pulsatility and resistance indexes, which may forecast greater cardiovascular risk.",2.8423167282822487e-07,0.08907746932750493,0.09977324263038548,0.02176111757738247,0.07589734824923555,0.12298611111111113,0.0217296184914344,0.09786672181175193,0.11885745551222454,2.8423167282822487e-07,0.12032774904324794,0.11188271604938273
248,1.1,9,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Can increased carotid artery pulsatility and resistance indexes be seen as initial signs of vascular abnormalities in young obese males? Yes, these increased pulsatility and resistance indexes serve as early markers of vascular abnormalities, indicating an increased future risk for cardiovascular disease in young obese males.",1.6580180914979784e-07,0.017153113319544833,0.09204470742932275,0.012693985253473108,0.05684859724147717,0.13155822427126712,0.012675610786670066,0.06647069152002283,0.14808396092920617,1.6580180914979784e-07,0.04389137176129676,0.1388888888888889
248,1.1,10,ai,"Question: Are increased carotid artery pulsatility and resistance indexes early signs of vascular abnormalities in young obese males? Answer: Yes, increased carotid artery pulsatility and resistance indexes can be considered early signs of vascular abnormalities in young obese males. These abnormalities may indicate an increased risk of developing cardiovascular diseases in the future.","Are early vascular abnormalities in young obese males indicated by increased carotid artery pulsatility and resistance indexes? Yes, elevated pulsatility and resistance indexes of the carotid artery in young obese males can be regarded as early signs of vascular abnormalities with potential long-term cardiovascular risk.",1.8948778188548325e-07,0.041027324561357936,0.06882558233909586,0.014507411718254981,0.03166093785221147,0.13000000000000003,0.014486412327622933,0.042172589258711035,0.14753123140987512,1.8948778188548325e-07,0.019793820182236743,0.1388888888888889
249,1.1,1,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: When metastatic carcinoma is found in the cervical nodes but the primary head and neck site is unknown, is neck dissection necessary? Answer: Based on our experience, definitive radiotherapy targeting the neck and potential mucosal sites, with or without prior neck dissection, effectively achieves good local control in unknown primary head and neck cancers. Neck dissection is specifically indicated mainly for early nodal disease.",1.6580180914979784e-07,0.13186437317614974,0.020050941945405625,0.012693985253473136,0.14936986045528045,0.03171190540177372,0.012675610786670066,0.12933170602184685,0.016124697661918846,1.6580180914979784e-07,0.10863384100279827,0.0
249,1.1,2,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Inquiry: For metastatic carcinoma in cervical lymph nodes from an unidentified primary head and neck tumor, is performing a neck dissection required? Response: Our findings indicate that definitive radiotherapy to the neck and possible mucosal regions, regardless of preceding neck dissection, successfully provides good local control in unknown primary head and neck cancers. Neck dissection is particularly considered in early nodal involvement.",2.3685972735685406e-07,0.18413474306267474,0.02307956613746471,0.018134264647818754,0.20036049186458804,0.033293697978596916,0.018108015409528666,0.1800655752867959,0.01694411414982164,2.3685972735685406e-07,0.15906469462968964,0.0
249,1.1,3,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: In cases of metastatic carcinoma to cervical nodes with an unknown head and neck primary site, must a neck dissection be done? Answer: Our experience shows that definitive radiotherapy to the neck and likely mucosal sites, administered with or without neck dissection beforehand, is effective for good local control in unknown primary head and neck cancers. Neck dissection is especially indicated in early nodal disease.",1.4211583641411244e-07,0.12307718273548485,0.051889456084376624,0.010880558788691264,0.11127300808218354,0.015621063240110858,0.0108648092457172,0.0909717782057271,0.0,1.4211583641411244e-07,0.09237332013101707,0.0
249,1.1,4,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Query: Does metastatic carcinoma in cervical nodes from an unknown primary head and neck site warrant neck dissection? Answer: We have observed that definitive radiotherapy aimed at the neck and probable mucosal locations, whether preceded by neck dissection or not, can effectively achieve good local control for unknown primary cancers in the head and neck. The role of neck dissection is more pertinent for early nodal stages.",1.1842986367842703e-07,0.07746269699030872,0.003180193646085898,0.009067132323909391,0.07410797215372167,0.0,0.009054007704764333,0.07522342123759085,0.0,1.1842986367842703e-07,0.0763729787845735,0.0
249,1.1,5,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Should neck dissection be performed when metastatic carcinoma involves cervical nodes but the head and neck primary is unknown? Answer: According to our experience, definitive radiotherapy focused on the neck and potential mucosal sites, either with prior neck dissection or alone, effectively ensures good local control in unknown primary head and neck cancer cases. Neck dissection is mainly indicated for early nodal involvement.",1.8948778188548325e-07,0.15729354826070896,0.054927254626946705,0.014507411718255009,0.14372044347394297,0.016124697661918846,0.014486412327622933,0.12323264042395188,0.0,1.8948778188548325e-07,0.1251631429540092,0.0
249,1.1,6,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Is neck dissection necessary for metastatic cervical lymph node carcinoma originating from an unknown head and neck primary? Answer: Our experience demonstrates that definitive radiotherapy to the neck and mucosal areas, with or without preceding neck dissection, achieves satisfactory local control in unknown primary head and neck cancers. Neck dissection is particularly recommended for early node-positive cases.",3.316036182995957e-07,0.23401565224285203,0.010297855525652516,0.025387970506946245,0.24789880776277862,0.017851239669421492,0.025351221573340132,0.22677331936479117,0.0,3.316036182995957e-07,0.23052365861183333,0.0
249,1.1,7,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Inquiry: For patients presenting with metastatic carcinoma to cervical nodes from an unknown primary head and neck site, is neck dissection needed? Answer: In our clinical experience, definitive radiotherapy applied to the neck and potential mucosal sites, irrespective of whether neck dissection has been done upfront, is effective for good local disease control in unknown primary head and neck cancers. The indication for neck dissection is stronger in early nodal disease.",2.3685972735685406e-08,0.08190902135195355,0.0740396572231834,0.0018134264647818865,0.07466240532687607,0.04338842975206613,0.0018108015409528666,0.055372162983504225,0.029384756657483944,2.3685972735685406e-08,0.035506046398873004,0.014921946740128552
249,1.1,8,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: When metastatic carcinoma is detected in cervical nodes but the primary tumor in the head and neck is not identified, is a neck dissection required? Answer: From our observations, definitive radiotherapy covering the neck and possible mucosal sites, regardless of prior neck dissection, effectively achieves good local control in unknown primary cancers of the head and neck. Neck dissection is particularly warranted in early nodal disease.",1.1842986367842703e-07,0.07746269699030872,0.003180193646085891,0.009067132323909391,0.09543557770941291,0.015380859375,0.009054007704764333,0.07522342123759085,0.0,1.1842986367842703e-07,0.0763729787845735,0.0
249,1.1,9,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Query: In the scenario of metastatic carcinoma involving cervical nodes with an unknown primary site in the head and neck region, is neck dissection needed? Answer: According to our data, definitive radiotherapy targeting the neck and mucosal sites, whether or not there has been a neck dissection beforehand, is effective in providing good local control in unknown primary head and neck cancers. Neck dissection is indicated chiefly for early nodal cases.",2.3685972735685406e-08,0.08190902135195355,0.0740396572231834,0.0018134264647818865,0.03447996007702692,0.014489619377162637,0.0018108015409528666,0.014598799421153608,0.0,2.3685972735685406e-08,0.0148150857851439,0.0
249,1.1,10,human,"Question: Metastatic carcinoma to the cervical nodes from an unknown head and neck primary site: Is there a need for neck dissection? Answer: In our experience, definitive radiotherapy to the neck and the potential mucosal sites, whether preceded by neck dissection or not, is effective to achieve a good local control rate in the unknown primary cancer of the head and neck. The indication for neck dissection, in particular for early nodal","Question: Must neck dissection be undertaken when metastatic carcinoma involves cervical lymph nodes but the primary tumor in the head and neck is unknown? Answer: Our experience suggests that definitive radiotherapy directed at the neck and potential mucosal sites, with or without preceding neck dissection, effectively achieves good local control for unknown primary head and neck cancers; neck dissection is particularly indicated in early nodal disease.",1.4211583641411244e-07,0.09369960573726299,0.003874505363141788,0.010880558788691264,0.11127300808218354,0.015621063240110858,0.0108648092457172,0.0909717782057271,0.0,1.4211583641411244e-07,0.09237332013101707,0.0
250,1.1,1,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy affect peri-sinusoidal cell function? Laparoscopic surgery induces noticeable harm to Kupffer and endothelial cells, indicated by increased post-operative HA serum concentrations. However, liver hepatocyte and peri-sinusoidal cell damage appear clinically insignificant.",1.421158364141118e-07,0.17351699543761612,0.004650168801939046,0.010880558788691257,0.17185025692666,0.0,0.010864809245717227,0.17693070815907896,0.0,1.4211583641411244e-07,0.18232155679395534,0.0
250,1.1,2,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is peri-sinusoidal cell activity altered by laparoscopic cholecystectomy? Laparoscopic interventions resulted in measurable injury to Kupffer and endothelial cells, demonstrated by heightened post-operative HA serum levels. Nonetheless, damage to hepatocytes and perisinusoidal cells lacks clinical significance.",9.47438909427412e-08,0.07266757538074708,0.025623268698060954,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
250,1.1,3,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"What impact does laparoscopic cholecystectomy have on peri-sinusoidal cell activity? The laparoscopic method causes visible injury to Kupffer and endothelial cells, shown by elevated HA serum post-surgery. Still, harm to liver hepatocytes and perisinusoidal cells has no notable clinical consequence.",0.0,0.035546009259483924,0.025623268698060954,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
250,1.1,4,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does the practice of laparoscopic cholecystectomy modify peri-sinusoidal cell activity? The laparoscopic approach leads to detectable damage in Kupffer and endothelial cells, as seen from increased post-op HA serum levels. Liver hepatocyte and perisinusoidal cell injuries do not translate into clinical effects.",4.7371945471370706e-08,0.08555642983414735,0.025623268698060954,0.0036268529295637453,0.051293294387549704,0.0,0.003621603081905733,0.05264373348541884,0.0,4.737194547137081e-08,0.05406722127027619,0.0
250,1.1,5,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Can laparoscopic cholecystectomy influence the activity of peri-sinusoidal cells? This surgical technique causes evident damage to Kupffer and endothelial cells, reflected by raised HA serum after operation. Such damage to hepatocytes and perisinusoidal cells is not clinically relevant.",4.73719454713706e-08,0.054565139391337336,0.0013829041414452105,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
250,1.1,6,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does laparoscopic cholecystectomy have an effect on peri-sinusoidal cell behavior? Laparoscopic procedures brought about identifiable damage to Kupffer and endothelial cells, indicated by post-operative elevation in HA serum. Damage to liver hepatocytes and perisinusoidal cells remains clinically inconsequential.",4.73719454713706e-08,0.054565139391337336,0.0013829041414452105,0.0036268529295637453,0.05406722127027619,0.0,0.003621603081905733,0.055569851154812167,0.0,4.737194547137081e-08,0.05715841383994835,0.0
250,1.1,7,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Is activity in peri-sinusoidal cells affected by laparoscopic cholecystectomy? The laparoscopic process results in discernible injury to Kupffer and endothelial cells, shown by increased post-surgery HA serum levels. There is no clinical impact from related liver hepatocyte and perisinusoidal cell damage.",2.36859727356853e-08,0.06086381724377565,0.025623268698060954,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
250,1.1,8,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"What are the effects of laparoscopic cholecystectomy on peri-sinusoidal cell activity? Laparoscopic surgery produced detectable damage to Kupffer and endothelial cells, as evidenced by higher HA serum post-operation. However, the injury to hepatocytes and perisinusoidal cells lacks clinical importance.",2.36859727356853e-08,0.00957052285622595,0.025623268698060954,0.0018134264647818726,0.026668247082160867,0.0,0.0018108015409528666,0.02739897418811532,0.0,2.3685972735685406e-08,0.028170876966696845,0.0
250,1.1,9,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Does the laparoscopic cholecystectomy procedure impact peri-sinusoidal cells? It causes noticeable harm to Kupffer and endothelial cells, demonstrated by elevated post-op HA serum levels. Damage sustained by liver hepatocytes and perisinusoidal cells shows no clinical significance.",9.47438909427412e-08,0.07266757538074708,0.025623268698060954,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
250,1.1,10,human,Question: Does laparoscopic cholecystectomy influence peri-sinusoidal cell activity? Answer: Laparoscopic procedures caused detectable damage to Kupffer and endothelial cells as reflected by elevation of post-operative HA serum levels. The damage to the liver hepatocytes and perisinusoidal cells has no clinical,"Will laparoscopic cholecystectomy influence peri-sinusoidal cell activity? The procedure induces measurable damage to Kupffer and endothelial cells, with post-operative HA serum levels rising accordingly. Yet, the liver hepatocyte and perisinusoidal cell damage holds no clinical relevance.",9.47438909427412e-08,0.07266757538074708,0.025623268698060954,0.0072537058591274975,0.11122563511022454,0.0,0.00724320616381148,0.11441035117774545,0.0,9.474389094274162e-08,0.11778303565638382,0.0
251,1.1,1,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does losing consciousness forecast neuropsychological decline following a concussion? The findings of this research question the significance of loss of consciousness (LOC) as an indicator of neuropsychological test outcomes in the early recovery period after mild traumatic brain injury. Neuropsychological assessments,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
251,1.1,2,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a predictor of neuropsychological impairment after experiencing a concussion? This study's results suggest that LOC may not be a reliable predictor of neuropsychological test performance during the acute phase of mild traumatic brain injury recovery. Neuropsychological evaluation,4.737194547137081e-08,0.11810488222542581,0.049861495844875335,0.0036268529295637453,0.08555642983414735,0.025623268698060954,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
251,1.1,3,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness predict neuropsychological deficits post-concussion? The study's findings challenge the relevance of LOC as a predictor for neuropsychological test performance in the immediate recovery phase following mild traumatic brain injury. Neuropsychological testing,1.8948778188548261e-07,0.21130909366720596,0.0,0.014507411718254995,0.21706450523782772,0.0,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
251,1.1,4,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does the occurrence of loss of consciousness anticipate neuropsychological performance decrements after a concussion? The study results bring into question the role of LOC in forecasting neuropsychological test scores during the acute recovery phase of mild traumatic brain injury. Neuropsychological assessments,4.737194547137081e-08,0.048790164169431716,0.0,0.0036268529295637453,0.05001042057466343,0.0,0.003621603081905733,0.051293294387549704,0.0,4.737194547137081e-08,0.05264373348541884,0.0
251,1.1,5,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is LOC indicative of neuropsychological impairment after concussion? Evidence from this research doubts the importance of LOC as a predictor of neuropsychological testing outcomes early after mild traumatic brain injury. Neuropsychological examination,2.605457000925385e-07,0.34840158673757227,0.0322222222222222,0.019947691112600634,0.31237468504215293,0.0,0.019918816950481574,0.321583624127463,0.0,2.6054570009253947e-07,0.3313571359544403,0.0
251,1.1,6,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does experiencing loss of consciousness predict neuropsychological test outcome declines following a concussion? Findings here undermine the value of LOC as a predictive factor for neuropsychological performance in the acute phase after mild traumatic brain injury. Neuropsychological evaluation,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
251,1.1,7,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Can loss of consciousness serve as a predictor for neuropsychological deficits after concussion? This study questions the predictive utility of LOC regarding neuropsychological test results in the early recovery stages of mild traumatic brain injury. Neuropsychological testing,1.42115836414112e-07,0.1541506798272576,0.0,0.010880558788691236,0.15822400521489444,0.0,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
251,1.1,8,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness forecast impairments in neuropsychological testing after concussion? The research data cast doubt on considering LOC as an important predictor of neuropsychological outcomes during the acute recovery period following mild traumatic brain injury. Neuropsychological assessment,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
251,1.1,9,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Is loss of consciousness a meaningful predictor of neuropsychological decrements following a concussion? The study’s findings contest the significance of LOC in predicting neuropsychological test performance during the initial phase of mild traumatic brain injury recovery. Neuropsychological testing,1.1842986367842671e-07,0.1267517056391423,0.0,0.009067132323909363,0.1300531282481976,0.0,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
251,1.1,10,human,Question: Does loss of consciousness predict neuropsychological decrements after concussion? Answer: The results of this study cast doubt on the importance of LOC as a predictor of neuropsychological test performance during the acute phase of recovery from mild traumatic brain injury. Neuropsychological testing,Does loss of consciousness accurately predict neuropsychological test performance decline after concussion? This study suggests skepticism over LOC’s role as a predictor during the acute phase following mild traumatic brain injury. Neuropsychological examination,2.3685972735685321e-07,0.2719337154836414,0.0,0.018134264647818754,0.27958486221916123,0.0,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
252,1.1,1,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: How effective is PET/CT compared to multidetector CT in preoperative staging of liver metastases from colorectal carcinoma? Answer: PET/CT plays a limited role in the hepatic staging of LMCRC. While PET/CT is more sensitive in detecting extrahepatic disease in certain locations, its findings are...",7.105791820705622e-08,0.06796903311257019,0.0014484404281270083,0.005440279394345618,0.06744128079553224,0.0,0.0054324046228586,0.06899287148695166,0.0,7.105791820705622e-08,0.07061756721395396,0.0
252,1.1,2,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: In the preoperative evaluation of liver metastases in colorectal cancer patients, does PET/CT offer advantages over multidetector CT? Answer: PET/CT has a restricted role in hepatic staging of LMCRC, although it exhibits greater sensitivity in identifying extrahepatic disease in specific anatomical regions, its results are...",4.737194547137081e-08,0.013989487235059883,0.0212665406427221,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
252,1.1,3,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: For patients with colorectal carcinoma liver metastases, does PET/CT provide added value beyond multidetector CT in preoperative staging? Answer: The role of PET/CT is limited in liver metastasis staging of colorectal cancer. Despite PET/CT’s superior sensitivity for detecting extrahepatic disease at some sites, its outcomes are...",2.3685972735685406e-08,0.007989419483715121,0.0212665406427221,0.0018134264647818726,0.021978906718775004,0.0,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
252,1.1,4,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does preoperative PET/CT improve staging accuracy for liver metastases from colorectal carcinoma compared to multidetector CT? Answer: PET/CT’s role in hepatic staging of colorectal liver metastases is limited. It does show higher sensitivity for extrahepatic disease detection in some anatomical areas, but its results are...",4.737194547137081e-08,0.04479602859327958,0.0009442031589307898,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
252,1.1,5,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: How does PET/CT compare with multidetector CT for preoperative staging in patients with liver metastases from colorectal cancer? Answer: PET/CT has a limited role in the hepatic staging of LMCRC; it is more sensitive for detecting extrahepatic disease in certain locations, but its findings are...",4.737194547137081e-08,0.013989487235059883,0.0212665406427221,0.0036268529295637453,0.04445176257083272,0.0,0.003621603081905733,0.04546237407675724,0.0,4.737194547137081e-08,0.04652001563489394,0.0
252,1.1,6,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Does integrating PET/CT into preoperative staging protocols for colorectal carcinoma liver metastases offer benefits over multidetector CT? Answer: PET/CT’s contribution to hepatic staging of liver metastases from colorectal cancer is limited, though it provides higher sensitivity in detecting extrahepatic disease in specific regions, its results are...",2.3685972735685406e-08,0.02214741445367352,0.00046185441900629606,0.0018134264647818726,0.021978906718775004,0.0,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
252,1.1,7,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: What is the added value of PET/CT in hepatic staging of liver metastases from colorectal carcinoma compared to multidetector CT? Answer: PET/CT is limited in its role for staging hepatic metastases of colorectal cancer, even though it is more sensitive for extrahepatic disease detection at some anatomical sites, its results are...",9.474389094274162e-08,0.11117365571894577,0.0212665406427221,0.0072537058591274906,0.08338160893905089,0.0,0.007243206163811466,0.08515780834030728,0.0,9.474389094274162e-08,0.08701137698962924,0.0
252,1.1,8,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Can PET/CT improve preoperative staging of liver metastases in colorectal carcinoma over multidetector CT? Answer: The role of PET/CT in hepatic staging of LMCRC is limited. Although PET/CT is more sensitive for detecting extrahepatic disease in some locations, its results are...",1.4211583641411244e-07,0.14089196788936142,0.003108459357277899,0.010880558788691236,0.13976194237515838,0.0,0.0108648092457172,0.1431008436406751,0.0,1.4211583641411244e-07,0.14660347419187536,0.0
252,1.1,9,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: Assessing PET/CT’s usefulness in staging colorectal cancer liver metastases preoperatively — is it superior to multidetector CT? Answer: PET/CT plays a limited role in staging hepatic metastases of colorectal cancer. It shows increased sensitivity for extrahepatic disease detection in some anatomical areas, but its results are...",2.3685972735685406e-08,0.02214741445367352,0.00046185441900629606,0.0018134264647818726,0.021978906718775004,0.0,0.0018108015409528666,0.022472855852057716,0.0,2.3685972735685406e-08,0.022989518224699523,0.0
252,1.1,10,human,"Question: Preoperative staging of patients with liver metastases of colorectal carcinoma. Does PET/CT really add something to multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC. Although PET-CT has higher sensitivity for the detection of extrahepatic disease in some anatomic locations, its results are","Question: What incremental benefit does PET/CT provide in preoperative staging of colorectal carcinoma liver metastases versus multidetector CT? Answer: PET/CT has a limited role in hepatic staging of LMCRC as, despite greater sensitivity in detecting extrahepatic disease in certain sites, its results are...",1.1842986367842703e-07,0.11598936732010312,0.0025288192620964538,0.009067132323909363,0.11506932978478668,0.0,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
253,1.1,1,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is screening for coeliac disease in risk groups warranted? Long-term adherence to diet in individuals detected by screening was satisfactory. Quality of life and bone mineral density matched those of non-coeliac individuals and the broader population. Therefore, proactive screening in high-risk groups for coeliac disease appears to be beneficial rather than detrimental.",4.737194547137081e-08,0.07051601483042269,0.02181372915664468,0.0036268529295637453,0.013096107297856374,0.019991670137442734,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,1.1,2,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should coeliac disease screening be conducted in risk groups? The long-term dietary compliance among patients identified through screening was favorable. Their quality of life and bone mineral density were similar to those without coeliac disease and the general population. Hence, screening actively in groups at risk for coeliac disease seems justified rather than harmful.",9.474389094274162e-08,0.10116117916265299,0.015929419323235466,0.0072537058591274906,0.08004270767353683,0.0,0.007243206163811466,0.0816780310142673,0.0,9.474389094274162e-08,0.08338160893905089,0.0
253,1.1,3,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it justified to screen risk groups for coeliac disease? Patients detected by screening showed good long-term compliance with dietary recommendations. Their quality of life and bone mineral density were comparable to non-coeliac individuals and the general population. Thus, active screening of high-risk groups for coeliac disease appears reasonable and not harmful.",4.737194547137081e-08,0.07051601483042269,0.02181372915664468,0.0036268529295637453,0.013096107297856374,0.019991670137442734,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,1.1,4,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Does screening for coeliac disease in at-risk groups make sense? Screen-detected patients maintained good long-term adherence to their diet. Their quality of life and bone density were on par with those of non-coeliac subjects and the general population. Consequently, active screening in risk groups for coeliac disease is probably beneficial rather than harmful.",7.105791820705622e-08,0.0909795715480981,0.022564083175803364,0.005440279394345618,0.03344237944153461,0.019599999999999992,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
253,1.1,5,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is coeliac disease screening justified in groups at risk? Patients who were diagnosed through screening had good long-term dietary compliance. Their quality of life and bone mineral density were comparable to people without coeliac disease and the general population. Active screening of coeliac disease in these groups seems more advantageous than harmful.,4.737194547137081e-08,0.0602562473056274,0.01900259737396756,0.0036268529295637453,0.04082199452025437,0.0,0.003621603081905733,0.04167269640056892,0.0,4.737194547137081e-08,0.04255961441879652,0.0
253,1.1,6,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it appropriate to screen for coeliac disease in risk groups? Those detected by screening demonstrated sustained adherence to their diet over the long term. Their quality of life and bone mineral density matched those of non-coeliac individuals and the general population. Hence, screening risk groups for coeliac disease actively appears to be justified and safe.",1.4211583641411244e-07,0.14997734804764473,0.024652228423222386,0.010880558788691236,0.0921109178578674,0.01851192595229618,0.0108648092457172,0.12014431184206309,0.0,1.4211583641411244e-07,0.12260232209233335,0.0
253,1.1,7,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is screening for coeliac disease in risk populations warranted? Long-term dietary compliance among screen-detected patients was strong. Quality of life and bone mineral density were equivalent to those found in non-coeliac people and the wider population. Active screening within groups at risk seems to be a reasonable approach rather than a harmful one.,7.105791820705622e-08,0.14429858543732488,0.060964083175803374,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
253,1.1,8,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Should individuals in risk groups be screened for coeliac disease? The patients detected through screening showed excellent long-term dietary compliance. Their quality of life and bone mineral density were similar to those of healthy individuals and the general public. Therefore, screening actively for coeliac disease in risk groups seems justified and not harmful.",7.105791820705622e-08,0.06432006460348472,0.003488031530655508,0.005440279394345618,0.03344237944153461,0.019599999999999992,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
253,1.1,9,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,Is it reasonable to implement coeliac disease screening in risk groups? Patients identified by screening adhered well to dietary guidelines over the long term. Their quality of life and bone density was comparable to non-coeliac subjects and the general population. Active screening in these risk groups appears to be beneficial rather than problematic.,7.105791820705622e-08,0.11763907849271149,0.041740707551043664,0.005440279394345618,0.06062462181643413,0.0,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
253,1.1,10,human,Question: Is coeliac disease screening in risk groups justified? Answer: Long-term dietary compliance in screen-detected patients was good. Quality of life and bone mineral density were comparable with those in non-coeliac subjects and the general population. Active screening in coeliac disease risk groups seems to be reasonable rather than harmful.,"Is it defensible to conduct coeliac disease screening among risk groups? Long-term adherence to diet in patients found by screening was effective. Their quality of life and bone mineral density were akin to those in non-coeliac subjects and the general populace. Thus, active screening for coeliac disease in at-risk groups seems to be a reasonable and safe practice.",1.8948778188548325e-07,0.2117851809865896,0.043425817869680916,0.014507411718254981,0.1541506798272585,0.0,0.014486412327622933,0.15718558352241319,0.0,1.8948778188548325e-07,0.16034265007518078,0.0
254,1.1,1,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the insertion allele of the ACE gene I/D polymorphism a candidate gene for insulin resistance? Answer: Our findings indicate that the higher cardiovascular risk associated with the DD genotype does not result from insulin resistance or fibrinolysis defects. However, we observed greater sensitivity in NIDDM patients carrying the ACE DD genotype.",4.737194547137081e-08,0.06801298065346462,0.020707179930795856,0.0036268529295637453,0.04000533461369837,0.0,0.003621603081905733,0.04082199452025437,0.0,4.737194547137081e-08,0.04167269640056892,0.0
254,1.1,2,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the insertion allele of the ACE gene I/D polymorphism be linked to insulin resistance? Answer: We found that the DD genotype's elevated cardiovascular risk is not caused by insulin resistance or fibrinolysis issues, but rather, NIDDM individuals with the ACE DD genotype show increased sensitivity.",9.474389094274162e-08,0.058066668431643986,0.01820216049382717,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,1.1,3,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism relate to insulin resistance? Answer: The data suggest that the cardiovascular risk associated with the DD genotype is not driven by insulin resistance or fibrinolytic abnormalities; instead, NIDDM subjects with the ACE DD genotype demonstrate heightened sensitivity.",7.105791820705622e-08,0.09491050338732743,0.0236025022956841,0.005440279394345618,0.06317890162153228,0.0,0.0054324046228586,0.06453852113757153,0.0,7.105791820705622e-08,0.06595796779179608,0.0
254,1.1,4,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene I/D polymorphism's insertion allele a gene involved in insulin resistance? Answer: Our conclusion is that higher cardiovascular risk for the DD genotype is not linked to insulin resistance or fibrinolysis abnormalities. On the other hand, NIDDM patients with the ACE DD genotype display increased sensitivity.",2.3685972735685406e-08,0.02133437618373879,0.0008118618278758691,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
254,1.1,5,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Could the ACE gene I/D polymorphism insertion allele be a candidate for insulin resistance? Answer: We conclude that the cardiovascular risk increase seen in the DD genotype is independent of insulin resistance or fibrinolytic abnormalities. Conversely, NIDDM subjects with the ACE DD genotype exhibit enhanced sensitivity.",9.474389094274162e-08,0.08820350236903352,0.0034578741965105436,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,1.1,6,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Does the insertion allele of the ACE gene I/D polymorphism serve as a candidate gene for insulin resistance? Answer: The study concludes that the elevated risk of cardiovascular problems in the DD genotype does not stem from insulin resistance or fibrinolysis disorders. However, NIDDM individuals with the ACE DD genotype show increased sensitivity.",7.105791820705622e-08,0.061407687809529765,0.002252739331026543,0.005440279394345618,0.05942342047080107,0.0,0.0054324046228586,0.06062462181643413,0.0,7.105791820705622e-08,0.06187540371808753,0.0
254,1.1,7,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Is the ACE gene insertion allele from I/D polymorphism involved in insulin resistance? Answer: We conclude that increased cardiovascular risk linked to the DD genotype is not due to insulin resistance or fibrinolysis abnormalities, but NIDDM subjects with the ACE DD genotype have greater sensitivity.",1.1842986367842703e-07,0.11152182392946974,0.004417740820864123,0.009067132323909363,0.107630664192365,0.0,0.009054007704764333,0.11000089521432876,0.0,1.1842986367842703e-07,0.11247798342669002,0.0
254,1.1,8,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: Is the ACE gene I/D polymorphism insertion allele connected to insulin resistance? Answer: Our research suggests that the heightened cardiovascular risk of the DD genotype is unrelated to insulin resistance or clot breakdown irregularities, though NIDDM patients with this genotype demonstrate increased responsiveness.",1.4211583641411244e-07,0.10388828709054065,0.017215574484706456,0.010880558788691236,0.13062018241706452,0.0,0.0108648092457172,0.13353139262452318,0.0,1.4211583641411244e-07,0.13657553500575004,0.0
254,1.1,9,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Can the insertion allele of the ACE gene I/D polymorphism be considered a candidate gene for insulin resistance? Answer: We conclude that the DD genotype’s increased cardiovascular risk is not mediated by insulin resistance or fibrinolytic abnormalities, yet NIDDM subjects with this genotype show heightened sensitivity.",9.474389094274162e-08,0.027929834494255346,0.039930555555555566,0.0072537058591274906,0.08515780834030728,0.0,0.007243206163811466,0.08701137698962924,0.0,9.474389094274162e-08,0.0889474860164956,0.0
254,1.1,10,human,"Question: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Answer: We conclude that increased cardiovascular risk of the DD genotype is not mediated through insulin resistance or abnormalities in fibrinolysis. Conversely, we report an increased sensitivity in NIDDM subjects with the ACE DD genotype.","Question: Question: Is the insertion allele of the ACE gene I/D polymorphism a factor in insulin resistance? Answer: The findings show that the cardiovascular risk in the DD genotype does not arise from insulin resistance or fibrinolysis flaws. By contrast, NIDDM individuals with the ACE DD genotype have elevated sensitivity.",2.3685972735685406e-08,0.02133437618373879,0.0008118618278758691,0.0018134264647818726,0.02061928720273576,0.0,0.0018108015409528666,0.02105340919783316,0.0,2.3685972735685406e-08,0.02150620522096336,0.0
255,1.1,1,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does using a neuroendoscope simultaneously affect the rate of ventriculoperitoneal shunt infections? Our current study found that employing an endoscope during VPS surgeries did not raise infection risk.,1.658018091497971e-07,0.1897502950494827,0.029384756657483937,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
255,1.1,2,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is the concurrent application of a neuroendoscope related to the occurrence of ventriculoperitoneal shunt infections? This study showed no increased risk of infection when endoscopes were used in VPS procedures.,1.184298636784265e-07,0.11829133106733902,0.029384756657483937,0.009067132323909398,0.16430305129127598,0.0,0.009054007704764368,0.16989903679539697,0.0,1.1842986367842703e-07,0.17589066646366414,0.0
255,1.1,3,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does simultaneous neuroendoscope utilization impact the frequency of ventriculoperitoneal shunt infections? Findings indicate that endoscope use during VPS operations does not heighten surgical infection risk.,2.36859727356853e-07,0.30753333070586697,0.029384756657483937,0.018134264647818796,0.36101334553733055,0.0,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
255,1.1,4,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is there an effect on ventriculoperitoneal shunt infection rates when a neuroendoscope is used simultaneously? The study revealed that employing an endoscope with VPS does not elevate infection chances.,1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,1.1,5,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the simultaneous use of a neuroendoscope alter the incidence of infections related to ventriculoperitoneal shunts? Our research demonstrated that endoscope usage in VPS surgeries isn't associated with a higher infection risk.,7.10579182070559e-08,0.05159995656866556,0.029384756657483937,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
255,1.1,6,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical","Does using a neuroendoscope at the same time influence ventriculoperitoneal shunt infection rates? According to the present study, utilizing an endoscope during VPS did not increase surgical infection risk.",1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,1.1,7,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is the use of a neuroendoscope during VPS procedures linked to a change in shunt infection occurrence? The current study found no added risk of infection with endoscope use.,1.421158364141118e-07,0.15338265087860803,0.029384756657483937,0.010880558788691277,0.20067069546215066,0.0,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
255,1.1,8,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does simultaneous neuroendoscope usage affect the incidence of infections in ventriculoperitoneal shunt procedures? The research showed that endoscope application during VPS does not raise infection risk.,2.131737546211677e-07,0.26671133618561216,0.029384756657483937,0.016320838183036916,0.3184537311185349,0.0,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
255,1.1,9,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Is there an association between neuroendoscope simultaneous use and ventriculoperitoneal shunt infection frequency? This study concluded there was no increased infection risk with endoscope utilization in VPS operations.,1.658018091497971e-07,0.1897502950494827,0.029384756657483937,0.012693985253473157,0.23841102344499765,0.0,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
255,1.1,10,human,"Question: Does the Simultaneous Use of a Neuroendoscope Influence the Incidence of Ventriculoperitoneal Shunt Infection? Answer: In the present study, the use of an endoscope during VPS procedures did not increase the risk of surgical",Does the concurrent use of a neuroendoscope have an impact on infection rates following ventriculoperitoneal shunting? Our findings indicate that endoscope use during VPS procedures does not contribute to higher infection rates.,7.10579182070559e-08,0.05159995656866556,0.029384756657483937,0.005440279394345639,0.09531017980432521,0.0,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
256,1.1,1,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is it possible for APC mutation analysis to influence treatment choices in familial adenomatous polyposis? Answer: Since the age of onset and disease progression can vary significantly even among individuals with the same germline mutations, treatment decisions ought to be made according to colonoscopy results for each patient, not solely on mutation location. Nonetheless, for those with certain mutations...",7.105791820705622e-08,0.07694100961913897,0.017851239669421492,0.005440279394345618,0.05310982531394792,0.0,0.0054324046228586,0.05406722127027486,0.0,7.105791820705622e-08,0.05505977718302857,0.0
256,1.1,2,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can the analysis of APC mutations affect therapy decisions in familial adenomatous polyposis? Answer: Given that the age of disease presentation and progression can differ considerably even among patients with the same germline mutations, therapeutic choices should rely on individual colonoscopic evaluations rather than mutation site alone. However, in patients harboring mutations...",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
256,1.1,3,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Does APC mutation analysis have a role in guiding therapy decisions in familial adenomatous polyposis? Answer: Because disease manifestation age and course may vary greatly even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopy findings in each patient rather than mutation location. Yet, in patients with mutations...",9.474389094274162e-08,0.04935271570515187,0.017851239669421492,0.0072537058591274906,0.07550755250814589,0.0,0.007243206163811466,0.07696104113612989,0.0,9.474389094274162e-08,0.07847161544149417,0.0
256,1.1,4,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation testing assist in therapeutic decision-making for familial adenomatous polyposis? Answer: Since there is considerable variability in age of onset and disease course, even among those with the same germline mutations, treatment should be guided by colonoscopic findings individually, not by mutation position alone. Nevertheless, among patients with mutations...",1.1842986367842703e-07,0.06877080156225457,0.017851239669421492,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,1.1,5,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation analysis useful for informing therapeutic strategies in familial adenomatous polyposis? Answer: As the age at disease onset and progression may differ even in patients with identical germline mutations, treatment choices must be based on colonoscopic findings in each case rather than mutation site. However, for patients with mutations...",1.1842986367842703e-07,0.09595304393715409,0.001748760330578504,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,1.1,6,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can analyzing APC mutations influence therapy decisions in familial adenomatous polyposis? Answer: Given the variability in disease manifestation and progression among carriers of the same germline mutations, therapeutic approaches should be determined by individual colonoscopic findings rather than mutation location. Still, in patients with mutations...",2.6054570009253947e-07,0.19393394451626023,0.017851239669421492,0.0199476911126006,0.22314355131420927,0.0,0.019918816950481533,0.22778393087071303,0.0,2.6054570009253947e-07,0.2326222952687531,0.0
256,1.1,7,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Does the analysis of APC mutations contribute to treatment decisions in familial adenomatous polyposis? Answer: Because there can be significant differences in age of onset and disease course even among carriers of identical germline mutations, decisions regarding therapy should be based on colonoscopy outcomes uniquely for each patient rather than mutation site. However, in patients with mutations...",2.3685972735685406e-08,0.042454833547970416,0.017851239669421492,0.0018134264647818726,0.018018505502678472,0.0,0.0018108015409528666,0.018349138668195764,0.0,2.3685972735685406e-08,0.018692133012154333,0.0
256,1.1,8,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Can APC mutation analysis impact therapeutic decision-making in familial adenomatous polyposis? Answer: Since the manifestation age and disease progression vary quite a bit, even in patients with the same germline mutations, treatment plans should rely on individual colonoscopic assessments rather than mutation location alone. Nonetheless, for those with mutations...",1.6580180914979784e-07,0.10877613617595294,0.017851239669421492,0.012693985253473108,0.13613217432458002,0.0,0.012675610786670066,0.13883644485421742,0.0,1.6580180914979784e-07,0.14165051706302645,0.0
256,1.1,9,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Is APC mutation analysis relevant to making therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and disease course can differ among patients with the same germline mutations, treatment decisions should be primarily based on colonoscopy findings for each patient instead of mutation site. However, in patients with mutations...",1.1842986367842703e-07,0.09595304393715409,0.001748760330578504,0.009067132323909363,0.09531017980432566,0.0,0.009054007704764333,0.0971637484536485,0.0,1.1842986367842703e-07,0.09909090264422993,0.0
256,1.1,10,human,"Question: Can APC mutation analysis contribute to therapeutic decisions in familial adenomatous polyposis? Answer: As age at manifestation and course of the disease may be rather variable, even in carriers of identical germline mutations, therapeutic decisions should be based on colonoscopic findings in individual patients rather than on the site of mutation. However, in patients with mutations","Question: Could APC mutation analysis guide therapeutic decisions for familial adenomatous polyposis? Answer: Considering the variability in age of disease onset and progression among carriers of the identical germline mutations, therapy decisions should be founded upon the colonoscopic findings of each individual rather than on where the mutation occurs. Nevertheless, in patients with mutations...",7.105791820705622e-08,0.030304520734458773,0.017851239669421492,0.005440279394345618,0.056089466651043196,0.0,0.0054324046228586,0.05715841383995013,0.0,7.105791820705622e-08,0.05826890812397556,0.0
257,1.1,1,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Does the uptake of an IT innovation in primary care depend on general practice characteristics? The analysis indicates that structural aspects of a practice do not impact the adoption of a new IT system, but usage might be affected by post-graduate education related to the clinical condition. Specifically for this diabetes system, the involvement of practice nurses was essential.",9.474389094274162e-08,0.04587382847518118,0.014986149584487515,0.0072537058591274906,0.0678225963387602,0.0,0.007243206163811466,0.06899287148694988,0.0,9.474389094274162e-08,0.07020425867324764,0.0
257,1.1,2,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Are general practice attributes influential in adopting IT innovations in primary care? Findings reveal that practice structural factors are unrelated to IT innovation uptake, yet its utilization could be shaped by clinicians having post-graduate education relevant to the condition. Particularly with this diabetes technology, practice nurse participation was crucial.",3.316036182995957e-07,0.21121420119784906,0.0322222222222222,0.025387970506946217,0.2607262624632525,0.0,0.025351221573340132,0.2657031657330049,0.0,3.316036182995957e-07,0.2708749541353992,0.0
257,1.1,3,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do the features of general practice affect the acceptance of an IT innovation in primary care? Analysis shows that the structure of a practice doesn’t correlate with the adoption of new IT tools, though usage may be swayed by post-graduate training in the pertinent clinical area. For this diabetes system, the role of practice nurses was vital.",1.4211583641411244e-07,0.057063521370590564,0.0322222222222222,0.010880558788691236,0.10354067894083929,0.0,0.0108648092457172,0.10536051565782412,0.0,1.4211583641411244e-07,0.10724553035359774,0.0
257,1.1,4,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Is the uptake of an information technology innovation in primary care influenced by the characteristics of general practices? Results demonstrate that structural characteristics have no association with adoption rates, but use may be influenced by post-graduate education in the related clinical field. In the case of the diabetes system studied, use by practice nurses was fundamental.",1.6580180914979784e-07,0.12549273091399238,0.004089632530358787,0.012693985253473108,0.12188981760903506,0.0,0.012675610786670066,0.12405264866997845,0.0,1.6580180914979784e-07,0.12629372532429084,0.0
257,1.1,5,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Does the structure of a general practice affect the adoption of IT innovations in primary care? Studies indicate structural traits of practices aren’t linked to uptake, although usage might depend on advanced clinical education. Regarding this diabetes system, practice nurse involvement was significant.",4.737194547137081e-07,0.34474559382237224,0.0322222222222222,0.03626852929563745,0.3973017974690025,0.0,0.03621603081905733,0.4054651081081633,0.0,4.737194547137081e-07,0.4139757977760743,0.0
257,1.1,6,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do characteristics of general practices impact the adoption of IT innovations within primary care? Analysis suggests no link between structural features and uptake, but post-graduate education in the condition may influence usage. For this diabetes system in particular, the engagement of practice nurses was critical.",4.263475092423373e-07,0.2982255781874783,0.0322222222222222,0.03264167636607371,0.3496737484797481,0.0,0.0325944277371516,0.35667494393873156,0.0,4.263475092423373e-07,0.36396537720141087,0.0
257,1.1,7,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Does uptake of IT innovations in primary care relate to general practice characteristics? Research findings assert structural features of practices are not tied to adoption, yet usage can be influenced by post-graduate education relevant to the condition. For the diabetes system examined, practice nurse usage was key.",3.789755637709665e-07,0.2537738156166456,0.0322222222222222,0.029014823436509962,0.30421137440299084,0.0,0.028972824655245866,0.3101549283038376,0.0,3.789755637709665e-07,0.31633732821215643,0.0
257,1.1,8,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Are general practice characteristics predictors of IT innovation adoption in primary care? Data shows structural practice factors don’t correspond with uptake, but postgraduate educational qualifications concerning the clinical condition might impact usage. For this diabetes system specifically, practice nurse involvement proved essential.",4.974054274493935e-07,0.36884314540143226,0.0322222222222222,0.038081955760419325,0.4219944100593742,0.0,0.0380268323600102,0.430782916092455,0.0,4.974054274493935e-07,0.43995128417933227,0.0
257,1.1,9,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Do general practice structural features affect how IT innovations are adopted in primary care? The analysis shows no association between practice structure and technology uptake, but use may be affected by post-graduate education focused on the clinical area. Specifically, practice nurse use was crucial for the diabetes system.",3.552895910352811e-07,0.23226761039568222,0.0322222222222222,0.02720139697172809,0.28223246768421584,0.0,0.027162023114293,0.2876820724517799,0.0,3.552895910352811e-07,0.2933478099874569,0.0
257,1.1,10,human,"Question: Do general practice characteristics influence uptake of an information technology (IT) innovation in primary care? Answer: The analyses show that structural characteristics of a practice are not associated with uptake of a new IT facility, but that its use may be influenced by post-graduate education in the relevant clinical condition. For this diabetes system at least, practice nurse use was critical in","Does the adoption of new IT solutions in primary care depend on general practice characteristics? Results reveal that structural aspects are not associated with uptake, though the extent of use could be influenced by advanced educational qualifications related to the clinical condition, with practice nurse involvement being critical for this diabetes system.",2.6054570009253947e-07,0.15058957938141493,0.0322222222222222,0.0199476911126006,0.19885085874516495,0.0,0.019918816950481533,0.20252426411147262,0.0,2.6054570009253947e-07,0.20633643299782767,0.0
258,1.1,1,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Does the timing affect the link between urban living and non-communicable disease risk in Thailand? Yes, timing is crucial. The length of exposure to urban surroundings, time spent outside, and when certain activities occur can all influence health outcomes.",5.921493183921349e-07,0.37352053227277526,0.09418282548476452,0.045335661619546816,0.4267781265221622,0.06420927467300831,0.045270038523821665,0.45917651451458275,0.049048751486325794,5.921493183921352e-07,0.4927866886953569,0.033293697978596916
258,1.1,2,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","In Thailand, does the timing influence the non-communicable disease risk associated with urban living? Indeed, it does. Duration of exposure, outdoor activity times, and timing of behaviors play significant roles in health risks.",7.342651548062467e-07,0.5453707891994353,0.09418282548476452,0.05621622040823808,0.6037088346812411,0.06420927467300831,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.6808389201982972,0.033293697978596916
258,1.1,3,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","When considering urban life and non-communicable diseases in Thailand, does timing matter? Absolutely. How long one is exposed, the periods spent outdoors, and the timing of daily activities impact the individual's health risk.",7.342651548062467e-07,0.5453707891994353,0.09418282548476452,0.05621622040823808,0.6037088346812411,0.06420927467300831,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.6808389201982972,0.033293697978596916
258,1.1,4,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Is timing important in the relationship between living in urban areas and non-communicable diseases in Thailand? Yes, it is. Factors like exposure time, outdoor hours, and activity timing affect health outcomes.",7.816371002776173e-07,0.6099093103370068,0.09418282548476452,0.05984307333780184,0.6704002091799146,0.06420927467300831,0.05975645085144465,0.7104909427954889,0.049048751486325794,7.816371002776184e-07,0.7522978841804409,0.033293697978596916
258,1.1,5,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Does timing influence the risk of non-communicable diseases due to urban living in Thailand? Timing is indeed important. The duration of being in urban environments, timing of outdoor exposure, and when activities are performed may change health risks.",6.158352911278202e-07,0.40018877935493613,0.09418282548476452,0.04714908808432869,0.4541771007102775,0.06420927467300831,0.04708084006477453,0.4873473914812796,0.049048751486325794,6.158352911278206e-07,0.5217742255686084,0.033293697978596916
258,1.1,6,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Regarding urban living and non-communicable disease risk in Thailand, does timing play a role? Timing is key. The length of exposure, outdoor time, and activity schedules can all affect health impacts.",7.816371002776173e-07,0.6099093103370068,0.09418282548476452,0.05984307333780184,0.6704002091799146,0.06420927467300831,0.05975645085144465,0.7104909427954889,0.049048751486325794,7.816371002776184e-07,0.7522978841804409,0.033293697978596916
258,1.1,7,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Is the timing significant for the connection between urban environments and non-communicable diseases in Thailand? Yes, timing matters a lot. Duration in urban areas, timing of outdoor exposure, and timing of activities can influence health risk.",6.632072365991908e-07,0.4953670408274595,0.06563611268199636,0.05077594101389244,0.5113355145502259,0.06420927467300831,0.05070244314668028,0.5461878915042129,0.049048751486325794,6.632072365991914e-07,0.5823988473850439,0.033293697978596916
258,1.1,8,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","When looking at urban living and disease risk in Thailand, is timing relevant? Yes, timing plays a critical part. How long one is exposed, time outside, and activity timing help determine health effects.",7.342651548062467e-07,0.5453707891994353,0.09418282548476452,0.05621622040823808,0.6037088346812411,0.06420927467300831,0.0561348477695389,0.6414980713085381,0.049048751486325794,7.342651548062476e-07,0.6808389201982972,0.033293697978596916
258,1.1,9,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","Does the timing of exposure affect non-communicable disease risk related to urban living in Thailand? Timing is significant. The amount of exposure, when outdoor activities occur, and activity schedules influence health outcomes.",7.57951127541932e-07,0.5771194875140151,0.09418282548476452,0.05802964687301996,0.6364986575042328,0.06420927467300831,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7159302400095662,0.033293697978596916
258,1.1,10,ai,"Question: Living in an urban environment and non-communicable disease risk in Thailand: Does timing matter? Answer: Timing does matter when it comes to living in an urban environment and the risk of non-communicable diseases in Thailand. Factors such as the duration of exposure, time spent outdoors, and the timing of activities can all play a role in determining the impact on an individual's health.","In Thailand, does the timing matter for non-communicable disease risk linked to urban living? Yes, timing matters. Factors such as exposure duration, outdoor time, and activity timing impact an individual's health risks.",7.57951127541932e-07,0.5771194875140151,0.09418282548476452,0.05802964687301996,0.6364986575042328,0.06420927467300831,0.05794564931049177,0.6753996229842198,0.049048751486325794,7.57951127541933e-07,0.7159302400095662,0.033293697978596916
259,1.1,1,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Is the anxiety caused by alcohol withdrawal linked to a deficiency in beta-endorphin? Answer: Our findings provide the first proof that reduced beta-endorphin levels during alcohol withdrawal might be a factor contributing to anxiety, a frequent symptom in this condition.",1.658018091497971e-07,0.15771453361945964,0.02498356344510192,0.01269398525347313,0.19782574332991798,0.0,0.012675610786670094,0.20359895524123983,0.0,1.6580180914979784e-07,0.20972053098207066,0.0
259,1.1,2,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Does beta-endorphin deficiency underlie withdrawal-induced anxiety in alcoholism? Answer: We present initial evidence demonstrating that decreased beta-endorphin during alcohol withdrawal could promote anxiety, which commonly occurs in this phase.",9.47438909427412e-08,0.12921173148000697,0.0,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
259,1.1,3,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is the anxiety experienced during alcohol withdrawal due to a lack of beta-endorphin? Answer: Our results offer the first indication that lower beta-endorphin levels during withdrawal may be responsible for anxiety commonly observed in this state.,7.10579182070559e-08,0.08701137698963013,0.0,0.005440279394345639,0.08961215868968697,0.0,0.005432404622858621,0.09237332013101529,0.0,7.105791820705622e-08,0.09531017980432521,0.0
259,1.1,4,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Is withdrawal-related anxiety in alcoholics caused by a deficiency in beta-endorphins? Answer: The study's results reveal initial evidence that reduced beta-endorphin during alcohol withdrawal contributes to anxiety, a typical impairment during this phase.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,1.1,5,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Can withdrawal-induced anxiety in alcoholism be attributed to beta-endorphin deficiency? Answer: Our research offers initial proof that decreased beta-endorphin during withdrawal may cause anxiety, frequently seen in this condition.",9.47438909427412e-08,0.12921173148000697,0.0,0.007253705859127518,0.1335313926245223,0.0,0.007243206163811494,0.13815033848081715,0.0,9.474389094274162e-08,0.14310084364067244,0.0
259,1.1,6,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Does a deficit in beta-endorphin cause anxiety related to alcohol withdrawal? Answer: Our findings provide the first evidence that lowered beta-endorphin during alcohol withdrawal may lead to anxiety, a common disturbance during withdrawal.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,1.1,7,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,"Question: Is the anxiety noted during alcohol withdrawal linked to a shortage of beta-endorphin? Answer: The evidence from our study suggests that lower beta-endorphin levels in withdrawal could be a determinant of anxiety, a usual symptom during this period.",1.184298636784265e-07,0.14107859825990632,0.0,0.009067132323909384,0.14518200984449914,0.0,0.00905400770476436,0.14953173397096364,0.0,1.1842986367842703e-07,0.1541506798272585,0.0
259,1.1,8,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is a deficiency in beta-endorphin responsible for anxiety during alcohol withdrawal? Answer: Our data give initial evidence that reduced beta-endorphin levels during withdrawal can contribute to the anxiety commonly observed in this state.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
259,1.1,9,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Does anxiety in alcoholism withdrawal result from beta-endorphin deficiency? Answer: The results justify the first evidence that lower beta-endorphin during withdrawal contributes to frequent anxiety during this phase.,1.184298636784265e-07,0.16430305129127598,0.0,0.009067132323909398,0.16989903679539697,0.0,0.009054007704764368,0.17589066646366414,0.0,1.1842986367842703e-07,0.1823215567939549,0.0
259,1.1,10,human,Question: Is withdrawal-induced anxiety in alcoholism based on beta-endorphin deficiency? Answer: Our results give first evidence that lowered beta E during alcohol withdrawal may contribute to anxiety as a common disturbance during this state.,Question: Is beta-endorphin deficiency the cause of anxiety triggered by alcohol withdrawal? Answer: Our findings represent the first evidence that diminished beta-endorphin during withdrawal may be linked to anxiety commonly experienced in this condition.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
260,1.1,1,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts truly real? Answer: Based on our research findings and global literature, the globulomaxillary cyst as an entity lacks justification.",1.421158364141118e-07,0.24116205681688863,0.0,0.010880558788691277,0.2513144282809079,0.0,0.010864809245717241,0.26236426446749217,0.0,1.4211583641411233e-07,0.27443684570175986,0.0
260,1.1,2,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts actually exist? Answer: Our study results together with international data indicate that the concept of a globulomaxillary cyst is no longer valid.,7.10579182070559e-08,0.11332868530700413,0.0,0.005440279394345639,0.11778303565638426,0.0,0.005432404622858621,0.1226023220923329,0.0,7.105791820705622e-08,0.1278333715098845,0.0
260,1.1,3,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the globulomaxillary cyst a genuine entity? Answer: The evidence from our work and worldwide literature shows that the globulomaxillary cyst is no longer a justified diagnosis.,2.36859727356853e-08,0.13905611536494122,0.07359999999999998,0.0018134264647818796,0.09105934187207376,0.03840000000000001,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
260,1.1,4,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Are globulomaxillary cysts a real clinical entity? Answer: According to our study and international references, the recognition of globulomaxillary cyst as a distinct entity is not supported anymore.",0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
260,1.1,5,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts exist as a defined entity? Answer: Findings from our study and the international literature suggest that the globulomaxillary cyst does not have a justified existence.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
260,1.1,6,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Question: Are globulomaxillary cysts physically real? Answer: Both our study and international literature confirm that the notion of the globulomaxillary cyst is unjustified today.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,1.1,7,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Is the so-called globulomaxillary cyst an actual entity? Answer: Our research and data from global literature prove that the globulomaxillary cyst is no longer justified as a diagnosis.,0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
260,1.1,8,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.",Question: Do globulomaxillary cysts genuinely occur? Answer: Results from our study along with international literature deny the justification of globulomaxillary cyst as a standalone entity.,9.47438909427412e-08,0.15415067982725894,0.0,0.007253705859127518,0.1603426500751799,0.0,0.007243206163811494,0.16705408466316696,0.0,9.474389094274162e-08,0.17435338714477844,0.0
260,1.1,9,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the globulomaxillary cyst a valid pathological entity? Answer: Based on study results and literature globally, this entity is no longer supported scientifically.",1.184298636784265e-07,0.19671029424605457,0.0,0.009067132323909398,0.20479441264601395,0.0,0.009054007704764368,0.2135741002980609,0.0,1.1842986367842698e-07,0.2231435513142097,0.0
260,1.1,10,human,"Question: Globulomaxillary cysts--do they really exist? Answer: According to the results of our study and the data from the international literature, the entity globulomaxillary cyst is no longer justified.","Question: Is the presence of globulomaxillary cysts real? Answer: According to our investigation and international scholarly work, the existence of the globulomaxillary cyst is no longer justified.",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
261,1.1,1,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: Is aerobic fitness impacted by obstructive sleep apnea? Answer: In a US Air Force group, obstructive sleep apnea (OSA) generally does not predict reduced aerobic fitness as measured by cycle ergometry. However, those with an apnea-hypopnea index above 20 do show a statistically significant drop in aerobic fitness compared to normal individuals. This study.",0.0,0.009689780440084839,0.039215686274509776,0.0,0.05231299475924134,0.03767781622452902,0.0,0.026659506944613387,0.01922337562475971,0.0,0.0,0.0
261,1.1,2,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: Does obstructive sleep apnea influence aerobic capacity? Answer: Among US Air Force personnel, OSA does not typically forecast a decline in aerobic fitness determined by cycle ergometry. Yet, patients with an apnea-hypopnea index over 20 exhibit a statistically significant reduction in aerobic fitness when compared to the normal population. This study.",7.105791820705622e-08,0.034506545194199933,0.016212967780149266,0.005440279394345618,0.033681800587132216,0.01768614608708629,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
261,1.1,3,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: How does obstructive sleep apnea affect aerobic fitness? Answer: In a US Air Force cohort, obstructive sleep apnea is not a predictor of decreased aerobic fitness measured by cycle ergometry. Nonetheless, individuals with an apnea-hypopnea index exceeding 20 have a statistically meaningful lower aerobic fitness relative to normal subjects. This study.",7.105791820705622e-08,0.06168878756909946,0.00323042820069204,0.005440279394345618,0.033681800587132216,0.01768614608708629,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
261,1.1,4,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: Is aerobic performance affected by obstructive sleep apnea? Answer: In the US Air Force population, OSA does not serve as a predictor for reduced aerobic fitness through cycle ergometry tests. However, those with an apnea-hypopnea index greater than 20 have statistically significant lower aerobic fitness compared to the regular population. This study.",4.737194547137081e-08,0.012616518468088866,0.03613994617454825,0.0036268529295637453,0.013846713931445542,0.03767781622452902,0.003621603081905733,0.012561206208669073,0.01922337562475971,4.737194547137081e-08,0.04000533461369837,0.0
261,1.1,5,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: Does obstructive sleep apnea reduce aerobic fitness levels? Answer: Overall, in a sample of US Air Force personnel, OSA does not predict a decrease in aerobic capacity as assessed by cycle ergometry. But patients with an apnea-hypopnea index above 20 show significantly decreased aerobic fitness compared to normal individuals. This study.",7.105791820705622e-08,0.007324302819299966,0.03576332179930797,0.005440279394345618,0.005955913364734222,0.03767781622452902,0.0054324046228586,0.03276391352618768,0.01922337562475971,7.105791820705622e-08,0.06062462181643413,0.0
261,1.1,6,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: What is the relationship between obstructive sleep apnea and aerobic fitness? Answer: Within a US Air Force group, obstructive sleep apnea does not predict a decline in aerobic fitness measured by cycle ergometry; however, subjects with an apnea-hypopnea index above 20 demonstrate a statistically notable drop in aerobic fitness versus normal controls. This study.",0.0,0.025672117798516858,0.01823667820069204,0.0,0.0,0.0,0.0,0.026659506944613387,0.01922337562475971,0.0,0.0,0.0
261,1.1,7,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: Does obstructive sleep apnea have an impact on aerobic fitness? Answer: In US Air Force members, OSA generally does not predict aerobic fitness reduction on cycle ergometry, yet those with an apnea-hypopnea index greater than 20 experience a statistically significant decline compared to normal populations. This study.",1.6580180914979784e-07,0.061820091458667736,0.05536332179930796,0.012693985253473108,0.08933752230378511,0.03767781622452902,0.012675610786670066,0.11792172186649497,0.01922337562475971,1.6580180914979784e-07,0.14763599880606337,0.0
261,1.1,8,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: Can obstructive sleep apnea affect aerobic fitness? Answer: Among US Air Force individuals, OSA is not associated with lower aerobic fitness as indicated by cycle ergometry, but patients whose apnea-hypopnea index surpasses 20 have a significant decrease in aerobic fitness statistically compared to normal people. This study.",1.6580180914979784e-07,0.09131571616334622,0.034096781156585855,0.012693985253473108,0.08933752230378511,0.03767781622452902,0.012675610786670066,0.11792172186649497,0.01922337562475971,1.6580180914979784e-07,0.14763599880606337,0.0
261,1.1,9,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: Is there an effect of obstructive sleep apnea on aerobic fitness? Answer: In US Air Force cohorts, obstructive sleep apnea does not predict diminished aerobic fitness via cycle ergometry testing; however, a higher apnea-hypopnea index above 20 is linked to a statistically significant decrease in aerobic fitness compared to the general population. This study.",0.0,4.440892098500626e-16,0.0,0.0,0.026156497379620447,0.01881686947896689,0.0,0.026659506944613387,0.01922337562475971,0.0,0.0,0.0
261,1.1,10,human,"Question: Does obstructive sleep apnea affect aerobic fitness? Answer: Overall, in a US Air Force population, OSA does not predict a decrease in aerobic fitness as measured by cycle ergometry. However, patients with an apnea-hypopnea index of greater than 20 have a statistically significant decrease in aerobic fitness compared to the normal population. This study","Question: Does having obstructive sleep apnea lower aerobic fitness? Answer: In a US Air Force population, OSA typically does not indicate a lower aerobic fitness based on cycle ergometry measurements, but individuals with an apnea-hypopnea index exceeding 20 demonstrate statistically meaningful decreased aerobic capacity relative to normal populations. This study.",1.1842986367842703e-07,0.0484391167136069,0.03496401624375241,0.009067132323909363,0.04677790788498859,0.03767781622452902,0.009054007704764333,0.0744366099267566,0.01922337562475971,1.1842986367842703e-07,0.10318423623523065,0.0
262,1.1,1,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Do globulomaxillary cysts actually exist? Answer: Yes, they do. Globulomaxillary cysts are rare, non-cancerous lesions found between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.12742698604294844,0.03840000000000001,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,1.1,2,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts real? Answer: Indeed, globulomaxillary cysts are real. They are uncommon benign cysts located between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.12742698604294844,0.03840000000000001,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,1.1,3,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Do globulomaxillary cysts truly exist? Answer: Yes, these cysts exist. They are rare, benign growths occurring between the roots of the maxillary lateral incisor and canine teeth.",2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
262,1.1,4,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Is the existence of globulomaxillary cysts confirmed? Answer: Yes, globulomaxillary cysts are confirmed to exist. They are uncommon, benign lesions situated between the maxillary lateral incisor and canine roots.",2.36859727356853e-08,0.012711934020451121,0.03443877551020409,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
262,1.1,5,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts a recognized condition? Answer: Yes, they are recognized. Globulomaxillary cysts occur rarely as benign lesions between the roots of the maxillary lateral incisor and canine.",0.0,0.04951051289713915,0.035665294924554176,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
262,1.1,6,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Do globulomaxillary cysts exist in dental pathology? Answer: Yes, globulomaxillary cysts are indeed present, though rare. They are benign lesions appearing between the roots of the maxillary lateral incisor and canine.",7.10579182070559e-08,0.05706352137059145,0.0322222222222222,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
262,1.1,7,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Is there evidence supporting the existence of globulomaxillary cysts? Answer: Yes, evidence shows that globulomaxillary cysts exist. They are rare benign lesions located between the maxillary lateral incisor and canine roots.",7.10579182070559e-08,0.10178269430994247,0.0,0.005440279394345639,0.10536051565782545,0.0,0.005432404622858621,0.10919929196499067,0.0,7.105791820705622e-08,0.11332868530700413,0.0
262,1.1,8,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts commonly found? Answer: They do exist, but they are rare benign lesions found between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
262,1.1,9,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Can globulomaxillary cysts be found in the oral cavity? Answer: Yes, these cysts are rare benign lesions that occur between the roots of the maxillary lateral incisor and canine.",2.36859727356853e-08,0.035091319811269006,0.0,0.0018134264647818796,0.03636764417087468,0.0,0.0018108015409528735,0.03774032798284699,0.0,2.3685972735685406e-08,0.03922071315328246,0.0
262,1.1,10,ai,"Question: Globulomaxillary cysts--do they really exist? Answer: Yes, globulomaxillary cysts do exist. They are rare, benign lesions that occur between the roots of the maxillary lateral incisor and canine","Question: Are globulomaxillary cysts a legitimate clinical finding? Answer: Yes, they are legitimate, rare, benign lesions occurring between the roots of the maxillary lateral incisor and canine.",4.73719454713706e-08,0.07410797215372167,0.0,0.003626852929563759,0.07696104113612945,0.0,0.003621603081905747,0.08004270767353727,0.0,4.737194547137081e-08,0.08338160893905044,0.0
263,1.1,1,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is opioid dependence and methadone maintenance treatment (MMT) recorded in the medical records? Answer: For patients undergoing MMT and receiving medical care at various locations, documentation of opioid dependence and MMT is present for most, but absent in some cases.",7.105791820705622e-08,0.012677764647723855,0.04218321158444751,0.005440279394345618,0.04363996421702332,0.021876731301939047,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
263,1.1,2,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) noted in the medical records? Answer: Among patients treated with MMT and attending different care sites, the majority have opioid dependence and MMT documented in their medical records, although documentation is missing in some.",2.3685972735685406e-08,0.03941310038151791,0.04454470742932283,0.0018134264647818726,0.008104408028834165,0.023125,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
263,1.1,3,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Does the medical record document opioid dependence and methadone maintenance treatment (MMT)? Answer: In patients receiving MMT and care across multiple sites, most have documentation of opioid dependence and MMT in their records, but some lack this information.",1.1842986367842682e-07,0.06761920209085259,0.039575571626853705,0.009067132323909363,0.09820510360836066,0.020493827160493836,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
263,1.1,4,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) recorded in the patients' medical records? Answer: For individuals receiving MMT and medical services at various facilities, most have opioid dependence and MMT documented, though some records lack this.",1.4211583641411212e-07,0.09625941839224605,0.03816715640891467,0.010880558788691236,0.1266448393288484,0.01974489795918367,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
263,1.1,5,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is there documentation of opioid dependence and methadone maintenance treatment (MMT) in the medical record? Answer: Among patients receiving MMT and care at different sites, the majority have their opioid dependence and MMT noted in the medical record, but some do not.",2.3685972735685406e-08,0.02660091681466925,0.0021381180554416873,0.0018134264647818726,0.025707649559455703,0.0011522024983563403,0.0018108015409528666,0.0246926125903717,0.0,2.3685972735685406e-08,0.02531780798429173,0.0
263,1.1,6,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) recorded within the medical records? Answer: Most patients undergoing MMT and care at multiple locations have documentation of both opioid dependence and MMT, but some records are incomplete.",1.6580180914979742e-07,0.12573991564510534,0.03668138563001487,0.012693985253473108,0.15591594991548163,0.01895328719723184,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
263,1.1,7,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Does the medical record include documentation of opioid dependence and methadone maintenance treatment (MMT)? Answer: In patients receiving MMT and treatment at various sites, documentation exists for most, though it is missing for some cases.",1.8948778188548272e-07,0.0768944392162525,0.09204470742932284,0.014507411718254988,0.1452950764710219,0.0475,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
263,1.1,8,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is opioid dependence and methadone maintenance treatment (MMT) recorded in medical records? Answer: For the majority of patients treated with MMT across diverse sites, opioid dependence and MMT are documented, but in some instances, documentation is absent.",1.4211583641411212e-07,0.09625941839224605,0.03816715640891467,0.010880558788691236,0.1266448393288484,0.01974489795918367,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
263,1.1,9,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Are opioid dependence and methadone maintenance treatment (MMT) reflected in medical records? Answer: Among individuals receiving MMT and care at different facilities, most have opioid dependence and MMT recorded, but this is not universal.",2.1317375462116802e-07,0.1874287032142039,0.033450957429322845,0.016320838183036868,0.21715695965463944,0.0172265625,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
263,1.1,10,human,"Question: Are opioid dependence and methadone maintenance treatment (MMT) documented in the medical record? Answer: Among patients receiving MMT and medical care at different sites, documentation of opioid dependence and MMT in the medical record occurs for the majority, but is missing in a","Question: Is there evidence of opioid dependence and methadone maintenance treatment (MMT) in the medical records? Answer: While most patients receiving MMT across various sites have these documented, some do not have opioid dependence or MMT reflected in their records.",9.474389094274152e-08,0.004226863835505412,0.06642143873126188,0.0072537058591274906,0.03406944136079737,0.0475,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
264,1.1,1,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Neck pain treatment using acupuncture: is the quantity of needles significant? For this condition, whether 5 or 11 needles are used, the therapeutic outcome appears unaffected when stimulation duration is consistent between groups.",3.3160361829959484e-07,0.30263182581459036,0.043388429752066124,0.025387970506946245,0.3418687439269532,0.02221074380165289,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
264,1.1,2,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Does the number of acupuncture needles influence treatment for neck pain? In this case, having either 5 or 11 needles does not seem to impact the therapeutic effect provided the stimulation time is equal across groups.",2.6054570009253894e-07,0.2130196671249034,0.043388429752066124,0.019947691112600606,0.24949542379593792,0.02221074380165289,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
264,1.1,3,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Regarding acupuncture for neck pain, does needle count matter? It seems that using either 5 or 11 needles yields similar therapeutic effects when the stimulation time is the same in both groups.",3.5528959103528014e-07,0.3343805241291702,0.043388429752066124,0.027201396971728124,0.3746585667499449,0.02221074380165289,0.02716202311429304,0.41689380393178865,0.0,3.552895910352811e-07,0.42899560551835814,0.0
264,1.1,4,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","When treating neck pain with acupuncture, does the needle number play a role? For this disorder, using 5 versus 11 needles does not appear to affect the treatment result if the stimulation duration is matched.",2.8423167282822424e-07,0.2420072039981549,0.043388429752066124,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
264,1.1,5,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Is there a difference in neck pain treatment efficacy with varying needles in acupuncture? For this pathology, number of needles (5 or 11) does not seem to influence therapeutic outcomes if stimulation time remains identical.",2.8423167282822424e-07,0.2420072039981549,0.043388429752066124,0.021761117577382486,0.2793483869456197,0.02221074380165289,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
264,1.1,6,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","In acupuncture for neck pain, is the number of needles important? The therapeutic effect appears unchanged whether 5 or 11 needles are used, so long as stimulation time is the same between groups.",3.3160361829959484e-07,0.34595352459958795,0.012170947962263819,0.025387970506946245,0.3418687439269532,0.02221074380165289,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
264,1.1,7,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Does acupuncture needle count impact neck pain treatment? It seems not, given that the therapeutic effect is similar whether 5 or 11 needles are applied, assuming equal stimulation time.",4.2634750924233604e-07,0.43616321843911265,0.043388429752066124,0.03264167636607376,0.48001908240777036,0.02221074380165289,0.03259442773715166,0.5260930958967793,0.0,4.263475092423373e-07,0.5423242908253623,0.0
264,1.1,8,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","For neck pain treatment via acupuncture, does number of needles affect outcomes? Evidence suggests that using 5 or 11 needles leads to comparable therapeutic effects if both groups receive the same stimulation period.",3.3160361829959484e-07,0.30263182581459036,0.043388429752066124,0.025387970506946245,0.3418687439269532,0.02221074380165289,0.025351221573340167,0.3829922522561069,0.0,3.316036182995957e-07,0.39390428570708913,0.0
264,1.1,9,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","When managing neck pain with acupuncture, does the quantity of needles influence results? The treatment effect appears consistent whether employing 5 or 11 needles, provided stimulation time matches in both groups.",3.7897556377096544e-07,0.3671703469521619,0.043388429752066124,0.029014823436510004,0.4085601184256267,0.02221074380165289,0.028972824655245914,0.45198512374305766,0.0,3.789755637709665e-07,0.4653632496892328,0.0
264,1.1,10,human,"Question: Neck pain treatment with acupuncture: does the number of needles matter? Answer: For this pathology, the number of needles, 5 or 11, seems not to be an important variable in determining the therapeutic effect when the time of stimulation is the same in the two groups.","Does needle quantity matter in acupuncture for neck pain? For this condition, the therapeutic effect seems independent of using 5 or 11 needles if both groups have equal stimulation duration.",4.0266153650665074e-07,0.40107189862784365,0.043388429752066124,0.030828249901291883,0.4436514382368957,0.02221074380165289,0.030783626196198788,0.48835276791393234,0.0,4.026615365066519e-07,0.5031035776720798,0.0
265,1.1,1,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is the formation of endometrial polyps linked to heightened expression of vascular endothelial growth factor and transforming growth factor-beta1? Yes, research indicates that endometrial polyp formation correlates with increased levels of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors are involved in angiogenesis and tissue remodeling, processes that may support the development and growth of endometrial polyps.",4.737194547137081e-08,0.07271224709374247,0.0671050070960362,0.0036268529295637453,0.07602683132943211,0.07464890548601068,0.003621603081905733,0.05602737294713922,0.06333351139193497,4.737194547137081e-08,0.0577213515017827,0.06540855546143882
265,1.1,2,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Does endometrial polyp development associate with elevated expression of VEGF and TGF-beta1? Indeed, endometrial polyp formation has been shown to correspond with boosted expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These factors contribute to angiogenesis and tissue remodeling, which may promote polyp growth.",3.789755637709665e-07,0.08792230530609224,0.1374616600452818,0.029014823436509962,0.09725671032891459,0.14097543609825555,0.028972824655245866,0.16785455199775523,0.09719008264462808,3.789755637709665e-07,0.19463039821051442,0.08264462809917351
265,1.1,3,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is there a relationship between endometrial polyp formation and increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1)? Yes, endometrial polyps have been linked with higher expression levels of VEGF and TGF-beta1, growth factors that play important roles in angiogenesis and tissue remodeling, potentially aiding polyp growth.",3.079176455639103e-07,0.03294434782135225,0.17993079584775093,0.023574544042164344,0.03407780870738231,0.14097543609825555,0.023540420032387266,0.1033160308601837,0.09719008264462808,3.079176455639103e-07,0.12867243041871834,0.08264462809917351
265,1.1,4,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is endometrial polyp formation associated with the upregulation of VEGF and TGF-beta1? The answer is yes; endometrial polyps show increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1), which are involved in processes like angiogenesis and tissue remodeling that contribute to polyp development.",4.026615365066519e-07,0.05043726111769864,0.17993079584775093,0.030828249901291835,0.11923561704768959,0.14097543609825555,0.030783626196198732,0.19032740784981295,0.09719008264462808,4.026615365066519e-07,0.21761991643521394,0.08264462809917351
265,1.1,5,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Are increased expressions of vascular endothelial growth factor and transforming growth factor-beta1 linked to endometrial polyp formation? Yes, studies have found that endometrial polyps exhibit elevated expression of these growth factors, which are key to angiogenesis and tissue remodeling, aiding polyp formation.",5.210914001850789e-07,0.16550659090248532,0.17993079584775093,0.0398953822252012,0.23701865270407296,0.14097543609825555,0.039837633900963065,0.31095539563843033,0.09719008264462808,5.210914001850789e-07,0.3412338724023898,0.08264462809917351
265,1.1,6,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Does the formation of endometrial polyps coincide with higher expression of VEGF and TGF-beta1? Yes, there is an association between polyp formation and increased levels of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1), both involved in angiogenesis and tissue remodeling.",4.974054274493935e-07,0.1414090393234253,0.17993079584775093,0.038081955760419325,0.21232604011370126,0.14097543609825555,0.0380268323600102,0.2856375876541386,0.09719008264462808,4.974054274493935e-07,0.3152583859991318,0.08264462809917351
265,1.1,7,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is increased expression of vascular endothelial growth factor and transforming growth factor-beta1 connected to the development of endometrial polyps? Yes, endometrial polyp formation has been correlated with elevated expression of VEGF and TGF-beta1, which contribute to the processes of angiogenesis and tissue remodeling relevant to polyp growth.",4.026615365066519e-07,0.11071092899247637,0.13654236609568482,0.030828249901291835,0.11923561704768959,0.14097543609825555,0.030783626196198732,0.19032740784981295,0.09719008264462808,4.026615365066519e-07,0.21761991643521394,0.08264462809917351
265,1.1,8,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Does the presence of endometrial polyps correlate with increased vascular endothelial growth factor and transforming growth factor-beta1 expression? Yes, findings suggest that polyps are associated with heightened VEGF and TGF-beta1 expression, factors that play a role in angiogenesis and tissue restructuring.",5.447773729207643e-07,0.19019920349285702,0.17993079584775093,0.04170880868998307,0.2623364606883647,0.14097543609825555,0.04164843544191593,0.3369308820416883,0.09719008264462808,5.447773729207643e-07,0.36790211948455065,0.08264462809917351
265,1.1,9,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Is there an association between vascular endothelial growth factor and transforming growth factor-beta1 expression and endometrial polyp formation? Yes, the formation of endometrial polyps has been linked to increased expression of VEGF and TGF-beta1, growth factors that facilitate angiogenesis and tissue remodeling important for polyp development.",4.263475092423373e-07,0.07241616783647364,0.17993079584775093,0.03264167636607371,0.1417084728997473,0.14097543609825555,0.0325944277371516,0.21331692607451247,0.09719008264462808,4.263475092423373e-07,0.24115041384540836,0.08264462809917351
265,1.1,10,ai,"Question: Is endometrial polyp formation associated with increased expression of vascular endothelial growth factor and transforming growth factor-beta1? Answer: Yes, endometrial polyp formation has been found to be associated with increased expression of vascular endothelial growth factor (VEGF) and transforming growth factor-beta1 (TGF-beta1). These growth factors play a role in angiogenesis and tissue remodeling, which may contribute to the development and growth of endometrial","Are vascular endothelial growth factor and transforming growth factor-beta1 more highly expressed in cases of endometrial polyp formation? Yes; increased levels of VEGF and TGF-beta1 have been observed during the formation of endometrial polyps, contributing to angiogenesis and tissue remodeling involved in polyp growth.",4.737194547137081e-07,0.1501179456602051,0.1566881654622634,0.03626852929563745,0.18822848853464125,0.14097543609825555,0.03621603081905733,0.2609449750637669,0.09719008264462808,4.737194547137081e-07,0.2899405780148401,0.08264462809917351
266,1.1,1,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Question: Could gestational age misclassification account for the birthweight differences between Australian Aborigines and whites? Answer: Gestational age misclassification might help explain the birthweight disparities, but it is not the only cause; other factors like socioeconomic status also play a role.",9.474389094274162e-08,0.021264573289847988,0.07888970051132212,0.0072537058591274906,0.004226863835505412,0.06642143873126188,0.007243206163811466,0.06707644995888984,0.023795359904818555,9.474389094274162e-08,0.10265415406008227,0.0
266,1.1,2,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Question: Is gestational age misclassification the reason for birthweight differences between Australian Aborigines and whites? Answer: While gestational age misclassification may influence the birthweight gap, it is not the only explanation; socioeconomic inequalities and other variables also contribute.",1.6580180914979753e-07,0.027659721426677386,0.09951908886271818,0.012693985253473108,0.0872317389473305,0.0642896053885065,0.012675610786670066,0.14931454819586287,0.023795359904818555,1.6580180914979784e-07,0.18721154208814594,0.0
266,1.1,3,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and",Question: Does misclassifying gestational age explain why Australian Aborigines and whites have different birthweights? Answer: Misclassification of gestational age might partly explain birthweight differences but other aspects such as socioeconomic differences are also important.,2.605457000925387e-07,0.10914416230755286,0.12312320238312635,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
266,1.1,4,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Question: Can differences in gestational age classification explain the birthweight variations between Australian Aborigines and whites? Answer: Although gestational age misclassification could partly explain these differences, socioeconomic and other factors are involved as well.",2.605457000925387e-07,0.10914416230755286,0.12312320238312635,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
266,1.1,5,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Question: Is the difference in birthweights between Australian Aborigines and whites due to gestational age misclassification? Answer: Gestational age misclassification may be a contributing factor, but socioeconomic disparities and other influences also affect birthweights.",2.605457000925387e-07,0.10914416230755286,0.12312320238312635,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
266,1.1,6,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and",Question: Does gestational age misclassification account for birthweight disparities in Australian Aborigines versus whites? Answer: Gestational age misclassification might contribute but does not fully explain the birthweight differences; socioeconomic factors are also significant.,2.84231672828224e-07,0.18455029851036509,0.09117441766090412,0.0217611175773825,0.2429744691598703,0.05982248520710063,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
266,1.1,7,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Question: Might gestational age misclassification clarify the birthweight differences seen between Australian Aborigines and whites? Answer: It may partially do so, but differences in socioeconomic conditions and other factors also have an impact.",2.84231672828224e-07,0.0979069009403708,0.15339663988312635,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
266,1.1,8,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Question: Is gestational age misclassification responsible for birthweight differences between Australian Aborigines and whites? Answer: It could be a factor, but it is not the sole reason since socioeconomic disparities also play a key role.",2.3685972735685343e-07,0.037282279123935336,0.15339663988312635,0.01813426464781874,0.13573493923918578,0.09204470742932283,0.018108015409528687,0.23892670688554984,0.023795359904818555,2.3685972735685406e-07,0.27958486221916123,0.0
266,1.1,9,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Question: Could misclassification of gestational age explain birthweight differences between Australian Aborigines and whites? Answer: It may partly explain the variation, but it is not the only factor, with socioeconomic disparities also contributing.",2.84231672828224e-07,0.0979069009403708,0.15339663988312635,0.0217611175773825,0.1982552962205193,0.09204470742932283,0.021729618491434434,0.30346522802312137,0.023795359904818555,2.8423167282822487e-07,0.3462762367178347,0.0
266,1.1,10,ai,"Question: Does gestational age misclassification explain the difference in birthweights for Australian aborigines and whites? Answer: Gestational age misclassification may contribute to the difference in birthweights between Australian aborigines and whites, but it is not the sole factor. Other factors such as socioeconomic disparities and","Question: Does the misclassification of gestational age explain why birthweights differ between Australian Aborigines and whites? Answer: Misclassification may contribute to the birthweight differences, but other factors like socioeconomic status also influence these differences.",2.605457000925387e-07,0.06713524227361711,0.15339663988312635,0.01994769111260062,0.16650659790593947,0.09204470742932283,0.01991881695048156,0.27067540520012967,0.023795359904818555,2.6054570009253947e-07,0.31237468504215293,0.0
267,1.1,1,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does the allocation of health care benefits in Kenya align with the principles of universal coverage? Universal coverage mandates that everyone should receive health care based on their needs. However, Kenya's health sector displays clear inequities, with benefits not distributed according to need. Intentional measures must be taken to reform the Kenyan health system.",1.6580180914979784e-07,0.011579709937611149,0.07990448535320333,0.012693985253473108,0.055804181538533726,0.0507015306122449,0.012675610786670066,0.10471575090623375,0.017236072637734686,1.6580180914979784e-07,0.13102826240640475,0.0
267,1.1,2,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the distribution of health care benefits in Kenya consistent with universal coverage principles? Universal coverage insists that health care benefits should be granted to all individuals based on their needs. Kenya's health sector, however, is evidently unequal, and the benefits are not allocated on a needs basis. The Kenyan health system needs targeted restructuring efforts.",1.1842986367842703e-07,0.023997996938725397,0.044401526773321646,0.009067132323909363,0.04373597135420315,0.03218960465994872,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
267,1.1,3,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does Kenya's distribution of health care benefits follow the core principles of universal coverage? Universal coverage requires health care to be accessible to all based on need. The Kenyan health sector currently shows significant inequity, with benefits not distributed according to need. Therefore, focused efforts should aim at restructuring the country's health system.",1.8948778188548325e-07,0.031130914473296745,0.07954205647400575,0.014507411718254981,0.07522226739563642,0.0507015306122449,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
267,1.1,4,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Are health care benefits in Kenya distributed in accordance with the universal coverage principles? According to these principles, everyone should receive health care in line with their needs. In Kenya, the health system is evidently inequitable; benefits are not allocated according to need. Deliberate restructuring efforts are necessary for the Kenyan health system.",1.8948778188548325e-07,0.05779042141791013,0.060365432098765444,0.014507411718254981,0.07522226739563642,0.0507015306122449,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
267,1.1,5,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does the way health care benefits are distributed in Kenya meet universal coverage ideals? Universal coverage principles dictate that health care should be provided to all based on need. Kenya's health sector lacks equity, as benefits are not distributed on this basis. Hence, proactive restructuring of the health system is required.",2.3685972735685406e-07,0.1268697823491589,0.039009886603066035,0.018134264647818726,0.1152276020093348,0.0507015306122449,0.018108015409528666,0.16534037272266788,0.017236072637734686,2.3685972735685406e-07,0.19290366612449228,0.0
267,1.1,6,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the health care benefits distribution in Kenya aligned with the universal coverage principles? The principles state that all individuals should benefit from health care according to their needs. However, Kenya's health sector is inequitable, and benefits aren't distributed per need. Systematic restructuring should thus be pursued.",3.316036182995957e-07,0.15721056355840535,0.07703703703703706,0.025387970506946217,0.20038541034964208,0.0507015306122449,0.025351221573340132,0.2523517497122971,0.017236072637734686,3.316036182995957e-07,0.2818511521409879,0.0
267,1.1,7,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does the distribution of health care benefits in Kenya satisfy universal coverage principles? These principles emphasize that health care must be accessible to everyone relative to their needs. Yet, the Kenyan health sector remains inequitable, with benefits not allocated based on need. Intentional reforms should be focused on restructuring the health system.",2.1317375462116866e-07,0.05107173576068558,0.07916543209876546,0.016320838183036854,0.09502489469181619,0.0507015306122449,0.0162972138685758,0.14472108551993212,0.017236072637734686,2.1317375462116866e-07,0.17185025692665912,0.0
267,1.1,8,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Are Kenya's health care benefits fairly distributed in line with the universal coverage principles? Universal coverage requires equitable access to health services based on need. Presently, Kenya's health sector is distinctly unequal and benefits are not given based on need. Hence, deliberate effort to reform the health system is necessary.",2.6054570009253947e-07,0.17706171462151632,0.017777777777777795,0.0199476911126006,0.16472802173540124,0.029877628394046618,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
267,1.1,9,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Does Kenya implement universal coverage principles in distributing health care benefits? Those principles require that health care access be need-based for everyone. The Kenyan health sector is currently unequal, with benefits not distributed accordingly. Thus, targeted restructuring of the health care system is essential.",4.026615365066519e-07,0.27116237939339394,0.0035839924794912326,0.030828249901291835,0.26937828183659374,0.0507015306122449,0.030783626196198732,0.3229693169262511,0.017236072637734686,4.026615365066519e-07,0.354171813720614,0.0
267,1.1,10,human,Question: Does the distribution of health care benefits in Kenya meet the principles of universal coverage? Answer: The principles of universal coverage require that all should benefit from health care according to need. The Kenyan health sector is clearly inequitable and benefits are not distributed on the basis of need. Deliberate efforts should be directed to restructuring the Kenyan health system,"Is the distribution method of health care benefits in Kenya consistent with universal coverage principles? Universal coverage dictates care should be based on individual needs. Kenya's health sector displays clear inequities, and benefits do not follow a need-based allocation. Therefore, dedicated efforts are needed to overhaul the Kenyan health system.",2.6054570009253947e-07,0.09218654965499251,0.0783661265432099,0.0199476911126006,0.13584688921207055,0.0507015306122449,0.019918816950481533,0.18639378192050104,0.017236072637734686,2.6054570009253947e-07,0.21440987134545564,0.0
268,1.1,1,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Postictal psychotic episodes (PPEs) do not invariably predict the occurrence of interictal psychotic episodes (IPEs). Although PPEs can manifest directly after seizures, their long-term role in forecasting IPEs remains unclear.",3.7897556377096533e-07,0.22908984622170703,0.18908204260520867,0.02901482343651001,0.32595836364124864,0.09,0.02897282465524592,0.4331238459422586,0.023242630385487524,3.789755637709665e-07,0.4795730802618854,0.0
268,1.1,2,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is",PPEs are not necessarily indicators of future IPEs. These psychotic episodes happen right after seizures but do not reliably forecast the long-term presence of IPEs.,4.974054274493918e-07,0.37052859202851485,0.22352081811541274,0.03808195576041941,0.5226686578873032,0.09,0.03802683236001029,0.6379182585882726,0.023242630385487524,4.974054274493935e-07,0.6931471805599463,0.0
268,1.1,3,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","The occurrence of postictal psychotic episodes does not guarantee the future development of interictal psychotic episodes. They happen after seizures, but their long-term predictive value for IPEs is limited.",4.0266153650665063e-07,0.2163779122012559,0.22352081811541274,0.03082824990129189,0.3623260078121233,0.09,0.030783626196198795,0.4708641739251056,0.023242630385487524,4.026615365066519e-07,0.5187937934151678,0.0
268,1.1,4,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","There is no definitive evidence that PPEs predict interictal psychotic episodes. While they can emerge soon after seizures, their significance in long-term prediction of IPEs is uncertain.",4.5003348197802123e-07,0.2904858843549776,0.22352081811541274,0.03445510283085565,0.43928704894825277,0.09,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
268,1.1,5,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Postictal psychotic episodes are not definitive predictors of interictal psychotic episodes, despite appearing shortly following seizures; their long-term implication for IPEs remains ambiguous.",5.447773729207624e-07,0.45753996901814453,0.22352081811541274,0.04170880868998317,0.6136404360930312,0.09,0.041648435441916036,0.7332284383925978,0.023242630385487524,5.447773729207642e-07,0.7932306391169277,0.0
268,1.1,6,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Experiencing a postictal psychotic episode does not necessarily mean an interictal psychotic episode will occur later. Although PPEs arise immediately after seizures, their predictive power over the long term is unclear.",3.5528959103528003e-07,0.19359485275163468,0.19022712013681584,0.02720139697172813,0.29086704382997963,0.09,0.027162023114293048,0.39675620177138393,0.023242630385487524,3.552895910352811e-07,0.4418327522790384,0.0
268,1.1,7,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","PPEs, which follow seizures, do not automatically suggest that IPEs will develop later. Their role as a long-term predictor for interictal episodes is not firmly established.",4.7371945471370653e-07,0.32970659750826004,0.22352081811541274,0.03626852929563753,0.4801090434685076,0.09,0.036216030819057415,0.5934664960174385,0.023242630385487524,4.737194547137081e-07,0.6466271649250523,0.0
268,1.1,8,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","The presence of postictal psychotic episodes does not inherently forecast interictal psychotic episodes. These episodes occur after seizures, but their long-term predictive nature for IPEs is undetermined.",4.5003348197802123e-07,0.2904858843549776,0.22352081811541274,0.03445510283085565,0.43928704894825277,0.09,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
268,1.1,9,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is",Postictal psychotic episodes are acute events that do not necessarily predict the later occurrence of interictal psychotic episodes. Their long-term significance in this regard is not clearly established.,4.2634750924233593e-07,0.2527455563721306,0.22352081811541274,0.03264167636607377,0.4000663357949703,0.09,0.03259442773715167,0.5100848870783881,0.023242630385487524,4.263475092423373e-07,0.5596157879354227,0.0
268,1.1,10,ai,"Question: Long-term significance of postictal psychotic episodes II. Are they predictive of interictal psychotic episodes? Answer: Postictal psychotic episodes (PPEs) are not necessarily predictive of interictal psychotic episodes (IPEs). While PPEs may occur immediately following seizures, the long-term significance of these episodes in predicting IPEs is","Although postictal psychotic episodes occur immediately after seizures, they are not reliable predictors of future interictal psychotic episodes. Their role in long-term prognosis for IPEs is uncertain.",4.5003348197802123e-07,0.2904858843549776,0.22352081811541274,0.03445510283085565,0.43928704894825277,0.09,0.03440522927810454,0.5509068815986429,0.023242630385487524,4.500334819780227e-07,0.6021754023542183,0.0
269,1.1,1,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness affect microvascular function in healthy adults at risk for Type 2 diabetes? Yes, aerobic fitness positively impacts microvascular function in these individuals, with regular aerobic exercise enhancing blood flow and increasing capillary density.",4.737194547137076e-07,0.29355148247221274,0.1025390625,0.03626852929563746,0.2723478253238141,0.1306152433425161,0.036216030819057346,0.2645323730486764,0.14617283950617282,4.737194547137081e-07,0.2988912671694086,0.131358024691358
269,1.1,2,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Is there a link between aerobic fitness and microvascular function in healthy adults susceptible to Type 2 diabetes? Indeed, aerobic fitness benefits microvascular function by improving blood circulation and boosting the density of small blood vessels.",4.737194547137076e-07,0.2539430721545015,0.1305670339761249,0.03626852929563746,0.23157446176146435,0.16000000000000003,0.036216030819057346,0.2645323730486764,0.14617283950617282,4.737194547137081e-07,0.2988912671694086,0.131358024691358
269,1.1,3,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Can aerobic fitness improve microvascular function in healthy adults at risk of Type 2 diabetes? Yes, consistent aerobic exercise has been proven to enhance microvascular performance and increase the number of small blood vessels in the body.",4.500334819780223e-07,0.14655537455238266,0.1875,0.03445510283085558,0.20258692488821284,0.16000000000000003,0.03440522927810447,0.2346794098989946,0.14617283950617282,4.500334819780227e-07,0.2681196085026549,0.131358024691358
269,1.1,4,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does engaging in aerobic fitness influence the microvascular function of healthy adults who may develop Type 2 diabetes? Aerobic fitness positively affects microvascular function, promoting better blood flow and greater capillary vascularization.",5.684633456564488e-07,0.3408062814626973,0.1552777777777778,0.04352223515476498,0.35673760471547133,0.16000000000000003,0.04345923698286884,0.39374410452868336,0.14617283950617282,5.684633456564497e-07,0.4324226597939309,0.131358024691358
269,1.1,5,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood",Is microvascular function in adults vulnerable to Type 2 diabetes affected by aerobic fitness? Evidence shows aerobic fitness supports microvascular performance by increasing both blood flow and the density of small vessels.,5.684633456564488e-07,0.2960871085233463,0.1875,0.04352223515476498,0.35673760471547133,0.16000000000000003,0.04345923698286884,0.39374410452868336,0.14617283950617282,5.684633456564497e-07,0.4324226597939309,0.131358024691358
269,1.1,6,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood",How does aerobic fitness affect the microvascular function of healthy adults at risk for Type 2 diabetes? Aerobic fitness promotes better microvascular function through enhanced blood circulation and higher capillary density.,5.921493183921341e-07,0.4212965554209971,0.12117346938775513,0.04533566161954686,0.3906391563911531,0.16000000000000003,0.045270038523821714,0.42883542433995236,0.14617283950617282,5.921493183921352e-07,0.4687903039648056,0.131358024691358
269,1.1,7,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does improved aerobic fitness contribute to microvascular function in individuals at risk for Type 2 diabetes? Yes, aerobic exercise enhances small blood vessel density and improves overall microvascular flow in these adults.",5.684633456564488e-07,0.2960871085233463,0.1875,0.04352223515476498,0.35673760471547133,0.16000000000000003,0.04345923698286884,0.39374410452868336,0.14617283950617282,5.684633456564497e-07,0.4324226597939309,0.131358024691358
269,1.1,8,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Can aerobic fitness positively impact the microvascular system in healthy adults with a risk of Type 2 diabetes? Yes, it improves microvascular function by boosting blood flow and increasing the density of the microvasculature.",5.210914001850782e-07,0.23356675154201278,0.1875,0.03989538222520122,0.2921990835778998,0.16000000000000003,0.03983763390096309,0.3270527300300099,0.14617283950617282,5.210914001850789e-07,0.36342978830698014,0.131358024691358
269,1.1,9,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood",Is there an effect of aerobic fitness on microvascular health in healthy adults susceptible to Type 2 diabetes? Aerobic fitness benefits this aspect by raising blood flow and small vessel density.,5.921493183921341e-07,0.37508674338366754,0.1542063020214031,0.04533566161954686,0.3906391563911531,0.16000000000000003,0.045270038523821714,0.42883542433995236,0.14617283950617282,5.921493183921352e-07,0.4687903039648056,0.131358024691358
269,1.1,10,ai,"Question: Does aerobic fitness influence microvascular function in healthy adults at risk of developing Type 2 diabetes? Answer: Yes, aerobic fitness has been shown to have a positive influence on microvascular function in healthy adults at risk of developing Type 2 diabetes. Regular aerobic exercise can improve blood flow and increase the density of small blood","Does aerobic fitness have a positive effect on microvascular function in healthy adults at high risk of Type 2 diabetes? Indeed, aerobic fitness increases microvascular efficiency by enhancing blood circulation and the density of small vessels.",4.737194547137076e-07,0.21433466183679073,0.15895328719723184,0.03626852929563746,0.23157446176146435,0.16000000000000003,0.036216030819057346,0.2645323730486764,0.14617283950617282,4.737194547137081e-07,0.2988912671694086,0.131358024691358
270,1.1,1,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early migraine treatment reduce the time to headache peak and lessen its severity? Early intervention with triptans might shorten the duration between migraine onset and peak but does not reduce headache severity.,1.184298636784265e-07,0.14518200984449914,0.0,0.009067132323909391,0.14953173397096364,0.0,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
270,1.1,2,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is the time to headache peak shortened and severity reduced by early migraine treatment? Early use of triptans can result in a quicker progression to headache peak but does not diminish headache intensity.,1.184298636784265e-07,0.23182540741449342,0.06222222222222223,0.009067132323909391,0.19425090691031466,0.0322222222222222,0.009054007704764368,0.1541506798272585,0.0,1.1842986367842703e-07,0.15906469462968875,0.0
270,1.1,3,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early migraine treatment lead to a faster headache peak and mitigate severity? Prompt triptan administration may decrease time to maximum headache but does not ease the headache pain.,2.131737546211677e-07,0.27871340246902143,0.0,0.01632083818303691,0.2876820724517808,0.0,0.016297213868575862,0.29725152346793093,0.0,2.1317375462116866e-07,0.3074846997479619,0.0
270,1.1,4,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does administering migraine treatment early quicken headache peak time and reduce severity? Using triptans early may shorten the interval from migraine start to peak but does not relieve headache severity.,1.894877818854824e-07,0.24362208265775243,0.0,0.01450741171825503,0.2513144282809061,0.0,0.014486412327622988,0.25951119548508395,0.0,1.8948778188548325e-07,0.2682639865946794,0.0
270,1.1,5,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Is early migraine treatment effective in speeding up headache peak and reducing pain severity? Early triptan use might accelerate reaching headache peak without alleviating the headache itself.,2.605457000925383e-07,0.4061403885119699,0.03840000000000001,0.01994769111260067,0.36464311358791024,0.0,0.01991881695048161,0.3772942311414682,0.0,2.6054570009253947e-07,0.39086630868701233,0.0
270,1.1,6,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,"Does early treatment of migraine accelerate the headache peak and lower its severity? Initiating triptan therapy promptly can shorten duration to headache peak, but does not lessen headache severity.",2.131737546211677e-07,0.27871340246902143,0.0,0.01632083818303691,0.2876820724517808,0.0,0.016297213868575862,0.29725152346793093,0.0,2.1317375462116866e-07,0.3074846997479619,0.0
270,1.1,7,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Can early migraine treatment shorten the duration to headache peak and reduce intensity? Early triptan use may hasten peak headache time but does not reduce headache severity.,2.605457000925383e-07,0.3528213746227431,0.0,0.01994769111260067,0.36464311358791024,0.0,0.01991881695048161,0.3772942311414682,0.0,2.6054570009253947e-07,0.39086630868701233,0.0
270,1.1,8,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early migraine care reduce the time until headache peak and ease its severity? Treatment with triptans early in migraine onset might speed up peak occurrence but does not diminish headache pain.,1.421158364141118e-07,0.17693070815907896,0.0,0.01088055878869127,0.18232155679395534,0.0,0.010864809245717241,0.18805223150294026,0.0,1.4211583641411244e-07,0.19415601444095776,0.0
270,1.1,9,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,"Is the time from migraine onset to headache peak decreased and severity alleviated by early treatment? Early triptan administration can shorten time to peak, though it doesn’t reduce headache severity.",1.894877818854824e-07,0.24362208265775243,0.0,0.01450741171825503,0.2513144282809061,0.0,0.014486412327622988,0.25951119548508395,0.0,1.8948778188548325e-07,0.2682639865946794,0.0
270,1.1,10,human,Question: Does early migraine treatment shorten time to headache peak and reduce its severity? Answer: Early treatment and use of triptans may lead to shorter duration from migraine headache onset to its peak but did not alleviate headache,Does early migraine treatment impact the time to headache peak and decrease severity? Starting triptans early may shorten the time to peak headache but lacks effect on headache alleviation.,2.131737546211677e-07,0.37773442826330017,0.07100591715976333,0.01632083818303691,0.33902630804881406,0.03698224852071005,0.016297213868575862,0.29725152346793093,0.0,2.1317375462116866e-07,0.3074846997479619,0.0
271,1.1,1,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting a geriatric oncologist alter the cancer treatment strategy for elderly patients? The geriatric oncology consultation resulted in changes to the cancer treatment plan in over one third of cases. More research is required to assess whether these alterations benefit the outcomes for older patients.,1.1842986367842703e-07,0.028344162262276207,0.05441713572234577,0.009067132323909363,0.05426218925129378,0.03824910210495426,0.009054007704764333,0.08111976269099808,0.020823902218198284,1.1842986367842703e-07,0.11247798342669002,0.0
271,1.1,2,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Can a geriatric oncology consultation change the cancer treatment regimen in elderly patients? In more than one third of cases, the consultation with a geriatric oncologist brought modifications to the treatment plan. Additional studies are necessary to determine the impact of these changes on patient outcomes.",1.1842986367842703e-07,0.00246237909594349,0.07655468829711257,0.009067132323909363,0.02275549922584119,0.060964083175803374,0.009054007704764333,0.08111976269099808,0.020823902218198284,1.1842986367842703e-07,0.11247798342669002,0.0
271,1.1,3,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does involving a geriatric oncologist influence the cancer therapy plan for elderly individuals? The consultation led to adjustments in the cancer treatment plan in more than one third of cases. Further research is needed to evaluate if these changes improve outcomes for elderly patients.,1.6580180914979784e-07,0.07667226111654246,0.05236448028436925,0.012693985253473108,0.06927551486073513,0.060964083175803374,0.012675610786670066,0.1287478116802525,0.020823902218198284,1.6580180914979784e-07,0.16126814759612174,0.0
271,1.1,4,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Is the cancer treatment plan for elderly patients altered through a geriatric oncology consultation? The treatment plan was modified in over one third of the cases following such consultations. More investigations are needed to ascertain whether these modifications positively affect patient outcomes.,2.1317375462116866e-07,0.09363356020013835,0.07439043209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,1.1,5,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does a consultation with a geriatric oncologist alter the treatment protocol for cancer in elderly patients? The cancer treatment plan was changed in more than a third of cases after geriatric oncology consultations. Further studies are essential to see if these changes enhance outcomes for older patients.,9.474389094274162e-08,0.05524782717293819,0.09876543209876545,0.0072537058591274906,0.0002826433737834755,0.060964083175803374,0.007243206163811466,0.05813024446629855,0.020823902218198284,9.474389094274162e-08,0.0889474860164956,0.0
271,1.1,6,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does consulting a geriatric oncology specialist affect the cancer treatment plan in elderly patients? Over one third of cases saw a modification to the treatment plan after such a consultation. More research is needed to determine the benefits of these modifications on elderly patient outcomes.,1.4211583641411244e-07,0.020710625423347118,0.07605045102791634,0.010880558788691236,0.045745017450540715,0.060964083175803374,0.0108648092457172,0.1046502601011925,0.020823902218198284,1.4211583641411244e-07,0.13657553500575004,0.0
271,1.1,7,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Can the cancer treatment plan for elderly patients be changed by a geriatric oncology consultation? In more than one third of cases, the plan was adjusted following the consultation. Additional studies are required to investigate the effect of these modifications on outcomes.",2.1317375462116866e-07,0.05982150261184849,0.09876543209876545,0.016320838183036854,0.11806567903016685,0.060964083175803374,0.0162972138685758,0.17875823225491594,0.020823902218198284,2.1317375462116866e-07,0.21256144198367144,0.0
271,1.1,8,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Do geriatric oncology consultations lead to changes in the cancer treatment plan for elderly patients? More than one third of cases experienced treatment plan modifications after consultation. Further research is necessary to understand the impact of these changes on patient outcomes.,2.3685972735685406e-07,0.11917147423021657,0.07378186865366354,0.018134264647818726,0.14338348701445858,0.060964083175803374,0.018108015409528666,0.2047337186581739,0.020823902218198284,2.3685972735685406e-07,0.2392296890658323,0.0
271,1.1,9,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,Does having a geriatric oncology consultation modify cancer treatment plans for elderly patients? The consultation resulted in changes to the cancer treatment plans in over one third of cases. More studies are needed to determine whether these changes improve outcomes for these patients.,1.8948778188548325e-07,0.10173796822897252,0.05126543209876544,0.014507411718254981,0.12718512402808502,0.03658908317580337,0.014486412327622933,0.1534404242706242,0.020823902218198284,1.8948778188548325e-07,0.18658595558041347,0.0
271,1.1,10,human,Question: Does a geriatric oncology consultation modify the cancer treatment plan for elderly patients? Answer: The geriatric oncology consultation led to a modification of the cancer treatment plan in more than one third of cases. Further studies are needed to determine whether these modifications improve the outcome of these older patients.,"Are cancer treatment plans for elderly patients altered after geriatric oncology consultations? In over one third of cases, the treatment plans were modified. Additional research is needed to establish if these plan changes lead to better outcomes.",3.3160361829959526e-07,0.22838280755782092,0.07101033005794913,0.025387970506946217,0.2515970716546896,0.060964083175803374,0.02535122157334014,0.31595935376839845,0.020823902218198284,3.316036182995957e-07,0.35364004024357776,0.0
272,1.1,1,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is computerised tomography capable of substituting bone scintigraphy for identifying bone metastases from breast cancer? Answer: Both computerised tomography (CT) and bone scintigraphy serve as imaging methods to detect bone metastases originating from breast cancer. While CT can,7.10579182070559e-08,0.13435442760238114,0.03508266051518644,0.005440279394345625,0.16610411515276358,0.05859375,0.005432404622858614,0.12902029702356588,0.0302734375,7.105791820705622e-08,0.08961215868968697,0.0
272,1.1,2,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can bone scintigraphy be replaced by computerised tomography in the detection of bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are imaging tools employed to identify bone metastases stemming from breast cancer. While CT can,9.47438909427412e-08,0.16407159919085013,0.03766439909297048,0.0072537058591274975,0.19277236223492444,0.05859375,0.00724320616381148,0.1564192712116812,0.0302734375,9.474389094274162e-08,0.11778303565638382,0.0
272,1.1,3,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Does computerised tomography offer an alternative to bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: Both computerised tomography (CT) and bone scintigraphy are used imaging modalities to find bone metastases arising from breast cancer. While CT can,1.184298636784265e-07,0.22760136712908707,0.06438194951708463,0.00906713232390937,0.21874784863818242,0.05859375,0.009054007704764347,0.18308751829384207,0.0302734375,1.1842986367842703e-07,0.14518200984449914,0.0
272,1.1,4,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can computerised tomography take the place of bone scintigraphy to detect bone metastases associated with breast cancer? Answer: Imaging techniques such as computerised tomography (CT) and bone scintigraphy are utilized to detect bone metastases caused by breast cancer. While CT can,1.421158364141119e-07,0.18720576886200035,0.019290123456790056,0.010880558788691243,0.17475093856648005,0.008732254155124665,0.010864809245717214,0.17351699543761612,0.004650168801939046,1.4211583641411244e-07,0.17185025692666,0.0
272,1.1,5,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is it possible for computerised tomography to replace bone scintigraphy in identifying bone metastases from breast cancer? Answer: Both computerised tomography (CT) and bone scintigraphy are diagnostic imaging approaches to detect bone metastases due to breast cancer. While CT can,1.184298636784265e-07,0.22760136712908707,0.06438194951708463,0.00906713232390937,0.21874784863818242,0.05859375,0.009054007704764347,0.18308751829384207,0.0302734375,1.1842986367842703e-07,0.14518200984449914,0.0
272,1.1,6,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can CT substitute bone scintigraphy in the diagnosis of bone metastases from breast cancer? Answer: Computerised tomography (CT) along with bone scintigraphy are imaging techniques used for detecting bone metastases from breast cancer. While CT can,2.36859727356853e-08,0.07218022176415229,0.029513888888888867,0.0018134264647818796,0.031317443362529396,0.0016607839761248952,0.0018108015409528735,0.031088519621267796,0.0008886808425160632,2.3685972735685406e-08,0.030771658666753687,0.0
272,1.1,7,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Could computerised tomography be an alternative to bone scintigraphy for detecting bone metastases in breast cancer patients? Answer: Both computerised tomography (CT) and bone scintigraphy function as imaging methods to identify bone metastases originating from breast cancer. While CT can,1.184298636784265e-07,0.22760136712908707,0.06438194951708463,0.00906713232390937,0.21874784863818242,0.05859375,0.009054007704764347,0.18308751829384207,0.0302734375,1.1842986367842703e-07,0.14518200984449914,0.0
272,1.1,8,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can computerized tomography (CT) effectively replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: CT and bone scintigraphy are imaging techniques utilized for detecting bone metastases caused by breast cancer. While CT can,0.0,0.07921682063542201,0.05392795138888887,0.0,0.04077336356235017,0.029208993342516063,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0
272,1.1,9,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Is computerised tomography a viable replacement for bone scintigraphy in detecting bone metastases from breast cancer? Answer: Both CT and bone scintigraphy are commonly used imaging techniques to identify bone metastases due to breast cancer. While CT can,7.10579182070559e-08,0.20731728871395516,0.08641975308641972,0.005440279394345625,0.16610411515276358,0.05859375,0.005432404622858614,0.12902029702356588,0.0302734375,7.105791820705622e-08,0.08961215868968697,0.0
272,1.1,10,ai,Question: Can computerised tomography replace bone scintigraphy in detecting bone metastases from breast cancer? Answer: Computerised tomography (CT) and bone scintigraphy are both imaging techniques used to detect bone metastases from breast cancer. While CT can,Question: Can computerised tomography serve as a substitute for bone scintigraphy in the detection of breast cancer bone metastases? Answer: Computerised tomography (CT) and bone scintigraphy are imaging modalities used to detect bone metastases from breast cancer. While CT can,9.47438909427412e-08,0.23516361770981797,0.08775667559451342,0.0072537058591274975,0.19277236223492444,0.05859375,0.00724320616381148,0.1564192712116812,0.0302734375,9.474389094274162e-08,0.11778303565638382,0.0
273,1.1,1,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should HIV-infected individuals undergo screening for silent myocardial ischemia with gated myocardial perfusion SPECT? Currently, no agreement exists on routine screening for these patients. More studies are required to assess the pros, cons, and economic viability of this screening method. Healthcare providers should base screening choices on patient-specific factors and relevant guidelines.",3.552895910352811e-07,0.13798013155822275,0.08496765297328354,0.02720139697172809,0.17705384224472986,0.06127385111529163,0.027162023114293,0.22374108646404967,0.031217481789802295,3.552895910352811e-07,0.2719337154836441,0.0
273,1.1,2,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is it advisable to screen HIV-positive patients for silent myocardial ischemia using gated myocardial perfusion SPECT? At present, no consensus supports routine screening. Further investigations are necessary to determine the clinical value, risks, and cost-effectiveness. Clinicians need to individualize decisions according to each patient's circumstances and available recommendations.",4.500334819780227e-07,0.19247592019759052,0.10456765297328353,0.03445510283085558,0.26043545118378075,0.06127385111529163,0.034405229278104466,0.30889889480435695,0.031217481789802295,4.500334819780227e-07,0.35894509247327333,0.0
273,1.1,3,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should patients with HIV be screened for silent myocardial ischemia by gated myocardial perfusion SPECT? There is no current consensus supporting routine use of this screening. Additional research must evaluate its benefits, potential harms, and economic impact. Screening should be guided by personalized patient assessment and clinical guidelines.",4.500334819780227e-07,0.19247592019759052,0.10456765297328353,0.03445510283085558,0.26043545118378075,0.06127385111529163,0.034405229278104466,0.30889889480435695,0.031217481789802295,4.500334819780227e-07,0.35894509247327333,0.0
273,1.1,4,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Are HIV-infected patients recommended for screening of silent myocardial ischemia via gated myocardial perfusion SPECT? Currently, routine screening lacks consensus. Further research is vital to appraise the advantages, risks, and cost-effectiveness in this group. Medical professionals should factor patient details and guidelines into decision-making.",5.447773729207643e-07,0.2814234062140861,0.10456765297328353,0.04170880868998307,0.3514072293895074,0.06127385111529163,0.04164843544191593,0.4019893178703686,0.031217481789802295,5.447773729207643e-07,0.454255272277599,0.0
273,1.1,5,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should silent myocardial ischemia screening using gated myocardial perfusion SPECT be conducted in HIV-infected patients? At this time, no standardized agreement exists to recommend routine screening. More studies are needed to analyze the benefits, risks, and cost-effectiveness. Physicians should make screening decisions based on individual patient factors and established guidelines.",4.026615365066519e-07,0.1508032237970216,0.10456765297328353,0.030828249901291835,0.21787583676498423,0.06127385111529163,0.030783626196198732,0.2654137828646186,0.031217481789802295,4.026615365066519e-07,0.3144933299024406,0.0
273,1.1,6,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is routine screening with gated myocardial perfusion SPECT for silent myocardial ischemia indicated in patients with HIV? There is no universal consensus presently. Additional research must clarify the clinical benefits, risks, and cost implications. Clinicians are advised to consider patient-specific characteristics and current guidelines when deciding on screening.",4.500334819780227e-07,0.19247592019759052,0.10456765297328353,0.03445510283085558,0.26043545118378075,0.06127385111529163,0.034405229278104466,0.30889889480435695,0.031217481789802295,4.500334819780227e-07,0.35894509247327333,0.0
273,1.1,7,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Does screening for silent myocardial ischemia using gated myocardial perfusion SPECT in HIV-positive patients have consensus support? Presently, no agreement exists for routine screening. Further studies should clarify its benefits, risks, and financial feasibility. Healthcare providers should include patient factors and practice guidelines in screening decisions.",4.974054274493935e-07,0.23596103213732889,0.10456765297328353,0.038081955760419325,0.3048872137546135,0.06127385111529163,0.0380268323600102,0.3543612688811142,0.031217481789802295,4.974054274493935e-07,0.40546510810816727,0.0
273,1.1,8,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should HIV-infected patients routinely undergo gated myocardial perfusion SPECT to detect silent myocardial ischemia? There is presently no consensus to endorse this practice. More research is required to weigh the benefits, risks, and cost-effectiveness. Clinicians must consider individualized patient factors and directive guidelines before screening.",5.210914001850789e-07,0.2584338879893866,0.10456765297328353,0.0398953822252012,0.327876731979313,0.06127385111529163,0.039837633900963065,0.3778917662913086,0.031217481789802295,5.210914001850789e-07,0.4295626596872273,0.0
273,1.1,9,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Is it appropriate to screen HIV patients for silent myocardial ischemia with gated myocardial perfusion SPECT? Currently, no consensus supports routine screening. Further studies are essential to determine benefits, potential risks, and cost-effectiveness. Decision-making should be based on patient-specific assessment and clinical guidelines.",5.684633456564497e-07,0.30495390362428054,0.10456765297328353,0.04352223515476494,0.37550478096856743,0.06127385111529163,0.0434592369828688,0.4266819304607403,0.031217481789802295,5.684633456564497e-07,0.4795730802618907,0.0
273,1.1,10,ai,"Question: Should HIV-infected patients be screened for silent myocardial ischaemia using gated myocardial perfusion SPECT? Answer: There is currently no consensus on whether HIV-infected patients should be routinely screened for silent myocardial ischemia using gated myocardial perfusion SPECT. Further research is needed to evaluate the benefits, risks, and cost-effectiveness of such screening in this population. Clinicians should consider individual patient factors and guidelines when making screening decisions.","Should gated myocardial perfusion SPECT be used to screen for silent myocardial ischemia in HIV-infected individuals? At present, no consensus exists to routinely recommend this. Additional research is necessary to evaluate the advantages, risks, and economics of the approach. Clinical decisions should integrate patient factors and existing guidelines.",4.500334819780227e-07,0.19247592019759052,0.10456765297328353,0.03445510283085558,0.26043545118378075,0.06127385111529163,0.034405229278104466,0.30889889480435695,0.031217481789802295,4.500334819780227e-07,0.35894509247327333,0.0
274,1.1,1,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Is there a link between crime and over-the-counter syringe sales at pharmacies? Answer: No direct link exists between crime and over-the-counter syringe sales at pharmacies, though improper disposal or misuse of syringes may impact public health.",7.10579182070559e-08,0.060019843129145656,0.09964620187304896,0.005440279394345639,0.06510819411387114,0.10767140709908657,0.005432404622858621,0.07072013411838318,0.11555555555555559,7.105791820705622e-08,0.03071658029748292,0.09000000000000004
274,1.1,2,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Does crime relate to over-the-counter sales of syringes in pharmacies? Answer: There isn't a direct connection between crime and over-the-counter pharmacy syringe sales, but improper use or disposal of syringes can affect community health.",2.36859727356853e-08,0.07309743965520443,0.030969041469467145,0.0018134264647818796,0.07409335745175127,0.031217481789802305,0.0018108015409528735,0.031748698314579826,0.0,2.3685972735685406e-08,0.0327898228229917,0.0
274,1.1,3,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Are over-the-counter syringe sales in pharmacies linked to crime? Answer: Over-the-counter pharmacy syringe sales are not directly associated with crime; however, improper syringe misuse or disposal poses public health risks.",7.10579182070559e-08,0.05750215177378237,0.027060100148354166,0.005440279394345639,0.0551183740282557,0.031217481789802305,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
274,1.1,4,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Is selling syringes over-the-counter at pharmacies associated with crime? Answer: Direct association between crime and over-the-counter pharmacy syringe sales is lacking, although improper syringe disposal or use can harm public health.",4.73719454713706e-08,0.02149748308653887,0.06035379812695108,0.003626852929563759,0.02121682235257394,0.031217481789802305,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
274,1.1,5,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Does crime correlate with over-the-counter syringe sales at pharmacies? Answer: Crime is not directly correlated with over-the-counter pharmacy syringe sales; nonetheless, misuse or improper disposal of syringes could contribute to public health concerns.",0.0,0.042008920033936636,0.030080360626951082,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0,0.0,0.0,0.0
274,1.1,6,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Is crime connected to over-the-counter pharmacy syringe sales? Answer: No direct crime connection exists regarding over-the-counter syringe sales at pharmacies, but improper syringe misuse or disposal may affect public health.",7.10579182070559e-08,0.011292339736452828,0.06035379812695108,0.005440279394345639,0.0551183740282557,0.031217481789802305,0.005432404622858621,0.10178269430994247,0.0,7.105791820705622e-08,0.10536051565782545,0.0
274,1.1,7,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Are over-the-counter pharmacy syringe sales related to crime? Answer: There is no direct relation between crime and over-the-counter syringe sales in pharmacies; however, syringes improperly used or discarded can impact public health.",2.36859727356853e-08,0.00992448261612111,0.029136316337148777,0.0018134264647818796,0.01157300047041776,0.031217481789802305,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
274,1.1,8,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Does the sale of syringes over-the-counter in pharmacies relate to crime? Answer: Over-the-counter pharmacy syringe sales are not directly related to crime, but improper syringe handling or disposal might affect public health.",2.36859727356853e-08,0.0532461814011187,0.06035379812695108,0.0018134264647818796,0.01157300047041776,0.031217481789802305,0.0018108015409528735,0.0327898228229917,0.0,2.3685972735685406e-08,0.03390155167568176,0.0
274,1.1,9,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Is there an association between crime and over-the-counter syringe sales in pharmacies? Answer: No direct association between crime and over-the-counter pharmacy syringe sales exists, though unsafe syringe practices can pose public health risks.",0.0,0.12602676010180813,0.08632987534243663,0.0,0.08664339756999295,0.06152924829343195,0.0,0.08943834587870247,0.06420927467300831,0.0,0.046209812037329545,0.033293697978596916
274,1.1,10,ai,"Question: Is crime associated with over-the-counter pharmacy syringe sales? Answer: There is no direct association between crime and over-the-counter pharmacy syringe sales. However, improper disposal or misuse of syringes can contribute to public health","Question: Is crime linked to pharmacies selling syringes over-the-counter? Answer: There is no direct link between crime and over-the-counter pharmacy syringe sales; however, improper syringe use or disposal can impact public health.",4.73719454713706e-08,0.02149748308653887,0.06035379812695108,0.003626852929563759,0.02121682235257394,0.031217481789802305,0.003621603081905747,0.06669137449867346,0.0,4.737194547137081e-08,0.06899287148695077,0.0
275,1.1,1,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Is D-dimer viable as a novel diagnostic marker for acute appendicitis? Answer: Current research indicates that D-dimer, a blood assay utilized to identify blood presence",4.73719454713706e-08,0.07696104113612945,0.0,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,1.1,2,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Could D-dimer serve as a fresh diagnostic tool for acute appendicitis? Answer: Recent investigations reveal that D-dimer, a blood test designed to detect blood",7.10579182070559e-08,0.11778303565638426,0.0,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
275,1.1,3,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Can D-dimer be considered a new biomarker for diagnosing acute appendicitis? Answer: Studies have recently found that D-dimer, a blood assay used for detecting blood",4.73719454713706e-08,0.07696104113612945,0.0,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,1.1,4,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Might D-dimer become an innovative diagnostic criterion for acute appendicitis? Answer: Recent findings suggest that D-dimer, a blood test applied to recognize blood existence",7.10579182070559e-08,0.11778303565638426,0.0,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
275,1.1,5,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Is it possible for D-dimer to act as a new diagnostic indicator for acute appendicitis? Answer: Latest studies have demonstrated that D-dimer, a blood test that detects blood",2.36859727356853e-08,0.03636764417087468,0.0,0.0018134264647818796,0.03774032798284699,0.0,0.0018108015409528735,0.03922071315328246,0.0,2.3685972735685406e-08,0.04082199452025481,0.0
275,1.1,6,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Could D-dimer be introduced as a new marker for diagnosing acute appendicitis? Answer: Recent research has proved that D-dimer, a blood assay for spotting blood presence",2.36859727356853e-08,0.03774032798284699,0.0,0.0018134264647818796,0.03922071315328246,0.0,0.0018108015409528735,0.04082199452025481,0.0,2.3685972735685406e-08,0.04255961441879563,0.0
275,1.1,7,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Can D-dimer function as a novel parameter for the diagnosis of acute appendicitis? Answer: Studies show that D-dimer, a blood test used to identify blood,",4.73719454713706e-08,0.07696104113612945,0.0,0.003626852929563759,0.08004270767353727,0.0,0.003621603081905747,0.08338160893905044,0.0,4.737194547137081e-08,0.08701137698962969,0.0
275,1.1,8,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Is D-dimer a potential new diagnostic parameter for acute appendicitis? Answer: Current studies indicate that D-dimer, a blood test employed to detect blood presence",7.10579182070559e-08,0.11778303565638426,0.0,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
275,1.1,9,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Could D-dimer be utilized as a new method for diagnosing acute appendicitis? Answer: Recent research demonstrates that D-dimer, a blood test for blood detection",7.10579182070559e-08,0.11778303565638426,0.0,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
275,1.1,10,ai,"Question: Can D-dimer become a new diagnostic parameter for acute appendicitis? Answer: Recent studies have shown that D-dimer, a blood test used to detect the presence of blood","Question: Might D-dimer serve as a new diagnostic marker for acute appendicitis? Answer: Studies have shown that D-dimer, a blood test used to detect blood",7.10579182070559e-08,0.11778303565638426,0.0,0.005440279394345639,0.1226023220923329,0.0,0.005432404622858621,0.1278333715098845,0.0,7.105791820705622e-08,0.13353139262452363,0.0
276,1.1,1,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Does the lipid-lowering agent bezafibrate, which activates peroxisome proliferator-activated receptors, help prevent colon cancer in patients with coronary artery disease? There is limited evidence indicating that bezafibrate may reduce colon cancer risk in these patients.",2.1317375462116802e-07,0.14665533965185373,0.0626599507718389,0.016320838183036868,0.1751480396207037,0.047500000000000014,0.01629721386857582,0.21402410631629154,0.024375,2.1317375462116866e-07,0.25489224962878954,0.0
276,1.1,2,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Is bezafibrate, a peroxisome proliferator-activated receptor ligand used to lower lipids, effective in preventing colon cancer in coronary artery disease patients? Some limited evidence suggests it might have a protective effect.",3.079176455639092e-07,0.231045119043511,0.09204470742932284,0.023574544042164386,0.30435977110071066,0.047500000000000014,0.023540420032387314,0.34755549894081383,0.024375,3.079176455639103e-07,0.3930425881096067,0.0
276,1.1,3,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Can bezafibrate, a lipid-lowering drug that acts on peroxisome proliferator-activated receptors, prevent colon cancer in individuals with coronary artery disease? Evidence is limited but suggests a potential preventive benefit.",3.552895910352798e-07,0.30003799053046176,0.09204470742932284,0.027201396971728145,0.37581873508285435,0.047500000000000014,0.02716202311429306,0.4216634710945355,0.024375,3.552895910352811e-07,0.47000362924573613,0.0
276,1.1,4,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients",Does the lipid-lowering peroxisome proliferator-activated receptor ligand bezafibrate offer colon cancer prevention for patients with coronary artery disease? Available evidence is limited but indicates such a possibility.,4.026615365066504e-07,0.37414596268418343,0.09204470742932284,0.030828249901291904,0.4527797762189838,0.047500000000000014,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
276,1.1,5,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Is there a preventive role of bezafibrate, a lipid-lowering drug targeting peroxisome proliferator-activated receptors, against colon cancer in coronary artery disease patients? Evidence is scarce but suggestive.",4.026615365066504e-07,0.37414596268418343,0.09204470742932284,0.030828249901291904,0.4527797762189838,0.047500000000000014,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
276,1.1,6,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Might bezafibrate, known to lower lipids via peroxisome proliferator-activated receptor activation, act to prevent colon cancer in those with coronary artery disease? There is limited evidence supporting this.",3.789755637709651e-07,0.33640563470133644,0.09204470742932284,0.029014823436510025,0.41355906306570134,0.047500000000000014,0.028972824655245935,0.46088418424781796,0.024375,3.789755637709665e-07,0.5108256237659909,0.0
276,1.1,7,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Does bezafibrate, which lowers lipids by activating peroxisome proliferator-activated receptors, help prevent colon cancer in patients with coronary artery disease? Some limited data suggest it may.",4.263475092423357e-07,0.4133666758374659,0.09204470742932284,0.032641676366073784,0.4936017707392386,0.047500000000000014,0.03259442773715168,0.5442657931868684,0.024375,4.263475092423373e-07,0.5978370007556206,0.0
276,1.1,8,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Is the lipid-lowering drug bezafibrate, a peroxisome proliferator-activated receptor ligand, effective in colon cancer prevention for coronary artery disease patients? Limited evidence points to a possible effect.",4.026615365066504e-07,0.37414596268418343,0.09204470742932284,0.030828249901291904,0.4527797762189838,0.047500000000000014,0.03078362619619881,0.5017061787680728,0.024375,4.026615365066519e-07,0.5533852381847866,0.0
276,1.1,9,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Can bezafibrate, activating peroxisome proliferator-activated receptors and lowering lipid levels, prevent colon cancer in patients with coronary artery disease? There is limited but suggestive evidence.",4.50033481978021e-07,0.4541886703577207,0.09204470742932284,0.03445510283085566,0.5361613851580342,0.047500000000000014,0.034405229278104556,0.5887175557577025,0.024375,4.500334819780227e-07,0.6443570163905146,0.0
276,1.1,10,ai,"Question: Does the lipid-lowering peroxisome proliferator-activated receptors ligand bezafibrate prevent colon cancer in patients with coronary artery disease? Answer: There is limited evidence suggesting that bezafibrate, a lipid-lowering drug that activates peroxisome proliferator-activated receptors, may have a preventive effect on colon cancer in patients","Does administration of bezafibrate, a peroxisome proliferator-activated receptor lipid-lowering ligand, prevent colon cancer in coronary artery disease patients? Evidence remains limited but implies potential benefit.",4.50033481978021e-07,0.4541886703577207,0.09204470742932284,0.03445510283085566,0.5361613851580342,0.047500000000000014,0.034405229278104556,0.5887175557577025,0.024375,4.500334819780227e-07,0.6443570163905146,0.0
277,1.1,1,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Is there a connection between stretch-sensitive KCNQ1 mutation and environmental factors in causing atrial fibrillation? Answer: Our findings indicate that the R14C mutation in KCNQ1 by itself does not cause atrial fibrillation. Instead, we propose a model where a 'second hit,' such as an environmental factor like hypertension that leads to atrial stretch, contributes to the disease.",7.105791820705622e-08,0.07973933906879171,0.01851192595229618,0.005440279394345618,0.05505977718302857,0.0,0.0054324046228586,0.056089466651043196,0.0,7.105791820705622e-08,0.05715841383995013,0.0
277,1.1,2,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Does the stretch-sensitive KCNQ1 mutation link genetics and environment in atrial fibrillation development? Answer: The data show that the R14C mutation in KCNQ1 alone is not enough to trigger atrial fibrillation. We suggest a model where an additional factor, like hypertension causing atrial stretch, acts as a 'second hit.'",1.1842986367842703e-07,0.07149163065513164,0.01851192595229618,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
277,1.1,3,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Stretch-sensitive KCNQ1 mutation—are genetic and environmental factors connected in atrial fibrillation development? Answer: These results imply the R14C KCNQ1 mutation by itself isn’t sufficient to cause atrial fibrillation. We propose that a 'second hit', such as an environmental influence like hypertension which induces atrial stretch, plays a crucial role.",1.1842986367842703e-07,0.07149163065513164,0.01851192595229618,0.009067132323909363,0.09909090264422993,0.0,0.009054007704764333,0.10109611687136999,0.0,1.1842986367842703e-07,0.10318423623523065,0.0
277,1.1,4,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Could the stretch-sensitive KCNQ1 mutation indicate a genetic-environmental interaction in atrial fibrillation pathogenesis? Answer: Evidence suggests the R14C mutation alone cannot initiate AF. We promote a model where a 'second hit' from an environmental factor, such as hypertension resulting in atrial stretch, is necessary.",2.3685972735685406e-07,0.21062898487294923,0.004203055118552929,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
277,1.1,5,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Is the stretch-sensitive KCNQ1 mutation a link between genetic and environmental factors in atrial fibrillation? Answer: Data indicate the R14C KCNQ1 mutation alone doesn’t cause AF. We support a model where a 'second hit', like hypertension-induced atrial stretch, contributes to disease onset.",2.8423167282822487e-07,0.25864931908048217,0.005283433952522374,0.02176111757738247,0.2567198468478131,0.0,0.0217296184914344,0.2623642644674917,0.0,2.8423167282822487e-07,0.26826398659468076,0.0
277,1.1,6,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Stretch-sensitive mutation in KCNQ1: connecting genetics and environment in atrial fibrillation? Answer: Findings reveal the R14C mutation within KCNQ1 is insufficient on its own for AF. A model is suggested where an additional insult, such as hypertension-mediated atrial stretch, is required.",3.079176455639103e-07,0.2497398620614506,0.01851192595229618,0.023574544042164344,0.2814124594381848,0.0,0.023540420032387266,0.28768207245178345,0.0,3.079176455639103e-07,0.29423947299793873,0.0
277,1.1,7,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: Does the stretch-sensitive KCNQ1 mutation bridge genetic and environmental factors in atrial fibrillation? Answer: The R14C mutation alone cannot cause AF, according to the data. A hypothesis is proposed whereby a 'second hit', such as atrial stretch induced by hypertension, contributes to disease development.",2.3685972735685406e-07,0.17912229484749664,0.01851192595229618,0.018134264647818726,0.2090917978585587,0.0,0.018108015409528666,0.21357410029806,0.0,2.3685972735685406e-07,0.21825356602001733,0.0
277,1.1,8,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby","Question: How does the stretch-sensitive KCNQ1 mutation relate genetics and environment to atrial fibrillation? Answer: Results imply the R14C KCNQ1 mutation is inadequate alone to trigger AF. Instead, an environmental 'second hit', e.g., hypertension-related atrial stretch, is needed.",4.026615365066516e-07,0.3898614312869353,0.008494246887209983,0.030828249901291835,0.3867729750960107,0.0,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
277,1.1,9,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby",Question: Genetic and environmental interrelation in atrial fibrillation via stretch-sensitive KCNQ1 mutation? Answer: Data suggest that R14C mutation in KCNQ1 cannot singly cause AF; a 'second hit' such as hypertension-induced atrial stretch is proposed as a necessary factor.,4.026615365066516e-07,0.35239401612153287,0.01851192595229618,0.030828249901291835,0.3867729750960107,0.0,0.030783626196198732,0.39589565709201446,0.0,4.026615365066519e-07,0.4054651081081633,0.0
277,1.1,10,human,"Question: Stretch-sensitive KCNQ1 mutation A link between genetic and environmental factors in the pathogenesis of atrial fibrillation? Answer: These data suggest that the R14C KCNQ1 mutation alone is insufficient to cause AF. Rather, we suggest a model in which a ""second hit"", such as an environmental factor like hypertension, which promotes atrial stretch and thereby",Question: Stretch-sensitive KCNQ1 mutation: a genetic and environmental factor link in atrial fibrillation pathogenesis? Answer: The study suggests R14C KCNQ1 mutation alone doesn't cause AF but requires an additional factor like hypertension promoting atrial stretch to contribute.,4.263475092423369e-07,0.3797929903096482,0.01851192595229618,0.03264167636607371,0.41494385206270756,0.0,0.032594427737151606,0.42488319396526597,0.0,4.263475092423373e-07,0.43531807125784505,0.0
278,1.1,1,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient to assess cervical spine fractures in elderly blunt trauma patients with low-energy mechanisms? Answer: Clinical predictors seem insufficient for evaluating the cervical spine in elderly trauma patients with low-energy mechanisms.,0.0,0.0,2.7755575615628914e-17,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,1.1,2,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Can clinical predictors reliably identify cervical spine fractures in geriatric patients experiencing blunt trauma from low-energy mechanisms? Answer: Clinical predictors are inadequate for cervical spine assessment in geriatric trauma patients with low-energy mechanisms.,2.36859727356853e-08,0.08876045812260802,0.07836734693877552,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
278,1.1,3,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors effective for detecting cervical spine fractures in elderly blunt trauma patients with low-energy injuries? Answer: Clinical predictors do not adequately evaluate the cervical spine in geriatric trauma patients with low-energy injuries.,0.0,0.04077336356234973,0.025680069887645984,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
278,1.1,4,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,"Question: In geriatric patients with blunt trauma from low-energy mechanisms, are clinical predictors enough for assessing cervical spine fractures? Answer: Clinical predictors are insufficient for cervical spine evaluation in elderly trauma patients with low-energy trauma.",0.0,0.12232009068704963,0.08095839792732913,0.0,0.08401784006787238,0.06035379812695108,0.0,0.043321698784997587,0.031217481789802305,0.0,0.0,0.0
278,1.1,5,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: How adequate are clinical predictors for diagnosing cervical spine fractures in geriatric blunt trauma cases with low-energy mechanisms? Answer: They appear inadequate for evaluating the cervical spine in such elderly trauma cases.,4.73719454713706e-08,0.14069386077266488,0.13714986514897326,0.003626852929563759,0.02149748308653887,0.06035379812695108,0.003621603081905747,0.02121682235257394,0.031217481789802305,4.737194547137081e-08,0.06669137449867346,0.0
278,1.1,6,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Do clinical predictors suffice in assessing cervical spine fractures in elderly patients after low-energy blunt trauma? Answer: Clinical predictors fall short in evaluating cervical spine injuries in geriatric patients with low-energy blunt trauma.,2.36859727356853e-08,0.08876045812260802,0.07836734693877552,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
278,1.1,7,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors reliable for cervical spine fracture evaluation in blunt trauma geriatric patients with low-energy mechanisms? Answer: They are inadequate for this purpose in elderly trauma patients.,1.421158364141118e-07,0.05048416693314017,0.16836734693877556,0.010880558788691277,0.11665285539427828,0.06035379812695108,0.010864809245717241,0.16431766599324638,0.031217481789802305,1.4211583641411244e-07,0.2151113796169466,0.0
278,1.1,8,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Is the use of clinical predictors adequate for cervical spine fracture assessment in elderly blunt trauma individuals with low-energy impacts? Answer: Clinical predictors are inadequate for evaluating cervical spine injuries in this group.,2.36859727356853e-08,0.13076937815654377,0.10801354881182448,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
278,1.1,9,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,"Question: Can clinical predictors alone effectively assess cervical spine fractures in geriatric patients following low-energy blunt trauma? Answer: No, they seem inadequate for this evaluation.",2.36859727356853e-07,0.10366651289411877,0.16836734693877556,0.018134264647818796,0.27699550546945817,0.06035379812695108,0.018108015409528735,0.33137175065641333,0.031217481789802305,2.3685972735685406e-07,0.38946476676172503,0.0
278,1.1,10,human,Question: Cervical spine fractures in geriatric blunt trauma patients with low-energy mechanism: are clinical predictors adequate? Answer: Clinical predictors appear inadequate for the evaluation of the cervical spine in geriatric trauma patients with low-energy mechanism.,Question: Are clinical predictors sufficient for cervical spine evaluation in elderly blunt trauma patients injured through low-energy mechanisms? Answer: Clinical predictors are not sufficient for adequate assessment of the cervical spine in these patients.,2.36859727356853e-08,0.08876045812260802,0.07836734693877552,0.0018134264647818796,0.0532461814011187,0.06035379812695108,0.0018108015409528735,0.01157300047041776,0.031217481789802305,2.3685972735685406e-08,0.0327898228229917,0.0
279,1.1,1,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,The study examined prostate bed target interfractional motion based on RTOG consensus definitions with daily CT on rails and found no significant difference in motion between the superior and inferior parts of the clinical target volume.,5.210914001850784e-07,0.2444936693065598,0.16749660479855144,0.039895382225201205,0.3257043709790013,0.12244897959183676,0.03983763390096308,0.38479886366418237,0.08999999999999998,5.210914001850789e-07,0.4205596725704823,0.0736
279,1.1,2,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"Using RTOG consensus guidelines and daily CT on rails, the research assessed prostate bed target motion and concluded that target movement does not significantly vary between the superior and inferior regions of the clinical target volume.",5.210914001850784e-07,0.2444936693065598,0.16749660479855144,0.039895382225201205,0.3257043709790013,0.12244897959183676,0.03983763390096308,0.38479886366418237,0.08999999999999998,5.210914001850789e-07,0.4205596725704823,0.0736
279,1.1,3,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"In assessing interfractional motion in the prostate bed target with RTOG standards and daily CT scans, no notable difference was found between the superior and inferior sections of the clinical target volume.",6.158352911278196e-07,0.3658545263108266,0.16749660479855144,0.04714908808432872,0.4508675139330083,0.12244897959183676,0.04708084006477457,0.5140105951441893,0.08999999999999998,6.158352911278206e-07,0.5540910651950046,0.0736
279,1.1,4,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,The investigation into prostate bed target motion using RTOG definitions and daily CT imaging showed that motion between the upper and lower portions of the clinical target volume is not significantly different.,6.158352911278196e-07,0.3658545263108266,0.16749660479855144,0.04714908808432872,0.4508675139330083,0.12244897959183676,0.04708084006477457,0.5140105951441893,0.08999999999999998,6.158352911278206e-07,0.5540910651950046,0.0736
279,1.1,5,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"According to the study using daily CT scans and RTOG consensus definitions, there is no considerable variation in interfractional motion between superior and inferior parts of the prostate bed clinical target volume.",6.158352911278196e-07,0.3658545263108266,0.16749660479855144,0.04714908808432872,0.4508675139330083,0.12244897959183676,0.04708084006477457,0.5140105951441893,0.08999999999999998,6.158352911278206e-07,0.5540910651950046,0.0736
279,1.1,6,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,Evaluating prostate bed target motion through RTOG criteria and daily CT on rails revealed no significant discrepancy in motion between the top and bottom areas of the clinical target volume.,6.632072365991902e-07,0.43254590080950006,0.16749660479855144,0.05077594101389248,0.519860385419959,0.12244897959183676,0.05070244314668032,0.585469559126333,0.08999999999999998,6.632072365991914e-07,0.6281990373487263,0.0736
279,1.1,7,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"This study confirmed that interfractional motion in the prostate bed clinical target volume does not differ significantly between its superior and inferior regions, based on RTOG guidelines and daily CT imaging.",6.395212638635049e-07,0.3986443491338183,0.16749660479855144,0.0489625145491106,0.48476906560869004,0.12244897959183676,0.04889164160572745,0.5491019149554583,0.08999999999999998,6.39521263863506e-07,0.5904587093658793,0.0736
279,1.1,8,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,The research focused on prostate bed target motion employing RTOG consensus and daily CT scans and found no significant difference in target movement between superior and inferior portions of the clinical target volume.,5.921493183921343e-07,0.3341058279962468,0.16749660479855144,0.045335661619546844,0.4180776911100166,0.12244897959183676,0.0452700385238217,0.4801090434685076,0.08999999999999998,5.921493183921352e-07,0.5189997453837356,0.0736
279,1.1,9,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"Using RTOG consensus definitions with daily CT on rails, the study determined that interfractional motion in the clinical target volume of the prostate bed is consistent between superior and inferior portions.",6.395212638635049e-07,0.3986443491338183,0.16749660479855144,0.0489625145491106,0.48476906560869004,0.12244897959183676,0.04889164160572745,0.5491019149554583,0.08999999999999998,6.39521263863506e-07,0.5904587093658793,0.0736
279,1.1,10,ai,Question: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume? Answer: The study found that there is no significant difference in target motion between the superior and inferior portions of the clinical target volume in prostate bed target,"The findings indicate that, when analyzed with RTOG standards and daily CT scans, prostate bed clinical target volume motion does not significantly differ between the upper (superior) and lower (inferior) sections.",6.395212638635049e-07,0.3986443491338183,0.16749660479855144,0.0489625145491106,0.48476906560869004,0.12244897959183676,0.04889164160572745,0.5491019149554583,0.08999999999999998,6.39521263863506e-07,0.5904587093658793,0.0736
280,1.1,1,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Can mental imagery using functional magnetic resonance imaging forecast recovery in patients with consciousness disorders?,1.1132407185772118e-06,1.1592210758353034,0.2808159722222222,0.08523104384474815,1.3214510505925796,0.14532871972318342,0.08510767242478488,1.4281551919509514,0.11649408284023667,1.1132407185772135e-06,1.5430396031687468,0.08543965824136704
280,1.1,2,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Is it possible for mental imagery functional MRI to predict recovery in patients suffering from disorders of consciousness?,1.0421828003701558e-06,0.9650650613943457,0.2808159722222222,0.07979076445040252,1.1138116858143357,0.14532871972318342,0.07967526780192627,1.2050116406367417,0.11649408284023667,1.0421828003701574e-06,1.301877546351859,0.08543965824136704
280,1.1,3,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Mental imagery functional magnetic resonance imaging can predict recovery outcomes in patients with disorders of consciousness, correct?",1.065868773105841e-06,1.0256896832107807,0.2808159722222222,0.0816041909151844,1.1783502069519063,0.14532871972318342,0.08148606934287914,1.2740045121236938,0.11649408284023667,1.0658687731058429e-06,1.3759855185055803,0.08543965824136704
280,1.1,4,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Does mental imagery functional MRI have the capability to anticipate recovery in patients experiencing consciousness disorders?,1.0895547458415264e-06,1.0902282043483513,0.2808159722222222,0.08341761737996628,1.2473430784388584,0.14532871972318342,0.08329687088383202,1.348112484277415,0.11649408284023667,1.0895547458415283e-06,1.4560282261791166,0.08543965824136704
280,1.1,5,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Studies indicate that mental imagery functional magnetic resonance imaging can foresee recovery in patients with consciousness disorders, is that true?",9.94810854898785e-07,0.8538394262841216,0.2808159722222222,0.07616391152083876,0.9960286501579518,0.14532871972318342,0.07605366472002052,1.079848497682736,0.11649408284023667,9.948108548987868e-07,1.1683461537273363,0.08543965824136704
280,1.1,6,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Can mental imagery assessed through functional MRI serve as a predictor for recovery in patients with disorders of consciousness?,1.0184968276344703e-06,0.9079066475543969,0.2808159722222222,0.07797733798562065,1.0531870639979006,0.14532871972318342,0.07786446626097339,1.140473119499171,0.11649408284023667,1.0184968276344723e-06,1.232884674864907,0.08543965824136704
280,1.1,7,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","Using mental imagery with functional magnetic resonance imaging can predict the likelihood of recovery in patients who have consciousness disorders, right?",9.711248821630995e-07,0.8025461318965714,0.2808159722222222,0.07435048505605689,0.9419614288876765,0.14532871972318342,0.07424286317906764,1.0226900838427873,0.11649408284023667,9.711248821631014e-07,1.1077215319109013,0.08543965824136704
280,1.1,8,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Is mental imagery fMRI an effective tool for predicting recovery in individuals with disorders of consciousness?,1.0895547458415264e-06,1.0902282043483513,0.2808159722222222,0.08341761737996628,1.2473430784388584,0.14532871972318342,0.08329687088383202,1.348112484277415,0.11649408284023667,1.0895547458415283e-06,1.4560282261791166,0.08543965824136704
280,1.1,9,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.","The use of mental imagery functional magnetic resonance imaging can reveal recovery potential in patients with consciousness disorders, doesn't it?",9.94810854898785e-07,0.8538394262841216,0.2808159722222222,0.07616391152083876,0.9960286501579518,0.14532871972318342,0.07605366472002052,1.079848497682736,0.11649408284023667,9.948108548987868e-07,1.1683461537273363,0.08543965824136704
280,1.1,10,ai,"Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: Yes, studies have shown that mental imagery functional magnetic resonance imaging (fMRI) can potentially predict recovery in patients with disorders of consciousness. By assessing neural activity during mental imagery tasks, fMRI can provide insights into the cognitive capabilities and potential for recovery in these patients.",Does assessing neural activity via mental imagery functional MRI aid in forecasting recovery for patients with disorders of consciousness?,1.0184968276344703e-06,0.9079066475543969,0.2808159722222222,0.07797733798562065,1.0531870639979006,0.14532871972318342,0.07786446626097339,1.140473119499171,0.11649408284023667,1.0184968276344723e-06,1.232884674864907,0.08543965824136704
281,1.1,1,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix based reimbursement encourage the advancement of process-oriented care delivery? This research shows that hospital administration can promote the creation of care programs by integrating case-mix reimbursement into the budgeting processes of hospitals. Further studies are advised to validate this outcome and to explore whether these care programs will eventually result in more...,1.6580180914979784e-07,0.034684615956276144,0.06378368135361139,0.012693985253473108,0.055804181538533726,0.0507015306122449,0.012675610786670066,0.10471575090623375,0.017236072637734686,1.6580180914979784e-07,0.13102826240640475,0.0
281,1.1,2,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is process-oriented care delivery fostered by case-mix based reimbursement? The study indicates that hospital management can encourage the development of care programs by adopting case-mix reimbursement within their budgeting procedures. Future investigations are necessary to verify this finding and to ascertain if the establishment of care programs will ultimately lead to a more...,1.8948778188548325e-07,0.08089532743657513,0.044244628099173504,0.014507411718254981,0.10240450977053595,0.031101530612244906,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
281,1.1,3,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,"Can case-mix based reimbursement stimulate the growth of process-focused care provision? The findings suggest that hospitals can promote care program development by incorporating case-mix reimbursement into their budgeting strategies. It is recommended that subsequent research be conducted to confirm this and to assess whether the formation of care programs will, over time, contribute to a more...",1.1842986367842703e-07,0.028513153103694844,0.08264462809917351,0.009067132323909363,0.018063853555686293,0.0507015306122449,0.009054007704764333,0.06624947007843796,0.017236072637734686,1.1842986367842703e-07,0.09180754925312229,0.0
281,1.1,4,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does the use of case-mix based reimbursement promote process-oriented care delivery? This study demonstrates that hospital officials can encourage the initiation of care programs by implementing case-mix reimbursement in hospital budgets. Additional research is suggested to confirm these results and to establish whether such care programs will eventually foster a more...,2.3685972735685406e-07,0.0945229139230288,0.06265295796173079,0.018134264647818726,0.1152276020093348,0.0507015306122449,0.018108015409528666,0.16534037272266788,0.017236072637734686,2.3685972735685406e-07,0.19290366612449228,0.0
281,1.1,5,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,"Does linking reimbursement to case-mix drive process-oriented care delivery developments? The study reveals that hospital management can foster care program growth through case-mix reimbursement within financial planning frameworks. Further research is needed to confirm these insights and to determine if the creation of care programs will, in due time, support a more...",2.1317375462116866e-07,0.04699439940445105,0.08264462809917351,0.016320838183036854,0.09502489469181619,0.0507015306122449,0.0162972138685758,0.14472108551993212,0.017236072637734686,2.1317375462116866e-07,0.17185025692665912,0.0
281,1.1,6,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Is the development of process-oriented care delivery propelled by case-mix reimbursement models? This research indicates that the introduction of case-mix reimbursement into hospital budgeting can motivate the creation of care programs. It is recommended to undertake future research to validate this result and examine if care programs will indeed lead to a more...,1.8948778188548325e-07,0.05423582049196174,0.0634212524744138,0.014507411718254981,0.07522226739563642,0.0507015306122449,0.014486412327622933,0.12451837820241352,0.017236072637734686,1.8948778188548325e-07,0.15123096972392336,0.0
281,1.1,7,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Do reimbursement schemes based on case-mix incentivize process-oriented care delivery improvements? The current study highlights that hospital administration can push forward care program implementations by adopting case-mix reimbursement in budgeting. Further examination is warranted to verify this finding and to explore whether these programs result in more...,3.316036182995957e-07,0.1501786356396817,0.08264462809917351,0.025387970506946217,0.20038541034964208,0.0507015306122449,0.025351221573340132,0.2523517497122971,0.017236072637734686,3.316036182995957e-07,0.2818511521409879,0.0
281,1.1,8,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does case-mix reimbursement contribute to fostering process-oriented care delivery? Findings from this study suggest that hospital managers can stimulate the development of care programs by integrating case-mix reimbursement into the hospitals’ budget processes. Follow-up studies are recommended to confirm these findings and to analyze if the establishment of care programs will gradually lead to more...,1.4211583641411244e-07,0.06685233896005105,0.027281306299865554,0.010880558788691236,0.06291248394746152,0.03184058386668277,0.0108648092457172,0.08529766504913106,0.017236072637734686,1.4211583641411244e-07,0.11122563511022499,0.0
281,1.1,9,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,"Can the use of case-mix based reimbursement within hospital budgeting promote the advancement of process-oriented care delivery? The study demonstrates that management can encourage creating care programs through this adoption. It calls for future research to verify these findings and to examine whether care programs established in this manner will, in the longer term, produce a more...",9.474389094274162e-08,0.02177640215780352,0.06479338842975202,0.0072537058591274906,0.0002852851125094702,0.0507015306122449,0.007243206163811466,0.04755733706628362,0.017236072637734686,9.474389094274162e-08,0.07275935428242919,0.0
281,1.1,10,human,Question: Does case-mix based reimbursement stimulate the development of process-oriented care delivery? Answer: This study demonstrates that hospital management can stimulate the development of care programmes by the adoption of case-mix reimbursement within hospitals' budgeting processes. Future research is recommended to confirm this finding and to determine whether the establishment of care programmes will in time indeed lead to a more,Does the application of case-mix based reimbursement in hospitals’ budget planning encourage process-oriented care delivery development? This study shows that hospital leadership can foster care program growth by adopting case-mix reimbursement processes. It suggests further studies to confirm this observation and to determine if care programs will ultimately result in a more...,2.1317375462116866e-07,0.04699439940445105,0.08264462809917351,0.016320838183036854,0.09502489469181619,0.0507015306122449,0.0162972138685758,0.14472108551993212,0.017236072637734686,2.1317375462116866e-07,0.17185025692665912,0.0
282,1.1,1,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration during pregnancy harm the kidneys of women with multiple parities? Research indicates it does not necessarily cause kidney damage, though more studies are essential to ascertain long-term risks.",4.974054274493925e-07,0.3844572716628756,0.14035916824196598,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5313240662799146,0.020399305555555556,4.974054274493935e-07,0.5753641449035616,0.0
282,1.1,2,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Is kidney damage caused by glomerular hyperfiltration in pregnant women who have had multiple births? Current research suggests no definite harm, but further investigation is required to evaluate the long-term implications.",4.974054274493925e-07,0.3844572716628756,0.14035916824196598,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5313240662799146,0.020399305555555556,4.974054274493935e-07,0.5753641449035616,0.0
282,1.1,3,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Can glomerular hyperfiltration in pregnancy damage the kidneys of women with higher parity? Studies show it doesn’t always result in kidney injury, yet additional research is needed to clarify long-term effects.",4.974054274493925e-07,0.3844572716628756,0.14035916824196598,0.03808195576041937,0.4892754009968767,0.039930555555555566,0.03802683236001025,0.5313240662799146,0.020399305555555556,4.974054274493935e-07,0.5753641449035616,0.0
282,1.1,4,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does pregnancy-related glomerular hyperfiltration damage kidneys in women with several children? Evidence implies it may not cause damage, but comprehensive studies are necessary to understand potential long-range consequences.",5.684633456564484e-07,0.489817787320701,0.14035916824196598,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6446527515869187,0.020399305555555556,5.684633456564497e-07,0.6931471805599458,0.0
282,1.1,5,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Is there kidney damage from glomerular hyperfiltration during pregnancy in women with multiple births? Research so far suggests no clear kidney harm, but further research is needed to determine any long-term risks.",4.7371945471370717e-07,0.3516674488398839,0.14035916824196598,0.03626852929563749,0.45537384932119496,0.039930555555555566,0.036216030819057374,0.49623274646864557,0.020399305555555556,4.737194547137081e-07,0.5389965007326869,0.0
282,1.1,6,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does glomerular hyperfiltration in pregnancy lead to kidney harm in women with greater parity? Findings indicate it does not necessarily cause injury, although more studies are required for full understanding.",5.210914001850778e-07,0.41835882333855734,0.14035916824196598,0.03989538222520125,0.5243667208081457,0.039930555555555566,0.03983763390096312,0.5676917104507893,0.020399305555555556,5.210914001850789e-07,0.6131044728864086,0.0
282,1.1,7,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","May glomerular hyperfiltration during pregnancy damage the kidneys of women with more parities? Research suggests no definitive damage, but additional studies are needed to assess long-term effects.",5.921493183921337e-07,0.527558115303548,0.14035916824196598,0.045335661619546885,0.6376954061151499,0.039930555555555566,0.04527003852382174,0.6854747461071735,0.020399305555555556,5.921493183921352e-07,0.7357067949787415,0.0
282,1.1,8,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Is kidney injury a result of glomerular hyperfiltration in women with numerous pregnancies? Current evidence does not confirm damage, though further research is important to understand long-term outcomes.",5.684633456564484e-07,0.489817787320701,0.14035916824196598,0.043522235154765006,0.5984746929618674,0.039930555555555566,0.04345923698286887,0.6446527515869187,0.020399305555555556,5.684633456564497e-07,0.6931471805599458,0.0
282,1.1,9,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Does the increased glomerular filtration in pregnancy cause kidney damage in women with multiple pregnancies? Studies indicate it does not always cause harm, but further investigation is necessary to evaluate potential risks.",4.7371945471370717e-07,0.3516674488398839,0.14035916824196598,0.03626852929563749,0.45537384932119496,0.039930555555555566,0.036216030819057374,0.49623274646864557,0.020399305555555556,4.737194547137081e-07,0.5389965007326869,0.0
282,1.1,10,ai,"Question: Does glomerular hyperfiltration in pregnancy damage the kidney in women with more parities? Answer: Research suggests that glomerular hyperfiltration during pregnancy does not necessarily lead to kidney damage in women with more parities. However, further studies are needed to fully understand the long-term effects and potential risks associated with glomerular hyperfiltration","Can kidney damage result from glomerular hyperfiltration during pregnancy in women with more pregnancies? Research shows it may not lead to damage, yet more studies are essential to fully comprehend long-term effects.",4.7371945471370717e-07,0.3516674488398839,0.14035916824196598,0.03626852929563749,0.45537384932119496,0.039930555555555566,0.036216030819057374,0.49623274646864557,0.020399305555555556,4.737194547137081e-07,0.5389965007326869,0.0
283,1.1,1,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Does septoplasty alter the size of compensatory hypertrophy in the middle turbinate? Septoplasty is performed to correct a deviated septum, whereas compensatory hypertrophy involves the middle turbinate growing larger.",1.421158364141118e-07,0.1708569495481882,0.016403031851683084,0.010880558788691277,0.1586617754282149,0.0302734375,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
283,1.1,2,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Can septoplasty affect the extent of compensatory hypertrophy of the middle turbinate? Septoplasty corrects a deviated septum, and compensatory hypertrophy refers to swelling of the middle turbinate.",1.894877818854824e-07,0.3059009375753097,0.026012601083071532,0.014507411718255037,0.29107459100913946,0.00965711805555556,0.014486412327622988,0.28768207245178123,0.0,1.8948778188548325e-07,0.29849298855599704,0.0
283,1.1,3,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle",Is there a change in the compensatory hypertrophy dimension of the middle turbinate after septoplasty? Septoplasty addresses a deviated septum while compensatory hypertrophy is enlargement of the middle turbinate.,1.421158364141118e-07,0.2203674624453269,0.018191050988553614,0.010880558788691277,0.21000601102524818,0.006708811020710047,0.010864809245717241,0.20763936477824396,0.0,1.4211583641411244e-07,0.2151113796169466,0.0
283,1.1,4,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle",Does septoplasty modify the dimensions of middle turbinate compensatory hypertrophy? Septoplasty fixes septal deviation; compensatory hypertrophy involves the middle turbinate expanding.,3.3160361829959426e-07,0.47762287843111784,0.03754745316657108,0.025387970506946314,0.5100596622661042,0.0302734375,0.02535122157334023,0.5753641449035616,0.0,3.316036182995955e-07,0.6007738604289306,0.0
283,1.1,5,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle",Will septoplasty impact the size of compensatory hypertrophy in the middle turbinate? Septoplasty treats a deviated septum; hypertrophy is the enlargement of the middle turbinate.,2.36859727356853e-07,0.2837488686278289,0.04582104731012315,0.018134264647818796,0.3190044255033948,0.0302734375,0.018108015409528735,0.3746934494414109,0.0,2.3685972735685406e-07,0.38946476676172503,0.0
283,1.1,6,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle",Does the size of compensatory hypertrophy of the middle turbinate change following septoplasty? Septoplasty corrects a deviated septum; compensatory hypertrophy is middle turbinate enlargement.,2.605457000925383e-07,0.3890935537495199,0.0012411485579316844,0.019947691112600675,0.36345618807422886,0.0302734375,0.01991881695048161,0.42121346507630486,0.0,2.605457000925394e-07,0.4382549309311563,0.0
283,1.1,7,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","After septoplasty, do the dimensions of compensatory hypertrophy in the middle turbinate change? Septoplasty is surgery for septal deviation; hypertrophy is growth of the middle turbinate.",2.131737546211677e-07,0.2406163835057087,0.047478393455890854,0.016320838183036916,0.2764448110845992,0.0302734375,0.016297213868575862,0.33024168687057687,0.0,2.1317375462116866e-07,0.3429447511268311,0.0
283,1.1,8,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Can septoplasty result in dimensional changes to the compensatory hypertrophy of the middle turbinate? Septoplasty corrects deviation of the septum, while compensatory hypertrophy denotes enlarged middle turbinate tissue.",1.658018091497971e-07,0.21089203911885068,0.013808949011446428,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
283,1.1,9,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Is compensatory hypertrophy of the middle turbinate altered in size by septoplasty? Septoplasty is intended to fix a crooked septum, and compensatory hypertrophy means an enlarged middle turbinate.",1.658018091497971e-07,0.1595478035218174,0.050426700490736366,0.012693985253473157,0.1964021034110619,0.0302734375,0.012675610786670115,0.24686007793152642,0.0,1.6580180914979784e-07,0.2559333741372014,0.0
283,1.1,10,ai,"Question: Does septoplasty change the dimensions of compensatory hypertrophy of the middle turbinate? Answer: Septoplasty is a surgical procedure aimed at correcting a deviated septum, while compensatory hypertrophy refers to the enlargement of the middle","Does the procedure of septoplasty change how large the compensatory hypertrophy of the middle turbinate is? Septoplasty is used to correct a deviated septum, with compensatory hypertrophy being the middle turbinate swelling.",7.10579182070559e-08,0.10421074826202092,0.008254316294676059,0.005440279394345639,0.09951107180771901,0.003020260478596916,0.005432404622858621,0.09844007281325329,0.0,7.105791820705622e-08,0.10178269430994247,0.0
284,1.1,1,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to support the claim that Indigenous Australians experience premature aging. Nevertheless, elements like socioeconomic challenges, healthcare accessibility, and lifestyle decisions might influence health conditions related to aging.",9.474389094274141e-08,0.07055087191658371,0.02120343316289264,0.0072537058591274906,0.0688420964717924,0.024375,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
284,1.1,2,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: Scientific research does not indicate that Indigenous Australians undergo premature aging. However, factors including socioeconomic status, healthcare access, and lifestyle habits may impact health issues that affect aging.",1.8948778188548261e-07,0.18606844003337164,0.018115243342516078,0.014507411718254995,0.18325244764953785,0.024375,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
284,1.1,3,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: No scientific data confirms that Indigenous Australians age earlier than usual. Still, aspects such as socioeconomic disadvantage, healthcare availability, and lifestyle can contribute to health problems that influence the aging process.",1.1842986367842671e-07,0.13567251877376396,0.006377551020408163,0.009067132323909363,0.13474924735768257,0.003380102040816329,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
284,1.1,4,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: There is no evidence from scientific studies that Indigenous Australians have premature aging. Yet, socioeconomic difficulties, limited healthcare access, and lifestyle choices may play a role in health issues that modify aging.",9.474389094274141e-08,0.07055087191658371,0.02120343316289264,0.0072537058591274906,0.0688420964717924,0.024375,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
284,1.1,5,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: Scientific findings do not show that Indigenous Australians experience early aging. However, health issues related to aging may be affected by socioeconomic disadvantage, healthcare access, and lifestyle factors.",1.8948778188548261e-07,0.18606844003337164,0.018115243342516078,0.014507411718254995,0.18325244764953785,0.024375,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
284,1.1,6,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: Indigenous Australians are not scientifically proven to age prematurely. Still, socioeconomic challenges, healthcare accessibility, and lifestyle factors might contribute to aging-related health concerns.",3.079176455639091e-07,0.3521630249324308,0.013061224489795922,0.023574544042164393,0.34755549894081383,0.024375,0.02354042003238732,0.3930425881096067,0.0,3.079176455639103e-07,0.40546510810816194,0.0
284,1.1,7,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: Currently, no scientific evidence points to premature aging in Indigenous Australians. Yet, socioeconomic struggles, differences in healthcare access, and lifestyle decisions could impact their aging process.",2.3685972735685321e-07,0.20591969828745738,0.047500000000000014,0.018134264647818754,0.24577280463087137,0.024375,0.0181080154095287,0.28768207245178123,0.0,2.3685972735685406e-07,0.29626581614317127,0.0
284,1.1,8,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: There is no scientific proof of premature aging among Indigenous Australians. However, health issues affecting aging might arise from factors like socioeconomic status, healthcare availability, and lifestyle choices.",1.8948778188548261e-07,0.1452950764710219,0.047500000000000014,0.014507411718254995,0.18325244764953785,0.024375,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
284,1.1,9,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: Scientific evidence does not verify premature aging in Indigenous Australians. Nonetheless, factors such as socioeconomic hardship, healthcare accessibility, and lifestyle may influence health conditions that impact aging.",2.1317375462116791e-07,0.1751480396207037,0.047500000000000014,0.016320838183036875,0.21402410631629154,0.024375,0.016297213868575827,0.25489224962878954,0.0,2.1317375462116866e-07,0.2623642644674895,0.0
284,1.1,10,ai,"Question: Do Indigenous Australians age prematurely? Answer: There is no scientific evidence to suggest that Indigenous Australians age prematurely. However, factors such as socioeconomic disadvantage, access to healthcare, and lifestyle choices may contribute to health issues that can affect the overall aging process.","Question: Do Indigenous Australians age prematurely? Answer: Research offers no support for the idea that Indigenous Australians age prematurely. Yet, health factors influenced by socioeconomic disadvantage, healthcare access, and lifestyle habits could affect their aging process.",1.6580180914979731e-07,0.19552436023319242,0.00943296602387509,0.012693985253473115,0.1941728480622058,0.005009756657483936,0.01267561078667008,0.19237189264745602,0.0,1.6580180914979784e-07,0.19782574332991798,0.0
285,1.1,1,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Is there discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology? Indeed, differences in training, experience, or subjective interpretation may cause disagreement. Effective communication and cooperation are vital to ensure correct diagnoses and proper patient care.",5.210914001850789e-07,0.23701865270407385,0.14097543609825555,0.0398953822252012,0.2882292585708912,0.11282578875171473,0.039837633900963065,0.3412338724023898,0.08264462809917351,5.210914001850789e-07,0.396129987475736,0.0507015306122449
285,1.1,2,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Could there be differences between clinical pathologists and clinicians when reporting and interpreting red blood cell morphology? Yes, discrepancies might arise due to variation in expertise and subjective judgment. Collaborative efforts and clear communication help guarantee accurate diagnosis and treatment.",5.447773729207642e-07,0.2623364606883656,0.14097543609825555,0.04170880868998307,0.3142047449741492,0.11282578875171473,0.04164843544191593,0.36790211948455065,0.08264462809917351,5.447773729207643e-07,0.42352896166385134,0.0507015306122449
285,1.1,3,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Is a discordance present between clinical pathologists and clinicians with respect to red blood cell morphology reporting and interpretation? Such discrepancies may occur because of different backgrounds, experience levels, or personal interpretation. Ensuring dialogue and teamwork is critical for accurate diagnosis and patient management.",4.500334819780227e-07,0.16469799112444772,0.14097543609825555,0.03445510283085558,0.21412128641716777,0.11282578875171473,0.034405229278104466,0.2652479654244684,0.08264462809917351,4.500334819780227e-07,0.31816844600602545,0.0507015306122449
285,1.1,4,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Are clinical pathologists and clinicians in agreement regarding red blood cell morphology reporting and interpretation? Potential discordance exists, by virtue of differing training, experience, or subjective views. Communication and collaboration are key to achieving accurate diagnostic outcomes and optimized care.",5.447773729207642e-07,0.2623364606883656,0.14097543609825555,0.04170880868998307,0.3142047449741492,0.11282578875171473,0.04164843544191593,0.36790211948455065,0.08264462809917351,5.447773729207643e-07,0.42352896166385134,0.0507015306122449
285,1.1,5,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Do clinical pathologists and clinicians sometimes differ in their reporting and interpretation of red blood cell morphology? Yes, this may result from variations in training, expertise, or subjective readings. To promote precise diagnoses and effective management, collaboration between the groups is necessary.",4.974054274493935e-07,0.21232604011370215,0.14097543609825555,0.038081955760419325,0.2629114505865995,0.11282578875171473,0.0380268323600102,0.3152583859991318,0.08264462809917351,4.974054274493935e-07,0.36946174039357516,0.0507015306122449
285,1.1,6,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Is there a mismatch between clinical pathologists and clinicians in red blood cell morphology assessment? Differences in training and interpretation could lead to discordance; therefore, active communication and partnership are crucial to ensure diagnostic accuracy and appropriate patient treatment.",5.684633456564495e-07,0.28831194709162355,0.14097543609825555,0.04352223515476494,0.34087299205631005,0.11282578875171473,0.0434592369828688,0.39530109367266597,0.08264462809917351,5.684633456564497e-07,0.4516998386305482,0.0507015306122449
285,1.1,7,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Does discordance occur between clinical pathologists and clinicians regarding the evaluation and reporting of red blood cell morphology? It can, due to training differences or subjective evaluation. Effective interplay and collaboration help secure precise diagnosis and suitable patient care.",5.684633456564495e-07,0.28831194709162355,0.14097543609825555,0.04352223515476494,0.34087299205631005,0.11282578875171473,0.0434592369828688,0.39530109367266597,0.08264462809917351,5.684633456564497e-07,0.4516998386305482,0.0507015306122449
285,1.1,8,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.",Are clinical pathologists and clinicians aligned when it comes to reporting and interpreting red blood cell morphology? Variations in education and viewpoints may cause conflict. Continued communication and joint efforts are essential for accurate diagnosis and patient care management.,5.684633456564495e-07,0.28831194709162355,0.14097543609825555,0.04352223515476494,0.34087299205631005,0.11282578875171473,0.0434592369828688,0.39530109367266597,0.08264462809917351,5.684633456564497e-07,0.4516998386305482,0.0507015306122449
285,1.1,9,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Is there a potential disagreement between clinical pathologists and clinicians in the interpretation and reporting of red blood cell morphology? Yes, often because of diverse backgrounds and subjective interpretations. To achieve accurate diagnosis and patient management, collaboration and open communication are important.",4.974054274493935e-07,0.21232604011370215,0.14097543609825555,0.038081955760419325,0.2629114505865995,0.11282578875171473,0.0380268323600102,0.3152583859991318,0.08264462809917351,4.974054274493935e-07,0.36946174039357516,0.0507015306122449
285,1.1,10,ai,"Question: Reporting and interpreting red blood cell morphology: is there discordance between clinical pathologists and clinicians? Answer: There may be discordance between clinical pathologists and clinicians in reporting and interpreting red blood cell morphology. This could be due to differences in training, experience, or subjective interpretation. Communication and collaboration between the two groups are essential to ensure accurate diagnoses and appropriate patient management.","Might clinical pathologists and clinicians have differing perspectives when reporting and interpreting red blood cell morphology? Differences in experience, training, or interpretation styles can cause discordance, highlighting the necessity of communication and collaboration for accurate diagnoses and patient care.",5.684633456564495e-07,0.28831194709162355,0.14097543609825555,0.04352223515476494,0.34087299205631005,0.11282578875171473,0.0434592369828688,0.39530109367266597,0.08264462809917351,5.684633456564497e-07,0.4516998386305482,0.0507015306122449
286,1.1,1,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are lower fasting plasma glucose (FPG) levels at the time of type 2 diabetes diagnosis linked to better clinical outcomes? Patients diagnosed with type 2 diabetes exhibiting lower initial blood sugar, likely indicating earlier disease stage, experienced fewer negative clinical events despite comparable glycemic worsening. Because these patients usually show no symptoms when diagnosed, proactive screening programs are necessary to detect them.",7.105791820705622e-08,0.05013979453644435,0.0015317282073249762,0.005440279394345618,0.04989039778937254,0.0007929921939854173,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
286,1.1,2,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there a relationship between reduced fasting plasma glucose levels at type 2 diabetes diagnosis and enhanced health outcomes? People with type 2 diabetes who have lower initial blood glucose—suggesting earlier disease detection—tend to have fewer adverse outcomes even with similar rates of blood sugar worsening. Since these individuals are mostly asymptomatic at diagnosis, systematic case finding programs would be needed for identification.",4.737194547137081e-08,0.033146172468936363,0.001004740432419906,0.0036268529295637453,0.03298232688703617,0.0005200023124060579,0.003621603081905733,0.03278982282299214,0.0,4.737194547137081e-08,0.03333642026759165,0.0
286,1.1,3,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Do lower fasting plasma glucose readings at the diagnosis of type 2 diabetes correlate with better patient outcomes? Individuals diagnosed with type 2 diabetes with lower initial hyperglycemia, possibly earlier in the disease process, showed fewer negative clinical outcomes despite comparable progression of glycemia. Given most are symptom-free on diagnosis, active case detection initiatives are essential for finding them.",1.4211583641411244e-07,0.1029216278599776,0.0032212937204017973,0.010880558788691236,0.10239973986211481,0.0016693787296396152,0.0108648092457172,0.10178269430994202,0.0,1.4211583641411244e-07,0.10354067894083929,0.0
286,1.1,4,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Does having lower fasting plasma glucose levels when first diagnosed with type 2 diabetes improve outcomes? Patients presenting with lower blood sugar levels at diagnosis, indicating earlier stage diabetes, had fewer harmful clinical outcomes despite similar progression in glucose levels. Because they are usually asymptomatic when found, detection through active screening programs is necessary.",2.6054570009253947e-07,0.1452694710225555,0.031217481789802295,0.0199476911126006,0.16988633541137954,0.01586888657648284,0.019918816950481533,0.1953087523207664,0.0,2.6054570009253947e-07,0.19885085874516495,0.0
286,1.1,5,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are early-stage type 2 diabetes patients with lower fasting plasma glucose at diagnosis more likely to have better clinical results? Those with lower initial glycemia, possibly reflecting earlier disease phase, experienced fewer adverse events though their glycemic control worsened comparably. As most show no symptoms at diagnosis, active case-finding efforts are required to identify them.",2.3685972735685406e-07,0.15224945580891802,0.012705555837506113,0.018134264647818726,0.15083814044068644,0.01586888657648284,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
286,1.1,6,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is there an association between lower fasting plasma glucose levels upon the diagnosis of type 2 diabetes and improved disease outcomes? Patients presenting with lower initial glycemic levels, suggesting early disease course, had a reduction in adverse clinical events notwithstanding similar glycemic deterioration. Since these patients mostly lack symptoms upon diagnosis, detection programs geared toward active case finding are needed.",1.1842986367842703e-07,0.038023940668957756,0.031217481789802295,0.009067132323909363,0.06068704344638842,0.01586888657648284,0.009054007704764333,0.0840831172105414,0.0,1.1842986367842703e-07,0.08552217343816082,0.0
286,1.1,7,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Does having lower fasting plasma glucose levels at the time of type 2 diabetes diagnosis relate to better health outcomes? Individuals with type 2 diabetes who were initially less hyperglycemic, indicating possibly earlier disease, had fewer negative clinical outcomes even though glycemic progression was similar. Because they often show no symptoms at diagnosis, active detection programs are necessary to identify them.",9.474389094274162e-08,0.06742663438990615,0.002076216188794621,0.0072537058591274906,0.06708912468234107,0.0010752275733388016,0.007243206163811466,0.06669137449867257,0.0,9.474389094274162e-08,0.0678225963387602,0.0
286,1.1,8,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are improved outcomes linked to lower fasting plasma glucose levels at type 2 diabetes diagnosis? Those with type 2 diabetes and lower initial glycemia, likely representing an earlier disease stage, faced fewer adverse clinical results despite similar worsening of glycemic control. As most are asymptomatic at diagnosis, active screening approaches would be needed for identification.",2.3685972735685406e-07,0.17792157360743488,0.005764766730907759,0.018134264647818726,0.17699463782030733,0.0029920601690792935,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
286,1.1,9,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Is lower fasting plasma glucose at the diagnosis of type 2 diabetes predictive of better patient outcomes? Patients newly diagnosed with lower blood sugar levels, presumably earlier in disease progression, experienced fewer unfavorable clinical outcomes despite comparable increases in glycemia. Given their asymptomatic status at diagnosis, active case detection programs are needed to find them.",2.3685972735685406e-07,0.12657733801040116,0.031217481789802295,0.018134264647818726,0.15083814044068644,0.01586888657648284,0.018108015409528666,0.1758906664636637,0.0,2.3685972735685406e-07,0.17904823144898518,0.0
286,1.1,10,human,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: People presenting with type 2 diabetes with lower initial glycemia who may be earlier in the course of their disease had fewer adverse clinical outcomes despite similar glycemic progression. Since most such people are asymptomatic at diagnosis, active case detection programs would be required to identify them.","Are better outcomes associated with lower fasting plasma glucose at the point of type 2 diabetes diagnosis? People with type 2 diabetes who presented with lower initial blood glucose, likely signifying early disease, had fewer adverse outcomes even though their glycemic deterioration was similar. As they usually have no symptoms at diagnosis, proactive case finding would be necessary to detect these patients.",7.105791820705622e-08,0.07286593160398347,0.0178312696965235,0.005440279394345618,0.04989039778937254,0.0007929921939854173,0.0054324046228586,0.04959694113937285,0.0,7.105791820705622e-08,0.05043085362689137,0.0
287,1.1,1,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Numerous children have a tendency to underestimate how overweight they are. This misperception was also common among their parents and their physicians. The study highlights the need for better physician education to accurately identify obesity and overweight and to provide appropriate counseling to both children and their families.",1.8948778188548325e-07,0.1086920222904677,0.046323207657277585,0.014507411718254981,0.13815033848081626,0.0,0.014486412327622933,0.1405819506211894,0.0,1.8948778188548325e-07,0.14310084364067155,0.0
287,1.1,2,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do parents, their children, and the children's doctors perceive body image in different ways? Answer: Many children fail to recognize the extent of their overweight condition. Their parents and attending doctors often have the same misjudgment. This research emphasizes the necessity of training physicians to detect obesity and overweight to effectively advise children and their families.",2.3685972735685406e-08,0.043223857523040365,0.0181755829903978,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
287,1.1,3,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are body image perceptions different among parents, their children, and the children's physicians? Answer: A lot of children underestimate how overweight they actually are. Their parents and doctors share this false perception as well. The study underscores the need to further educate physicians so they can identify obesity and overweight and guide children and families accordingly.",2.3685972735685406e-08,0.043223857523040365,0.0181755829903978,0.0018134264647818726,0.018349138668195764,0.0,0.0018108015409528666,0.018692133012154333,0.0,2.3685972735685406e-08,0.0190481949706931,0.0
287,1.1,4,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: In terms of body perception, do children, their parents, and their children's doctors differ in viewpoint? Answer: Many children underestimate their overweight status, a misperception shared by their parents and physicians. This study suggests the importance of enhancing physician education to better recognize overweight and obesity and to advise families.",1.1842986367842703e-07,0.07010482778396376,0.0181755829903978,0.009067132323909363,0.0971637484536485,0.0,0.009054007704764333,0.09909090264422993,0.0,1.1842986367842703e-07,0.10109611687136999,0.0
287,1.1,5,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do the perceptions of body image vary among children, their parents, and their children's doctors? Answer: Children mostly tend to undervalue the extent of their overweight condition, a misjudgment that is also common among their parents and doctors. This study calls for more education of physicians to improve diagnosis of obesity and overweight and counseling for families.",4.737194547137081e-08,0.060923434622440986,0.0181755829903978,0.0036268529295637453,0.036367644170874236,0.0,0.003621603081905733,0.037041271680350096,0.0,4.737194547137081e-08,0.03774032798284743,0.0
287,1.1,6,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are parents, children, and pediatricians seeing body image differently? Answer: Many children underestimate their overweight; this misunderstanding is mirrored by their parents and physicians. The study points out a pressing need to educate doctors better so that they can identify overweight children and offer proper counseling.",2.1317375462116866e-07,0.15348643672301465,0.0181755829903978,0.016320838183036854,0.18232155679395579,0.0,0.0162972138685758,0.18610227963385917,0.0,2.1317375462116866e-07,0.1900436028878656,0.0
287,1.1,7,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Is there a difference in body perception between children, their parents, and their physicians? Answer: Many children misjudge how overweight they are, and this is a view shared by their parents and attending physicians. The findings highlight the necessity for ongoing physician education to recognize obesity and provide better guidance to families.",7.105791820705622e-08,0.030884114630681303,0.0181755829903978,0.005440279394345618,0.05715841383995013,0.0,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
287,1.1,8,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: How do children, parents, and physicians view body image differently? Answer: A significant number of children underestimate their weight status; this error is also found among their parents and physicians. The study indicates the urgent need to enhance physician training for identifying obesity and supporting affected families.",1.8948778188548325e-07,0.1319802315020513,0.0181755829903978,0.014507411718254981,0.16034265007518078,0.0,0.014486412327622933,0.16362942378180145,0.0,1.8948778188548325e-07,0.16705408466316607,0.0
287,1.1,9,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Do children, their parents, and doctors perceive body image differently? Answer: Many children do not realize how overweight they are, with their parents and doctors sharing the same misunderstanding. This research shows the importance of educating physicians to better detect overweight conditions and provide counseling.",2.3685972735685406e-07,0.20627188480000935,0.00403516081125509,0.018134264647818726,0.2047944126460135,0.0,0.018108015409528666,0.2090917978585587,0.0,2.3685972735685406e-07,0.21357410029806,0.0
287,1.1,10,human,"Question: Body perception: do parents, their children, and their children's physicians perceive body image differently? Answer: Many children underestimated their degree of overweight. Their parents and even their attending physicians shared this misperception. This study demonstrates the need to further educate physicians to recognize obesity and overweight so that they can counsel children and their families.","Question: Are there differing perceptions of body image among children, their parents, and children's doctors? Answer: The majority of children underestimate their overweight status, a misjudgment that is equally present in their parents and doctors. The study underscores the critical need for improved physician education to recognize and counsel on obesity and overweight issues.",4.737194547137081e-08,0.011835919659988203,0.0181755829903978,0.0036268529295637453,0.03774032798284743,0.0,0.003621603081905733,0.038466280827795796,0.0,4.737194547137081e-08,0.03922071315328246,0.0
288,1.1,1,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is screening for coeliac disease in at-risk populations warranted? Yes, screening for coeliac disease in at-risk groups is justified. These groups include people with a family history, autoimmune disorders, or symptoms such as chronic diarrhea or weight loss. Early diagnosis is beneficial.",1.8948778188548325e-07,0.13858793421299698,0.06690917107583767,0.014507411718254981,0.205426462812619,0.0161208039995919,0.014486412327622933,0.20473710924483024,0.012855831037649243,1.8948778188548325e-07,0.20374442999950348,0.009080706050403016
288,1.1,2,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Should coeliac disease screening be conducted in risk groups? Indeed, screening is justified for individuals at risk, including those with family history, autoimmune conditions, and symptoms like persistent diarrhea or weight loss. Early detection facilitates better outcomes.",3.0791764556390986e-07,0.09958077451974523,0.18650793650793648,0.023574544042164344,0.20032841932515355,0.08264462809917357,0.023540420032387273,0.23530020297986054,0.06353305785123965,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
288,1.1,3,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is it appropriate to screen for coeliac disease in high-risk groups? Screening is recommended for those at higher risk, such as people with a family history, autoimmune diseases, or chronic symptoms like diarrhea and weight loss. Early identification helps manage the condition.",1.8948778188548325e-07,0.03047235372845236,0.18650793650793648,0.014507411718254981,0.06679702670063081,0.08264462809917357,0.014486412327622933,0.09809908146637802,0.06353305785123965,1.8948778188548325e-07,0.13078156888793036,0.043388429752066124
288,1.1,4,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Does screening for coeliac disease in risk groups have merit? Yes, screening in risk groups including family history, autoimmune disease, and symptoms of chronic diarrhea or weight loss is justified since early diagnosis is crucial.",3.5528959103528046e-07,0.23828591548439348,0.12791418650793648,0.027201396971728103,0.3011778393820226,0.05237119059917357,0.02716202311429302,0.295924824796296,0.06353305785123965,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
288,1.1,5,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is coeliac disease screening necessary for populations at risk? Yes, screening risk groups—those with familial history, autoimmune issues, or symptoms like chronic diarrhea and weight loss—is justified, enabling early diagnosis.",4.7371945471370696e-07,0.31580388298938233,0.18650793650793648,0.0362685292956375,0.4234719706393628,0.08264462809917357,0.03621603081905739,0.465823861591693,0.06353305785123965,4.737194547137081e-07,0.5102711905928343,0.043388429752066124
288,1.1,6,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is it reasonable to screen risk groups for coeliac disease? Absolutely; those at risk, including individuals with family history, autoimmune disorders, or chronic symptoms, should be screened to allow early detection and treatment.",4.0266153650665106e-07,0.21736381017612905,0.18650793650793648,0.030828249901291863,0.32168927632942035,0.08264462809917357,0.030783626196198767,0.36046334593386753,0.06353305785123965,4.026615365066519e-07,0.40107189862784365,0.043388429752066124
288,1.1,7,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Can coeliac disease screening in risk groups be justified? It certainly can; risk groups such as people with family history, autoimmune diseases, or persistent diarrhea/weight loss benefit from early detection through screening.",4.2634750924233636e-07,0.2938316814300599,0.15428571428571428,0.03264167636607374,0.35447909915241205,0.08264462809917357,0.03259442773715164,0.3943648976095493,0.06353305785123965,4.263475092423373e-07,0.43616321843911265,0.043388429752066124
288,1.1,8,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Does it make sense to screen risk groups for coeliac disease? Yes, given that coeliac disease screening for individuals with family history, autoimmune disorders, or relevant symptoms improves early diagnosis, it is justified.",4.0266153650665106e-07,0.21736381017612905,0.18650793650793648,0.030828249901291863,0.32168927632942035,0.08264462809917357,0.030783626196198767,0.36046334593386753,0.06353305785123965,4.026615365066519e-07,0.40107189862784365,0.043388429752066124
288,1.1,9,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Is screening for coeliac disease justified in individuals at risk? Indeed, screening is warranted for risk groups including those with hereditary links, autoimmune conditions, or symptoms like chronic diarrhea or weight loss for timely detection.",3.5528959103528046e-07,0.15673918835969358,0.18650793650793648,0.027201396971728103,0.25916891934808683,0.08264462809917357,0.02716202311429302,0.295924824796296,0.06353305785123965,3.552895910352811e-07,0.3343805241291702,0.043388429752066124
288,1.1,10,ai,"Question: Is coeliac disease screening in risk groups justified? Answer: Yes, coeliac disease screening in risk groups is justified. Risk groups include individuals with a family history of the disease, those with autoimmune disorders, and individuals with symptoms like chronic diarrhea or weight loss. Early detection and diagnosis can lead","Should individuals in risk categories be screened for coeliac disease? Screening is justified for risk groups, encompassing people with a family history, autoimmune diseases, or symptoms such as chronic diarrhea and weight loss to achieve early diagnosis.",3.0791764556390986e-07,0.09958077451974523,0.18650793650793648,0.023574544042164344,0.20032841932515355,0.08264462809917357,0.023540420032387273,0.23530020297986054,0.06353305785123965,3.079176455639103e-07,0.2718601671478367,0.043388429752066124
289,1.1,1,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice at residency teaching sites mirror community practice? The residency training locations of the Northeastern Ohio Universities College of Medicine offer patient care experiences comparable to a national study of family and general practitioners.,1.184298636784265e-07,0.13353139262452274,0.0,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
289,1.1,2,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,"Is family practice at residency teaching sites representative of community practice? At the Northeastern Ohio Universities College of Medicine, residency training sites provide patient care opportunities that align with those reported in a national survey of family and general practitioners.",2.36859727356853e-08,0.02531780798429173,0.0,0.0018134264647818726,0.025975486403257975,0.0,0.0018108015409528666,0.026668247082160867,0.0,2.3685972735685406e-08,0.02739897418811532,0.0
289,1.1,3,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Do residency teaching sites for family practice represent community practice? The residency sites at Northeastern Ohio Universities College of Medicine deliver patient care experiences similar to those in a nationwide survey of family and general practitioners.,1.184298636784265e-07,0.13353139262452274,0.0,0.00906713232390937,0.13720112151348252,0.0,0.009054007704764347,0.14107859825990632,0.0,1.1842986367842703e-07,0.14518200984449914,0.0
289,1.1,4,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice in residency teaching environments reflect the community practice setting? The patient care provided at Northeastern Ohio Universities College of Medicine residency sites resembles that found in a national survey of family and general practitioners.,9.47438909427412e-08,0.10536051565782589,0.0,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
289,1.1,5,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Are family practice residency teaching sites indicative of community practice? Residency training locations at Northeastern Ohio Universities College of Medicine offer patient care opportunities akin to those identified in a national survey of family and general practitioners.,9.47438909427412e-08,0.10536051565782589,0.0,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
289,1.1,6,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does the family practice experience at residency sites emulate community practice? The residency programs at Northeastern Ohio Universities College of Medicine provide patient care comparable to that documented in a national survey of family and general practitioners.,9.47438909427412e-08,0.10536051565782589,0.0,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
289,1.1,7,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Is the family practice at residency teaching locations consistent with community practice? Patient care opportunities at the residency sites of Northeastern Ohio Universities College of Medicine closely match those from a national survey of family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
289,1.1,8,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does family practice in residency teaching settings correspond to community practice? Residency sites at Northeastern Ohio Universities College of Medicine engage in patient care similar to that noted in a national survey of family and general practitioners.,9.47438909427412e-08,0.10536051565782589,0.0,0.0072537058591274906,0.10821358464023101,0.0,0.007243206163811473,0.11122563511022454,0.0,9.474389094274162e-08,0.11441035117774545,0.0
289,1.1,9,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Are the patient care experiences at family practice residency teaching sites reflective of community practice? The residency training locations at Northeastern Ohio Universities College of Medicine provide care akin to that found in a national survey of family and general practitioners.,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
289,1.1,10,human,Question: Does family practice at residency teaching sites reflect community practice? Answer: The residency training sites of the Northeastern Ohio Universities College of Medicine provide patient care opportunities similar to those found in a national survey of family and general practitioners.,Does residency training in family practice at teaching sites parallel community practice? The residency sites of Northeastern Ohio Universities College of Medicine present patient care opportunities comparable to those in a national survey involving family and general practitioners.,7.10579182070559e-08,0.07796154146971057,0.0,0.005440279394345618,0.08004270767353416,0.0,0.0054324046228586,0.08223809823697303,0.0,7.105791820705622e-08,0.08455738802806367,0.0
290,1.1,1,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,Does measuring end-tidal carbon dioxide correlate with arterial carbon dioxide levels in extremely low birth weight infants during their first week? There is a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 levels are between 30-50 mmHg. Monitoring end-tidal CO2 can be useful for trend observation.,0.0,0.053319013889226774,0.03798888888888887,0.0,0.027182242374899523,0.019599999999999996,0.0,0.0,0.0,0.0,0.0,0.0
290,1.1,2,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there a correlation between end-tidal carbon dioxide measurements and arterial carbon dioxide in extremely low birth weight babies within their initial week? Data shows good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 is in the 30-50 mmHg range, making end-tidal CO2 monitoring valuable for trending.",0.0,0.0,0.0,0.0,0.027182242374899523,0.019599999999999996,0.0,0.0,0.0,0.0,0.0,0.0
290,1.1,3,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Does the measurement of end-tidal carbon dioxide align with arterial carbon dioxide in extremely low birth weight infants during the first week of life? There exists a good correlation and agreement between end-tidal and arterial CO2 for ELBW infants with EtCO2 levels ranging from 30 to 50 mmHg; thus, monitoring EtCO2 can aid in tracking trends.",7.105791820705622e-08,0.13752214240913485,0.05821330589849108,0.005440279394345618,0.08434065621484965,0.019599999999999996,0.0054324046228586,0.05826890812397556,0.0,7.105791820705622e-08,0.05942342047080107,0.0
290,1.1,4,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there an association between end-tidal CO2 levels and arterial CO2 in extremely low birth weight infants during their first week? Research indicates a strong correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants when EtCO2 is centered between 30 and 50 mmHg, suggesting end-tidal CO2 monitoring assists in trend evaluation.",2.3685972735685406e-08,0.041125368014701014,0.0775269101151853,0.0018134264647818726,0.03337819260183794,0.037876051645147873,0.0018108015409528666,0.007379615078719759,0.019599999999999992,2.3685972735685406e-08,0.02020270731751861,0.0
290,1.1,5,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Do end-tidal carbon dioxide measurements correlate with arterial CO2 in extremely low birth weight infants during their first week post-birth? There's good correlation and agreement between end-tidal CO2 and arterial CO2 for ELBW infants in the EtCO2 range of 30 to 50 mmHg, making EtCO2 monitoring beneficial for trend tracking.",7.105791820705622e-08,0.018922885652144394,0.05598958333333333,0.005440279394345618,0.03344237944153461,0.019599999999999996,0.0054324046228586,0.06187540371808753,0.0,7.105791820705622e-08,0.06317890162153228,0.0
290,1.1,6,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there a link between end-tidal CO2 and arterial carbon dioxide in extremely low birth weight infants in their first week of life? Good correlation and agreement are evident between end-tidal and arterial CO2 in ELBW infants when EtCO2 values are between 30 and 50 mmHg, so monitoring end-tidal CO2 helps in tracking.",0.0,0.026659506944613387,0.018912837243741015,0.0,0.027182242374899523,0.019599999999999996,0.0,0.0,0.0,0.0,0.0,0.0
290,1.1,7,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Does end-tidal CO2 monitoring align well with arterial CO2 measurements in extremely low birth weight infants within the first week? There is solid correlation and agreement between end-tidal and arterial CO2 in ELBW infants for EtCO2 levels of 30–50 mmHg; thus, end-tidal CO2 monitoring supports trend observation.",1.4211583641411244e-07,0.10637479612604661,0.011488942972177132,0.010880558788691236,0.12878744193732583,0.0026107438016528955,0.0108648092457172,0.1278333715098836,0.0,1.4211583641411244e-07,0.13062018241706452,0.0
290,1.1,8,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Are end-tidal carbon dioxide measurements consistent with arterial carbon dioxide levels in extremely low birth weight infants during their initial week of life? A strong correlation and agreement exist between end-tidal and arterial CO2 in ELBW infants in the EtCO2 range from 30 to 50 mmHg, allowing for effective trending with end-tidal CO2 monitoring.",2.3685972735685406e-08,0.09952972536952576,0.05752794214332675,0.0018134264647818726,0.04660032823200222,0.019599999999999996,0.0018108015409528666,0.019802627296179764,0.0,2.3685972735685406e-08,0.02020270731751861,0.0
290,1.1,9,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Does the measurement of end-tidal carbon dioxide correspond with arterial CO2 in extremely low birth weight infants after birth during the first week? There is a notable correlation and agreement between end-tidal and arterial CO2 in ELBW infants for EtCO2 values spanning 30-50 mmHg, and EtCO2 monitoring can be useful for trend assessment.",0.0,0.053319013889226774,0.03798888888888887,0.0,0.0,3.469446951953614e-18,0.0,0.0,0.0,0.0,0.0,0.0
290,1.1,10,human,Question: Dose end-tidal carbon dioxide measurement correlate with arterial carbon dioxide in extremely low birth weight infants in the first week of life? Answer: There is good correlation and agreement between end-tidal CO(2) and arterial CO(2) in ELBW infants in the EtCO(2) range 30-50 mmHg. End-tidal CO(2) monitoring can be helpful in trending,"Is there a reliable correlation between end-tidal and arterial carbon dioxide levels in extremely low birth weight infants during their first week of life? Evidence shows good correlation and agreement between end-tidal CO2 and arterial CO2 in ELBW infants for EtCO2 ranges of 30 to 50 mmHg, making end-tidal CO2 monitoring advantageous for monitoring trends.",4.737194547137081e-08,0.06736200236575085,0.02102556708958092,0.0036268529295637453,0.06564852320269532,0.019599999999999996,0.003621603081905733,0.03922071315328246,0.0,4.737194547137081e-08,0.04000533461369837,0.0
291,1.1,1,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle assessment a more effective predictor of IVF outcome compared to age and FSH? It provides useful data in predicting IVF success. While age and FSH are key factors, antral follicle count gives further understanding of ovarian reserve and response to treatment, possibly making it a superior predictor.",3.079176455639103e-07,0.1493005252376749,0.09063513363697676,0.023574544042164344,0.2169467161978802,0.016388888888888897,0.023540420032387266,0.24419696051204154,0.0,3.079176455639103e-07,0.2488960474166242,0.0
291,1.1,2,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","In predicting IVF outcomes, can assessing antral follicle count outperform age and FSH levels? Antral follicle evaluation offers critical insights beyond age and FSH, as it reflects ovarian reserve and treatment response, potentially serving as a better predictor.",5.921493183921348e-07,0.4485542977238661,0.07750000000000001,0.045335661619546816,0.504628788649661,0.016388888888888897,0.045270038523821665,0.538996500732686,0.0,5.921493183921352e-07,0.5511769192895568,0.0
291,1.1,3,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Does antral follicle assessment exceed age and FSH in forecasting IVF results? This measure yields valuable information about ovarian reserve and how a woman might respond to IVF, suggesting it could be a more reliable predictor than age and FSH alone.",5.210914001850789e-07,0.3649726439793439,0.08151605517553284,0.0398953822252012,0.46013209023561075,0.009234379809172057,0.039837633900963065,0.456758402495713,0.0,5.210914001850789e-07,0.46661953126149314,0.0
291,1.1,4,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle count a stronger predictor of IVF success than age and FSH? While both age and FSH are significant, antral follicle assessment provides additional perspective on ovarian reserve and treatment potential, which may enhance its predictive power.",5.684633456564495e-07,0.41991408142247266,0.07890841521793904,0.04352223515476494,0.47722981446154566,0.016388888888888897,0.0434592369828688,0.5108256237659892,0.0,5.684633456564497e-07,0.5221893824163053,0.0
291,1.1,5,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","How does antral follicle assessment compare to age and FSH in predicting IVF outcomes? It offers valuable supplementary data regarding ovarian reserve and possible response to therapy, indicating it might be a better tool for prediction.",6.395212638635054e-07,0.42918931854787257,0.13137755102040818,0.04896251454911057,0.5617872024896093,0.016388888888888897,0.04889164160572741,0.5978370007556193,0.0,6.39521263863506e-07,0.6118015411059923,0.0
291,1.1,6,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Can antral follicle counting better predict IVF outcomes than age and FSH levels? This assessment adds crucial insights into ovarian reserve and responsiveness to treatment, potentially outperforming the predictive value of age and FSH.",6.86893209334876e-07,0.5300387386047416,0.10110411352040818,0.05258936747867433,0.6224118243060448,0.016388888888888897,0.05251324468763316,0.6603573577369528,0.0,6.868932093348768e-07,0.6763400622435638,0.0
291,1.1,7,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is using antral follicle assessment as a predictor in IVF more effective than relying on age and FSH? It contributes beneficial details about ovarian function and treatment response, possibly providing better predictive accuracy.",7.105791820705613e-07,0.5188014772375595,0.13137755102040818,0.05440279394345621,0.6541605226206246,0.016388888888888897,0.05432404622858603,0.6931471805599445,0.0,7.105791820705622e-07,0.7102416139192456,0.0
291,1.1,8,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Does counting antral follicles provide a superior prediction for IVF outcomes compared to age and FSH? This evaluation informs more about ovarian reserve and anticipated treatment response, making it a potentially better predictor.",7.105791820705613e-07,0.5188014772375595,0.13137755102040818,0.05440279394345621,0.6541605226206246,0.016388888888888897,0.05432404622858603,0.6931471805599445,0.0,7.105791820705622e-07,0.7102416139192456,0.0
291,1.1,9,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","Is antral follicle assessment a preferable predictor for IVF results over age and FSH measurements? It offers extra valuable insight into ovarian reserve and how patients might respond to IVF treatments, suggesting enhanced predictive capability.",6.632072365991907e-07,0.4581768554211241,0.13137755102040818,0.05077594101389245,0.5916401656392911,0.016388888888888897,0.050702443146680286,0.628608659422373,0.0,6.632072365991914e-07,0.6435502394205721,0.0
291,1.1,10,ai,"Question: Antral follicle assessment as a tool for predicting outcome in IVF--is it a better predictor than age and FSH? Answer: Antral follicle assessment can provide valuable information for predicting IVF outcome. Although age and FSH levels are important factors, antral follicle count can offer additional insight into a woman's ovarian reserve and potential response to treatment, making it a potentially better predictor.","In terms of predicting IVF success, is antral follicle count superior to age and FSH? It supplies important additional information regarding ovarian reserve and treatment responsiveness, which may make it a better predictor.",7.105791820705613e-07,0.5188014772375595,0.13137755102040818,0.05440279394345621,0.6541605226206246,0.016388888888888897,0.05432404622858603,0.6931471805599445,0.0,7.105791820705622e-07,0.7102416139192456,0.0
292,1.1,1,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Can primary angioplasty be considered a viable alternative to thrombolysis? Answer: Restructuring services to provide primary angioplasty was well received by patients and their families. Satisfaction remained high across care types, except for issues related to discharge and aftercare.",9.474389094274152e-08,0.06870567132945338,0.020777683116335252,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
292,1.1,2,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Is primary angioplasty a reasonable substitute for thrombolysis? Answer: Patients and caregivers accepted the reorganization of care to offer primary angioplasty. High satisfaction was reported regardless of treatment type, aside from concerns about discharge and aftercare.",1.6580180914979742e-07,0.11320236974350362,0.046400951814396206,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
292,1.1,3,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Might primary angioplasty serve as an acceptable option instead of thrombolysis? Answer: Care reorganization to include primary angioplasty was embraced by patients and their carers. Satisfaction was generally high across different care forms, except concerning discharge and follow-up care.",9.474389094274152e-08,0.06870567132945338,0.020777683116335252,0.0072537058591274906,0.10008345855698142,0.0,0.007243206163811466,0.10265415406008227,0.0,9.474389094274162e-08,0.10536051565782589,0.0
292,1.1,4,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Is using primary angioplasty an acceptable alternative to thrombolysis? Answer: Introducing primary angioplasty through care reorganization was acceptable to patients and their caregivers, with satisfaction levels high for all care types except discharge and aftercare.",1.8948778188548272e-07,0.1809816570279117,0.017854239011628047,0.014507411718254988,0.21130909366720596,0.0,0.014486412327622947,0.21706450523782772,0.0,1.8948778188548325e-07,0.2231435513142097,0.0
292,1.1,5,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Can primary angioplasty replace thrombolysis as an acceptable treatment? Answer: The shift to offer primary angioplasty was welcomed by patients and carers, and satisfaction levels were high regardless of treatment, except for issues in discharge and aftercare.",1.4211583641411212e-07,0.12327081072079071,0.01939477897489004,0.010880558788691236,0.1541506798272576,0.0,0.0108648092457172,0.15822400521489444,0.0,1.4211583641411244e-07,0.16251892949777424,0.0
292,1.1,6,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Is primary angioplasty an acceptable alternative treatment compared to thrombolysis? Answer: Patients and carers found the care reorganization to enable primary angioplasty acceptable; satisfaction was high regardless of care type, except for discharge and post-care services.",1.6580180914979742e-07,0.15171054644127846,0.018645849773579876,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
292,1.1,7,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Could primary angioplasty be an acceptable alternative to thrombolysis? Answer: The offering of primary angioplasty due to care reorganization was accepted by patients and their caregivers. Satisfaction levels were consistently high across care types, except in discharge and aftercare quality.",7.105791820705622e-08,0.042499213113674106,0.021417388369294285,0.005440279394345618,0.07410797215372344,0.0,0.0054324046228586,0.0759859069779214,0.0,7.105791820705622e-08,0.07796154146971057,0.0
292,1.1,8,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Is primary angioplasty a suitable alternative to thrombolysis? Answer: Care restructuring to provide primary angioplasty was satisfactory to patients and carers, who maintained high satisfaction levels regardless of treatment type, except for discharge and aftercare aspects.",1.6580180914979742e-07,0.15171054644127846,0.018645849773579876,0.012693985253473108,0.18232155679395445,0.0,0.012675610786670073,0.18721154208814594,0.0,1.6580180914979784e-07,0.19237189264745602,0.0
292,1.1,9,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Is primary angioplasty an approved alternative to thrombolysis? Answer: Patients and their carers accepted the care changes to enable primary angioplasty, showing high satisfaction overall independent of care type, except for discharge and aftercare.",2.1317375462116802e-07,0.17036078358345197,0.046400951814396206,0.016320838183036868,0.24116205681688774,0.0,0.01629721386857582,0.2478361639045814,0.0,2.1317375462116866e-07,0.25489224962878954,0.0
292,1.1,10,human,"Question: Is primary angioplasty an acceptable alternative to thrombolysis? Answer: Reorganization of care to offer a primary angioplasty service was acceptable to patients and their carers. Satisfaction levels were high regardless of the type of care received, with the exception of discharge and aftercare.","Question: Is primary angioplasty considered an acceptable alternative to thrombolysis? Answer: Care reorganization to implement primary angioplasty was acceptable to patients and carers, resulting in high satisfaction irrespective of care received, with the only exception being discharge and aftercare.",1.1842986367842682e-07,0.09561657902901377,0.020104384977288833,0.009067132323909363,0.1267517056391423,0.0,0.009054007704764333,0.1300531282481976,0.0,1.1842986367842703e-07,0.13353139262452274,0.0
293,1.1,1,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are reduced fasting plasma glucose levels at the time of diagnosing type 2 diabetes linked to better health outcomes? Lower fasting glucose at diagnosis suggests improved glycemic control and a decreased risk of complications, promoting better long-term health in type 2 diabetes patients.",5.210914001850789e-07,0.1676240862848699,0.23409999999999995,0.0398953822252012,0.24332799328823196,0.1287043876824493,0.039837633900963065,0.25937823917374914,0.1262002743484225,5.210914001850789e-07,0.2882292585708912,0.11282578875171474
293,1.1,2,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Do lower fasting plasma glucose values upon diagnosis of type 2 diabetes correspond with enhanced patient outcomes? Yes, as they indicate superior glycemic regulation and a lower chance of complications, resulting in improved long-term health prospects for individuals with type 2 diabetes.",5.447773729207643e-07,0.15951967825603575,0.257225,0.04170880868998307,0.2342085482903138,0.1530793876824493,0.04164843544191593,0.28469604715804087,0.1262002743484225,5.447773729207643e-07,0.3142047449741492,0.11282578875171474
293,1.1,3,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is there an association between lower fasting plasma glucose at diagnosis and improved outcomes in type 2 diabetes? Lower glucose levels at diagnosis reflect better blood sugar control and reduced complication risks, leading to favorable long-term outcomes for type 2 diabetes patients.",5.447773729207643e-07,0.19333173584432561,0.23294779750164363,0.04170880868998307,0.2342085482903138,0.1530793876824493,0.04164843544191593,0.28469604715804087,0.1262002743484225,5.447773729207643e-07,0.3142047449741492,0.11282578875171474
293,1.1,4,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Can lower fasting plasma glucose levels at the diagnosis of type 2 diabetes predict better clinical outcomes? Indeed, these lower levels signify enhanced glycemic control and a diminished risk of complications, improving long-term health results for patients.",6.63207236599191e-07,0.25576074891594347,0.28159999999999996,0.050775941013892434,0.3677399409148365,0.1530793876824493,0.05070244314668027,0.4218971686715234,0.1262002743484225,6.632072365991914e-07,0.4552833432340555,0.11282578875171474
293,1.1,5,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are improved outcomes linked to lower fasting plasma glucose at the time type 2 diabetes is diagnosed? Yes, because lower glucose at diagnosis signals better management of blood sugar and fewer complications, contributing to better long-term health.",6.63207236599191e-07,0.2942689256137183,0.25384489795918364,0.050775941013892434,0.3677399409148365,0.1530793876824493,0.05070244314668027,0.4218971686715234,0.1262002743484225,6.632072365991914e-07,0.4552833432340555,0.11282578875171474
293,1.1,6,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is there a correlation between low fasting plasma glucose at type 2 diabetes diagnosis and improved patient outcomes? Lower fasting glucose indicates effective glycemic control and a reduced likelihood of complications, which supports better long-term outcomes.",6.868932093348762e-07,0.2839316258826403,0.28159999999999996,0.05258936747867431,0.39672747778808803,0.1530793876824493,0.052513244687633145,0.45175013182120516,0.1262002743484225,6.868932093348768e-07,0.4860550019008092,0.11282578875171474
293,1.1,7,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Does having lower fasting plasma glucose at diagnosis of type 2 diabetes result in better health outcomes? Lower levels suggest enhanced glycemic regulation and decreased complication risks, which help patients achieve improved long-term prognosis.",7.342651548062468e-07,0.3427721259055736,0.28159999999999996,0.05621622040823807,0.4573520996045235,0.1530793876824493,0.05613484776953889,0.5142704888025387,0.1262002743484225,7.342651548062476e-07,0.5505935230383807,0.11282578875171474
293,1.1,8,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are better outcomes observed in patients with lower fasting plasma glucose levels when diagnosed with type 2 diabetes? Such lowering denotes superior blood sugar control and a reduced risk of complications, facilitating improved long-term health.",7.105791820705615e-07,0.3129191627558918,0.28159999999999996,0.05440279394345619,0.4265804409377698,0.1530793876824493,0.05432404622858602,0.48252179048795885,0.1262002743484225,7.105791820705622e-07,0.517803700215389,0.11282578875171474
293,1.1,9,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Is lower fasting plasma glucose at the diagnosis of type 2 diabetes associated with better prognosis? Yes, it indicates improved glycemic control and a lowered risk of complications that lead to favorable long-term health.",7.342651548062468e-07,0.3427721259055736,0.28159999999999996,0.05621622040823807,0.4573520996045235,0.1530793876824493,0.05613484776953889,0.5142704888025387,0.1262002743484225,7.342651548062476e-07,0.5505935230383807,0.11282578875171474
293,1.1,10,ai,"Question: Are lower fasting plasma glucose levels at diagnosis of type 2 diabetes associated with improved outcomes? Answer: Lower fasting plasma glucose levels at diagnosis of type 2 diabetes are associated with improved outcomes, as they indicate better glycemic control and reduced risk of complications. Maintaining lower glucose levels through appropriate management strategies can lead to better long-term health outcomes for patients with type 2","Are reduced fasting plasma glucose concentrations at type 2 diabetes diagnosis linked to improved clinical results? Lower glucose levels reflect better blood sugar management and minimized complication risks, enhancing long-term health outcomes for patients.",7.342651548062468e-07,0.3427721259055736,0.28159999999999996,0.05621622040823807,0.4573520996045235,0.1530793876824493,0.05613484776953889,0.5142704888025387,0.1262002743484225,7.342651548062476e-07,0.5505935230383807,0.11282578875171474
294,1.1,1,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does head positioning affect anterior chamber depth in pseudoexfoliation syndrome? In patients with visible unilateral pseudoexfoliation, the lens in the affected eye appears more mobile, leading to a shallower anterior chamber when the head is prone.",2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
294,1.1,2,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Is the anterior chamber depth influenced by head positioning in pseudoexfoliation syndrome? Patients with clinical unilateral pseudoexfoliation show increased lens mobility in the affected eye, causing the anterior chamber to be shallower in the prone head position.",2.1317375462116823e-07,0.2770549986910944,0.03829633172275386,0.016320838183036854,0.2684499827465596,0.02854671280276816,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
294,1.1,3,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does the position of the head impact anterior chamber depth in cases of pseudoexfoliation syndrome? In unilateral pseudoexfoliation patients, the lens of the affected eye tends to move more, making the anterior chamber shallower when lying prone.",2.1317375462116823e-07,0.23854682199331956,0.011015025422888292,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
294,1.1,4,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","How does head positioning influence the anterior chamber depth in pseudoexfoliation syndrome? The lens in the affected eye of patients with unilateral pseudoexfoliation is more mobile, which results in a decreased chamber depth when the head is prone.",1.8948778188548293e-07,0.17159890957505697,0.017342123536913518,0.014507411718254981,0.20067069546215155,0.0,0.014486412327622933,0.20585205420414887,0.0,1.8948778188548325e-07,0.21130909366720596,0.0
294,1.1,5,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","In pseudoexfoliation syndrome, does head posture change anterior chamber depth? Clinically obvious unilateral pseudoexfoliation patients have a more mobile lens in the affected eye, causing the anterior chamber to be shallower when head is positioned prone.",2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
294,1.1,6,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Is the depth of the anterior chamber affected by head positioning in pseudoexfoliation syndrome? For those with unilateral pseudoexfoliation, the lens in the afflicted eye moves more, leading to a shallower anterior chamber during prone positioning.",2.3685972735685353e-07,0.22930975588217795,0.015801583573651523,0.018134264647818733,0.2578291093020999,0.0,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
294,1.1,7,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does the orientation of the head alter anterior chamber depth in cases of pseudoexfoliation syndrome? The lens in the affected eye of clinically unilateral pseudoexfoliation patients is more mobile, resulting in a shallow anterior chamber when the head faces down.",1.4211583641411233e-07,0.152579779443204,0.006783916917955768,0.010880558788691236,0.14660347419187536,0.0,0.0108648092457172,0.1502822030493367,0.0,1.4211583641411244e-07,0.1541506798272576,0.0
294,1.1,8,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Can head positioning modify anterior chamber depth in pseudoexfoliation syndrome? Patients exhibiting unilateral pseudoexfoliation show increased lens mobility in the affected eye, making the anterior chamber shallower with a prone head.",3.5528959103528003e-07,0.39006183742905476,0.011054598397822767,0.02720139697172813,0.41689380393178865,0.0,0.027162023114293048,0.42899560551835814,0.0,3.552895910352811e-07,0.4418327522790384,0.0
294,1.1,9,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","Does head angle affect the anterior chamber depth in pseudoexfoliation syndrome? The lens appears more mobile in the affected eye of unilateral pseudoexfoliation patients, causing the anterior chamber to become shallower when the head is prone.",2.3685972735685353e-07,0.26891816619988873,0.012584669647455422,0.018134264647818733,0.29860247286444963,0.029384756657483937,0.01810801540952868,0.26469255422708216,0.0,2.3685972735685406e-07,0.2719337154836414,0.0
294,1.1,10,human,"Question: Does head positioning influence anterior chamber depth in pseudoexfoliation syndrome? Answer: In patients with clinically apparent unilateral pseudoexfoliation, the lens seems to be more mobile in the affected eye. This results in a shallower anterior chamber when the head is placed in a prone position.","In cases of pseudoexfoliation syndrome, does head position influence anterior chamber depth? The lens in the affected eye of patients with unilateral pseudoexfoliation moves more, leading to a shallow anterior chamber when the head is positioned prone.",2.1317375462116823e-07,0.20003864529554471,0.016593194335603353,0.016320838183036854,0.2288415724288484,0.0,0.016297213868575806,0.23483959107740038,0.0,2.1317375462116866e-07,0.24116205681688774,0.0
295,1.1,1,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does automatic transmission enhance the driving performance of elderly drivers? Answer: Limited studies have examined the specific effects of automatic transmission on the driving habits of older individuals. Nonetheless, the common belief is that automatic transmission",2.36859727356853e-08,0.11110367476650351,0.06230486685032138,0.0018134264647818796,0.11053426399795141,0.05859375,0.0018108015409528735,0.07186188318361753,0.0302734375,2.3685972735685406e-08,0.030771658666753687,0.0
295,1.1,2,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Can automatic transmission positively affect driving behavior in seniors? Answer: Research on how automatic transmission influences driving behavior among older drivers is scarce. However, it is widely thought that automatic transmission",9.47438909427412e-08,0.05940534964856514,0.038463718820861664,0.007253705859127518,0.04361641582930709,0.05859375,0.007243206163811494,0.08720281144607123,0.0302734375,9.474389094274162e-08,0.1335313926245223,0.0
295,1.1,3,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does having an automatic transmission improve how older drivers operate a vehicle? Answer: There is a lack of extensive research on the precise impact of automatic transmissions on elderly drivers' behavior. Yet, it is generally accepted that automatic transmission",9.47438909427412e-08,0.2856595739340042,0.1799322868574946,0.0072537058591274975,0.19277236223492444,0.05859375,0.00724320616381148,0.1564192712116812,0.0302734375,9.474389094274162e-08,0.11778303565638382,0.0
295,1.1,4,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Is driving behavior better in older drivers who use automatic transmission? Answer: Few studies address the effects of automatic transmission on the driving behavior of seniors. However, it is generally considered that automatic transmission",2.36859727356853e-08,0.10245773455530571,0.14696180555555555,0.0018134264647818796,0.051693763975018125,0.05859375,0.0018108015409528735,0.011237261367182061,0.0302734375,2.3685972735685406e-08,0.031748698314579826,0.0
295,1.1,5,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does the use of automatic transmission benefit the driving habits of older people? Answer: While specific research is limited on the influence of automatic transmission on older drivers’ behavior, it is commonly believed that automatic transmission",2.36859727356853e-08,0.11110367476650351,0.06230486685032138,0.0018134264647818796,0.07092585368024018,0.03004703719723184,0.0018108015409528735,0.07186188318361753,0.0302734375,2.3685972735685406e-08,0.030771658666753687,0.0
295,1.1,6,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does automatic transmission improve the way older drivers behave on the road? Answer: Research focusing on the impact of automatic transmission on senior drivers' behavior is limited. Still, it is generally believed that automatic transmission",0.0,0.07921682063542246,0.05809461805555555,0.0,0.0815467271246999,0.05859375,0.0,0.04200892003393575,0.0302734375,0.0,0.0,0.0
295,1.1,7,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Is driving behavior in elderly drivers improved by automatic transmission? Answer: There is little research dedicated to the effects of automatic transmission on driving behavior in older adults. Nonetheless, it is commonly viewed that automatic transmission",2.36859727356853e-08,0.12563834542662944,0.122910927456382,0.0018134264647818796,0.07092585368024018,0.03004703719723184,0.0018108015409528735,0.07186188318361753,0.0302734375,2.3685972735685406e-08,0.030771658666753687,0.0
295,1.1,8,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does automatic transmission contribute to better driving conduct in older drivers? Answer: Specific studies about the influence of automatic transmission on the driving styles of elderly drivers are limited. However, the general consensus is that automatic transmission",4.73719454713706e-08,0.17948517765389704,0.09453514739229023,0.003626852929563752,0.13870514096464825,0.05859375,0.003621603081905747,0.10084942005686903,0.0302734375,4.737194547137081e-08,0.060624621816435464,0.0
295,1.1,9,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Can automatic transmission lead to improved driving behavior among older drivers? Answer: The research available on this topic is limited, but it is generally thought that automatic transmission",1.658018091497971e-07,0.05966206565809129,0.16989026063100138,0.012693985253473157,0.14897693148713254,0.05859375,0.012675610786670115,0.1964021034110619,0.0302734375,1.6580180914979784e-07,0.24686007793152642,0.0
295,1.1,10,ai,"Question: Does automatic transmission improve driving behavior in older drivers? Answer: There is limited research on the specific impact of automatic transmission on driving behavior in older drivers. However, it is generally believed that automatic transmission","Question: Does the presence of automatic transmission affect driving behavior positively in older drivers? Answer: Although research is scarce on this issue, it is commonly believed that automatic transmission",1.658018091497971e-07,0.05966206565809129,0.16989026063100138,0.012693985253473157,0.14897693148713254,0.05859375,0.012675610786670115,0.1964021034110619,0.0302734375,1.6580180914979784e-07,0.24686007793152642,0.0
296,1.1,1,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does the use of provider service networks lead to reduced spending compared to HMOs or primary care case management in Florida's Medicaid program? The Medicaid Demonstration in Florida seems to have resulted in lower PMPM costs. Demonstration PSNs achieved marginally higher expenditure reductions than Demonstration HMOs. PSNs seem to be an effective model for providing care to Medicaid recipients.,0.0,0.07170488074758108,0.05157024793388431,0.0,0.024320953703857562,0.017538265306122455,0.0,0.0,0.0,0.0,0.0,0.0
296,1.1,2,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are provider service networks associated with lower expenses than HMOs or primary care case management in Florida’s Medicaid program? Evidence from Florida's Medicaid Demonstration indicates it leads to decreased PMPM expenditures. Demonstration PSNs produced slightly larger expenditure reductions than those seen in Demonstration HMOs. PSNs show promise as a care delivery model for Medicaid enrollees.,9.474389094274162e-08,0.0002459167654373928,0.05157024793388431,0.0072537058591274906,0.04843840057857163,0.017538265306122455,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
296,1.1,3,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"In Florida's Medicaid program, do provider service networks reduce costs more than HMOs or primary care case management? The Medicaid Demonstration in Florida appears to lower PMPM expenses. PSNs in the Demonstration program generated somewhat greater cost savings than Demonstration HMOs. PSNs appear to be a promising way to deliver care to Medicaid beneficiaries.",1.1842986367842703e-07,0.01844621624671694,0.05157024793388431,0.009067132323909363,0.06748659554926473,0.017538265306122455,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
296,1.1,4,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Is expenditure lower with provider service networks compared to HMOs or primary care case management in Florida Medicaid? The Medicaid Demonstration in Florida shows a trend toward reduced PMPM spending. Demonstration PSNs resulted in marginally larger expenditure decreases than Demonstration HMOs. PSNs seem to offer an encouraging model for Medicaid care delivery.,1.6580180914979784e-07,0.08409473944941226,0.03197024793388432,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,1.1,5,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks cut costs more effectively than HMOs or primary care case management within Florida's Medicaid program? Florida's Medicaid Demonstration suggests lower per member per month expenditures. Demonstration PSNs provided slightly more reductions in spending compared to Demonstration HMOs. PSNs seem to be a viable option for delivering Medicaid care.,1.6580180914979784e-07,0.08409473944941226,0.03197024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,1.1,6,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"Within Florida’s Medicaid program, do provider service networks lead to lower expenses compared to HMOs or primary care case management? The Medicaid Demonstration suggests it reduces PMPM expenditures. Demonstration PSNs achieved somewhat greater decreases in costs than the Demonstration HMOs. PSNs look promising as a care model for Medicaid enrollees.",2.1317375462116866e-07,0.09691783168821111,0.05157024793388431,0.016320838183036854,0.14752930322280156,0.017538265306122455,0.0162972138685758,0.17520408902509166,0.0,2.1317375462116866e-07,0.17869178874337655,0.0
296,1.1,7,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Are expenditures lower under provider service networks compared to HMOs or primary care case management in Florida’s Medicaid program? The Medicaid Demonstration in Florida appears to reduce PMPM expenditures. Demonstration PSNs yielded slightly greater cuts in expenditures relative to Demonstration HMOs. PSNs seem to provide a promising framework to deliver Medicaid care.,1.6580180914979784e-07,0.056912497074512736,0.05157024793388431,0.012693985253473108,0.10670730870254719,0.017538265306122455,0.012675610786670066,0.13353139262452274,0.0,1.6580180914979784e-07,0.13613217432458002,0.0
296,1.1,8,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Does Florida’s Medicaid program experience reduced spending with provider service networks versus HMOs or primary care case management? The Medicaid Demonstration in Florida is associated with lower per member per month costs. Demonstration PSNs recorded a slight edge in expenditure reduction over Demonstration HMOs. PSNs are a promising method for delivering care to Medicaid members.,9.474389094274162e-08,0.0002459167654373928,0.05157024793388431,0.0072537058591274906,0.04843840057857163,0.017538265306122455,0.007243206163811466,0.07410797215372167,0.0,9.474389094274162e-08,0.07550755250814589,0.0
296,1.1,9,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,"In Florida Medicaid, do provider service networks offer cost savings compared to HMOs or primary care case management? The Medicaid Demonstration appears to lower PMPM expenses. Demonstration PSNs achieved marginally greater reductions in spending than Demonstration HMOs. PSNs are a promising care delivery model for Medicaid recipients.",2.8423167282822487e-07,0.1600967333097434,0.05157024793388431,0.02176111757738247,0.21206782436037308,0.017538265306122455,0.0217296184914344,0.24116205681688774,0.0,2.8423167282822487e-07,0.2461330695389088,0.0
296,1.1,10,human,Question: Do provider service networks result in lower expenditures compared with HMOs or primary care case management in Florida's Medicaid program? Answer: The Medicaid Demonstration in Florida appears to result in lower PMPM expenditures. Demonstration PSNs generated slightly greater reductions in expenditures compared to Demonstration HMOs. PSNs appear to be a promising model for delivering care to Medicaid enrollees.,Do provider service networks result in lower monthly expenditures on a per member basis than HMOs or primary care case management in Florida’s Medicaid program? Florida’s Medicaid Demonstration indicates a decrease in PMPM costs. Demonstration PSNs produced slightly larger expenditure drops than Demonstration HMOs. PSNs seem effective as a care model for Medicaid enrollees.,1.1842986367842703e-07,0.04460271362633783,0.032709301188322173,0.009067132323909363,0.06748659554926473,0.017538265306122455,0.009054007704764333,0.09352605801082436,0.0,1.1842986367842703e-07,0.09531017980432566,0.0
297,1.1,1,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers release GABA? Answer: We have presented strong evidence indicating the presence of a GABAergic signal from mossy fibers. The physiological function of this mossy fiber-derived GABAergic signal remains unclear, though it could play a role in development. Additional findings support this notion.",7.105791820705622e-08,0.10420034732491601,0.025289256198347116,0.005440279394345618,0.10442962480224383,0.024375,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,1.1,2,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are GABA neurotransmitters released by mossy fibers? Answer: Our data convincingly demonstrate that mossy fibers emit a GABAergic signal. The exact physiological purpose of this mossy fiber GABA signal is not well understood but may be important during development. Further evidence also points to this.,7.105791820705622e-08,0.1350068886831357,0.04750000000000001,0.005440279394345618,0.10442962480224383,0.024375,0.0054324046228586,0.07232066157962613,0.0,7.105791820705622e-08,0.07410797215372344,0.0
297,1.1,3,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Is there GABA release from mossy fibers? Answer: We have provided strong proof for the existence of a GABAergic signal originating from mossy fibers. The functional role in physiology of this mossy fiber GABA transmission is uncertain, potentially relevant in developmental stages. Other data support these observations.",1.1842986367842703e-07,0.1489963759181956,0.026233459357277906,0.009067132323909363,0.14888138737307655,0.024375,0.009054007704764333,0.11778303565638337,0.0,1.1842986367842703e-07,0.12062798778861739,0.0
297,1.1,4,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers secrete GABA? Answer: Compelling evidence has been offered showing a GABAergic signal from mossy fibers. While the physiological significance of this mossy fiber GABA release is unknown, it may hold developmental relevance. Additional supporting proof exists.",7.105791820705611e-08,0.008093954957539395,0.04750000000000001,0.005440279394345618,0.042173849389631535,0.024375,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
297,1.1,5,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Are mossy fibers a source of GABA release? Answer: We have demonstrated with convincing evidence that mossy fibers produce a GABAergic signal. The physiological role of this signal is unclear but could be crucial for development. Other studies also indicate this possibility.,0.0,0.03300700859809247,0.023704640095181452,0.0,0.03381205758828987,0.024375,0.0,0.0,0.0,0.0,0.0,0.0
297,1.1,6,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Is GABA released by the mossy fibers? Answer: Evidence strongly suggests the presence of a GABAergic signal from mossy fibers. The physiological function remains uncertain, although it might be developmentally important. Additional evidence corroborates this finding.",1.42115836414112e-07,0.08813666263107356,0.04750000000000001,0.010880558788691236,0.12441194762660457,0.024375,0.010864809245717207,0.16251892949777424,0.0,1.4211583641411244e-07,0.1670540846631643,0.0
297,1.1,7,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this","Question: Do mossy fibers contribute to GABA release? Answer: We have found compelling evidence of a mossy fiber GABAergic signal. Though the physiological role is not fully defined, it might have developmental significance. Other evidence also supports this idea.",9.474389094274141e-08,0.03406944136079737,0.04750000000000001,0.0072537058591274906,0.0688420964717924,0.024375,0.007243206163811466,0.10536051565782589,0.0,9.474389094274162e-08,0.10821358464023101,0.0
297,1.1,8,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Can mossy fibers release GABA? Answer: Strong evidence supports a mossy fiber GABAergic signal. The physiologic importance of this signal is not fully known but may be critical in developmental contexts. There is further evidence indicating this.,1.1842986367842671e-07,0.06073768844295824,0.04750000000000001,0.009067132323909363,0.09624107065990772,0.024375,0.009054007704764333,0.13353139262452274,0.0,1.1842986367842703e-07,0.13720112151348252,0.0
297,1.1,9,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Is there a GABAergic signal released by mossy fibers? Answer: Our findings provide persuasive evidence that mossy fibers emit a GABAergic signal. The physiological role is uncertain but possibly linked to development. Additional findings lend support to this claim.,7.105791820705611e-08,0.04363996421702332,0.021876731301939054,0.005440279394345618,0.042173849389631535,0.024375,0.0054324046228586,0.07796154146971057,0.0,7.105791820705622e-08,0.08004270767353416,0.0
297,1.1,10,human,"Question: Do mossy fibers release GABA? Answer: We have thus provided compelling evidence that there is a mossy fiber GABAergic signal. The physiologic role of this mossy fiber GABAergic signal is uncertain, but may be of developmental importance. Other evidence suggests that this",Question: Do mossy fibers emit GABA? Answer: We have given compelling evidence for a GABAergic signal stemming from mossy fibers. Its physiological function remains unclear but may be of developmental importance. Supporting evidence also exists.,1.8948778188548261e-07,0.1452950764710219,0.04750000000000001,0.014507411718254995,0.18325244764953785,0.024375,0.014486412327622954,0.2231435513142097,0.0,1.8948778188548325e-07,0.2295744416444978,0.0
298,1.1,1,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","What is the prognosis for low-tone sudden deafness—does it always develop into Meniere's disease? There is no certainty that low-tone sudden deafness will inevitably lead to Meniere's disease. Although it can happen in some cases, it is not an automatic progression. Each case has a distinct prognosis.",0.0,0.09041050181216681,0.06443940539178636,0.0,0.061613082716439393,0.04434829637641968,0.0,0.0,0.0,0.0,0.0,0.0
298,1.1,2,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness necessarily evolve into Meniere's disease? Low-tone sudden deafness does not necessarily progress to Meniere's disease. While it can occur occasionally, it is not guaranteed for all patients. Prognosis varies by individual.",2.8423167282822424e-07,0.2632802632480771,0.027574050453514756,0.021761117577382486,0.29055076562133575,0.014074858876419682,0.02172961849143442,0.31845373111853537,0.0,2.8423167282822487e-07,0.32721291120841567,0.0
298,1.1,3,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Is it inevitable for low-tone sudden deafness to become Meniere's disease? The progression from low-tone sudden deafness to Meniere's disease is not guaranteed. Some patients may experience this transition, but it is not an absolute outcome. Prognoses are patient-specific.",1.8948778188548304e-07,0.21643362323629978,0.01763842792018766,0.014507411718254981,0.20906632474046027,0.009529254643988495,0.014486412327622933,0.2391788721599264,0.02775510204081633,1.8948778188548325e-07,0.20585205420414887,0.0
298,1.1,4,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Will low-tone sudden deafness always develop into Meniere's disease? Low-tone sudden deafness does not always progress to Meniere's disease. Although it may occur in some individuals, it is not a universal progression. Each prognosis is unique.",2.6054570009253894e-07,0.23196281988554768,0.02923483442963965,0.019947691112600606,0.25946224600006795,0.014963539718935746,0.019918816950481547,0.2876820724517817,0.0,2.6054570009253947e-07,0.29546421289383584,0.0
298,1.1,5,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness lead inevitably to Meniere's disease? There is no guarantee that low-tone sudden deafness inevitably leads to Meniere's disease. Some cases might progress this way, but it is not a certainty. Each prognosis depends on the individual case.",1.4211583641411244e-07,0.12318668370959385,0.011660861081710522,0.010880558788691236,0.11703377018371963,0.01872502767835873,0.0108648092457172,0.14660347419187536,0.0,1.4211583641411244e-07,0.1502822030493367,0.0
298,1.1,6,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Can low-tone sudden deafness predictably advance to Meniere's disease? It is not guaranteed that low-tone sudden deafness will advance to Meniere's disease. Some patients might experience this, but many will not. Prognosis must be assessed case by case.",2.1317375462116834e-07,0.2470458087569245,0.020351942429864475,0.016320838183036854,0.23854682199331956,0.011015025422888292,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
298,1.1,7,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Is it certain that low-tone sudden deafness progresses to Meniere's disease? Low-tone sudden deafness does not certainly progress to Meniere's disease. While it can occur in a subset of patients, this is not a guaranteed outcome. Prognoses differ individually.",1.8948778188548304e-07,0.179952192680513,0.00780045351473925,0.014507411718254981,0.17159890957505697,0.017342123536913518,0.014486412327622933,0.20067069546215155,0.0,1.8948778188548325e-07,0.20585205420414887,0.0
298,1.1,8,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Does low-tone sudden deafness inevitably progress into Meniere's disease? The condition of low-tone sudden deafness does not inevitably move into Meniere's disease. There are cases where it does, but this is not universally true. Each patient's prognosis varies.",2.1317375462116834e-07,0.20957839359152208,0.005717973463895409,0.016320838183036854,0.20003864529554471,0.016593194335603353,0.0162972138685758,0.2288415724288484,0.0,2.1317375462116866e-07,0.23483959107740038,0.0
298,1.1,9,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Will low-tone sudden deafness always culminate in Meniere's disease? No, low-tone sudden deafness does not always culminate in Meniere's disease. Some people may experience progression but it is not a guaranteed outcome for everyone. Prognosis must be personalized.",2.1317375462116834e-07,0.2845132239223269,0.045668137046485244,0.016320838183036854,0.2770549986910944,0.03829633172275386,0.0162972138685758,0.2684499827465596,0.02854671280276816,2.1317375462116866e-07,0.23483959107740038,0.0
298,1.1,10,ai,"Question: Prognosis of low-tone sudden deafness - does it inevitably progress to Meniere's disease? Answer: There is no guarantee that low-tone sudden deafness will progress to Meniere's disease. While there may be some cases where this occurs, it is not a universal outcome. The prognosis for each","Is progression from low-tone sudden deafness to Meniere's disease inevitable? Progression from low-tone sudden deafness to Meniere's disease is not inevitable. Though it can happen, it doesn’t occur in every case. Prognostic outcomes differ among patients.",2.6054570009253894e-07,0.4300048714741034,0.10133219954648524,0.019947691112600606,0.46332906381181616,0.1240190505623559,0.019918816950481547,0.4977266726214622,0.1466836734693877,2.6054570009253947e-07,0.4687510080338231,0.12244897959183673
299,1.1,1,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Can mental imagery fMRI predict recovery in patients with consciousness disorders? The mental imagery fMRI paradigm shows strong alignment with patients' clinical progression in vegetative states. All 5 VS patients with significant ROI activation experienced favorable outcomes throughout the observation. Hence,",4.974054274493935e-07,0.4577880759407478,0.025458187885478434,0.038081955760419325,0.4432240193332744,0.008961389927592697,0.0380268323600102,0.43995128417933227,0.0,4.974054274493935e-07,0.4495250979021934,0.0
299,1.1,2,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Is it possible for mental imagery functional MRI to predict recovery in patients with disorders of consciousness? Mental imagery fMRI demonstrates a strong correlation with clinical progression in vegetative state patients. Each of the 5 VS patients with notable ROI activation had positive clinical outcomes until the study ended. Therefore,",2.8423167282822487e-07,0.20745859817108192,0.008306334102894372,0.02176111757738247,0.20003864529554383,0.016661878770468257,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
299,1.1,3,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Does mental imagery functional MRI predict recovery in patients who have consciousness disorders? Mental imagery fMRI exhibits high agreement with subsequent clinical outcomes in patients with vegetative states. All five VS patients with significant ROI activation showed favorable courses through the observation period. Consequently,",4.263475092423373e-07,0.3782135485180538,0.02032624851367419,0.03264167636607371,0.333570037920067,0.016661878770468257,0.0325944277371516,0.36396537720141087,0.0,4.263475092423373e-07,0.37156355643248284,0.0
299,1.1,4,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,Can functional MRI using mental imagery forecast recovery among patients with consciousness disorders? The mental imagery fMRI paradigm aligns closely with the clinical course in vegetative state patients. All five patients in VS showing marked activation in brain regions had positive outcomes by the observation's end. We thus,3.316036182995957e-07,0.2220434759653136,0.0277822108436037,0.025387970506946217,0.24259825971434035,0.016661878770468257,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
299,1.1,5,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Can mental imagery fMRI serve as a predictor of recovery in patients suffering from consciousness disorders? The mental imagery fMRI method corresponds well with the further clinical progression in vegetative state patients. All five VS patients exhibiting significant regional brain activation experienced favorable follow-ups during the observation window. Thus,",3.079176455639103e-07,0.22925670710946378,0.007460849785002541,0.023574544042164344,0.25058767919805547,0.004604661872253845,0.023540420032387266,0.2488960474166242,0.0,3.079176455639103e-07,0.25378052077609947,0.0
299,1.1,6,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Is mental imagery functional MRI effective in predicting recovery for patients with consciousness disorder? The fMRI mental imagery approach correlates strongly with clinical trajectories in vegetative state patients. All five patients in VS with meaningful ROI activation had beneficial outcomes until the observation finished. As such,",3.789755637709665e-07,0.2668395045585932,0.02683800768467291,0.029014823436509962,0.28705002228517307,0.016661878770468257,0.028972824655245866,0.31633732821215643,0.0,3.789755637709665e-07,0.32277339226305113,0.0
299,1.1,7,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Can mental imagery functional MRI predict outcomes in patients with disorders of consciousness? The mental imagery fMRI paradigm consistently reflects the clinical course of patients in vegetative states. Every one of the 5 VS patients with notable ROI activity had favorable progress up to the observation's conclusion. Accordingly,",3.316036182995957e-07,0.2515391006699921,0.00657961568385667,0.025387970506946217,0.24259825971434035,0.016661878770468257,0.025351221573340132,0.2708749541353992,0.0,3.316036182995957e-07,0.2762533766281572,0.0
299,1.1,8,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"May mental imagery functional MRI indicate recovery prospects in patients with consciousness disorders? The mental imagery fMRI paradigm exhibits high concordance with clinical developments in patients in a vegetative state. All five VS patients presenting significant brain region activation demonstrated positive courses throughout observation. Therefore,",4.026615365066519e-07,0.32151919910333593,0.003697277563423307,0.030828249901291835,0.3100395405098726,0.016661878770468257,0.030783626196198732,0.33986782562235085,0.0,4.026615365066519e-07,0.34687094384211115,0.0
299,1.1,9,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Using mental imagery functional MRI, can recovery be predicted in patients with consciousness disorders? The mental imagery fMRI framework shows strong agreement with clinical progression in patients diagnosed with vegetative states. Each of the five VS patients with prominent ROI activations had good further outcomes over the observation period. Hence,",2.8423167282822487e-07,0.23575031982659,0.01191533168947758,0.02176111757738247,0.20003864529554383,0.016661878770468257,0.0217296184914344,0.22738984219566083,0.0,2.8423167282822487e-07,0.23180161405732447,0.0
299,1.1,10,human,Question: Can mental imagery functional magnetic resonance imaging predict recovery in patients with disorders of consciousness? Answer: The fMRI paradigm mental imagery displays a high concordance with the further clinical course of patients in a VS. All 5 patients in a VS who showed significant activation of ROIs had a favorable further course until the end of the observation period. We therefore,"Is the mental imagery fMRI paradigm able to predict recovery in vegetative state patients with disorders of consciousness? It reveals a strong correlation with subsequent clinical outcomes in such patients. All 5 patients in VS showing significant ROI activations proceeded favorably to the observation end. Accordingly,",3.789755637709665e-07,0.23603296320037348,0.0490487514863258,0.029014823436509962,0.28705002228517307,0.016661878770468257,0.028972824655245866,0.31633732821215643,0.0,3.789755637709665e-07,0.32277339226305113,0.0
